data_1y3j_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1y3j _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.2 m . . . . . 0 C--O 1.236 0.393 0 N-CA-C 112.323 0.49 . . . . 3.48 112.323 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 22.9 t -113.19 178.08 4.4 Favored 'General case' 0 N--CA 1.463 0.18 0 C-N-CA 125.423 1.489 . . . . 3.48 108.149 177.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.39 159.28 37.5 Favored 'General case' 0 N--CA 1.46 0.052 0 CA-C-N 118.273 0.488 . . . . 5.4299999999999997 112.005 -176.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 53.6 t -138.77 154.12 48.49 Favored 'General case' 0 C--N 1.333 -0.144 0 N-CA-C 106.635 -1.617 . . . . 2.48 106.635 176.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 81.3 m-85 -98.75 154.37 18.04 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 107.405 -1.331 . . . . 4.2800000000000002 107.405 178.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 18.2 mt -148.66 132.16 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 N-CA-C 105.379 -2.082 . . . . 2.6400000000000001 105.379 -176.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 48.5 tp60 -100.86 126.13 47.44 Favored 'General case' 0 N--CA 1.432 -1.364 0 N-CA-C 105.553 -2.017 . . . . 3.8599999999999999 105.553 176.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 30.1 m -98.85 137.09 27.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 C-N-CA 124.087 0.955 . . . . 3.21 109.209 179.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 25.3 m -78.81 74.85 5.33 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 109.501 -0.555 . . . . 2.8399999999999999 109.501 179.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 117.81 77.32 0.59 Allowed Glycine 0 C--N 1.335 0.487 0 CA-C-O 124.513 2.174 . . . . 2.2400000000000002 110.485 173.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.9 -65.91 0.62 Allowed 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 110.024 -3.088 . . . . 5.1399999999999997 108.398 176.691 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.6 t -79.09 41.97 0.46 Allowed 'General case' 0 CA--C 1.54 0.586 0 O-C-N 121.3 -0.875 . . . . 5.5300000000000002 111.173 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 45.3 t -68.69 -43.9 75.12 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 107.115 -1.439 . . . . 2.7999999999999998 107.115 156.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 76.76 161.0 0.22 Allowed 'General case' 0 C--N 1.344 0.341 0 C-N-CA 126.688 1.995 . . . . 3.9500000000000002 110.104 -174.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 10.8 m 72.05 -53.38 0.69 Allowed 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 125.183 1.393 . . . . 3.46 112.039 -176.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 31.5 m -29.56 -54.65 0.15 Allowed 'General case' 0 C--O 1.223 -0.294 0 C-N-CA 127.278 2.231 . . . . 3.04 110.96 167.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 1.2 t -69.58 -36.37 70.62 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.048 0 N-CA-C 112.488 0.551 . . . . 4.3399999999999999 112.488 -174.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.27 -45.42 93.38 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 109.232 -0.655 . . . . 1.6699999999999999 109.232 173.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -57.54 -47.39 82.14 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 109.094 -0.706 . . . . 3.5099999999999998 109.094 173.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . 0.251 53.9 mt -64.16 -44.84 97.61 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 O-C-N 121.571 -0.706 . . . . 3.02 111.296 -172.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -47.76 -51.79 20.98 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 119.383 0.992 . . . . 3.25 111.755 165.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 8.4 mmt85 -57.75 -38.22 74.99 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 118.011 -0.995 . . . . 5.4199999999999999 112.714 176.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 71.2 m-20 -63.2 -55.74 22.49 Favored 'General case' 0 C--O 1.222 -0.35 0 CA-C-N 120.237 1.38 . . . . 3.1499999999999999 108.03 177.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 17.5 mt -77.14 -51.34 11.16 Favored 'General case' 0 N--CA 1.434 -1.229 0 C-N-CA 124.621 1.168 . . . . 4.3499999999999996 112.308 -159.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 3.1 ttm105 -65.44 -13.44 58.76 Favored 'General case' 0 N--CA 1.421 -1.915 0 O-C-N 121.499 -0.751 . . . . 8.9900000000000002 112.682 -173.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.1 mtp180 -42.15 -64.57 0.57 Allowed 'General case' 0 N--CA 1.448 -0.529 0 CA-C-O 118.369 -0.824 . . . . 8.9199999999999999 111.068 160.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 169.76 -176.66 0.03 OUTLIER 'General case' 0 C--N 1.344 0.366 0 CA-C-N 119.012 0.824 . . . . 7.3499999999999996 110.794 -156.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 84.82 53.46 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 127.314 2.246 . . . . 5.3600000000000003 109.747 178.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 72.44 14.58 77.27 Favored Glycine 0 CA--C 1.527 0.826 0 CA-C-O 118.466 -1.186 . . . . 1.3 114.668 168.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 1.1 mt -84.75 130.07 36.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 N-CA-C 107.091 -1.448 . . . . 2.6800000000000002 107.091 -178.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -137.57 43.03 2.31 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-O 122.734 1.254 . . . . 3.5499999999999998 111.223 160.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.5 t -170.21 147.63 3.16 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 128.858 2.863 . . . . 2.7400000000000002 105.187 134.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.6 pp -77.72 159.62 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 N-CA-C 108.141 -1.059 . . . . 2.96 108.141 176.109 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.5 pp -73.96 137.16 43.39 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 104.488 -2.412 . . . . 5.5499999999999998 104.488 158.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.1 t -160.46 150.85 5.52 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.104 0 N-CA-C 106.112 -1.81 . . . . 2.0600000000000001 106.112 123.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -158.73 53.54 0.42 Allowed 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 104.325 -2.472 . . . . 1.7 104.325 165.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.1 tt -66.11 -31.1 71.76 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 107.294 -1.373 . . . . 4.6100000000000003 107.294 -178.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 27.7 ttt -45.0 -41.95 7.86 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.108 1.363 . . . . 4.1200000000000001 111.875 170.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -85.76 -55.58 3.9 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 108.524 -0.917 . . . . 1.8300000000000001 108.524 171.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 143.17 43.98 0.05 OUTLIER Glycine 0 CA--C 1.523 0.553 0 C-N-CA 125.089 1.328 . . . . 0.81999999999999995 111.885 167.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 14.1 pttp -159.92 -179.3 7.69 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 118.078 0.939 . . . . 5.1399999999999997 108.9 -164.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -130.72 143.45 50.75 Favored 'General case' 0 N--CA 1.441 -0.877 0 C-N-CA 127.475 2.31 . . . . 1.73 108.953 -177.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -144.01 89.13 2.01 Favored 'General case' 0 C--N 1.341 0.238 0 C-N-CA 124.104 0.961 . . . . 3.8700000000000001 111.215 173.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 14.0 p -80.71 137.32 21.61 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.22 0 N-CA-C 108.901 -0.777 . . . . 2.9900000000000002 108.901 -176.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 70.8 ttt180 -106.58 126.75 52.67 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 107.655 -1.239 . . . . 6.0700000000000003 107.655 171.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 7.9 p90 -157.48 175.88 13.38 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 123.384 0.674 . . . . 3.54 109.844 -167.041 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 3.3 p30 -103.89 135.18 19.39 Favored Pre-proline 0 N--CA 1.451 -0.396 0 N-CA-C 107.752 -1.203 . . . . 3.2599999999999998 107.752 164.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -81.32 1.79 9.03 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 122.29 1.993 . . . . 2.5299999999999998 113.314 -174.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -91.87 -49.08 6.43 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-N 119.41 1.005 . . . . 2.0699999999999998 108.535 -167.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 24.4 t -58.78 -60.39 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.755 0 C-N-CA 124.354 1.062 . . . . 1.98 109.855 175.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 19.2 tt -93.56 -53.42 8.5 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.233 0 CA-C-O 118.855 -0.593 . . . . 2.96 112.258 -163.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 9.1 mm-40 101.16 129.72 0.02 OUTLIER Pre-proline 0 CA--C 1.541 0.598 0 C-N-CA 129.574 3.15 . . . . 3.3199999999999998 112.304 -175.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_exo -50.89 -48.95 18.53 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 124.787 3.658 . . . . 1.26 116.71 177.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -54.45 -50.55 13.06 Favored 'Trans proline' 0 N--CA 1.442 -1.514 0 CA-C-N 120.66 1.271 . . . . 1.24 108.873 169.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 64.1 mtt -63.03 -44.07 96.93 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 120.528 -0.469 . . . . 3.6299999999999999 110.708 -167.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 16.2 tt -61.76 -35.19 66.15 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.25 0 C-N-CA 119.61 -0.836 . . . . 3.1800000000000002 111.686 -175.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -69.93 -58.03 4.33 Favored 'General case' 0 N--CA 1.452 -0.325 0 O-C-N 122.33 -0.231 . . . . 2.3700000000000001 110.875 171.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -47.98 -49.29 31.15 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 125.613 1.565 . . . . 3.1699999999999999 111.861 -174.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 16.2 m-30 -44.18 -40.42 5.03 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.748 0.819 . . . . 4.7999999999999998 112.453 177.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 65.9 mt -65.16 -26.76 40.54 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 O-C-N 121.513 -0.742 . . . . 2.2400000000000002 110.66 -174.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 36.0 mtm180 -58.27 -61.21 2.74 Favored 'General case' 0 C--N 1.341 0.238 0 CA-C-N 118.939 0.791 . . . . 6.5599999999999996 109.642 174.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -60.59 -39.18 87.12 Favored 'General case' 0 N--CA 1.44 -0.974 0 C-N-CA 123.63 0.772 . . . . 4.5199999999999996 112.77 -166.081 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -98.36 -27.53 14.06 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 113.187 0.81 . . . . 3.2000000000000002 113.187 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -112.96 -82.14 1.14 Allowed Glycine 0 CA--C 1.526 0.743 0 CA-C-N 119.215 0.916 . . . . 3.3199999999999998 111.968 -172.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -177.05 164.94 2.32 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.562 1.145 . . . . 5.7800000000000002 109.605 -162.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -59.83 115.17 7.16 Favored Glycine 0 N--CA 1.439 -1.148 0 N-CA-C 109.601 -1.4 . . . . 1.74 109.601 -171.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -115.25 91.76 3.71 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 125.435 1.494 . . . . 1.75 109.068 -169.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -84.39 119.14 24.76 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 108.263 -1.014 . . . . 3.1400000000000001 108.263 -178.584 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 8.3 p -81.23 141.9 14.53 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 C-N-CA 123.265 0.626 . . . . 3.6499999999999999 109.584 -174.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 15.0 mt -139.79 99.06 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 C-N-CA 124.817 1.247 . . . . 2.8900000000000001 107.675 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 . . . . . 0 CA--C 1.535 0.369 0 O-C-N 121.462 -0.774 . . . . 6.3600000000000003 109.755 174.252 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.4 m . . . . . 0 CA--C 1.533 0.303 0 N-CA-C 112.549 0.574 . . . . 3.5299999999999998 112.549 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 26.1 m -149.04 176.23 10.63 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 126.106 1.762 . . . . 2.52 107.558 -176.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 39.2 pttt -125.18 158.16 34.66 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-N 119.173 0.897 . . . . 4.7000000000000002 109.108 154.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 36.6 t -142.3 152.44 42.98 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 107.275 -1.38 . . . . 2.0 107.275 175.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 54.3 m-85 -84.44 148.69 26.43 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 107.421 -1.325 . . . . 3.4300000000000002 107.421 176.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 5.6 mm -130.5 141.19 46.89 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.817 0 N-CA-C 104.61 -2.367 . . . . 3.0099999999999998 104.61 173.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -98.24 128.27 44.6 Favored 'General case' 0 N--CA 1.435 -1.189 0 N-CA-C 103.882 -2.636 . . . . 3.5899999999999999 103.882 166.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.4 p -126.41 122.53 61.4 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 C-N-CA 124.674 1.19 . . . . 3.6000000000000001 108.41 179.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.8 t -72.76 136.9 45.56 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 109.434 -0.58 . . . . 3.4500000000000002 109.434 -176.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 113.8 -52.19 0.66 Allowed Glycine 0 C--N 1.335 0.518 0 N-CA-C 108.146 -1.981 . . . . 2.8500000000000001 108.146 177.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 59.9 mtt 75.94 -69.96 0.15 Allowed 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 126.197 1.799 . . . . 5.1600000000000001 110.314 158.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 11.8 t -112.13 11.74 20.4 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 125.907 1.683 . . . . 5.0099999999999998 109.957 174.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.436 ' SG ' ' HB2' ' A' ' 17' ' ' CYS 0.267 17.2 p -63.14 144.64 56.74 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 119.017 0.826 . . . . 3.25 109.436 -176.212 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -52.61 109.9 0.45 Allowed 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 116.212 -0.449 . . . . 3.7999999999999998 111.98 -158.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.7 m 69.23 6.72 5.83 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 125.355 1.462 . . . . 3.3900000000000001 113.873 175.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.436 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 48.8 t -43.99 -49.06 8.75 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 123.765 1.745 . . . . 3.79 108.607 163.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -72.67 -46.64 53.55 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.521 0 CA-C-N 112.199 -2.273 . . . . 3.8900000000000001 109.856 -172.182 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.67 -42.06 87.58 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 110.212 -0.292 . . . . 2.2999999999999998 110.212 175.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -60.03 -60.44 3.83 Favored 'General case' 0 CA--C 1.521 -0.163 0 C-N-CA 124.571 1.148 . . . . 2.5600000000000001 108.455 178.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.7 mt -43.69 -54.72 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 C-N-CA 123.801 0.84 . . . . 2.7599999999999998 111.314 173.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -54.65 -50.05 69.11 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 119.702 1.137 . . . . 3.9199999999999999 111.517 176.102 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.94 -48.93 51.65 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.592 0.757 . . . . 5.4000000000000004 112.095 176.458 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -76.28 -60.39 2.36 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 118.139 0.427 . . . . 3.5699999999999998 111.766 -177.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.57 -36.77 73.8 Favored 'General case' 0 C--O 1.22 -0.47 0 C-N-CA 125.756 1.623 . . . . 4.3600000000000003 112.595 -152.679 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -21.5 -74.61 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 128.616 2.766 . . . . 8.8699999999999992 114.722 -158.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . 0.287 7.9 ptp180 -91.9 -29.9 16.43 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 127.339 2.255 . . . . 14.07 116.286 166.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 41.8 mm-40 -81.05 128.4 33.67 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 114.855 -1.066 . . . . 6.7999999999999998 108.868 -134.299 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 60.0 55.84 3.63 Favored 'General case' 0 N--CA 1.442 -0.825 0 CA-C-O 122.856 1.312 . . . . 5.0899999999999999 111.189 -171.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 76.16 30.87 56.52 Favored Glycine 0 CA--C 1.523 0.566 0 CA-C-N 114.006 -1.452 . . . . 1.53 112.742 162.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.6 mt -96.03 147.44 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 N-CA-C 108.322 -0.992 . . . . 2.98 108.322 171.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -147.88 47.03 1.09 Allowed 'General case' 0 C--O 1.233 0.22 0 CA-C-O 122.309 1.052 . . . . 3.6800000000000002 111.815 158.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 10.3 t -165.83 148.0 7.28 Favored 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 126.995 2.118 . . . . 2.9500000000000002 107.252 148.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.5 pp -82.4 134.35 27.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 CA-C-O 122.666 1.222 . . . . 3.27 110.375 175.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -79.79 64.05 4.53 Favored 'General case' 0 N--CA 1.433 -1.295 0 C-N-CA 127.687 2.395 . . . . 5.7400000000000002 111.624 -173.315 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 52.8 t -133.52 131.43 57.31 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 O-C-N 120.721 -1.237 . . . . 1.9399999999999999 113.131 174.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -138.8 76.23 1.56 Allowed 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 105.217 -2.142 . . . . 2.1200000000000001 105.217 152.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -54.54 -39.78 68.01 Favored 'General case' 0 CA--C 1.511 -0.526 0 N-CA-C 109.595 -0.52 . . . . 4.1900000000000004 109.595 175.138 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 24.0 ttt -85.06 44.22 1.06 Allowed 'General case' 0 N--CA 1.442 -0.836 0 CA-C-O 121.767 0.794 . . . . 5.9100000000000001 109.1 -164.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -179.33 -36.71 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 129.013 2.925 . . . . 2.3100000000000001 107.076 -167.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 106.11 46.72 1.14 Allowed Glycine 0 C--N 1.336 0.569 0 C-N-CA 126.062 1.791 . . . . 0.92000000000000004 108.983 157.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 24.8 mttm -155.27 175.14 14.24 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 108.392 -0.966 . . . . 5.4800000000000004 108.392 -157.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -144.2 142.6 30.61 Favored 'General case' 0 N--CA 1.44 -0.967 0 C-N-CA 125.315 1.446 . . . . 1.9099999999999999 107.978 -178.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -132.99 97.37 4.0 Favored 'General case' 0 C--N 1.338 0.103 0 N-CA-C 113.379 0.881 . . . . 3.27 113.379 171.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.3 p -81.11 114.96 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.518 0 N-CA-C 107.423 -1.325 . . . . 2.8799999999999999 107.423 -178.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 54.5 ttp180 -87.36 124.78 33.75 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 105.71 -1.959 . . . . 6.3399999999999999 105.71 163.114 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -158.22 170.72 21.62 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 122.96 0.504 . . . . 3.4900000000000002 110.6 -164.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 47.5 t-20 -108.53 88.26 4.97 Favored Pre-proline 0 N--CA 1.451 -0.421 0 C-N-CA 124.038 0.935 . . . . 2.6600000000000001 109.346 173.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -61.79 88.23 0.1 Allowed 'Trans proline' 0 N--CA 1.448 -1.163 0 C-N-CA 122.328 2.019 . . . . 1.6000000000000001 108.973 165.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -169.97 -57.56 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 130.423 3.489 . . . . 1.99 105.101 169.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 65.7 t -58.45 -54.37 33.95 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 C-N-CA 124.879 1.272 . . . . 1.97 110.207 175.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 8.4 tp -93.61 -73.02 0.48 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.364 0 CA-C-O 118.725 -0.655 . . . . 3.1600000000000001 111.93 -167.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 117.17 134.99 0.0 OUTLIER Pre-proline 0 N--CA 1.472 0.626 0 C-N-CA 130.753 3.621 . . . . 3.52 108.185 -176.365 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -50.24 -50.86 12.24 Favored 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 123.595 2.863 . . . . 1.1299999999999999 114.449 172.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -50.07 -54.31 5.66 Favored 'Trans proline' 0 N--CA 1.444 -1.39 0 CA-C-N 120.451 1.197 . . . . 0.95999999999999996 110.069 167.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 62.0 mtt -62.45 -37.61 86.57 Favored 'General case' 0 C--N 1.342 0.261 0 C-N-CA 118.336 -1.346 . . . . 3.02 111.469 -170.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 3.5 tt -70.37 -45.23 75.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-N 118.808 0.731 . . . . 3.0299999999999998 110.312 178.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -58.8 -32.85 69.72 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.102 0.561 . . . . 1.8899999999999999 112.254 176.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -71.78 -60.13 2.39 Favored 'General case' 0 N--CA 1.441 -0.895 0 C-N-CA 126.388 1.875 . . . . 3.5600000000000001 111.585 176.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -41.63 -45.32 3.35 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.79 0.836 . . . . 4.8700000000000001 111.791 -173.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 49.7 mt -57.39 -52.48 56.31 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 C-N-CA 123.88 0.872 . . . . 2.1699999999999999 110.923 -177.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 1.3 ptt85 -71.5 -49.68 38.73 Favored 'General case' 0 CA--C 1.521 -0.139 0 N-CA-C 109.596 -0.52 . . . . 4.6399999999999997 109.596 -177.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -59.61 -34.51 72.84 Favored 'General case' 0 N--CA 1.441 -0.896 0 C-N-CA 123.387 0.675 . . . . 6.3899999999999997 111.627 -173.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 86.1 mt -83.0 -47.89 11.23 Favored 'General case' 0 C--N 1.34 0.194 0 CA-C-N 118.754 0.706 . . . . 4.0499999999999998 111.446 170.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -95.98 -92.27 1.78 Allowed Glycine 0 CA--C 1.526 0.773 0 N-CA-C 111.692 -0.563 . . . . 2.7400000000000002 111.692 -174.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -135.53 -72.13 0.47 Allowed 'General case' 0 CA--C 1.513 -0.469 0 CA-C-O 121.679 0.752 . . . . 4.5599999999999996 112.962 -153.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 173.73 119.23 0.53 Allowed Glycine 0 N--CA 1.441 -1.028 0 N-CA-C 107.935 -2.066 . . . . 1.5700000000000001 107.935 -156.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -156.5 161.41 40.02 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 122.904 0.482 . . . . 1.76 110.996 -173.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 26.2 m -153.94 148.57 26.34 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 124.031 0.932 . . . . 3.8799999999999999 108.599 178.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 14.3 p -82.3 143.75 11.52 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 123.624 0.77 . . . . 3.6400000000000001 109.74 -177.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 22.5 mm -133.13 140.16 47.76 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 C-N-CA 125.774 1.629 . . . . 3.1099999999999999 107.528 -178.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 . . . . . 0 N--CA 1.453 -0.322 0 C-N-CA 123.741 0.817 . . . . 4.9400000000000004 109.108 179.045 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.4 m . . . . . 0 N--CA 1.454 -0.236 0 N-CA-C 108.605 -0.887 . . . . 3.02 108.605 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 23.0 t -141.93 169.56 17.37 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 108.956 -0.757 . . . . 3.6200000000000001 108.956 171.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 71.9 tttt -104.72 158.33 16.58 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.309 1.443 . . . . 4.4900000000000002 107.211 163.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 36.3 t -155.55 155.09 32.75 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 109.046 -0.724 . . . . 2.21 109.046 167.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 5.1 m-30 -106.45 135.01 48.7 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 125.848 1.659 . . . . 3.6899999999999999 108.771 -178.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.3 mm -129.06 139.75 51.05 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 N-CA-C 105.463 -2.051 . . . . 3.46 105.463 -173.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 51.3 tp60 -112.2 122.93 49.12 Favored 'General case' 0 N--CA 1.424 -1.728 0 N-CA-C 104.693 -2.336 . . . . 3.7000000000000002 104.693 -179.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 15.7 m -105.3 173.08 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 C-N-CA 124.378 1.071 . . . . 3.5699999999999998 108.687 178.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -134.42 88.73 2.48 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.562 0.745 . . . . 3.73 111.045 -173.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 154.9 -62.81 0.35 Allowed Glycine 0 CA--C 1.524 0.619 0 N-CA-C 107.667 -2.173 . . . . 3.7999999999999998 107.667 174.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 1.9 mtt 66.38 -71.71 0.09 Allowed 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 126.691 1.997 . . . . 4.46 111.213 170.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 33.1 p -79.47 52.85 1.44 Allowed 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 124.42 1.088 . . . . 5.7300000000000004 108.496 176.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 55.8 m -92.42 176.29 6.52 Favored 'General case' 0 N--CA 1.445 -0.725 0 C-N-CA 124.794 1.238 . . . . 2.7599999999999998 107.895 175.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -75.64 73.42 2.63 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 121.454 0.645 . . . . 4.29 110.097 166.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.5 m 74.94 26.99 1.22 Allowed 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 115.24 -0.891 . . . . 3.1400000000000001 113.129 159.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 69.9 m -44.27 -43.25 7.21 Favored 'General case' 0 CA--C 1.523 -0.075 0 C-N-CA 124.357 1.063 . . . . 3.0800000000000001 108.912 157.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 24.5 m -63.53 -50.97 76.14 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.001 0 CA-C-N 114.138 -1.392 . . . . 3.6299999999999999 109.993 -177.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -52.73 -43.82 65.97 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 122.994 0.518 . . . . 2.5899999999999999 110.972 172.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -56.53 -50.77 70.88 Favored 'General case' 0 C--O 1.227 -0.123 0 N-CA-C 109.303 -0.628 . . . . 2.4700000000000002 109.303 174.508 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 7.1 mt -58.44 -60.73 1.91 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 C-N-CA 123.541 0.736 . . . . 3.0600000000000001 109.039 -179.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -39.61 -54.92 1.95 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.942 1.297 . . . . 3.6299999999999999 112.259 172.02 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -59.83 -44.63 93.95 Favored 'General case' 0 CA--C 1.528 0.133 0 O-C-N 121.666 -0.646 . . . . 6.8099999999999996 112.422 178.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -56.83 -55.87 28.83 Favored 'General case' 0 C--O 1.226 -0.153 0 N-CA-C 108.4 -0.963 . . . . 3.0899999999999999 108.4 179.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -74.84 -23.95 58.52 Favored 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 114.369 1.248 . . . . 3.2599999999999998 114.369 -172.325 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.55 -15.33 62.6 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 120.583 1.538 . . . . 7.2400000000000002 114.802 -170.122 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 73.7 mtt180 -65.79 -19.55 65.93 Favored 'General case' 0 N--CA 1.462 0.142 0 N-CA-C 113.333 0.864 . . . . 8.2200000000000006 113.333 -157.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 71.25 23.25 4.09 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 125.08 1.352 . . . . 10.470000000000001 112.446 -172.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -76.46 59.3 1.44 Allowed 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 127.56 2.344 . . . . 5.6399999999999997 108.766 171.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 75.51 32.91 53.9 Favored Glycine 0 CA--C 1.535 1.311 0 C-N-CA 124.261 0.934 . . . . 1.53 113.641 -178.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -142.27 135.66 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 C-N-CA 127.212 2.205 . . . . 4.2199999999999998 105.665 -170.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 41.2 m-85 -145.29 48.13 1.28 Allowed 'General case' 0 C--O 1.233 0.195 0 CA-C-O 123.155 1.455 . . . . 3.6800000000000002 111.702 171.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 14.0 t -164.84 -178.64 5.35 Favored 'General case' 0 C--N 1.317 -0.841 0 C-N-CA 129.875 3.27 . . . . 2.4100000000000001 106.135 151.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -125.2 127.49 72.16 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 C-N-CA 124.474 1.11 . . . . 3.52 109.42 174.243 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -78.35 71.0 4.79 Favored 'General case' 0 N--CA 1.439 -0.993 0 O-C-N 121.099 -1.001 . . . . 5.5099999999999998 110.85 -176.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 18.7 t -123.9 139.83 49.19 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.885 0 CA-C-O 122.183 0.992 . . . . 1.9299999999999999 109.414 159.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -155.62 58.95 0.62 Allowed 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 126.418 1.887 . . . . 1.77 107.139 168.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.2 pp -56.86 -32.14 65.51 Favored 'General case' 0 CA--C 1.51 -0.566 0 C-N-CA 123.45 0.7 . . . . 4.1699999999999999 112.474 -175.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 65.1 mtt -65.53 -40.44 92.94 Favored 'General case' 0 N--CA 1.441 -0.898 0 C-N-CA 119.761 -0.775 . . . . 5.5300000000000002 108.913 -165.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -76.84 -42.22 41.09 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.721 0.808 . . . . 2.25 109.842 167.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 111.88 57.16 0.46 Allowed Glycine 0 C--N 1.338 0.652 0 N-CA-C 109.426 -1.469 . . . . 1.02 109.426 176.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -160.24 -178.37 6.91 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 107.002 -1.481 . . . . 5.3899999999999997 107.002 -169.149 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -146.35 130.1 17.09 Favored 'General case' 0 N--CA 1.434 -1.259 0 C-N-CA 126.334 1.854 . . . . 2.0 106.001 -172.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -135.94 114.36 11.69 Favored 'General case' 0 C--N 1.342 0.261 0 CA-C-N 120.926 1.693 . . . . 2.5099999999999998 113.277 177.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.2 p -90.12 150.18 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.273 0 C-N-CA 125.02 1.328 . . . . 2.3700000000000001 110.17 -171.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 35.4 ttm180 -125.75 131.02 52.6 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 104.863 -2.273 . . . . 4.9900000000000002 104.863 159.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 3.8 p90 -160.18 169.73 22.66 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-N 118.219 0.463 . . . . 3.6200000000000001 111.569 -165.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . 0.271 49.1 p30 -104.3 97.18 11.24 Favored Pre-proline 0 CA--C 1.542 0.671 0 N-CA-C 113.234 0.827 . . . . 3.9900000000000002 113.234 170.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -72.51 73.19 2.86 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 122.526 2.15 . . . . 1.46 111.331 177.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -150.27 -57.39 0.18 Allowed 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 126.548 1.939 . . . . 2.2999999999999998 106.041 171.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 78.6 t -58.62 -54.6 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.787 0 C-N-CA 123.778 0.831 . . . . 2.29 109.299 171.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.43 ' CG2' ' H ' ' A' ' 53' ' ' GLN 0.265 2.5 tp -90.54 -72.97 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-O 118.306 -0.854 . . . . 2.8100000000000001 112.103 -165.613 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.43 ' H ' ' CG2' ' A' ' 52' ' ' ILE . 0.0 OUTLIER 112.98 136.66 0.0 OUTLIER Pre-proline 0 N--CA 1.476 0.87 0 C-N-CA 131.122 3.769 . . . . 3.7599999999999998 108.653 -177.48 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -51.03 -51.13 11.85 Favored 'Trans proline' 0 CA--C 1.534 0.503 0 C-N-CA 124.054 3.17 . . . . 1.23 115.345 174.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -53.8 -48.83 19.64 Favored 'Trans proline' 0 N--CA 1.444 -1.409 0 CA-C-N 120.448 1.196 . . . . 0.89000000000000001 110.282 167.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 74.5 mtp -69.13 -33.16 73.01 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 118.301 -1.359 . . . . 3.21 110.65 -168.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 6.9 tt -66.42 -50.95 63.26 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 CA-C-N 119.935 1.243 . . . . 3.29 110.324 179.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -51.65 -53.97 33.07 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.09 0.956 . . . . 1.97 110.814 176.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 54.4 mm-40 -65.31 -38.08 89.09 Favored 'General case' 0 N--CA 1.429 -1.509 0 CA-C-O 118.866 -0.588 . . . . 3.5299999999999998 111.999 -177.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -54.54 -34.25 61.47 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 120.192 1.36 . . . . 5.7599999999999998 111.207 173.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.6 mm -60.47 -53.28 51.0 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 N-CA-C 107.746 -1.205 . . . . 3.5299999999999998 107.746 172.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 15.7 mtp-105 -55.58 -47.73 75.97 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 125.161 1.384 . . . . 7.6100000000000003 114.301 -177.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -45.92 -35.38 4.57 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 127.023 2.129 . . . . 3.1400000000000001 112.933 -175.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 58.8 mt -79.11 -16.39 56.78 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 122.93 0.492 . . . . 3.1699999999999999 111.196 -174.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 130.93 50.06 0.11 Allowed Glycine 0 CA--C 1.527 0.805 0 C-N-CA 125.182 1.372 . . . . 3.6000000000000001 111.168 170.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -136.39 169.62 17.38 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-O 123.519 1.628 . . . . 4.6399999999999997 113.673 -168.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -115.18 126.89 7.39 Favored Glycine 0 N--CA 1.442 -0.957 0 N-CA-C 105.949 -2.861 . . . . 1.76 105.949 168.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -153.24 81.52 1.19 Allowed 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 124.533 1.133 . . . . 2.1699999999999999 108.3 -172.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -84.8 138.04 32.83 Favored 'General case' 0 C--O 1.225 -0.227 0 C-N-CA 123.704 0.802 . . . . 2.8900000000000001 108.882 -175.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 97.0 t -84.89 109.19 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 N-CA-C 108.552 -0.907 . . . . 2.9300000000000002 108.552 -177.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 18.9 mm -130.8 60.15 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 C-N-CA 125.156 1.383 . . . . 3.8999999999999999 109.002 -171.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 . . . . . 0 C--N 1.328 -0.356 0 CA-C-N 115.397 -0.819 . . . . 3.75 109.478 155.086 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 88.4 p . . . . . 0 CA--C 1.531 0.236 0 N-CA-C 106.999 -1.482 . . . . 2.96 106.999 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 18.6 m -155.34 153.98 31.34 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 124.902 1.281 . . . . 2.8599999999999999 108.022 177.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 9.3 mtmp? -91.82 161.01 15.03 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 123.33 0.652 . . . . 4.1200000000000001 111.937 176.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 49.3 t -155.25 157.71 37.71 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 105.974 -1.861 . . . . 2.1000000000000001 105.974 166.12 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -98.34 146.4 25.72 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 119.804 1.184 . . . . 4.8700000000000001 108.007 171.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 12.0 mm -128.16 113.42 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 N-CA-C 105.138 -2.171 . . . . 3.0299999999999998 105.138 174.01 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 16.6 tp60 -82.38 124.49 30.06 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 104.825 -2.287 . . . . 3.6800000000000002 104.825 172.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.5 p -117.72 99.02 7.3 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-O 122.175 0.988 . . . . 3.5699999999999998 110.597 -169.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 7.0 m -67.03 94.3 0.33 Allowed 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 109.155 -0.683 . . . . 3.27 109.155 -179.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 135.24 3.94 2.67 Favored Glycine 0 C--O 1.221 -0.705 0 C-N-CA 125.124 1.345 . . . . 2.54 113.047 -175.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -43.98 -46.89 8.49 Favored 'General case' 0 C--N 1.321 -0.647 0 O-C-N 121.561 -0.964 . . . . 4.0300000000000002 110.612 162.277 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 15.3 t -74.43 12.13 0.84 Allowed 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.192 0.997 . . . . 6.7400000000000002 112.887 176.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 16.9 t -57.4 -41.77 80.95 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 107.011 -1.477 . . . . 2.8599999999999999 107.011 160.145 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 84.27 145.3 0.07 Allowed 'General case' 0 C--N 1.348 0.52 0 C-N-CA 127.934 2.494 . . . . 4.3799999999999999 110.138 -175.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.6 m 71.49 -30.91 0.22 Allowed 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 115.083 1.512 . . . . 3.3100000000000001 115.083 174.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 11.0 m -62.83 -18.21 62.49 Favored 'General case' 0 CA--C 1.517 -0.294 0 C-N-CA 128.825 2.85 . . . . 3.5299999999999998 111.821 -175.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 14.0 m -41.12 -43.78 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 N-CA-C 112.162 0.431 . . . . 3.27 112.162 159.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -52.77 -46.36 67.52 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.088 0.955 . . . . 2.3799999999999999 111.547 173.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -59.19 -51.98 67.65 Favored 'General case' 0 C--O 1.224 -0.249 0 N-CA-C 108.671 -0.863 . . . . 2.2200000000000002 108.671 175.353 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 38.4 mm -53.54 -59.39 1.91 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 C-N-CA 123.601 0.76 . . . . 3.1800000000000002 109.123 -179.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -42.54 -61.07 1.31 Allowed 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.057 1.343 . . . . 3.3999999999999999 110.977 175.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.93 -48.93 78.21 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 119.369 -0.348 . . . . 8.7100000000000009 110.933 -175.231 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -49.86 -60.32 3.02 Favored 'General case' 0 CA--C 1.519 -0.228 0 C-N-CA 123.989 0.916 . . . . 3.29 108.839 -179.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -70.57 -32.14 69.44 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 115.623 -0.717 . . . . 3.0 109.499 -170.397 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . 0.578 68.6 mtp180 -63.0 3.17 0.25 Allowed 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 117.827 2.529 . . . . 7.0800000000000001 117.827 163.217 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 3.5 mmt85 -43.58 -34.09 1.32 Allowed 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 116.914 -1.914 . . . . 8.7899999999999991 112.233 146.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . 0.25 4.2 mt-10 78.86 33.15 0.26 Allowed 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 127.191 2.196 . . . . 8.8100000000000005 112.135 176.436 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 80.1 mt-10 -73.55 69.62 1.25 Allowed 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 127.101 2.161 . . . . 5.9299999999999997 110.436 179.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 67.15 28.43 73.74 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 123.453 0.549 . . . . 1.3899999999999999 111.932 -179.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.0 mm -98.3 140.12 18.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 C-N-CA 128.416 2.686 . . . . 3.3799999999999999 109.208 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -148.47 42.51 0.99 Allowed 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 122.404 1.097 . . . . 4.79 113.12 163.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 33.6 t -166.87 149.41 6.4 Favored 'General case' 0 C--N 1.317 -0.805 0 C-N-CA 131.01 3.724 . . . . 3.21 104.828 144.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.7 pp -83.45 151.73 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 N-CA-C 108.157 -1.053 . . . . 2.6699999999999999 108.157 163.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -87.22 78.55 8.8 Favored 'General case' 0 N--CA 1.436 -1.138 0 C-N-CA 127.185 2.194 . . . . 5.4699999999999998 110.939 178.005 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 24.5 t -134.99 137.51 50.5 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 CA-C-O 121.368 0.604 . . . . 1.98 110.145 165.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -155.92 58.47 0.6 Allowed 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 113.912 -1.494 . . . . 1.97 107.397 164.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -63.61 -28.6 70.03 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.058 0.943 . . . . 4.3499999999999996 110.39 -173.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 63.3 mtt -46.37 -41.34 13.4 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.311 0.644 . . . . 5.54 111.666 170.027 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -88.68 -41.52 12.55 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 122.769 0.428 . . . . 2.4700000000000002 109.95 172.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 113.18 53.2 0.47 Allowed Glycine 0 C--N 1.335 0.488 0 N-CA-C 108.607 -1.797 . . . . 1.04 108.607 179.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 37.6 mtmt -151.71 175.41 12.42 Favored 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 108.293 -1.003 . . . . 4.4699999999999998 108.293 -164.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -148.0 119.25 7.8 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 105.646 -1.983 . . . . 1.8899999999999999 105.646 -174.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -128.24 96.94 4.59 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 123.553 0.741 . . . . 3.2599999999999998 111.433 -171.34 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 10.7 p -81.62 147.93 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.285 0 C-N-CA 123.226 0.61 . . . . 2.3399999999999999 109.362 -170.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 21.5 ttt-85 -123.13 127.76 49.14 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 105.774 -1.936 . . . . 6.9199999999999999 105.774 156.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 3.8 p90 -157.88 175.04 14.37 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 108.426 -0.953 . . . . 3.3999999999999999 108.426 -169.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -109.12 104.3 54.67 Favored Pre-proline 0 CA--C 1.537 0.467 0 CA-C-O 118.579 -0.724 . . . . 3.9500000000000002 111.647 176.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -70.78 76.61 1.52 Allowed 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 123.257 2.638 . . . . 1.5700000000000001 111.571 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -165.53 -46.97 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 126.524 1.929 . . . . 2.2599999999999998 107.224 167.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 99.2 t -62.71 -45.54 98.57 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.885 0 C-N-CA 125.148 1.379 . . . . 2.2000000000000002 110.056 177.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . 0.273 6.0 tp -113.17 -73.32 0.63 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.303 0 CA-C-O 118.16 -0.924 . . . . 3.1299999999999999 112.187 -167.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 27.8 mm100 110.86 131.93 0.0 OUTLIER Pre-proline 0 CA--C 1.54 0.588 0 C-N-CA 129.424 3.09 . . . . 4.0 111.757 174.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -44.86 -53.68 4.93 Favored 'Trans proline' 0 CA--C 1.534 0.516 0 C-N-CA 125.23 3.954 . . . . 1.4199999999999999 116.427 176.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_endo -53.04 -47.29 28.34 Favored 'Trans proline' 0 N--CA 1.447 -1.222 0 CA-C-N 120.825 1.33 . . . . 1.0900000000000001 110.022 172.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 64.7 mtt -62.4 -46.41 88.71 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 118.181 -0.914 . . . . 3.21 111.41 -177.079 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 18.0 pt -61.93 -45.08 99.49 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-N 120.616 1.553 . . . . 3.52 111.318 176.094 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -53.93 -52.65 59.91 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 121.195 0.521 . . . . 2.1699999999999999 110.443 179.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 62.1 mm-40 -61.43 -48.49 80.95 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-O 118.359 -0.829 . . . . 3.5899999999999999 111.853 177.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -47.25 -42.44 20.57 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 119.659 1.118 . . . . 5.1299999999999999 111.385 176.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 54.8 mt -67.05 -40.2 84.96 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 O-C-N 122.037 -0.414 . . . . 1.9299999999999999 110.186 178.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 54.6 mtt180 -64.74 -50.62 66.15 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.647 0.779 . . . . 5.3399999999999999 111.934 177.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -43.66 -55.13 4.55 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 126.462 1.905 . . . . 2.9399999999999999 111.674 -175.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.38 -31.04 12.58 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 113.043 0.757 . . . . 3.0 113.043 -179.523 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -114.9 -85.67 1.31 Allowed Glycine 0 CA--C 1.528 0.891 0 CA-C-N 119.148 0.885 . . . . 3.0099999999999998 113.911 -165.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -147.81 156.03 42.29 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 113.558 0.948 . . . . 4.2300000000000004 113.558 -146.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -70.03 82.3 0.33 Allowed Glycine 0 N--CA 1.444 -0.786 0 CA-C-N 114.629 -1.169 . . . . 1.5 111.112 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -82.72 144.42 30.22 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 125.229 1.412 . . . . 1.76 109.655 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.6 t -142.92 139.97 30.96 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 106.007 -1.849 . . . . 2.96 106.007 165.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.6 m -83.67 145.63 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 N-CA-C 109.586 -0.524 . . . . 3.6499999999999999 109.586 -176.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 14.9 mm -141.27 147.73 22.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 C-N-CA 126.064 1.746 . . . . 3.3999999999999999 107.309 -177.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 . . . . . 0 CA--C 1.531 0.244 0 C-N-CA 126.351 1.86 . . . . 3.7999999999999998 106.355 168.152 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.0 m . . . . . 0 N--CA 1.451 -0.393 0 N-CA-C 108.142 -1.058 . . . . 2.8300000000000001 108.142 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.1 m -109.18 144.02 37.82 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 126.247 1.819 . . . . 2.7799999999999998 108.116 -176.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 35.5 tttt -95.54 164.02 12.97 Favored 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 123.37 0.668 . . . . 5.6399999999999997 110.611 -178.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 7.8 p -153.99 174.31 14.83 Favored 'General case' 0 C--O 1.232 0.16 0 N-CA-C 109.141 -0.689 . . . . 2.6400000000000001 109.141 156.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -122.54 142.11 50.95 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 125.348 1.459 . . . . 4.0300000000000002 108.296 -175.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 10.9 mt -146.0 132.61 14.25 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 N-CA-C 106.812 -1.551 . . . . 2.3300000000000001 106.812 -167.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 12.5 tp60 -84.2 125.35 32.11 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 105.508 -2.034 . . . . 4.3600000000000003 105.508 165.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 6.7 p -110.37 101.98 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 C-N-CA 124.341 1.057 . . . . 3.1499999999999999 108.336 177.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 21.0 m -71.69 80.79 0.85 Allowed 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 108.974 -0.751 . . . . 3.0099999999999998 108.974 176.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -171.19 -52.59 0.04 OUTLIER Glycine 0 CA--C 1.53 1.012 0 C-N-CA 129.02 3.2 . . . . 2.29 106.977 172.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 63.8 mtt 62.92 -66.38 0.09 Allowed 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 127.489 2.315 . . . . 4.6600000000000001 112.319 175.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 14.6 t -151.72 53.38 0.83 Allowed 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.036 1.334 . . . . 5.5300000000000002 107.751 173.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.0 p -43.7 -50.29 7.6 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.586 1.154 . . . . 3.1000000000000001 109.784 173.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -172.52 93.99 0.13 Allowed 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 126.748 2.019 . . . . 4.3899999999999997 106.87 156.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.7 m 59.11 42.48 18.83 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 121.562 0.696 . . . . 3.1299999999999999 110.548 -173.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 6.9 t -43.34 -41.99 4.33 Favored 'General case' 0 N--CA 1.461 0.109 0 C-N-CA 126.766 2.026 . . . . 4.0300000000000002 108.192 166.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 4.9 m -66.99 -53.32 35.1 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.972 0 C-N-CA 125.532 1.533 . . . . 3.0299999999999998 110.935 -173.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -50.78 -47.85 59.55 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.136 0.975 . . . . 1.6899999999999999 109.493 171.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -55.43 -53.29 58.05 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 108.927 -0.768 . . . . 2.4100000000000001 108.927 177.504 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.1 mp -53.69 -54.94 15.98 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 C-N-CA 124.469 1.108 . . . . 3.3999999999999999 110.386 178.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -48.91 -60.3 2.87 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 119.429 1.013 . . . . 2.96 109.541 -178.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 8.8 mpt_? -60.6 -38.65 85.4 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 115.131 -0.94 . . . . 7.71 110.71 -176.059 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -62.24 -60.13 4.03 Favored 'General case' 0 C--O 1.227 -0.088 0 C-N-CA 122.686 0.394 . . . . 3.5099999999999998 110.208 177.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -75.87 -64.6 1.05 Allowed 'General case' 0 N--CA 1.437 -1.11 0 CA-C-N 116.732 -0.213 . . . . 2.98 110.552 -159.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.53 -15.25 0.63 Allowed 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 115.665 1.728 . . . . 7.3300000000000001 115.665 -162.435 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -31.25 -59.02 0.24 Allowed 'General case' 0 N--CA 1.439 -0.99 0 C-N-CA 126.361 1.864 . . . . 7.7699999999999996 109.805 -175.077 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . 0.313 0.0 OUTLIER -167.15 -108.52 0.01 OUTLIER 'General case' 0 N--CA 1.447 -0.616 0 O-C-N 125.043 1.464 . . . . 7.3399999999999999 108.027 -171.113 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 44.48 31.16 0.57 Allowed 'General case' 0 C--N 1.314 -0.966 0 C-N-CA 127.256 2.222 . . . . 4.9000000000000004 114.628 156.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 60.21 31.09 72.27 Favored Glycine 0 CA--C 1.53 1.008 0 CA-C-O 118.483 -1.176 . . . . 1.29 113.537 -178.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 1.4 mp -78.43 139.31 18.69 Favored 'Isoleucine or valine' 0 C--N 1.34 0.167 0 CA-C-N 119.196 1.498 . . . . 3.7999999999999998 107.529 169.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -148.22 36.45 0.83 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 120.382 -0.527 . . . . 6.8799999999999999 112.275 158.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 34.0 t -169.36 143.64 2.91 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 130.117 3.367 . . . . 3.1499999999999999 104.32 139.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.7 pp -82.09 147.16 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 CA-C-N 119.683 1.129 . . . . 2.6400000000000001 109.06 172.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -79.41 80.39 5.78 Favored 'General case' 0 N--CA 1.44 -0.948 0 C-N-CA 125.77 1.628 . . . . 5.3700000000000001 111.384 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 85.6 t -130.64 138.9 52.57 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.121 0 CA-C-O 121.499 0.666 . . . . 2.2000000000000002 109.252 162.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -153.73 57.02 0.74 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 113.666 -1.607 . . . . 1.74 107.364 165.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -73.01 -15.58 61.52 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 114.913 -1.04 . . . . 4.0199999999999996 111.623 -172.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 93.7 mtp -49.43 -35.94 20.79 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 121.485 -0.76 . . . . 4.4699999999999998 110.885 162.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -95.39 -46.82 6.55 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.391 0.676 . . . . 1.98 110.483 170.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 111.25 63.56 0.49 Allowed Glycine 0 C--N 1.339 0.722 0 N-CA-C 107.809 -2.117 . . . . 1.1799999999999999 107.809 -171.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 4.4 pttt -160.82 175.4 12.61 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 118.279 1.04 . . . . 5.2000000000000002 108.541 -178.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -123.36 125.67 45.43 Favored 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 128.038 2.535 . . . . 2.4300000000000002 107.456 -176.216 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -140.22 92.75 2.56 Favored 'General case' 0 N--CA 1.457 -0.104 0 CA-C-O 122.01 0.909 . . . . 3.21 113.063 175.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.7 p -79.16 153.38 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.21 0 C-N-CA 125.405 1.482 . . . . 2.3700000000000001 109.219 -172.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 65.0 ttt180 -122.61 141.05 52.13 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 106.504 -1.665 . . . . 6.21 106.504 159.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 32.5 p90 -152.04 159.09 43.8 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 122.918 0.487 . . . . 3.5899999999999999 110.18 -165.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -98.19 98.74 6.0 Favored Pre-proline 0 CA--C 1.539 0.525 0 C-N-CA 123.676 0.791 . . . . 2.9399999999999999 110.329 170.245 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -75.22 75.99 3.62 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 122.765 2.31 . . . . 1.95 111.203 -176.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -159.51 -43.71 0.05 Allowed 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 125.235 1.414 . . . . 2.3599999999999999 108.915 169.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 33.9 t -52.13 -56.53 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.737 0 C-N-CA 124.452 1.101 . . . . 2.54 109.1 169.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 6.4 tt -124.69 -128.5 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.44 -0.957 0 CA-C-N 114.603 -1.181 . . . . 2.9100000000000001 108.817 -167.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 4.9 tp60 -175.18 112.65 0.28 Allowed Pre-proline 0 CA--C 1.539 0.542 0 N-CA-C 108.686 -0.857 . . . . 3.04 108.686 -159.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -47.59 -44.51 25.63 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 124.728 3.619 . . . . 1.75 116.767 176.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -54.33 -56.83 2.19 Favored 'Trans proline' 0 N--CA 1.445 -1.373 0 CA-C-N 121.212 1.469 . . . . 1.4299999999999999 109.687 167.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 87.1 mtp -53.56 -48.46 69.11 Favored 'General case' 0 C--N 1.342 0.247 0 CA-C-O 119.065 -0.493 . . . . 3.71 112.317 -175.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 3.6 pt -60.38 -41.14 86.26 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 CA-C-N 119.155 0.889 . . . . 4.1900000000000004 111.829 -177.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.96 -60.16 4.23 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 119.704 1.138 . . . . 2.73 111.038 169.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -46.12 -52.69 11.71 Favored 'General case' 0 N--CA 1.442 -0.867 0 C-N-CA 126.497 1.919 . . . . 3.4500000000000002 112.341 -174.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -44.14 -39.81 4.57 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.647 0.779 . . . . 5.2000000000000002 112.972 -179.484 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 43.0 mt -61.32 -36.96 76.37 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 C-N-CA 122.81 0.444 . . . . 2.6499999999999999 110.005 -178.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 60.2 mtt180 -62.52 -62.04 2.02 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 124.237 1.015 . . . . 5.0099999999999998 108.982 178.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -39.4 -52.24 2.08 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 124.987 1.315 . . . . 4.9500000000000002 112.57 173.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.6 pp -83.35 -18.19 39.74 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 113.969 1.1 . . . . 3.6099999999999999 113.969 -176.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -171.47 -66.15 0.04 OUTLIER Glycine 0 CA--C 1.533 1.199 0 CA-C-N 120.018 1.281 . . . . 2.4700000000000002 115.757 -178.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -130.22 146.82 51.88 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 122.058 0.932 . . . . 4.6100000000000003 113.5 -147.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -75.42 81.8 0.94 Allowed Glycine 0 N--CA 1.449 -0.442 0 CA-C-N 115.516 -0.765 . . . . 1.52 112.276 -167.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -83.22 90.7 7.14 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 126.335 1.854 . . . . 2.1699999999999999 110.507 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 20.0 p -99.55 126.83 45.59 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 125.161 1.384 . . . . 3.27 108.439 177.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 90.3 t -82.64 130.23 36.1 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.712 0 C-N-CA 124.523 1.129 . . . . 3.0 109.494 -173.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 24.5 mt -142.06 63.37 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 C-N-CA 125.503 1.521 . . . . 3.3300000000000001 108.285 -175.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.539 0.525 0 N-CA-C 109.171 -0.677 . . . . 4.9400000000000004 109.171 168.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.6 p . . . . . 0 C--O 1.235 0.317 0 CA-C-O 122.551 1.167 . . . . 3.1299999999999999 108.723 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.8 p -97.31 172.4 7.81 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 127.795 2.438 . . . . 3.2000000000000002 109.733 -169.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.98 153.6 50.17 Favored 'General case' 0 C--N 1.339 0.129 0 C-N-CA 122.848 0.459 . . . . 4.3899999999999997 111.12 -179.771 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 41.1 t -146.8 155.75 42.6 Favored 'General case' 0 C--O 1.231 0.107 0 C-N-CA 124.95 1.3 . . . . 3.1600000000000001 109.13 -175.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -97.39 136.88 37.21 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 126.081 1.752 . . . . 4.0800000000000001 108.145 174.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.1 mm -139.94 123.53 18.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 107.078 -1.453 . . . . 3.1099999999999999 107.078 -177.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 5.9 mm-40 -77.93 159.37 28.89 Favored 'General case' 0 N--CA 1.455 -0.194 0 O-C-N 120.745 -1.222 . . . . 3.7000000000000002 110.228 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.4 p -137.91 139.75 42.06 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 O-C-N 123.469 0.481 . . . . 4.1100000000000003 111.925 -172.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.3 m -76.77 63.89 2.25 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.436 1.095 . . . . 4.2800000000000002 113.306 -176.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -161.03 -60.44 0.02 OUTLIER Glycine 0 C--O 1.227 -0.293 0 N-CA-C 105.98 -2.848 . . . . 3.5099999999999998 105.98 157.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 9.4 ttm 54.39 20.79 2.89 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.474 1.11 . . . . 5.21 111.421 -176.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 61.4 m -160.99 -38.67 0.05 OUTLIER 'General case' 0 C--N 1.335 -0.062 0 C-N-CA 124.61 1.164 . . . . 6.2400000000000002 109.856 -156.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 28.4 p -59.04 132.85 55.26 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 108.452 -0.944 . . . . 3.3399999999999999 108.452 -179.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -53.53 -31.35 45.95 Favored 'General case' 0 CA--C 1.535 0.374 0 O-C-N 121.314 -0.866 . . . . 4.2400000000000002 110.491 179.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.4 m -53.17 -39.74 63.84 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 126.109 1.764 . . . . 3.6499999999999999 114.443 172.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -35.21 -57.74 0.57 Allowed 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 125.713 1.605 . . . . 4.8099999999999996 111.601 -146.479 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -62.87 -50.19 80.63 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.874 0 CA-C-N 114.794 -1.094 . . . . 4.3700000000000001 112.525 -177.121 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -54.63 -44.52 73.25 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.382 1.073 . . . . 2.0499999999999998 110.484 172.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -54.62 -59.94 4.02 Favored 'General case' 0 C--O 1.226 -0.167 0 N-CA-C 108.635 -0.876 . . . . 4.96 108.635 175.659 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.3 mt -61.09 -42.27 92.53 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.14 0 O-C-N 121.406 -0.809 . . . . 3.75 110.952 -174.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 69.1 mt-10 -60.85 -25.49 66.69 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 125.557 1.543 . . . . 3.6099999999999999 112.938 174.018 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 10.5 mmm180 -73.1 -42.31 63.08 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 119.344 0.975 . . . . 8.0899999999999999 111.954 158.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -70.93 -49.71 42.62 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 124.427 1.091 . . . . 4.4299999999999997 113.692 -160.266 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.9 mp -78.11 -60.05 2.53 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 118.977 0.808 . . . . 3.8999999999999999 112.872 -176.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 9.5 ptm180 -39.38 -19.87 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 129.933 3.293 . . . . 6.7699999999999996 118.481 -158.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 19.9 mtm105 -67.34 -51.97 45.84 Favored 'General case' 0 N--CA 1.439 -0.98 0 C-N-CA 127.337 2.255 . . . . 8.9900000000000002 109.487 -161.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 168.59 152.03 0.03 OUTLIER 'General case' 0 CA--C 1.512 -0.515 0 N-CA-C 105.519 -2.03 . . . . 7.2199999999999998 105.519 -152.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 99.91 44.84 0.0 OUTLIER 'General case' 0 C--N 1.34 0.157 0 C-N-CA 128.132 2.573 . . . . 7.1500000000000004 112.088 -168.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 56.35 42.57 89.21 Favored Glycine 0 CA--C 1.528 0.894 0 CA-C-N 116.275 -0.42 . . . . 2.2999999999999998 112.527 171.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -77.26 135.29 26.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 N-CA-C 107.104 -1.443 . . . . 3.9300000000000002 107.104 174.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 54.0 m-85 -141.62 37.55 1.66 Allowed 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 122.061 0.934 . . . . 4.9900000000000002 113.397 164.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 75.0 m -166.39 154.41 10.24 Favored 'General case' 0 C--N 1.321 -0.663 1 C-N-CA 131.989 4.116 . . . . 3.7000000000000002 103.964 122.32 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -98.3 136.6 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 N-CA-C 104.931 -2.248 . . . . 3.79 104.931 158.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -156.21 175.81 13.5 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 124.403 1.081 . . . . 7.7599999999999998 110.375 -179.484 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 24.0 t -158.8 117.43 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.421 -1.875 0 C-N-CA 127.22 2.208 . . . . 2.9199999999999999 106.545 -177.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -77.98 62.59 2.8 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 108.464 -0.939 . . . . 2.1499999999999999 108.464 168.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.59 -32.96 74.84 Favored 'General case' 0 C--N 1.342 0.266 0 O-C-N 121.687 -0.633 . . . . 3.4500000000000002 111.705 -168.069 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 51.5 ttp -55.09 -35.67 64.84 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.299 0.64 . . . . 6.75 111.199 173.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -86.99 -20.85 26.66 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.608 0.763 . . . . 2.5499999999999998 110.913 176.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 84.35 60.01 1.97 Allowed Glycine 0 C--N 1.335 0.518 0 N-CA-C 107.768 -2.133 . . . . 0.97999999999999998 107.768 169.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.96 167.53 20.43 Favored 'General case' 0 N--CA 1.437 -1.082 0 N-CA-C 106.363 -1.717 . . . . 5.7999999999999998 106.363 173.122 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -77.83 145.29 36.41 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 105.975 -1.861 . . . . 2.3900000000000001 105.975 167.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -94.56 167.48 11.45 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 105.774 -1.936 . . . . 2.9100000000000001 105.774 151.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.1 p -134.81 141.7 42.41 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 N-CA-C 104.606 -2.368 . . . . 2.5899999999999999 104.606 157.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 70.8 ttt180 -113.5 129.25 56.59 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 106.597 -1.631 . . . . 5.9400000000000004 106.597 158.089 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 7.2 p90 -157.3 172.22 19.0 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 122.968 0.507 . . . . 3.2000000000000002 111.783 -162.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 65.0 t-20 -109.21 88.56 5.96 Favored Pre-proline 0 CA--C 1.537 0.469 0 CA-C-N 114.677 -1.147 . . . . 2.5299999999999998 111.08 -177.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -67.67 79.55 0.49 Allowed 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 123.209 2.606 . . . . 2.0299999999999998 110.129 173.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -169.78 -47.91 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 127.712 2.405 . . . . 2.4300000000000002 106.726 172.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 57.5 t -69.87 -49.69 55.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 C-N-CA 124.261 1.025 . . . . 2.0299999999999998 109.405 173.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.9 tp -98.06 -68.89 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 CA-C-O 118.654 -0.689 . . . . 3.8100000000000001 111.832 -166.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 56.9 tp60 109.24 124.67 0.0 OUTLIER Pre-proline 0 CA--C 1.549 0.909 0 C-N-CA 128.946 2.898 . . . . 4.8200000000000003 109.894 176.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_exo -47.43 -59.51 1.22 Allowed 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 124.113 3.208 . . . . 1.3700000000000001 117.24 -172.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_endo -49.06 -43.57 35.76 Favored 'Trans proline' 0 N--CA 1.45 -1.052 0 C-N-CA 121.62 1.546 . . . . 1.8400000000000001 110.645 172.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 58.9 mtp -68.21 -34.32 76.04 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 118.602 -0.713 . . . . 2.9100000000000001 111.302 -177.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 3.2 tt -62.2 -39.17 83.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-N 120.707 1.594 . . . . 3.0699999999999998 110.977 177.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -56.55 -46.98 80.41 Favored 'General case' 0 CA--C 1.529 0.159 0 O-C-N 122.176 -0.328 . . . . 1.95 111.219 173.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -58.91 -52.41 65.86 Favored 'General case' 0 N--CA 1.435 -1.201 0 C-N-CA 123.197 0.599 . . . . 2.7400000000000002 111.99 176.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -58.29 -31.39 67.44 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 118.343 0.519 . . . . 6.0899999999999999 111.343 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 69.1 mt -62.95 -57.29 12.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-N 119.219 0.918 . . . . 2.1499999999999999 109.95 166.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 87.2 mtt180 -48.64 -42.09 33.21 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.633 0.773 . . . . 4.9199999999999999 112.62 -178.066 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 91.3 mt-10 -50.9 -29.84 13.07 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 124.621 1.168 . . . . 3.7999999999999998 113.272 177.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 51.1 mt -82.04 -16.28 50.71 Favored 'General case' 0 N--CA 1.454 -0.26 0 O-C-N 121.711 -0.618 . . . . 2.8599999999999999 110.316 -178.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 134.66 -44.91 1.15 Allowed Glycine 0 C--N 1.34 0.756 0 C-N-CA 124.731 1.158 . . . . 3.5 110.546 169.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 5.0 m-30 -78.37 129.04 34.51 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-O 121.278 0.561 . . . . 3.9500000000000002 109.612 -166.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -73.15 108.18 2.43 Favored Glycine 0 N--CA 1.442 -0.934 0 N-CA-C 110.878 -0.889 . . . . 1.49 110.878 -171.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -82.91 124.33 30.25 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.073 0.949 . . . . 2.4199999999999999 109.72 179.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -118.34 126.35 51.94 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 108.36 -0.978 . . . . 3.2799999999999998 108.36 164.113 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 65.3 t -83.36 139.11 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 C-N-CA 125.42 1.488 . . . . 2.9300000000000002 109.299 -169.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 12.1 mt -134.44 59.76 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 CA-C-O 122.439 1.114 . . . . 3.46 109.001 -178.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 81.8 mt-10 . . . . . 0 CA--C 1.534 0.336 0 N-CA-C 107.969 -1.123 . . . . 4.6699999999999999 107.969 159.664 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.4 t . . . . . 0 C--O 1.231 0.097 0 N-CA-C 108.147 -1.057 . . . . 3.96 108.147 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.7 m -90.57 177.44 6.36 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 107.688 -1.227 . . . . 2.71 107.688 165.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.14 152.28 31.1 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 118.909 -0.567 . . . . 7.1100000000000003 110.636 165.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 49.1 t -137.82 154.65 49.51 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 124.63 1.172 . . . . 2.21 108.973 171.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 2.5 m-30 -100.83 150.55 22.69 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 106.916 -1.513 . . . . 3.54 106.916 176.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 13.5 mt -144.27 126.25 10.35 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 N-CA-C 104.773 -2.306 . . . . 2.6200000000000001 104.773 -175.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 3.6 tp60 -88.23 134.36 33.81 Favored 'General case' 0 N--CA 1.442 -0.866 0 N-CA-C 106.045 -1.835 . . . . 3.4100000000000001 106.045 173.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 16.1 m -128.39 175.81 9.18 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 C-N-CA 125.343 1.457 . . . . 3.4700000000000002 109.457 -176.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 13.7 t -140.0 179.19 6.76 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 109.339 -0.615 . . . . 4.71 109.339 172.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 84.51 -54.81 4.96 Favored Glycine 0 C--N 1.332 0.351 0 N-CA-C 105.566 -3.014 . . . . 2.8900000000000001 105.566 -163.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 32.4 ttm 82.48 -58.67 0.19 Allowed 'General case' 0 N--CA 1.441 -0.887 0 C-N-CA 126.964 2.106 . . . . 3.9500000000000002 108.955 158.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.8 t -157.96 98.85 1.64 Allowed 'General case' 0 N--CA 1.442 -0.875 0 N-CA-C 106.441 -1.689 . . . . 6.4699999999999998 106.441 153.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.4 m -72.46 55.18 0.34 Allowed 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.184 0.994 . . . . 3.1699999999999999 109.01 175.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 50.93 71.04 0.46 Allowed 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.668 1.187 . . . . 3.3700000000000001 111.338 -160.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.4 m 78.24 21.48 0.84 Allowed 'General case' 0 C--O 1.226 -0.177 0 C-N-CA 124.89 1.276 . . . . 4.5 113.607 169.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -51.72 -32.42 30.18 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 124.62 1.168 . . . . 3.5499999999999998 109.558 166.068 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 19.6 m -53.85 -40.46 44.29 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 CA-C-N 115.28 -0.873 . . . . 3.4900000000000002 111.622 175.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.63 -46.15 70.4 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.157 0.983 . . . . 1.9099999999999999 110.15 175.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -58.43 -52.95 63.45 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 108.872 -0.788 . . . . 2.3500000000000001 108.872 171.832 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 58.2 mt -56.65 -56.32 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-O 118.473 -0.775 . . . . 2.9500000000000002 109.102 -173.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -39.61 -61.21 0.85 Allowed 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 126.132 1.773 . . . . 3.1299999999999999 110.893 171.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.43 -39.99 61.65 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 124.068 0.947 . . . . 7.7199999999999998 111.176 178.004 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -71.04 -53.65 13.98 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 124.293 1.037 . . . . 3.2599999999999998 108.831 -175.492 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -64.1 -27.34 69.03 Favored 'General case' 0 N--CA 1.462 0.17 0 O-C-N 121.07 -1.019 . . . . 3.1800000000000002 112.247 -177.103 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 58.3 mtp180 -67.95 -14.48 63.0 Favored 'General case' 0 N--CA 1.452 -0.368 0 O-C-N 121.761 -0.587 . . . . 6.7300000000000004 111.7 178.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -57.92 -38.79 76.51 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-N 119.158 0.89 . . . . 8.7300000000000004 112.69 161.624 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -93.05 68.3 4.35 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-O 121.977 0.894 . . . . 8.5299999999999994 109.255 -149.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -27.1 109.71 0.04 OUTLIER 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 127.116 2.166 . . . . 5.5800000000000001 110.057 163.462 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 135.51 -48.72 0.92 Allowed Glycine 0 CA--C 1.528 0.867 0 N-CA-C 108.246 -1.942 . . . . 1.9199999999999999 108.246 -151.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -78.64 133.42 30.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 C-N-CA 124.521 1.129 . . . . 3.7400000000000002 110.298 -173.085 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 24.7 t80 -141.32 35.87 1.69 Allowed 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 122.065 0.936 . . . . 7.2300000000000004 110.632 172.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 43.2 t -167.5 147.14 5.12 Favored 'General case' 0 N--CA 1.449 -0.478 1 C-N-CA 132.854 4.461 . . . . 3.4900000000000002 101.54 140.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.8 pp -78.71 156.58 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 C-N-CA 118.561 -1.256 . . . . 2.8999999999999999 108.536 165.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.423 HD21 ' CG1' ' A' ' 45' ' ' VAL . 0.6 OUTLIER -96.18 72.15 2.87 Favored 'General case' 0 N--CA 1.427 -1.591 0 C-N-CA 126.767 2.027 . . . . 5.4100000000000001 109.771 -173.978 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 24.7 t -135.13 141.04 43.92 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 O-C-N 121.017 -1.052 . . . . 2.1899999999999999 108.518 163.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -156.9 59.91 0.53 Allowed 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 125.866 1.666 . . . . 2.0099999999999998 106.632 169.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -46.11 -36.95 6.28 Favored 'General case' 0 CA--C 1.512 -0.515 0 C-N-CA 125.603 1.561 . . . . 4.21 113.12 -178.637 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.83 -41.12 96.0 Favored 'General case' 0 N--CA 1.439 -0.987 0 N-CA-C 108.511 -0.922 . . . . 5.7999999999999998 108.511 -164.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -77.05 -42.49 38.21 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.494 0.717 . . . . 2.2999999999999998 109.903 167.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 102.37 64.93 0.74 Allowed Glycine 0 C--N 1.336 0.572 0 N-CA-C 109.072 -1.611 . . . . 1.46 109.072 179.019 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -160.07 176.14 12.16 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 106.982 -1.488 . . . . 6.7400000000000002 106.982 -179.472 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -131.94 137.39 47.93 Favored 'General case' 0 N--CA 1.435 -1.188 0 C-N-CA 126.382 1.873 . . . . 2.1000000000000001 107.907 174.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -128.8 109.0 10.9 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 114.456 1.28 . . . . 2.6899999999999999 114.456 177.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.423 ' CG1' HD21 ' A' ' 35' ' ' LEU . 3.7 m -83.9 103.33 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 N-CA-C 108.522 -0.918 . . . . 4.29 108.522 176.765 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 7.8 ttm105 -84.43 114.34 21.83 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 103.837 -2.653 . . . . 8.0299999999999994 103.837 160.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -151.77 173.02 15.24 Favored 'General case' 0 C--N 1.332 -0.16 0 O-C-N 121.53 -0.731 . . . . 3.6099999999999999 112.728 -163.057 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -126.05 105.1 25.74 Favored Pre-proline 0 N--CA 1.447 -0.598 0 C-N-CA 123.666 0.786 . . . . 4.0800000000000001 110.603 172.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -79.74 63.53 8.75 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 122.804 2.336 . . . . 1.72 109.17 -178.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -130.68 -49.6 1.05 Allowed 'General case' 0 C--O 1.227 -0.119 0 C-N-CA 124.187 0.995 . . . . 3.0699999999999998 109.005 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 43.0 t -63.66 -57.98 9.42 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 N-CA-C 109.609 -0.515 . . . . 2.9199999999999999 109.609 174.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 19.9 tt -115.01 -118.04 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.694 0 C-N-CA 124.147 0.979 . . . . 3.1499999999999999 108.469 -167.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 5.7 tp60 179.99 111.73 0.19 Allowed Pre-proline 0 CA--C 1.541 0.602 0 N-CA-C 109.296 -0.631 . . . . 2.8599999999999999 109.296 -155.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo -46.61 -49.72 11.61 Favored 'Trans proline' 0 CA--C 1.533 0.457 0 C-N-CA 124.42 3.413 . . . . 1.9199999999999999 116.43 176.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -51.25 -54.21 5.79 Favored 'Trans proline' 0 N--CA 1.444 -1.439 0 C-N-CA 121.251 1.301 . . . . 1.4199999999999999 109.868 170.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 65.6 mtt -52.45 -48.64 65.71 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 118.339 0.518 . . . . 2.4300000000000002 111.558 -179.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 81.5 mt -51.74 -54.09 14.31 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.862 0 CA-C-N 117.876 0.307 . . . . 3.96 110.654 175.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.85 -33.15 74.66 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 120.76 -1.212 . . . . 2.5600000000000001 113.761 176.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -70.58 -52.85 18.74 Favored 'General case' 0 N--CA 1.44 -0.935 0 O-C-N 120.36 -1.462 . . . . 3.8300000000000001 110.676 -177.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -46.1 -43.74 15.03 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 122.548 1.165 . . . . 5.9100000000000001 111.855 -178.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.8 mt -55.61 -44.5 76.88 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 C-N-CA 124.078 0.951 . . . . 2.29 111.531 176.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 70.6 mtm180 -70.84 -42.04 70.7 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 124.509 1.123 . . . . 5.0700000000000003 111.428 176.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -54.52 -38.92 67.11 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 123.6 0.76 . . . . 2.8999999999999999 110.328 175.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 83.8 mt -79.36 -37.49 37.32 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 118.843 -0.598 . . . . 3.77 110.771 174.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 165.76 -34.09 0.24 Allowed Glycine 0 CA--C 1.529 0.937 0 N-CA-C 115.641 1.016 . . . . 3.1899999999999999 115.641 165.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -77.85 128.74 34.45 Favored 'General case' 0 C--N 1.334 -0.078 0 CA-C-N 118.504 1.152 . . . . 4.1600000000000001 111.369 -159.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -70.21 79.08 0.41 Allowed Glycine 0 CA--C 1.523 0.541 0 C-N-CA 124.307 0.956 . . . . 1.6899999999999999 113.019 -175.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -83.53 126.66 33.03 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 125.561 1.545 . . . . 1.7 111.044 -178.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -131.7 136.0 47.31 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 107.002 -1.481 . . . . 2.8199999999999998 107.002 174.175 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 25.6 m -82.05 153.47 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 CA-C-N 118.753 0.706 . . . . 4.3399999999999999 110.757 -171.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 50.3 mt -136.07 120.06 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 C-N-CA 125.952 1.701 . . . . 3.3199999999999998 106.553 173.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 . . . . . 0 C--N 1.332 -0.177 0 N-CA-C 107.936 -1.135 . . . . 5.8399999999999999 107.936 -176.853 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.2 p . . . . . 0 N--CA 1.45 -0.445 0 CA-C-O 120.803 0.335 . . . . 3.3900000000000001 111.15 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 18.7 m -149.62 174.75 12.21 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 107.595 -1.261 . . . . 2.2999999999999998 107.595 173.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -142.71 142.78 32.05 Favored 'General case' 0 CA--C 1.528 0.116 0 N-CA-C 108.209 -1.034 . . . . 4.3200000000000003 108.209 177.431 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 10.2 t -140.48 155.66 46.6 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 123.15 0.58 . . . . 2.0099999999999998 110.981 -163.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 52.6 m-85 -110.06 83.79 1.82 Allowed 'General case' 0 C--O 1.222 -0.348 0 C-N-CA 124.997 1.319 . . . . 3.4500000000000002 108.793 -178.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 50.8 mt -78.6 139.06 19.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 106.51 -1.663 . . . . 2.5600000000000001 106.51 -177.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -104.6 135.9 45.15 Favored 'General case' 0 C--O 1.231 0.126 0 N-CA-C 107.203 -1.406 . . . . 5.5199999999999996 107.203 168.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 46.5 t -131.53 108.95 15.2 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 C-N-CA 124.787 1.235 . . . . 4.04 108.917 -168.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 17.9 p -60.35 99.15 0.07 Allowed 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 120.957 0.408 . . . . 4.1399999999999997 111.176 -179.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 109.85 -28.41 10.63 Favored Glycine 0 C--N 1.338 0.667 0 C-N-CA 124.975 1.274 . . . . 2.1400000000000001 111.22 178.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 4.1 mpp? 67.53 -65.55 0.23 Allowed 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 127.011 2.124 . . . . 6.0099999999999998 108.059 -166.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -154.93 -103.62 0.04 OUTLIER 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 105.01 -2.218 . . . . 9.3800000000000008 105.01 160.558 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.0 p -145.58 35.77 1.06 Allowed 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.032 0.533 . . . . 3.4500000000000002 111.364 176.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 81.1 132.87 0.06 Allowed 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 127.166 2.186 . . . . 4.7599999999999998 111.687 179.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 13.8 m 72.99 -39.24 0.44 Allowed 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 125.623 1.569 . . . . 5.5 114.667 173.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 34.4 m -50.33 -28.55 8.13 Favored 'General case' 0 CA--C 1.517 -0.309 0 C-N-CA 130.346 3.458 . . . . 5.1500000000000004 111.487 175.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 5.8 m -41.88 -41.18 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 112.165 0.431 . . . . 3.8999999999999999 112.165 167.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.66 -41.65 73.95 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 124.732 1.213 . . . . 3.0 111.976 178.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.424 HD21 ' N ' ' A' ' 21' ' ' ILE . 0.0 OUTLIER -61.18 -51.88 67.15 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 108.229 -1.026 . . . . 4.21 108.229 170.026 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.424 ' N ' HD21 ' A' ' 20' ' ' ASN . 22.6 mt -64.37 -57.11 12.83 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.542 0 N-CA-C 107.617 -1.253 . . . . 4.4800000000000004 107.617 -166.085 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -44.72 -45.5 9.88 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 126.706 2.002 . . . . 6.1100000000000003 113.237 -179.356 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 40.3 ttp180 -59.25 -47.52 85.07 Favored 'General case' 0 N--CA 1.449 -0.482 0 O-C-N 121.338 -0.852 . . . . 5.5199999999999996 111.0 171.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -62.94 -22.08 66.53 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.708 1.603 . . . . 4.1799999999999997 110.355 177.385 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 12.1 mt -75.96 -60.49 2.3 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 124.478 1.111 . . . . 4.2199999999999998 112.575 170.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 33.7 mtm180 -65.39 -17.66 64.7 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-N 119.146 0.884 . . . . 8.6699999999999999 112.768 -178.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -39.76 -53.35 2.24 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-O 116.064 -1.922 . . . . 8.1600000000000001 112.528 158.096 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -168.5 173.17 7.68 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 118.256 2.687 . . . . 6.9100000000000001 118.256 -164.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 77.57 57.7 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 129.61 3.164 . . . . 5.7599999999999998 111.726 170.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 57.2 27.4 57.57 Favored Glycine 0 CA--C 1.527 0.809 0 CA-C-N 114.945 -1.025 . . . . 1.74 112.616 176.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.9 mm -88.25 136.42 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 C-N-CA 124.413 1.085 . . . . 3.2999999999999998 108.447 175.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -143.03 48.39 1.49 Allowed 'General case' 0 C--N 1.341 0.235 0 CA-C-O 123.22 1.486 . . . . 4.7699999999999996 112.703 169.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 43.5 t -160.31 -179.27 7.56 Favored 'General case' 0 C--N 1.316 -0.874 0 C-N-CA 129.576 3.151 . . . . 2.96 105.484 152.029 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -100.06 172.74 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 107.181 -1.414 . . . . 3.5 107.181 153.085 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.441 ' HB3' ' CA ' ' A' ' 45' ' ' VAL . 0.3 OUTLIER -137.62 63.07 1.56 Allowed 'General case' 0 N--CA 1.429 -1.486 0 C-N-CA 130.904 3.682 . . . . 4.8899999999999997 108.555 -168.686 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 10.1 t -130.27 129.67 65.19 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.857 0 CA-C-N 115.33 -0.85 . . . . 2.2000000000000002 109.414 164.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -130.15 62.92 1.56 Allowed 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 105.824 -1.917 . . . . 1.8300000000000001 105.824 162.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.81 -31.12 71.32 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 109.687 -0.486 . . . . 4.6100000000000003 109.687 -172.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 27.7 ptm -46.79 -38.24 9.84 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.406 1.082 . . . . 4.79 113.245 169.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -94.07 -48.27 6.3 Favored 'General case' 0 C--N 1.339 0.137 0 C-N-CA 123.618 0.767 . . . . 1.9299999999999999 109.415 177.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 115.13 45.24 0.64 Allowed Glycine 0 CA--C 1.522 0.53 0 N-CA-C 108.517 -1.833 . . . . 1.0800000000000001 108.517 179.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 61.6 mttt -147.6 176.63 9.92 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 126.343 1.857 . . . . 5.1699999999999999 108.016 -171.205 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -142.12 112.48 7.09 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 124.228 1.011 . . . . 1.8 110.26 -169.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -105.01 85.63 2.31 Favored 'General case' 0 C--N 1.349 0.551 0 N-CA-C 115.718 1.747 . . . . 3.3500000000000001 115.718 -171.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.441 ' CA ' ' HB3' ' A' ' 35' ' ' LEU . 7.9 p -81.81 150.02 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.173 0 C-N-CA 123.259 0.624 . . . . 2.4700000000000002 109.592 -174.05 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 20.1 ttt85 -119.94 129.38 54.3 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 104.637 -2.357 . . . . 5.3899999999999997 104.637 157.064 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 4.6 p90 -150.32 164.28 36.18 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 124.508 1.123 . . . . 3.5899999999999999 110.862 -163.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -109.95 90.48 9.46 Favored Pre-proline 0 C--O 1.237 0.406 0 C-N-CA 124.373 1.069 . . . . 2.6499999999999999 111.471 175.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -69.57 79.34 0.89 Allowed 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 122.769 2.313 . . . . 1.5800000000000001 110.697 172.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -160.88 -48.07 0.05 OUTLIER 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 128.683 2.793 . . . . 1.98 105.156 173.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 73.4 t -67.34 -68.04 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.855 0 C-N-CA 123.877 0.871 . . . . 2.9399999999999999 108.893 162.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . 0.256 16.8 tt -88.59 -57.51 4.18 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 N-CA-C 115.903 1.816 . . . . 3.3399999999999999 115.903 -153.631 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER 83.72 133.48 0.04 OUTLIER Pre-proline 0 CA--C 1.543 0.675 0 C-N-CA 127.414 2.286 . . . . 3.6099999999999999 110.984 -173.446 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -37.4 -49.51 1.77 Allowed 'Trans proline' 0 CA--C 1.537 0.664 1 C-N-CA 126.603 4.869 . . . . 1.75 117.707 171.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -44.09 -61.89 0.51 Allowed 'Trans proline' 0 N--CA 1.448 -1.158 0 C-N-CA 121.847 1.698 . . . . 1.4299999999999999 110.642 167.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 43.0 mtt -60.12 -41.81 93.42 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 118.759 -0.639 . . . . 2.7400000000000002 112.291 -175.14 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -55.87 -40.45 62.12 Favored 'Isoleucine or valine' 0 C--N 1.348 0.519 0 CA-C-N 119.304 0.957 . . . . 4.3899999999999997 111.604 -178.106 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.35 -55.42 9.17 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 121.655 0.74 . . . . 2.27 110.681 171.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -64.37 -35.51 81.14 Favored 'General case' 0 N--CA 1.437 -1.083 0 N-CA-C 114.128 1.158 . . . . 3.2599999999999998 114.128 -162.047 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 39.0 m-85 -53.28 -36.85 61.62 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 119.596 1.089 . . . . 4.5 110.946 170.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 17.3 mt -68.81 -34.02 62.39 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 O-C-N 121.154 -0.966 . . . . 2.5699999999999998 109.638 -179.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 68.8 mtt180 -61.34 -50.77 71.58 Favored 'General case' 0 C--N 1.341 0.203 0 N-CA-C 109.282 -0.636 . . . . 4.7199999999999998 109.282 171.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -56.61 -35.7 68.57 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 123.717 0.807 . . . . 2.9900000000000002 111.905 177.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 77.1 mt -77.35 -17.88 57.89 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 118.891 -0.576 . . . . 3.25 111.277 175.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 151.56 -24.41 0.95 Allowed Glycine 0 CA--C 1.527 0.782 0 CA-C-N 118.973 0.806 . . . . 2.71 114.261 163.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -121.36 129.76 53.24 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 118.633 1.217 . . . . 4.7199999999999998 111.806 -152.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -69.56 91.93 0.33 Allowed Glycine 0 N--CA 1.447 -0.624 0 N-CA-C 111.057 -0.817 . . . . 1.8200000000000001 111.057 -169.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -92.55 137.18 32.59 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 126.325 1.85 . . . . 1.6200000000000001 111.84 -178.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 3.3 t -134.17 144.3 48.42 Favored 'General case' 0 N--CA 1.439 -0.989 0 N-CA-C 108.161 -1.052 . . . . 3.6400000000000001 108.161 166.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 8.8 p -94.14 129.55 44.3 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 C-N-CA 126.17 1.788 . . . . 3.3799999999999999 109.657 -167.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 19.4 mm -137.59 126.85 35.09 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 C-N-CA 124.082 0.953 . . . . 4.9900000000000002 108.627 -178.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 . . . . . 0 CA--C 1.533 0.296 0 CA-C-O 121.946 0.879 . . . . 4.3700000000000001 109.556 165.978 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.0 p . . . . . 0 N--CA 1.452 -0.375 0 N-CA-C 110.464 -0.199 . . . . 3.7000000000000002 110.464 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.4 t -113.76 175.51 5.43 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 124.675 1.19 . . . . 3.5899999999999999 109.136 174.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 59.9 tttt -106.7 151.18 25.45 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 124.753 1.221 . . . . 5.4299999999999997 110.638 -174.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 42.1 t -147.61 150.48 34.51 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 108.343 -0.984 . . . . 2.2999999999999998 108.343 167.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -96.01 133.94 39.63 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 107.171 -1.418 . . . . 3.5699999999999998 107.171 178.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 19.3 mt -135.88 90.78 0.9 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.364 0 N-CA-C 105.748 -1.945 . . . . 3.25 105.748 -170.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . 0.291 0.8 OUTLIER -81.43 123.9 28.97 Favored 'General case' 0 N--CA 1.435 -1.185 0 C-N-CA 125.977 1.711 . . . . 4.0599999999999996 108.619 -162.347 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 30.6 m -117.47 175.07 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 C-N-CA 124.201 1.0 . . . . 3.1600000000000001 110.315 -171.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.9 t -148.3 37.22 0.84 Allowed 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 112.435 0.531 . . . . 4.1399999999999997 112.435 175.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -139.31 130.02 4.63 Favored Glycine 0 N--CA 1.446 -0.693 1 N-CA-C 102.148 -4.381 . . . . 3.6099999999999999 102.148 138.315 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -164.04 -33.82 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 124.357 1.063 . . . . 3.8700000000000001 111.016 -169.536 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 6.7 t -111.88 23.72 13.49 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 108.379 -0.971 . . . . 5.0300000000000002 108.379 162.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 24.4 p -80.97 38.0 0.45 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.889 1.276 . . . . 3.0699999999999998 110.95 -175.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 72.48 177.54 0.25 Allowed 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.654 1.582 . . . . 3.7599999999999998 110.637 -152.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -77.26 32.09 0.15 Allowed 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 114.674 1.361 . . . . 3.5 114.674 -162.683 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 85.7 m -48.79 -39.15 24.19 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 126.065 1.746 . . . . 3.54 110.576 175.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 29.1 m -46.16 -48.08 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 C-N-CA 124.795 1.238 . . . . 4.2199999999999998 111.303 174.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.94 -43.77 70.09 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 124.351 1.06 . . . . 1.8999999999999999 110.469 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -65.76 -51.81 56.06 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 108.566 -0.902 . . . . 3.0600000000000001 108.566 174.374 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 31.1 mt -60.35 -53.36 49.87 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 N-CA-C 108.384 -0.969 . . . . 3.6699999999999999 108.384 -168.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -40.68 -58.68 1.57 Allowed 'General case' 0 C--O 1.234 0.242 0 C-N-CA 126.316 1.847 . . . . 4.0899999999999999 111.588 171.009 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 20.0 mmm180 -56.59 -41.2 76.56 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.062 -0.517 . . . . 6.6500000000000004 110.907 177.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -71.7 -29.76 64.91 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 124.388 1.075 . . . . 3.3999999999999999 110.38 -176.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -70.51 -58.1 4.06 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 124.499 1.119 . . . . 3.3399999999999999 110.0 176.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . 0.258 62.1 mtt180 -65.06 -14.52 60.67 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 115.062 1.504 . . . . 10.5 115.062 -171.205 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 16.9 mtm180 -54.24 -38.23 65.53 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 119.426 1.012 . . . . 8.1300000000000008 111.484 166.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 38.7 mm-40 -92.14 81.82 5.04 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 107.985 -1.117 . . . . 6.7999999999999998 107.985 -153.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 46.2 tt0 -41.68 125.06 2.68 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.97 0.908 . . . . 8.6799999999999997 108.943 174.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 127.65 -52.36 0.83 Allowed Glycine 0 CA--C 1.522 0.501 0 N-CA-C 107.733 -2.147 . . . . 2.0600000000000001 107.733 -155.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 1.3 mt -83.46 143.3 12.18 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.147 0 C-N-CA 124.718 1.207 . . . . 2.9900000000000002 108.274 171.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -144.93 42.11 1.31 Allowed 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 119.032 -1.067 . . . . 3.6400000000000001 113.579 150.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 68.2 m -163.19 143.85 9.28 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 127.632 2.373 . . . . 2.8999999999999999 109.767 156.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.48 ' H ' ' CD1' ' A' ' 34' ' ' ILE . 0.0 OUTLIER -81.44 134.25 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.836 0 C-N-CA 125.948 1.699 . . . . 3.54 111.144 -178.973 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -80.02 71.73 6.75 Favored 'General case' 0 N--CA 1.432 -1.361 0 O-C-N 121.072 -1.018 . . . . 5.71 110.061 174.051 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 22.3 t -135.63 131.06 50.55 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 CA-C-O 121.631 0.729 . . . . 2.0099999999999998 111.847 169.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -149.15 67.15 1.03 Allowed 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 127.685 2.394 . . . . 1.97 106.796 167.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -53.3 -31.97 46.57 Favored 'General case' 0 CA--C 1.512 -0.502 0 N-CA-C 113.228 0.825 . . . . 4.4000000000000004 113.228 -177.117 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 63.8 mtt -66.74 -42.95 85.4 Favored 'General case' 0 N--CA 1.44 -0.929 0 C-N-CA 119.385 -0.926 . . . . 5.3700000000000001 109.099 -165.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -73.31 -36.27 66.22 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.426 0.69 . . . . 2.1000000000000001 109.69 166.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 97.8 55.35 1.15 Allowed Glycine 0 CA--C 1.507 -0.449 0 N-CA-C 106.548 -2.621 . . . . 1.1699999999999999 106.548 178.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 24.0 mmtm -150.15 176.06 11.18 Favored 'General case' 0 N--CA 1.44 -0.928 0 N-CA-C 106.18 -1.785 . . . . 7.2999999999999998 106.18 -165.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -162.07 127.05 3.37 Favored 'General case' 0 N--CA 1.432 -1.341 0 N-CA-C 107.142 -1.429 . . . . 2.2200000000000002 107.142 -162.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -151.84 107.73 3.38 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 113.371 0.878 . . . . 3.9900000000000002 113.371 -174.206 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.7 p -81.79 155.06 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.022 0 C-N-CA 124.001 0.92 . . . . 2.6899999999999999 109.62 -169.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 46.0 ttt180 -118.78 128.81 54.83 Favored 'General case' 0 CA--C 1.521 -0.162 0 N-CA-C 106.769 -1.567 . . . . 6.2199999999999998 106.769 158.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -158.63 175.23 13.91 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 123.824 0.85 . . . . 3.5800000000000001 110.35 -167.715 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -110.79 140.08 22.3 Favored Pre-proline 0 N--CA 1.448 -0.53 0 N-CA-C 106.979 -1.489 . . . . 3.0800000000000001 106.979 156.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -85.41 3.72 7.08 Favored 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 122.385 2.056 . . . . 2.98 113.29 -175.027 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -91.3 -50.18 5.96 Favored 'General case' 0 CA--C 1.519 -0.248 0 N-CA-C 107.943 -1.132 . . . . 2.04 107.943 -168.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 45.0 t -61.78 -59.07 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.97 0 C-N-CA 124.557 1.143 . . . . 1.9399999999999999 110.379 178.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 10.7 tt -95.38 -37.06 7.22 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.261 0 CA-C-O 118.615 -0.707 . . . . 2.73 112.743 -162.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 13.4 mm-40 88.78 125.74 0.03 OUTLIER Pre-proline 0 CA--C 1.54 0.56 0 C-N-CA 128.926 2.89 . . . . 3.2000000000000002 113.466 176.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_exo -49.89 -48.76 18.18 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 124.593 3.529 . . . . 1.6599999999999999 116.944 179.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -53.11 -50.74 12.98 Favored 'Trans proline' 0 N--CA 1.444 -1.407 0 CA-C-N 120.758 1.307 . . . . 1.71 108.843 172.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 66.4 mtt -65.18 -43.77 90.61 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 120.62 -0.432 . . . . 2.7200000000000002 110.486 -171.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 7.5 tt -63.54 -35.4 72.47 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 C-N-CA 120.386 -0.526 . . . . 3.23 110.407 -177.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -65.86 -50.14 65.61 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 121.916 0.865 . . . . 1.74 110.384 171.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -70.87 -35.93 72.6 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-O 117.483 -1.246 . . . . 3.04 113.964 -166.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 9.2 m-30 -45.88 -41.75 11.74 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 119.642 1.11 . . . . 4.4500000000000002 110.206 172.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 7.9 mt -69.54 -35.54 66.89 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 O-C-N 121.825 -0.547 . . . . 2.1699999999999999 111.164 -178.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 68.9 mtt180 -66.27 -52.72 44.69 Favored 'General case' 0 C--O 1.226 -0.169 0 N-CA-C 109.013 -0.736 . . . . 5.0700000000000003 109.013 176.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -55.31 -53.54 54.83 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 125.633 1.573 . . . . 2.9399999999999999 110.792 -178.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 74.6 mt -84.52 -32.51 23.87 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 119.17 -0.443 . . . . 3.5600000000000001 111.916 -172.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -115.59 -87.64 1.42 Allowed Glycine 0 CA--C 1.525 0.705 0 N-CA-C 111.7 -0.56 . . . . 3.1499999999999999 111.7 -174.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -140.64 -69.1 0.4 Allowed 'General case' 0 CA--C 1.512 -0.514 0 CA-C-O 122.219 1.009 . . . . 4.5099999999999998 112.767 -152.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 168.14 137.95 2.35 Favored Glycine 0 N--CA 1.437 -1.293 0 N-CA-C 105.648 -2.981 . . . . 2.04 105.648 -149.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -155.93 110.99 2.93 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 108.481 -0.933 . . . . 2.0 108.481 -170.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.4 p -116.36 113.59 23.12 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 125.15 1.38 . . . . 2.9100000000000001 107.947 -174.256 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 12.1 m -81.39 138.51 19.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 N-CA-C 109.365 -0.605 . . . . 3.9199999999999999 109.365 -170.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 19.5 pt -144.68 152.26 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 N-CA-C 107.74 -1.207 . . . . 3.98 107.74 175.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 . . . . . 0 N--CA 1.455 -0.18 0 N-CA-C 107.085 -1.45 . . . . 6.1100000000000003 107.085 167.129 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.4 m . . . . . 0 CA--C 1.54 0.588 0 N-CA-C 109.47 -0.567 . . . . 3.54 109.47 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.5 m -94.83 135.02 36.83 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 125.303 1.441 . . . . 2.5699999999999998 109.273 -175.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 52.5 tttt -85.86 118.25 25.23 Favored 'General case' 0 CA--C 1.528 0.097 0 C-N-CA 124.281 1.033 . . . . 4.8300000000000001 109.222 175.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 96.5 m -127.16 131.2 50.79 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 108.872 -0.788 . . . . 3.9900000000000002 108.872 -178.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -89.52 135.87 33.35 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 124.491 1.117 . . . . 3.7599999999999998 108.533 -171.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 9.0 mt -132.16 157.24 43.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 106.529 -1.656 . . . . 2.7200000000000002 106.529 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 29.9 tp60 -129.98 127.1 39.33 Favored 'General case' 0 N--CA 1.434 -1.261 0 N-CA-C 104.743 -2.317 . . . . 3.5699999999999998 104.743 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 27.0 m -106.91 176.95 1.09 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 C-N-CA 125.177 1.391 . . . . 3.23 110.085 -172.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 12.1 t -141.49 145.02 34.69 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 109.107 -0.701 . . . . 3.6099999999999999 109.107 167.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 67.9 115.79 0.02 OUTLIER Glycine 0 C--N 1.335 0.508 0 N-CA-C 105.443 -3.063 . . . . 2.8599999999999999 105.443 -138.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 65.6 mtp -89.59 -101.44 0.09 Allowed 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 113.481 -1.359 . . . . 4.9699999999999998 108.88 -176.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 10.9 p -75.17 -42.28 56.27 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.153 0.981 . . . . 6.3899999999999997 109.726 177.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 56.7 m 55.34 21.92 4.52 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 126.697 1.999 . . . . 2.6800000000000002 112.099 178.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 50.87 36.62 15.16 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.297 1.039 . . . . 3.1299999999999999 113.495 -168.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 76.2 p 145.61 16.79 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 128.275 2.63 . . . . 3.1499999999999999 115.739 160.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.7 m -60.02 -35.98 76.26 Favored 'General case' 0 C--O 1.234 0.265 0 O-C-N 120.71 -1.244 . . . . 2.9399999999999999 109.872 175.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 15.2 m -65.95 -52.94 43.19 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 CA-C-N 116.089 -0.505 . . . . 3.2200000000000002 110.963 -179.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -47.94 -46.01 31.65 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.152 0.581 . . . . 1.78 110.616 171.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -55.43 -52.05 64.87 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 120.995 0.426 . . . . 2.0600000000000001 110.144 174.059 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -61.9 -48.1 90.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 C-N-CA 123.768 0.827 . . . . 2.6299999999999999 110.686 -175.243 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -52.25 -53.8 39.27 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 125.113 1.365 . . . . 3.1299999999999999 109.178 173.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 29.9 mmt180 -55.3 -41.53 72.46 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 118.414 -0.803 . . . . 5.8300000000000001 111.573 176.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 56.9 m-20 -74.34 -67.97 0.57 Allowed 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 118.829 0.74 . . . . 3.98 112.406 -177.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -75.8 -14.79 60.31 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 126.594 1.958 . . . . 3.29 113.558 -164.637 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -21.1 -74.49 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 128.433 2.693 . . . . 10.19 113.51 -168.165 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . 0.266 11.3 ptp180 -95.74 -62.13 1.34 Allowed 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 117.589 2.44 . . . . 13.66 117.589 170.696 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 30.54 -150.95 0.0 OUTLIER 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 129.711 3.205 . . . . 6.0800000000000001 111.965 -154.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -95.68 92.53 6.63 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 106.058 -1.83 . . . . 7.4000000000000004 106.058 167.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 115.07 13.94 8.8 Favored Glycine 0 CA--C 1.529 0.916 0 CA-C-O 117.137 -1.924 . . . . 1.4099999999999999 115.654 164.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 1.6 mt -104.04 129.52 56.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-N 120.531 2.166 . . . . 2.96 108.53 172.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -136.83 43.41 2.41 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 121.828 0.823 . . . . 3.8999999999999999 111.19 159.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 67.7 m -170.74 143.52 2.14 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 129.295 3.038 . . . . 2.4900000000000002 106.35 135.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -83.9 160.89 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 CA-C-O 122.012 0.91 . . . . 3.0899999999999999 110.783 175.099 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -72.44 69.72 0.85 Allowed 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 129.437 3.095 . . . . 6.3799999999999999 109.091 -179.035 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 23.9 t -130.6 130.83 65.04 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 CA-C-O 121.844 0.83 . . . . 2.6099999999999999 113.09 170.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -158.04 56.86 0.47 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 127.635 2.374 . . . . 1.76 107.201 156.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -74.3 -11.08 60.17 Favored 'General case' 0 N--CA 1.463 0.191 0 O-C-N 121.058 -1.026 . . . . 6.3700000000000001 112.542 -171.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 27.6 ttt -53.81 -40.13 66.11 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 109.848 -0.427 . . . . 4.6500000000000004 109.848 163.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -89.39 -34.41 16.51 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.423 0.689 . . . . 1.71 110.487 172.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 106.02 44.62 1.37 Allowed Glycine 0 CA--C 1.524 0.649 0 N-CA-C 109.379 -1.488 . . . . 0.84999999999999998 109.379 -179.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 45.8 mttt -155.02 -177.52 6.59 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 125.869 1.668 . . . . 5.4900000000000002 107.364 -153.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -153.87 146.98 24.6 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 125.483 1.513 . . . . 2.3199999999999998 110.432 -168.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -129.22 106.52 8.88 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-O 121.265 0.555 . . . . 4.3200000000000003 110.021 161.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -83.74 116.84 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 N-CA-C 106.165 -1.791 . . . . 3.1200000000000001 106.165 173.239 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 29.8 ttm180 -109.2 116.3 31.64 Favored 'General case' 0 CA--C 1.515 -0.381 0 N-CA-C 106.192 -1.781 . . . . 6.4699999999999998 106.192 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -148.97 173.66 13.1 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 114.65 1.352 . . . . 3.52 114.65 -158.025 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -102.7 94.64 5.35 Favored Pre-proline 0 N--CA 1.452 -0.347 0 N-CA-C 106.795 -1.558 . . . . 3.4900000000000002 106.795 166.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -67.75 -4.27 11.92 Favored 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 122.408 2.072 . . . . 2.6099999999999999 113.292 -172.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -82.47 -28.56 31.14 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 124.175 0.99 . . . . 2.1099999999999999 108.554 177.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 87.0 t -84.85 -67.33 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.137 0 C-N-CA 124.629 1.172 . . . . 2.2999999999999998 107.939 -174.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 15.2 tt -87.45 -36.58 9.9 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 N-CA-C 113.016 0.747 . . . . 2.7999999999999998 113.016 -163.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 15.7 mm-40 86.88 119.18 0.03 OUTLIER Pre-proline 0 CA--C 1.541 0.625 0 C-N-CA 129.27 3.028 . . . . 3.3599999999999999 112.834 -179.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -50.18 -47.94 21.92 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 125.117 3.878 . . . . 1.1599999999999999 117.907 -178.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -59.08 -44.56 33.75 Favored 'Trans proline' 0 N--CA 1.442 -1.505 0 N-CA-C 108.785 -1.275 . . . . 1.23 108.785 172.026 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 87.6 mtp -69.46 -40.93 76.83 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-O 119.373 -0.346 . . . . 2.9399999999999999 110.11 -167.023 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 16.4 tt -61.87 -54.37 35.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 119.628 -0.829 . . . . 3.3199999999999998 110.765 175.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -46.88 -51.65 16.23 Favored 'General case' 0 C--N 1.342 0.262 0 C-N-CA 123.73 0.812 . . . . 1.9299999999999999 112.138 174.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -54.79 -51.35 66.05 Favored 'General case' 0 N--CA 1.442 -0.855 0 C-N-CA 125.292 1.437 . . . . 3.4300000000000002 111.237 175.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -48.68 -40.43 28.06 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 123.55 0.74 . . . . 4.5899999999999999 111.525 178.013 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.4 mm -58.14 -40.87 79.11 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-O 121.606 0.717 . . . . 3.6099999999999999 110.069 179.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 27.0 mtt85 -67.24 -50.54 60.28 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 123.623 0.769 . . . . 4.9299999999999997 109.114 177.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -53.88 -48.98 69.52 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 124.034 0.933 . . . . 2.75 111.405 -178.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.7 pp -83.26 -30.98 27.21 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 119.271 -0.395 . . . . 4.2599999999999998 111.831 -175.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -123.3 -87.82 0.83 Allowed Glycine 0 CA--C 1.524 0.63 0 N-CA-C 111.455 -0.658 . . . . 2.5800000000000001 111.455 -175.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 26.5 m-85 -139.62 -74.85 0.36 Allowed 'General case' 0 CA--C 1.513 -0.452 0 CA-C-O 121.837 0.827 . . . . 5.1900000000000004 112.888 -151.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 171.34 128.9 1.07 Allowed Glycine 0 N--CA 1.438 -1.175 0 N-CA-C 107.825 -2.11 . . . . 1.8400000000000001 107.825 -155.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -155.2 127.51 7.78 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 123.843 0.857 . . . . 1.7 109.243 -172.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -118.23 131.03 56.39 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 126.166 1.787 . . . . 3.3399999999999999 106.724 179.312 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 79.6 t -87.05 127.68 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.737 0 C-N-CA 125.164 1.385 . . . . 2.75 107.94 -175.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 13.5 mt -134.38 62.04 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 CA-C-O 122.387 1.089 . . . . 2.6000000000000001 108.515 -173.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 . . . . . 0 C--N 1.327 -0.405 0 C-N-CA 124.231 1.012 . . . . 4.7599999999999998 109.449 171.744 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 56.4 p . . . . . 0 CA--C 1.536 0.406 0 N-CA-C 114.703 1.372 . . . . 4.9699999999999998 114.703 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.0 m -139.71 169.93 16.83 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 124.53 1.132 . . . . 2.6000000000000001 109.564 -176.328 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.32 143.08 35.63 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 110.329 -0.249 . . . . 5.0899999999999999 110.329 168.637 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 51.4 t -141.28 149.62 41.52 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 125.072 1.349 . . . . 1.8500000000000001 108.532 -171.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -106.26 142.9 35.17 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.185 1.394 . . . . 4.3099999999999996 108.422 179.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -141.43 109.09 2.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 107.255 -1.387 . . . . 3.5099999999999998 107.255 -163.003 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 17.5 tt0 -79.21 147.09 32.73 Favored 'General case' 0 N--CA 1.422 -1.851 0 N-CA-C 107.094 -1.447 . . . . 4.0099999999999998 107.094 -178.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.1 p -150.83 134.41 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 N-CA-C 108.825 -0.806 . . . . 4.0099999999999998 108.825 -168.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 6.1 m -83.19 73.5 10.09 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 121.959 0.885 . . . . 3.3799999999999999 110.66 -167.232 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 121.57 94.25 1.3 Allowed Glycine 0 N--CA 1.443 -0.862 0 CA-C-O 124.664 2.258 . . . . 2.8500000000000001 107.765 175.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 11.9 tpt -95.56 -70.21 0.72 Allowed 'General case' 0 N--CA 1.422 -1.829 0 CA-C-N 109.456 -3.372 . . . . 8.3900000000000006 107.521 -172.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 5.7 m -108.08 52.89 0.7 Allowed 'General case' 0 N--CA 1.456 -0.175 0 N-CA-C 108.585 -0.895 . . . . 6.5599999999999996 108.585 -177.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 21.3 m -64.82 -61.02 2.43 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 107.507 -1.294 . . . . 3.7799999999999998 107.507 176.076 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -174.37 70.18 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 127.556 2.343 . . . . 3.2200000000000002 106.979 174.046 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . 0.26 16.6 p 77.63 23.0 0.85 Allowed 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 126.959 2.104 . . . . 2.98 114.676 176.22 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 80.1 m -52.12 -39.43 59.87 Favored 'General case' 0 CA--C 1.536 0.416 0 O-C-N 121.108 -0.995 . . . . 3.27 109.413 157.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -42.49 -47.87 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.034 0 C-N-CA 126.248 1.819 . . . . 3.8300000000000001 114.12 161.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.73 -36.07 82.54 Favored 'General case' 0 C--O 1.234 0.247 0 O-C-N 121.511 -0.743 . . . . 2.1099999999999999 110.396 176.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -58.56 -51.79 68.4 Favored 'General case' 0 C--O 1.219 -0.522 0 N-CA-C 108.341 -0.985 . . . . 2.2200000000000002 108.341 169.708 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 86.6 mt -53.88 -52.55 34.51 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-N 119.108 0.867 . . . . 3.6400000000000001 109.863 -176.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -48.33 -48.7 36.09 Favored 'General case' 0 N--CA 1.444 -0.774 0 O-C-N 121.006 -1.059 . . . . 3.6099999999999999 112.722 172.22 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 5.6 ttm-85 -66.42 -27.35 67.76 Favored 'General case' 0 N--CA 1.444 -0.744 0 O-C-N 121.736 -0.603 . . . . 7.5 112.426 173.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -72.78 -56.91 4.55 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 119.309 0.959 . . . . 4.46 110.571 -169.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.4 mt -69.52 -33.11 72.34 Favored 'General case' 0 C--O 1.223 -0.309 0 C-N-CA 119.429 -0.908 . . . . 4.4100000000000001 113.003 -161.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.59 -17.78 0.36 Allowed 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 114.498 1.295 . . . . 8.6999999999999993 114.498 168.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -35.67 -56.44 0.68 Allowed 'General case' 0 C--N 1.343 0.308 0 O-C-N 121.014 -1.054 . . . . 10.84 111.559 162.601 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -96.36 119.58 35.11 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 118.972 -1.091 . . . . 9.4900000000000002 111.492 -140.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 47.8 mp0 -58.51 106.4 0.39 Allowed 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.303 1.441 . . . . 5.0099999999999998 109.197 179.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 122.02 -1.1 10.81 Favored Glycine 0 CA--C 1.529 0.941 0 CA-C-O 118.992 -0.893 . . . . 1.3 111.915 -171.2 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -78.52 138.19 20.64 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-N 118.432 1.116 . . . . 2.9900000000000002 110.672 177.225 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -147.91 48.34 1.07 Allowed 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 122.038 0.923 . . . . 3.7000000000000002 112.993 164.129 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.7 m -169.2 173.24 6.85 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 129.354 3.062 . . . . 3.3799999999999999 106.487 129.186 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.8 pp -120.1 139.41 47.48 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 N-CA-C 102.841 -3.022 . . . . 3.7200000000000002 102.841 161.045 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.7 mp -148.14 157.17 43.35 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 119.269 0.941 . . . . 7.6699999999999999 109.523 -167.136 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.1 t -155.05 73.0 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 CA-C-O 124.857 2.265 . . . . 2.3100000000000001 107.649 -159.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -80.29 59.51 3.42 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 113.714 -1.584 . . . . 1.97 109.089 169.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.64 -29.91 68.35 Favored 'General case' 0 CA--C 1.505 -0.78 0 O-C-N 121.462 -0.774 . . . . 5.1200000000000001 111.608 173.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 2.7 mpt? -62.35 -34.46 76.7 Favored 'General case' 0 N--CA 1.438 -1.045 0 C-N-CA 118.861 -1.136 . . . . 4.7599999999999998 109.167 -169.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -76.99 -53.87 7.28 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.523 0.729 . . . . 2.6800000000000002 109.336 164.082 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 131.39 50.37 0.1 Allowed Glycine 0 C--N 1.338 0.676 0 N-CA-C 109.943 -1.263 . . . . 1.6399999999999999 109.943 173.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 75.1 mttt -149.86 150.82 32.5 Favored 'General case' 0 N--CA 1.442 -0.87 0 N-CA-C 108.656 -0.868 . . . . 5.1900000000000004 108.656 -169.176 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -76.11 163.53 27.02 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 105.577 -2.008 . . . . 2.6400000000000001 105.577 155.056 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 52.5 tt0 -128.24 157.68 40.22 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 106.108 -1.812 . . . . 3.5899999999999999 106.108 163.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 6.8 p -132.46 134.06 59.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 N-CA-C 106.176 -1.787 . . . . 2.6600000000000001 106.176 173.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 33.2 ttm105 -105.34 130.23 53.5 Favored 'General case' 0 N--CA 1.456 -0.165 0 N-CA-C 105.632 -1.988 . . . . 5.5800000000000001 105.632 157.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 5.1 p90 -155.63 172.8 17.68 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 123.082 0.553 . . . . 3.3500000000000001 110.262 -164.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -117.78 80.59 14.24 Favored Pre-proline 0 C--O 1.238 0.45 0 CA-C-N 115.969 -0.559 . . . . 2.96 112.211 -174.143 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -66.47 87.17 0.27 Allowed 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 123.46 2.773 . . . . 2.5299999999999998 108.531 174.201 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -178.45 -47.35 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 130.25 3.42 . . . . 2.9199999999999999 105.937 -176.213 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 73.9 t -81.42 -57.62 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.712 0 N-CA-C 108.588 -0.893 . . . . 2.7400000000000002 108.588 168.291 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 12.1 tt -90.09 -44.97 15.07 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.21 0 N-CA-C 115.44 1.644 . . . . 3.5699999999999998 115.44 -146.451 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 21.9 tp60 91.86 110.94 0.02 OUTLIER Pre-proline 0 CA--C 1.55 0.979 0 C-N-CA 127.244 2.218 . . . . 4.04 111.087 176.005 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -43.04 -48.35 7.8 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 124.773 3.649 . . . . 1.46 118.127 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -54.84 -43.35 60.1 Favored 'Trans proline' 0 N--CA 1.448 -1.162 0 CA-C-N 121.329 1.51 . . . . 1.3400000000000001 110.507 172.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 63.9 mtt -62.37 -44.82 95.56 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 118.397 -0.811 . . . . 3.04 110.044 178.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 5.7 mm -48.4 -57.06 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 CA-C-N 119.08 0.855 . . . . 4.3300000000000001 109.903 172.305 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -55.22 -46.71 75.94 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.052 0.541 . . . . 2.5699999999999998 112.073 -177.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -70.23 -44.91 67.6 Favored 'General case' 0 N--CA 1.44 -0.948 0 C-N-CA 124.62 1.168 . . . . 3.0899999999999999 112.74 -176.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -48.59 -36.81 16.47 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 123.968 0.907 . . . . 5.1399999999999997 111.571 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 22.1 mt -69.98 -40.58 78.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 N-CA-C 109.658 -0.497 . . . . 2.4900000000000002 109.658 178.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 80.1 mtm-85 -70.96 -31.36 67.91 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 118.24 -0.886 . . . . 5.0099999999999998 112.692 -178.283 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 87.1 mt-10 -41.19 -44.33 2.55 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.926 1.291 . . . . 4.7000000000000002 113.764 179.238 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.42 -12.89 58.78 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.105 0.962 . . . . 4.0300000000000002 111.704 -173.696 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 111.32 -2.03 28.09 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 124.742 1.163 . . . . 3.4399999999999999 111.499 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -76.57 86.2 3.26 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 107.993 -1.114 . . . . 4.0999999999999996 107.993 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -61.4 104.41 0.69 Allowed Glycine 0 N--CA 1.442 -0.932 0 C-N-CA 125.672 1.606 . . . . 1.8 109.177 -178.008 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -137.99 151.84 48.31 Favored 'General case' 0 N--CA 1.45 -0.457 0 O-C-N 124.981 1.048 . . . . 2.71 112.494 -163.369 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 29.8 m -135.34 138.63 43.59 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 125.769 1.627 . . . . 3.2599999999999998 107.976 -170.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 12.7 t -82.77 111.36 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 C-N-CA 124.972 1.309 . . . . 2.7999999999999998 107.73 -177.034 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 16.2 mt -134.27 66.03 0.29 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.331 0 C-N-CA 124.499 1.119 . . . . 3.8500000000000001 109.231 -172.048 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 . . . . . 0 CA--C 1.531 0.239 0 C-N-CA 129.794 3.238 . . . . 8.0999999999999996 106.121 150.16 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 12.1 m . . . . . 0 CA--C 1.529 0.156 0 CA-C-O 123.105 1.431 . . . . 2.71 107.682 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -84.69 127.36 34.06 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 128.586 2.755 . . . . 3.2200000000000002 109.955 -168.426 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 37.2 tttt -81.83 144.13 31.25 Favored 'General case' 0 C--N 1.34 0.178 0 CA-C-N 118.761 0.71 . . . . 4.8799999999999999 109.272 174.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 45.5 t -143.18 156.01 44.67 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.402 0.681 . . . . 2.1899999999999999 109.324 170.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -102.52 139.67 37.82 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 124.555 1.142 . . . . 4.04 108.528 175.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.7 mp -133.24 130.01 57.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 N-CA-C 104.91 -2.255 . . . . 3.3300000000000001 104.91 174.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 36.4 tp60 -91.7 126.04 36.64 Favored 'General case' 0 N--CA 1.433 -1.289 0 N-CA-C 104.042 -2.577 . . . . 4.0099999999999998 104.042 169.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.4 m -109.4 136.35 45.56 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 N-CA-C 108.386 -0.968 . . . . 3.2999999999999998 108.386 179.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 6.1 m -87.22 55.35 3.51 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 108.925 -0.768 . . . . 2.8500000000000001 108.925 171.487 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -143.95 123.08 1.95 Allowed Glycine 0 N--CA 1.445 -0.732 0 N-CA-C 103.464 -3.854 . . . . 3.1600000000000001 103.464 148.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 70.6 mtm -136.6 -71.92 0.45 Allowed 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 106.515 -1.661 . . . . 5.0499999999999998 106.515 -176.202 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 4.9 t -74.93 51.04 0.48 Allowed 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 109.307 -0.627 . . . . 6.6699999999999999 109.307 163.121 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 14.5 t -114.42 121.65 44.21 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 105.12 -2.178 . . . . 3.0499999999999998 105.12 175.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -71.53 82.19 0.81 Allowed 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 123.57 0.748 . . . . 3.4100000000000001 111.999 -157.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 87.63 38.12 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 127.684 2.394 . . . . 2.7000000000000002 109.857 -177.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.8 t -47.59 -41.0 20.7 Favored 'General case' 0 CA--C 1.521 -0.136 0 C-N-CA 125.082 1.353 . . . . 3.7799999999999998 108.83 168.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 15.1 m -66.32 -53.34 37.43 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.06 0 CA-C-N 113.49 -1.687 . . . . 3.2000000000000002 110.321 -175.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -50.44 -45.15 55.78 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.39 0.676 . . . . 1.8400000000000001 110.309 172.485 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -56.84 -56.39 22.17 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 109.597 -0.52 . . . . 2.3599999999999999 109.597 175.66 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 27.5 mt -52.58 -54.46 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 C-N-CA 124.268 1.027 . . . . 3.3300000000000001 110.199 -179.262 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -50.32 -59.01 4.4 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 124.985 1.314 . . . . 2.9300000000000002 110.088 176.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 21.5 tpt180 -55.48 -41.83 73.55 Favored 'General case' 0 N--CA 1.443 -0.801 0 C-N-CA 124.666 1.186 . . . . 5.7699999999999996 111.515 -176.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 15.3 m-20 -72.31 -64.46 0.94 Allowed 'General case' 0 C--O 1.222 -0.362 0 N-CA-C 109.609 -0.515 . . . . 3.52 109.609 179.163 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . 0.319 6.9 mt -80.54 -11.09 59.71 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 128.69 2.796 . . . . 5.0099999999999998 116.808 -159.484 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -19.57 -71.5 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 126.777 2.031 . . . . 10.65 114.345 175.458 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 30.4 mmt180 -92.35 -60.7 1.77 Allowed 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 118.828 2.899 . . . . 14.33 118.828 -179.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . 0.262 2.5 mm-40 8.27 62.84 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.685 1 C-N-CA 132.665 4.386 . . . . 5.8300000000000001 112.314 -152.328 . . . . . . . . 3 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 18.06 58.13 0.01 OUTLIER 'General case' 0 C--N 1.343 0.299 0 C-N-CA 129.685 3.194 . . . . 6.9400000000000004 113.257 -169.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 166.63 -28.7 0.18 Allowed Glycine 0 CA--C 1.522 0.503 0 C-N-CA 120.134 -1.031 . . . . 1.75 113.488 -171.189 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.7 mt -81.6 111.96 18.87 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 N-CA-C 106.212 -1.773 . . . . 2.8500000000000001 106.212 174.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 47.9 m-85 -122.6 44.16 2.71 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 122.832 1.301 . . . . 3.5800000000000001 110.547 166.371 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 33.7 t -166.78 137.54 3.24 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 126.799 2.04 . . . . 2.8799999999999999 105.952 142.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.2 pp -78.59 151.44 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.651 0 N-CA-C 107.5 -1.296 . . . . 2.7799999999999998 107.5 171.374 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.446 ' H ' ' CD2' ' A' ' 35' ' ' LEU . 0.3 OUTLIER -94.69 77.43 3.73 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 129.466 3.106 . . . . 5.1600000000000001 110.243 -169.273 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 43.3 t -131.59 139.71 49.97 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.801 0 N-CA-C 108.997 -0.742 . . . . 2.3300000000000001 108.997 168.24 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -155.99 55.99 0.59 Allowed 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 106.618 -1.623 . . . . 1.77 106.618 168.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -71.61 -20.32 62.0 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 114.74 -1.118 . . . . 3.9900000000000002 111.017 -172.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 53.0 ttm -45.23 -38.29 5.34 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.621 0.768 . . . . 4.3799999999999999 110.935 164.157 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -95.51 -48.67 5.74 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.234 0.614 . . . . 1.8799999999999999 110.235 170.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 119.67 54.82 0.26 Allowed Glycine 0 C--N 1.338 0.64 0 N-CA-C 109.813 -1.315 . . . . 1.0900000000000001 109.813 -177.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 10.2 pttt -159.15 177.98 10.5 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 107.991 -1.114 . . . . 4.9900000000000002 107.991 -173.007 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -132.31 124.36 28.67 Favored 'General case' 0 N--CA 1.441 -0.904 0 C-N-CA 127.081 2.153 . . . . 1.8600000000000001 108.705 -169.102 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -125.03 89.06 2.99 Favored 'General case' 0 C--N 1.343 0.296 0 N-CA-C 113.776 1.028 . . . . 3.29 113.776 -175.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 9.6 p -78.65 152.1 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.088 0 N-CA-C 108.707 -0.849 . . . . 2.6200000000000001 108.707 -174.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 63.9 ttm-85 -114.85 112.58 22.99 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 106.705 -1.591 . . . . 5.79 106.705 156.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -123.15 165.42 16.89 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 124.304 1.041 . . . . 3.6099999999999999 113.19 -169.629 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 32.6 t30 -126.94 90.99 48.12 Favored Pre-proline 0 N--CA 1.451 -0.386 0 C-N-CA 125.99 1.716 . . . . 2.4199999999999999 109.015 -178.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -71.64 71.26 2.6 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 122.895 2.397 . . . . 1.8500000000000001 112.081 179.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -123.92 -49.11 1.86 Allowed 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 126.201 1.8 . . . . 3.0299999999999998 106.853 157.054 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 41.0 t -83.52 -61.44 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.923 0 C-N-CA 124.741 1.216 . . . . 2.5899999999999999 110.567 175.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 6.1 tp -78.58 -71.67 0.29 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.414 0 N-CA-C 113.008 0.744 . . . . 2.5600000000000001 113.008 -161.277 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 82.81 128.78 0.03 OUTLIER Pre-proline 0 CA--C 1.548 0.887 0 C-N-CA 128.293 2.637 . . . . 4.7800000000000002 113.248 -176.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -42.88 -52.48 4.62 Favored 'Trans proline' 0 C--N 1.349 0.562 1 C-N-CA 126.744 4.963 . . . . 1.4299999999999999 117.687 177.594 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -54.06 -49.25 17.73 Favored 'Trans proline' 0 N--CA 1.442 -1.553 0 CA-C-N 120.11 1.075 . . . . 0.92000000000000004 109.678 173.305 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 61.3 mtt -64.93 -45.26 86.57 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.193 -0.669 . . . . 3.2999999999999998 109.193 -170.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 16.2 tt -59.7 -49.75 82.58 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 C-N-CA 119.087 -1.045 . . . . 3.6000000000000001 111.527 177.287 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -51.8 -53.78 36.2 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 118.319 0.508 . . . . 1.79 111.758 176.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -56.53 -54.49 45.25 Favored 'General case' 0 N--CA 1.432 -1.367 0 C-N-CA 124.511 1.125 . . . . 3.1200000000000001 110.676 -179.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 18.7 m-30 -50.25 -43.1 52.99 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 119.103 0.865 . . . . 5.46 110.833 178.154 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 85.6 mt -65.43 -40.83 89.53 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 O-C-N 121.712 -0.617 . . . . 2.0699999999999998 110.083 -179.307 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 51.8 mtp180 -59.12 -51.83 68.33 Favored 'General case' 0 CA--C 1.533 0.322 0 O-C-N 121.905 -0.497 . . . . 6.3899999999999997 111.211 171.177 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -56.5 -32.95 65.53 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 125.507 1.523 . . . . 3.0899999999999999 111.673 179.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 59.5 mt -77.2 -17.43 58.52 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 119.184 -0.436 . . . . 3.04 110.629 176.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 135.42 -9.67 4.36 Favored Glycine 0 CA--C 1.526 0.72 0 C-N-CA 124.069 0.842 . . . . 3.2799999999999998 112.964 167.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -110.28 115.03 28.96 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 118.481 1.14 . . . . 4.5199999999999996 110.02 -160.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -63.71 86.96 0.06 OUTLIER Glycine 0 N--CA 1.447 -0.625 0 CA-C-N 115.868 -0.606 . . . . 1.4099999999999999 112.065 -176.264 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -84.06 127.74 34.09 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 126.074 1.75 . . . . 1.78 109.829 178.284 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 9.6 t -122.18 130.38 53.15 Favored 'General case' 0 N--CA 1.436 -1.132 0 N-CA-C 105.785 -1.932 . . . . 3.2999999999999998 105.785 165.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 77.0 t -83.74 135.89 23.91 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.89 0 N-CA-C 107.398 -1.334 . . . . 3.0 107.398 -177.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 17.9 mt -126.91 73.81 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 N-CA-C 107.034 -1.469 . . . . 2.7200000000000002 107.034 -178.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 115.097 -0.956 . . . . 3.7200000000000002 110.958 167.02 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.1 p . . . . . 0 CA--C 1.538 0.519 0 N-CA-C 114.57 1.322 . . . . 2.8900000000000001 114.57 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.6 p -91.49 172.38 8.55 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 128.096 2.559 . . . . 3.3900000000000001 111.075 -177.213 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 6.1 tttt -108.53 156.47 19.46 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 124.755 1.222 . . . . 5.3099999999999996 108.563 166.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -145.26 175.35 10.35 Favored 'General case' 0 C--O 1.235 0.324 0 O-C-N 124.142 0.901 . . . . 2.9100000000000001 109.97 162.32 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 45.0 m-85 -115.93 139.79 49.89 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 126.31 1.844 . . . . 4.3300000000000001 108.321 -171.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.7 pt -136.28 122.9 31.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 C-N-CA 123.914 0.885 . . . . 4.25 110.602 178.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -80.33 132.48 35.81 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 106.677 -1.601 . . . . 4.9699999999999998 106.677 171.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.7 m -107.85 121.1 60.32 Favored 'Isoleucine or valine' 0 C--O 1.232 0.147 0 O-C-N 124.038 0.836 . . . . 3.04 109.658 -176.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.3 m -66.17 73.48 0.08 Allowed 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.138 0.975 . . . . 3.2200000000000002 111.596 177.229 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -173.47 -59.14 0.05 OUTLIER Glycine 0 CA--C 1.522 0.478 0 N-CA-C 106.788 -2.525 . . . . 3.3700000000000001 106.788 172.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 25.2 ttm 69.03 -33.21 0.24 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 126.686 1.994 . . . . 5.2599999999999998 114.664 170.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.7 t -155.22 52.87 0.62 Allowed 'General case' 0 N--CA 1.446 -0.625 0 C-N-CA 124.668 1.187 . . . . 5.4000000000000004 108.163 177.068 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 12.5 p -58.01 -43.05 86.47 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 108.413 -0.958 . . . . 2.7000000000000002 108.413 164.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 156.92 -59.88 0.0 OUTLIER 'General case' 0 CA--C 1.521 -0.16 0 C-N-CA 129.514 3.126 . . . . 3.8900000000000001 107.177 166.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.0 p -99.11 42.63 1.09 Allowed 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.367 1.067 . . . . 3.6299999999999999 110.916 -174.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 37.7 m -52.79 -51.73 59.59 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 108.49 -0.93 . . . . 4.7000000000000002 108.49 178.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.2 p -63.77 -55.31 23.21 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.67 0 CA-C-O 121.936 0.874 . . . . 4.3499999999999996 111.232 -178.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.32 -30.88 67.03 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.513 -1.221 . . . . 2.2599999999999998 112.598 -175.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -68.19 -57.22 6.37 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 119.68 1.127 . . . . 4.2300000000000004 108.276 169.401 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . 0.255 1.5 mt -62.83 -35.69 72.13 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.894 0 O-C-N 121.868 -0.52 . . . . 2.9900000000000002 110.362 -166.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -43.59 -56.7 3.54 Favored 'General case' 0 N--CA 1.453 -0.302 0 O-C-N 121.483 -0.761 . . . . 3.3799999999999999 110.385 171.043 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -63.5 -44.57 93.93 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 115.414 -0.812 . . . . 7.3099999999999996 110.438 175.783 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -60.31 -42.46 95.61 Favored 'General case' 0 C--O 1.223 -0.299 0 C-N-CA 122.922 0.489 . . . . 3.9399999999999999 111.717 -168.741 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . 0.337 5.2 mp -80.33 -43.93 20.37 Favored 'General case' 0 N--CA 1.435 -1.21 0 C-N-CA 126.081 1.752 . . . . 3.79 113.101 175.486 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 83.7 mtt180 -66.2 -20.47 66.14 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 119.364 -2.085 . . . . 8.5999999999999996 112.721 -174.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 4.8 mmt180 -29.98 -62.86 0.14 Allowed 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 125.717 1.607 . . . . 9.3000000000000007 112.992 162.055 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 150.98 176.92 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.178 0 C-N-CA 128.049 2.54 . . . . 7.5 106.345 -158.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 101.88 32.09 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 129.477 3.111 . . . . 8.5399999999999991 111.379 -167.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 55.9 42.88 87.26 Favored Glycine 0 CA--C 1.526 0.736 0 O-C-N 121.752 -0.592 . . . . 2.3100000000000001 111.682 177.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 1.4 mp -74.04 142.57 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 CA-C-N 117.066 0.433 . . . . 3.4300000000000002 110.102 176.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -145.81 41.86 1.22 Allowed 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 122.449 1.118 . . . . 5.1200000000000001 113.657 158.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 58.8 m -167.93 157.8 10.15 Favored 'General case' 0 C--N 1.319 -0.743 1 C-N-CA 132.698 4.399 . . . . 3.3599999999999999 104.12 133.14 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -109.65 144.95 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 N-CA-C 104.712 -2.329 . . . . 3.3599999999999999 104.712 155.636 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.417 ' CD1' ' N ' ' A' ' 35' ' ' LEU . 0.3 OUTLIER -147.65 148.43 31.05 Favored 'General case' 0 N--CA 1.434 -1.247 0 C-N-CA 125.965 1.706 . . . . 7.4100000000000001 106.504 -167.543 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.429 ' CG1' ' HG ' ' A' ' 38' ' ' LEU . 1.3 t -156.7 96.18 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 N-CA-C 105.207 -2.145 . . . . 2.52 105.207 174.396 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -77.22 66.35 2.99 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 115.295 -0.866 . . . . 1.73 109.419 176.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.429 ' HG ' ' CG1' ' A' ' 36' ' ' VAL . 9.5 mt -53.18 -36.58 61.08 Favored 'General case' 0 C--N 1.342 0.245 0 C-N-CA 123.35 0.66 . . . . 3.46 110.832 173.752 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 16.3 tpt -51.42 -39.66 57.77 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.715 0.806 . . . . 6.0300000000000002 111.809 173.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -88.68 -23.94 22.88 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.621 0.769 . . . . 1.9399999999999999 111.436 178.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 89.09 41.83 5.77 Favored Glycine 0 C--N 1.335 0.488 0 N-CA-C 110.188 -1.165 . . . . 1.05 110.188 179.048 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 58.4 pttt -156.1 158.16 37.25 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 107.879 -1.156 . . . . 4.3300000000000001 107.879 177.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -83.88 163.98 19.73 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 108.798 -0.816 . . . . 2.4300000000000002 108.798 170.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -131.2 157.72 42.44 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.214 -0.661 . . . . 2.77 109.214 174.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 13.4 m -134.7 142.43 40.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 N-CA-C 109.432 -0.581 . . . . 3.8700000000000001 109.432 173.1 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 49.1 ttt180 -127.02 125.72 41.9 Favored 'General case' 0 CA--C 1.516 -0.353 0 N-CA-C 106.487 -1.671 . . . . 6.4500000000000002 106.487 158.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 22.1 p90 -157.37 171.94 19.49 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 109.187 -0.672 . . . . 3.4199999999999999 109.187 -163.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 50.7 t-20 -103.69 93.52 5.22 Favored Pre-proline 0 CA--C 1.534 0.329 0 C-N-CA 123.207 0.603 . . . . 2.71 110.544 176.12 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -65.24 80.86 0.21 Allowed 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 123.015 2.477 . . . . 1.6799999999999999 110.26 169.37 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -168.85 -56.61 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 128.916 2.886 . . . . 1.98 104.894 172.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 68.1 t -57.24 -55.42 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 C-N-CA 124.509 1.124 . . . . 1.8200000000000001 109.689 171.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.406 ' CG2' ' H ' ' A' ' 53' ' ' GLN 0.251 9.7 tp -95.73 -75.82 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.369 0 CA-C-O 118.514 -0.755 . . . . 3.6299999999999999 111.54 -172.079 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.406 ' H ' ' CG2' ' A' ' 52' ' ' ILE . 0.0 OUTLIER 114.2 137.06 0.0 OUTLIER Pre-proline 0 N--CA 1.47 0.545 0 C-N-CA 130.815 3.646 . . . . 3.3199999999999998 107.012 -173.163 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_exo -50.98 -50.89 12.46 Favored 'Trans proline' 0 CA--C 1.534 0.476 0 C-N-CA 123.432 2.755 . . . . 1.1899999999999999 114.57 176.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -52.1 -48.8 19.84 Favored 'Trans proline' 0 N--CA 1.444 -1.406 0 CA-C-N 120.525 1.223 . . . . 1.1399999999999999 110.383 168.084 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 62.7 mtt -66.14 -35.05 79.45 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 118.447 -1.301 . . . . 4.0700000000000003 110.879 -171.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 4.4 tt -70.13 -44.98 77.64 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 CA-C-N 119.502 1.047 . . . . 3.21 109.933 176.274 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -53.67 -41.06 66.47 Favored 'General case' 0 C--N 1.341 0.228 0 N-CA-C 112.266 0.469 . . . . 2.1299999999999999 112.266 175.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 30.8 mm-40 -66.66 -59.94 3.15 Favored 'General case' 0 N--CA 1.437 -1.093 0 C-N-CA 124.94 1.296 . . . . 2.6200000000000001 110.564 174.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -54.41 -42.75 70.84 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 117.897 0.317 . . . . 5.8700000000000001 110.231 -170.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.8 mt -56.26 -37.15 48.85 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 O-C-N 121.487 -0.758 . . . . 2.75 111.637 176.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 42.6 mtm105 -70.18 -44.33 68.94 Favored 'General case' 0 N--CA 1.456 -0.142 0 O-C-N 121.605 -0.684 . . . . 4.6100000000000003 111.22 173.27 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -56.55 -33.89 66.55 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 119.189 0.904 . . . . 3.2400000000000002 111.604 175.266 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 83.6 mt -78.74 -16.58 57.04 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.845 0.858 . . . . 4.0099999999999998 111.362 175.253 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 136.65 -12.49 3.98 Favored Glycine 0 CA--C 1.528 0.852 0 CA-C-O 119.335 -0.703 . . . . 2.7599999999999998 113.988 164.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -107.94 119.43 39.44 Favored 'General case' 0 CA--C 1.522 -0.125 0 CA-C-N 118.738 1.269 . . . . 5.1600000000000001 110.523 -159.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -68.44 69.4 0.37 Allowed Glycine 0 C--N 1.336 0.574 0 C-N-CA 125.917 1.722 . . . . 1.74 113.969 -172.222 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -83.6 121.13 26.83 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 126.482 1.913 . . . . 2.25 110.738 -173.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 25.7 p -124.04 119.39 29.37 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 125.486 1.514 . . . . 3.6400000000000001 108.504 -179.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 74.9 t -81.03 128.46 38.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 C-N-CA 124.917 1.287 . . . . 2.8300000000000001 109.54 -165.486 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 5.0 pt -139.13 59.49 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-O 122.197 0.999 . . . . 4.1399999999999997 112.174 -173.335 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 . . . . . 0 N--CA 1.448 -0.537 0 N-CA-C 108.596 -0.89 . . . . 5.0800000000000001 108.596 171.092 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 27.9 t . . . . . 0 C--O 1.236 0.349 0 N-CA-C 110.094 -0.336 . . . . 3.9300000000000002 110.094 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 10.6 p -85.8 141.31 29.75 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 126.245 1.818 . . . . 4.0800000000000001 108.259 164.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.35 147.87 28.71 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 105.384 -2.08 . . . . 8.6500000000000004 105.384 169.644 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 32.6 t -150.74 159.74 44.32 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 106.497 -1.668 . . . . 1.9299999999999999 106.497 176.167 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -135.3 148.39 49.49 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 106.143 -1.799 . . . . 4.6299999999999999 106.143 -178.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.1 pt -141.3 121.61 12.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 108.178 -1.045 . . . . 4.0 108.178 -168.28 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 24.1 tp60 -80.81 125.2 29.79 Favored 'General case' 0 N--CA 1.438 -1.033 0 N-CA-C 103.685 -2.709 . . . . 3.75 103.685 174.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.1 p -136.15 136.98 49.02 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.175 0 C-N-CA 123.803 0.841 . . . . 3.8300000000000001 110.169 -168.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.7 m -83.3 67.54 9.3 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 115.86 -0.609 . . . . 3.2200000000000002 111.843 -164.375 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 143.78 90.64 0.12 Allowed Glycine 0 CA--C 1.505 -0.548 0 N-CA-C 108.394 -1.882 . . . . 2.79 108.394 164.137 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 6.0 mmt -102.14 -56.16 2.33 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 110.704 -2.748 . . . . 8.1500000000000004 109.713 171.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.8 m -72.35 57.06 0.37 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.594 1.158 . . . . 6.0499999999999998 109.056 172.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 4.3 t -112.13 173.55 6.31 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 126.946 2.099 . . . . 3.6000000000000001 105.954 179.041 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -81.68 123.09 28.42 Favored 'General case' 0 CA--C 1.52 -0.208 0 N-CA-C 107.204 -1.406 . . . . 3.21 107.204 166.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 27.5 t 57.33 -84.65 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 118.607 -0.711 . . . . 4.29 109.227 -152.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 5.3 m -19.36 -21.35 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 118.142 2.645 . . . . 3.0499999999999998 118.142 -99.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.54 ' CG2' ' CG1' ' A' ' 36' ' ' VAL . 0.3 OUTLIER -41.18 -38.08 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 N-CA-C 115.502 1.667 . . . . 3.9500000000000002 115.502 172.326 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.26 -44.39 83.88 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.137 0.494 . . . . 1.98 110.83 177.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -61.47 -51.04 70.31 Favored 'General case' 0 C--O 1.222 -0.365 0 N-CA-C 108.408 -0.96 . . . . 2.21 108.408 174.047 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.475 ' O ' ' ND2' ' A' ' 24' ' ' ASN 0.251 11.1 mm -47.78 -60.84 0.56 Allowed 'Isoleucine or valine' 0 C--O 1.209 -1.052 0 C-N-CA 124.59 1.156 . . . . 3.6000000000000001 109.479 175.0 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -43.44 -45.77 6.45 Favored 'General case' 0 C--N 1.318 -0.771 0 O-C-N 116.911 -3.618 . . . . 4.9100000000000001 114.274 172.355 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 27.1 mmt85 -64.07 -31.56 72.79 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 120.857 -1.152 . . . . 5.8499999999999996 113.568 168.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.486 ' ND2' ' H ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -60.6 -67.27 0.41 Allowed 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 127.423 2.289 . . . . 5.1500000000000004 111.666 -171.522 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.486 ' H ' ' ND2' ' A' ' 24' ' ' ASN 0.354 5.2 mp -75.05 -26.98 59.81 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 119.508 -0.877 . . . . 4.3099999999999996 111.086 -163.163 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 92.8 mtt180 -61.74 -17.59 56.46 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 113.8 1.037 . . . . 7.71 113.8 168.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 23.6 mmt180 -57.11 -40.06 76.32 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 120.205 1.366 . . . . 9.5700000000000003 111.254 166.253 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -100.48 79.71 2.14 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-O 121.662 0.744 . . . . 9.2200000000000006 109.523 -146.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -37.02 114.91 0.35 Allowed 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 125.412 1.485 . . . . 5.6299999999999999 111.229 176.235 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 122.71 -21.73 7.47 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 111.048 -0.821 . . . . 1.3700000000000001 111.048 -167.23 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 1.2 mm -78.17 146.3 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 C-N-CA 125.079 1.352 . . . . 4.0999999999999996 108.282 164.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -137.96 37.37 2.37 Favored 'General case' 0 C--N 1.342 0.261 0 CA-C-O 123.065 1.412 . . . . 4.7599999999999998 113.002 153.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.417 ' CB ' ' HE ' ' A' ' 46' ' ' ARG . 0.5 OUTLIER -167.88 124.65 1.11 Allowed 'General case' 0 C--N 1.318 -0.8 0 C-N-CA 125.19 1.396 . . . . 3.5499999999999998 109.026 172.134 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.426 ' CD1' ' C ' ' A' ' 34' ' ' ILE . 0.0 OUTLIER -106.83 105.5 18.88 Favored 'Isoleucine or valine' 0 C--N 1.346 0.418 0 CA-C-N 119.872 1.214 . . . . 3.6000000000000001 108.929 168.237 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.473 ' N ' ' CD1' ' A' ' 35' ' ' LEU . 6.7 mp -118.22 151.77 36.99 Favored 'General case' 0 CA--C 1.502 -0.878 0 N-CA-C 106.612 -1.625 . . . . 8.9800000000000004 106.612 -168.639 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.54 ' CG1' ' CG2' ' A' ' 18' ' ' VAL 0.286 1.0 OUTLIER -159.68 95.2 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.427 -1.624 0 CA-C-O 122.647 1.213 . . . . 2.4900000000000002 111.12 -172.842 . . . . . . . . 4 4 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -80.11 73.37 6.94 Favored 'General case' 0 CA--C 1.532 0.277 0 O-C-N 119.966 -1.709 . . . . 2.25 109.109 178.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 80.6 mt -44.22 -52.35 7.5 Favored 'General case' 0 C--N 1.342 0.243 0 C-N-CA 124.414 1.086 . . . . 3.7400000000000002 111.227 -176.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 75.1 mtm -56.11 -32.62 64.35 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.912 1.285 . . . . 4.1399999999999997 112.272 -178.016 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -84.05 -2.11 56.09 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 122.932 0.493 . . . . 2.3300000000000001 111.77 179.235 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 82.36 18.86 65.64 Favored Glycine 0 C--N 1.337 0.623 0 N-CA-C 111.12 -0.792 . . . . 1.6699999999999999 111.12 175.112 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 26.7 pttt -146.78 146.85 30.41 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 118.223 1.011 . . . . 5.4900000000000002 111.741 -170.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -83.99 162.92 20.25 Favored 'General case' 0 N--CA 1.442 -0.835 0 C-N-CA 124.904 1.282 . . . . 2.5699999999999998 109.618 165.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -135.32 135.84 41.09 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 126.217 1.807 . . . . 3.0 112.808 -170.055 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.0 t -131.47 138.07 53.91 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 O-C-N 120.832 -1.168 . . . . 4.2699999999999996 109.457 -162.29 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.417 ' HE ' ' CB ' ' A' ' 33' ' ' SER . 47.8 ttp180 -150.18 107.59 3.63 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.92 0.888 . . . . 6.4199999999999999 109.512 179.538 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 11.5 p90 -155.58 179.21 9.4 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 124.608 1.163 . . . . 3.6099999999999999 110.168 -155.22 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -118.62 123.01 29.47 Favored Pre-proline 0 CA--C 1.535 0.395 0 C-N-CA 124.167 0.987 . . . . 3.1200000000000001 111.219 176.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -84.44 62.42 6.54 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 121.566 1.511 . . . . 1.6599999999999999 110.236 -173.565 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -131.33 -70.66 0.58 Allowed 'General case' 0 CA--C 1.519 -0.237 0 N-CA-C 107.0 -1.481 . . . . 1.9199999999999999 107.0 177.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 89.6 t -56.55 -44.31 80.43 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.779 0 C-N-CA 124.517 1.127 . . . . 2.4300000000000002 111.035 177.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.3 tt -113.16 -24.01 4.07 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.415 0 N-CA-C 114.053 1.131 . . . . 3.3999999999999999 114.053 -149.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 70.92 120.47 0.03 OUTLIER Pre-proline 0 N--CA 1.471 0.602 0 C-N-CA 125.724 1.609 . . . . 3.3500000000000001 113.228 175.073 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -46.87 -43.51 23.91 Favored 'Trans proline' 0 CA--C 1.532 0.42 0 C-N-CA 124.228 3.286 . . . . 1.5700000000000001 115.77 169.014 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -58.92 -54.35 2.86 Favored 'Trans proline' 0 N--CA 1.442 -1.537 0 CA-C-N 120.835 1.334 . . . . 1.4399999999999999 109.762 167.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 52.0 mtp -69.02 -28.58 66.7 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 118.396 -1.322 . . . . 3.1899999999999999 111.622 -166.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 12.4 tt -64.43 -37.04 78.98 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 CA-C-N 119.713 1.142 . . . . 3.02 110.844 174.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.8 -47.64 84.89 Favored 'General case' 0 N--CA 1.455 -0.176 0 O-C-N 121.416 -0.803 . . . . 2.0800000000000001 111.159 171.155 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -60.84 -57.47 12.54 Favored 'General case' 0 N--CA 1.432 -1.367 0 C-N-CA 123.718 0.807 . . . . 2.9399999999999999 112.355 -178.237 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -49.4 -38.51 29.16 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 123.488 0.715 . . . . 4.9900000000000002 111.386 -173.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 90.2 mt -60.99 -47.36 93.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 O-C-N 121.644 -0.66 . . . . 2.4700000000000002 110.894 175.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 22.2 mtm105 -66.28 -32.1 73.3 Favored 'General case' 0 CA--C 1.522 -0.113 0 O-C-N 121.588 -0.695 . . . . 4.5599999999999996 112.113 177.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 78.3 mt-10 -58.44 -23.55 57.78 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 118.699 0.681 . . . . 3.27 112.264 172.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 66.0 mt -80.81 -15.98 54.95 Favored 'General case' 0 CA--C 1.535 0.37 0 O-C-N 121.515 -0.741 . . . . 2.7599999999999998 111.568 173.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 112.08 -11.39 26.88 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 125.265 1.412 . . . . 3.2400000000000002 111.717 -177.129 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -79.8 101.63 8.6 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 117.812 0.806 . . . . 4.3899999999999997 110.167 -173.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -63.94 86.45 0.06 OUTLIER Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 125.26 1.41 . . . . 1.53 110.89 -179.26 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -111.51 130.11 55.83 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 128.211 2.604 . . . . 1.8300000000000001 111.526 -173.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 5.3 t -121.65 138.42 54.34 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 125.309 1.444 . . . . 2.77 107.301 175.194 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.7 t -83.54 136.36 22.97 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 C-N-CA 125.869 1.667 . . . . 2.8399999999999999 110.173 -171.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 36.5 mt -145.87 83.94 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 125.301 1.44 . . . . 2.8700000000000001 109.258 -176.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 31.8 mp0 . . . . . 0 C--N 1.326 -0.444 0 C-N-CA 123.932 0.893 . . . . 4.7199999999999998 110.471 160.845 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 12.9 m . . . . . 0 CA--C 1.538 0.49 0 CA-C-O 122.148 0.975 . . . . 2.9300000000000002 112.969 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.2 m -157.35 170.48 22.37 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 128.13 2.572 . . . . 2.5899999999999999 105.873 172.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 75.8 tttt -130.51 152.76 49.54 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 108.548 -0.908 . . . . 4.1399999999999997 108.548 177.052 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 47.1 t -148.56 156.3 42.26 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 107.505 -1.294 . . . . 2.1000000000000001 107.505 170.257 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 -106.15 138.05 43.0 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 107.123 -1.436 . . . . 3.6200000000000001 107.123 169.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 15.9 mt -138.09 139.53 42.07 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 N-CA-C 104.357 -2.46 . . . . 2.52 104.357 -172.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 11.5 mt-30 -122.6 119.34 30.51 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 120.127 1.33 . . . . 5.2400000000000002 108.327 -177.201 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 99.1 t -112.32 138.83 39.85 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 O-C-N 124.184 0.928 . . . . 3.8599999999999999 110.766 -158.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.4 m -66.86 -42.88 84.92 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 113.492 0.923 . . . . 2.6499999999999999 113.492 -168.063 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -138.77 48.59 0.86 Allowed Glycine 0 C--N 1.341 0.831 0 CA-C-O 124.252 2.029 . . . . 3.7000000000000002 111.226 172.19 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . 0.257 42.7 ttp -14.31 -52.2 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 109.408 -3.396 . . . . 4.4500000000000002 111.206 136.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 12.8 t -122.07 126.38 48.3 Favored 'General case' 0 N--CA 1.44 -0.963 0 C-N-CA 126.531 1.933 . . . . 5.1200000000000001 106.591 168.126 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.3 p -110.92 64.98 0.61 Allowed 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 107.134 -1.432 . . . . 3.1600000000000001 107.134 119.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 64.87 -64.57 0.16 Allowed 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 128.507 2.723 . . . . 3.2999999999999998 111.737 -172.199 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.1 m -47.24 -49.25 23.69 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 127.001 2.12 . . . . 4.3499999999999996 112.133 -179.481 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 74.8 m -69.04 -20.16 64.11 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 114.59 1.329 . . . . 3.1299999999999999 114.59 -142.089 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 1.2 t -52.89 -37.96 27.25 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.281 0 CA-C-N 119.09 0.859 . . . . 3.4700000000000002 110.398 169.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.3 -52.22 65.33 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 123.139 0.576 . . . . 2.5 110.515 171.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -58.66 -53.75 54.87 Favored 'General case' 0 C--O 1.227 -0.102 0 C-N-CA 124.189 0.996 . . . . 2.2599999999999998 109.157 -176.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.4 mt -49.04 -60.87 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.997 0 C-N-CA 125.557 1.543 . . . . 2.5699999999999998 109.789 174.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -48.09 -59.74 3.16 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 119.916 1.235 . . . . 4.0099999999999998 113.049 176.018 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.49 -39.12 67.23 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.161 0.584 . . . . 7.8799999999999999 110.764 -177.06 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 -64.88 -60.87 2.58 Favored 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 108.417 -0.957 . . . . 3.1299999999999999 108.417 178.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.13 -42.61 59.73 Favored 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 111.911 0.337 . . . . 3.3100000000000001 111.911 -161.075 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 4.5 ttm180 -67.4 -19.17 65.36 Favored 'General case' 0 N--CA 1.433 -1.285 0 CA-C-N 119.022 0.828 . . . . 8.3399999999999999 112.526 -160.242 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 31.3 mtm105 -45.82 -61.56 1.67 Allowed 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.039 0.936 . . . . 7.7800000000000002 111.941 -177.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -175.32 12.78 0.01 OUTLIER 'General case' 0 N--CA 1.461 0.119 0 N-CA-C 114.311 1.226 . . . . 7.0999999999999996 114.311 -158.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -101.24 53.49 0.83 Allowed 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 122.587 1.184 . . . . 6.5899999999999999 108.877 -144.135 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 57.56 12.29 9.14 Favored Glycine 0 CA--C 1.531 1.091 0 CA-C-N 114.053 -1.431 . . . . 1.76 113.377 -172.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 1.1 pp -84.83 161.89 3.05 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 CA-C-N 119.238 1.519 . . . . 5.5800000000000001 110.645 -177.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -146.61 46.0 1.2 Allowed 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 122.596 1.189 . . . . 3.6699999999999999 111.666 146.101 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 70.0 m -164.16 175.91 9.74 Favored 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 131.094 3.757 . . . . 2.8799999999999999 105.22 154.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.2 pp -105.06 138.48 29.75 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.133 0 CA-C-O 122.421 1.105 . . . . 2.8999999999999999 109.859 160.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.402 ' CD2' ' N ' ' A' ' 35' ' ' LEU . 0.1 OUTLIER -77.4 66.47 3.16 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 129.684 3.194 . . . . 5.4699999999999998 111.021 -178.157 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 19.2 t -134.51 140.53 45.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 O-C-N 121.139 -0.976 . . . . 1.78 110.078 169.284 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -150.18 64.47 0.96 Allowed 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 103.31 -2.848 . . . . 1.8899999999999999 103.31 162.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -59.04 -43.26 91.64 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 108.517 -0.92 . . . . 4.21 108.517 -173.643 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 66.9 mtt -44.25 -37.48 3.26 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.556 0.742 . . . . 5.29 112.795 169.209 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -97.52 -10.25 25.61 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.564 1.146 . . . . 2.52 112.923 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 87.44 36.87 8.45 Favored Glycine 0 C--N 1.341 0.825 0 CA-C-N 120.114 1.325 . . . . 1.23 110.956 173.138 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 2.3 ptmt -162.47 178.52 8.54 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 119.03 1.415 . . . . 4.25 110.25 -174.278 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -118.56 133.02 56.18 Favored 'General case' 0 N--CA 1.441 -0.907 0 C-N-CA 128.051 2.54 . . . . 2.0099999999999998 108.899 175.066 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -126.06 82.58 2.08 Favored 'General case' 0 C--N 1.339 0.127 0 C-N-CA 123.995 0.918 . . . . 3.0 112.012 -172.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 9.9 p -83.19 134.53 26.72 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 C-N-CA 123.237 0.615 . . . . 2.6000000000000001 110.39 -169.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 35.6 ttm105 -113.14 127.64 56.25 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 103.955 -2.609 . . . . 5.0599999999999996 103.955 158.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 4.2 p90 -157.73 175.36 14.0 Favored 'General case' 0 CA--C 1.515 -0.373 0 C-N-CA 123.407 0.683 . . . . 3.3900000000000001 109.279 -170.172 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -122.68 94.63 47.39 Favored Pre-proline 0 CA--C 1.533 0.325 0 CA-C-O 119.021 -0.514 . . . . 3.29 110.245 178.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -71.36 73.73 2.12 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 123.78 2.987 . . . . 1.46 112.234 -176.105 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -146.93 -51.61 0.21 Allowed 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 125.883 1.673 . . . . 2.2000000000000002 106.533 165.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 95.9 t -53.95 -57.61 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.768 0 C-N-CA 124.517 1.127 . . . . 2.0699999999999998 109.535 170.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . 0.252 11.5 tt -94.81 -71.08 0.58 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.371 0 CA-C-O 118.341 -0.838 . . . . 2.71 113.169 -169.454 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 109.54 139.45 0.0 OUTLIER Pre-proline 0 N--CA 1.469 0.523 0 C-N-CA 129.993 3.317 . . . . 3.7400000000000002 108.498 -173.54 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_exo -51.27 -50.86 12.58 Favored 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 124.215 3.277 . . . . 1.23 114.595 172.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -47.03 -55.55 3.79 Favored 'Trans proline' 0 N--CA 1.446 -1.308 0 C-N-CA 121.533 1.489 . . . . 1.25 110.308 166.147 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 25.1 mtm -62.66 -35.87 81.04 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 118.067 -1.453 . . . . 3.02 112.242 -172.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . 0.261 2.7 tt -68.35 -39.56 81.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-N 119.023 0.829 . . . . 2.96 111.035 179.391 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.22 -55.6 32.87 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 118.933 0.788 . . . . 1.75 112.162 169.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -50.25 -47.04 55.33 Favored 'General case' 0 N--CA 1.442 -0.864 0 C-N-CA 126.169 1.788 . . . . 4.0499999999999998 110.835 -178.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -46.1 -42.76 14.08 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.246 0.618 . . . . 5.7999999999999998 112.325 174.433 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 40.7 mt -74.63 -44.6 46.61 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 N-CA-C 108.405 -0.961 . . . . 2.52 108.405 -177.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.1 -62.13 1.97 Allowed 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 124.969 1.308 . . . . 9.2699999999999996 112.894 -178.409 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -57.64 -58.71 7.12 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 124.117 0.967 . . . . 3.1299999999999999 111.447 -163.042 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.33 -34.39 23.69 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 122.766 0.427 . . . . 3.2000000000000002 111.649 -179.033 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -93.66 -91.69 1.58 Allowed Glycine 0 CA--C 1.525 0.709 0 N-CA-C 111.089 -0.805 . . . . 2.8599999999999999 111.089 -174.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -138.1 -79.17 0.36 Allowed 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 122.422 1.106 . . . . 3.9500000000000002 112.837 -157.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 156.19 122.38 0.75 Allowed Glycine 0 N--CA 1.445 -0.707 0 N-CA-C 105.406 -3.078 . . . . 2.1600000000000001 105.406 -143.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -145.86 116.67 7.71 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 107.929 -1.137 . . . . 2.1200000000000001 107.929 -167.318 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 41.1 p -93.7 118.52 31.5 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 107.093 -1.447 . . . . 3.1899999999999999 107.093 176.318 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.2 t -83.56 121.29 36.08 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 N-CA-C 107.176 -1.416 . . . . 2.6200000000000001 107.176 177.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 47.0 mt -145.24 77.12 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.307 0 N-CA-C 108.213 -1.032 . . . . 2.7400000000000002 108.213 -169.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 . . . . . 0 CA--C 1.541 0.601 0 C-N-CA 123.893 0.877 . . . . 5.1299999999999999 111.011 166.803 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.7 p . . . . . 0 CA--C 1.529 0.169 0 CA-C-O 122.779 1.276 . . . . 3.5499999999999998 110.181 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.8 m -106.73 142.37 36.47 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 125.929 1.692 . . . . 2.9700000000000002 108.471 -165.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 18.7 ttpt -93.58 154.05 18.07 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 118.96 -0.543 . . . . 4.5099999999999998 110.219 177.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 9.3 t -153.59 160.63 42.5 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 108.377 -0.972 . . . . 2.79 108.377 167.234 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -105.41 157.62 17.22 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.376 1.071 . . . . 3.6800000000000002 109.249 -173.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.3 mt -145.22 147.05 19.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 N-CA-C 107.315 -1.365 . . . . 2.77 107.315 179.504 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 -108.59 141.26 40.78 Favored 'General case' 0 C--O 1.232 0.16 0 N-CA-C 107.88 -1.156 . . . . 5.25 107.88 170.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 57.0 t -108.08 126.27 64.67 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 O-C-N 124.086 0.866 . . . . 3.8500000000000001 109.807 179.163 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 11.1 m -75.33 75.3 2.43 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.61 0.764 . . . . 3.5299999999999998 110.968 -179.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 164.05 -62.47 0.25 Allowed Glycine 0 C--O 1.227 -0.323 0 N-CA-C 105.544 -3.022 . . . . 4.0300000000000002 105.544 173.382 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . 0.333 0.0 OUTLIER 59.28 138.38 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 129.347 3.059 . . . . 4.7699999999999996 114.512 178.352 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 7.0 m 73.31 -59.11 0.58 Allowed 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 126.161 1.784 . . . . 5.79 109.767 -177.395 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 38.5 m 51.38 -124.27 2.22 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.893 1.277 . . . . 3.1299999999999999 108.729 170.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -155.86 142.95 19.11 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 106.099 -1.815 . . . . 2.7999999999999998 106.099 152.397 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 56.9 p 64.54 -25.1 0.08 Allowed 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 116.536 2.05 . . . . 3.9500000000000002 116.536 -179.266 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 99.2 m -38.57 -38.69 0.41 Allowed 'General case' 0 C--O 1.225 -0.236 0 C-N-CA 125.141 1.376 . . . . 2.8500000000000001 112.186 171.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.6 t -65.38 -45.97 91.64 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.359 0 C-N-CA 124.544 1.137 . . . . 3.48 109.796 -178.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.97 -47.01 78.43 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 123.603 0.761 . . . . 2.4700000000000002 109.292 173.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -58.18 -58.52 8.12 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 109.005 -0.739 . . . . 2.29 109.005 179.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 40.5 mt -46.62 -60.05 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 C-N-CA 126.308 1.843 . . . . 2.6600000000000001 110.343 179.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 73.1 mt-10 -47.38 -61.77 1.75 Allowed 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.494 0.718 . . . . 3.0499999999999998 111.783 174.174 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 7.1 mpt_? -62.06 -32.59 73.13 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.978 -0.555 . . . . 7.6399999999999997 111.308 -168.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 18.9 m-20 -71.85 -64.58 0.9 Allowed 'General case' 0 CA--C 1.528 0.134 0 CA-C-O 121.515 0.674 . . . . 3.6400000000000001 110.67 175.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.3 mt -78.73 -9.87 59.57 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 125.556 1.542 . . . . 4.8799999999999999 111.545 -162.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.502 ' CG ' ' H ' ' A' ' 27' ' ' ARG . 0.0 OUTLIER -21.36 -77.34 0.01 OUTLIER 'General case' 0 N--CA 1.444 -0.76 0 C-N-CA 130.223 3.409 . . . . 9.8200000000000003 112.917 -166.411 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.502 ' H ' ' CG ' ' A' ' 26' ' ' ARG . 11.1 ptp180 -92.76 -37.93 12.07 Favored 'General case' 0 N--CA 1.435 -1.185 0 C-N-CA 129.284 3.034 . . . . 13.529999999999999 116.501 154.552 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 11.22 56.15 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.289 1.436 . . . . 8.0199999999999996 113.455 -144.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 14.3 mp0 32.07 54.53 0.31 Allowed 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 128.125 2.57 . . . . 7.6299999999999999 112.711 -174.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 179.3 -37.49 0.07 OUTLIER Glycine 0 CA--C 1.54 1.612 0 C-N-CA 123.979 0.8 . . . . 1.8500000000000001 113.978 -172.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 6.0 mt -81.98 145.85 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 C-N-CA 127.705 2.402 . . . . 3.0299999999999998 107.199 167.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 79.7 m-85 -147.45 47.8 1.12 Allowed 'General case' 0 N--CA 1.456 -0.15 0 CA-C-O 122.315 1.055 . . . . 5.5700000000000003 111.119 157.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.8 t -168.15 135.64 2.17 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 126.15 1.78 . . . . 2.73 106.972 145.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.7 pp -82.98 152.06 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 CA-C-O 123.582 1.658 . . . . 2.77 112.223 -171.197 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.497 ' H ' ' CD2' ' A' ' 35' ' ' LEU . 1.9 pt? -76.48 58.48 1.34 Allowed 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 131.517 3.927 . . . . 5.5999999999999996 111.541 -167.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 76.8 t -135.46 122.99 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 O-C-N 121.129 -0.982 . . . . 2.1800000000000002 113.556 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -133.56 57.23 1.81 Allowed 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 106.43 -1.692 . . . . 1.79 106.43 150.351 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -75.45 -6.39 49.87 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 123.615 0.766 . . . . 6.4900000000000002 111.838 -175.122 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 66.8 mtt -59.49 -41.02 88.87 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 109.791 -0.448 . . . . 5.79 109.791 161.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -86.99 -41.25 14.04 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.133 0.573 . . . . 2.1699999999999999 110.072 177.305 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 117.95 48.0 0.42 Allowed Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.094 -1.202 . . . . 0.93000000000000005 110.094 176.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -162.48 177.53 9.41 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 106.561 -1.644 . . . . 5.04 106.561 -170.166 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -140.89 140.59 34.56 Favored 'General case' 0 N--CA 1.441 -0.906 0 C-N-CA 125.132 1.373 . . . . 2.0600000000000001 108.887 -167.509 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -141.86 104.72 4.56 Favored 'General case' 0 C--N 1.344 0.363 0 CA-C-N 118.968 0.804 . . . . 3.2599999999999998 110.538 179.421 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.7 p -90.99 142.09 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.101 0 C-N-CA 124.33 1.052 . . . . 2.7400000000000002 108.474 -172.358 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 16.6 tpp180 -107.43 122.63 47.0 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 106.07 -1.826 . . . . 6.0700000000000003 106.07 163.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -160.45 179.13 8.88 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 118.832 0.742 . . . . 3.6200000000000001 112.19 -168.725 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 35.7 m-20 -109.24 109.82 60.46 Favored Pre-proline 0 CA--C 1.53 0.198 0 N-CA-C 108.123 -1.066 . . . . 3.6000000000000001 108.123 163.206 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -76.4 58.77 5.88 Favored 'Trans proline' 0 CA--C 1.536 0.603 0 C-N-CA 123.508 2.805 . . . . 2.3199999999999998 110.598 -178.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -157.44 -51.08 0.07 Allowed 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 125.873 1.669 . . . . 2.8900000000000001 107.224 -172.217 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 74.1 t -61.24 -43.56 96.71 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.866 0 C-N-CA 124.34 1.056 . . . . 2.7400000000000002 109.867 173.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.2 tp -109.52 -54.62 5.42 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.255 0 C-N-CA 122.891 0.476 . . . . 2.6600000000000001 110.743 -175.06 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 2.2 mm-40 95.5 128.35 0.02 OUTLIER Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 129.21 3.004 . . . . 4.2599999999999998 110.813 171.547 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -55.88 -43.26 58.79 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 123.506 2.804 . . . . 1.26 116.521 -172.444 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -58.35 -43.1 49.32 Favored 'Trans proline' 0 N--CA 1.445 -1.347 0 CA-C-N 121.533 1.583 . . . . 1.1699999999999999 109.079 175.377 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 63.5 mtt -61.77 -44.51 96.75 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 118.403 -0.808 . . . . 2.8900000000000001 109.928 179.233 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -62.27 -48.54 87.89 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 CA-C-N 120.084 1.311 . . . . 3.5299999999999998 110.903 177.359 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -54.23 -38.45 65.75 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 124.332 1.053 . . . . 2.1000000000000001 112.165 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -70.01 -60.7 2.14 Favored 'General case' 0 N--CA 1.442 -0.828 0 C-N-CA 125.405 1.482 . . . . 3.3100000000000001 110.644 172.185 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -44.91 -43.78 9.18 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 124.191 0.996 . . . . 4.9699999999999998 112.464 -177.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 67.8 mt -63.23 -43.54 98.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 O-C-N 121.912 -0.493 . . . . 2.1099999999999999 110.017 -178.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . 0.301 7.6 ptp180 -70.83 -42.16 70.56 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-O 119.359 -0.353 . . . . 4.6100000000000003 111.604 179.152 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -55.39 -45.05 76.65 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.154 0.981 . . . . 3.0499999999999998 110.836 174.479 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 63.7 mt -81.2 -38.72 26.56 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-O 119.507 -0.283 . . . . 3.3900000000000001 110.628 -174.152 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -104.93 -90.77 2.19 Favored Glycine 0 CA--C 1.527 0.808 0 N-CA-C 111.33 -0.708 . . . . 3.02 111.33 179.172 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 18.1 m-85 -142.29 -56.97 0.45 Allowed 'General case' 0 CA--C 1.509 -0.615 0 CA-C-O 122.464 1.126 . . . . 5.0300000000000002 111.699 -157.013 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 162.27 126.3 0.81 Allowed Glycine 0 N--CA 1.432 -1.599 0 N-CA-C 105.784 -2.927 . . . . 1.5700000000000001 105.784 -149.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -157.05 153.77 28.45 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 117.234 0.517 . . . . 2.2599999999999998 110.102 177.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 2.4 t -128.16 144.69 51.13 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 106.747 -1.575 . . . . 3.3399999999999999 106.747 174.434 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 12.6 p -81.23 150.74 4.52 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 N-CA-C 107.173 -1.418 . . . . 3.1699999999999999 107.173 170.178 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 4.8 pt -154.95 175.91 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 C-N-CA 126.368 1.867 . . . . 3.8399999999999999 106.833 177.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 . . . . . 0 N--CA 1.454 -0.259 0 N-CA-C 108.286 -1.005 . . . . 4.8899999999999997 108.286 167.316 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.5 m . . . . . 0 N--CA 1.455 -0.187 0 N-CA-C 109.169 -0.678 . . . . 3.3900000000000001 109.169 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 22.7 m -89.26 161.36 16.45 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 107.916 -1.142 . . . . 2.5699999999999998 107.916 160.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 51.6 mtmt -113.41 160.48 18.37 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 123.777 0.831 . . . . 4.7999999999999998 108.847 162.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 49.7 t -155.52 154.2 31.41 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 106.931 -1.507 . . . . 2.4500000000000002 106.931 170.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -100.93 154.91 18.28 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 122.173 0.987 . . . . 4.1500000000000004 108.663 175.386 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.7 mp -134.04 138.22 50.69 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 N-CA-C 104.792 -2.299 . . . . 2.9700000000000002 104.792 169.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 47.9 tp60 -95.56 122.96 38.86 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 103.332 -2.84 . . . . 3.3900000000000001 103.332 165.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 26.0 m -118.38 147.71 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 C-N-CA 124.671 1.189 . . . . 3.7200000000000002 108.008 -178.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 6.9 m -105.05 70.03 0.88 Allowed 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.02 0.528 . . . . 3.1699999999999999 109.694 -175.557 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 156.55 -36.49 0.59 Allowed Glycine 0 C--N 1.341 0.814 0 C-N-CA 121.029 -0.605 . . . . 2.3599999999999999 114.274 170.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 2.6 mpp? 46.91 42.16 11.81 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.48 1.112 . . . . 4.8399999999999999 110.589 -168.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.2 p 56.78 1.79 0.09 Allowed 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 115.919 1.822 . . . . 11.82 115.919 -173.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . 0.372 0.1 OUTLIER 77.39 174.28 0.2 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 127.334 2.254 . . . . 4.0300000000000002 112.442 -166.695 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.03 132.74 54.37 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.034 0.934 . . . . 5.0999999999999996 111.221 -169.428 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 10.4 m 74.15 -37.68 0.37 Allowed 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.124 1.369 . . . . 5.3700000000000001 113.63 174.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 75.6 m -54.94 -28.41 50.96 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 127.159 2.184 . . . . 5.6699999999999999 111.08 176.011 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 8.1 m -38.31 -40.98 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 N-CA-C 113.378 0.881 . . . . 3.6699999999999999 113.378 164.032 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -45.56 -49.12 14.21 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 124.153 0.981 . . . . 2.6099999999999999 110.876 174.203 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -54.7 -57.43 11.51 Favored 'General case' 0 CA--C 1.519 -0.237 0 N-CA-C 109.346 -0.613 . . . . 3.2000000000000002 109.346 173.403 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 3.6 tp -67.72 -39.29 81.81 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.382 0 CA-C-N 118.401 0.546 . . . . 5.7300000000000004 109.816 -163.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.408 ' HG2' ' CG1' ' A' ' 34' ' ' ILE . 59.0 mt-10 -56.18 -56.6 18.94 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.993 1.317 . . . . 3.6699999999999999 110.61 171.233 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.7 tmt_? -52.99 -39.36 63.0 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 109.616 -0.513 . . . . 7.4400000000000004 109.616 176.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -72.41 -42.28 65.31 Favored 'General case' 0 N--CA 1.431 -1.383 0 CA-C-O 118.037 -0.983 . . . . 3.6699999999999999 109.148 -178.187 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -56.72 -37.89 71.59 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 121.335 1.88 . . . . 3.3199999999999998 109.253 176.71 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 56.7 mtp180 -65.46 -12.34 51.56 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 115.262 1.578 . . . . 7.2800000000000002 115.262 175.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -66.02 -17.87 64.97 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 121.028 1.74 . . . . 9.3399999999999999 111.294 167.247 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -104.06 90.85 3.72 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 108.931 -0.766 . . . . 7.7400000000000002 108.931 -166.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -43.64 133.15 4.69 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 107.724 -1.213 . . . . 8.4399999999999995 107.724 166.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 110.82 -36.27 4.33 Favored Glycine 0 CA--C 1.527 0.787 0 CA-C-O 118.639 -1.09 . . . . 1.9199999999999999 111.786 -166.149 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.7 mt -83.03 126.44 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 CA-C-N 119.316 1.558 . . . . 3.1200000000000001 108.772 174.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -134.89 42.07 2.82 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 122.363 1.078 . . . . 3.8300000000000001 112.4 160.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 9.1 t -167.76 137.78 2.73 Favored 'General case' 0 C--N 1.316 -0.866 0 C-N-CA 128.008 2.523 . . . . 3.3199999999999998 106.911 144.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.552 ' H ' ' CD1' ' A' ' 34' ' ' ILE . 0.0 OUTLIER -78.86 134.54 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.369 0 CA-C-O 122.814 1.293 . . . . 3.2400000000000002 109.535 -179.598 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -81.31 68.21 7.54 Favored 'General case' 0 N--CA 1.431 -1.382 0 CA-C-N 115.317 -0.856 . . . . 5.5499999999999998 110.481 -176.527 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 4.9 t -130.42 139.46 51.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 121.917 0.865 . . . . 2.5899999999999999 111.487 167.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -151.95 72.8 1.03 Allowed 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 127.602 2.361 . . . . 2.1400000000000001 107.621 169.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.496 ' H ' ' CD2' ' A' ' 38' ' ' LEU . 0.2 OUTLIER -46.96 -43.69 19.38 Favored 'General case' 0 CA--C 1.509 -0.621 0 C-N-CA 124.08 0.952 . . . . 4.3899999999999997 110.572 169.006 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 24.3 ptt? -79.81 42.31 0.53 Allowed 'General case' 0 CA--C 1.545 0.786 0 CA-C-O 121.65 0.738 . . . . 5.71 111.649 -167.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -178.23 -40.81 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 129.751 3.22 . . . . 2.3500000000000001 106.878 -171.423 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 98.44 49.9 1.63 Allowed Glycine 0 C--N 1.339 0.735 0 N-CA-C 108.072 -2.011 . . . . 0.97999999999999998 108.072 172.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 46.5 mttm -152.7 179.87 8.24 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 126.217 1.807 . . . . 5.6699999999999999 108.727 -158.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -151.18 131.71 13.86 Favored 'General case' 0 N--CA 1.442 -0.831 0 C-N-CA 125.29 1.436 . . . . 2.25 108.109 -171.174 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -136.59 102.96 5.08 Favored 'General case' 0 C--N 1.342 0.242 0 CA-C-N 118.967 0.803 . . . . 2.77 112.22 -175.627 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.4 p -82.65 146.94 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.215 0 N-CA-C 108.989 -0.745 . . . . 2.77 108.989 -176.536 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 60.6 ttp180 -122.69 123.25 40.69 Favored 'General case' 0 C--N 1.339 0.126 0 N-CA-C 105.823 -1.917 . . . . 6.5 105.823 159.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 1.5 p90 -160.27 175.23 13.1 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 118.298 0.499 . . . . 3.4300000000000002 110.994 -164.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -110.44 117.94 50.07 Favored Pre-proline 0 CA--C 1.539 0.546 0 C-N-CA 123.472 0.709 . . . . 3.5099999999999998 109.224 166.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -74.78 23.84 0.38 Allowed 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 122.933 2.422 . . . . 1.98 113.91 -170.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -109.55 -49.33 3.12 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.752 1.221 . . . . 1.8 108.403 -178.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 98.4 t -65.52 -50.3 72.96 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.89 0 C-N-CA 124.271 1.028 . . . . 2.3199999999999998 109.917 -179.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 3.3 tp -102.64 -62.62 2.0 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.391 0 CA-C-O 118.652 -0.69 . . . . 2.46 112.401 -163.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 11.4 mm-40 96.14 127.12 0.02 OUTLIER Pre-proline 0 CA--C 1.548 0.873 0 C-N-CA 129.85 3.26 . . . . 4.29 112.318 176.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_exo -44.15 -51.83 6.29 Favored 'Trans proline' 0 C--N 1.351 0.708 1 C-N-CA 125.349 4.033 . . . . 1.3200000000000001 116.4 174.33 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -52.51 -46.41 33.39 Favored 'Trans proline' 0 N--CA 1.446 -1.291 0 CA-C-N 120.706 1.288 . . . . 0.90000000000000002 110.17 173.284 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 60.1 mtp -64.46 -46.26 83.85 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 118.723 -0.656 . . . . 3.7799999999999998 111.053 -176.541 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 20.6 pt -60.19 -49.91 82.29 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-N 119.897 1.226 . . . . 3.4900000000000002 110.944 175.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -48.04 -49.63 30.66 Favored 'General case' 0 C--N 1.341 0.199 0 C-N-CA 123.442 0.697 . . . . 2.02 110.998 176.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -61.92 -57.1 13.01 Favored 'General case' 0 N--CA 1.434 -1.234 0 C-N-CA 124.234 1.014 . . . . 3.0899999999999999 112.369 178.069 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 9.0 m-30 -47.66 -50.05 25.82 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 118.796 0.726 . . . . 4.75 109.773 -174.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 20.0 mt -51.92 -43.23 35.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 123.319 0.648 . . . . 2.3799999999999999 112.009 175.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 91.2 mtt180 -65.37 -59.4 4.07 Favored 'General case' 0 N--CA 1.457 -0.076 0 N-CA-C 109.477 -0.564 . . . . 5.0700000000000003 109.477 175.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -44.62 -54.54 6.04 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 125.758 1.623 . . . . 2.9399999999999999 111.941 -173.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . 0.253 0.3 OUTLIER -84.37 -13.39 52.43 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 114.071 1.137 . . . . 3.8199999999999998 114.071 179.44 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -152.74 -88.52 0.07 OUTLIER Glycine 0 CA--C 1.531 1.036 0 CA-C-N 119.84 1.2 . . . . 2.48 115.994 -165.105 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -136.43 147.25 47.15 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-O 121.732 0.777 . . . . 4.8300000000000001 112.665 -147.016 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -58.68 108.3 1.49 Allowed Glycine 0 N--CA 1.441 -0.978 0 N-CA-C 109.097 -1.601 . . . . 2.0099999999999998 109.097 177.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -116.54 130.07 56.54 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 126.41 1.884 . . . . 2.2599999999999998 109.088 -173.212 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 41.6 m -128.24 129.29 46.17 Favored 'General case' 0 CA--C 1.528 0.097 0 C-N-CA 124.964 1.306 . . . . 3.9700000000000002 107.921 175.137 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 13.3 p -82.42 140.35 16.53 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 C-N-CA 123.741 0.817 . . . . 3.4300000000000002 109.698 -175.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 46.7 mt -143.26 143.18 25.02 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 125.315 1.446 . . . . 3.1000000000000001 108.493 -175.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 . . . . . 0 N--CA 1.451 -0.387 0 N-CA-C 107.056 -1.461 . . . . 4.1200000000000001 107.056 166.145 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.5 p . . . . . 0 N--CA 1.45 -0.461 0 CA-C-O 121.002 0.429 . . . . 2.7000000000000002 110.833 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 47.5 m -154.93 165.77 35.65 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.419 1.088 . . . . 2.4500000000000002 108.939 179.161 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.53 130.74 56.61 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 125.006 1.322 . . . . 5.54 107.988 174.784 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 51.2 t -123.01 146.42 47.66 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 118.973 0.806 . . . . 2.3100000000000001 109.427 173.196 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -92.24 133.1 36.13 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.47 1.108 . . . . 3.9300000000000002 108.952 172.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.0 mm -124.3 151.9 29.75 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 N-CA-C 103.822 -2.658 . . . . 3.6200000000000001 103.822 178.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 45.1 tp60 -117.37 125.01 50.29 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 103.551 -2.759 . . . . 4.0800000000000001 103.551 168.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.8 m -87.91 141.36 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 N-CA-C 108.695 -0.854 . . . . 3.2799999999999998 108.695 178.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 52.6 p -104.4 84.99 2.27 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 105.255 -2.128 . . . . 4.1799999999999997 105.255 165.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 177.74 -67.82 0.08 OUTLIER Glycine 0 CA--C 1.522 0.493 0 N-CA-C 105.392 -3.083 . . . . 2.3599999999999999 105.392 -178.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 14.1 ttp 70.99 -61.64 0.48 Allowed 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 126.774 2.029 . . . . 4.5800000000000001 112.441 165.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.8 m -142.65 49.43 1.5 Allowed 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 125.946 1.698 . . . . 5.6399999999999997 106.878 173.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.9 p -53.99 -51.77 62.85 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 109.119 -0.697 . . . . 3.4700000000000002 109.119 177.14 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 176.73 120.19 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 127.221 2.209 . . . . 4.7800000000000002 107.352 157.172 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 4.2 p 48.92 38.61 12.65 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.426 0.69 . . . . 3.75 111.044 -171.005 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 29.5 t -55.14 -44.77 75.41 Favored 'General case' 0 N--CA 1.461 0.094 0 C-N-CA 126.591 1.956 . . . . 4.0099999999999998 108.141 -178.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.2 m -70.79 -49.58 49.87 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.089 0 CA-C-N 113.955 -1.475 . . . . 3.1899999999999999 110.989 -171.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.64 -41.7 73.96 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.955 0.902 . . . . 1.8 110.824 171.074 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -55.05 -50.99 67.71 Favored 'General case' 0 C--N 1.341 0.205 0 N-CA-C 108.566 -0.901 . . . . 2.5299999999999998 108.566 172.346 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 4.6 mt -56.09 -51.21 64.62 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 CA-C-O 118.494 -0.765 . . . . 3.54 110.024 178.196 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -49.98 -57.03 8.39 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 119.332 0.969 . . . . 3.4199999999999999 110.065 177.253 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 32.6 mmt180 -51.72 -46.63 64.02 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 122.743 0.417 . . . . 5.5300000000000002 111.814 177.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 67.4 m-20 -67.13 -63.93 0.96 Allowed 'General case' 0 C--O 1.224 -0.242 0 CA-C-O 121.825 0.821 . . . . 3.3500000000000001 109.612 -176.038 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -71.1 -28.52 64.38 Favored 'General case' 0 N--CA 1.439 -1.022 0 C-N-CA 124.339 1.056 . . . . 3.1899999999999999 110.316 -165.773 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . 0.487 28.1 mtp-105 -70.11 0.51 6.03 Favored 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 116.192 1.923 . . . . 6.46 116.192 167.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 9.5 mmt180 -38.07 -36.03 0.19 Allowed 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 117.777 -1.569 . . . . 8.9499999999999993 112.393 143.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 70.04 43.61 0.88 Allowed 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 126.075 1.75 . . . . 8.6899999999999995 108.359 -178.061 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -73.77 58.46 0.63 Allowed 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 126.832 2.053 . . . . 5.2000000000000002 108.795 179.008 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 66.0 34.28 87.98 Favored Glycine 0 CA--C 1.532 1.128 0 O-C-N 121.316 -0.865 . . . . 1.3300000000000001 112.375 -172.13 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -113.96 135.8 52.49 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 C-N-CA 126.167 1.787 . . . . 2.8999999999999999 106.993 -179.096 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -140.83 47.21 1.75 Allowed 'General case' 0 CA--C 1.53 0.184 0 CA-C-O 122.923 1.344 . . . . 3.8700000000000001 111.6 159.503 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.7 t -168.64 133.63 1.65 Allowed 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 127.791 2.437 . . . . 3.2599999999999998 105.546 144.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -81.0 150.99 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 CA-C-O 121.805 0.812 . . . . 2.9300000000000002 109.37 177.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -81.13 65.5 6.29 Favored 'General case' 0 N--CA 1.435 -1.177 0 C-N-CA 124.151 0.98 . . . . 5.46 111.04 -177.469 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 11.4 t -117.2 140.62 39.2 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 CA-C-O 121.956 0.884 . . . . 2.46 111.321 162.018 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -155.79 59.78 0.6 Allowed 'General case' 0 C--O 1.236 0.389 0 C-N-CA 127.323 2.249 . . . . 1.8200000000000001 106.893 166.007 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.18 60.11 3.57 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 124.445 1.098 . . . . 4.25 109.293 179.464 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 51.6 ttm -131.97 -52.2 0.97 Allowed 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 105.112 -2.181 . . . . 4.2800000000000002 105.112 163.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -69.13 -30.49 68.76 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.574 -0.739 . . . . 1.77 111.169 165.005 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 96.32 45.46 2.78 Favored Glycine 0 C--N 1.341 0.835 0 N-CA-C 109.552 -1.419 . . . . 1.1200000000000001 109.552 -178.514 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 50.1 mttt -147.73 -179.14 6.67 Favored 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 124.725 1.21 . . . . 5.1500000000000004 108.295 -156.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -157.39 118.74 3.65 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 108.077 -1.082 . . . . 2.54 108.077 -159.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -133.01 105.95 7.38 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 119.413 1.006 . . . . 2.6000000000000001 112.83 178.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.1 p -82.38 133.17 29.72 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.317 0 C-N-CA 124.421 1.088 . . . . 2.4500000000000002 108.405 -177.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 71.4 ttt180 -110.17 127.07 54.72 Favored 'General case' 0 CA--C 1.52 -0.173 0 N-CA-C 105.764 -1.939 . . . . 5.29 105.764 166.44 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 4.9 p90 -157.23 169.21 25.28 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 117.995 0.361 . . . . 3.3399999999999999 111.145 -161.024 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -114.43 98.19 48.3 Favored Pre-proline 0 CA--C 1.539 0.523 0 C-N-CA 124.548 1.139 . . . . 3.8399999999999999 111.338 174.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.44 79.55 0.84 Allowed 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 122.802 2.335 . . . . 1.6299999999999999 111.46 176.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -143.63 -56.79 0.39 Allowed 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 105.867 -1.901 . . . . 2.6299999999999999 105.867 159.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 91.4 t -56.76 -62.37 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 C-N-CA 124.646 1.178 . . . . 2.4399999999999999 109.492 171.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . 0.28 9.6 tp -89.3 -77.48 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 CA-C-O 118.669 -0.681 . . . . 2.5800000000000001 112.338 -160.341 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 99.37 142.79 0.03 OUTLIER Pre-proline 0 CA--C 1.54 0.592 0 C-N-CA 129.808 3.243 . . . . 3.9100000000000001 111.414 -179.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_exo -47.95 -47.82 17.96 Favored 'Trans proline' 0 CA--C 1.536 0.614 1 C-N-CA 126.525 4.817 . . . . 1.3 116.917 174.213 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -49.1 -62.11 0.48 Allowed 'Trans proline' 0 N--CA 1.446 -1.29 0 CA-C-N 120.874 1.348 . . . . 1.21 109.777 163.445 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 1.1 ttt -53.94 -45.9 71.39 Favored 'General case' 0 N--CA 1.428 -1.541 0 N-CA-C 114.397 1.258 . . . . 5.0499999999999998 114.397 -173.18 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 5.0 pt -54.61 -50.08 62.11 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-N 120.15 1.341 . . . . 4.6200000000000001 111.101 175.063 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -55.33 -52.07 64.69 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 118.365 0.529 . . . . 2.2999999999999998 111.34 177.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -60.94 -58.53 8.03 Favored 'General case' 0 N--CA 1.432 -1.359 0 C-N-CA 123.769 0.828 . . . . 2.7400000000000002 111.235 -178.274 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -50.14 -35.23 25.06 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.163 0.985 . . . . 4.8499999999999996 111.909 -178.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 54.3 mt -64.44 -62.8 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 O-C-N 121.933 -0.479 . . . . 2.0899999999999999 109.901 169.542 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 38.7 mtp180 -50.94 -43.56 60.24 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.451 0.701 . . . . 6.2400000000000002 112.799 -174.304 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -46.09 -33.11 3.27 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 126.058 1.743 . . . . 3.0 112.439 177.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 68.5 mt -82.36 -17.2 46.47 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 123.193 0.597 . . . . 2.8700000000000001 112.029 -176.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 124.6 -35.52 3.15 Favored Glycine 0 C--N 1.339 0.708 0 CA-C-N 118.576 0.625 . . . . 3.25 112.682 169.366 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 28.6 p90 -84.29 131.71 34.7 Favored 'General case' 0 N--CA 1.457 -0.106 0 N-CA-C 106.784 -1.562 . . . . 6.4100000000000001 106.784 177.24 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -88.4 162.05 31.71 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.787 -0.925 . . . . 2.1800000000000002 110.787 -163.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -137.53 144.12 41.98 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.487 1.115 . . . . 1.79 109.025 -179.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 12.3 p -129.53 127.01 39.89 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 106.257 -1.756 . . . . 3.2599999999999998 106.257 172.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 28.1 t -84.66 118.04 31.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 N-CA-C 107.962 -1.125 . . . . 2.9700000000000002 107.962 -176.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 28.4 mt -141.98 68.78 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 N-CA-C 107.511 -1.292 . . . . 2.9700000000000002 107.511 -172.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.539 0.532 0 CA-C-N 115.673 -0.694 . . . . 4.9400000000000004 110.337 178.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.6 m . . . . . 0 N--CA 1.451 -0.39 0 N-CA-C 111.916 0.339 . . . . 3.4900000000000002 111.916 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.3 t -91.89 163.32 14.07 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 124.31 1.044 . . . . 3.1800000000000002 110.679 -169.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 3.6 ttpm? -88.96 159.5 17.61 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 125.845 1.658 . . . . 5.3600000000000003 109.968 -175.098 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 52.9 t -155.37 159.15 39.69 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 107.822 -1.177 . . . . 2.8599999999999999 107.822 153.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -107.49 144.48 34.38 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 125.529 1.532 . . . . 4.1100000000000003 107.151 168.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.7 mt -138.01 138.83 43.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 107.867 -1.16 . . . . 2.6600000000000001 107.867 -179.482 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 66.0 mt-30 -77.1 145.62 37.71 Favored 'General case' 0 CA--C 1.522 -0.12 0 N-CA-C 106.179 -1.785 . . . . 5.5300000000000002 106.179 173.412 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 17.2 m -136.93 127.42 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 N-CA-C 108.502 -0.925 . . . . 3.0600000000000001 108.502 172.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 72.8 p -79.81 64.52 4.69 Favored 'General case' 0 CA--C 1.534 0.344 0 O-C-N 121.863 -0.523 . . . . 4.5599999999999996 110.227 -174.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 152.8 55.94 0.01 OUTLIER Glycine 0 C--N 1.339 0.695 0 CA-C-O 124.904 2.391 . . . . 3.2799999999999998 113.432 169.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 16.7 tmm? -43.06 -50.65 6.02 Favored 'General case' 0 N--CA 1.432 -1.329 0 CA-C-N 109.816 -3.192 . . . . 5.3300000000000001 109.39 137.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.27 -33.95 76.38 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 125.821 1.648 . . . . 6.2400000000000002 112.848 -168.215 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 21.4 m -61.79 143.35 56.43 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 109.345 -0.613 . . . . 2.8199999999999998 109.345 -173.046 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -61.6 146.53 48.63 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 108.304 -0.998 . . . . 3.1400000000000001 108.304 163.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 79.92 -62.76 0.25 Allowed 'General case' 0 C--O 1.22 -0.474 0 C-N-CA 124.965 1.306 . . . . 3.54 112.251 179.839 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 51.8 m -36.26 -48.9 0.66 Allowed 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 125.995 1.718 . . . . 3.0699999999999998 114.54 -154.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -43.95 -43.48 1.9 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.915 0 C-N-CA 125.905 1.682 . . . . 3.7799999999999998 113.553 175.467 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.02 -44.55 94.53 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 125.828 1.651 . . . . 1.8999999999999999 111.528 170.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -59.4 -51.01 71.73 Favored 'General case' 0 C--O 1.218 -0.593 0 CA-C-O 118.016 -0.993 . . . . 2.1400000000000001 108.823 173.376 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.5 mt -45.7 -58.76 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 C-N-CA 124.898 1.279 . . . . 3.1899999999999999 109.895 173.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -34.94 -59.58 0.48 Allowed 'General case' 0 C--N 1.328 -0.338 0 O-C-N 119.924 -1.735 . . . . 4.2699999999999996 113.382 166.062 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 92.7 mtt180 -59.81 -35.3 74.41 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 114.517 1.303 . . . . 6.0700000000000003 114.517 173.423 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -64.91 -58.74 5.36 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 125.836 1.654 . . . . 4.3700000000000001 109.567 -163.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . 0.256 7.3 mp -73.62 -19.83 60.75 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 121.22 0.533 . . . . 4.1299999999999999 109.896 179.105 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . 0.495 84.0 mtp180 -67.17 2.91 1.34 Allowed 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 116.465 2.024 . . . . 6.3700000000000001 116.465 164.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -38.86 -32.71 0.09 Allowed 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 116.49 -2.084 . . . . 7.5999999999999996 113.879 145.654 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . 0.267 2.0 mt-10 64.11 45.49 4.08 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 126.366 1.867 . . . . 7.9100000000000001 111.294 174.395 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 70.1 mt-10 -105.4 79.77 1.5 Allowed 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 126.467 1.907 . . . . 6.0 108.921 -174.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 64.39 26.55 70.76 Favored Glycine 0 CA--C 1.532 1.119 0 CA-C-O 121.669 0.594 . . . . 1.51 111.733 -175.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.1 mm -93.72 158.06 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 C-N-CA 126.19 1.796 . . . . 3.0299999999999998 108.408 176.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 12.6 t80 -154.37 41.76 0.49 Allowed 'General case' 0 C--N 1.339 0.12 0 C-N-CA 119.857 -0.737 . . . . 6.4100000000000001 111.482 170.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 48.4 t -171.39 -179.42 2.61 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 128.773 2.829 . . . . 2.8300000000000001 105.319 141.372 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.1 tp -134.65 141.17 44.05 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.353 0 N-CA-C 106.909 -1.515 . . . . 4.6799999999999997 106.909 149.294 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.457 ' HB2' ' CB ' ' A' ' 44' ' ' GLU . 0.3 OUTLIER -149.02 144.03 26.47 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 114.473 -1.24 . . . . 7.7199999999999998 109.619 -158.103 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . 0.258 0.9 OUTLIER -154.64 80.77 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.437 -1.095 0 CA-C-O 124.196 1.951 . . . . 2.2999999999999998 108.786 -164.012 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -77.2 61.39 2.09 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 113.543 -1.662 . . . . 1.8 109.527 169.21 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -46.71 -44.85 19.08 Favored 'General case' 0 CA--C 1.512 -0.487 0 C-N-CA 123.828 0.851 . . . . 4.7199999999999998 110.046 169.007 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 27.8 ttt -63.81 -36.37 83.69 Favored 'General case' 0 N--CA 1.441 -0.892 0 C-N-CA 120.208 -0.597 . . . . 6.29 110.145 -169.199 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -74.86 -36.07 62.33 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.294 0.638 . . . . 2.2400000000000002 110.29 172.625 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 109.8 39.57 1.56 Allowed Glycine 0 C--N 1.334 0.471 0 C-N-CA 124.945 1.259 . . . . 1.3700000000000001 111.009 173.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 29.5 pttt -158.75 157.04 30.94 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 108.436 -0.95 . . . . 4.3399999999999999 108.436 -176.464 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -82.59 147.95 28.3 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 107.279 -1.378 . . . . 2.1299999999999999 107.279 167.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.457 ' CB ' ' HB2' ' A' ' 35' ' ' LEU . 36.1 mt-10 -103.61 153.28 20.78 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 105.962 -1.866 . . . . 2.9700000000000002 105.962 171.008 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 34.1 m -137.95 148.4 25.31 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-N 119.195 0.907 . . . . 3.96 109.528 171.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 58.3 ttm-85 -133.47 130.77 39.05 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 106.234 -1.765 . . . . 6.1900000000000004 106.234 164.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 26.7 p90 -156.45 167.69 29.68 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 110.099 -0.334 . . . . 3.46 110.099 -167.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -105.97 104.3 48.67 Favored Pre-proline 0 CA--C 1.542 0.661 0 C-N-CA 123.311 0.644 . . . . 3.2799999999999998 111.056 178.364 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -75.82 73.02 4.93 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 122.627 2.218 . . . . 1.98 111.661 -175.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -142.71 -63.72 0.42 Allowed 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 105.979 -1.86 . . . . 2.21 105.979 161.493 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 72.7 t -56.07 -52.32 51.63 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.749 0 C-N-CA 124.905 1.282 . . . . 2.3199999999999998 110.263 175.343 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 20.1 tt -84.16 -52.19 13.05 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.403 0 N-CA-C 114.125 1.158 . . . . 4.5800000000000001 114.125 -151.415 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER 71.3 109.5 0.03 OUTLIER Pre-proline 0 CA--C 1.538 0.517 0 C-N-CA 127.968 2.507 . . . . 3.25 111.266 -165.702 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_exo -46.72 -41.29 24.67 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 123.358 2.705 . . . . 1.53 115.102 162.186 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_endo -55.09 -50.41 13.21 Favored 'Trans proline' 0 N--CA 1.447 -1.261 0 CA-C-N 121.707 1.645 . . . . 1.3700000000000001 109.754 168.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 77.0 mtp -59.97 -42.51 94.3 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 118.595 -1.242 . . . . 3.6899999999999999 111.934 -179.501 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.1 pt -58.24 -47.07 88.44 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-N 121.61 2.005 . . . . 3.6600000000000001 111.829 173.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -51.9 -46.44 64.59 Favored 'General case' 0 C--N 1.341 0.201 0 C-N-CA 122.761 0.424 . . . . 1.9399999999999999 111.096 179.31 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -64.19 -60.8 2.77 Favored 'General case' 0 N--CA 1.434 -1.242 0 C-N-CA 123.853 0.861 . . . . 2.9399999999999999 111.84 175.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 8.2 m-30 -45.76 -47.39 15.51 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 125.418 1.487 . . . . 4.6900000000000004 110.071 -175.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 74.6 mt -57.75 -39.83 72.56 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 CA-C-N 116.62 -0.264 . . . . 2.2799999999999998 111.311 -178.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 21.3 mtm105 -69.82 -46.61 65.27 Favored 'General case' 0 N--CA 1.455 -0.185 0 O-C-N 121.683 -0.636 . . . . 4.2599999999999998 111.362 173.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -54.06 -47.21 71.91 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 122.834 0.453 . . . . 3.2400000000000002 111.24 -179.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.4 pp -90.0 -34.71 15.88 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 112.989 0.737 . . . . 3.8500000000000001 112.989 -176.07 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -123.67 -79.29 0.43 Allowed Glycine 0 C--N 1.34 0.763 0 N-CA-C 114.392 0.517 . . . . 3.21 114.392 -157.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -165.74 165.61 18.42 Favored 'General case' 0 N--CA 1.465 0.291 0 O-C-N 122.12 -0.635 . . . . 6.0899999999999999 110.994 -154.798 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -78.64 66.11 3.35 Favored Glycine 0 C--N 1.337 0.631 0 C-N-CA 124.649 1.118 . . . . 1.95 113.496 -157.408 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -90.02 148.44 23.07 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 124.696 1.198 . . . . 2.21 113.151 -164.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.6 t -141.59 145.09 34.63 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 107.552 -1.277 . . . . 3.04 107.552 174.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 1.8 t -81.84 130.12 36.35 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 C-N-CA 125.116 1.367 . . . . 2.7400000000000002 107.998 -178.301 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 4.9 pt -148.03 59.83 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.339 0.141 0 C-N-CA 124.564 1.146 . . . . 4.4299999999999997 110.91 -172.34 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 . . . . . 0 C--O 1.235 0.318 0 CA-C-N 116.27 -0.423 . . . . 5.6900000000000004 110.066 176.393 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.7 p . . . . . 0 CA--C 1.535 0.382 0 N-CA-C 112.069 0.396 . . . . 3.6400000000000001 112.069 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 45.5 m -149.61 157.8 43.58 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 126.565 1.946 . . . . 2.79 107.934 -177.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 33.4 mtmt -103.86 147.43 27.32 Favored 'General case' 0 C--O 1.231 0.081 0 N-CA-C 107.202 -1.407 . . . . 6.0099999999999998 107.202 168.349 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 38.3 t -153.25 150.47 29.0 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 108.922 -0.77 . . . . 2.0699999999999998 108.922 172.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -112.34 146.3 38.53 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 125.927 1.691 . . . . 3.6600000000000001 106.546 -179.064 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -139.24 107.74 3.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 107.509 -1.293 . . . . 3.6499999999999999 107.509 -168.698 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 48.4 tp60 -82.78 123.05 28.96 Favored 'General case' 0 N--CA 1.428 -1.535 0 N-CA-C 106.036 -1.839 . . . . 3.7400000000000002 106.036 -172.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 9.9 p -89.38 157.26 3.02 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 C-N-CA 125.322 1.449 . . . . 4.7999999999999998 108.86 -177.232 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.8 t -111.18 21.68 16.07 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 123.115 0.566 . . . . 3.3900000000000001 112.453 176.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -143.35 117.36 1.09 Allowed Glycine 0 N--CA 1.444 -0.798 0 N-CA-C 106.304 -2.719 . . . . 2.3399999999999999 106.304 154.272 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 1.5 ttp -90.16 -61.78 1.61 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 113.445 -1.378 . . . . 5.6299999999999999 108.314 174.03 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 14.1 t -82.38 47.91 1.22 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.544 0.738 . . . . 7.0300000000000002 110.529 -175.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 15.6 p -79.38 -44.0 22.34 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 109.169 -0.678 . . . . 2.8199999999999998 109.169 170.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 143.14 -121.66 0.0 OUTLIER 'General case' 0 C--N 1.34 0.16 0 C-N-CA 130.663 3.585 . . . . 4.0099999999999998 106.244 177.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.2 m -79.41 60.58 3.22 Favored 'General case' 0 N--CA 1.451 -0.394 0 O-C-N 121.493 -0.754 . . . . 3.8700000000000001 111.261 -175.389 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 4.2 t -48.59 -44.87 37.32 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 125.827 1.651 . . . . 4.6500000000000004 109.116 177.399 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.5 p -55.3 -61.61 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.816 0 CA-C-N 113.988 -1.46 . . . . 4.1799999999999997 110.627 177.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -54.28 -35.56 62.71 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.406 -1.27 . . . . 2.27 110.644 -178.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -63.69 -58.64 6.28 Favored 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 109.734 -0.469 . . . . 2.5099999999999998 109.734 170.701 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.2 mp -54.4 -48.36 68.83 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 CA-C-N 119.605 1.093 . . . . 3.4900000000000002 111.18 -175.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -45.94 -43.08 13.67 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 120.89 -1.131 . . . . 2.9100000000000001 111.168 177.07 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.61 -46.82 58.06 Favored 'General case' 0 CA--C 1.536 0.429 0 O-C-N 121.434 -0.791 . . . . 7.4699999999999998 111.012 168.712 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -55.3 -47.23 75.87 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.808 1.243 . . . . 4.2400000000000002 113.392 -165.745 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . 0.382 0.8 OUTLIER -79.04 -23.61 44.18 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 122.11 0.957 . . . . 4.2800000000000002 112.465 -172.413 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . 0.585 53.7 mtp85 -54.14 2.12 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 120.769 3.618 . . . . 6.7300000000000004 120.769 176.458 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.411 ' NH1' ' CG ' ' A' ' 27' ' ' ARG . 0.1 OUTLIER -45.85 -32.27 2.53 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 117.308 -1.757 . . . . 10.550000000000001 111.03 154.046 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 64.34 -155.13 0.3 Allowed 'General case' 0 C--N 1.342 0.27 0 C-N-CA 123.845 0.858 . . . . 7.3600000000000003 108.947 -175.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 58.93 54.25 5.19 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 122.37 1.081 . . . . 6.5 109.062 -179.079 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 152.26 -46.3 0.59 Allowed Glycine 0 C--N 1.335 0.521 0 N-CA-C 110.528 -1.029 . . . . 2.5800000000000001 110.528 -171.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.9 mp -81.66 153.73 4.12 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 C-N-CA 124.323 1.049 . . . . 3.46 108.781 -171.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -151.58 36.04 0.57 Allowed 'General case' 0 CA--C 1.546 0.824 0 CA-C-O 121.99 0.9 . . . . 4.2000000000000002 112.616 167.579 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 57.9 m -167.55 161.59 13.82 Favored 'General case' 0 C--N 1.326 -0.444 1 C-N-CA 131.871 4.068 . . . . 3.3399999999999999 103.069 145.017 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.436 HD11 ' H ' ' A' ' 35' ' ' LEU . 10.8 tp -139.97 133.64 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 CA-C-N 122.77 2.532 . . . . 5.5999999999999996 110.863 155.379 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.465 ' N ' ' CD1' ' A' ' 35' ' ' LEU . 0.0 OUTLIER -167.92 -179.08 4.03 Favored 'General case' 0 N--CA 1.44 -0.925 0 CA-C-N 111.73 -2.486 . . . . 7.1100000000000003 108.864 -153.739 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.4 t -159.57 128.44 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.253 0 C-N-CA 125.695 1.598 . . . . 2.8199999999999998 107.213 -175.088 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -84.23 63.64 7.83 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 107.905 -1.146 . . . . 1.8700000000000001 107.905 175.007 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -60.31 -31.75 70.56 Favored 'General case' 0 CA--C 1.532 0.25 0 O-C-N 122.043 -0.411 . . . . 3.4700000000000002 111.552 -169.507 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 67.2 mtt -53.6 -36.89 62.44 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.526 0.73 . . . . 3.98 111.707 172.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -92.22 7.25 43.48 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.589 1.156 . . . . 2.2999999999999998 111.947 176.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.27 38.6 96.11 Favored Glycine 0 CA--C 1.522 0.483 0 C-N-CA 125.473 1.511 . . . . 1.1899999999999999 112.029 174.491 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -162.02 152.43 17.18 Favored 'General case' 0 N--CA 1.442 -0.857 0 N-CA-C 108.075 -1.083 . . . . 5.0599999999999996 108.075 -162.177 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -81.77 157.98 24.3 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 108.928 -0.768 . . . . 2.2200000000000002 108.928 176.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . 0.335 2.2 tm-20 -129.37 157.36 42.13 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 108.612 -0.885 . . . . 4.6299999999999999 108.612 165.581 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.0 p -151.97 138.12 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 N-CA-C 106.476 -1.676 . . . . 2.7400000000000002 106.476 -176.298 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 4.0 mtm180 -104.35 133.01 49.97 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 105.545 -2.02 . . . . 8.0700000000000003 105.545 158.023 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -157.32 167.64 29.69 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 123.716 0.807 . . . . 3.29 108.844 -171.407 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 54.6 t30 -116.79 97.48 50.52 Favored Pre-proline 0 CA--C 1.533 0.312 0 C-N-CA 123.83 0.852 . . . . 3.3599999999999999 110.378 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.3 72.25 2.89 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 123.309 2.672 . . . . 1.8700000000000001 111.538 -178.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -147.56 -56.8 0.24 Allowed 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 106.062 -1.829 . . . . 2.6699999999999999 106.062 169.293 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 45.6 t -57.52 -54.78 26.58 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 C-N-CA 124.116 0.966 . . . . 2.73 109.694 173.191 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . 0.25 10.5 tp -94.2 -75.06 0.42 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.352 0 N-CA-C 112.692 0.627 . . . . 3.3500000000000001 112.692 -164.463 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 108.45 135.48 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.452 0 C-N-CA 129.845 3.258 . . . . 3.1699999999999999 108.208 -176.58 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -44.22 -51.15 7.05 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 124.63 3.553 . . . . 1.51 114.796 171.021 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -47.19 -56.05 3.39 Favored 'Trans proline' 0 N--CA 1.448 -1.195 0 CA-C-N 121.307 1.502 . . . . 1.28 110.929 167.008 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 51.0 mtt -59.51 -36.34 75.89 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 118.029 -1.468 . . . . 3.0499999999999998 113.134 -178.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -62.13 -46.81 95.63 Favored 'Isoleucine or valine' 0 C--N 1.344 0.351 0 CA-C-N 120.675 1.58 . . . . 4.29 110.619 173.841 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -53.38 -52.36 59.56 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 121.189 0.519 . . . . 2.2599999999999998 109.978 178.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -56.77 -49.1 76.29 Favored 'General case' 0 N--CA 1.426 -1.652 0 C-N-CA 123.474 0.709 . . . . 3.2599999999999998 111.337 176.55 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 3.9 m-30 -53.81 -33.98 57.75 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 119.31 0.959 . . . . 5.4400000000000004 111.39 178.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 42.0 mt -70.84 -51.35 36.82 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 O-C-N 121.477 -0.764 . . . . 2.23 109.292 173.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 35.6 mtp-105 -63.85 -27.88 69.47 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 113.54 0.941 . . . . 6.6399999999999997 113.54 -174.396 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -45.93 -55.11 7.18 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 125.058 1.343 . . . . 4.9699999999999998 111.072 177.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -130.27 -19.65 3.11 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 124.453 1.101 . . . . 3.4199999999999999 113.525 -166.8 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -96.52 -102.67 2.05 Favored Glycine 0 N--CA 1.446 -0.642 0 N-CA-C 109.086 -1.606 . . . . 3.96 109.086 -179.03 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 27.9 m-85 -149.53 166.17 30.0 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 122.172 0.987 . . . . 4.0999999999999996 110.936 -154.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -78.94 69.06 2.96 Favored Glycine 0 N--CA 1.443 -0.859 0 CA-C-N 114.53 -1.213 . . . . 1.76 110.551 -178.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -82.64 141.78 32.23 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 113.867 -1.167 . . . . 2.52 109.852 -176.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 9.3 t -115.25 139.65 49.77 Favored 'General case' 0 N--CA 1.439 -1.013 0 N-CA-C 106.77 -1.567 . . . . 3.0600000000000001 106.77 178.448 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.0 t -83.59 125.9 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.612 0 C-N-CA 125.132 1.373 . . . . 3.04 108.952 -172.385 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 13.7 mm -130.62 59.54 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 C-N-CA 125.254 1.422 . . . . 3.2999999999999998 108.472 -177.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 . . . . . 0 CA--C 1.532 0.26 0 N-CA-C 108.195 -1.039 . . . . 4.8099999999999996 108.195 162.015 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 . . . . . 0 N--CA 1.479 0.992 0 N-CA-C 108.295 -1.002 . . . . 7.9900000000000002 108.295 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.2 m -47.92 132.45 15.03 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 125.544 1.538 . . . . 3.48 112.323 -176.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 22.9 t -113.19 178.08 4.4 Favored 'General case' 0 N--CA 1.463 0.18 0 C-N-CA 125.423 1.489 . . . . 3.48 108.149 177.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.39 159.28 37.5 Favored 'General case' 0 N--CA 1.46 0.052 0 CA-C-N 118.273 0.488 . . . . 5.4299999999999997 112.005 -176.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 53.6 t -138.77 154.12 48.49 Favored 'General case' 0 C--N 1.333 -0.144 0 N-CA-C 106.635 -1.617 . . . . 2.48 106.635 176.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 81.3 m-85 -98.75 154.37 18.04 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 107.405 -1.331 . . . . 4.2800000000000002 107.405 178.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 18.2 mt -148.66 132.16 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 N-CA-C 105.379 -2.082 . . . . 2.6400000000000001 105.379 -176.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 48.5 tp60 -100.86 126.13 47.44 Favored 'General case' 0 N--CA 1.432 -1.364 0 N-CA-C 105.553 -2.017 . . . . 3.8599999999999999 105.553 176.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 30.1 m -98.85 137.09 27.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 C-N-CA 124.087 0.955 . . . . 3.21 109.209 179.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 25.3 m -78.81 74.85 5.33 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 109.501 -0.555 . . . . 2.8399999999999999 109.501 179.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 117.81 77.32 0.59 Allowed Glycine 0 C--N 1.335 0.487 0 CA-C-O 124.513 2.174 . . . . 2.2400000000000002 110.485 173.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.9 -65.91 0.62 Allowed 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 110.024 -3.088 . . . . 5.1399999999999997 108.398 176.691 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.6 t -79.09 41.97 0.46 Allowed 'General case' 0 CA--C 1.54 0.586 0 O-C-N 121.3 -0.875 . . . . 5.5300000000000002 111.173 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 45.3 t -68.69 -43.9 75.12 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 107.115 -1.439 . . . . 2.7999999999999998 107.115 156.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 76.76 161.0 0.22 Allowed 'General case' 0 C--N 1.344 0.341 0 C-N-CA 126.688 1.995 . . . . 3.9500000000000002 110.104 -174.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 10.8 m 72.05 -53.38 0.69 Allowed 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 125.183 1.393 . . . . 3.46 112.039 -176.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 31.5 m -29.56 -54.65 0.15 Allowed 'General case' 0 C--O 1.223 -0.294 0 C-N-CA 127.278 2.231 . . . . 3.04 110.96 167.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 1.2 t -69.58 -36.37 70.62 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.048 0 N-CA-C 112.488 0.551 . . . . 4.3399999999999999 112.488 -174.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.27 -45.42 93.38 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 109.232 -0.655 . . . . 1.6699999999999999 109.232 173.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -57.54 -47.39 82.14 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 109.094 -0.706 . . . . 3.5099999999999998 109.094 173.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . 0.251 53.9 mt -64.16 -44.84 97.61 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 O-C-N 121.571 -0.706 . . . . 3.02 111.296 -172.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -47.76 -51.79 20.98 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 119.383 0.992 . . . . 3.25 111.755 165.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 8.4 mmt85 -57.75 -38.22 74.99 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 118.011 -0.995 . . . . 5.4199999999999999 112.714 176.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 71.2 m-20 -63.2 -55.74 22.49 Favored 'General case' 0 C--O 1.222 -0.35 0 CA-C-N 120.237 1.38 . . . . 3.1499999999999999 108.03 177.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 17.5 mt -77.14 -51.34 11.16 Favored 'General case' 0 N--CA 1.434 -1.229 0 C-N-CA 124.621 1.168 . . . . 4.3499999999999996 112.308 -159.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 3.1 ttm105 -65.44 -13.44 58.76 Favored 'General case' 0 N--CA 1.421 -1.915 0 O-C-N 121.499 -0.751 . . . . 8.9900000000000002 112.682 -173.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.1 mtp180 -42.15 -64.57 0.57 Allowed 'General case' 0 N--CA 1.448 -0.529 0 CA-C-O 118.369 -0.824 . . . . 8.9199999999999999 111.068 160.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 169.76 -176.66 0.03 OUTLIER 'General case' 0 C--N 1.344 0.366 0 CA-C-N 119.012 0.824 . . . . 7.3499999999999996 110.794 -156.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 84.82 53.46 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 127.314 2.246 . . . . 5.3600000000000003 109.747 178.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 72.44 14.58 77.27 Favored Glycine 0 CA--C 1.527 0.826 0 CA-C-O 118.466 -1.186 . . . . 1.3 114.668 168.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 1.1 mt -84.75 130.07 36.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 N-CA-C 107.091 -1.448 . . . . 2.6800000000000002 107.091 -178.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -137.57 43.03 2.31 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-O 122.734 1.254 . . . . 3.5499999999999998 111.223 160.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.5 t -170.21 147.63 3.16 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 128.858 2.863 . . . . 2.7400000000000002 105.187 134.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.6 pp -77.72 159.62 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 N-CA-C 108.141 -1.059 . . . . 2.96 108.141 176.109 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.5 pp -73.96 137.16 43.39 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 104.488 -2.412 . . . . 5.5499999999999998 104.488 158.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.1 t -160.46 150.85 5.52 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.104 0 N-CA-C 106.112 -1.81 . . . . 2.0600000000000001 106.112 123.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -158.73 53.54 0.42 Allowed 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 104.325 -2.472 . . . . 1.7 104.325 165.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.1 tt -66.11 -31.1 71.76 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 107.294 -1.373 . . . . 4.6100000000000003 107.294 -178.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 27.7 ttt -45.0 -41.95 7.86 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.108 1.363 . . . . 4.1200000000000001 111.875 170.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -85.76 -55.58 3.9 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 108.524 -0.917 . . . . 1.8300000000000001 108.524 171.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 143.17 43.98 0.05 OUTLIER Glycine 0 CA--C 1.523 0.553 0 C-N-CA 125.089 1.328 . . . . 0.81999999999999995 111.885 167.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 14.1 pttp -159.92 -179.3 7.69 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 118.078 0.939 . . . . 5.1399999999999997 108.9 -164.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -130.72 143.45 50.75 Favored 'General case' 0 N--CA 1.441 -0.877 0 C-N-CA 127.475 2.31 . . . . 1.73 108.953 -177.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -144.01 89.13 2.01 Favored 'General case' 0 C--N 1.341 0.238 0 C-N-CA 124.104 0.961 . . . . 3.8700000000000001 111.215 173.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 14.0 p -80.71 137.32 21.61 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.22 0 N-CA-C 108.901 -0.777 . . . . 2.9900000000000002 108.901 -176.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 70.8 ttt180 -106.58 126.75 52.67 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 107.655 -1.239 . . . . 6.0700000000000003 107.655 171.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 7.9 p90 -157.48 175.88 13.38 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 123.384 0.674 . . . . 3.54 109.844 -167.041 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 3.3 p30 -103.89 135.18 19.39 Favored Pre-proline 0 N--CA 1.451 -0.396 0 N-CA-C 107.752 -1.203 . . . . 3.2599999999999998 107.752 164.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -81.32 1.79 9.03 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 122.29 1.993 . . . . 2.5299999999999998 113.314 -174.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -91.87 -49.08 6.43 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-N 119.41 1.005 . . . . 2.0699999999999998 108.535 -167.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 24.4 t -58.78 -60.39 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.755 0 C-N-CA 124.354 1.062 . . . . 1.98 109.855 175.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 19.2 tt -93.56 -53.42 8.5 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.233 0 CA-C-O 118.855 -0.593 . . . . 2.96 112.258 -163.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 9.1 mm-40 101.16 129.72 0.02 OUTLIER Pre-proline 0 CA--C 1.541 0.598 0 C-N-CA 129.574 3.15 . . . . 3.3199999999999998 112.304 -175.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_exo -50.89 -48.95 18.53 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 124.787 3.658 . . . . 1.26 116.71 177.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -54.45 -50.55 13.06 Favored 'Trans proline' 0 N--CA 1.442 -1.514 0 CA-C-N 120.66 1.271 . . . . 1.24 108.873 169.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 64.1 mtt -63.03 -44.07 96.93 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 120.528 -0.469 . . . . 3.6299999999999999 110.708 -167.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 16.2 tt -61.76 -35.19 66.15 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.25 0 C-N-CA 119.61 -0.836 . . . . 3.1800000000000002 111.686 -175.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -69.93 -58.03 4.33 Favored 'General case' 0 N--CA 1.452 -0.325 0 O-C-N 122.33 -0.231 . . . . 2.3700000000000001 110.875 171.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -47.98 -49.29 31.15 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 125.613 1.565 . . . . 3.1699999999999999 111.861 -174.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 16.2 m-30 -44.18 -40.42 5.03 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.748 0.819 . . . . 4.7999999999999998 112.453 177.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 65.9 mt -65.16 -26.76 40.54 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 O-C-N 121.513 -0.742 . . . . 2.2400000000000002 110.66 -174.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 36.0 mtm180 -58.27 -61.21 2.74 Favored 'General case' 0 C--N 1.341 0.238 0 CA-C-N 118.939 0.791 . . . . 6.5599999999999996 109.642 174.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -60.59 -39.18 87.12 Favored 'General case' 0 N--CA 1.44 -0.974 0 C-N-CA 123.63 0.772 . . . . 4.5199999999999996 112.77 -166.081 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -98.36 -27.53 14.06 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 113.187 0.81 . . . . 3.2000000000000002 113.187 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -112.96 -82.14 1.14 Allowed Glycine 0 CA--C 1.526 0.743 0 CA-C-N 119.215 0.916 . . . . 3.3199999999999998 111.968 -172.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -177.05 164.94 2.32 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.562 1.145 . . . . 5.7800000000000002 109.605 -162.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -59.83 115.17 7.16 Favored Glycine 0 N--CA 1.439 -1.148 0 N-CA-C 109.601 -1.4 . . . . 1.74 109.601 -171.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -115.25 91.76 3.71 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 125.435 1.494 . . . . 1.75 109.068 -169.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -84.39 119.14 24.76 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 108.263 -1.014 . . . . 3.1400000000000001 108.263 -178.584 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 8.3 p -81.23 141.9 14.53 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 C-N-CA 123.265 0.626 . . . . 3.6499999999999999 109.584 -174.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 15.0 mt -139.79 99.06 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 C-N-CA 124.817 1.247 . . . . 2.8900000000000001 107.675 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -81.8 50.09 1.47 Allowed 'General case' 0 CA--C 1.535 0.369 0 O-C-N 121.462 -0.774 . . . . 6.3600000000000003 109.755 174.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -169.13 169.2 9.53 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 108.169 -1.048 . . . . 5.5599999999999996 108.169 -175.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 6.0 tp -160.4 124.64 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 N-CA-C 107.189 -1.411 . . . . 10.33 107.189 174.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -160.02 156.34 26.86 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 106.088 -1.819 . . . . 10.0 106.088 177.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 158.47 -178.39 34.72 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 108.972 -1.651 . . . . 12.66 108.972 -178.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.211 0 N-CA-C 104.506 -2.405 . . . . 22.68 104.506 174.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 . . . . . 0 N--CA 1.479 1.022 0 CA-C-O 118.858 -0.592 . . . . 7.6699999999999999 110.347 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.4 m -43.64 120.49 2.0 Allowed 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.732 1.613 . . . . 3.5299999999999998 112.549 -177.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 26.1 m -149.04 176.23 10.63 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 126.106 1.762 . . . . 2.52 107.558 -176.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 39.2 pttt -125.18 158.16 34.66 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-N 119.173 0.897 . . . . 4.7000000000000002 109.108 154.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 36.6 t -142.3 152.44 42.98 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 107.275 -1.38 . . . . 2.0 107.275 175.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 54.3 m-85 -84.44 148.69 26.43 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 107.421 -1.325 . . . . 3.4300000000000002 107.421 176.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 5.6 mm -130.5 141.19 46.89 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.817 0 N-CA-C 104.61 -2.367 . . . . 3.0099999999999998 104.61 173.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -98.24 128.27 44.6 Favored 'General case' 0 N--CA 1.435 -1.189 0 N-CA-C 103.882 -2.636 . . . . 3.5899999999999999 103.882 166.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.4 p -126.41 122.53 61.4 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 C-N-CA 124.674 1.19 . . . . 3.6000000000000001 108.41 179.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.8 t -72.76 136.9 45.56 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 109.434 -0.58 . . . . 3.4500000000000002 109.434 -176.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 113.8 -52.19 0.66 Allowed Glycine 0 C--N 1.335 0.518 0 N-CA-C 108.146 -1.981 . . . . 2.8500000000000001 108.146 177.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 59.9 mtt 75.94 -69.96 0.15 Allowed 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 126.197 1.799 . . . . 5.1600000000000001 110.314 158.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 11.8 t -112.13 11.74 20.4 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 125.907 1.683 . . . . 5.0099999999999998 109.957 174.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.436 ' SG ' ' HB2' ' A' ' 17' ' ' CYS 0.267 17.2 p -63.14 144.64 56.74 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 119.017 0.826 . . . . 3.25 109.436 -176.212 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -52.61 109.9 0.45 Allowed 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 116.212 -0.449 . . . . 3.7999999999999998 111.98 -158.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.7 m 69.23 6.72 5.83 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 125.355 1.462 . . . . 3.3900000000000001 113.873 175.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.436 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 48.8 t -43.99 -49.06 8.75 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 123.765 1.745 . . . . 3.79 108.607 163.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -72.67 -46.64 53.55 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.521 0 CA-C-N 112.199 -2.273 . . . . 3.8900000000000001 109.856 -172.182 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.67 -42.06 87.58 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 110.212 -0.292 . . . . 2.2999999999999998 110.212 175.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -60.03 -60.44 3.83 Favored 'General case' 0 CA--C 1.521 -0.163 0 C-N-CA 124.571 1.148 . . . . 2.5600000000000001 108.455 178.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.7 mt -43.69 -54.72 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 C-N-CA 123.801 0.84 . . . . 2.7599999999999998 111.314 173.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -54.65 -50.05 69.11 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 119.702 1.137 . . . . 3.9199999999999999 111.517 176.102 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.94 -48.93 51.65 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.592 0.757 . . . . 5.4000000000000004 112.095 176.458 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -76.28 -60.39 2.36 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 118.139 0.427 . . . . 3.5699999999999998 111.766 -177.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.57 -36.77 73.8 Favored 'General case' 0 C--O 1.22 -0.47 0 C-N-CA 125.756 1.623 . . . . 4.3600000000000003 112.595 -152.679 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -21.5 -74.61 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 128.616 2.766 . . . . 8.8699999999999992 114.722 -158.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . 0.287 7.9 ptp180 -91.9 -29.9 16.43 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 127.339 2.255 . . . . 14.07 116.286 166.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 41.8 mm-40 -81.05 128.4 33.67 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 114.855 -1.066 . . . . 6.7999999999999998 108.868 -134.299 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 60.0 55.84 3.63 Favored 'General case' 0 N--CA 1.442 -0.825 0 CA-C-O 122.856 1.312 . . . . 5.0899999999999999 111.189 -171.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 76.16 30.87 56.52 Favored Glycine 0 CA--C 1.523 0.566 0 CA-C-N 114.006 -1.452 . . . . 1.53 112.742 162.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.6 mt -96.03 147.44 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 N-CA-C 108.322 -0.992 . . . . 2.98 108.322 171.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -147.88 47.03 1.09 Allowed 'General case' 0 C--O 1.233 0.22 0 CA-C-O 122.309 1.052 . . . . 3.6800000000000002 111.815 158.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 10.3 t -165.83 148.0 7.28 Favored 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 126.995 2.118 . . . . 2.9500000000000002 107.252 148.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.5 pp -82.4 134.35 27.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 CA-C-O 122.666 1.222 . . . . 3.27 110.375 175.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -79.79 64.05 4.53 Favored 'General case' 0 N--CA 1.433 -1.295 0 C-N-CA 127.687 2.395 . . . . 5.7400000000000002 111.624 -173.315 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 52.8 t -133.52 131.43 57.31 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 O-C-N 120.721 -1.237 . . . . 1.9399999999999999 113.131 174.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -138.8 76.23 1.56 Allowed 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 105.217 -2.142 . . . . 2.1200000000000001 105.217 152.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -54.54 -39.78 68.01 Favored 'General case' 0 CA--C 1.511 -0.526 0 N-CA-C 109.595 -0.52 . . . . 4.1900000000000004 109.595 175.138 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 24.0 ttt -85.06 44.22 1.06 Allowed 'General case' 0 N--CA 1.442 -0.836 0 CA-C-O 121.767 0.794 . . . . 5.9100000000000001 109.1 -164.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -179.33 -36.71 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 129.013 2.925 . . . . 2.3100000000000001 107.076 -167.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 106.11 46.72 1.14 Allowed Glycine 0 C--N 1.336 0.569 0 C-N-CA 126.062 1.791 . . . . 0.92000000000000004 108.983 157.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 24.8 mttm -155.27 175.14 14.24 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 108.392 -0.966 . . . . 5.4800000000000004 108.392 -157.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -144.2 142.6 30.61 Favored 'General case' 0 N--CA 1.44 -0.967 0 C-N-CA 125.315 1.446 . . . . 1.9099999999999999 107.978 -178.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -132.99 97.37 4.0 Favored 'General case' 0 C--N 1.338 0.103 0 N-CA-C 113.379 0.881 . . . . 3.27 113.379 171.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.3 p -81.11 114.96 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.518 0 N-CA-C 107.423 -1.325 . . . . 2.8799999999999999 107.423 -178.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 54.5 ttp180 -87.36 124.78 33.75 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 105.71 -1.959 . . . . 6.3399999999999999 105.71 163.114 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -158.22 170.72 21.62 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 122.96 0.504 . . . . 3.4900000000000002 110.6 -164.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 47.5 t-20 -108.53 88.26 4.97 Favored Pre-proline 0 N--CA 1.451 -0.421 0 C-N-CA 124.038 0.935 . . . . 2.6600000000000001 109.346 173.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -61.79 88.23 0.1 Allowed 'Trans proline' 0 N--CA 1.448 -1.163 0 C-N-CA 122.328 2.019 . . . . 1.6000000000000001 108.973 165.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -169.97 -57.56 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 130.423 3.489 . . . . 1.99 105.101 169.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 65.7 t -58.45 -54.37 33.95 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 C-N-CA 124.879 1.272 . . . . 1.97 110.207 175.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 8.4 tp -93.61 -73.02 0.48 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.364 0 CA-C-O 118.725 -0.655 . . . . 3.1600000000000001 111.93 -167.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 117.17 134.99 0.0 OUTLIER Pre-proline 0 N--CA 1.472 0.626 0 C-N-CA 130.753 3.621 . . . . 3.52 108.185 -176.365 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -50.24 -50.86 12.24 Favored 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 123.595 2.863 . . . . 1.1299999999999999 114.449 172.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -50.07 -54.31 5.66 Favored 'Trans proline' 0 N--CA 1.444 -1.39 0 CA-C-N 120.451 1.197 . . . . 0.95999999999999996 110.069 167.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 62.0 mtt -62.45 -37.61 86.57 Favored 'General case' 0 C--N 1.342 0.261 0 C-N-CA 118.336 -1.346 . . . . 3.02 111.469 -170.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 3.5 tt -70.37 -45.23 75.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-N 118.808 0.731 . . . . 3.0299999999999998 110.312 178.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -58.8 -32.85 69.72 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.102 0.561 . . . . 1.8899999999999999 112.254 176.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -71.78 -60.13 2.39 Favored 'General case' 0 N--CA 1.441 -0.895 0 C-N-CA 126.388 1.875 . . . . 3.5600000000000001 111.585 176.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -41.63 -45.32 3.35 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.79 0.836 . . . . 4.8700000000000001 111.791 -173.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 49.7 mt -57.39 -52.48 56.31 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 C-N-CA 123.88 0.872 . . . . 2.1699999999999999 110.923 -177.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 1.3 ptt85 -71.5 -49.68 38.73 Favored 'General case' 0 CA--C 1.521 -0.139 0 N-CA-C 109.596 -0.52 . . . . 4.6399999999999997 109.596 -177.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -59.61 -34.51 72.84 Favored 'General case' 0 N--CA 1.441 -0.896 0 C-N-CA 123.387 0.675 . . . . 6.3899999999999997 111.627 -173.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 86.1 mt -83.0 -47.89 11.23 Favored 'General case' 0 C--N 1.34 0.194 0 CA-C-N 118.754 0.706 . . . . 4.0499999999999998 111.446 170.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -95.98 -92.27 1.78 Allowed Glycine 0 CA--C 1.526 0.773 0 N-CA-C 111.692 -0.563 . . . . 2.7400000000000002 111.692 -174.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -135.53 -72.13 0.47 Allowed 'General case' 0 CA--C 1.513 -0.469 0 CA-C-O 121.679 0.752 . . . . 4.5599999999999996 112.962 -153.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 173.73 119.23 0.53 Allowed Glycine 0 N--CA 1.441 -1.028 0 N-CA-C 107.935 -2.066 . . . . 1.5700000000000001 107.935 -156.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -156.5 161.41 40.02 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 122.904 0.482 . . . . 1.76 110.996 -173.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 26.2 m -153.94 148.57 26.34 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 124.031 0.932 . . . . 3.8799999999999999 108.599 178.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 14.3 p -82.3 143.75 11.52 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 123.624 0.77 . . . . 3.6400000000000001 109.74 -177.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 22.5 mm -133.13 140.16 47.76 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 C-N-CA 125.774 1.629 . . . . 3.1099999999999999 107.528 -178.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -156.65 160.41 39.35 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 123.741 0.817 . . . . 4.9400000000000004 109.108 179.045 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 7.5 m-20 -91.97 92.54 8.36 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 108.24 -1.022 . . . . 6.5300000000000002 108.24 -179.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 10.2 tp -54.93 145.75 4.7 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 C-N-CA 122.62 0.368 . . . . 10.98 110.427 174.083 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -146.47 160.52 41.99 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 106.254 -1.758 . . . . 11.210000000000001 106.254 177.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -148.41 -121.49 1.18 Allowed Glycine 0 CA--C 1.527 0.8 0 N-CA-C 110.662 -0.975 . . . . 13.779999999999999 110.662 -178.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.248 1.009 0 N-CA-C 104.289 -2.485 . . . . 21.52 104.289 169.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 . . . . . 0 N--CA 1.476 0.839 0 N-CA-C 107.172 -1.418 . . . . 7.0700000000000003 107.172 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.4 m -146.4 162.14 38.86 Favored 'General case' 0 N--CA 1.454 -0.236 0 O-C-N 124.359 1.037 . . . . 3.02 108.605 -176.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 23.0 t -141.93 169.56 17.37 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 108.956 -0.757 . . . . 3.6200000000000001 108.956 171.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 71.9 tttt -104.72 158.33 16.58 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.309 1.443 . . . . 4.4900000000000002 107.211 163.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 36.3 t -155.55 155.09 32.75 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 109.046 -0.724 . . . . 2.21 109.046 167.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 5.1 m-30 -106.45 135.01 48.7 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 125.848 1.659 . . . . 3.6899999999999999 108.771 -178.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.3 mm -129.06 139.75 51.05 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 N-CA-C 105.463 -2.051 . . . . 3.46 105.463 -173.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 51.3 tp60 -112.2 122.93 49.12 Favored 'General case' 0 N--CA 1.424 -1.728 0 N-CA-C 104.693 -2.336 . . . . 3.7000000000000002 104.693 -179.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 15.7 m -105.3 173.08 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 C-N-CA 124.378 1.071 . . . . 3.5699999999999998 108.687 178.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -134.42 88.73 2.48 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.562 0.745 . . . . 3.73 111.045 -173.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 154.9 -62.81 0.35 Allowed Glycine 0 CA--C 1.524 0.619 0 N-CA-C 107.667 -2.173 . . . . 3.7999999999999998 107.667 174.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 1.9 mtt 66.38 -71.71 0.09 Allowed 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 126.691 1.997 . . . . 4.46 111.213 170.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 33.1 p -79.47 52.85 1.44 Allowed 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 124.42 1.088 . . . . 5.7300000000000004 108.496 176.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 55.8 m -92.42 176.29 6.52 Favored 'General case' 0 N--CA 1.445 -0.725 0 C-N-CA 124.794 1.238 . . . . 2.7599999999999998 107.895 175.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -75.64 73.42 2.63 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 121.454 0.645 . . . . 4.29 110.097 166.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.5 m 74.94 26.99 1.22 Allowed 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 115.24 -0.891 . . . . 3.1400000000000001 113.129 159.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 69.9 m -44.27 -43.25 7.21 Favored 'General case' 0 CA--C 1.523 -0.075 0 C-N-CA 124.357 1.063 . . . . 3.0800000000000001 108.912 157.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 24.5 m -63.53 -50.97 76.14 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.001 0 CA-C-N 114.138 -1.392 . . . . 3.6299999999999999 109.993 -177.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -52.73 -43.82 65.97 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 122.994 0.518 . . . . 2.5899999999999999 110.972 172.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -56.53 -50.77 70.88 Favored 'General case' 0 C--O 1.227 -0.123 0 N-CA-C 109.303 -0.628 . . . . 2.4700000000000002 109.303 174.508 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 7.1 mt -58.44 -60.73 1.91 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 C-N-CA 123.541 0.736 . . . . 3.0600000000000001 109.039 -179.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -39.61 -54.92 1.95 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.942 1.297 . . . . 3.6299999999999999 112.259 172.02 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -59.83 -44.63 93.95 Favored 'General case' 0 CA--C 1.528 0.133 0 O-C-N 121.666 -0.646 . . . . 6.8099999999999996 112.422 178.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -56.83 -55.87 28.83 Favored 'General case' 0 C--O 1.226 -0.153 0 N-CA-C 108.4 -0.963 . . . . 3.0899999999999999 108.4 179.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -74.84 -23.95 58.52 Favored 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 114.369 1.248 . . . . 3.2599999999999998 114.369 -172.325 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.55 -15.33 62.6 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 120.583 1.538 . . . . 7.2400000000000002 114.802 -170.122 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 73.7 mtt180 -65.79 -19.55 65.93 Favored 'General case' 0 N--CA 1.462 0.142 0 N-CA-C 113.333 0.864 . . . . 8.2200000000000006 113.333 -157.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 71.25 23.25 4.09 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 125.08 1.352 . . . . 10.470000000000001 112.446 -172.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -76.46 59.3 1.44 Allowed 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 127.56 2.344 . . . . 5.6399999999999997 108.766 171.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 75.51 32.91 53.9 Favored Glycine 0 CA--C 1.535 1.311 0 C-N-CA 124.261 0.934 . . . . 1.53 113.641 -178.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -142.27 135.66 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 C-N-CA 127.212 2.205 . . . . 4.2199999999999998 105.665 -170.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 41.2 m-85 -145.29 48.13 1.28 Allowed 'General case' 0 C--O 1.233 0.195 0 CA-C-O 123.155 1.455 . . . . 3.6800000000000002 111.702 171.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 14.0 t -164.84 -178.64 5.35 Favored 'General case' 0 C--N 1.317 -0.841 0 C-N-CA 129.875 3.27 . . . . 2.4100000000000001 106.135 151.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -125.2 127.49 72.16 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 C-N-CA 124.474 1.11 . . . . 3.52 109.42 174.243 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -78.35 71.0 4.79 Favored 'General case' 0 N--CA 1.439 -0.993 0 O-C-N 121.099 -1.001 . . . . 5.5099999999999998 110.85 -176.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 18.7 t -123.9 139.83 49.19 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.885 0 CA-C-O 122.183 0.992 . . . . 1.9299999999999999 109.414 159.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -155.62 58.95 0.62 Allowed 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 126.418 1.887 . . . . 1.77 107.139 168.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.2 pp -56.86 -32.14 65.51 Favored 'General case' 0 CA--C 1.51 -0.566 0 C-N-CA 123.45 0.7 . . . . 4.1699999999999999 112.474 -175.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 65.1 mtt -65.53 -40.44 92.94 Favored 'General case' 0 N--CA 1.441 -0.898 0 C-N-CA 119.761 -0.775 . . . . 5.5300000000000002 108.913 -165.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -76.84 -42.22 41.09 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.721 0.808 . . . . 2.25 109.842 167.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 111.88 57.16 0.46 Allowed Glycine 0 C--N 1.338 0.652 0 N-CA-C 109.426 -1.469 . . . . 1.02 109.426 176.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -160.24 -178.37 6.91 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 107.002 -1.481 . . . . 5.3899999999999997 107.002 -169.149 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -146.35 130.1 17.09 Favored 'General case' 0 N--CA 1.434 -1.259 0 C-N-CA 126.334 1.854 . . . . 2.0 106.001 -172.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -135.94 114.36 11.69 Favored 'General case' 0 C--N 1.342 0.261 0 CA-C-N 120.926 1.693 . . . . 2.5099999999999998 113.277 177.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.2 p -90.12 150.18 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.273 0 C-N-CA 125.02 1.328 . . . . 2.3700000000000001 110.17 -171.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 35.4 ttm180 -125.75 131.02 52.6 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 104.863 -2.273 . . . . 4.9900000000000002 104.863 159.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 3.8 p90 -160.18 169.73 22.66 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-N 118.219 0.463 . . . . 3.6200000000000001 111.569 -165.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . 0.271 49.1 p30 -104.3 97.18 11.24 Favored Pre-proline 0 CA--C 1.542 0.671 0 N-CA-C 113.234 0.827 . . . . 3.9900000000000002 113.234 170.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -72.51 73.19 2.86 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 122.526 2.15 . . . . 1.46 111.331 177.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -150.27 -57.39 0.18 Allowed 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 126.548 1.939 . . . . 2.2999999999999998 106.041 171.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 78.6 t -58.62 -54.6 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.787 0 C-N-CA 123.778 0.831 . . . . 2.29 109.299 171.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.43 ' CG2' ' H ' ' A' ' 53' ' ' GLN 0.265 2.5 tp -90.54 -72.97 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-O 118.306 -0.854 . . . . 2.8100000000000001 112.103 -165.613 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.43 ' H ' ' CG2' ' A' ' 52' ' ' ILE . 0.0 OUTLIER 112.98 136.66 0.0 OUTLIER Pre-proline 0 N--CA 1.476 0.87 0 C-N-CA 131.122 3.769 . . . . 3.7599999999999998 108.653 -177.48 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -51.03 -51.13 11.85 Favored 'Trans proline' 0 CA--C 1.534 0.503 0 C-N-CA 124.054 3.17 . . . . 1.23 115.345 174.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -53.8 -48.83 19.64 Favored 'Trans proline' 0 N--CA 1.444 -1.409 0 CA-C-N 120.448 1.196 . . . . 0.89000000000000001 110.282 167.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 74.5 mtp -69.13 -33.16 73.01 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 118.301 -1.359 . . . . 3.21 110.65 -168.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 6.9 tt -66.42 -50.95 63.26 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 CA-C-N 119.935 1.243 . . . . 3.29 110.324 179.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -51.65 -53.97 33.07 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.09 0.956 . . . . 1.97 110.814 176.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 54.4 mm-40 -65.31 -38.08 89.09 Favored 'General case' 0 N--CA 1.429 -1.509 0 CA-C-O 118.866 -0.588 . . . . 3.5299999999999998 111.999 -177.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -54.54 -34.25 61.47 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 120.192 1.36 . . . . 5.7599999999999998 111.207 173.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.6 mm -60.47 -53.28 51.0 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 N-CA-C 107.746 -1.205 . . . . 3.5299999999999998 107.746 172.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 15.7 mtp-105 -55.58 -47.73 75.97 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 125.161 1.384 . . . . 7.6100000000000003 114.301 -177.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -45.92 -35.38 4.57 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 127.023 2.129 . . . . 3.1400000000000001 112.933 -175.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 58.8 mt -79.11 -16.39 56.78 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 122.93 0.492 . . . . 3.1699999999999999 111.196 -174.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 130.93 50.06 0.11 Allowed Glycine 0 CA--C 1.527 0.805 0 C-N-CA 125.182 1.372 . . . . 3.6000000000000001 111.168 170.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -136.39 169.62 17.38 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-O 123.519 1.628 . . . . 4.6399999999999997 113.673 -168.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -115.18 126.89 7.39 Favored Glycine 0 N--CA 1.442 -0.957 0 N-CA-C 105.949 -2.861 . . . . 1.76 105.949 168.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -153.24 81.52 1.19 Allowed 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 124.533 1.133 . . . . 2.1699999999999999 108.3 -172.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -84.8 138.04 32.83 Favored 'General case' 0 C--O 1.225 -0.227 0 C-N-CA 123.704 0.802 . . . . 2.8900000000000001 108.882 -175.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 97.0 t -84.89 109.19 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 N-CA-C 108.552 -0.907 . . . . 2.9300000000000002 108.552 -177.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 18.9 mm -130.8 60.15 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 C-N-CA 125.156 1.383 . . . . 3.8999999999999999 109.002 -171.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -79.6 175.58 10.48 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.397 -0.819 . . . . 3.75 109.478 155.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 42.3 m-80 49.86 47.14 23.52 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.135 0.974 . . . . 6.8700000000000001 111.111 175.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 13.2 tt -73.85 165.65 3.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 C-N-CA 124.417 1.087 . . . . 10.949999999999999 109.936 178.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 58.16 48.4 12.93 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.681 1.192 . . . . 11.81 111.983 176.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -65.1 157.95 45.91 Favored Glycine 0 CA--C 1.53 1.02 0 N-CA-C 109.918 -1.273 . . . . 10.33 109.918 165.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.252 1.215 0 N-CA-C 103.459 -2.793 . . . . 17.260000000000002 103.459 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 . . . . . 0 N--CA 1.48 1.059 0 N-CA-C 110.63 -0.137 . . . . 7.4400000000000004 110.63 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 88.4 p -170.97 155.98 4.73 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 125.604 1.562 . . . . 2.96 106.999 171.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 18.6 m -155.34 153.98 31.34 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 124.902 1.281 . . . . 2.8599999999999999 108.022 177.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 9.3 mtmp? -91.82 161.01 15.03 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 123.33 0.652 . . . . 4.1200000000000001 111.937 176.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 49.3 t -155.25 157.71 37.71 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 105.974 -1.861 . . . . 2.1000000000000001 105.974 166.12 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -98.34 146.4 25.72 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 119.804 1.184 . . . . 4.8700000000000001 108.007 171.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 12.0 mm -128.16 113.42 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 N-CA-C 105.138 -2.171 . . . . 3.0299999999999998 105.138 174.01 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 16.6 tp60 -82.38 124.49 30.06 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 104.825 -2.287 . . . . 3.6800000000000002 104.825 172.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.5 p -117.72 99.02 7.3 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-O 122.175 0.988 . . . . 3.5699999999999998 110.597 -169.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 7.0 m -67.03 94.3 0.33 Allowed 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 109.155 -0.683 . . . . 3.27 109.155 -179.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 135.24 3.94 2.67 Favored Glycine 0 C--O 1.221 -0.705 0 C-N-CA 125.124 1.345 . . . . 2.54 113.047 -175.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -43.98 -46.89 8.49 Favored 'General case' 0 C--N 1.321 -0.647 0 O-C-N 121.561 -0.964 . . . . 4.0300000000000002 110.612 162.277 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 15.3 t -74.43 12.13 0.84 Allowed 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.192 0.997 . . . . 6.7400000000000002 112.887 176.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 16.9 t -57.4 -41.77 80.95 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 107.011 -1.477 . . . . 2.8599999999999999 107.011 160.145 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 84.27 145.3 0.07 Allowed 'General case' 0 C--N 1.348 0.52 0 C-N-CA 127.934 2.494 . . . . 4.3799999999999999 110.138 -175.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.6 m 71.49 -30.91 0.22 Allowed 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 115.083 1.512 . . . . 3.3100000000000001 115.083 174.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 11.0 m -62.83 -18.21 62.49 Favored 'General case' 0 CA--C 1.517 -0.294 0 C-N-CA 128.825 2.85 . . . . 3.5299999999999998 111.821 -175.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 14.0 m -41.12 -43.78 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 N-CA-C 112.162 0.431 . . . . 3.27 112.162 159.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -52.77 -46.36 67.52 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.088 0.955 . . . . 2.3799999999999999 111.547 173.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -59.19 -51.98 67.65 Favored 'General case' 0 C--O 1.224 -0.249 0 N-CA-C 108.671 -0.863 . . . . 2.2200000000000002 108.671 175.353 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 38.4 mm -53.54 -59.39 1.91 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 C-N-CA 123.601 0.76 . . . . 3.1800000000000002 109.123 -179.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -42.54 -61.07 1.31 Allowed 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.057 1.343 . . . . 3.3999999999999999 110.977 175.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.93 -48.93 78.21 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 119.369 -0.348 . . . . 8.7100000000000009 110.933 -175.231 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -49.86 -60.32 3.02 Favored 'General case' 0 CA--C 1.519 -0.228 0 C-N-CA 123.989 0.916 . . . . 3.29 108.839 -179.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -70.57 -32.14 69.44 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 115.623 -0.717 . . . . 3.0 109.499 -170.397 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . 0.578 68.6 mtp180 -63.0 3.17 0.25 Allowed 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 117.827 2.529 . . . . 7.0800000000000001 117.827 163.217 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 3.5 mmt85 -43.58 -34.09 1.32 Allowed 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 116.914 -1.914 . . . . 8.7899999999999991 112.233 146.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . 0.25 4.2 mt-10 78.86 33.15 0.26 Allowed 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 127.191 2.196 . . . . 8.8100000000000005 112.135 176.436 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 80.1 mt-10 -73.55 69.62 1.25 Allowed 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 127.101 2.161 . . . . 5.9299999999999997 110.436 179.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 67.15 28.43 73.74 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 123.453 0.549 . . . . 1.3899999999999999 111.932 -179.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.0 mm -98.3 140.12 18.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 C-N-CA 128.416 2.686 . . . . 3.3799999999999999 109.208 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -148.47 42.51 0.99 Allowed 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 122.404 1.097 . . . . 4.79 113.12 163.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 33.6 t -166.87 149.41 6.4 Favored 'General case' 0 C--N 1.317 -0.805 0 C-N-CA 131.01 3.724 . . . . 3.21 104.828 144.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.7 pp -83.45 151.73 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 N-CA-C 108.157 -1.053 . . . . 2.6699999999999999 108.157 163.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -87.22 78.55 8.8 Favored 'General case' 0 N--CA 1.436 -1.138 0 C-N-CA 127.185 2.194 . . . . 5.4699999999999998 110.939 178.005 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 24.5 t -134.99 137.51 50.5 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 CA-C-O 121.368 0.604 . . . . 1.98 110.145 165.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -155.92 58.47 0.6 Allowed 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 113.912 -1.494 . . . . 1.97 107.397 164.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -63.61 -28.6 70.03 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.058 0.943 . . . . 4.3499999999999996 110.39 -173.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 63.3 mtt -46.37 -41.34 13.4 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.311 0.644 . . . . 5.54 111.666 170.027 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -88.68 -41.52 12.55 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 122.769 0.428 . . . . 2.4700000000000002 109.95 172.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 113.18 53.2 0.47 Allowed Glycine 0 C--N 1.335 0.488 0 N-CA-C 108.607 -1.797 . . . . 1.04 108.607 179.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 37.6 mtmt -151.71 175.41 12.42 Favored 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 108.293 -1.003 . . . . 4.4699999999999998 108.293 -164.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -148.0 119.25 7.8 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 105.646 -1.983 . . . . 1.8899999999999999 105.646 -174.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -128.24 96.94 4.59 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 123.553 0.741 . . . . 3.2599999999999998 111.433 -171.34 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 10.7 p -81.62 147.93 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.285 0 C-N-CA 123.226 0.61 . . . . 2.3399999999999999 109.362 -170.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 21.5 ttt-85 -123.13 127.76 49.14 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 105.774 -1.936 . . . . 6.9199999999999999 105.774 156.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 3.8 p90 -157.88 175.04 14.37 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 108.426 -0.953 . . . . 3.3999999999999999 108.426 -169.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -109.12 104.3 54.67 Favored Pre-proline 0 CA--C 1.537 0.467 0 CA-C-O 118.579 -0.724 . . . . 3.9500000000000002 111.647 176.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -70.78 76.61 1.52 Allowed 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 123.257 2.638 . . . . 1.5700000000000001 111.571 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -165.53 -46.97 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 126.524 1.929 . . . . 2.2599999999999998 107.224 167.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 99.2 t -62.71 -45.54 98.57 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.885 0 C-N-CA 125.148 1.379 . . . . 2.2000000000000002 110.056 177.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . 0.273 6.0 tp -113.17 -73.32 0.63 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.303 0 CA-C-O 118.16 -0.924 . . . . 3.1299999999999999 112.187 -167.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 27.8 mm100 110.86 131.93 0.0 OUTLIER Pre-proline 0 CA--C 1.54 0.588 0 C-N-CA 129.424 3.09 . . . . 4.0 111.757 174.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -44.86 -53.68 4.93 Favored 'Trans proline' 0 CA--C 1.534 0.516 0 C-N-CA 125.23 3.954 . . . . 1.4199999999999999 116.427 176.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_endo -53.04 -47.29 28.34 Favored 'Trans proline' 0 N--CA 1.447 -1.222 0 CA-C-N 120.825 1.33 . . . . 1.0900000000000001 110.022 172.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 64.7 mtt -62.4 -46.41 88.71 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 118.181 -0.914 . . . . 3.21 111.41 -177.079 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 18.0 pt -61.93 -45.08 99.49 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-N 120.616 1.553 . . . . 3.52 111.318 176.094 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -53.93 -52.65 59.91 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 121.195 0.521 . . . . 2.1699999999999999 110.443 179.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 62.1 mm-40 -61.43 -48.49 80.95 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-O 118.359 -0.829 . . . . 3.5899999999999999 111.853 177.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -47.25 -42.44 20.57 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 119.659 1.118 . . . . 5.1299999999999999 111.385 176.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 54.8 mt -67.05 -40.2 84.96 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 O-C-N 122.037 -0.414 . . . . 1.9299999999999999 110.186 178.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 54.6 mtt180 -64.74 -50.62 66.15 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.647 0.779 . . . . 5.3399999999999999 111.934 177.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -43.66 -55.13 4.55 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 126.462 1.905 . . . . 2.9399999999999999 111.674 -175.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.38 -31.04 12.58 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 113.043 0.757 . . . . 3.0 113.043 -179.523 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -114.9 -85.67 1.31 Allowed Glycine 0 CA--C 1.528 0.891 0 CA-C-N 119.148 0.885 . . . . 3.0099999999999998 113.911 -165.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -147.81 156.03 42.29 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 113.558 0.948 . . . . 4.2300000000000004 113.558 -146.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -70.03 82.3 0.33 Allowed Glycine 0 N--CA 1.444 -0.786 0 CA-C-N 114.629 -1.169 . . . . 1.5 111.112 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -82.72 144.42 30.22 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 125.229 1.412 . . . . 1.76 109.655 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.6 t -142.92 139.97 30.96 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 106.007 -1.849 . . . . 2.96 106.007 165.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.6 m -83.67 145.63 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 N-CA-C 109.586 -0.524 . . . . 3.6499999999999999 109.586 -176.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 14.9 mm -141.27 147.73 22.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 C-N-CA 126.064 1.746 . . . . 3.3999999999999999 107.309 -177.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -173.52 -176.43 1.29 Allowed 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 126.351 1.86 . . . . 3.7999999999999998 106.355 168.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -156.43 157.24 35.2 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 107.845 -1.168 . . . . 6.7300000000000004 107.845 176.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 15.8 tt -75.26 162.88 4.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 123.43 0.692 . . . . 11.449999999999999 109.243 173.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -139.16 153.03 47.88 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 105.405 -2.072 . . . . 12.949999999999999 105.405 174.284 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 160.5 -170.07 36.4 Favored Glycine 0 CA--C 1.527 0.84 0 CA-C-N 118.92 0.782 . . . . 13.34 111.327 -176.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.016 0 N-CA-C 104.158 -2.534 . . . . 20.890000000000001 104.158 178.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 41.6 t30 . . . . . 0 N--CA 1.477 0.906 0 N-CA-C 107.858 -1.164 . . . . 7.4299999999999997 107.858 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.0 m -152.68 101.43 2.63 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 108.142 -1.058 . . . . 2.8300000000000001 108.142 170.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.1 m -109.18 144.02 37.82 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 126.247 1.819 . . . . 2.7799999999999998 108.116 -176.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 35.5 tttt -95.54 164.02 12.97 Favored 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 123.37 0.668 . . . . 5.6399999999999997 110.611 -178.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 7.8 p -153.99 174.31 14.83 Favored 'General case' 0 C--O 1.232 0.16 0 N-CA-C 109.141 -0.689 . . . . 2.6400000000000001 109.141 156.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -122.54 142.11 50.95 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 125.348 1.459 . . . . 4.0300000000000002 108.296 -175.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 10.9 mt -146.0 132.61 14.25 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 N-CA-C 106.812 -1.551 . . . . 2.3300000000000001 106.812 -167.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 12.5 tp60 -84.2 125.35 32.11 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 105.508 -2.034 . . . . 4.3600000000000003 105.508 165.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 6.7 p -110.37 101.98 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 C-N-CA 124.341 1.057 . . . . 3.1499999999999999 108.336 177.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 21.0 m -71.69 80.79 0.85 Allowed 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 108.974 -0.751 . . . . 3.0099999999999998 108.974 176.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -171.19 -52.59 0.04 OUTLIER Glycine 0 CA--C 1.53 1.012 0 C-N-CA 129.02 3.2 . . . . 2.29 106.977 172.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 63.8 mtt 62.92 -66.38 0.09 Allowed 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 127.489 2.315 . . . . 4.6600000000000001 112.319 175.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 14.6 t -151.72 53.38 0.83 Allowed 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.036 1.334 . . . . 5.5300000000000002 107.751 173.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.0 p -43.7 -50.29 7.6 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.586 1.154 . . . . 3.1000000000000001 109.784 173.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -172.52 93.99 0.13 Allowed 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 126.748 2.019 . . . . 4.3899999999999997 106.87 156.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.7 m 59.11 42.48 18.83 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 121.562 0.696 . . . . 3.1299999999999999 110.548 -173.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 6.9 t -43.34 -41.99 4.33 Favored 'General case' 0 N--CA 1.461 0.109 0 C-N-CA 126.766 2.026 . . . . 4.0300000000000002 108.192 166.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 4.9 m -66.99 -53.32 35.1 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.972 0 C-N-CA 125.532 1.533 . . . . 3.0299999999999998 110.935 -173.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -50.78 -47.85 59.55 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.136 0.975 . . . . 1.6899999999999999 109.493 171.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -55.43 -53.29 58.05 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 108.927 -0.768 . . . . 2.4100000000000001 108.927 177.504 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.1 mp -53.69 -54.94 15.98 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 C-N-CA 124.469 1.108 . . . . 3.3999999999999999 110.386 178.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -48.91 -60.3 2.87 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 119.429 1.013 . . . . 2.96 109.541 -178.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 8.8 mpt_? -60.6 -38.65 85.4 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 115.131 -0.94 . . . . 7.71 110.71 -176.059 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -62.24 -60.13 4.03 Favored 'General case' 0 C--O 1.227 -0.088 0 C-N-CA 122.686 0.394 . . . . 3.5099999999999998 110.208 177.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -75.87 -64.6 1.05 Allowed 'General case' 0 N--CA 1.437 -1.11 0 CA-C-N 116.732 -0.213 . . . . 2.98 110.552 -159.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.53 -15.25 0.63 Allowed 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 115.665 1.728 . . . . 7.3300000000000001 115.665 -162.435 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -31.25 -59.02 0.24 Allowed 'General case' 0 N--CA 1.439 -0.99 0 C-N-CA 126.361 1.864 . . . . 7.7699999999999996 109.805 -175.077 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . 0.313 0.0 OUTLIER -167.15 -108.52 0.01 OUTLIER 'General case' 0 N--CA 1.447 -0.616 0 O-C-N 125.043 1.464 . . . . 7.3399999999999999 108.027 -171.113 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 44.48 31.16 0.57 Allowed 'General case' 0 C--N 1.314 -0.966 0 C-N-CA 127.256 2.222 . . . . 4.9000000000000004 114.628 156.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 60.21 31.09 72.27 Favored Glycine 0 CA--C 1.53 1.008 0 CA-C-O 118.483 -1.176 . . . . 1.29 113.537 -178.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 1.4 mp -78.43 139.31 18.69 Favored 'Isoleucine or valine' 0 C--N 1.34 0.167 0 CA-C-N 119.196 1.498 . . . . 3.7999999999999998 107.529 169.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -148.22 36.45 0.83 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 120.382 -0.527 . . . . 6.8799999999999999 112.275 158.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 34.0 t -169.36 143.64 2.91 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 130.117 3.367 . . . . 3.1499999999999999 104.32 139.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.7 pp -82.09 147.16 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 CA-C-N 119.683 1.129 . . . . 2.6400000000000001 109.06 172.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -79.41 80.39 5.78 Favored 'General case' 0 N--CA 1.44 -0.948 0 C-N-CA 125.77 1.628 . . . . 5.3700000000000001 111.384 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 85.6 t -130.64 138.9 52.57 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.121 0 CA-C-O 121.499 0.666 . . . . 2.2000000000000002 109.252 162.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -153.73 57.02 0.74 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 113.666 -1.607 . . . . 1.74 107.364 165.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -73.01 -15.58 61.52 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 114.913 -1.04 . . . . 4.0199999999999996 111.623 -172.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 93.7 mtp -49.43 -35.94 20.79 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 121.485 -0.76 . . . . 4.4699999999999998 110.885 162.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -95.39 -46.82 6.55 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.391 0.676 . . . . 1.98 110.483 170.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 111.25 63.56 0.49 Allowed Glycine 0 C--N 1.339 0.722 0 N-CA-C 107.809 -2.117 . . . . 1.1799999999999999 107.809 -171.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 4.4 pttt -160.82 175.4 12.61 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 118.279 1.04 . . . . 5.2000000000000002 108.541 -178.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -123.36 125.67 45.43 Favored 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 128.038 2.535 . . . . 2.4300000000000002 107.456 -176.216 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -140.22 92.75 2.56 Favored 'General case' 0 N--CA 1.457 -0.104 0 CA-C-O 122.01 0.909 . . . . 3.21 113.063 175.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.7 p -79.16 153.38 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.21 0 C-N-CA 125.405 1.482 . . . . 2.3700000000000001 109.219 -172.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 65.0 ttt180 -122.61 141.05 52.13 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 106.504 -1.665 . . . . 6.21 106.504 159.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 32.5 p90 -152.04 159.09 43.8 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 122.918 0.487 . . . . 3.5899999999999999 110.18 -165.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -98.19 98.74 6.0 Favored Pre-proline 0 CA--C 1.539 0.525 0 C-N-CA 123.676 0.791 . . . . 2.9399999999999999 110.329 170.245 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -75.22 75.99 3.62 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 122.765 2.31 . . . . 1.95 111.203 -176.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -159.51 -43.71 0.05 Allowed 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 125.235 1.414 . . . . 2.3599999999999999 108.915 169.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 33.9 t -52.13 -56.53 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.737 0 C-N-CA 124.452 1.101 . . . . 2.54 109.1 169.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 6.4 tt -124.69 -128.5 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.44 -0.957 0 CA-C-N 114.603 -1.181 . . . . 2.9100000000000001 108.817 -167.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 4.9 tp60 -175.18 112.65 0.28 Allowed Pre-proline 0 CA--C 1.539 0.542 0 N-CA-C 108.686 -0.857 . . . . 3.04 108.686 -159.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -47.59 -44.51 25.63 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 124.728 3.619 . . . . 1.75 116.767 176.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -54.33 -56.83 2.19 Favored 'Trans proline' 0 N--CA 1.445 -1.373 0 CA-C-N 121.212 1.469 . . . . 1.4299999999999999 109.687 167.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 87.1 mtp -53.56 -48.46 69.11 Favored 'General case' 0 C--N 1.342 0.247 0 CA-C-O 119.065 -0.493 . . . . 3.71 112.317 -175.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 3.6 pt -60.38 -41.14 86.26 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 CA-C-N 119.155 0.889 . . . . 4.1900000000000004 111.829 -177.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.96 -60.16 4.23 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 119.704 1.138 . . . . 2.73 111.038 169.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -46.12 -52.69 11.71 Favored 'General case' 0 N--CA 1.442 -0.867 0 C-N-CA 126.497 1.919 . . . . 3.4500000000000002 112.341 -174.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -44.14 -39.81 4.57 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.647 0.779 . . . . 5.2000000000000002 112.972 -179.484 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 43.0 mt -61.32 -36.96 76.37 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 C-N-CA 122.81 0.444 . . . . 2.6499999999999999 110.005 -178.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 60.2 mtt180 -62.52 -62.04 2.02 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 124.237 1.015 . . . . 5.0099999999999998 108.982 178.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -39.4 -52.24 2.08 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 124.987 1.315 . . . . 4.9500000000000002 112.57 173.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.6 pp -83.35 -18.19 39.74 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 113.969 1.1 . . . . 3.6099999999999999 113.969 -176.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -171.47 -66.15 0.04 OUTLIER Glycine 0 CA--C 1.533 1.199 0 CA-C-N 120.018 1.281 . . . . 2.4700000000000002 115.757 -178.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -130.22 146.82 51.88 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 122.058 0.932 . . . . 4.6100000000000003 113.5 -147.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -75.42 81.8 0.94 Allowed Glycine 0 N--CA 1.449 -0.442 0 CA-C-N 115.516 -0.765 . . . . 1.52 112.276 -167.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -83.22 90.7 7.14 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 126.335 1.854 . . . . 2.1699999999999999 110.507 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 20.0 p -99.55 126.83 45.59 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 125.161 1.384 . . . . 3.27 108.439 177.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 90.3 t -82.64 130.23 36.1 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.712 0 C-N-CA 124.523 1.129 . . . . 3.0 109.494 -173.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 24.5 mt -142.06 63.37 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 C-N-CA 125.503 1.521 . . . . 3.3300000000000001 108.285 -175.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -65.2 154.63 37.51 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 109.171 -0.677 . . . . 4.9400000000000004 109.171 168.294 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 4.1 p30 165.46 126.23 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 128.35 2.66 . . . . 6.2400000000000002 109.249 168.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -163.21 138.97 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 N-CA-C 104.46 -2.422 . . . . 9.1400000000000006 104.46 175.005 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 26.67 64.7 0.08 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 126.671 1.988 . . . . 11.42 114.879 -175.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -151.77 47.92 0.56 Allowed Glycine 0 CA--C 1.522 0.528 0 N-CA-C 108.071 -2.012 . . . . 10.1 108.071 177.095 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 38.4 ttt85 . . . . . 0 C--O 1.255 1.37 0 CA-C-O 116.733 -1.603 . . . . 15.15 107.562 -142.101 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 . . . . . 0 N--CA 1.476 0.834 0 N-CA-C 109.136 -0.69 . . . . 8.2899999999999991 109.136 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.6 p -165.08 59.42 0.12 Allowed 'General case' 0 C--O 1.235 0.317 0 CA-C-O 122.551 1.167 . . . . 3.1299999999999999 108.723 -179.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.8 p -97.31 172.4 7.81 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 127.795 2.438 . . . . 3.2000000000000002 109.733 -169.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.98 153.6 50.17 Favored 'General case' 0 C--N 1.339 0.129 0 C-N-CA 122.848 0.459 . . . . 4.3899999999999997 111.12 -179.771 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 41.1 t -146.8 155.75 42.6 Favored 'General case' 0 C--O 1.231 0.107 0 C-N-CA 124.95 1.3 . . . . 3.1600000000000001 109.13 -175.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -97.39 136.88 37.21 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 126.081 1.752 . . . . 4.0800000000000001 108.145 174.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.1 mm -139.94 123.53 18.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 107.078 -1.453 . . . . 3.1099999999999999 107.078 -177.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 5.9 mm-40 -77.93 159.37 28.89 Favored 'General case' 0 N--CA 1.455 -0.194 0 O-C-N 120.745 -1.222 . . . . 3.7000000000000002 110.228 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.4 p -137.91 139.75 42.06 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 O-C-N 123.469 0.481 . . . . 4.1100000000000003 111.925 -172.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.3 m -76.77 63.89 2.25 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.436 1.095 . . . . 4.2800000000000002 113.306 -176.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -161.03 -60.44 0.02 OUTLIER Glycine 0 C--O 1.227 -0.293 0 N-CA-C 105.98 -2.848 . . . . 3.5099999999999998 105.98 157.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 9.4 ttm 54.39 20.79 2.89 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.474 1.11 . . . . 5.21 111.421 -176.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 61.4 m -160.99 -38.67 0.05 OUTLIER 'General case' 0 C--N 1.335 -0.062 0 C-N-CA 124.61 1.164 . . . . 6.2400000000000002 109.856 -156.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 28.4 p -59.04 132.85 55.26 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 108.452 -0.944 . . . . 3.3399999999999999 108.452 -179.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -53.53 -31.35 45.95 Favored 'General case' 0 CA--C 1.535 0.374 0 O-C-N 121.314 -0.866 . . . . 4.2400000000000002 110.491 179.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.4 m -53.17 -39.74 63.84 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 126.109 1.764 . . . . 3.6499999999999999 114.443 172.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -35.21 -57.74 0.57 Allowed 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 125.713 1.605 . . . . 4.8099999999999996 111.601 -146.479 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -62.87 -50.19 80.63 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.874 0 CA-C-N 114.794 -1.094 . . . . 4.3700000000000001 112.525 -177.121 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -54.63 -44.52 73.25 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.382 1.073 . . . . 2.0499999999999998 110.484 172.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -54.62 -59.94 4.02 Favored 'General case' 0 C--O 1.226 -0.167 0 N-CA-C 108.635 -0.876 . . . . 4.96 108.635 175.659 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.3 mt -61.09 -42.27 92.53 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.14 0 O-C-N 121.406 -0.809 . . . . 3.75 110.952 -174.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 69.1 mt-10 -60.85 -25.49 66.69 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 125.557 1.543 . . . . 3.6099999999999999 112.938 174.018 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 10.5 mmm180 -73.1 -42.31 63.08 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 119.344 0.975 . . . . 8.0899999999999999 111.954 158.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -70.93 -49.71 42.62 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 124.427 1.091 . . . . 4.4299999999999997 113.692 -160.266 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.9 mp -78.11 -60.05 2.53 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 118.977 0.808 . . . . 3.8999999999999999 112.872 -176.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 9.5 ptm180 -39.38 -19.87 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 129.933 3.293 . . . . 6.7699999999999996 118.481 -158.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 19.9 mtm105 -67.34 -51.97 45.84 Favored 'General case' 0 N--CA 1.439 -0.98 0 C-N-CA 127.337 2.255 . . . . 8.9900000000000002 109.487 -161.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 168.59 152.03 0.03 OUTLIER 'General case' 0 CA--C 1.512 -0.515 0 N-CA-C 105.519 -2.03 . . . . 7.2199999999999998 105.519 -152.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 99.91 44.84 0.0 OUTLIER 'General case' 0 C--N 1.34 0.157 0 C-N-CA 128.132 2.573 . . . . 7.1500000000000004 112.088 -168.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 56.35 42.57 89.21 Favored Glycine 0 CA--C 1.528 0.894 0 CA-C-N 116.275 -0.42 . . . . 2.2999999999999998 112.527 171.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -77.26 135.29 26.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 N-CA-C 107.104 -1.443 . . . . 3.9300000000000002 107.104 174.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 54.0 m-85 -141.62 37.55 1.66 Allowed 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 122.061 0.934 . . . . 4.9900000000000002 113.397 164.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 75.0 m -166.39 154.41 10.24 Favored 'General case' 0 C--N 1.321 -0.663 1 C-N-CA 131.989 4.116 . . . . 3.7000000000000002 103.964 122.32 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -98.3 136.6 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 N-CA-C 104.931 -2.248 . . . . 3.79 104.931 158.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -156.21 175.81 13.5 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 124.403 1.081 . . . . 7.7599999999999998 110.375 -179.484 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 24.0 t -158.8 117.43 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.421 -1.875 0 C-N-CA 127.22 2.208 . . . . 2.9199999999999999 106.545 -177.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -77.98 62.59 2.8 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 108.464 -0.939 . . . . 2.1499999999999999 108.464 168.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.59 -32.96 74.84 Favored 'General case' 0 C--N 1.342 0.266 0 O-C-N 121.687 -0.633 . . . . 3.4500000000000002 111.705 -168.069 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 51.5 ttp -55.09 -35.67 64.84 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.299 0.64 . . . . 6.75 111.199 173.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -86.99 -20.85 26.66 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.608 0.763 . . . . 2.5499999999999998 110.913 176.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 84.35 60.01 1.97 Allowed Glycine 0 C--N 1.335 0.518 0 N-CA-C 107.768 -2.133 . . . . 0.97999999999999998 107.768 169.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.96 167.53 20.43 Favored 'General case' 0 N--CA 1.437 -1.082 0 N-CA-C 106.363 -1.717 . . . . 5.7999999999999998 106.363 173.122 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -77.83 145.29 36.41 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 105.975 -1.861 . . . . 2.3900000000000001 105.975 167.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -94.56 167.48 11.45 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 105.774 -1.936 . . . . 2.9100000000000001 105.774 151.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.1 p -134.81 141.7 42.41 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 N-CA-C 104.606 -2.368 . . . . 2.5899999999999999 104.606 157.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 70.8 ttt180 -113.5 129.25 56.59 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 106.597 -1.631 . . . . 5.9400000000000004 106.597 158.089 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 7.2 p90 -157.3 172.22 19.0 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 122.968 0.507 . . . . 3.2000000000000002 111.783 -162.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 65.0 t-20 -109.21 88.56 5.96 Favored Pre-proline 0 CA--C 1.537 0.469 0 CA-C-N 114.677 -1.147 . . . . 2.5299999999999998 111.08 -177.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -67.67 79.55 0.49 Allowed 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 123.209 2.606 . . . . 2.0299999999999998 110.129 173.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -169.78 -47.91 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 127.712 2.405 . . . . 2.4300000000000002 106.726 172.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 57.5 t -69.87 -49.69 55.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 C-N-CA 124.261 1.025 . . . . 2.0299999999999998 109.405 173.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.9 tp -98.06 -68.89 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 CA-C-O 118.654 -0.689 . . . . 3.8100000000000001 111.832 -166.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 56.9 tp60 109.24 124.67 0.0 OUTLIER Pre-proline 0 CA--C 1.549 0.909 0 C-N-CA 128.946 2.898 . . . . 4.8200000000000003 109.894 176.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_exo -47.43 -59.51 1.22 Allowed 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 124.113 3.208 . . . . 1.3700000000000001 117.24 -172.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_endo -49.06 -43.57 35.76 Favored 'Trans proline' 0 N--CA 1.45 -1.052 0 C-N-CA 121.62 1.546 . . . . 1.8400000000000001 110.645 172.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 58.9 mtp -68.21 -34.32 76.04 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 118.602 -0.713 . . . . 2.9100000000000001 111.302 -177.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 3.2 tt -62.2 -39.17 83.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-N 120.707 1.594 . . . . 3.0699999999999998 110.977 177.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -56.55 -46.98 80.41 Favored 'General case' 0 CA--C 1.529 0.159 0 O-C-N 122.176 -0.328 . . . . 1.95 111.219 173.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -58.91 -52.41 65.86 Favored 'General case' 0 N--CA 1.435 -1.201 0 C-N-CA 123.197 0.599 . . . . 2.7400000000000002 111.99 176.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -58.29 -31.39 67.44 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 118.343 0.519 . . . . 6.0899999999999999 111.343 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 69.1 mt -62.95 -57.29 12.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-N 119.219 0.918 . . . . 2.1499999999999999 109.95 166.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 87.2 mtt180 -48.64 -42.09 33.21 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.633 0.773 . . . . 4.9199999999999999 112.62 -178.066 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 91.3 mt-10 -50.9 -29.84 13.07 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 124.621 1.168 . . . . 3.7999999999999998 113.272 177.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 51.1 mt -82.04 -16.28 50.71 Favored 'General case' 0 N--CA 1.454 -0.26 0 O-C-N 121.711 -0.618 . . . . 2.8599999999999999 110.316 -178.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 134.66 -44.91 1.15 Allowed Glycine 0 C--N 1.34 0.756 0 C-N-CA 124.731 1.158 . . . . 3.5 110.546 169.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 5.0 m-30 -78.37 129.04 34.51 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-O 121.278 0.561 . . . . 3.9500000000000002 109.612 -166.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -73.15 108.18 2.43 Favored Glycine 0 N--CA 1.442 -0.934 0 N-CA-C 110.878 -0.889 . . . . 1.49 110.878 -171.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -82.91 124.33 30.25 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.073 0.949 . . . . 2.4199999999999999 109.72 179.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -118.34 126.35 51.94 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 108.36 -0.978 . . . . 3.2799999999999998 108.36 164.113 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 65.3 t -83.36 139.11 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 C-N-CA 125.42 1.488 . . . . 2.9300000000000002 109.299 -169.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 12.1 mt -134.44 59.76 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 CA-C-O 122.439 1.114 . . . . 3.46 109.001 -178.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 81.8 mt-10 -59.93 148.06 36.48 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 107.969 -1.123 . . . . 4.6699999999999999 107.969 159.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -154.14 -69.43 0.14 Allowed 'General case' 0 CA--C 1.531 0.236 0 O-C-N 122.173 -0.329 . . . . 6.9299999999999997 111.675 -167.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 19.6 tt -59.8 116.18 1.53 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-N 118.861 0.755 . . . . 9.6099999999999994 110.186 178.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -61.47 -52.52 64.18 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.946 0.899 . . . . 11.27 110.366 -178.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 68.57 -125.62 20.53 Favored Glycine 0 CA--C 1.528 0.893 0 N-CA-C 109.764 -1.334 . . . . 14.01 109.764 -175.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 56.1 ttt85 . . . . . 0 C--O 1.251 1.149 0 N-CA-C 105.178 -2.156 . . . . 23.420000000000002 105.178 175.439 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 . . . . . 0 N--CA 1.477 0.923 0 N-CA-C 107.383 -1.34 . . . . 8.0 107.383 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.4 t -67.92 141.16 56.44 Favored 'General case' 0 C--O 1.231 0.097 0 N-CA-C 108.147 -1.057 . . . . 3.96 108.147 169.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.7 m -90.57 177.44 6.36 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 107.688 -1.227 . . . . 2.71 107.688 165.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.14 152.28 31.1 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 118.909 -0.567 . . . . 7.1100000000000003 110.636 165.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 49.1 t -137.82 154.65 49.51 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 124.63 1.172 . . . . 2.21 108.973 171.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 2.5 m-30 -100.83 150.55 22.69 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 106.916 -1.513 . . . . 3.54 106.916 176.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 13.5 mt -144.27 126.25 10.35 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 N-CA-C 104.773 -2.306 . . . . 2.6200000000000001 104.773 -175.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 3.6 tp60 -88.23 134.36 33.81 Favored 'General case' 0 N--CA 1.442 -0.866 0 N-CA-C 106.045 -1.835 . . . . 3.4100000000000001 106.045 173.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 16.1 m -128.39 175.81 9.18 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 C-N-CA 125.343 1.457 . . . . 3.4700000000000002 109.457 -176.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 13.7 t -140.0 179.19 6.76 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 109.339 -0.615 . . . . 4.71 109.339 172.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 84.51 -54.81 4.96 Favored Glycine 0 C--N 1.332 0.351 0 N-CA-C 105.566 -3.014 . . . . 2.8900000000000001 105.566 -163.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 32.4 ttm 82.48 -58.67 0.19 Allowed 'General case' 0 N--CA 1.441 -0.887 0 C-N-CA 126.964 2.106 . . . . 3.9500000000000002 108.955 158.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.8 t -157.96 98.85 1.64 Allowed 'General case' 0 N--CA 1.442 -0.875 0 N-CA-C 106.441 -1.689 . . . . 6.4699999999999998 106.441 153.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.4 m -72.46 55.18 0.34 Allowed 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.184 0.994 . . . . 3.1699999999999999 109.01 175.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 50.93 71.04 0.46 Allowed 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.668 1.187 . . . . 3.3700000000000001 111.338 -160.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.4 m 78.24 21.48 0.84 Allowed 'General case' 0 C--O 1.226 -0.177 0 C-N-CA 124.89 1.276 . . . . 4.5 113.607 169.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -51.72 -32.42 30.18 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 124.62 1.168 . . . . 3.5499999999999998 109.558 166.068 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 19.6 m -53.85 -40.46 44.29 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 CA-C-N 115.28 -0.873 . . . . 3.4900000000000002 111.622 175.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.63 -46.15 70.4 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.157 0.983 . . . . 1.9099999999999999 110.15 175.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -58.43 -52.95 63.45 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 108.872 -0.788 . . . . 2.3500000000000001 108.872 171.832 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 58.2 mt -56.65 -56.32 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-O 118.473 -0.775 . . . . 2.9500000000000002 109.102 -173.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -39.61 -61.21 0.85 Allowed 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 126.132 1.773 . . . . 3.1299999999999999 110.893 171.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.43 -39.99 61.65 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 124.068 0.947 . . . . 7.7199999999999998 111.176 178.004 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -71.04 -53.65 13.98 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 124.293 1.037 . . . . 3.2599999999999998 108.831 -175.492 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -64.1 -27.34 69.03 Favored 'General case' 0 N--CA 1.462 0.17 0 O-C-N 121.07 -1.019 . . . . 3.1800000000000002 112.247 -177.103 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 58.3 mtp180 -67.95 -14.48 63.0 Favored 'General case' 0 N--CA 1.452 -0.368 0 O-C-N 121.761 -0.587 . . . . 6.7300000000000004 111.7 178.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -57.92 -38.79 76.51 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-N 119.158 0.89 . . . . 8.7300000000000004 112.69 161.624 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -93.05 68.3 4.35 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-O 121.977 0.894 . . . . 8.5299999999999994 109.255 -149.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -27.1 109.71 0.04 OUTLIER 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 127.116 2.166 . . . . 5.5800000000000001 110.057 163.462 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 135.51 -48.72 0.92 Allowed Glycine 0 CA--C 1.528 0.867 0 N-CA-C 108.246 -1.942 . . . . 1.9199999999999999 108.246 -151.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -78.64 133.42 30.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 C-N-CA 124.521 1.129 . . . . 3.7400000000000002 110.298 -173.085 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 24.7 t80 -141.32 35.87 1.69 Allowed 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 122.065 0.936 . . . . 7.2300000000000004 110.632 172.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 43.2 t -167.5 147.14 5.12 Favored 'General case' 0 N--CA 1.449 -0.478 1 C-N-CA 132.854 4.461 . . . . 3.4900000000000002 101.54 140.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.8 pp -78.71 156.58 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 C-N-CA 118.561 -1.256 . . . . 2.8999999999999999 108.536 165.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.423 HD21 ' CG1' ' A' ' 45' ' ' VAL . 0.6 OUTLIER -96.18 72.15 2.87 Favored 'General case' 0 N--CA 1.427 -1.591 0 C-N-CA 126.767 2.027 . . . . 5.4100000000000001 109.771 -173.978 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 24.7 t -135.13 141.04 43.92 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 O-C-N 121.017 -1.052 . . . . 2.1899999999999999 108.518 163.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -156.9 59.91 0.53 Allowed 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 125.866 1.666 . . . . 2.0099999999999998 106.632 169.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -46.11 -36.95 6.28 Favored 'General case' 0 CA--C 1.512 -0.515 0 C-N-CA 125.603 1.561 . . . . 4.21 113.12 -178.637 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.83 -41.12 96.0 Favored 'General case' 0 N--CA 1.439 -0.987 0 N-CA-C 108.511 -0.922 . . . . 5.7999999999999998 108.511 -164.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -77.05 -42.49 38.21 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.494 0.717 . . . . 2.2999999999999998 109.903 167.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 102.37 64.93 0.74 Allowed Glycine 0 C--N 1.336 0.572 0 N-CA-C 109.072 -1.611 . . . . 1.46 109.072 179.019 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -160.07 176.14 12.16 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 106.982 -1.488 . . . . 6.7400000000000002 106.982 -179.472 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -131.94 137.39 47.93 Favored 'General case' 0 N--CA 1.435 -1.188 0 C-N-CA 126.382 1.873 . . . . 2.1000000000000001 107.907 174.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -128.8 109.0 10.9 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 114.456 1.28 . . . . 2.6899999999999999 114.456 177.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.423 ' CG1' HD21 ' A' ' 35' ' ' LEU . 3.7 m -83.9 103.33 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 N-CA-C 108.522 -0.918 . . . . 4.29 108.522 176.765 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 7.8 ttm105 -84.43 114.34 21.83 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 103.837 -2.653 . . . . 8.0299999999999994 103.837 160.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -151.77 173.02 15.24 Favored 'General case' 0 C--N 1.332 -0.16 0 O-C-N 121.53 -0.731 . . . . 3.6099999999999999 112.728 -163.057 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -126.05 105.1 25.74 Favored Pre-proline 0 N--CA 1.447 -0.598 0 C-N-CA 123.666 0.786 . . . . 4.0800000000000001 110.603 172.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -79.74 63.53 8.75 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 122.804 2.336 . . . . 1.72 109.17 -178.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -130.68 -49.6 1.05 Allowed 'General case' 0 C--O 1.227 -0.119 0 C-N-CA 124.187 0.995 . . . . 3.0699999999999998 109.005 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 43.0 t -63.66 -57.98 9.42 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 N-CA-C 109.609 -0.515 . . . . 2.9199999999999999 109.609 174.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 19.9 tt -115.01 -118.04 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.694 0 C-N-CA 124.147 0.979 . . . . 3.1499999999999999 108.469 -167.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 5.7 tp60 179.99 111.73 0.19 Allowed Pre-proline 0 CA--C 1.541 0.602 0 N-CA-C 109.296 -0.631 . . . . 2.8599999999999999 109.296 -155.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo -46.61 -49.72 11.61 Favored 'Trans proline' 0 CA--C 1.533 0.457 0 C-N-CA 124.42 3.413 . . . . 1.9199999999999999 116.43 176.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -51.25 -54.21 5.79 Favored 'Trans proline' 0 N--CA 1.444 -1.439 0 C-N-CA 121.251 1.301 . . . . 1.4199999999999999 109.868 170.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 65.6 mtt -52.45 -48.64 65.71 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 118.339 0.518 . . . . 2.4300000000000002 111.558 -179.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 81.5 mt -51.74 -54.09 14.31 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.862 0 CA-C-N 117.876 0.307 . . . . 3.96 110.654 175.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.85 -33.15 74.66 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 120.76 -1.212 . . . . 2.5600000000000001 113.761 176.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -70.58 -52.85 18.74 Favored 'General case' 0 N--CA 1.44 -0.935 0 O-C-N 120.36 -1.462 . . . . 3.8300000000000001 110.676 -177.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -46.1 -43.74 15.03 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 122.548 1.165 . . . . 5.9100000000000001 111.855 -178.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.8 mt -55.61 -44.5 76.88 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 C-N-CA 124.078 0.951 . . . . 2.29 111.531 176.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 70.6 mtm180 -70.84 -42.04 70.7 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 124.509 1.123 . . . . 5.0700000000000003 111.428 176.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -54.52 -38.92 67.11 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 123.6 0.76 . . . . 2.8999999999999999 110.328 175.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 83.8 mt -79.36 -37.49 37.32 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 118.843 -0.598 . . . . 3.77 110.771 174.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 165.76 -34.09 0.24 Allowed Glycine 0 CA--C 1.529 0.937 0 N-CA-C 115.641 1.016 . . . . 3.1899999999999999 115.641 165.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -77.85 128.74 34.45 Favored 'General case' 0 C--N 1.334 -0.078 0 CA-C-N 118.504 1.152 . . . . 4.1600000000000001 111.369 -159.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -70.21 79.08 0.41 Allowed Glycine 0 CA--C 1.523 0.541 0 C-N-CA 124.307 0.956 . . . . 1.6899999999999999 113.019 -175.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -83.53 126.66 33.03 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 125.561 1.545 . . . . 1.7 111.044 -178.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -131.7 136.0 47.31 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 107.002 -1.481 . . . . 2.8199999999999998 107.002 174.175 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 25.6 m -82.05 153.47 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 CA-C-N 118.753 0.706 . . . . 4.3399999999999999 110.757 -171.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 50.3 mt -136.07 120.06 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 C-N-CA 125.952 1.701 . . . . 3.3199999999999998 106.553 173.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -150.33 43.81 0.86 Allowed 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 107.936 -1.135 . . . . 5.8399999999999999 107.936 -176.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 13.2 p-10 -177.59 165.87 2.15 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 107.002 -1.481 . . . . 7.7999999999999998 107.002 -161.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 36.0 pt -142.47 163.38 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 N-CA-C 106.431 -1.692 . . . . 8.2200000000000006 106.431 170.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -162.75 -179.14 6.62 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 106.781 -1.562 . . . . 12.26 106.781 178.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -158.75 158.97 29.86 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 108.193 -1.963 . . . . 12.74 108.193 175.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.254 1.326 0 N-CA-C 105.1 -2.185 . . . . 18.260000000000002 105.1 179.157 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 . . . . . 0 N--CA 1.479 0.988 0 N-CA-C 107.897 -1.149 . . . . 5.7800000000000002 107.897 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.2 p -63.0 160.48 14.9 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 118.453 0.57 . . . . 3.3900000000000001 111.15 176.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 18.7 m -149.62 174.75 12.21 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 107.595 -1.261 . . . . 2.2999999999999998 107.595 173.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -142.71 142.78 32.05 Favored 'General case' 0 CA--C 1.528 0.116 0 N-CA-C 108.209 -1.034 . . . . 4.3200000000000003 108.209 177.431 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 10.2 t -140.48 155.66 46.6 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 123.15 0.58 . . . . 2.0099999999999998 110.981 -163.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 52.6 m-85 -110.06 83.79 1.82 Allowed 'General case' 0 C--O 1.222 -0.348 0 C-N-CA 124.997 1.319 . . . . 3.4500000000000002 108.793 -178.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 50.8 mt -78.6 139.06 19.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 106.51 -1.663 . . . . 2.5600000000000001 106.51 -177.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -104.6 135.9 45.15 Favored 'General case' 0 C--O 1.231 0.126 0 N-CA-C 107.203 -1.406 . . . . 5.5199999999999996 107.203 168.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 46.5 t -131.53 108.95 15.2 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 C-N-CA 124.787 1.235 . . . . 4.04 108.917 -168.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 17.9 p -60.35 99.15 0.07 Allowed 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 120.957 0.408 . . . . 4.1399999999999997 111.176 -179.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 109.85 -28.41 10.63 Favored Glycine 0 C--N 1.338 0.667 0 C-N-CA 124.975 1.274 . . . . 2.1400000000000001 111.22 178.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 4.1 mpp? 67.53 -65.55 0.23 Allowed 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 127.011 2.124 . . . . 6.0099999999999998 108.059 -166.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -154.93 -103.62 0.04 OUTLIER 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 105.01 -2.218 . . . . 9.3800000000000008 105.01 160.558 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.0 p -145.58 35.77 1.06 Allowed 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.032 0.533 . . . . 3.4500000000000002 111.364 176.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 81.1 132.87 0.06 Allowed 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 127.166 2.186 . . . . 4.7599999999999998 111.687 179.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 13.8 m 72.99 -39.24 0.44 Allowed 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 125.623 1.569 . . . . 5.5 114.667 173.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 34.4 m -50.33 -28.55 8.13 Favored 'General case' 0 CA--C 1.517 -0.309 0 C-N-CA 130.346 3.458 . . . . 5.1500000000000004 111.487 175.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 5.8 m -41.88 -41.18 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 112.165 0.431 . . . . 3.8999999999999999 112.165 167.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.66 -41.65 73.95 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 124.732 1.213 . . . . 3.0 111.976 178.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.424 HD21 ' N ' ' A' ' 21' ' ' ILE . 0.0 OUTLIER -61.18 -51.88 67.15 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 108.229 -1.026 . . . . 4.21 108.229 170.026 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.424 ' N ' HD21 ' A' ' 20' ' ' ASN . 22.6 mt -64.37 -57.11 12.83 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.542 0 N-CA-C 107.617 -1.253 . . . . 4.4800000000000004 107.617 -166.085 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -44.72 -45.5 9.88 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 126.706 2.002 . . . . 6.1100000000000003 113.237 -179.356 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 40.3 ttp180 -59.25 -47.52 85.07 Favored 'General case' 0 N--CA 1.449 -0.482 0 O-C-N 121.338 -0.852 . . . . 5.5199999999999996 111.0 171.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -62.94 -22.08 66.53 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.708 1.603 . . . . 4.1799999999999997 110.355 177.385 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 12.1 mt -75.96 -60.49 2.3 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 124.478 1.111 . . . . 4.2199999999999998 112.575 170.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 33.7 mtm180 -65.39 -17.66 64.7 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-N 119.146 0.884 . . . . 8.6699999999999999 112.768 -178.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -39.76 -53.35 2.24 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-O 116.064 -1.922 . . . . 8.1600000000000001 112.528 158.096 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -168.5 173.17 7.68 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 118.256 2.687 . . . . 6.9100000000000001 118.256 -164.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 77.57 57.7 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 129.61 3.164 . . . . 5.7599999999999998 111.726 170.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 57.2 27.4 57.57 Favored Glycine 0 CA--C 1.527 0.809 0 CA-C-N 114.945 -1.025 . . . . 1.74 112.616 176.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.9 mm -88.25 136.42 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 C-N-CA 124.413 1.085 . . . . 3.2999999999999998 108.447 175.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -143.03 48.39 1.49 Allowed 'General case' 0 C--N 1.341 0.235 0 CA-C-O 123.22 1.486 . . . . 4.7699999999999996 112.703 169.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 43.5 t -160.31 -179.27 7.56 Favored 'General case' 0 C--N 1.316 -0.874 0 C-N-CA 129.576 3.151 . . . . 2.96 105.484 152.029 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -100.06 172.74 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 107.181 -1.414 . . . . 3.5 107.181 153.085 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.441 ' HB3' ' CA ' ' A' ' 45' ' ' VAL . 0.3 OUTLIER -137.62 63.07 1.56 Allowed 'General case' 0 N--CA 1.429 -1.486 0 C-N-CA 130.904 3.682 . . . . 4.8899999999999997 108.555 -168.686 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 10.1 t -130.27 129.67 65.19 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.857 0 CA-C-N 115.33 -0.85 . . . . 2.2000000000000002 109.414 164.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -130.15 62.92 1.56 Allowed 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 105.824 -1.917 . . . . 1.8300000000000001 105.824 162.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.81 -31.12 71.32 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 109.687 -0.486 . . . . 4.6100000000000003 109.687 -172.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 27.7 ptm -46.79 -38.24 9.84 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.406 1.082 . . . . 4.79 113.245 169.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -94.07 -48.27 6.3 Favored 'General case' 0 C--N 1.339 0.137 0 C-N-CA 123.618 0.767 . . . . 1.9299999999999999 109.415 177.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 115.13 45.24 0.64 Allowed Glycine 0 CA--C 1.522 0.53 0 N-CA-C 108.517 -1.833 . . . . 1.0800000000000001 108.517 179.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 61.6 mttt -147.6 176.63 9.92 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 126.343 1.857 . . . . 5.1699999999999999 108.016 -171.205 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -142.12 112.48 7.09 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 124.228 1.011 . . . . 1.8 110.26 -169.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -105.01 85.63 2.31 Favored 'General case' 0 C--N 1.349 0.551 0 N-CA-C 115.718 1.747 . . . . 3.3500000000000001 115.718 -171.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.441 ' CA ' ' HB3' ' A' ' 35' ' ' LEU . 7.9 p -81.81 150.02 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.173 0 C-N-CA 123.259 0.624 . . . . 2.4700000000000002 109.592 -174.05 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 20.1 ttt85 -119.94 129.38 54.3 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 104.637 -2.357 . . . . 5.3899999999999997 104.637 157.064 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 4.6 p90 -150.32 164.28 36.18 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 124.508 1.123 . . . . 3.5899999999999999 110.862 -163.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -109.95 90.48 9.46 Favored Pre-proline 0 C--O 1.237 0.406 0 C-N-CA 124.373 1.069 . . . . 2.6499999999999999 111.471 175.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -69.57 79.34 0.89 Allowed 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 122.769 2.313 . . . . 1.5800000000000001 110.697 172.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -160.88 -48.07 0.05 OUTLIER 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 128.683 2.793 . . . . 1.98 105.156 173.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 73.4 t -67.34 -68.04 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.855 0 C-N-CA 123.877 0.871 . . . . 2.9399999999999999 108.893 162.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . 0.256 16.8 tt -88.59 -57.51 4.18 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 N-CA-C 115.903 1.816 . . . . 3.3399999999999999 115.903 -153.631 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER 83.72 133.48 0.04 OUTLIER Pre-proline 0 CA--C 1.543 0.675 0 C-N-CA 127.414 2.286 . . . . 3.6099999999999999 110.984 -173.446 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -37.4 -49.51 1.77 Allowed 'Trans proline' 0 CA--C 1.537 0.664 1 C-N-CA 126.603 4.869 . . . . 1.75 117.707 171.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -44.09 -61.89 0.51 Allowed 'Trans proline' 0 N--CA 1.448 -1.158 0 C-N-CA 121.847 1.698 . . . . 1.4299999999999999 110.642 167.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 43.0 mtt -60.12 -41.81 93.42 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 118.759 -0.639 . . . . 2.7400000000000002 112.291 -175.14 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -55.87 -40.45 62.12 Favored 'Isoleucine or valine' 0 C--N 1.348 0.519 0 CA-C-N 119.304 0.957 . . . . 4.3899999999999997 111.604 -178.106 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.35 -55.42 9.17 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 121.655 0.74 . . . . 2.27 110.681 171.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -64.37 -35.51 81.14 Favored 'General case' 0 N--CA 1.437 -1.083 0 N-CA-C 114.128 1.158 . . . . 3.2599999999999998 114.128 -162.047 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 39.0 m-85 -53.28 -36.85 61.62 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 119.596 1.089 . . . . 4.5 110.946 170.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 17.3 mt -68.81 -34.02 62.39 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 O-C-N 121.154 -0.966 . . . . 2.5699999999999998 109.638 -179.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 68.8 mtt180 -61.34 -50.77 71.58 Favored 'General case' 0 C--N 1.341 0.203 0 N-CA-C 109.282 -0.636 . . . . 4.7199999999999998 109.282 171.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -56.61 -35.7 68.57 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 123.717 0.807 . . . . 2.9900000000000002 111.905 177.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 77.1 mt -77.35 -17.88 57.89 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 118.891 -0.576 . . . . 3.25 111.277 175.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 151.56 -24.41 0.95 Allowed Glycine 0 CA--C 1.527 0.782 0 CA-C-N 118.973 0.806 . . . . 2.71 114.261 163.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -121.36 129.76 53.24 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 118.633 1.217 . . . . 4.7199999999999998 111.806 -152.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -69.56 91.93 0.33 Allowed Glycine 0 N--CA 1.447 -0.624 0 N-CA-C 111.057 -0.817 . . . . 1.8200000000000001 111.057 -169.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -92.55 137.18 32.59 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 126.325 1.85 . . . . 1.6200000000000001 111.84 -178.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 3.3 t -134.17 144.3 48.42 Favored 'General case' 0 N--CA 1.439 -0.989 0 N-CA-C 108.161 -1.052 . . . . 3.6400000000000001 108.161 166.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 8.8 p -94.14 129.55 44.3 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 C-N-CA 126.17 1.788 . . . . 3.3799999999999999 109.657 -167.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 19.4 mm -137.59 126.85 35.09 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 C-N-CA 124.082 0.953 . . . . 4.9900000000000002 108.627 -178.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -139.25 49.68 1.83 Allowed 'General case' 0 CA--C 1.533 0.296 0 CA-C-O 121.946 0.879 . . . . 4.3700000000000001 109.556 165.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 47.9 t30 -160.85 164.39 31.36 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 106.458 -1.682 . . . . 7.1299999999999999 106.458 173.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 1.9 pp -84.31 175.54 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 N-CA-C 109.46 -0.57 . . . . 8.5 109.46 168.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 57.0 tt0 -157.54 159.7 37.43 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 106.361 -1.718 . . . . 12.65 106.361 172.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -171.74 103.48 0.19 Allowed Glycine 0 CA--C 1.526 0.735 0 N-CA-C 108.919 -1.673 . . . . 12.43 108.919 179.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 2.8 ppt_? . . . . . 0 C--O 1.255 1.365 0 C-N-CA 126.741 2.016 . . . . 20.43 105.816 -179.229 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 . . . . . 0 N--CA 1.477 0.917 0 N-CA-C 107.842 -1.17 . . . . 7.96 107.842 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.0 p -79.7 145.33 33.01 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 123.425 0.69 . . . . 3.7000000000000002 110.464 -176.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.4 t -113.76 175.51 5.43 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 124.675 1.19 . . . . 3.5899999999999999 109.136 174.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 59.9 tttt -106.7 151.18 25.45 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 124.753 1.221 . . . . 5.4299999999999997 110.638 -174.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 42.1 t -147.61 150.48 34.51 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 108.343 -0.984 . . . . 2.2999999999999998 108.343 167.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -96.01 133.94 39.63 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 107.171 -1.418 . . . . 3.5699999999999998 107.171 178.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 19.3 mt -135.88 90.78 0.9 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.364 0 N-CA-C 105.748 -1.945 . . . . 3.25 105.748 -170.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . 0.291 0.8 OUTLIER -81.43 123.9 28.97 Favored 'General case' 0 N--CA 1.435 -1.185 0 C-N-CA 125.977 1.711 . . . . 4.0599999999999996 108.619 -162.347 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 30.6 m -117.47 175.07 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 C-N-CA 124.201 1.0 . . . . 3.1600000000000001 110.315 -171.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.9 t -148.3 37.22 0.84 Allowed 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 112.435 0.531 . . . . 4.1399999999999997 112.435 175.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -139.31 130.02 4.63 Favored Glycine 0 N--CA 1.446 -0.693 1 N-CA-C 102.148 -4.381 . . . . 3.6099999999999999 102.148 138.315 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -164.04 -33.82 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 124.357 1.063 . . . . 3.8700000000000001 111.016 -169.536 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 6.7 t -111.88 23.72 13.49 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 108.379 -0.971 . . . . 5.0300000000000002 108.379 162.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 24.4 p -80.97 38.0 0.45 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.889 1.276 . . . . 3.0699999999999998 110.95 -175.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 72.48 177.54 0.25 Allowed 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.654 1.582 . . . . 3.7599999999999998 110.637 -152.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -77.26 32.09 0.15 Allowed 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 114.674 1.361 . . . . 3.5 114.674 -162.683 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 85.7 m -48.79 -39.15 24.19 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 126.065 1.746 . . . . 3.54 110.576 175.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 29.1 m -46.16 -48.08 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 C-N-CA 124.795 1.238 . . . . 4.2199999999999998 111.303 174.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.94 -43.77 70.09 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 124.351 1.06 . . . . 1.8999999999999999 110.469 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -65.76 -51.81 56.06 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 108.566 -0.902 . . . . 3.0600000000000001 108.566 174.374 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 31.1 mt -60.35 -53.36 49.87 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 N-CA-C 108.384 -0.969 . . . . 3.6699999999999999 108.384 -168.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -40.68 -58.68 1.57 Allowed 'General case' 0 C--O 1.234 0.242 0 C-N-CA 126.316 1.847 . . . . 4.0899999999999999 111.588 171.009 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 20.0 mmm180 -56.59 -41.2 76.56 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.062 -0.517 . . . . 6.6500000000000004 110.907 177.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -71.7 -29.76 64.91 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 124.388 1.075 . . . . 3.3999999999999999 110.38 -176.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -70.51 -58.1 4.06 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 124.499 1.119 . . . . 3.3399999999999999 110.0 176.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . 0.258 62.1 mtt180 -65.06 -14.52 60.67 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 115.062 1.504 . . . . 10.5 115.062 -171.205 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 16.9 mtm180 -54.24 -38.23 65.53 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 119.426 1.012 . . . . 8.1300000000000008 111.484 166.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 38.7 mm-40 -92.14 81.82 5.04 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 107.985 -1.117 . . . . 6.7999999999999998 107.985 -153.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 46.2 tt0 -41.68 125.06 2.68 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.97 0.908 . . . . 8.6799999999999997 108.943 174.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 127.65 -52.36 0.83 Allowed Glycine 0 CA--C 1.522 0.501 0 N-CA-C 107.733 -2.147 . . . . 2.0600000000000001 107.733 -155.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 1.3 mt -83.46 143.3 12.18 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.147 0 C-N-CA 124.718 1.207 . . . . 2.9900000000000002 108.274 171.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -144.93 42.11 1.31 Allowed 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 119.032 -1.067 . . . . 3.6400000000000001 113.579 150.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 68.2 m -163.19 143.85 9.28 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 127.632 2.373 . . . . 2.8999999999999999 109.767 156.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.48 ' H ' ' CD1' ' A' ' 34' ' ' ILE . 0.0 OUTLIER -81.44 134.25 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.836 0 C-N-CA 125.948 1.699 . . . . 3.54 111.144 -178.973 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -80.02 71.73 6.75 Favored 'General case' 0 N--CA 1.432 -1.361 0 O-C-N 121.072 -1.018 . . . . 5.71 110.061 174.051 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 22.3 t -135.63 131.06 50.55 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 CA-C-O 121.631 0.729 . . . . 2.0099999999999998 111.847 169.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -149.15 67.15 1.03 Allowed 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 127.685 2.394 . . . . 1.97 106.796 167.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -53.3 -31.97 46.57 Favored 'General case' 0 CA--C 1.512 -0.502 0 N-CA-C 113.228 0.825 . . . . 4.4000000000000004 113.228 -177.117 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 63.8 mtt -66.74 -42.95 85.4 Favored 'General case' 0 N--CA 1.44 -0.929 0 C-N-CA 119.385 -0.926 . . . . 5.3700000000000001 109.099 -165.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -73.31 -36.27 66.22 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.426 0.69 . . . . 2.1000000000000001 109.69 166.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 97.8 55.35 1.15 Allowed Glycine 0 CA--C 1.507 -0.449 0 N-CA-C 106.548 -2.621 . . . . 1.1699999999999999 106.548 178.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 24.0 mmtm -150.15 176.06 11.18 Favored 'General case' 0 N--CA 1.44 -0.928 0 N-CA-C 106.18 -1.785 . . . . 7.2999999999999998 106.18 -165.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -162.07 127.05 3.37 Favored 'General case' 0 N--CA 1.432 -1.341 0 N-CA-C 107.142 -1.429 . . . . 2.2200000000000002 107.142 -162.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -151.84 107.73 3.38 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 113.371 0.878 . . . . 3.9900000000000002 113.371 -174.206 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.7 p -81.79 155.06 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.022 0 C-N-CA 124.001 0.92 . . . . 2.6899999999999999 109.62 -169.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 46.0 ttt180 -118.78 128.81 54.83 Favored 'General case' 0 CA--C 1.521 -0.162 0 N-CA-C 106.769 -1.567 . . . . 6.2199999999999998 106.769 158.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -158.63 175.23 13.91 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 123.824 0.85 . . . . 3.5800000000000001 110.35 -167.715 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -110.79 140.08 22.3 Favored Pre-proline 0 N--CA 1.448 -0.53 0 N-CA-C 106.979 -1.489 . . . . 3.0800000000000001 106.979 156.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -85.41 3.72 7.08 Favored 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 122.385 2.056 . . . . 2.98 113.29 -175.027 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -91.3 -50.18 5.96 Favored 'General case' 0 CA--C 1.519 -0.248 0 N-CA-C 107.943 -1.132 . . . . 2.04 107.943 -168.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 45.0 t -61.78 -59.07 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.97 0 C-N-CA 124.557 1.143 . . . . 1.9399999999999999 110.379 178.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 10.7 tt -95.38 -37.06 7.22 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.261 0 CA-C-O 118.615 -0.707 . . . . 2.73 112.743 -162.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 13.4 mm-40 88.78 125.74 0.03 OUTLIER Pre-proline 0 CA--C 1.54 0.56 0 C-N-CA 128.926 2.89 . . . . 3.2000000000000002 113.466 176.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_exo -49.89 -48.76 18.18 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 124.593 3.529 . . . . 1.6599999999999999 116.944 179.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -53.11 -50.74 12.98 Favored 'Trans proline' 0 N--CA 1.444 -1.407 0 CA-C-N 120.758 1.307 . . . . 1.71 108.843 172.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 66.4 mtt -65.18 -43.77 90.61 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 120.62 -0.432 . . . . 2.7200000000000002 110.486 -171.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 7.5 tt -63.54 -35.4 72.47 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 C-N-CA 120.386 -0.526 . . . . 3.23 110.407 -177.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -65.86 -50.14 65.61 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 121.916 0.865 . . . . 1.74 110.384 171.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -70.87 -35.93 72.6 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-O 117.483 -1.246 . . . . 3.04 113.964 -166.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 9.2 m-30 -45.88 -41.75 11.74 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 119.642 1.11 . . . . 4.4500000000000002 110.206 172.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 7.9 mt -69.54 -35.54 66.89 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 O-C-N 121.825 -0.547 . . . . 2.1699999999999999 111.164 -178.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 68.9 mtt180 -66.27 -52.72 44.69 Favored 'General case' 0 C--O 1.226 -0.169 0 N-CA-C 109.013 -0.736 . . . . 5.0700000000000003 109.013 176.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -55.31 -53.54 54.83 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 125.633 1.573 . . . . 2.9399999999999999 110.792 -178.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 74.6 mt -84.52 -32.51 23.87 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 119.17 -0.443 . . . . 3.5600000000000001 111.916 -172.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -115.59 -87.64 1.42 Allowed Glycine 0 CA--C 1.525 0.705 0 N-CA-C 111.7 -0.56 . . . . 3.1499999999999999 111.7 -174.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -140.64 -69.1 0.4 Allowed 'General case' 0 CA--C 1.512 -0.514 0 CA-C-O 122.219 1.009 . . . . 4.5099999999999998 112.767 -152.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 168.14 137.95 2.35 Favored Glycine 0 N--CA 1.437 -1.293 0 N-CA-C 105.648 -2.981 . . . . 2.04 105.648 -149.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -155.93 110.99 2.93 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 108.481 -0.933 . . . . 2.0 108.481 -170.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.4 p -116.36 113.59 23.12 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 125.15 1.38 . . . . 2.9100000000000001 107.947 -174.256 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 12.1 m -81.39 138.51 19.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 N-CA-C 109.365 -0.605 . . . . 3.9199999999999999 109.365 -170.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 19.5 pt -144.68 152.26 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 N-CA-C 107.74 -1.207 . . . . 3.98 107.74 175.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -108.66 -68.72 0.9 Allowed 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 107.085 -1.45 . . . . 6.1100000000000003 107.085 167.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 29.1 m120 -64.21 128.25 34.97 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 108.818 -0.808 . . . . 6.2999999999999998 108.818 171.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 29.6 mm -76.99 77.68 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 N-CA-C 107.624 -1.25 . . . . 9.5600000000000005 107.624 174.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -52.89 142.0 20.36 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.517 0.727 . . . . 11.48 111.14 179.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 173.07 -161.32 32.39 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 108.059 -2.017 . . . . 12.369999999999999 108.059 -176.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 35.9 ptt180 . . . . . 0 C--O 1.254 1.3 0 N-CA-C 105.502 -2.036 . . . . 21.280000000000001 105.502 172.766 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 . . . . . 0 N--CA 1.477 0.921 0 N-CA-C 105.305 -2.109 . . . . 9.9499999999999993 105.305 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.4 m -42.03 145.02 0.38 Allowed 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 109.47 -0.567 . . . . 3.54 109.47 133.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.5 m -94.83 135.02 36.83 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 125.303 1.441 . . . . 2.5699999999999998 109.273 -175.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 52.5 tttt -85.86 118.25 25.23 Favored 'General case' 0 CA--C 1.528 0.097 0 C-N-CA 124.281 1.033 . . . . 4.8300000000000001 109.222 175.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 96.5 m -127.16 131.2 50.79 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 108.872 -0.788 . . . . 3.9900000000000002 108.872 -178.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -89.52 135.87 33.35 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 124.491 1.117 . . . . 3.7599999999999998 108.533 -171.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 9.0 mt -132.16 157.24 43.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 106.529 -1.656 . . . . 2.7200000000000002 106.529 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 29.9 tp60 -129.98 127.1 39.33 Favored 'General case' 0 N--CA 1.434 -1.261 0 N-CA-C 104.743 -2.317 . . . . 3.5699999999999998 104.743 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 27.0 m -106.91 176.95 1.09 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 C-N-CA 125.177 1.391 . . . . 3.23 110.085 -172.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 12.1 t -141.49 145.02 34.69 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 109.107 -0.701 . . . . 3.6099999999999999 109.107 167.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 67.9 115.79 0.02 OUTLIER Glycine 0 C--N 1.335 0.508 0 N-CA-C 105.443 -3.063 . . . . 2.8599999999999999 105.443 -138.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 65.6 mtp -89.59 -101.44 0.09 Allowed 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 113.481 -1.359 . . . . 4.9699999999999998 108.88 -176.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 10.9 p -75.17 -42.28 56.27 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.153 0.981 . . . . 6.3899999999999997 109.726 177.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 56.7 m 55.34 21.92 4.52 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 126.697 1.999 . . . . 2.6800000000000002 112.099 178.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 50.87 36.62 15.16 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.297 1.039 . . . . 3.1299999999999999 113.495 -168.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 76.2 p 145.61 16.79 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 128.275 2.63 . . . . 3.1499999999999999 115.739 160.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.7 m -60.02 -35.98 76.26 Favored 'General case' 0 C--O 1.234 0.265 0 O-C-N 120.71 -1.244 . . . . 2.9399999999999999 109.872 175.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 15.2 m -65.95 -52.94 43.19 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 CA-C-N 116.089 -0.505 . . . . 3.2200000000000002 110.963 -179.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -47.94 -46.01 31.65 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.152 0.581 . . . . 1.78 110.616 171.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -55.43 -52.05 64.87 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 120.995 0.426 . . . . 2.0600000000000001 110.144 174.059 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -61.9 -48.1 90.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 C-N-CA 123.768 0.827 . . . . 2.6299999999999999 110.686 -175.243 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -52.25 -53.8 39.27 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 125.113 1.365 . . . . 3.1299999999999999 109.178 173.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 29.9 mmt180 -55.3 -41.53 72.46 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 118.414 -0.803 . . . . 5.8300000000000001 111.573 176.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 56.9 m-20 -74.34 -67.97 0.57 Allowed 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 118.829 0.74 . . . . 3.98 112.406 -177.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -75.8 -14.79 60.31 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 126.594 1.958 . . . . 3.29 113.558 -164.637 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -21.1 -74.49 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 128.433 2.693 . . . . 10.19 113.51 -168.165 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . 0.266 11.3 ptp180 -95.74 -62.13 1.34 Allowed 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 117.589 2.44 . . . . 13.66 117.589 170.696 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 30.54 -150.95 0.0 OUTLIER 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 129.711 3.205 . . . . 6.0800000000000001 111.965 -154.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -95.68 92.53 6.63 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 106.058 -1.83 . . . . 7.4000000000000004 106.058 167.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 115.07 13.94 8.8 Favored Glycine 0 CA--C 1.529 0.916 0 CA-C-O 117.137 -1.924 . . . . 1.4099999999999999 115.654 164.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 1.6 mt -104.04 129.52 56.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-N 120.531 2.166 . . . . 2.96 108.53 172.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -136.83 43.41 2.41 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 121.828 0.823 . . . . 3.8999999999999999 111.19 159.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 67.7 m -170.74 143.52 2.14 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 129.295 3.038 . . . . 2.4900000000000002 106.35 135.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -83.9 160.89 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 CA-C-O 122.012 0.91 . . . . 3.0899999999999999 110.783 175.099 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -72.44 69.72 0.85 Allowed 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 129.437 3.095 . . . . 6.3799999999999999 109.091 -179.035 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 23.9 t -130.6 130.83 65.04 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 CA-C-O 121.844 0.83 . . . . 2.6099999999999999 113.09 170.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -158.04 56.86 0.47 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 127.635 2.374 . . . . 1.76 107.201 156.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -74.3 -11.08 60.17 Favored 'General case' 0 N--CA 1.463 0.191 0 O-C-N 121.058 -1.026 . . . . 6.3700000000000001 112.542 -171.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 27.6 ttt -53.81 -40.13 66.11 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 109.848 -0.427 . . . . 4.6500000000000004 109.848 163.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -89.39 -34.41 16.51 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.423 0.689 . . . . 1.71 110.487 172.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 106.02 44.62 1.37 Allowed Glycine 0 CA--C 1.524 0.649 0 N-CA-C 109.379 -1.488 . . . . 0.84999999999999998 109.379 -179.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 45.8 mttt -155.02 -177.52 6.59 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 125.869 1.668 . . . . 5.4900000000000002 107.364 -153.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -153.87 146.98 24.6 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 125.483 1.513 . . . . 2.3199999999999998 110.432 -168.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -129.22 106.52 8.88 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-O 121.265 0.555 . . . . 4.3200000000000003 110.021 161.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -83.74 116.84 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 N-CA-C 106.165 -1.791 . . . . 3.1200000000000001 106.165 173.239 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 29.8 ttm180 -109.2 116.3 31.64 Favored 'General case' 0 CA--C 1.515 -0.381 0 N-CA-C 106.192 -1.781 . . . . 6.4699999999999998 106.192 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -148.97 173.66 13.1 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 114.65 1.352 . . . . 3.52 114.65 -158.025 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -102.7 94.64 5.35 Favored Pre-proline 0 N--CA 1.452 -0.347 0 N-CA-C 106.795 -1.558 . . . . 3.4900000000000002 106.795 166.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -67.75 -4.27 11.92 Favored 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 122.408 2.072 . . . . 2.6099999999999999 113.292 -172.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -82.47 -28.56 31.14 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 124.175 0.99 . . . . 2.1099999999999999 108.554 177.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 87.0 t -84.85 -67.33 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.137 0 C-N-CA 124.629 1.172 . . . . 2.2999999999999998 107.939 -174.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 15.2 tt -87.45 -36.58 9.9 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 N-CA-C 113.016 0.747 . . . . 2.7999999999999998 113.016 -163.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 15.7 mm-40 86.88 119.18 0.03 OUTLIER Pre-proline 0 CA--C 1.541 0.625 0 C-N-CA 129.27 3.028 . . . . 3.3599999999999999 112.834 -179.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -50.18 -47.94 21.92 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 125.117 3.878 . . . . 1.1599999999999999 117.907 -178.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -59.08 -44.56 33.75 Favored 'Trans proline' 0 N--CA 1.442 -1.505 0 N-CA-C 108.785 -1.275 . . . . 1.23 108.785 172.026 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 87.6 mtp -69.46 -40.93 76.83 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-O 119.373 -0.346 . . . . 2.9399999999999999 110.11 -167.023 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 16.4 tt -61.87 -54.37 35.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 119.628 -0.829 . . . . 3.3199999999999998 110.765 175.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -46.88 -51.65 16.23 Favored 'General case' 0 C--N 1.342 0.262 0 C-N-CA 123.73 0.812 . . . . 1.9299999999999999 112.138 174.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -54.79 -51.35 66.05 Favored 'General case' 0 N--CA 1.442 -0.855 0 C-N-CA 125.292 1.437 . . . . 3.4300000000000002 111.237 175.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -48.68 -40.43 28.06 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 123.55 0.74 . . . . 4.5899999999999999 111.525 178.013 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.4 mm -58.14 -40.87 79.11 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-O 121.606 0.717 . . . . 3.6099999999999999 110.069 179.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 27.0 mtt85 -67.24 -50.54 60.28 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 123.623 0.769 . . . . 4.9299999999999997 109.114 177.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -53.88 -48.98 69.52 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 124.034 0.933 . . . . 2.75 111.405 -178.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.7 pp -83.26 -30.98 27.21 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 119.271 -0.395 . . . . 4.2599999999999998 111.831 -175.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -123.3 -87.82 0.83 Allowed Glycine 0 CA--C 1.524 0.63 0 N-CA-C 111.455 -0.658 . . . . 2.5800000000000001 111.455 -175.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 26.5 m-85 -139.62 -74.85 0.36 Allowed 'General case' 0 CA--C 1.513 -0.452 0 CA-C-O 121.837 0.827 . . . . 5.1900000000000004 112.888 -151.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 171.34 128.9 1.07 Allowed Glycine 0 N--CA 1.438 -1.175 0 N-CA-C 107.825 -2.11 . . . . 1.8400000000000001 107.825 -155.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -155.2 127.51 7.78 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 123.843 0.857 . . . . 1.7 109.243 -172.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -118.23 131.03 56.39 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 126.166 1.787 . . . . 3.3399999999999999 106.724 179.312 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 79.6 t -87.05 127.68 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.737 0 C-N-CA 125.164 1.385 . . . . 2.75 107.94 -175.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 13.5 mt -134.38 62.04 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 CA-C-O 122.387 1.089 . . . . 2.6000000000000001 108.515 -173.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -73.1 67.2 0.88 Allowed 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 124.231 1.012 . . . . 4.7599999999999998 109.449 171.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 62.8 m-80 -134.36 170.49 15.66 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 124.554 1.142 . . . . 6.9000000000000004 109.168 -178.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 20.1 tt -142.94 147.19 20.89 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 N-CA-C 106.177 -1.786 . . . . 9.1500000000000004 106.177 172.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -140.18 169.02 18.46 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 125.098 1.359 . . . . 10.960000000000001 107.992 -174.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -147.99 -82.38 0.04 OUTLIER Glycine 0 CA--C 1.524 0.627 0 N-CA-C 109.106 -1.598 . . . . 12.16 109.106 174.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 4.2 tpp85 . . . . . 0 C--O 1.253 1.264 0 N-CA-C 105.455 -2.054 . . . . 18.93 105.455 173.193 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 1.3 m120 . . . . . 0 N--CA 1.475 0.807 0 CA-C-O 116.675 -1.631 . . . . 7.3399999999999999 107.35 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 56.4 p 38.46 89.65 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.205 1.802 . . . . 4.9699999999999998 114.703 166.159 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.0 m -139.71 169.93 16.83 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 124.53 1.132 . . . . 2.6000000000000001 109.564 -176.328 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.32 143.08 35.63 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 110.329 -0.249 . . . . 5.0899999999999999 110.329 168.637 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 51.4 t -141.28 149.62 41.52 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 125.072 1.349 . . . . 1.8500000000000001 108.532 -171.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -106.26 142.9 35.17 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.185 1.394 . . . . 4.3099999999999996 108.422 179.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -141.43 109.09 2.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 107.255 -1.387 . . . . 3.5099999999999998 107.255 -163.003 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 17.5 tt0 -79.21 147.09 32.73 Favored 'General case' 0 N--CA 1.422 -1.851 0 N-CA-C 107.094 -1.447 . . . . 4.0099999999999998 107.094 -178.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.1 p -150.83 134.41 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 N-CA-C 108.825 -0.806 . . . . 4.0099999999999998 108.825 -168.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 6.1 m -83.19 73.5 10.09 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 121.959 0.885 . . . . 3.3799999999999999 110.66 -167.232 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 121.57 94.25 1.3 Allowed Glycine 0 N--CA 1.443 -0.862 0 CA-C-O 124.664 2.258 . . . . 2.8500000000000001 107.765 175.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 11.9 tpt -95.56 -70.21 0.72 Allowed 'General case' 0 N--CA 1.422 -1.829 0 CA-C-N 109.456 -3.372 . . . . 8.3900000000000006 107.521 -172.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 5.7 m -108.08 52.89 0.7 Allowed 'General case' 0 N--CA 1.456 -0.175 0 N-CA-C 108.585 -0.895 . . . . 6.5599999999999996 108.585 -177.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 21.3 m -64.82 -61.02 2.43 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 107.507 -1.294 . . . . 3.7799999999999998 107.507 176.076 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -174.37 70.18 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 127.556 2.343 . . . . 3.2200000000000002 106.979 174.046 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . 0.26 16.6 p 77.63 23.0 0.85 Allowed 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 126.959 2.104 . . . . 2.98 114.676 176.22 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 80.1 m -52.12 -39.43 59.87 Favored 'General case' 0 CA--C 1.536 0.416 0 O-C-N 121.108 -0.995 . . . . 3.27 109.413 157.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -42.49 -47.87 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.034 0 C-N-CA 126.248 1.819 . . . . 3.8300000000000001 114.12 161.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.73 -36.07 82.54 Favored 'General case' 0 C--O 1.234 0.247 0 O-C-N 121.511 -0.743 . . . . 2.1099999999999999 110.396 176.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -58.56 -51.79 68.4 Favored 'General case' 0 C--O 1.219 -0.522 0 N-CA-C 108.341 -0.985 . . . . 2.2200000000000002 108.341 169.708 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 86.6 mt -53.88 -52.55 34.51 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-N 119.108 0.867 . . . . 3.6400000000000001 109.863 -176.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -48.33 -48.7 36.09 Favored 'General case' 0 N--CA 1.444 -0.774 0 O-C-N 121.006 -1.059 . . . . 3.6099999999999999 112.722 172.22 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 5.6 ttm-85 -66.42 -27.35 67.76 Favored 'General case' 0 N--CA 1.444 -0.744 0 O-C-N 121.736 -0.603 . . . . 7.5 112.426 173.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -72.78 -56.91 4.55 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 119.309 0.959 . . . . 4.46 110.571 -169.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.4 mt -69.52 -33.11 72.34 Favored 'General case' 0 C--O 1.223 -0.309 0 C-N-CA 119.429 -0.908 . . . . 4.4100000000000001 113.003 -161.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.59 -17.78 0.36 Allowed 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 114.498 1.295 . . . . 8.6999999999999993 114.498 168.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -35.67 -56.44 0.68 Allowed 'General case' 0 C--N 1.343 0.308 0 O-C-N 121.014 -1.054 . . . . 10.84 111.559 162.601 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -96.36 119.58 35.11 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 118.972 -1.091 . . . . 9.4900000000000002 111.492 -140.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 47.8 mp0 -58.51 106.4 0.39 Allowed 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.303 1.441 . . . . 5.0099999999999998 109.197 179.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 122.02 -1.1 10.81 Favored Glycine 0 CA--C 1.529 0.941 0 CA-C-O 118.992 -0.893 . . . . 1.3 111.915 -171.2 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -78.52 138.19 20.64 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-N 118.432 1.116 . . . . 2.9900000000000002 110.672 177.225 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -147.91 48.34 1.07 Allowed 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 122.038 0.923 . . . . 3.7000000000000002 112.993 164.129 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.7 m -169.2 173.24 6.85 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 129.354 3.062 . . . . 3.3799999999999999 106.487 129.186 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 1.8 pp -120.1 139.41 47.48 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 N-CA-C 102.841 -3.022 . . . . 3.7200000000000002 102.841 161.045 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.7 mp -148.14 157.17 43.35 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 119.269 0.941 . . . . 7.6699999999999999 109.523 -167.136 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.1 t -155.05 73.0 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 CA-C-O 124.857 2.265 . . . . 2.3100000000000001 107.649 -159.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -80.29 59.51 3.42 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 113.714 -1.584 . . . . 1.97 109.089 169.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.64 -29.91 68.35 Favored 'General case' 0 CA--C 1.505 -0.78 0 O-C-N 121.462 -0.774 . . . . 5.1200000000000001 111.608 173.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 2.7 mpt? -62.35 -34.46 76.7 Favored 'General case' 0 N--CA 1.438 -1.045 0 C-N-CA 118.861 -1.136 . . . . 4.7599999999999998 109.167 -169.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -76.99 -53.87 7.28 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.523 0.729 . . . . 2.6800000000000002 109.336 164.082 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 131.39 50.37 0.1 Allowed Glycine 0 C--N 1.338 0.676 0 N-CA-C 109.943 -1.263 . . . . 1.6399999999999999 109.943 173.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 75.1 mttt -149.86 150.82 32.5 Favored 'General case' 0 N--CA 1.442 -0.87 0 N-CA-C 108.656 -0.868 . . . . 5.1900000000000004 108.656 -169.176 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -76.11 163.53 27.02 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 105.577 -2.008 . . . . 2.6400000000000001 105.577 155.056 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 52.5 tt0 -128.24 157.68 40.22 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 106.108 -1.812 . . . . 3.5899999999999999 106.108 163.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 6.8 p -132.46 134.06 59.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 N-CA-C 106.176 -1.787 . . . . 2.6600000000000001 106.176 173.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 33.2 ttm105 -105.34 130.23 53.5 Favored 'General case' 0 N--CA 1.456 -0.165 0 N-CA-C 105.632 -1.988 . . . . 5.5800000000000001 105.632 157.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 5.1 p90 -155.63 172.8 17.68 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 123.082 0.553 . . . . 3.3500000000000001 110.262 -164.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -117.78 80.59 14.24 Favored Pre-proline 0 C--O 1.238 0.45 0 CA-C-N 115.969 -0.559 . . . . 2.96 112.211 -174.143 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -66.47 87.17 0.27 Allowed 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 123.46 2.773 . . . . 2.5299999999999998 108.531 174.201 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -178.45 -47.35 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 130.25 3.42 . . . . 2.9199999999999999 105.937 -176.213 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 73.9 t -81.42 -57.62 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.712 0 N-CA-C 108.588 -0.893 . . . . 2.7400000000000002 108.588 168.291 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 12.1 tt -90.09 -44.97 15.07 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.21 0 N-CA-C 115.44 1.644 . . . . 3.5699999999999998 115.44 -146.451 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 21.9 tp60 91.86 110.94 0.02 OUTLIER Pre-proline 0 CA--C 1.55 0.979 0 C-N-CA 127.244 2.218 . . . . 4.04 111.087 176.005 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -43.04 -48.35 7.8 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 124.773 3.649 . . . . 1.46 118.127 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -54.84 -43.35 60.1 Favored 'Trans proline' 0 N--CA 1.448 -1.162 0 CA-C-N 121.329 1.51 . . . . 1.3400000000000001 110.507 172.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 63.9 mtt -62.37 -44.82 95.56 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 118.397 -0.811 . . . . 3.04 110.044 178.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 5.7 mm -48.4 -57.06 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 CA-C-N 119.08 0.855 . . . . 4.3300000000000001 109.903 172.305 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -55.22 -46.71 75.94 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.052 0.541 . . . . 2.5699999999999998 112.073 -177.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -70.23 -44.91 67.6 Favored 'General case' 0 N--CA 1.44 -0.948 0 C-N-CA 124.62 1.168 . . . . 3.0899999999999999 112.74 -176.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -48.59 -36.81 16.47 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 123.968 0.907 . . . . 5.1399999999999997 111.571 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 22.1 mt -69.98 -40.58 78.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 N-CA-C 109.658 -0.497 . . . . 2.4900000000000002 109.658 178.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 80.1 mtm-85 -70.96 -31.36 67.91 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 118.24 -0.886 . . . . 5.0099999999999998 112.692 -178.283 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 87.1 mt-10 -41.19 -44.33 2.55 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.926 1.291 . . . . 4.7000000000000002 113.764 179.238 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.42 -12.89 58.78 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.105 0.962 . . . . 4.0300000000000002 111.704 -173.696 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 111.32 -2.03 28.09 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 124.742 1.163 . . . . 3.4399999999999999 111.499 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -76.57 86.2 3.26 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 107.993 -1.114 . . . . 4.0999999999999996 107.993 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -61.4 104.41 0.69 Allowed Glycine 0 N--CA 1.442 -0.932 0 C-N-CA 125.672 1.606 . . . . 1.8 109.177 -178.008 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -137.99 151.84 48.31 Favored 'General case' 0 N--CA 1.45 -0.457 0 O-C-N 124.981 1.048 . . . . 2.71 112.494 -163.369 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 29.8 m -135.34 138.63 43.59 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 125.769 1.627 . . . . 3.2599999999999998 107.976 -170.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 12.7 t -82.77 111.36 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 C-N-CA 124.972 1.309 . . . . 2.7999999999999998 107.73 -177.034 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 16.2 mt -134.27 66.03 0.29 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.331 0 C-N-CA 124.499 1.119 . . . . 3.8500000000000001 109.231 -172.048 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 178.67 158.38 0.52 Allowed 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 129.794 3.238 . . . . 8.0999999999999996 106.121 150.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 38.6 t-20 54.06 40.2 31.38 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.021 0.928 . . . . 10.449999999999999 111.819 167.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -65.04 -47.35 88.3 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 N-CA-C 108.875 -0.787 . . . . 14.02 108.875 -179.449 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -113.2 148.45 35.43 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 105.529 -2.026 . . . . 13.92 105.529 161.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 143.18 -126.37 2.8 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 107.892 -2.083 . . . . 16.719999999999999 107.892 -174.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.94 0 N-CA-C 107.363 -1.347 . . . . 23.75 107.363 -177.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 . . . . . 0 N--CA 1.476 0.83 0 N-CA-C 109.405 -0.591 . . . . 7.6600000000000001 109.405 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 12.1 m -158.08 57.28 0.47 Allowed 'General case' 0 CA--C 1.529 0.156 0 CA-C-O 123.105 1.431 . . . . 2.71 107.682 179.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -84.69 127.36 34.06 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 128.586 2.755 . . . . 3.2200000000000002 109.955 -168.426 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 37.2 tttt -81.83 144.13 31.25 Favored 'General case' 0 C--N 1.34 0.178 0 CA-C-N 118.761 0.71 . . . . 4.8799999999999999 109.272 174.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 45.5 t -143.18 156.01 44.67 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.402 0.681 . . . . 2.1899999999999999 109.324 170.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -102.52 139.67 37.82 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 124.555 1.142 . . . . 4.04 108.528 175.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.7 mp -133.24 130.01 57.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 N-CA-C 104.91 -2.255 . . . . 3.3300000000000001 104.91 174.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 36.4 tp60 -91.7 126.04 36.64 Favored 'General case' 0 N--CA 1.433 -1.289 0 N-CA-C 104.042 -2.577 . . . . 4.0099999999999998 104.042 169.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.4 m -109.4 136.35 45.56 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 N-CA-C 108.386 -0.968 . . . . 3.2999999999999998 108.386 179.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 6.1 m -87.22 55.35 3.51 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 108.925 -0.768 . . . . 2.8500000000000001 108.925 171.487 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -143.95 123.08 1.95 Allowed Glycine 0 N--CA 1.445 -0.732 0 N-CA-C 103.464 -3.854 . . . . 3.1600000000000001 103.464 148.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 70.6 mtm -136.6 -71.92 0.45 Allowed 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 106.515 -1.661 . . . . 5.0499999999999998 106.515 -176.202 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 4.9 t -74.93 51.04 0.48 Allowed 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 109.307 -0.627 . . . . 6.6699999999999999 109.307 163.121 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 14.5 t -114.42 121.65 44.21 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 105.12 -2.178 . . . . 3.0499999999999998 105.12 175.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -71.53 82.19 0.81 Allowed 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 123.57 0.748 . . . . 3.4100000000000001 111.999 -157.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 87.63 38.12 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 127.684 2.394 . . . . 2.7000000000000002 109.857 -177.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.8 t -47.59 -41.0 20.7 Favored 'General case' 0 CA--C 1.521 -0.136 0 C-N-CA 125.082 1.353 . . . . 3.7799999999999998 108.83 168.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 15.1 m -66.32 -53.34 37.43 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.06 0 CA-C-N 113.49 -1.687 . . . . 3.2000000000000002 110.321 -175.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -50.44 -45.15 55.78 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.39 0.676 . . . . 1.8400000000000001 110.309 172.485 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -56.84 -56.39 22.17 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 109.597 -0.52 . . . . 2.3599999999999999 109.597 175.66 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 27.5 mt -52.58 -54.46 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 C-N-CA 124.268 1.027 . . . . 3.3300000000000001 110.199 -179.262 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -50.32 -59.01 4.4 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 124.985 1.314 . . . . 2.9300000000000002 110.088 176.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 21.5 tpt180 -55.48 -41.83 73.55 Favored 'General case' 0 N--CA 1.443 -0.801 0 C-N-CA 124.666 1.186 . . . . 5.7699999999999996 111.515 -176.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 15.3 m-20 -72.31 -64.46 0.94 Allowed 'General case' 0 C--O 1.222 -0.362 0 N-CA-C 109.609 -0.515 . . . . 3.52 109.609 179.163 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . 0.319 6.9 mt -80.54 -11.09 59.71 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 128.69 2.796 . . . . 5.0099999999999998 116.808 -159.484 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -19.57 -71.5 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 126.777 2.031 . . . . 10.65 114.345 175.458 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 30.4 mmt180 -92.35 -60.7 1.77 Allowed 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 118.828 2.899 . . . . 14.33 118.828 -179.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . 0.262 2.5 mm-40 8.27 62.84 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.685 1 C-N-CA 132.665 4.386 . . . . 5.8300000000000001 112.314 -152.328 . . . . . . . . 3 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 18.06 58.13 0.01 OUTLIER 'General case' 0 C--N 1.343 0.299 0 C-N-CA 129.685 3.194 . . . . 6.9400000000000004 113.257 -169.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 166.63 -28.7 0.18 Allowed Glycine 0 CA--C 1.522 0.503 0 C-N-CA 120.134 -1.031 . . . . 1.75 113.488 -171.189 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.7 mt -81.6 111.96 18.87 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 N-CA-C 106.212 -1.773 . . . . 2.8500000000000001 106.212 174.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 47.9 m-85 -122.6 44.16 2.71 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 122.832 1.301 . . . . 3.5800000000000001 110.547 166.371 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 33.7 t -166.78 137.54 3.24 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 126.799 2.04 . . . . 2.8799999999999999 105.952 142.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.2 pp -78.59 151.44 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.651 0 N-CA-C 107.5 -1.296 . . . . 2.7799999999999998 107.5 171.374 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.446 ' H ' ' CD2' ' A' ' 35' ' ' LEU . 0.3 OUTLIER -94.69 77.43 3.73 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 129.466 3.106 . . . . 5.1600000000000001 110.243 -169.273 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 43.3 t -131.59 139.71 49.97 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.801 0 N-CA-C 108.997 -0.742 . . . . 2.3300000000000001 108.997 168.24 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -155.99 55.99 0.59 Allowed 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 106.618 -1.623 . . . . 1.77 106.618 168.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -71.61 -20.32 62.0 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 114.74 -1.118 . . . . 3.9900000000000002 111.017 -172.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 53.0 ttm -45.23 -38.29 5.34 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.621 0.768 . . . . 4.3799999999999999 110.935 164.157 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -95.51 -48.67 5.74 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.234 0.614 . . . . 1.8799999999999999 110.235 170.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 119.67 54.82 0.26 Allowed Glycine 0 C--N 1.338 0.64 0 N-CA-C 109.813 -1.315 . . . . 1.0900000000000001 109.813 -177.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 10.2 pttt -159.15 177.98 10.5 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 107.991 -1.114 . . . . 4.9900000000000002 107.991 -173.007 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -132.31 124.36 28.67 Favored 'General case' 0 N--CA 1.441 -0.904 0 C-N-CA 127.081 2.153 . . . . 1.8600000000000001 108.705 -169.102 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -125.03 89.06 2.99 Favored 'General case' 0 C--N 1.343 0.296 0 N-CA-C 113.776 1.028 . . . . 3.29 113.776 -175.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 9.6 p -78.65 152.1 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.088 0 N-CA-C 108.707 -0.849 . . . . 2.6200000000000001 108.707 -174.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 63.9 ttm-85 -114.85 112.58 22.99 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 106.705 -1.591 . . . . 5.79 106.705 156.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -123.15 165.42 16.89 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 124.304 1.041 . . . . 3.6099999999999999 113.19 -169.629 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 32.6 t30 -126.94 90.99 48.12 Favored Pre-proline 0 N--CA 1.451 -0.386 0 C-N-CA 125.99 1.716 . . . . 2.4199999999999999 109.015 -178.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -71.64 71.26 2.6 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 122.895 2.397 . . . . 1.8500000000000001 112.081 179.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -123.92 -49.11 1.86 Allowed 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 126.201 1.8 . . . . 3.0299999999999998 106.853 157.054 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 41.0 t -83.52 -61.44 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.923 0 C-N-CA 124.741 1.216 . . . . 2.5899999999999999 110.567 175.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 6.1 tp -78.58 -71.67 0.29 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.414 0 N-CA-C 113.008 0.744 . . . . 2.5600000000000001 113.008 -161.277 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 82.81 128.78 0.03 OUTLIER Pre-proline 0 CA--C 1.548 0.887 0 C-N-CA 128.293 2.637 . . . . 4.7800000000000002 113.248 -176.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -42.88 -52.48 4.62 Favored 'Trans proline' 0 C--N 1.349 0.562 1 C-N-CA 126.744 4.963 . . . . 1.4299999999999999 117.687 177.594 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -54.06 -49.25 17.73 Favored 'Trans proline' 0 N--CA 1.442 -1.553 0 CA-C-N 120.11 1.075 . . . . 0.92000000000000004 109.678 173.305 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 61.3 mtt -64.93 -45.26 86.57 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.193 -0.669 . . . . 3.2999999999999998 109.193 -170.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 16.2 tt -59.7 -49.75 82.58 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 C-N-CA 119.087 -1.045 . . . . 3.6000000000000001 111.527 177.287 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -51.8 -53.78 36.2 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 118.319 0.508 . . . . 1.79 111.758 176.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -56.53 -54.49 45.25 Favored 'General case' 0 N--CA 1.432 -1.367 0 C-N-CA 124.511 1.125 . . . . 3.1200000000000001 110.676 -179.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 18.7 m-30 -50.25 -43.1 52.99 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 119.103 0.865 . . . . 5.46 110.833 178.154 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 85.6 mt -65.43 -40.83 89.53 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 O-C-N 121.712 -0.617 . . . . 2.0699999999999998 110.083 -179.307 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 51.8 mtp180 -59.12 -51.83 68.33 Favored 'General case' 0 CA--C 1.533 0.322 0 O-C-N 121.905 -0.497 . . . . 6.3899999999999997 111.211 171.177 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -56.5 -32.95 65.53 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 125.507 1.523 . . . . 3.0899999999999999 111.673 179.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 59.5 mt -77.2 -17.43 58.52 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 119.184 -0.436 . . . . 3.04 110.629 176.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 135.42 -9.67 4.36 Favored Glycine 0 CA--C 1.526 0.72 0 C-N-CA 124.069 0.842 . . . . 3.2799999999999998 112.964 167.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -110.28 115.03 28.96 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 118.481 1.14 . . . . 4.5199999999999996 110.02 -160.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -63.71 86.96 0.06 OUTLIER Glycine 0 N--CA 1.447 -0.625 0 CA-C-N 115.868 -0.606 . . . . 1.4099999999999999 112.065 -176.264 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -84.06 127.74 34.09 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 126.074 1.75 . . . . 1.78 109.829 178.284 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 9.6 t -122.18 130.38 53.15 Favored 'General case' 0 N--CA 1.436 -1.132 0 N-CA-C 105.785 -1.932 . . . . 3.2999999999999998 105.785 165.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 77.0 t -83.74 135.89 23.91 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.89 0 N-CA-C 107.398 -1.334 . . . . 3.0 107.398 -177.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 17.9 mt -126.91 73.81 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 N-CA-C 107.034 -1.469 . . . . 2.7200000000000002 107.034 -178.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -58.99 162.43 4.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.097 -0.956 . . . . 3.7200000000000002 110.958 167.02 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 51.8 t30 -70.52 154.11 42.22 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 115.973 -0.558 . . . . 6.9299999999999997 111.019 -172.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 6.3 mt 54.03 63.68 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 C-N-CA 125.489 1.515 . . . . 8.6099999999999994 110.851 179.472 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -52.86 -47.3 67.91 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.022 0.929 . . . . 11.699999999999999 111.286 176.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 167.22 -158.93 32.11 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 108.007 -2.037 . . . . 11.050000000000001 108.007 -175.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.257 1.461 0 N-CA-C 105.893 -1.892 . . . . 17.100000000000001 105.893 172.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 2.3 m120 . . . . . 0 N--CA 1.479 1.022 0 N-CA-C 114.419 1.266 . . . . 9.0500000000000007 114.419 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.1 p -71.29 75.69 0.73 Allowed 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 120.163 1.347 . . . . 2.8900000000000001 114.57 -162.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.6 p -91.49 172.38 8.55 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 128.096 2.559 . . . . 3.3900000000000001 111.075 -177.213 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 6.1 tttt -108.53 156.47 19.46 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 124.755 1.222 . . . . 5.3099999999999996 108.563 166.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -145.26 175.35 10.35 Favored 'General case' 0 C--O 1.235 0.324 0 O-C-N 124.142 0.901 . . . . 2.9100000000000001 109.97 162.32 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 45.0 m-85 -115.93 139.79 49.89 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 126.31 1.844 . . . . 4.3300000000000001 108.321 -171.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.7 pt -136.28 122.9 31.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 C-N-CA 123.914 0.885 . . . . 4.25 110.602 178.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -80.33 132.48 35.81 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 106.677 -1.601 . . . . 4.9699999999999998 106.677 171.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.7 m -107.85 121.1 60.32 Favored 'Isoleucine or valine' 0 C--O 1.232 0.147 0 O-C-N 124.038 0.836 . . . . 3.04 109.658 -176.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.3 m -66.17 73.48 0.08 Allowed 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.138 0.975 . . . . 3.2200000000000002 111.596 177.229 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -173.47 -59.14 0.05 OUTLIER Glycine 0 CA--C 1.522 0.478 0 N-CA-C 106.788 -2.525 . . . . 3.3700000000000001 106.788 172.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 25.2 ttm 69.03 -33.21 0.24 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 126.686 1.994 . . . . 5.2599999999999998 114.664 170.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.7 t -155.22 52.87 0.62 Allowed 'General case' 0 N--CA 1.446 -0.625 0 C-N-CA 124.668 1.187 . . . . 5.4000000000000004 108.163 177.068 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 12.5 p -58.01 -43.05 86.47 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 108.413 -0.958 . . . . 2.7000000000000002 108.413 164.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 156.92 -59.88 0.0 OUTLIER 'General case' 0 CA--C 1.521 -0.16 0 C-N-CA 129.514 3.126 . . . . 3.8900000000000001 107.177 166.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.0 p -99.11 42.63 1.09 Allowed 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.367 1.067 . . . . 3.6299999999999999 110.916 -174.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 37.7 m -52.79 -51.73 59.59 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 108.49 -0.93 . . . . 4.7000000000000002 108.49 178.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.2 p -63.77 -55.31 23.21 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.67 0 CA-C-O 121.936 0.874 . . . . 4.3499999999999996 111.232 -178.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.32 -30.88 67.03 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.513 -1.221 . . . . 2.2599999999999998 112.598 -175.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -68.19 -57.22 6.37 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 119.68 1.127 . . . . 4.2300000000000004 108.276 169.401 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . 0.255 1.5 mt -62.83 -35.69 72.13 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.894 0 O-C-N 121.868 -0.52 . . . . 2.9900000000000002 110.362 -166.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -43.59 -56.7 3.54 Favored 'General case' 0 N--CA 1.453 -0.302 0 O-C-N 121.483 -0.761 . . . . 3.3799999999999999 110.385 171.043 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -63.5 -44.57 93.93 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 115.414 -0.812 . . . . 7.3099999999999996 110.438 175.783 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -60.31 -42.46 95.61 Favored 'General case' 0 C--O 1.223 -0.299 0 C-N-CA 122.922 0.489 . . . . 3.9399999999999999 111.717 -168.741 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . 0.337 5.2 mp -80.33 -43.93 20.37 Favored 'General case' 0 N--CA 1.435 -1.21 0 C-N-CA 126.081 1.752 . . . . 3.79 113.101 175.486 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 83.7 mtt180 -66.2 -20.47 66.14 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 119.364 -2.085 . . . . 8.5999999999999996 112.721 -174.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 4.8 mmt180 -29.98 -62.86 0.14 Allowed 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 125.717 1.607 . . . . 9.3000000000000007 112.992 162.055 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 150.98 176.92 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.178 0 C-N-CA 128.049 2.54 . . . . 7.5 106.345 -158.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 101.88 32.09 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 129.477 3.111 . . . . 8.5399999999999991 111.379 -167.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 55.9 42.88 87.26 Favored Glycine 0 CA--C 1.526 0.736 0 O-C-N 121.752 -0.592 . . . . 2.3100000000000001 111.682 177.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 1.4 mp -74.04 142.57 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 CA-C-N 117.066 0.433 . . . . 3.4300000000000002 110.102 176.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -145.81 41.86 1.22 Allowed 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 122.449 1.118 . . . . 5.1200000000000001 113.657 158.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 58.8 m -167.93 157.8 10.15 Favored 'General case' 0 C--N 1.319 -0.743 1 C-N-CA 132.698 4.399 . . . . 3.3599999999999999 104.12 133.14 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -109.65 144.95 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 N-CA-C 104.712 -2.329 . . . . 3.3599999999999999 104.712 155.636 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.417 ' CD1' ' N ' ' A' ' 35' ' ' LEU . 0.3 OUTLIER -147.65 148.43 31.05 Favored 'General case' 0 N--CA 1.434 -1.247 0 C-N-CA 125.965 1.706 . . . . 7.4100000000000001 106.504 -167.543 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.429 ' CG1' ' HG ' ' A' ' 38' ' ' LEU . 1.3 t -156.7 96.18 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 N-CA-C 105.207 -2.145 . . . . 2.52 105.207 174.396 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -77.22 66.35 2.99 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 115.295 -0.866 . . . . 1.73 109.419 176.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.429 ' HG ' ' CG1' ' A' ' 36' ' ' VAL . 9.5 mt -53.18 -36.58 61.08 Favored 'General case' 0 C--N 1.342 0.245 0 C-N-CA 123.35 0.66 . . . . 3.46 110.832 173.752 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 16.3 tpt -51.42 -39.66 57.77 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.715 0.806 . . . . 6.0300000000000002 111.809 173.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -88.68 -23.94 22.88 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.621 0.769 . . . . 1.9399999999999999 111.436 178.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 89.09 41.83 5.77 Favored Glycine 0 C--N 1.335 0.488 0 N-CA-C 110.188 -1.165 . . . . 1.05 110.188 179.048 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 58.4 pttt -156.1 158.16 37.25 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 107.879 -1.156 . . . . 4.3300000000000001 107.879 177.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -83.88 163.98 19.73 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 108.798 -0.816 . . . . 2.4300000000000002 108.798 170.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -131.2 157.72 42.44 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.214 -0.661 . . . . 2.77 109.214 174.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 13.4 m -134.7 142.43 40.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 N-CA-C 109.432 -0.581 . . . . 3.8700000000000001 109.432 173.1 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 49.1 ttt180 -127.02 125.72 41.9 Favored 'General case' 0 CA--C 1.516 -0.353 0 N-CA-C 106.487 -1.671 . . . . 6.4500000000000002 106.487 158.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 22.1 p90 -157.37 171.94 19.49 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 109.187 -0.672 . . . . 3.4199999999999999 109.187 -163.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 50.7 t-20 -103.69 93.52 5.22 Favored Pre-proline 0 CA--C 1.534 0.329 0 C-N-CA 123.207 0.603 . . . . 2.71 110.544 176.12 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -65.24 80.86 0.21 Allowed 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 123.015 2.477 . . . . 1.6799999999999999 110.26 169.37 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -168.85 -56.61 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 128.916 2.886 . . . . 1.98 104.894 172.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 68.1 t -57.24 -55.42 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 C-N-CA 124.509 1.124 . . . . 1.8200000000000001 109.689 171.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.406 ' CG2' ' H ' ' A' ' 53' ' ' GLN 0.251 9.7 tp -95.73 -75.82 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.369 0 CA-C-O 118.514 -0.755 . . . . 3.6299999999999999 111.54 -172.079 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.406 ' H ' ' CG2' ' A' ' 52' ' ' ILE . 0.0 OUTLIER 114.2 137.06 0.0 OUTLIER Pre-proline 0 N--CA 1.47 0.545 0 C-N-CA 130.815 3.646 . . . . 3.3199999999999998 107.012 -173.163 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_exo -50.98 -50.89 12.46 Favored 'Trans proline' 0 CA--C 1.534 0.476 0 C-N-CA 123.432 2.755 . . . . 1.1899999999999999 114.57 176.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -52.1 -48.8 19.84 Favored 'Trans proline' 0 N--CA 1.444 -1.406 0 CA-C-N 120.525 1.223 . . . . 1.1399999999999999 110.383 168.084 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 62.7 mtt -66.14 -35.05 79.45 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 118.447 -1.301 . . . . 4.0700000000000003 110.879 -171.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 4.4 tt -70.13 -44.98 77.64 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 CA-C-N 119.502 1.047 . . . . 3.21 109.933 176.274 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -53.67 -41.06 66.47 Favored 'General case' 0 C--N 1.341 0.228 0 N-CA-C 112.266 0.469 . . . . 2.1299999999999999 112.266 175.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 30.8 mm-40 -66.66 -59.94 3.15 Favored 'General case' 0 N--CA 1.437 -1.093 0 C-N-CA 124.94 1.296 . . . . 2.6200000000000001 110.564 174.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -54.41 -42.75 70.84 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 117.897 0.317 . . . . 5.8700000000000001 110.231 -170.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.8 mt -56.26 -37.15 48.85 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 O-C-N 121.487 -0.758 . . . . 2.75 111.637 176.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 42.6 mtm105 -70.18 -44.33 68.94 Favored 'General case' 0 N--CA 1.456 -0.142 0 O-C-N 121.605 -0.684 . . . . 4.6100000000000003 111.22 173.27 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -56.55 -33.89 66.55 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 119.189 0.904 . . . . 3.2400000000000002 111.604 175.266 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 83.6 mt -78.74 -16.58 57.04 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.845 0.858 . . . . 4.0099999999999998 111.362 175.253 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 136.65 -12.49 3.98 Favored Glycine 0 CA--C 1.528 0.852 0 CA-C-O 119.335 -0.703 . . . . 2.7599999999999998 113.988 164.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -107.94 119.43 39.44 Favored 'General case' 0 CA--C 1.522 -0.125 0 CA-C-N 118.738 1.269 . . . . 5.1600000000000001 110.523 -159.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -68.44 69.4 0.37 Allowed Glycine 0 C--N 1.336 0.574 0 C-N-CA 125.917 1.722 . . . . 1.74 113.969 -172.222 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -83.6 121.13 26.83 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 126.482 1.913 . . . . 2.25 110.738 -173.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 25.7 p -124.04 119.39 29.37 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 125.486 1.514 . . . . 3.6400000000000001 108.504 -179.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 74.9 t -81.03 128.46 38.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 C-N-CA 124.917 1.287 . . . . 2.8300000000000001 109.54 -165.486 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 5.0 pt -139.13 59.49 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-O 122.197 0.999 . . . . 4.1399999999999997 112.174 -173.335 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -83.15 69.33 9.87 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 108.596 -0.89 . . . . 5.0800000000000001 108.596 171.092 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -161.21 150.05 16.24 Favored 'General case' 0 CA--C 1.528 0.104 0 N-CA-C 109.224 -0.658 . . . . 6.8899999999999997 109.224 179.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 44.6 pt -141.63 22.98 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 C-N-CA 124.136 0.974 . . . . 8.1199999999999992 111.399 179.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -81.03 161.56 24.17 Favored 'General case' 0 CA--C 1.531 0.237 0 O-C-N 121.836 -0.54 . . . . 9.6400000000000006 110.256 -178.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 164.76 79.0 0.04 OUTLIER Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.383 -1.087 . . . . 11.720000000000001 110.383 -178.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.136 0 N-CA-C 105.031 -2.211 . . . . 18.359999999999999 105.031 173.303 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 . . . . . 0 N--CA 1.478 0.955 0 N-CA-C 107.622 -1.251 . . . . 5.6799999999999997 107.622 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 27.9 t -162.12 138.05 7.61 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 119.224 0.92 . . . . 3.9300000000000002 110.094 176.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 10.6 p -85.8 141.31 29.75 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 126.245 1.818 . . . . 4.0800000000000001 108.259 164.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.35 147.87 28.71 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 105.384 -2.08 . . . . 8.6500000000000004 105.384 169.644 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 32.6 t -150.74 159.74 44.32 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 106.497 -1.668 . . . . 1.9299999999999999 106.497 176.167 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -135.3 148.39 49.49 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 106.143 -1.799 . . . . 4.6299999999999999 106.143 -178.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.1 pt -141.3 121.61 12.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 108.178 -1.045 . . . . 4.0 108.178 -168.28 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 24.1 tp60 -80.81 125.2 29.79 Favored 'General case' 0 N--CA 1.438 -1.033 0 N-CA-C 103.685 -2.709 . . . . 3.75 103.685 174.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.1 p -136.15 136.98 49.02 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.175 0 C-N-CA 123.803 0.841 . . . . 3.8300000000000001 110.169 -168.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.7 m -83.3 67.54 9.3 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 115.86 -0.609 . . . . 3.2200000000000002 111.843 -164.375 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 143.78 90.64 0.12 Allowed Glycine 0 CA--C 1.505 -0.548 0 N-CA-C 108.394 -1.882 . . . . 2.79 108.394 164.137 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 6.0 mmt -102.14 -56.16 2.33 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 110.704 -2.748 . . . . 8.1500000000000004 109.713 171.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.8 m -72.35 57.06 0.37 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.594 1.158 . . . . 6.0499999999999998 109.056 172.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 4.3 t -112.13 173.55 6.31 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 126.946 2.099 . . . . 3.6000000000000001 105.954 179.041 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -81.68 123.09 28.42 Favored 'General case' 0 CA--C 1.52 -0.208 0 N-CA-C 107.204 -1.406 . . . . 3.21 107.204 166.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 27.5 t 57.33 -84.65 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 118.607 -0.711 . . . . 4.29 109.227 -152.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 5.3 m -19.36 -21.35 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 118.142 2.645 . . . . 3.0499999999999998 118.142 -99.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.54 ' CG2' ' CG1' ' A' ' 36' ' ' VAL . 0.3 OUTLIER -41.18 -38.08 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 N-CA-C 115.502 1.667 . . . . 3.9500000000000002 115.502 172.326 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.26 -44.39 83.88 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.137 0.494 . . . . 1.98 110.83 177.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -61.47 -51.04 70.31 Favored 'General case' 0 C--O 1.222 -0.365 0 N-CA-C 108.408 -0.96 . . . . 2.21 108.408 174.047 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.475 ' O ' ' ND2' ' A' ' 24' ' ' ASN 0.251 11.1 mm -47.78 -60.84 0.56 Allowed 'Isoleucine or valine' 0 C--O 1.209 -1.052 0 C-N-CA 124.59 1.156 . . . . 3.6000000000000001 109.479 175.0 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -43.44 -45.77 6.45 Favored 'General case' 0 C--N 1.318 -0.771 0 O-C-N 116.911 -3.618 . . . . 4.9100000000000001 114.274 172.355 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 27.1 mmt85 -64.07 -31.56 72.79 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 120.857 -1.152 . . . . 5.8499999999999996 113.568 168.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.486 ' ND2' ' H ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -60.6 -67.27 0.41 Allowed 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 127.423 2.289 . . . . 5.1500000000000004 111.666 -171.522 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.486 ' H ' ' ND2' ' A' ' 24' ' ' ASN 0.354 5.2 mp -75.05 -26.98 59.81 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 119.508 -0.877 . . . . 4.3099999999999996 111.086 -163.163 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 92.8 mtt180 -61.74 -17.59 56.46 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 113.8 1.037 . . . . 7.71 113.8 168.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 23.6 mmt180 -57.11 -40.06 76.32 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 120.205 1.366 . . . . 9.5700000000000003 111.254 166.253 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -100.48 79.71 2.14 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-O 121.662 0.744 . . . . 9.2200000000000006 109.523 -146.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -37.02 114.91 0.35 Allowed 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 125.412 1.485 . . . . 5.6299999999999999 111.229 176.235 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 122.71 -21.73 7.47 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 111.048 -0.821 . . . . 1.3700000000000001 111.048 -167.23 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 1.2 mm -78.17 146.3 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 C-N-CA 125.079 1.352 . . . . 4.0999999999999996 108.282 164.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -137.96 37.37 2.37 Favored 'General case' 0 C--N 1.342 0.261 0 CA-C-O 123.065 1.412 . . . . 4.7599999999999998 113.002 153.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.417 ' CB ' ' HE ' ' A' ' 46' ' ' ARG . 0.5 OUTLIER -167.88 124.65 1.11 Allowed 'General case' 0 C--N 1.318 -0.8 0 C-N-CA 125.19 1.396 . . . . 3.5499999999999998 109.026 172.134 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.426 ' CD1' ' C ' ' A' ' 34' ' ' ILE . 0.0 OUTLIER -106.83 105.5 18.88 Favored 'Isoleucine or valine' 0 C--N 1.346 0.418 0 CA-C-N 119.872 1.214 . . . . 3.6000000000000001 108.929 168.237 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.473 ' N ' ' CD1' ' A' ' 35' ' ' LEU . 6.7 mp -118.22 151.77 36.99 Favored 'General case' 0 CA--C 1.502 -0.878 0 N-CA-C 106.612 -1.625 . . . . 8.9800000000000004 106.612 -168.639 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.54 ' CG1' ' CG2' ' A' ' 18' ' ' VAL 0.286 1.0 OUTLIER -159.68 95.2 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.427 -1.624 0 CA-C-O 122.647 1.213 . . . . 2.4900000000000002 111.12 -172.842 . . . . . . . . 4 4 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -80.11 73.37 6.94 Favored 'General case' 0 CA--C 1.532 0.277 0 O-C-N 119.966 -1.709 . . . . 2.25 109.109 178.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 80.6 mt -44.22 -52.35 7.5 Favored 'General case' 0 C--N 1.342 0.243 0 C-N-CA 124.414 1.086 . . . . 3.7400000000000002 111.227 -176.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 75.1 mtm -56.11 -32.62 64.35 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.912 1.285 . . . . 4.1399999999999997 112.272 -178.016 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -84.05 -2.11 56.09 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 122.932 0.493 . . . . 2.3300000000000001 111.77 179.235 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 82.36 18.86 65.64 Favored Glycine 0 C--N 1.337 0.623 0 N-CA-C 111.12 -0.792 . . . . 1.6699999999999999 111.12 175.112 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 26.7 pttt -146.78 146.85 30.41 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 118.223 1.011 . . . . 5.4900000000000002 111.741 -170.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -83.99 162.92 20.25 Favored 'General case' 0 N--CA 1.442 -0.835 0 C-N-CA 124.904 1.282 . . . . 2.5699999999999998 109.618 165.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -135.32 135.84 41.09 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 126.217 1.807 . . . . 3.0 112.808 -170.055 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.0 t -131.47 138.07 53.91 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 O-C-N 120.832 -1.168 . . . . 4.2699999999999996 109.457 -162.29 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.417 ' HE ' ' CB ' ' A' ' 33' ' ' SER . 47.8 ttp180 -150.18 107.59 3.63 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.92 0.888 . . . . 6.4199999999999999 109.512 179.538 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 11.5 p90 -155.58 179.21 9.4 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 124.608 1.163 . . . . 3.6099999999999999 110.168 -155.22 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -118.62 123.01 29.47 Favored Pre-proline 0 CA--C 1.535 0.395 0 C-N-CA 124.167 0.987 . . . . 3.1200000000000001 111.219 176.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -84.44 62.42 6.54 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 121.566 1.511 . . . . 1.6599999999999999 110.236 -173.565 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -131.33 -70.66 0.58 Allowed 'General case' 0 CA--C 1.519 -0.237 0 N-CA-C 107.0 -1.481 . . . . 1.9199999999999999 107.0 177.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 89.6 t -56.55 -44.31 80.43 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.779 0 C-N-CA 124.517 1.127 . . . . 2.4300000000000002 111.035 177.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.3 tt -113.16 -24.01 4.07 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.415 0 N-CA-C 114.053 1.131 . . . . 3.3999999999999999 114.053 -149.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 70.92 120.47 0.03 OUTLIER Pre-proline 0 N--CA 1.471 0.602 0 C-N-CA 125.724 1.609 . . . . 3.3500000000000001 113.228 175.073 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -46.87 -43.51 23.91 Favored 'Trans proline' 0 CA--C 1.532 0.42 0 C-N-CA 124.228 3.286 . . . . 1.5700000000000001 115.77 169.014 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -58.92 -54.35 2.86 Favored 'Trans proline' 0 N--CA 1.442 -1.537 0 CA-C-N 120.835 1.334 . . . . 1.4399999999999999 109.762 167.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 52.0 mtp -69.02 -28.58 66.7 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 118.396 -1.322 . . . . 3.1899999999999999 111.622 -166.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 12.4 tt -64.43 -37.04 78.98 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 CA-C-N 119.713 1.142 . . . . 3.02 110.844 174.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.8 -47.64 84.89 Favored 'General case' 0 N--CA 1.455 -0.176 0 O-C-N 121.416 -0.803 . . . . 2.0800000000000001 111.159 171.155 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -60.84 -57.47 12.54 Favored 'General case' 0 N--CA 1.432 -1.367 0 C-N-CA 123.718 0.807 . . . . 2.9399999999999999 112.355 -178.237 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -49.4 -38.51 29.16 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 123.488 0.715 . . . . 4.9900000000000002 111.386 -173.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 90.2 mt -60.99 -47.36 93.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 O-C-N 121.644 -0.66 . . . . 2.4700000000000002 110.894 175.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 22.2 mtm105 -66.28 -32.1 73.3 Favored 'General case' 0 CA--C 1.522 -0.113 0 O-C-N 121.588 -0.695 . . . . 4.5599999999999996 112.113 177.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 78.3 mt-10 -58.44 -23.55 57.78 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 118.699 0.681 . . . . 3.27 112.264 172.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 66.0 mt -80.81 -15.98 54.95 Favored 'General case' 0 CA--C 1.535 0.37 0 O-C-N 121.515 -0.741 . . . . 2.7599999999999998 111.568 173.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 112.08 -11.39 26.88 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 125.265 1.412 . . . . 3.2400000000000002 111.717 -177.129 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -79.8 101.63 8.6 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 117.812 0.806 . . . . 4.3899999999999997 110.167 -173.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -63.94 86.45 0.06 OUTLIER Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 125.26 1.41 . . . . 1.53 110.89 -179.26 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -111.51 130.11 55.83 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 128.211 2.604 . . . . 1.8300000000000001 111.526 -173.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 5.3 t -121.65 138.42 54.34 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 125.309 1.444 . . . . 2.77 107.301 175.194 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.7 t -83.54 136.36 22.97 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 C-N-CA 125.869 1.667 . . . . 2.8399999999999999 110.173 -171.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 36.5 mt -145.87 83.94 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 125.301 1.44 . . . . 2.8700000000000001 109.258 -176.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 31.8 mp0 -57.6 165.11 1.72 Allowed 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 123.932 0.893 . . . . 4.7199999999999998 110.471 160.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 35.2 p30 -119.5 169.47 10.01 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 125.442 1.497 . . . . 7.9800000000000004 108.542 170.454 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 46.6 pt -143.69 165.0 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.116 0 C-N-CA 125.051 1.34 . . . . 8.4600000000000009 107.537 178.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -70.29 -55.35 9.43 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 109.049 -0.723 . . . . 12.390000000000001 109.049 172.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 140.75 -134.71 6.56 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 106.748 -2.541 . . . . 10.26 106.748 -170.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 78.5 mtt180 . . . . . 0 C--O 1.251 1.148 0 C-N-CA 125.77 1.628 . . . . 19.030000000000001 109.968 -173.324 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 . . . . . 0 N--CA 1.479 0.977 0 N-CA-C 110.244 -0.28 . . . . 6.1500000000000004 110.244 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 12.9 m 66.37 154.67 0.09 Allowed 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.182 1.393 . . . . 2.9300000000000002 112.969 -174.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.2 m -157.35 170.48 22.37 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 128.13 2.572 . . . . 2.5899999999999999 105.873 172.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 75.8 tttt -130.51 152.76 49.54 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 108.548 -0.908 . . . . 4.1399999999999997 108.548 177.052 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 47.1 t -148.56 156.3 42.26 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 107.505 -1.294 . . . . 2.1000000000000001 107.505 170.257 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 -106.15 138.05 43.0 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 107.123 -1.436 . . . . 3.6200000000000001 107.123 169.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 15.9 mt -138.09 139.53 42.07 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 N-CA-C 104.357 -2.46 . . . . 2.52 104.357 -172.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 11.5 mt-30 -122.6 119.34 30.51 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 120.127 1.33 . . . . 5.2400000000000002 108.327 -177.201 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 99.1 t -112.32 138.83 39.85 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 O-C-N 124.184 0.928 . . . . 3.8599999999999999 110.766 -158.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.4 m -66.86 -42.88 84.92 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 113.492 0.923 . . . . 2.6499999999999999 113.492 -168.063 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -138.77 48.59 0.86 Allowed Glycine 0 C--N 1.341 0.831 0 CA-C-O 124.252 2.029 . . . . 3.7000000000000002 111.226 172.19 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . 0.257 42.7 ttp -14.31 -52.2 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 109.408 -3.396 . . . . 4.4500000000000002 111.206 136.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 12.8 t -122.07 126.38 48.3 Favored 'General case' 0 N--CA 1.44 -0.963 0 C-N-CA 126.531 1.933 . . . . 5.1200000000000001 106.591 168.126 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.3 p -110.92 64.98 0.61 Allowed 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 107.134 -1.432 . . . . 3.1600000000000001 107.134 119.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 64.87 -64.57 0.16 Allowed 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 128.507 2.723 . . . . 3.2999999999999998 111.737 -172.199 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.1 m -47.24 -49.25 23.69 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 127.001 2.12 . . . . 4.3499999999999996 112.133 -179.481 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 74.8 m -69.04 -20.16 64.11 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 114.59 1.329 . . . . 3.1299999999999999 114.59 -142.089 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 1.2 t -52.89 -37.96 27.25 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.281 0 CA-C-N 119.09 0.859 . . . . 3.4700000000000002 110.398 169.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.3 -52.22 65.33 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 123.139 0.576 . . . . 2.5 110.515 171.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -58.66 -53.75 54.87 Favored 'General case' 0 C--O 1.227 -0.102 0 C-N-CA 124.189 0.996 . . . . 2.2599999999999998 109.157 -176.329 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.4 mt -49.04 -60.87 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.997 0 C-N-CA 125.557 1.543 . . . . 2.5699999999999998 109.789 174.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -48.09 -59.74 3.16 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 119.916 1.235 . . . . 4.0099999999999998 113.049 176.018 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.49 -39.12 67.23 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.161 0.584 . . . . 7.8799999999999999 110.764 -177.06 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 -64.88 -60.87 2.58 Favored 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 108.417 -0.957 . . . . 3.1299999999999999 108.417 178.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.13 -42.61 59.73 Favored 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 111.911 0.337 . . . . 3.3100000000000001 111.911 -161.075 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 4.5 ttm180 -67.4 -19.17 65.36 Favored 'General case' 0 N--CA 1.433 -1.285 0 CA-C-N 119.022 0.828 . . . . 8.3399999999999999 112.526 -160.242 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 31.3 mtm105 -45.82 -61.56 1.67 Allowed 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.039 0.936 . . . . 7.7800000000000002 111.941 -177.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -175.32 12.78 0.01 OUTLIER 'General case' 0 N--CA 1.461 0.119 0 N-CA-C 114.311 1.226 . . . . 7.0999999999999996 114.311 -158.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -101.24 53.49 0.83 Allowed 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 122.587 1.184 . . . . 6.5899999999999999 108.877 -144.135 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 57.56 12.29 9.14 Favored Glycine 0 CA--C 1.531 1.091 0 CA-C-N 114.053 -1.431 . . . . 1.76 113.377 -172.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 1.1 pp -84.83 161.89 3.05 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 CA-C-N 119.238 1.519 . . . . 5.5800000000000001 110.645 -177.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -146.61 46.0 1.2 Allowed 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 122.596 1.189 . . . . 3.6699999999999999 111.666 146.101 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 70.0 m -164.16 175.91 9.74 Favored 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 131.094 3.757 . . . . 2.8799999999999999 105.22 154.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.2 pp -105.06 138.48 29.75 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.133 0 CA-C-O 122.421 1.105 . . . . 2.8999999999999999 109.859 160.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.402 ' CD2' ' N ' ' A' ' 35' ' ' LEU . 0.1 OUTLIER -77.4 66.47 3.16 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 129.684 3.194 . . . . 5.4699999999999998 111.021 -178.157 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 19.2 t -134.51 140.53 45.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 O-C-N 121.139 -0.976 . . . . 1.78 110.078 169.284 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -150.18 64.47 0.96 Allowed 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 103.31 -2.848 . . . . 1.8899999999999999 103.31 162.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -59.04 -43.26 91.64 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 108.517 -0.92 . . . . 4.21 108.517 -173.643 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 66.9 mtt -44.25 -37.48 3.26 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.556 0.742 . . . . 5.29 112.795 169.209 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -97.52 -10.25 25.61 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.564 1.146 . . . . 2.52 112.923 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 87.44 36.87 8.45 Favored Glycine 0 C--N 1.341 0.825 0 CA-C-N 120.114 1.325 . . . . 1.23 110.956 173.138 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 2.3 ptmt -162.47 178.52 8.54 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 119.03 1.415 . . . . 4.25 110.25 -174.278 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -118.56 133.02 56.18 Favored 'General case' 0 N--CA 1.441 -0.907 0 C-N-CA 128.051 2.54 . . . . 2.0099999999999998 108.899 175.066 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -126.06 82.58 2.08 Favored 'General case' 0 C--N 1.339 0.127 0 C-N-CA 123.995 0.918 . . . . 3.0 112.012 -172.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 9.9 p -83.19 134.53 26.72 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 C-N-CA 123.237 0.615 . . . . 2.6000000000000001 110.39 -169.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 35.6 ttm105 -113.14 127.64 56.25 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 103.955 -2.609 . . . . 5.0599999999999996 103.955 158.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 4.2 p90 -157.73 175.36 14.0 Favored 'General case' 0 CA--C 1.515 -0.373 0 C-N-CA 123.407 0.683 . . . . 3.3900000000000001 109.279 -170.172 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -122.68 94.63 47.39 Favored Pre-proline 0 CA--C 1.533 0.325 0 CA-C-O 119.021 -0.514 . . . . 3.29 110.245 178.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -71.36 73.73 2.12 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 123.78 2.987 . . . . 1.46 112.234 -176.105 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -146.93 -51.61 0.21 Allowed 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 125.883 1.673 . . . . 2.2000000000000002 106.533 165.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 95.9 t -53.95 -57.61 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.768 0 C-N-CA 124.517 1.127 . . . . 2.0699999999999998 109.535 170.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . 0.252 11.5 tt -94.81 -71.08 0.58 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.371 0 CA-C-O 118.341 -0.838 . . . . 2.71 113.169 -169.454 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 109.54 139.45 0.0 OUTLIER Pre-proline 0 N--CA 1.469 0.523 0 C-N-CA 129.993 3.317 . . . . 3.7400000000000002 108.498 -173.54 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_exo -51.27 -50.86 12.58 Favored 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 124.215 3.277 . . . . 1.23 114.595 172.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -47.03 -55.55 3.79 Favored 'Trans proline' 0 N--CA 1.446 -1.308 0 C-N-CA 121.533 1.489 . . . . 1.25 110.308 166.147 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 25.1 mtm -62.66 -35.87 81.04 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 118.067 -1.453 . . . . 3.02 112.242 -172.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . 0.261 2.7 tt -68.35 -39.56 81.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-N 119.023 0.829 . . . . 2.96 111.035 179.391 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.22 -55.6 32.87 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 118.933 0.788 . . . . 1.75 112.162 169.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -50.25 -47.04 55.33 Favored 'General case' 0 N--CA 1.442 -0.864 0 C-N-CA 126.169 1.788 . . . . 4.0499999999999998 110.835 -178.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -46.1 -42.76 14.08 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.246 0.618 . . . . 5.7999999999999998 112.325 174.433 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 40.7 mt -74.63 -44.6 46.61 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 N-CA-C 108.405 -0.961 . . . . 2.52 108.405 -177.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.1 -62.13 1.97 Allowed 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 124.969 1.308 . . . . 9.2699999999999996 112.894 -178.409 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -57.64 -58.71 7.12 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 124.117 0.967 . . . . 3.1299999999999999 111.447 -163.042 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.33 -34.39 23.69 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 122.766 0.427 . . . . 3.2000000000000002 111.649 -179.033 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -93.66 -91.69 1.58 Allowed Glycine 0 CA--C 1.525 0.709 0 N-CA-C 111.089 -0.805 . . . . 2.8599999999999999 111.089 -174.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -138.1 -79.17 0.36 Allowed 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 122.422 1.106 . . . . 3.9500000000000002 112.837 -157.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 156.19 122.38 0.75 Allowed Glycine 0 N--CA 1.445 -0.707 0 N-CA-C 105.406 -3.078 . . . . 2.1600000000000001 105.406 -143.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -145.86 116.67 7.71 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 107.929 -1.137 . . . . 2.1200000000000001 107.929 -167.318 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 41.1 p -93.7 118.52 31.5 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 107.093 -1.447 . . . . 3.1899999999999999 107.093 176.318 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.2 t -83.56 121.29 36.08 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 N-CA-C 107.176 -1.416 . . . . 2.6200000000000001 107.176 177.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 47.0 mt -145.24 77.12 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.307 0 N-CA-C 108.213 -1.032 . . . . 2.7400000000000002 108.213 -169.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -67.27 69.6 0.09 Allowed 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.893 0.877 . . . . 5.1299999999999999 111.011 166.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 38.27 75.84 0.07 Allowed 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 128.492 2.717 . . . . 6.1900000000000004 114.631 171.277 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 42.4 mm -59.32 -41.32 83.82 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 C-N-CA 124.023 0.929 . . . . 9.9700000000000006 112.73 -177.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -143.26 157.52 44.42 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 107.154 -1.425 . . . . 9.9900000000000002 107.154 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -168.28 68.68 0.17 Allowed Glycine 0 CA--C 1.523 0.59 0 N-CA-C 108.933 -1.667 . . . . 9.8699999999999992 108.933 -177.063 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.255 1.346 0 C-N-CA 126.974 2.11 . . . . 15.029999999999999 105.658 -175.405 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 1.3 t30 . . . . . 0 N--CA 1.476 0.858 0 N-CA-C 108.626 -0.879 . . . . 5.6600000000000001 108.626 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.7 p 42.76 59.46 2.8 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 122.779 1.276 . . . . 3.5499999999999998 110.181 -166.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.8 m -106.73 142.37 36.47 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 125.929 1.692 . . . . 2.9700000000000002 108.471 -165.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 18.7 ttpt -93.58 154.05 18.07 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 118.96 -0.543 . . . . 4.5099999999999998 110.219 177.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 9.3 t -153.59 160.63 42.5 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 108.377 -0.972 . . . . 2.79 108.377 167.234 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -105.41 157.62 17.22 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.376 1.071 . . . . 3.6800000000000002 109.249 -173.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.3 mt -145.22 147.05 19.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 N-CA-C 107.315 -1.365 . . . . 2.77 107.315 179.504 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 -108.59 141.26 40.78 Favored 'General case' 0 C--O 1.232 0.16 0 N-CA-C 107.88 -1.156 . . . . 5.25 107.88 170.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 57.0 t -108.08 126.27 64.67 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 O-C-N 124.086 0.866 . . . . 3.8500000000000001 109.807 179.163 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 11.1 m -75.33 75.3 2.43 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.61 0.764 . . . . 3.5299999999999998 110.968 -179.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 164.05 -62.47 0.25 Allowed Glycine 0 C--O 1.227 -0.323 0 N-CA-C 105.544 -3.022 . . . . 4.0300000000000002 105.544 173.382 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . 0.333 0.0 OUTLIER 59.28 138.38 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 129.347 3.059 . . . . 4.7699999999999996 114.512 178.352 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 7.0 m 73.31 -59.11 0.58 Allowed 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 126.161 1.784 . . . . 5.79 109.767 -177.395 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 38.5 m 51.38 -124.27 2.22 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.893 1.277 . . . . 3.1299999999999999 108.729 170.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -155.86 142.95 19.11 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 106.099 -1.815 . . . . 2.7999999999999998 106.099 152.397 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 56.9 p 64.54 -25.1 0.08 Allowed 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 116.536 2.05 . . . . 3.9500000000000002 116.536 -179.266 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 99.2 m -38.57 -38.69 0.41 Allowed 'General case' 0 C--O 1.225 -0.236 0 C-N-CA 125.141 1.376 . . . . 2.8500000000000001 112.186 171.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.6 t -65.38 -45.97 91.64 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.359 0 C-N-CA 124.544 1.137 . . . . 3.48 109.796 -178.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.97 -47.01 78.43 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 123.603 0.761 . . . . 2.4700000000000002 109.292 173.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -58.18 -58.52 8.12 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 109.005 -0.739 . . . . 2.29 109.005 179.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 40.5 mt -46.62 -60.05 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 C-N-CA 126.308 1.843 . . . . 2.6600000000000001 110.343 179.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 73.1 mt-10 -47.38 -61.77 1.75 Allowed 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.494 0.718 . . . . 3.0499999999999998 111.783 174.174 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 7.1 mpt_? -62.06 -32.59 73.13 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.978 -0.555 . . . . 7.6399999999999997 111.308 -168.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 18.9 m-20 -71.85 -64.58 0.9 Allowed 'General case' 0 CA--C 1.528 0.134 0 CA-C-O 121.515 0.674 . . . . 3.6400000000000001 110.67 175.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.3 mt -78.73 -9.87 59.57 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 125.556 1.542 . . . . 4.8799999999999999 111.545 -162.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.502 ' CG ' ' H ' ' A' ' 27' ' ' ARG . 0.0 OUTLIER -21.36 -77.34 0.01 OUTLIER 'General case' 0 N--CA 1.444 -0.76 0 C-N-CA 130.223 3.409 . . . . 9.8200000000000003 112.917 -166.411 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.502 ' H ' ' CG ' ' A' ' 26' ' ' ARG . 11.1 ptp180 -92.76 -37.93 12.07 Favored 'General case' 0 N--CA 1.435 -1.185 0 C-N-CA 129.284 3.034 . . . . 13.529999999999999 116.501 154.552 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 11.22 56.15 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.289 1.436 . . . . 8.0199999999999996 113.455 -144.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 14.3 mp0 32.07 54.53 0.31 Allowed 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 128.125 2.57 . . . . 7.6299999999999999 112.711 -174.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 179.3 -37.49 0.07 OUTLIER Glycine 0 CA--C 1.54 1.612 0 C-N-CA 123.979 0.8 . . . . 1.8500000000000001 113.978 -172.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 6.0 mt -81.98 145.85 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 C-N-CA 127.705 2.402 . . . . 3.0299999999999998 107.199 167.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 79.7 m-85 -147.45 47.8 1.12 Allowed 'General case' 0 N--CA 1.456 -0.15 0 CA-C-O 122.315 1.055 . . . . 5.5700000000000003 111.119 157.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.8 t -168.15 135.64 2.17 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 126.15 1.78 . . . . 2.73 106.972 145.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.7 pp -82.98 152.06 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 CA-C-O 123.582 1.658 . . . . 2.77 112.223 -171.197 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.497 ' H ' ' CD2' ' A' ' 35' ' ' LEU . 1.9 pt? -76.48 58.48 1.34 Allowed 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 131.517 3.927 . . . . 5.5999999999999996 111.541 -167.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 76.8 t -135.46 122.99 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 O-C-N 121.129 -0.982 . . . . 2.1800000000000002 113.556 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -133.56 57.23 1.81 Allowed 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 106.43 -1.692 . . . . 1.79 106.43 150.351 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -75.45 -6.39 49.87 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 123.615 0.766 . . . . 6.4900000000000002 111.838 -175.122 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 66.8 mtt -59.49 -41.02 88.87 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 109.791 -0.448 . . . . 5.79 109.791 161.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -86.99 -41.25 14.04 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.133 0.573 . . . . 2.1699999999999999 110.072 177.305 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 117.95 48.0 0.42 Allowed Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.094 -1.202 . . . . 0.93000000000000005 110.094 176.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -162.48 177.53 9.41 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 106.561 -1.644 . . . . 5.04 106.561 -170.166 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -140.89 140.59 34.56 Favored 'General case' 0 N--CA 1.441 -0.906 0 C-N-CA 125.132 1.373 . . . . 2.0600000000000001 108.887 -167.509 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -141.86 104.72 4.56 Favored 'General case' 0 C--N 1.344 0.363 0 CA-C-N 118.968 0.804 . . . . 3.2599999999999998 110.538 179.421 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.7 p -90.99 142.09 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.101 0 C-N-CA 124.33 1.052 . . . . 2.7400000000000002 108.474 -172.358 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 16.6 tpp180 -107.43 122.63 47.0 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 106.07 -1.826 . . . . 6.0700000000000003 106.07 163.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -160.45 179.13 8.88 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 118.832 0.742 . . . . 3.6200000000000001 112.19 -168.725 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 35.7 m-20 -109.24 109.82 60.46 Favored Pre-proline 0 CA--C 1.53 0.198 0 N-CA-C 108.123 -1.066 . . . . 3.6000000000000001 108.123 163.206 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -76.4 58.77 5.88 Favored 'Trans proline' 0 CA--C 1.536 0.603 0 C-N-CA 123.508 2.805 . . . . 2.3199999999999998 110.598 -178.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -157.44 -51.08 0.07 Allowed 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 125.873 1.669 . . . . 2.8900000000000001 107.224 -172.217 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 74.1 t -61.24 -43.56 96.71 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.866 0 C-N-CA 124.34 1.056 . . . . 2.7400000000000002 109.867 173.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.2 tp -109.52 -54.62 5.42 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.255 0 C-N-CA 122.891 0.476 . . . . 2.6600000000000001 110.743 -175.06 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 2.2 mm-40 95.5 128.35 0.02 OUTLIER Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 129.21 3.004 . . . . 4.2599999999999998 110.813 171.547 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -55.88 -43.26 58.79 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 123.506 2.804 . . . . 1.26 116.521 -172.444 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -58.35 -43.1 49.32 Favored 'Trans proline' 0 N--CA 1.445 -1.347 0 CA-C-N 121.533 1.583 . . . . 1.1699999999999999 109.079 175.377 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 63.5 mtt -61.77 -44.51 96.75 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 118.403 -0.808 . . . . 2.8900000000000001 109.928 179.233 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -62.27 -48.54 87.89 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 CA-C-N 120.084 1.311 . . . . 3.5299999999999998 110.903 177.359 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -54.23 -38.45 65.75 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 124.332 1.053 . . . . 2.1000000000000001 112.165 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -70.01 -60.7 2.14 Favored 'General case' 0 N--CA 1.442 -0.828 0 C-N-CA 125.405 1.482 . . . . 3.3100000000000001 110.644 172.185 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -44.91 -43.78 9.18 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 124.191 0.996 . . . . 4.9699999999999998 112.464 -177.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 67.8 mt -63.23 -43.54 98.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 O-C-N 121.912 -0.493 . . . . 2.1099999999999999 110.017 -178.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . 0.301 7.6 ptp180 -70.83 -42.16 70.56 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-O 119.359 -0.353 . . . . 4.6100000000000003 111.604 179.152 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -55.39 -45.05 76.65 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.154 0.981 . . . . 3.0499999999999998 110.836 174.479 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 63.7 mt -81.2 -38.72 26.56 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-O 119.507 -0.283 . . . . 3.3900000000000001 110.628 -174.152 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -104.93 -90.77 2.19 Favored Glycine 0 CA--C 1.527 0.808 0 N-CA-C 111.33 -0.708 . . . . 3.02 111.33 179.172 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 18.1 m-85 -142.29 -56.97 0.45 Allowed 'General case' 0 CA--C 1.509 -0.615 0 CA-C-O 122.464 1.126 . . . . 5.0300000000000002 111.699 -157.013 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 162.27 126.3 0.81 Allowed Glycine 0 N--CA 1.432 -1.599 0 N-CA-C 105.784 -2.927 . . . . 1.5700000000000001 105.784 -149.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -157.05 153.77 28.45 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 117.234 0.517 . . . . 2.2599999999999998 110.102 177.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 2.4 t -128.16 144.69 51.13 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 106.747 -1.575 . . . . 3.3399999999999999 106.747 174.434 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 12.6 p -81.23 150.74 4.52 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 N-CA-C 107.173 -1.418 . . . . 3.1699999999999999 107.173 170.178 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 4.8 pt -154.95 175.91 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 C-N-CA 126.368 1.867 . . . . 3.8399999999999999 106.833 177.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -145.0 157.79 44.02 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 108.286 -1.005 . . . . 4.8899999999999997 108.286 167.316 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -134.15 98.39 4.11 Favored 'General case' 0 C--N 1.333 -0.115 0 N-CA-C 108.094 -1.076 . . . . 7.71 108.094 -173.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -57.95 115.6 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 N-CA-C 107.937 -1.134 . . . . 9.1699999999999999 107.937 168.233 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 62.96 -66.53 0.09 Allowed 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 126.443 1.897 . . . . 13.52 112.714 -171.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 63.4 43.06 98.84 Favored Glycine 0 CA--C 1.529 0.941 0 N-CA-C 110.066 -1.214 . . . . 14.43 110.066 -168.081 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.011 0 N-CA-C 107.703 -1.221 . . . . 18.899999999999999 107.703 176.476 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 . . . . . 0 N--CA 1.478 0.944 0 N-CA-C 107.229 -1.397 . . . . 7.4400000000000004 107.229 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.5 m -163.2 154.69 17.31 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 118.919 0.781 . . . . 3.3900000000000001 109.169 -174.076 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 22.7 m -89.26 161.36 16.45 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 107.916 -1.142 . . . . 2.5699999999999998 107.916 160.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 51.6 mtmt -113.41 160.48 18.37 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 123.777 0.831 . . . . 4.7999999999999998 108.847 162.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 49.7 t -155.52 154.2 31.41 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 106.931 -1.507 . . . . 2.4500000000000002 106.931 170.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -100.93 154.91 18.28 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 122.173 0.987 . . . . 4.1500000000000004 108.663 175.386 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.7 mp -134.04 138.22 50.69 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 N-CA-C 104.792 -2.299 . . . . 2.9700000000000002 104.792 169.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 47.9 tp60 -95.56 122.96 38.86 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 103.332 -2.84 . . . . 3.3900000000000001 103.332 165.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 26.0 m -118.38 147.71 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 C-N-CA 124.671 1.189 . . . . 3.7200000000000002 108.008 -178.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 6.9 m -105.05 70.03 0.88 Allowed 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.02 0.528 . . . . 3.1699999999999999 109.694 -175.557 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 156.55 -36.49 0.59 Allowed Glycine 0 C--N 1.341 0.814 0 C-N-CA 121.029 -0.605 . . . . 2.3599999999999999 114.274 170.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 2.6 mpp? 46.91 42.16 11.81 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.48 1.112 . . . . 4.8399999999999999 110.589 -168.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.2 p 56.78 1.79 0.09 Allowed 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 115.919 1.822 . . . . 11.82 115.919 -173.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . 0.372 0.1 OUTLIER 77.39 174.28 0.2 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 127.334 2.254 . . . . 4.0300000000000002 112.442 -166.695 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.03 132.74 54.37 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.034 0.934 . . . . 5.0999999999999996 111.221 -169.428 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 10.4 m 74.15 -37.68 0.37 Allowed 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.124 1.369 . . . . 5.3700000000000001 113.63 174.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 75.6 m -54.94 -28.41 50.96 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 127.159 2.184 . . . . 5.6699999999999999 111.08 176.011 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 8.1 m -38.31 -40.98 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 N-CA-C 113.378 0.881 . . . . 3.6699999999999999 113.378 164.032 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -45.56 -49.12 14.21 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 124.153 0.981 . . . . 2.6099999999999999 110.876 174.203 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -54.7 -57.43 11.51 Favored 'General case' 0 CA--C 1.519 -0.237 0 N-CA-C 109.346 -0.613 . . . . 3.2000000000000002 109.346 173.403 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 3.6 tp -67.72 -39.29 81.81 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.382 0 CA-C-N 118.401 0.546 . . . . 5.7300000000000004 109.816 -163.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.408 ' HG2' ' CG1' ' A' ' 34' ' ' ILE . 59.0 mt-10 -56.18 -56.6 18.94 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.993 1.317 . . . . 3.6699999999999999 110.61 171.233 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.7 tmt_? -52.99 -39.36 63.0 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 109.616 -0.513 . . . . 7.4400000000000004 109.616 176.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -72.41 -42.28 65.31 Favored 'General case' 0 N--CA 1.431 -1.383 0 CA-C-O 118.037 -0.983 . . . . 3.6699999999999999 109.148 -178.187 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -56.72 -37.89 71.59 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 121.335 1.88 . . . . 3.3199999999999998 109.253 176.71 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 56.7 mtp180 -65.46 -12.34 51.56 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 115.262 1.578 . . . . 7.2800000000000002 115.262 175.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -66.02 -17.87 64.97 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 121.028 1.74 . . . . 9.3399999999999999 111.294 167.247 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -104.06 90.85 3.72 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 108.931 -0.766 . . . . 7.7400000000000002 108.931 -166.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -43.64 133.15 4.69 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 107.724 -1.213 . . . . 8.4399999999999995 107.724 166.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 110.82 -36.27 4.33 Favored Glycine 0 CA--C 1.527 0.787 0 CA-C-O 118.639 -1.09 . . . . 1.9199999999999999 111.786 -166.149 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.7 mt -83.03 126.44 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 CA-C-N 119.316 1.558 . . . . 3.1200000000000001 108.772 174.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -134.89 42.07 2.82 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 122.363 1.078 . . . . 3.8300000000000001 112.4 160.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 9.1 t -167.76 137.78 2.73 Favored 'General case' 0 C--N 1.316 -0.866 0 C-N-CA 128.008 2.523 . . . . 3.3199999999999998 106.911 144.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.552 ' H ' ' CD1' ' A' ' 34' ' ' ILE . 0.0 OUTLIER -78.86 134.54 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.369 0 CA-C-O 122.814 1.293 . . . . 3.2400000000000002 109.535 -179.598 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -81.31 68.21 7.54 Favored 'General case' 0 N--CA 1.431 -1.382 0 CA-C-N 115.317 -0.856 . . . . 5.5499999999999998 110.481 -176.527 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 4.9 t -130.42 139.46 51.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 121.917 0.865 . . . . 2.5899999999999999 111.487 167.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -151.95 72.8 1.03 Allowed 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 127.602 2.361 . . . . 2.1400000000000001 107.621 169.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.496 ' H ' ' CD2' ' A' ' 38' ' ' LEU . 0.2 OUTLIER -46.96 -43.69 19.38 Favored 'General case' 0 CA--C 1.509 -0.621 0 C-N-CA 124.08 0.952 . . . . 4.3899999999999997 110.572 169.006 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 24.3 ptt? -79.81 42.31 0.53 Allowed 'General case' 0 CA--C 1.545 0.786 0 CA-C-O 121.65 0.738 . . . . 5.71 111.649 -167.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -178.23 -40.81 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 129.751 3.22 . . . . 2.3500000000000001 106.878 -171.423 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 98.44 49.9 1.63 Allowed Glycine 0 C--N 1.339 0.735 0 N-CA-C 108.072 -2.011 . . . . 0.97999999999999998 108.072 172.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 46.5 mttm -152.7 179.87 8.24 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 126.217 1.807 . . . . 5.6699999999999999 108.727 -158.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -151.18 131.71 13.86 Favored 'General case' 0 N--CA 1.442 -0.831 0 C-N-CA 125.29 1.436 . . . . 2.25 108.109 -171.174 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -136.59 102.96 5.08 Favored 'General case' 0 C--N 1.342 0.242 0 CA-C-N 118.967 0.803 . . . . 2.77 112.22 -175.627 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.4 p -82.65 146.94 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.215 0 N-CA-C 108.989 -0.745 . . . . 2.77 108.989 -176.536 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 60.6 ttp180 -122.69 123.25 40.69 Favored 'General case' 0 C--N 1.339 0.126 0 N-CA-C 105.823 -1.917 . . . . 6.5 105.823 159.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 1.5 p90 -160.27 175.23 13.1 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 118.298 0.499 . . . . 3.4300000000000002 110.994 -164.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -110.44 117.94 50.07 Favored Pre-proline 0 CA--C 1.539 0.546 0 C-N-CA 123.472 0.709 . . . . 3.5099999999999998 109.224 166.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -74.78 23.84 0.38 Allowed 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 122.933 2.422 . . . . 1.98 113.91 -170.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -109.55 -49.33 3.12 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.752 1.221 . . . . 1.8 108.403 -178.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 98.4 t -65.52 -50.3 72.96 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.89 0 C-N-CA 124.271 1.028 . . . . 2.3199999999999998 109.917 -179.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 3.3 tp -102.64 -62.62 2.0 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.391 0 CA-C-O 118.652 -0.69 . . . . 2.46 112.401 -163.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 11.4 mm-40 96.14 127.12 0.02 OUTLIER Pre-proline 0 CA--C 1.548 0.873 0 C-N-CA 129.85 3.26 . . . . 4.29 112.318 176.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_exo -44.15 -51.83 6.29 Favored 'Trans proline' 0 C--N 1.351 0.708 1 C-N-CA 125.349 4.033 . . . . 1.3200000000000001 116.4 174.33 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -52.51 -46.41 33.39 Favored 'Trans proline' 0 N--CA 1.446 -1.291 0 CA-C-N 120.706 1.288 . . . . 0.90000000000000002 110.17 173.284 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 60.1 mtp -64.46 -46.26 83.85 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 118.723 -0.656 . . . . 3.7799999999999998 111.053 -176.541 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 20.6 pt -60.19 -49.91 82.29 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-N 119.897 1.226 . . . . 3.4900000000000002 110.944 175.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -48.04 -49.63 30.66 Favored 'General case' 0 C--N 1.341 0.199 0 C-N-CA 123.442 0.697 . . . . 2.02 110.998 176.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -61.92 -57.1 13.01 Favored 'General case' 0 N--CA 1.434 -1.234 0 C-N-CA 124.234 1.014 . . . . 3.0899999999999999 112.369 178.069 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 9.0 m-30 -47.66 -50.05 25.82 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 118.796 0.726 . . . . 4.75 109.773 -174.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 20.0 mt -51.92 -43.23 35.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 123.319 0.648 . . . . 2.3799999999999999 112.009 175.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 91.2 mtt180 -65.37 -59.4 4.07 Favored 'General case' 0 N--CA 1.457 -0.076 0 N-CA-C 109.477 -0.564 . . . . 5.0700000000000003 109.477 175.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -44.62 -54.54 6.04 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 125.758 1.623 . . . . 2.9399999999999999 111.941 -173.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . 0.253 0.3 OUTLIER -84.37 -13.39 52.43 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 114.071 1.137 . . . . 3.8199999999999998 114.071 179.44 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -152.74 -88.52 0.07 OUTLIER Glycine 0 CA--C 1.531 1.036 0 CA-C-N 119.84 1.2 . . . . 2.48 115.994 -165.105 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -136.43 147.25 47.15 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-O 121.732 0.777 . . . . 4.8300000000000001 112.665 -147.016 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -58.68 108.3 1.49 Allowed Glycine 0 N--CA 1.441 -0.978 0 N-CA-C 109.097 -1.601 . . . . 2.0099999999999998 109.097 177.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -116.54 130.07 56.54 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 126.41 1.884 . . . . 2.2599999999999998 109.088 -173.212 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 41.6 m -128.24 129.29 46.17 Favored 'General case' 0 CA--C 1.528 0.097 0 C-N-CA 124.964 1.306 . . . . 3.9700000000000002 107.921 175.137 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 13.3 p -82.42 140.35 16.53 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 C-N-CA 123.741 0.817 . . . . 3.4300000000000002 109.698 -175.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 46.7 mt -143.26 143.18 25.02 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 125.315 1.446 . . . . 3.1000000000000001 108.493 -175.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -156.72 159.09 38.02 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 107.056 -1.461 . . . . 4.1200000000000001 107.056 166.145 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 48.5 m-80 -150.22 151.15 32.58 Favored 'General case' 0 N--CA 1.457 -0.122 0 N-CA-C 106.619 -1.623 . . . . 5.5599999999999996 106.619 -176.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 32.8 mm -138.06 140.52 40.35 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 N-CA-C 105.131 -2.174 . . . . 9.8900000000000006 105.131 175.265 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 3.64 77.52 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 129.671 3.188 . . . . 12.31 114.881 176.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -170.91 152.85 19.53 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 107.876 -2.089 . . . . 9.4000000000000004 107.876 175.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 39.5 ttt85 . . . . . 0 C--O 1.253 1.278 0 N-CA-C 105.032 -2.21 . . . . 16.670000000000002 105.032 -179.751 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 . . . . . 0 N--CA 1.477 0.901 0 N-CA-C 107.666 -1.235 . . . . 5.6799999999999997 107.666 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.5 p -67.32 162.32 23.1 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 119.528 1.058 . . . . 2.7000000000000002 110.833 175.149 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 47.5 m -154.93 165.77 35.65 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.419 1.088 . . . . 2.4500000000000002 108.939 179.161 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.53 130.74 56.61 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 125.006 1.322 . . . . 5.54 107.988 174.784 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 51.2 t -123.01 146.42 47.66 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 118.973 0.806 . . . . 2.3100000000000001 109.427 173.196 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -92.24 133.1 36.13 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.47 1.108 . . . . 3.9300000000000002 108.952 172.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.0 mm -124.3 151.9 29.75 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 N-CA-C 103.822 -2.658 . . . . 3.6200000000000001 103.822 178.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 45.1 tp60 -117.37 125.01 50.29 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 103.551 -2.759 . . . . 4.0800000000000001 103.551 168.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.8 m -87.91 141.36 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 N-CA-C 108.695 -0.854 . . . . 3.2799999999999998 108.695 178.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 52.6 p -104.4 84.99 2.27 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 105.255 -2.128 . . . . 4.1799999999999997 105.255 165.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 177.74 -67.82 0.08 OUTLIER Glycine 0 CA--C 1.522 0.493 0 N-CA-C 105.392 -3.083 . . . . 2.3599999999999999 105.392 -178.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 14.1 ttp 70.99 -61.64 0.48 Allowed 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 126.774 2.029 . . . . 4.5800000000000001 112.441 165.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.8 m -142.65 49.43 1.5 Allowed 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 125.946 1.698 . . . . 5.6399999999999997 106.878 173.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.9 p -53.99 -51.77 62.85 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 109.119 -0.697 . . . . 3.4700000000000002 109.119 177.14 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 176.73 120.19 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 127.221 2.209 . . . . 4.7800000000000002 107.352 157.172 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 4.2 p 48.92 38.61 12.65 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.426 0.69 . . . . 3.75 111.044 -171.005 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 29.5 t -55.14 -44.77 75.41 Favored 'General case' 0 N--CA 1.461 0.094 0 C-N-CA 126.591 1.956 . . . . 4.0099999999999998 108.141 -178.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.2 m -70.79 -49.58 49.87 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.089 0 CA-C-N 113.955 -1.475 . . . . 3.1899999999999999 110.989 -171.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.64 -41.7 73.96 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.955 0.902 . . . . 1.8 110.824 171.074 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -55.05 -50.99 67.71 Favored 'General case' 0 C--N 1.341 0.205 0 N-CA-C 108.566 -0.901 . . . . 2.5299999999999998 108.566 172.346 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 4.6 mt -56.09 -51.21 64.62 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 CA-C-O 118.494 -0.765 . . . . 3.54 110.024 178.196 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -49.98 -57.03 8.39 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 119.332 0.969 . . . . 3.4199999999999999 110.065 177.253 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 32.6 mmt180 -51.72 -46.63 64.02 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 122.743 0.417 . . . . 5.5300000000000002 111.814 177.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 67.4 m-20 -67.13 -63.93 0.96 Allowed 'General case' 0 C--O 1.224 -0.242 0 CA-C-O 121.825 0.821 . . . . 3.3500000000000001 109.612 -176.038 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -71.1 -28.52 64.38 Favored 'General case' 0 N--CA 1.439 -1.022 0 C-N-CA 124.339 1.056 . . . . 3.1899999999999999 110.316 -165.773 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . 0.487 28.1 mtp-105 -70.11 0.51 6.03 Favored 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 116.192 1.923 . . . . 6.46 116.192 167.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 9.5 mmt180 -38.07 -36.03 0.19 Allowed 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 117.777 -1.569 . . . . 8.9499999999999993 112.393 143.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 70.04 43.61 0.88 Allowed 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 126.075 1.75 . . . . 8.6899999999999995 108.359 -178.061 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -73.77 58.46 0.63 Allowed 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 126.832 2.053 . . . . 5.2000000000000002 108.795 179.008 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 66.0 34.28 87.98 Favored Glycine 0 CA--C 1.532 1.128 0 O-C-N 121.316 -0.865 . . . . 1.3300000000000001 112.375 -172.13 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -113.96 135.8 52.49 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 C-N-CA 126.167 1.787 . . . . 2.8999999999999999 106.993 -179.096 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -140.83 47.21 1.75 Allowed 'General case' 0 CA--C 1.53 0.184 0 CA-C-O 122.923 1.344 . . . . 3.8700000000000001 111.6 159.503 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.7 t -168.64 133.63 1.65 Allowed 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 127.791 2.437 . . . . 3.2599999999999998 105.546 144.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -81.0 150.99 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 CA-C-O 121.805 0.812 . . . . 2.9300000000000002 109.37 177.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -81.13 65.5 6.29 Favored 'General case' 0 N--CA 1.435 -1.177 0 C-N-CA 124.151 0.98 . . . . 5.46 111.04 -177.469 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 11.4 t -117.2 140.62 39.2 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 CA-C-O 121.956 0.884 . . . . 2.46 111.321 162.018 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -155.79 59.78 0.6 Allowed 'General case' 0 C--O 1.236 0.389 0 C-N-CA 127.323 2.249 . . . . 1.8200000000000001 106.893 166.007 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.18 60.11 3.57 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 124.445 1.098 . . . . 4.25 109.293 179.464 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 51.6 ttm -131.97 -52.2 0.97 Allowed 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 105.112 -2.181 . . . . 4.2800000000000002 105.112 163.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -69.13 -30.49 68.76 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.574 -0.739 . . . . 1.77 111.169 165.005 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 96.32 45.46 2.78 Favored Glycine 0 C--N 1.341 0.835 0 N-CA-C 109.552 -1.419 . . . . 1.1200000000000001 109.552 -178.514 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 50.1 mttt -147.73 -179.14 6.67 Favored 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 124.725 1.21 . . . . 5.1500000000000004 108.295 -156.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -157.39 118.74 3.65 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 108.077 -1.082 . . . . 2.54 108.077 -159.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -133.01 105.95 7.38 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 119.413 1.006 . . . . 2.6000000000000001 112.83 178.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.1 p -82.38 133.17 29.72 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.317 0 C-N-CA 124.421 1.088 . . . . 2.4500000000000002 108.405 -177.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 71.4 ttt180 -110.17 127.07 54.72 Favored 'General case' 0 CA--C 1.52 -0.173 0 N-CA-C 105.764 -1.939 . . . . 5.29 105.764 166.44 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 4.9 p90 -157.23 169.21 25.28 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 117.995 0.361 . . . . 3.3399999999999999 111.145 -161.024 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -114.43 98.19 48.3 Favored Pre-proline 0 CA--C 1.539 0.523 0 C-N-CA 124.548 1.139 . . . . 3.8399999999999999 111.338 174.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.44 79.55 0.84 Allowed 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 122.802 2.335 . . . . 1.6299999999999999 111.46 176.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -143.63 -56.79 0.39 Allowed 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 105.867 -1.901 . . . . 2.6299999999999999 105.867 159.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 91.4 t -56.76 -62.37 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 C-N-CA 124.646 1.178 . . . . 2.4399999999999999 109.492 171.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . 0.28 9.6 tp -89.3 -77.48 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 CA-C-O 118.669 -0.681 . . . . 2.5800000000000001 112.338 -160.341 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 99.37 142.79 0.03 OUTLIER Pre-proline 0 CA--C 1.54 0.592 0 C-N-CA 129.808 3.243 . . . . 3.9100000000000001 111.414 -179.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_exo -47.95 -47.82 17.96 Favored 'Trans proline' 0 CA--C 1.536 0.614 1 C-N-CA 126.525 4.817 . . . . 1.3 116.917 174.213 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -49.1 -62.11 0.48 Allowed 'Trans proline' 0 N--CA 1.446 -1.29 0 CA-C-N 120.874 1.348 . . . . 1.21 109.777 163.445 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 1.1 ttt -53.94 -45.9 71.39 Favored 'General case' 0 N--CA 1.428 -1.541 0 N-CA-C 114.397 1.258 . . . . 5.0499999999999998 114.397 -173.18 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 5.0 pt -54.61 -50.08 62.11 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-N 120.15 1.341 . . . . 4.6200000000000001 111.101 175.063 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -55.33 -52.07 64.69 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 118.365 0.529 . . . . 2.2999999999999998 111.34 177.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -60.94 -58.53 8.03 Favored 'General case' 0 N--CA 1.432 -1.359 0 C-N-CA 123.769 0.828 . . . . 2.7400000000000002 111.235 -178.274 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -50.14 -35.23 25.06 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.163 0.985 . . . . 4.8499999999999996 111.909 -178.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 54.3 mt -64.44 -62.8 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 O-C-N 121.933 -0.479 . . . . 2.0899999999999999 109.901 169.542 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 38.7 mtp180 -50.94 -43.56 60.24 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.451 0.701 . . . . 6.2400000000000002 112.799 -174.304 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -46.09 -33.11 3.27 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 126.058 1.743 . . . . 3.0 112.439 177.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 68.5 mt -82.36 -17.2 46.47 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 123.193 0.597 . . . . 2.8700000000000001 112.029 -176.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 124.6 -35.52 3.15 Favored Glycine 0 C--N 1.339 0.708 0 CA-C-N 118.576 0.625 . . . . 3.25 112.682 169.366 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 28.6 p90 -84.29 131.71 34.7 Favored 'General case' 0 N--CA 1.457 -0.106 0 N-CA-C 106.784 -1.562 . . . . 6.4100000000000001 106.784 177.24 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -88.4 162.05 31.71 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.787 -0.925 . . . . 2.1800000000000002 110.787 -163.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -137.53 144.12 41.98 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.487 1.115 . . . . 1.79 109.025 -179.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 12.3 p -129.53 127.01 39.89 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 106.257 -1.756 . . . . 3.2599999999999998 106.257 172.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 28.1 t -84.66 118.04 31.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 N-CA-C 107.962 -1.125 . . . . 2.9700000000000002 107.962 -176.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 28.4 mt -141.98 68.78 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 N-CA-C 107.511 -1.292 . . . . 2.9700000000000002 107.511 -172.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -51.11 -57.55 8.41 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 115.673 -0.694 . . . . 4.9400000000000004 110.337 178.603 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -131.94 163.73 27.7 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 124.832 1.253 . . . . 5.8899999999999997 108.563 -175.659 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 4.7 mp -130.8 134.59 61.64 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 124.636 1.174 . . . . 9.5299999999999994 108.102 -173.335 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -80.75 154.55 27.17 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.995 0.918 . . . . 12.0 109.831 178.137 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -110.99 151.2 17.76 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 109.999 -1.24 . . . . 11.369999999999999 109.999 178.199 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.252 1.236 0 N-CA-C 104.801 -2.296 . . . . 19.34 104.801 178.391 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 . . . . . 0 N--CA 1.477 0.925 0 N-CA-C 107.809 -1.182 . . . . 7.9199999999999999 107.809 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.6 m -55.88 118.55 4.7 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 124.179 0.992 . . . . 3.4900000000000002 111.916 -174.307 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.3 t -91.89 163.32 14.07 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 124.31 1.044 . . . . 3.1800000000000002 110.679 -169.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 3.6 ttpm? -88.96 159.5 17.61 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 125.845 1.658 . . . . 5.3600000000000003 109.968 -175.098 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 52.9 t -155.37 159.15 39.69 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 107.822 -1.177 . . . . 2.8599999999999999 107.822 153.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -107.49 144.48 34.38 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 125.529 1.532 . . . . 4.1100000000000003 107.151 168.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.7 mt -138.01 138.83 43.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 107.867 -1.16 . . . . 2.6600000000000001 107.867 -179.482 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 66.0 mt-30 -77.1 145.62 37.71 Favored 'General case' 0 CA--C 1.522 -0.12 0 N-CA-C 106.179 -1.785 . . . . 5.5300000000000002 106.179 173.412 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 17.2 m -136.93 127.42 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 N-CA-C 108.502 -0.925 . . . . 3.0600000000000001 108.502 172.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 72.8 p -79.81 64.52 4.69 Favored 'General case' 0 CA--C 1.534 0.344 0 O-C-N 121.863 -0.523 . . . . 4.5599999999999996 110.227 -174.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 152.8 55.94 0.01 OUTLIER Glycine 0 C--N 1.339 0.695 0 CA-C-O 124.904 2.391 . . . . 3.2799999999999998 113.432 169.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 16.7 tmm? -43.06 -50.65 6.02 Favored 'General case' 0 N--CA 1.432 -1.329 0 CA-C-N 109.816 -3.192 . . . . 5.3300000000000001 109.39 137.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.27 -33.95 76.38 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 125.821 1.648 . . . . 6.2400000000000002 112.848 -168.215 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 21.4 m -61.79 143.35 56.43 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 109.345 -0.613 . . . . 2.8199999999999998 109.345 -173.046 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -61.6 146.53 48.63 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 108.304 -0.998 . . . . 3.1400000000000001 108.304 163.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 79.92 -62.76 0.25 Allowed 'General case' 0 C--O 1.22 -0.474 0 C-N-CA 124.965 1.306 . . . . 3.54 112.251 179.839 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 51.8 m -36.26 -48.9 0.66 Allowed 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 125.995 1.718 . . . . 3.0699999999999998 114.54 -154.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -43.95 -43.48 1.9 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.915 0 C-N-CA 125.905 1.682 . . . . 3.7799999999999998 113.553 175.467 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.02 -44.55 94.53 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 125.828 1.651 . . . . 1.8999999999999999 111.528 170.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -59.4 -51.01 71.73 Favored 'General case' 0 C--O 1.218 -0.593 0 CA-C-O 118.016 -0.993 . . . . 2.1400000000000001 108.823 173.376 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.5 mt -45.7 -58.76 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 C-N-CA 124.898 1.279 . . . . 3.1899999999999999 109.895 173.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -34.94 -59.58 0.48 Allowed 'General case' 0 C--N 1.328 -0.338 0 O-C-N 119.924 -1.735 . . . . 4.2699999999999996 113.382 166.062 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 92.7 mtt180 -59.81 -35.3 74.41 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 114.517 1.303 . . . . 6.0700000000000003 114.517 173.423 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -64.91 -58.74 5.36 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 125.836 1.654 . . . . 4.3700000000000001 109.567 -163.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . 0.256 7.3 mp -73.62 -19.83 60.75 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 121.22 0.533 . . . . 4.1299999999999999 109.896 179.105 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . 0.495 84.0 mtp180 -67.17 2.91 1.34 Allowed 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 116.465 2.024 . . . . 6.3700000000000001 116.465 164.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -38.86 -32.71 0.09 Allowed 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 116.49 -2.084 . . . . 7.5999999999999996 113.879 145.654 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . 0.267 2.0 mt-10 64.11 45.49 4.08 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 126.366 1.867 . . . . 7.9100000000000001 111.294 174.395 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 70.1 mt-10 -105.4 79.77 1.5 Allowed 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 126.467 1.907 . . . . 6.0 108.921 -174.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 64.39 26.55 70.76 Favored Glycine 0 CA--C 1.532 1.119 0 CA-C-O 121.669 0.594 . . . . 1.51 111.733 -175.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.1 mm -93.72 158.06 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 C-N-CA 126.19 1.796 . . . . 3.0299999999999998 108.408 176.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 12.6 t80 -154.37 41.76 0.49 Allowed 'General case' 0 C--N 1.339 0.12 0 C-N-CA 119.857 -0.737 . . . . 6.4100000000000001 111.482 170.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 48.4 t -171.39 -179.42 2.61 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 128.773 2.829 . . . . 2.8300000000000001 105.319 141.372 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.1 tp -134.65 141.17 44.05 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.353 0 N-CA-C 106.909 -1.515 . . . . 4.6799999999999997 106.909 149.294 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.457 ' HB2' ' CB ' ' A' ' 44' ' ' GLU . 0.3 OUTLIER -149.02 144.03 26.47 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 114.473 -1.24 . . . . 7.7199999999999998 109.619 -158.103 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . 0.258 0.9 OUTLIER -154.64 80.77 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.437 -1.095 0 CA-C-O 124.196 1.951 . . . . 2.2999999999999998 108.786 -164.012 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -77.2 61.39 2.09 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 113.543 -1.662 . . . . 1.8 109.527 169.21 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -46.71 -44.85 19.08 Favored 'General case' 0 CA--C 1.512 -0.487 0 C-N-CA 123.828 0.851 . . . . 4.7199999999999998 110.046 169.007 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 27.8 ttt -63.81 -36.37 83.69 Favored 'General case' 0 N--CA 1.441 -0.892 0 C-N-CA 120.208 -0.597 . . . . 6.29 110.145 -169.199 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -74.86 -36.07 62.33 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.294 0.638 . . . . 2.2400000000000002 110.29 172.625 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 109.8 39.57 1.56 Allowed Glycine 0 C--N 1.334 0.471 0 C-N-CA 124.945 1.259 . . . . 1.3700000000000001 111.009 173.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 29.5 pttt -158.75 157.04 30.94 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 108.436 -0.95 . . . . 4.3399999999999999 108.436 -176.464 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -82.59 147.95 28.3 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 107.279 -1.378 . . . . 2.1299999999999999 107.279 167.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.457 ' CB ' ' HB2' ' A' ' 35' ' ' LEU . 36.1 mt-10 -103.61 153.28 20.78 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 105.962 -1.866 . . . . 2.9700000000000002 105.962 171.008 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 34.1 m -137.95 148.4 25.31 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-N 119.195 0.907 . . . . 3.96 109.528 171.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 58.3 ttm-85 -133.47 130.77 39.05 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 106.234 -1.765 . . . . 6.1900000000000004 106.234 164.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 26.7 p90 -156.45 167.69 29.68 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 110.099 -0.334 . . . . 3.46 110.099 -167.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -105.97 104.3 48.67 Favored Pre-proline 0 CA--C 1.542 0.661 0 C-N-CA 123.311 0.644 . . . . 3.2799999999999998 111.056 178.364 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -75.82 73.02 4.93 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 122.627 2.218 . . . . 1.98 111.661 -175.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -142.71 -63.72 0.42 Allowed 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 105.979 -1.86 . . . . 2.21 105.979 161.493 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 72.7 t -56.07 -52.32 51.63 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.749 0 C-N-CA 124.905 1.282 . . . . 2.3199999999999998 110.263 175.343 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 20.1 tt -84.16 -52.19 13.05 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.403 0 N-CA-C 114.125 1.158 . . . . 4.5800000000000001 114.125 -151.415 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER 71.3 109.5 0.03 OUTLIER Pre-proline 0 CA--C 1.538 0.517 0 C-N-CA 127.968 2.507 . . . . 3.25 111.266 -165.702 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_exo -46.72 -41.29 24.67 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 123.358 2.705 . . . . 1.53 115.102 162.186 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_endo -55.09 -50.41 13.21 Favored 'Trans proline' 0 N--CA 1.447 -1.261 0 CA-C-N 121.707 1.645 . . . . 1.3700000000000001 109.754 168.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 77.0 mtp -59.97 -42.51 94.3 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 118.595 -1.242 . . . . 3.6899999999999999 111.934 -179.501 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.1 pt -58.24 -47.07 88.44 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-N 121.61 2.005 . . . . 3.6600000000000001 111.829 173.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -51.9 -46.44 64.59 Favored 'General case' 0 C--N 1.341 0.201 0 C-N-CA 122.761 0.424 . . . . 1.9399999999999999 111.096 179.31 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -64.19 -60.8 2.77 Favored 'General case' 0 N--CA 1.434 -1.242 0 C-N-CA 123.853 0.861 . . . . 2.9399999999999999 111.84 175.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 8.2 m-30 -45.76 -47.39 15.51 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 125.418 1.487 . . . . 4.6900000000000004 110.071 -175.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 74.6 mt -57.75 -39.83 72.56 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 CA-C-N 116.62 -0.264 . . . . 2.2799999999999998 111.311 -178.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 21.3 mtm105 -69.82 -46.61 65.27 Favored 'General case' 0 N--CA 1.455 -0.185 0 O-C-N 121.683 -0.636 . . . . 4.2599999999999998 111.362 173.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -54.06 -47.21 71.91 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 122.834 0.453 . . . . 3.2400000000000002 111.24 -179.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.4 pp -90.0 -34.71 15.88 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 112.989 0.737 . . . . 3.8500000000000001 112.989 -176.07 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -123.67 -79.29 0.43 Allowed Glycine 0 C--N 1.34 0.763 0 N-CA-C 114.392 0.517 . . . . 3.21 114.392 -157.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -165.74 165.61 18.42 Favored 'General case' 0 N--CA 1.465 0.291 0 O-C-N 122.12 -0.635 . . . . 6.0899999999999999 110.994 -154.798 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -78.64 66.11 3.35 Favored Glycine 0 C--N 1.337 0.631 0 C-N-CA 124.649 1.118 . . . . 1.95 113.496 -157.408 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -90.02 148.44 23.07 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 124.696 1.198 . . . . 2.21 113.151 -164.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.6 t -141.59 145.09 34.63 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 107.552 -1.277 . . . . 3.04 107.552 174.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 1.8 t -81.84 130.12 36.35 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 C-N-CA 125.116 1.367 . . . . 2.7400000000000002 107.998 -178.301 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 4.9 pt -148.03 59.83 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.339 0.141 0 C-N-CA 124.564 1.146 . . . . 4.4299999999999997 110.91 -172.34 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -57.65 135.95 56.78 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 116.27 -0.423 . . . . 5.6900000000000004 110.066 176.393 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 178.86 145.06 0.14 Allowed 'General case' 0 N--CA 1.457 -0.093 0 C-N-CA 123.355 0.662 . . . . 5.71 111.979 -174.17 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 38.5 mt 64.31 78.86 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 C-N-CA 125.498 1.519 . . . . 9.9800000000000004 111.288 169.064 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -68.28 -47.95 66.32 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.22 0.608 . . . . 12.970000000000001 110.019 170.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 156.4 -163.31 31.97 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 107.015 -2.434 . . . . 13.93 107.015 -172.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.132 0 N-CA-C 104.573 -2.381 . . . . 20.399999999999999 104.573 171.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 8.1 p30 . . . . . 0 N--CA 1.477 0.892 0 N-CA-C 107.156 -1.424 . . . . 5.8600000000000003 107.156 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.7 p 69.91 142.05 0.05 OUTLIER 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 126.304 1.841 . . . . 3.6400000000000001 112.069 -173.301 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 45.5 m -149.61 157.8 43.58 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 126.565 1.946 . . . . 2.79 107.934 -177.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 33.4 mtmt -103.86 147.43 27.32 Favored 'General case' 0 C--O 1.231 0.081 0 N-CA-C 107.202 -1.407 . . . . 6.0099999999999998 107.202 168.349 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 38.3 t -153.25 150.47 29.0 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 108.922 -0.77 . . . . 2.0699999999999998 108.922 172.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -112.34 146.3 38.53 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 125.927 1.691 . . . . 3.6600000000000001 106.546 -179.064 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -139.24 107.74 3.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 107.509 -1.293 . . . . 3.6499999999999999 107.509 -168.698 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 48.4 tp60 -82.78 123.05 28.96 Favored 'General case' 0 N--CA 1.428 -1.535 0 N-CA-C 106.036 -1.839 . . . . 3.7400000000000002 106.036 -172.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 9.9 p -89.38 157.26 3.02 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 C-N-CA 125.322 1.449 . . . . 4.7999999999999998 108.86 -177.232 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.8 t -111.18 21.68 16.07 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 123.115 0.566 . . . . 3.3900000000000001 112.453 176.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -143.35 117.36 1.09 Allowed Glycine 0 N--CA 1.444 -0.798 0 N-CA-C 106.304 -2.719 . . . . 2.3399999999999999 106.304 154.272 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 1.5 ttp -90.16 -61.78 1.61 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 113.445 -1.378 . . . . 5.6299999999999999 108.314 174.03 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 14.1 t -82.38 47.91 1.22 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.544 0.738 . . . . 7.0300000000000002 110.529 -175.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 15.6 p -79.38 -44.0 22.34 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 109.169 -0.678 . . . . 2.8199999999999998 109.169 170.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 143.14 -121.66 0.0 OUTLIER 'General case' 0 C--N 1.34 0.16 0 C-N-CA 130.663 3.585 . . . . 4.0099999999999998 106.244 177.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.2 m -79.41 60.58 3.22 Favored 'General case' 0 N--CA 1.451 -0.394 0 O-C-N 121.493 -0.754 . . . . 3.8700000000000001 111.261 -175.389 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 4.2 t -48.59 -44.87 37.32 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 125.827 1.651 . . . . 4.6500000000000004 109.116 177.399 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.5 p -55.3 -61.61 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.816 0 CA-C-N 113.988 -1.46 . . . . 4.1799999999999997 110.627 177.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -54.28 -35.56 62.71 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.406 -1.27 . . . . 2.27 110.644 -178.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -63.69 -58.64 6.28 Favored 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 109.734 -0.469 . . . . 2.5099999999999998 109.734 170.701 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.2 mp -54.4 -48.36 68.83 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 CA-C-N 119.605 1.093 . . . . 3.4900000000000002 111.18 -175.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -45.94 -43.08 13.67 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 120.89 -1.131 . . . . 2.9100000000000001 111.168 177.07 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.61 -46.82 58.06 Favored 'General case' 0 CA--C 1.536 0.429 0 O-C-N 121.434 -0.791 . . . . 7.4699999999999998 111.012 168.712 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -55.3 -47.23 75.87 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.808 1.243 . . . . 4.2400000000000002 113.392 -165.745 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . 0.382 0.8 OUTLIER -79.04 -23.61 44.18 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 122.11 0.957 . . . . 4.2800000000000002 112.465 -172.413 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . 0.585 53.7 mtp85 -54.14 2.12 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 120.769 3.618 . . . . 6.7300000000000004 120.769 176.458 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.411 ' NH1' ' CG ' ' A' ' 27' ' ' ARG . 0.1 OUTLIER -45.85 -32.27 2.53 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 117.308 -1.757 . . . . 10.550000000000001 111.03 154.046 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 64.34 -155.13 0.3 Allowed 'General case' 0 C--N 1.342 0.27 0 C-N-CA 123.845 0.858 . . . . 7.3600000000000003 108.947 -175.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 58.93 54.25 5.19 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 122.37 1.081 . . . . 6.5 109.062 -179.079 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 152.26 -46.3 0.59 Allowed Glycine 0 C--N 1.335 0.521 0 N-CA-C 110.528 -1.029 . . . . 2.5800000000000001 110.528 -171.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.9 mp -81.66 153.73 4.12 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 C-N-CA 124.323 1.049 . . . . 3.46 108.781 -171.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -151.58 36.04 0.57 Allowed 'General case' 0 CA--C 1.546 0.824 0 CA-C-O 121.99 0.9 . . . . 4.2000000000000002 112.616 167.579 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 57.9 m -167.55 161.59 13.82 Favored 'General case' 0 C--N 1.326 -0.444 1 C-N-CA 131.871 4.068 . . . . 3.3399999999999999 103.069 145.017 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.436 HD11 ' H ' ' A' ' 35' ' ' LEU . 10.8 tp -139.97 133.64 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 CA-C-N 122.77 2.532 . . . . 5.5999999999999996 110.863 155.379 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.465 ' N ' ' CD1' ' A' ' 35' ' ' LEU . 0.0 OUTLIER -167.92 -179.08 4.03 Favored 'General case' 0 N--CA 1.44 -0.925 0 CA-C-N 111.73 -2.486 . . . . 7.1100000000000003 108.864 -153.739 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.4 t -159.57 128.44 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.253 0 C-N-CA 125.695 1.598 . . . . 2.8199999999999998 107.213 -175.088 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -84.23 63.64 7.83 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 107.905 -1.146 . . . . 1.8700000000000001 107.905 175.007 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -60.31 -31.75 70.56 Favored 'General case' 0 CA--C 1.532 0.25 0 O-C-N 122.043 -0.411 . . . . 3.4700000000000002 111.552 -169.507 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 67.2 mtt -53.6 -36.89 62.44 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.526 0.73 . . . . 3.98 111.707 172.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -92.22 7.25 43.48 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.589 1.156 . . . . 2.2999999999999998 111.947 176.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.27 38.6 96.11 Favored Glycine 0 CA--C 1.522 0.483 0 C-N-CA 125.473 1.511 . . . . 1.1899999999999999 112.029 174.491 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -162.02 152.43 17.18 Favored 'General case' 0 N--CA 1.442 -0.857 0 N-CA-C 108.075 -1.083 . . . . 5.0599999999999996 108.075 -162.177 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -81.77 157.98 24.3 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 108.928 -0.768 . . . . 2.2200000000000002 108.928 176.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . 0.335 2.2 tm-20 -129.37 157.36 42.13 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 108.612 -0.885 . . . . 4.6299999999999999 108.612 165.581 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.0 p -151.97 138.12 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 N-CA-C 106.476 -1.676 . . . . 2.7400000000000002 106.476 -176.298 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 4.0 mtm180 -104.35 133.01 49.97 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 105.545 -2.02 . . . . 8.0700000000000003 105.545 158.023 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -157.32 167.64 29.69 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 123.716 0.807 . . . . 3.29 108.844 -171.407 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 54.6 t30 -116.79 97.48 50.52 Favored Pre-proline 0 CA--C 1.533 0.312 0 C-N-CA 123.83 0.852 . . . . 3.3599999999999999 110.378 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.3 72.25 2.89 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 123.309 2.672 . . . . 1.8700000000000001 111.538 -178.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -147.56 -56.8 0.24 Allowed 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 106.062 -1.829 . . . . 2.6699999999999999 106.062 169.293 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 45.6 t -57.52 -54.78 26.58 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 C-N-CA 124.116 0.966 . . . . 2.73 109.694 173.191 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . 0.25 10.5 tp -94.2 -75.06 0.42 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.352 0 N-CA-C 112.692 0.627 . . . . 3.3500000000000001 112.692 -164.463 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 108.45 135.48 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.452 0 C-N-CA 129.845 3.258 . . . . 3.1699999999999999 108.208 -176.58 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -44.22 -51.15 7.05 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 124.63 3.553 . . . . 1.51 114.796 171.021 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -47.19 -56.05 3.39 Favored 'Trans proline' 0 N--CA 1.448 -1.195 0 CA-C-N 121.307 1.502 . . . . 1.28 110.929 167.008 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 51.0 mtt -59.51 -36.34 75.89 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 118.029 -1.468 . . . . 3.0499999999999998 113.134 -178.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -62.13 -46.81 95.63 Favored 'Isoleucine or valine' 0 C--N 1.344 0.351 0 CA-C-N 120.675 1.58 . . . . 4.29 110.619 173.841 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -53.38 -52.36 59.56 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 121.189 0.519 . . . . 2.2599999999999998 109.978 178.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -56.77 -49.1 76.29 Favored 'General case' 0 N--CA 1.426 -1.652 0 C-N-CA 123.474 0.709 . . . . 3.2599999999999998 111.337 176.55 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 3.9 m-30 -53.81 -33.98 57.75 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 119.31 0.959 . . . . 5.4400000000000004 111.39 178.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 42.0 mt -70.84 -51.35 36.82 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 O-C-N 121.477 -0.764 . . . . 2.23 109.292 173.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 35.6 mtp-105 -63.85 -27.88 69.47 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 113.54 0.941 . . . . 6.6399999999999997 113.54 -174.396 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -45.93 -55.11 7.18 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 125.058 1.343 . . . . 4.9699999999999998 111.072 177.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -130.27 -19.65 3.11 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 124.453 1.101 . . . . 3.4199999999999999 113.525 -166.8 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -96.52 -102.67 2.05 Favored Glycine 0 N--CA 1.446 -0.642 0 N-CA-C 109.086 -1.606 . . . . 3.96 109.086 -179.03 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 27.9 m-85 -149.53 166.17 30.0 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 122.172 0.987 . . . . 4.0999999999999996 110.936 -154.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -78.94 69.06 2.96 Favored Glycine 0 N--CA 1.443 -0.859 0 CA-C-N 114.53 -1.213 . . . . 1.76 110.551 -178.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -82.64 141.78 32.23 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 113.867 -1.167 . . . . 2.52 109.852 -176.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 9.3 t -115.25 139.65 49.77 Favored 'General case' 0 N--CA 1.439 -1.013 0 N-CA-C 106.77 -1.567 . . . . 3.0600000000000001 106.77 178.448 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.0 t -83.59 125.9 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.612 0 C-N-CA 125.132 1.373 . . . . 3.04 108.952 -172.385 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 13.7 mm -130.62 59.54 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 C-N-CA 125.254 1.422 . . . . 3.2999999999999998 108.472 -177.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -73.5 -45.38 54.25 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 108.195 -1.039 . . . . 4.8099999999999996 108.195 162.015 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 52.2 t30 47.91 73.0 0.22 Allowed 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.163 1.385 . . . . 6.25 113.611 157.071 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 8.8 tp -151.83 155.71 6.66 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 N-CA-C 107.246 -1.39 . . . . 8.8200000000000003 107.246 175.621 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -149.38 166.76 28.09 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 106.177 -1.786 . . . . 12.42 106.177 177.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 94.32 -166.77 27.1 Favored Glycine 0 CA--C 1.528 0.846 0 N-CA-C 110.402 -1.079 . . . . 14.029999999999999 110.402 -174.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 80.5 ttt180 . . . . . 0 C--O 1.249 1.061 0 N-CA-C 104.706 -2.331 . . . . 26.109999999999999 104.706 -179.895 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.2 m . . . . . 0 C--O 1.236 0.393 0 N-CA-C 112.323 0.49 . . . . 2.6299999999999999 112.323 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 22.9 t -113.19 178.08 4.4 Favored 'General case' 0 N--CA 1.463 0.18 0 C-N-CA 125.423 1.489 . . . . 3.1800000000000002 108.149 177.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.39 159.28 37.5 Favored 'General case' 0 N--CA 1.46 0.052 0 CA-C-N 118.273 0.488 . . . . 4.3799999999999999 112.005 -176.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 53.6 t -138.77 154.12 48.49 Favored 'General case' 0 C--N 1.333 -0.144 0 N-CA-C 106.635 -1.617 . . . . 1.45 106.635 176.078 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 81.3 m-85 -98.75 154.37 18.04 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 107.405 -1.331 . . . . 2.8700000000000001 107.405 178.369 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 18.2 mt -148.66 132.16 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 N-CA-C 105.379 -2.082 . . . . 1.6100000000000001 105.379 -176.043 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 48.5 tp60 -100.86 126.13 47.44 Favored 'General case' 0 N--CA 1.432 -1.364 0 N-CA-C 105.553 -2.017 . . . . 3.1200000000000001 105.553 176.669 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 30.1 m -98.85 137.09 27.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 C-N-CA 124.087 0.955 . . . . 2.2599999999999998 109.209 179.591 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 25.3 m -78.81 74.85 5.33 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 109.501 -0.555 . . . . 2.3399999999999999 109.501 179.271 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 117.81 77.32 0.59 Allowed Glycine 0 C--N 1.335 0.487 0 CA-C-O 124.513 2.174 . . . . 2.2400000000000002 110.485 173.637 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.9 -65.91 0.62 Allowed 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 110.024 -3.088 . . . . 4.1100000000000003 108.398 176.691 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.6 t -79.09 41.97 0.46 Allowed 'General case' 0 CA--C 1.54 0.586 0 O-C-N 121.3 -0.875 . . . . 4.8700000000000001 111.173 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 45.3 t -68.69 -43.9 75.12 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 107.115 -1.439 . . . . 2.4300000000000002 107.115 156.334 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 76.76 161.0 0.22 Allowed 'General case' 0 C--N 1.344 0.341 0 C-N-CA 126.688 1.995 . . . . 3.04 110.104 -174.197 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 10.8 m 72.05 -53.38 0.69 Allowed 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 125.183 1.393 . . . . 2.7400000000000002 112.039 -176.186 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 31.5 m -29.56 -54.65 0.15 Allowed 'General case' 0 C--O 1.223 -0.294 0 C-N-CA 127.278 2.231 . . . . 3.04 110.96 167.131 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.618 HG22 ' CG2' ' A' ' 36' ' ' VAL . 1.2 t -69.58 -36.37 70.62 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.048 0 N-CA-C 112.488 0.551 . . . . 3.2799999999999998 112.488 -174.239 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.27 -45.42 93.38 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 109.232 -0.655 . . . . 0.81000000000000005 109.232 173.805 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -57.54 -47.39 82.14 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 109.094 -0.706 . . . . 2.71 109.094 173.244 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.707 HG21 HD11 ' A' ' 35' ' ' LEU 0.251 53.9 mt -64.16 -44.84 97.61 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 O-C-N 121.571 -0.706 . . . . 1.95 111.296 -172.971 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -47.76 -51.79 20.98 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 119.383 0.992 . . . . 3.25 111.755 165.666 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 8.4 mmt85 -57.75 -38.22 74.99 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 118.011 -0.995 . . . . 4.5199999999999996 112.714 176.055 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -63.2 -55.74 22.49 Favored 'General case' 0 C--O 1.222 -0.35 0 CA-C-N 120.237 1.38 . . . . 3.1499999999999999 108.03 177.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 17.5 mt -77.14 -51.34 11.16 Favored 'General case' 0 N--CA 1.434 -1.229 0 C-N-CA 124.621 1.168 . . . . 2.9199999999999999 112.308 -159.868 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 3.1 ttm105 -65.44 -13.44 58.76 Favored 'General case' 0 N--CA 1.421 -1.915 0 O-C-N 121.499 -0.751 . . . . 8.1199999999999992 112.682 -173.544 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.1 mtp180 -42.15 -64.57 0.57 Allowed 'General case' 0 N--CA 1.448 -0.529 0 CA-C-O 118.369 -0.824 . . . . 7.9500000000000002 111.068 160.218 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 169.76 -176.66 0.03 OUTLIER 'General case' 0 C--N 1.344 0.366 0 CA-C-N 119.012 0.824 . . . . 7.3499999999999996 110.794 -156.706 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 84.82 53.46 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 127.314 2.246 . . . . 5.3600000000000003 109.747 178.356 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 72.44 14.58 77.27 Favored Glycine 0 CA--C 1.527 0.826 0 CA-C-O 118.466 -1.186 . . . . 0.94999999999999996 114.668 168.078 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 1.1 mt -84.75 130.07 36.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 N-CA-C 107.091 -1.448 . . . . 1.8500000000000001 107.091 -178.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -137.57 43.03 2.31 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-O 122.734 1.254 . . . . 3.1099999999999999 111.223 160.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.5 t -170.21 147.63 3.16 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 128.858 2.863 . . . . 1.6000000000000001 105.187 134.785 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.424 ' H ' HG13 ' A' ' 34' ' ' ILE . 2.6 pp -77.72 159.62 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 N-CA-C 108.141 -1.059 . . . . 2.0299999999999998 108.141 176.109 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.707 HD11 HG21 ' A' ' 21' ' ' ILE . 2.5 pp -73.96 137.16 43.39 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 104.488 -2.412 . . . . 4.7400000000000002 104.488 158.272 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.618 ' CG2' HG22 ' A' ' 18' ' ' VAL . 2.1 t -160.46 150.85 5.52 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.104 0 N-CA-C 106.112 -1.81 . . . . 1.3999999999999999 106.112 123.047 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -158.73 53.54 0.42 Allowed 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 104.325 -2.472 . . . . 0.68000000000000005 104.325 165.019 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.588 HD23 ' C ' ' A' ' 38' ' ' LEU . 1.1 tt -66.11 -31.1 71.76 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 107.294 -1.373 . . . . 3.4399999999999999 107.294 -178.689 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 27.7 ttt -45.0 -41.95 7.86 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.108 1.363 . . . . 3.29 111.875 170.037 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -85.76 -55.58 3.9 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 108.524 -0.917 . . . . 1.78 108.524 171.09 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 143.17 43.98 0.05 OUTLIER Glycine 0 CA--C 1.523 0.553 0 C-N-CA 125.089 1.328 . . . . 0.81999999999999995 111.885 167.184 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 14.1 pttp -159.92 -179.3 7.69 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 118.078 0.939 . . . . 4.0899999999999999 108.9 -164.84 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.574 ' CB ' HD13 ' A' ' 35' ' ' LEU . . . -130.72 143.45 50.75 Favored 'General case' 0 N--CA 1.441 -0.877 0 C-N-CA 127.475 2.31 . . . . 0.87 108.953 -177.799 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -144.01 89.13 2.01 Favored 'General case' 0 C--N 1.341 0.238 0 C-N-CA 124.104 0.961 . . . . 3.8700000000000001 111.215 173.065 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 14.0 p -80.71 137.32 21.61 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.22 0 N-CA-C 108.901 -0.777 . . . . 2.04 108.901 -176.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 70.8 ttt180 -106.58 126.75 52.67 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 107.655 -1.239 . . . . 5.2000000000000002 107.655 171.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 7.9 p90 -157.48 175.88 13.38 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 123.384 0.674 . . . . 2.1699999999999999 109.844 -167.041 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 3.3 p30 -103.89 135.18 19.39 Favored Pre-proline 0 N--CA 1.451 -0.396 0 N-CA-C 107.752 -1.203 . . . . 3.0099999999999998 107.752 164.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -81.32 1.79 9.03 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 122.29 1.993 . . . . 2.5299999999999998 113.314 -174.01 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -91.87 -49.08 6.43 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-N 119.41 1.005 . . . . 1.0800000000000001 108.535 -167.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 24.4 t -58.78 -60.39 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.755 0 C-N-CA 124.354 1.062 . . . . 0.97999999999999998 109.855 175.845 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 19.2 tt -93.56 -53.42 8.5 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.233 0 CA-C-O 118.855 -0.593 . . . . 1.8200000000000001 112.258 -163.517 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 9.1 mm-40 101.16 129.72 0.02 OUTLIER Pre-proline 0 CA--C 1.541 0.598 0 C-N-CA 129.574 3.15 . . . . 2.9199999999999999 112.304 -175.707 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_exo -50.89 -48.95 18.53 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 124.787 3.658 . . . . 1.1200000000000001 116.71 177.112 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -54.45 -50.55 13.06 Favored 'Trans proline' 0 N--CA 1.442 -1.514 0 CA-C-N 120.66 1.271 . . . . 1.2 108.873 169.428 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 64.1 mtt -63.03 -44.07 96.93 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 120.528 -0.469 . . . . 2.4900000000000002 110.708 -167.797 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 16.2 tt -61.76 -35.19 66.15 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.25 0 C-N-CA 119.61 -0.836 . . . . 2.2799999999999998 111.686 -175.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -69.93 -58.03 4.33 Favored 'General case' 0 N--CA 1.452 -0.325 0 O-C-N 122.33 -0.231 . . . . 1.4099999999999999 110.875 171.4 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -47.98 -49.29 31.15 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 125.613 1.565 . . . . 3.1699999999999999 111.861 -174.643 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 16.2 m-30 -44.18 -40.42 5.03 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.748 0.819 . . . . 3.73 112.453 177.348 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 65.9 mt -65.16 -26.76 40.54 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 O-C-N 121.513 -0.742 . . . . 1.1499999999999999 110.66 -174.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 36.0 mtm180 -58.27 -61.21 2.74 Favored 'General case' 0 C--N 1.341 0.238 0 CA-C-N 118.939 0.791 . . . . 5.5199999999999996 109.642 174.62 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -60.59 -39.18 87.12 Favored 'General case' 0 N--CA 1.44 -0.974 0 C-N-CA 123.63 0.772 . . . . 4.5199999999999996 112.77 -166.081 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -98.36 -27.53 14.06 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 113.187 0.81 . . . . 2.2400000000000002 113.187 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -112.96 -82.14 1.14 Allowed Glycine 0 CA--C 1.526 0.743 0 CA-C-N 119.215 0.916 . . . . 2.25 111.968 -172.441 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -177.05 164.94 2.32 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.562 1.145 . . . . 4.3799999999999999 109.605 -162.886 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -59.83 115.17 7.16 Favored Glycine 0 N--CA 1.439 -1.148 0 N-CA-C 109.601 -1.4 . . . . 1.1699999999999999 109.601 -171.379 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -115.25 91.76 3.71 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 125.435 1.494 . . . . 1.0700000000000001 109.068 -169.49 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -84.39 119.14 24.76 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 108.263 -1.014 . . . . 2.5899999999999999 108.263 -178.584 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 8.3 p -81.23 141.9 14.53 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 C-N-CA 123.265 0.626 . . . . 2.2400000000000002 109.584 -174.326 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 15.0 mt -139.79 99.06 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 C-N-CA 124.817 1.247 . . . . 1.8200000000000001 107.675 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 . . . . . 0 CA--C 1.535 0.369 0 O-C-N 121.462 -0.774 . . . . 6.3600000000000003 109.755 174.252 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.4 m . . . . . 0 CA--C 1.533 0.303 0 N-CA-C 112.549 0.574 . . . . 3.3100000000000001 112.549 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 26.1 m -149.04 176.23 10.63 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 126.106 1.762 . . . . 1.75 107.558 -176.277 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 39.2 pttt -125.18 158.16 34.66 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-N 119.173 0.897 . . . . 3.7999999999999998 109.108 154.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 36.6 t -142.3 152.44 42.98 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 107.275 -1.38 . . . . 1.6200000000000001 107.275 175.258 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 54.3 m-85 -84.44 148.69 26.43 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 107.421 -1.325 . . . . 2.1499999999999999 107.421 176.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.431 ' HB ' ' HB3' ' A' ' 43' ' ' ALA . 5.6 mm -130.5 141.19 46.89 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.817 0 N-CA-C 104.61 -2.367 . . . . 2.0600000000000001 104.61 173.264 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -98.24 128.27 44.6 Favored 'General case' 0 N--CA 1.435 -1.189 0 N-CA-C 103.882 -2.636 . . . . 3.5899999999999999 103.882 166.172 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.4 p -126.41 122.53 61.4 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 C-N-CA 124.674 1.19 . . . . 2.3999999999999999 108.41 179.163 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.8 t -72.76 136.9 45.56 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 109.434 -0.58 . . . . 2.6800000000000002 109.434 -176.661 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 113.8 -52.19 0.66 Allowed Glycine 0 C--N 1.335 0.518 0 N-CA-C 108.146 -1.981 . . . . 2.8500000000000001 108.146 177.244 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 59.9 mtt 75.94 -69.96 0.15 Allowed 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 126.197 1.799 . . . . 4.25 110.314 158.609 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 11.8 t -112.13 11.74 20.4 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 125.907 1.683 . . . . 4.8399999999999999 109.957 174.374 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.442 ' SG ' ' HB2' ' A' ' 17' ' ' CYS 0.267 17.2 p -63.14 144.64 56.74 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 119.017 0.826 . . . . 3.25 109.436 -176.212 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -52.61 109.9 0.45 Allowed 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 116.212 -0.449 . . . . 3.3300000000000001 111.98 -158.179 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.7 m 69.23 6.72 5.83 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 125.355 1.462 . . . . 3.02 113.873 175.713 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.442 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 48.8 t -43.99 -49.06 8.75 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 123.765 1.745 . . . . 3.79 108.607 163.626 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -72.67 -46.64 53.55 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.521 0 CA-C-N 112.199 -2.273 . . . . 2.6000000000000001 109.856 -172.182 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.67 -42.06 87.58 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 110.212 -0.292 . . . . 1.1299999999999999 110.212 175.575 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -60.03 -60.44 3.83 Favored 'General case' 0 CA--C 1.521 -0.163 0 C-N-CA 124.571 1.148 . . . . 2.0499999999999998 108.455 178.513 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.437 HG23 ' CD2' ' A' ' 35' ' ' LEU . 1.7 mt -43.69 -54.72 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 C-N-CA 123.801 0.84 . . . . 1.8400000000000001 111.314 173.868 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -54.65 -50.05 69.11 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 119.702 1.137 . . . . 3.9199999999999999 111.517 176.102 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.94 -48.93 51.65 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.592 0.757 . . . . 4.8399999999999999 112.095 176.458 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -76.28 -60.39 2.36 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 118.139 0.427 . . . . 3.5699999999999998 111.766 -177.753 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.57 -36.77 73.8 Favored 'General case' 0 C--O 1.22 -0.47 0 C-N-CA 125.756 1.623 . . . . 3.04 112.595 -152.679 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -21.5 -74.61 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 128.616 2.766 . . . . 7.7000000000000002 114.722 -158.871 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . 0.287 7.9 ptp180 -91.9 -29.9 16.43 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 127.339 2.255 . . . . 12.69 116.286 166.935 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 41.8 mm-40 -81.05 128.4 33.67 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 114.855 -1.066 . . . . 6.7999999999999998 108.868 -134.299 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 60.0 55.84 3.63 Favored 'General case' 0 N--CA 1.442 -0.825 0 CA-C-O 122.856 1.312 . . . . 5.0899999999999999 111.189 -171.752 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 76.16 30.87 56.52 Favored Glycine 0 CA--C 1.523 0.566 0 CA-C-N 114.006 -1.452 . . . . 1.26 112.742 162.681 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.6 mt -96.03 147.44 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 N-CA-C 108.322 -0.992 . . . . 2.0800000000000001 108.322 171.303 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -147.88 47.03 1.09 Allowed 'General case' 0 C--O 1.233 0.22 0 CA-C-O 122.309 1.052 . . . . 3.4199999999999999 111.815 158.298 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 10.3 t -165.83 148.0 7.28 Favored 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 126.995 2.118 . . . . 1.75 107.252 148.654 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.5 pp -82.4 134.35 27.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 CA-C-O 122.666 1.222 . . . . 2.4399999999999999 110.375 175.476 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.509 ' H ' ' CD2' ' A' ' 35' ' ' LEU . 0.4 OUTLIER -79.79 64.05 4.53 Favored 'General case' 0 N--CA 1.433 -1.295 0 C-N-CA 127.687 2.395 . . . . 4.71 111.624 -173.315 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.456 ' CG1' HD23 ' A' ' 38' ' ' LEU . 52.8 t -133.52 131.43 57.31 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 O-C-N 120.721 -1.237 . . . . 1.23 113.131 174.142 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -138.8 76.23 1.56 Allowed 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 105.217 -2.142 . . . . 0.87 105.217 152.375 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.456 HD23 ' CG1' ' A' ' 36' ' ' VAL . 0.3 OUTLIER -54.54 -39.78 68.01 Favored 'General case' 0 CA--C 1.511 -0.526 0 N-CA-C 109.595 -0.52 . . . . 3.3700000000000001 109.595 175.138 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 24.0 ttt -85.06 44.22 1.06 Allowed 'General case' 0 N--CA 1.442 -0.836 0 CA-C-O 121.767 0.794 . . . . 4.7999999999999998 109.1 -164.469 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -179.33 -36.71 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 129.013 2.925 . . . . 1.4199999999999999 107.076 -167.288 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 106.11 46.72 1.14 Allowed Glycine 0 C--N 1.336 0.569 0 C-N-CA 126.062 1.791 . . . . 0.87 108.983 157.837 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 24.8 mttm -155.27 175.14 14.24 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 108.392 -0.966 . . . . 4.6100000000000003 108.392 -157.668 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.431 ' HB3' ' HB ' ' A' ' 7' ' ' ILE . . . -144.2 142.6 30.61 Favored 'General case' 0 N--CA 1.44 -0.967 0 C-N-CA 125.315 1.446 . . . . 1.0800000000000001 107.978 -178.701 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -132.99 97.37 4.0 Favored 'General case' 0 C--N 1.338 0.103 0 N-CA-C 113.379 0.881 . . . . 3.27 113.379 171.408 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.3 p -81.11 114.96 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.518 0 N-CA-C 107.423 -1.325 . . . . 1.8200000000000001 107.423 -178.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 54.5 ttp180 -87.36 124.78 33.75 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 105.71 -1.959 . . . . 5.4299999999999997 105.71 163.114 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -158.22 170.72 21.62 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 122.96 0.504 . . . . 2.1499999999999999 110.6 -164.12 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 47.5 t-20 -108.53 88.26 4.97 Favored Pre-proline 0 N--CA 1.451 -0.421 0 C-N-CA 124.038 0.935 . . . . 2.6499999999999999 109.346 173.451 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -61.79 88.23 0.1 Allowed 'Trans proline' 0 N--CA 1.448 -1.163 0 C-N-CA 122.328 2.019 . . . . 1.6000000000000001 108.973 165.371 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -169.97 -57.56 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 130.423 3.489 . . . . 1.1799999999999999 105.101 169.332 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 65.7 t -58.45 -54.37 33.95 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 C-N-CA 124.879 1.272 . . . . 1.03 110.207 175.349 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.527 HG23 ' H ' ' A' ' 53' ' ' GLN . 8.4 tp -93.61 -73.02 0.48 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.364 0 CA-C-O 118.725 -0.655 . . . . 2.1400000000000001 111.93 -167.815 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.527 ' H ' HG23 ' A' ' 52' ' ' ILE . 0.0 OUTLIER 117.17 134.99 0.0 OUTLIER Pre-proline 0 N--CA 1.472 0.626 0 C-N-CA 130.753 3.621 . . . . 2.8900000000000001 108.185 -176.365 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -50.24 -50.86 12.24 Favored 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 123.595 2.863 . . . . 1.03 114.449 172.4 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -50.07 -54.31 5.66 Favored 'Trans proline' 0 N--CA 1.444 -1.39 0 CA-C-N 120.451 1.197 . . . . 0.80000000000000004 110.069 167.109 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 62.0 mtt -62.45 -37.61 86.57 Favored 'General case' 0 C--N 1.342 0.261 0 C-N-CA 118.336 -1.346 . . . . 2.0600000000000001 111.469 -170.487 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.451 HD12 HG21 ' A' ' 52' ' ' ILE . 3.5 tt -70.37 -45.23 75.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-N 118.808 0.731 . . . . 2.23 110.312 178.708 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -58.8 -32.85 69.72 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.102 0.561 . . . . 1.3200000000000001 112.254 176.017 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -71.78 -60.13 2.39 Favored 'General case' 0 N--CA 1.441 -0.895 0 C-N-CA 126.388 1.875 . . . . 3.5600000000000001 111.585 176.272 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -41.63 -45.32 3.35 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.79 0.836 . . . . 3.6400000000000001 111.791 -173.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 49.7 mt -57.39 -52.48 56.31 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 C-N-CA 123.88 0.872 . . . . 1.1299999999999999 110.923 -177.822 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 1.3 ptt85 -71.5 -49.68 38.73 Favored 'General case' 0 CA--C 1.521 -0.139 0 N-CA-C 109.596 -0.52 . . . . 3.9199999999999999 109.596 -177.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -59.61 -34.51 72.84 Favored 'General case' 0 N--CA 1.441 -0.896 0 C-N-CA 123.387 0.675 . . . . 6.3899999999999997 111.627 -173.855 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 86.1 mt -83.0 -47.89 11.23 Favored 'General case' 0 C--N 1.34 0.194 0 CA-C-N 118.754 0.706 . . . . 2.77 111.446 170.549 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -95.98 -92.27 1.78 Allowed Glycine 0 CA--C 1.526 0.773 0 N-CA-C 111.692 -0.563 . . . . 1.8400000000000001 111.692 -174.486 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -135.53 -72.13 0.47 Allowed 'General case' 0 CA--C 1.513 -0.469 0 CA-C-O 121.679 0.752 . . . . 3.4900000000000002 112.962 -153.304 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 173.73 119.23 0.53 Allowed Glycine 0 N--CA 1.441 -1.028 0 N-CA-C 107.935 -2.066 . . . . 1.49 107.935 -156.78 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -156.5 161.41 40.02 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 122.904 0.482 . . . . 1.1599999999999999 110.996 -173.717 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 26.2 m -153.94 148.57 26.34 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 124.031 0.932 . . . . 2.9199999999999999 108.599 178.514 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 14.3 p -82.3 143.75 11.52 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 123.624 0.77 . . . . 2.3900000000000001 109.74 -177.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 22.5 mm -133.13 140.16 47.76 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 C-N-CA 125.774 1.629 . . . . 2.0 107.528 -178.268 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 . . . . . 0 N--CA 1.453 -0.322 0 C-N-CA 123.741 0.817 . . . . 4.9400000000000004 109.108 179.045 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.4 m . . . . . 0 N--CA 1.454 -0.236 0 N-CA-C 108.605 -0.887 . . . . 3.02 108.605 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 23.0 t -141.93 169.56 17.37 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 108.956 -0.757 . . . . 2.5499999999999998 108.956 171.083 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 71.9 tttt -104.72 158.33 16.58 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.309 1.443 . . . . 3.7400000000000002 107.211 163.285 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 36.3 t -155.55 155.09 32.75 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 109.046 -0.724 . . . . 1.3600000000000001 109.046 167.753 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 5.1 m-30 -106.45 135.01 48.7 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 125.848 1.659 . . . . 2.3100000000000001 108.771 -178.263 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.3 mm -129.06 139.75 51.05 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 N-CA-C 105.463 -2.051 . . . . 2.1099999999999999 105.463 -173.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 51.3 tp60 -112.2 122.93 49.12 Favored 'General case' 0 N--CA 1.424 -1.728 0 N-CA-C 104.693 -2.336 . . . . 2.8900000000000001 104.693 -179.641 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 15.7 m -105.3 173.08 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 C-N-CA 124.378 1.071 . . . . 2.5600000000000001 108.687 178.73 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -134.42 88.73 2.48 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.562 0.745 . . . . 3.04 111.045 -173.762 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 154.9 -62.81 0.35 Allowed Glycine 0 CA--C 1.524 0.619 0 N-CA-C 107.667 -2.173 . . . . 3.7999999999999998 107.667 174.437 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 1.9 mtt 66.38 -71.71 0.09 Allowed 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 126.691 1.997 . . . . 3.73 111.213 170.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 33.1 p -79.47 52.85 1.44 Allowed 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 124.42 1.088 . . . . 5.0499999999999998 108.496 176.338 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 55.8 m -92.42 176.29 6.52 Favored 'General case' 0 N--CA 1.445 -0.725 0 C-N-CA 124.794 1.238 . . . . 2.7599999999999998 107.895 175.639 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -75.64 73.42 2.63 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 121.454 0.645 . . . . 3.3500000000000001 110.097 166.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.5 m 74.94 26.99 1.22 Allowed 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 115.24 -0.891 . . . . 2.46 113.129 159.683 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 69.9 m -44.27 -43.25 7.21 Favored 'General case' 0 CA--C 1.523 -0.075 0 C-N-CA 124.357 1.063 . . . . 3.0800000000000001 108.912 157.24 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 24.5 m -63.53 -50.97 76.14 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.001 0 CA-C-N 114.138 -1.392 . . . . 2.8399999999999999 109.993 -177.68 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -52.73 -43.82 65.97 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 122.994 0.518 . . . . 1.29 110.972 172.425 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -56.53 -50.77 70.88 Favored 'General case' 0 C--O 1.227 -0.123 0 N-CA-C 109.303 -0.628 . . . . 2.23 109.303 174.508 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.457 HG23 ' CD2' ' A' ' 25' ' ' LEU . 7.1 mt -58.44 -60.73 1.91 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 C-N-CA 123.541 0.736 . . . . 2.1000000000000001 109.039 -179.381 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -39.61 -54.92 1.95 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.942 1.297 . . . . 3.6299999999999999 112.259 172.02 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -59.83 -44.63 93.95 Favored 'General case' 0 CA--C 1.528 0.133 0 O-C-N 121.666 -0.646 . . . . 5.6299999999999999 112.422 178.319 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -56.83 -55.87 28.83 Favored 'General case' 0 C--O 1.226 -0.153 0 N-CA-C 108.4 -0.963 . . . . 2.8599999999999999 108.4 179.033 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.457 ' CD2' HG23 ' A' ' 21' ' ' ILE . 0.0 OUTLIER -74.84 -23.95 58.52 Favored 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 114.369 1.248 . . . . 2.2999999999999998 114.369 -172.325 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.55 -15.33 62.6 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 120.583 1.538 . . . . 6.5 114.802 -170.122 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 73.7 mtt180 -65.79 -19.55 65.93 Favored 'General case' 0 N--CA 1.462 0.142 0 N-CA-C 113.333 0.864 . . . . 7.2599999999999998 113.333 -157.532 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 71.25 23.25 4.09 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 125.08 1.352 . . . . 10.470000000000001 112.446 -172.065 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -76.46 59.3 1.44 Allowed 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 127.56 2.344 . . . . 5.6399999999999997 108.766 171.788 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 75.51 32.91 53.9 Favored Glycine 0 CA--C 1.535 1.311 0 C-N-CA 124.261 0.934 . . . . 1.4199999999999999 113.641 -178.644 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.45 HD12 ' HA ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -142.27 135.66 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 C-N-CA 127.212 2.205 . . . . 3.0699999999999998 105.665 -170.858 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 41.2 m-85 -145.29 48.13 1.28 Allowed 'General case' 0 C--O 1.233 0.195 0 CA-C-O 123.155 1.455 . . . . 3.2999999999999998 111.702 171.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 14.0 t -164.84 -178.64 5.35 Favored 'General case' 0 C--N 1.317 -0.841 0 C-N-CA 129.875 3.27 . . . . 2.0 106.135 151.304 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.494 HD13 ' H ' ' A' ' 34' ' ' ILE . 0.1 OUTLIER -125.2 127.49 72.16 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 C-N-CA 124.474 1.11 . . . . 2.5800000000000001 109.42 174.243 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.421 ' O ' ' HB1' ' A' ' 43' ' ' ALA . 0.9 OUTLIER -78.35 71.0 4.79 Favored 'General case' 0 N--CA 1.439 -0.993 0 O-C-N 121.099 -1.001 . . . . 4.7699999999999996 110.85 -176.834 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 18.7 t -123.9 139.83 49.19 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.885 0 CA-C-O 122.183 0.992 . . . . 1.3799999999999999 109.414 159.262 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -155.62 58.95 0.62 Allowed 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 126.418 1.887 . . . . 0.80000000000000004 107.139 168.623 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.2 pp -56.86 -32.14 65.51 Favored 'General case' 0 CA--C 1.51 -0.566 0 C-N-CA 123.45 0.7 . . . . 3.3599999999999999 112.474 -175.729 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 65.1 mtt -65.53 -40.44 92.94 Favored 'General case' 0 N--CA 1.441 -0.898 0 C-N-CA 119.761 -0.775 . . . . 4.6500000000000004 108.913 -165.438 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -76.84 -42.22 41.09 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.721 0.808 . . . . 1.48 109.842 167.242 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 111.88 57.16 0.46 Allowed Glycine 0 C--N 1.338 0.652 0 N-CA-C 109.426 -1.469 . . . . 1.02 109.426 176.061 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -160.24 -178.37 6.91 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 107.002 -1.481 . . . . 4.6100000000000003 107.002 -169.149 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.421 ' HB1' ' O ' ' A' ' 35' ' ' LEU . . . -146.35 130.1 17.09 Favored 'General case' 0 N--CA 1.434 -1.259 0 C-N-CA 126.334 1.854 . . . . 0.97999999999999998 106.001 -172.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -135.94 114.36 11.69 Favored 'General case' 0 C--N 1.342 0.261 0 CA-C-N 120.926 1.693 . . . . 2.5099999999999998 113.277 177.79 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.2 p -90.12 150.18 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.273 0 C-N-CA 125.02 1.328 . . . . 1.49 110.17 -171.87 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 35.4 ttm180 -125.75 131.02 52.6 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 104.863 -2.273 . . . . 4.1399999999999997 104.863 159.603 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 3.8 p90 -160.18 169.73 22.66 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-N 118.219 0.463 . . . . 2.2400000000000002 111.569 -165.305 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . 0.271 49.1 p30 -104.3 97.18 11.24 Favored Pre-proline 0 CA--C 1.542 0.671 0 N-CA-C 113.234 0.827 . . . . 3.9900000000000002 113.234 170.678 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -72.51 73.19 2.86 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 122.526 2.15 . . . . 1.46 111.331 177.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -150.27 -57.39 0.18 Allowed 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 126.548 1.939 . . . . 1.3400000000000001 106.041 171.58 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 78.6 t -58.62 -54.6 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.787 0 C-N-CA 123.778 0.831 . . . . 1.3200000000000001 109.299 171.695 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.429 HG23 ' H ' ' A' ' 53' ' ' GLN 0.265 2.5 tp -90.54 -72.97 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-O 118.306 -0.854 . . . . 1.75 112.103 -165.613 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.429 ' H ' HG23 ' A' ' 52' ' ' ILE . 0.8 OUTLIER 112.98 136.66 0.0 OUTLIER Pre-proline 0 N--CA 1.476 0.87 0 C-N-CA 131.122 3.769 . . . . 3.0299999999999998 108.653 -177.48 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -51.03 -51.13 11.85 Favored 'Trans proline' 0 CA--C 1.534 0.503 0 C-N-CA 124.054 3.17 . . . . 1.1100000000000001 115.345 174.777 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -53.8 -48.83 19.64 Favored 'Trans proline' 0 N--CA 1.444 -1.409 0 CA-C-N 120.448 1.196 . . . . 0.77000000000000002 110.282 167.831 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 74.5 mtp -69.13 -33.16 73.01 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 118.301 -1.359 . . . . 2.0600000000000001 110.65 -168.283 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 6.9 tt -66.42 -50.95 63.26 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 CA-C-N 119.935 1.243 . . . . 2.3700000000000001 110.324 179.451 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -51.65 -53.97 33.07 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.09 0.956 . . . . 1.0900000000000001 110.814 176.012 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 54.4 mm-40 -65.31 -38.08 89.09 Favored 'General case' 0 N--CA 1.429 -1.509 0 CA-C-O 118.866 -0.588 . . . . 3.5299999999999998 111.999 -177.741 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -54.54 -34.25 61.47 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 120.192 1.36 . . . . 4.3399999999999999 111.207 173.79 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.6 mm -60.47 -53.28 51.0 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 N-CA-C 107.746 -1.205 . . . . 2.1400000000000001 107.746 172.704 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 15.7 mtp-105 -55.58 -47.73 75.97 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 125.161 1.384 . . . . 6.3600000000000003 114.301 -177.837 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -45.92 -35.38 4.57 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 127.023 2.129 . . . . 3.1400000000000001 112.933 -175.414 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 58.8 mt -79.11 -16.39 56.78 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 122.93 0.492 . . . . 2.0299999999999998 111.196 -174.893 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 130.93 50.06 0.11 Allowed Glycine 0 CA--C 1.527 0.805 0 C-N-CA 125.182 1.372 . . . . 2.5699999999999998 111.168 170.418 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -136.39 169.62 17.38 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-O 123.519 1.628 . . . . 3.48 113.673 -168.652 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -115.18 126.89 7.39 Favored Glycine 0 N--CA 1.442 -0.957 0 N-CA-C 105.949 -2.861 . . . . 1.76 105.949 168.213 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -153.24 81.52 1.19 Allowed 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 124.533 1.133 . . . . 1.6299999999999999 108.3 -172.223 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -84.8 138.04 32.83 Favored 'General case' 0 C--O 1.225 -0.227 0 C-N-CA 123.704 0.802 . . . . 2.4399999999999999 108.882 -175.827 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 97.0 t -84.89 109.19 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 N-CA-C 108.552 -0.907 . . . . 1.6899999999999999 108.552 -177.145 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 18.9 mm -130.8 60.15 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 C-N-CA 125.156 1.383 . . . . 2.9500000000000002 109.002 -171.491 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 . . . . . 0 C--N 1.328 -0.356 0 CA-C-N 115.397 -0.819 . . . . 3.75 109.478 155.086 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 88.4 p . . . . . 0 CA--C 1.531 0.236 0 N-CA-C 106.999 -1.482 . . . . 2.4500000000000002 106.999 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 18.6 m -155.34 153.98 31.34 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 124.902 1.281 . . . . 2.0699999999999998 108.022 177.121 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 9.3 mtmp? -91.82 161.01 15.03 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 123.33 0.652 . . . . 3.3599999999999999 111.937 176.482 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 49.3 t -155.25 157.71 37.71 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 105.974 -1.861 . . . . 1.3300000000000001 105.974 166.12 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -98.34 146.4 25.72 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 119.804 1.184 . . . . 3.4100000000000001 108.007 171.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.509 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 12.0 mm -128.16 113.42 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 N-CA-C 105.138 -2.171 . . . . 2.1200000000000001 105.138 174.01 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 16.6 tp60 -82.38 124.49 30.06 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 104.825 -2.287 . . . . 2.8900000000000001 104.825 172.785 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.5 p -117.72 99.02 7.3 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-O 122.175 0.988 . . . . 2.3599999999999999 110.597 -169.058 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 7.0 m -67.03 94.3 0.33 Allowed 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 109.155 -0.683 . . . . 2.7799999999999998 109.155 -179.561 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 135.24 3.94 2.67 Favored Glycine 0 C--O 1.221 -0.705 0 C-N-CA 125.124 1.345 . . . . 2.54 113.047 -175.479 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -43.98 -46.89 8.49 Favored 'General case' 0 C--N 1.321 -0.647 0 O-C-N 121.561 -0.964 . . . . 3.27 110.612 162.277 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 15.3 t -74.43 12.13 0.84 Allowed 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.192 0.997 . . . . 5.9699999999999998 112.887 176.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 16.9 t -57.4 -41.77 80.95 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 107.011 -1.477 . . . . 2.5600000000000001 107.011 160.145 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 84.27 145.3 0.07 Allowed 'General case' 0 C--N 1.348 0.52 0 C-N-CA 127.934 2.494 . . . . 3.3199999999999998 110.138 -175.73 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.6 m 71.49 -30.91 0.22 Allowed 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 115.083 1.512 . . . . 3.0499999999999998 115.083 174.159 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 11.0 m -62.83 -18.21 62.49 Favored 'General case' 0 CA--C 1.517 -0.294 0 C-N-CA 128.825 2.85 . . . . 3.5299999999999998 111.821 -175.383 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 14.0 m -41.12 -43.78 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 N-CA-C 112.162 0.431 . . . . 2.25 112.162 159.207 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -52.77 -46.36 67.52 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.088 0.955 . . . . 1.1399999999999999 111.547 173.226 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -59.19 -51.98 67.65 Favored 'General case' 0 C--O 1.224 -0.249 0 N-CA-C 108.671 -0.863 . . . . 2.0099999999999998 108.671 175.353 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 38.4 mm -53.54 -59.39 1.91 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 C-N-CA 123.601 0.76 . . . . 2.04 109.123 -179.187 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -42.54 -61.07 1.31 Allowed 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.057 1.343 . . . . 3.3999999999999999 110.977 175.365 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.93 -48.93 78.21 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 119.369 -0.348 . . . . 7.8600000000000003 110.933 -175.231 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -49.86 -60.32 3.02 Favored 'General case' 0 CA--C 1.519 -0.228 0 C-N-CA 123.989 0.916 . . . . 3.1200000000000001 108.839 -179.06 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.611 ' CD2' HD21 ' A' ' 35' ' ' LEU . 0.0 OUTLIER -70.57 -32.14 69.44 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 115.623 -0.717 . . . . 2.1499999999999999 109.499 -170.397 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . 0.578 68.6 mtp180 -63.0 3.17 0.25 Allowed 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 117.827 2.529 . . . . 6.1600000000000001 117.827 163.217 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 3.5 mmt85 -43.58 -34.09 1.32 Allowed 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 116.914 -1.914 . . . . 7.8300000000000001 112.233 146.696 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . 0.25 4.2 mt-10 78.86 33.15 0.26 Allowed 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 127.191 2.196 . . . . 8.8100000000000005 112.135 176.436 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 80.1 mt-10 -73.55 69.62 1.25 Allowed 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 127.101 2.161 . . . . 5.9299999999999997 110.436 179.222 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 67.15 28.43 73.74 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 123.453 0.549 . . . . 1.0600000000000001 111.932 -179.16 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.0 mm -98.3 140.12 18.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 C-N-CA 128.416 2.686 . . . . 2.2799999999999998 109.208 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -148.47 42.51 0.99 Allowed 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 122.404 1.097 . . . . 3.9900000000000002 113.12 163.146 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 33.6 t -166.87 149.41 6.4 Favored 'General case' 0 C--N 1.317 -0.805 0 C-N-CA 131.01 3.724 . . . . 2.02 104.828 144.207 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.7 pp -83.45 151.73 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 N-CA-C 108.157 -1.053 . . . . 1.9199999999999999 108.157 163.548 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.611 HD21 ' CD2' ' A' ' 25' ' ' LEU . 0.4 OUTLIER -87.22 78.55 8.8 Favored 'General case' 0 N--CA 1.436 -1.138 0 C-N-CA 127.185 2.194 . . . . 4.4400000000000004 110.939 178.005 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 24.5 t -134.99 137.51 50.5 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 CA-C-O 121.368 0.604 . . . . 1.3300000000000001 110.145 165.861 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -155.92 58.47 0.6 Allowed 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 113.912 -1.494 . . . . 0.95999999999999996 107.397 164.675 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -63.61 -28.6 70.03 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.058 0.943 . . . . 3.3100000000000001 110.39 -173.819 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 63.3 mtt -46.37 -41.34 13.4 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.311 0.644 . . . . 4.5999999999999996 111.666 170.027 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -88.68 -41.52 12.55 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 122.769 0.428 . . . . 1.71 109.95 172.401 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 113.18 53.2 0.47 Allowed Glycine 0 C--N 1.335 0.488 0 N-CA-C 108.607 -1.797 . . . . 1.01 108.607 179.446 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 37.6 mtmt -151.71 175.41 12.42 Favored 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 108.293 -1.003 . . . . 3.7799999999999998 108.293 -164.202 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.525 ' HB1' HD12 ' A' ' 35' ' ' LEU . . . -148.0 119.25 7.8 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 105.646 -1.983 . . . . 0.93999999999999995 105.646 -174.089 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -128.24 96.94 4.59 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 123.553 0.741 . . . . 3.2599999999999998 111.433 -171.34 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 10.7 p -81.62 147.93 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.285 0 C-N-CA 123.226 0.61 . . . . 1.4399999999999999 109.362 -170.574 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 21.5 ttt-85 -123.13 127.76 49.14 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 105.774 -1.936 . . . . 5.8799999999999999 105.774 156.395 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 3.8 p90 -157.88 175.04 14.37 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 108.426 -0.953 . . . . 2.0600000000000001 108.426 -169.346 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -109.12 104.3 54.67 Favored Pre-proline 0 CA--C 1.537 0.467 0 CA-C-O 118.579 -0.724 . . . . 2.98 111.647 176.209 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -70.78 76.61 1.52 Allowed 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 123.257 2.638 . . . . 1.5700000000000001 111.571 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -165.53 -46.97 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 126.524 1.929 . . . . 1.3899999999999999 107.224 167.812 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 99.2 t -62.71 -45.54 98.57 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.885 0 C-N-CA 125.148 1.379 . . . . 1.1899999999999999 110.056 177.715 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.528 HG23 ' H ' ' A' ' 53' ' ' GLN 0.273 6.0 tp -113.17 -73.32 0.63 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.303 0 CA-C-O 118.16 -0.924 . . . . 1.99 112.187 -167.865 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.528 ' H ' HG23 ' A' ' 52' ' ' ILE . 27.8 mm100 110.86 131.93 0.0 OUTLIER Pre-proline 0 CA--C 1.54 0.588 0 C-N-CA 129.424 3.09 . . . . 3.4700000000000002 111.757 174.902 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -44.86 -53.68 4.93 Favored 'Trans proline' 0 CA--C 1.534 0.516 0 C-N-CA 125.23 3.954 . . . . 1.3100000000000001 116.427 176.014 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_endo -53.04 -47.29 28.34 Favored 'Trans proline' 0 N--CA 1.447 -1.222 0 CA-C-N 120.825 1.33 . . . . 1.0 110.022 172.737 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 64.7 mtt -62.4 -46.41 88.71 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 118.181 -0.914 . . . . 2.1299999999999999 111.41 -177.079 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 18.0 pt -61.93 -45.08 99.49 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-N 120.616 1.553 . . . . 2.3100000000000001 111.318 176.094 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -53.93 -52.65 59.91 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 121.195 0.521 . . . . 1.02 110.443 179.315 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 62.1 mm-40 -61.43 -48.49 80.95 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-O 118.359 -0.829 . . . . 3.5899999999999999 111.853 177.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -47.25 -42.44 20.57 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 119.659 1.118 . . . . 3.79 111.385 176.281 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 54.8 mt -67.05 -40.2 84.96 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 O-C-N 122.037 -0.414 . . . . 1.0 110.186 178.747 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 54.6 mtt180 -64.74 -50.62 66.15 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.647 0.779 . . . . 4.4500000000000002 111.934 177.258 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -43.66 -55.13 4.55 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 126.462 1.905 . . . . 2.9399999999999999 111.674 -175.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.38 -31.04 12.58 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 113.043 0.757 . . . . 1.8200000000000001 113.043 -179.523 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -114.9 -85.67 1.31 Allowed Glycine 0 CA--C 1.528 0.891 0 CA-C-N 119.148 0.885 . . . . 2.04 113.911 -165.631 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -147.81 156.03 42.29 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 113.558 0.948 . . . . 2.9399999999999999 113.558 -146.78 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -70.03 82.3 0.33 Allowed Glycine 0 N--CA 1.444 -0.786 0 CA-C-N 114.629 -1.169 . . . . 1.5 111.112 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -82.72 144.42 30.22 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 125.229 1.412 . . . . 1.1200000000000001 109.655 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.6 t -142.92 139.97 30.96 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 106.007 -1.849 . . . . 2.46 106.007 165.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.6 m -83.67 145.63 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 N-CA-C 109.586 -0.524 . . . . 2.54 109.586 -176.557 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 14.9 mm -141.27 147.73 22.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 C-N-CA 126.064 1.746 . . . . 2.21 107.309 -177.171 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 . . . . . 0 CA--C 1.531 0.244 0 C-N-CA 126.351 1.86 . . . . 3.7999999999999998 106.355 168.152 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.0 m . . . . . 0 N--CA 1.451 -0.393 0 N-CA-C 108.142 -1.058 . . . . 2.52 108.142 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.1 m -109.18 144.02 37.82 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 126.247 1.819 . . . . 2.0099999999999998 108.116 -176.713 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 35.5 tttt -95.54 164.02 12.97 Favored 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 123.37 0.668 . . . . 4.71 110.611 -178.162 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 7.8 p -153.99 174.31 14.83 Favored 'General case' 0 C--O 1.232 0.16 0 N-CA-C 109.141 -0.689 . . . . 2.02 109.141 156.674 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -122.54 142.11 50.95 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 125.348 1.459 . . . . 2.6699999999999999 108.296 -175.508 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.406 ' HB ' ' HB3' ' A' ' 43' ' ' ALA . 10.9 mt -146.0 132.61 14.25 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 N-CA-C 106.812 -1.551 . . . . 1.5600000000000001 106.812 -167.328 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 12.5 tp60 -84.2 125.35 32.11 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 105.508 -2.034 . . . . 3.5899999999999999 105.508 165.712 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 6.7 p -110.37 101.98 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 C-N-CA 124.341 1.057 . . . . 2.3100000000000001 108.336 177.405 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 21.0 m -71.69 80.79 0.85 Allowed 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 108.974 -0.751 . . . . 2.5299999999999998 108.974 176.814 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -171.19 -52.59 0.04 OUTLIER Glycine 0 CA--C 1.53 1.012 0 C-N-CA 129.02 3.2 . . . . 2.29 106.977 172.573 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 63.8 mtt 62.92 -66.38 0.09 Allowed 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 127.489 2.315 . . . . 3.9399999999999999 112.319 175.703 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 14.6 t -151.72 53.38 0.83 Allowed 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.036 1.334 . . . . 4.96 107.751 173.595 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.0 p -43.7 -50.29 7.6 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.586 1.154 . . . . 3.1000000000000001 109.784 173.829 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -172.52 93.99 0.13 Allowed 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 126.748 2.019 . . . . 3.1800000000000002 106.87 156.034 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.7 m 59.11 42.48 18.83 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 121.562 0.696 . . . . 2.6299999999999999 110.548 -173.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 6.9 t -43.34 -41.99 4.33 Favored 'General case' 0 N--CA 1.461 0.109 0 C-N-CA 126.766 2.026 . . . . 4.0300000000000002 108.192 166.12 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 4.9 m -66.99 -53.32 35.1 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.972 0 C-N-CA 125.532 1.533 . . . . 2.1899999999999999 110.935 -173.612 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -50.78 -47.85 59.55 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.136 0.975 . . . . 0.90000000000000002 109.493 171.849 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -55.43 -53.29 58.05 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 108.927 -0.768 . . . . 2.1099999999999999 108.927 177.504 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.454 HG21 HG23 ' A' ' 36' ' ' VAL . 1.1 mp -53.69 -54.94 15.98 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 C-N-CA 124.469 1.108 . . . . 2.0499999999999998 110.386 178.396 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -48.91 -60.3 2.87 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 119.429 1.013 . . . . 2.96 109.541 -178.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 8.8 mpt_? -60.6 -38.65 85.4 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 115.131 -0.94 . . . . 6.4699999999999998 110.71 -176.059 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -62.24 -60.13 4.03 Favored 'General case' 0 C--O 1.227 -0.088 0 C-N-CA 122.686 0.394 . . . . 3.2200000000000002 110.208 177.856 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.412 ' CD2' HD21 ' A' ' 35' ' ' LEU . 0.0 OUTLIER -75.87 -64.6 1.05 Allowed 'General case' 0 N--CA 1.437 -1.11 0 CA-C-N 116.732 -0.213 . . . . 2.21 110.552 -159.793 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.53 -15.25 0.63 Allowed 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 115.665 1.728 . . . . 6.3300000000000001 115.665 -162.435 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -31.25 -59.02 0.24 Allowed 'General case' 0 N--CA 1.439 -0.99 0 C-N-CA 126.361 1.864 . . . . 6.9800000000000004 109.805 -175.077 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . 0.313 0.0 OUTLIER -167.15 -108.52 0.01 OUTLIER 'General case' 0 N--CA 1.447 -0.616 0 O-C-N 125.043 1.464 . . . . 7.3399999999999999 108.027 -171.113 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 44.48 31.16 0.57 Allowed 'General case' 0 C--N 1.314 -0.966 0 C-N-CA 127.256 2.222 . . . . 4.8600000000000003 114.628 156.848 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 60.21 31.09 72.27 Favored Glycine 0 CA--C 1.53 1.008 0 CA-C-O 118.483 -1.176 . . . . 0.95999999999999996 113.537 -178.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 1.4 mp -78.43 139.31 18.69 Favored 'Isoleucine or valine' 0 C--N 1.34 0.167 0 CA-C-N 119.196 1.498 . . . . 2.5299999999999998 107.529 169.456 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -148.22 36.45 0.83 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 120.382 -0.527 . . . . 6.5899999999999999 112.275 158.527 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 34.0 t -169.36 143.64 2.91 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 130.117 3.367 . . . . 1.99 104.32 139.855 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.7 pp -82.09 147.16 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 CA-C-N 119.683 1.129 . . . . 1.95 109.06 172.388 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.55 ' HB2' ' HB1' ' A' ' 43' ' ' ALA . 0.4 OUTLIER -79.41 80.39 5.78 Favored 'General case' 0 N--CA 1.44 -0.948 0 C-N-CA 125.77 1.628 . . . . 4.6200000000000001 111.384 -179.765 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.454 HG23 HG21 ' A' ' 21' ' ' ILE . 85.6 t -130.64 138.9 52.57 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.121 0 CA-C-O 121.499 0.666 . . . . 1.5900000000000001 109.252 162.523 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -153.73 57.02 0.74 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 113.666 -1.607 . . . . 0.83999999999999997 107.364 165.152 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -73.01 -15.58 61.52 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 114.913 -1.04 . . . . 3.0899999999999999 111.623 -172.645 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 93.7 mtp -49.43 -35.94 20.79 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 121.485 -0.76 . . . . 3.5899999999999999 110.885 162.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -95.39 -46.82 6.55 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.391 0.676 . . . . 1.9399999999999999 110.483 170.47 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 111.25 63.56 0.49 Allowed Glycine 0 C--N 1.339 0.722 0 N-CA-C 107.809 -2.117 . . . . 0.97999999999999998 107.809 -171.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 4.4 pttt -160.82 175.4 12.61 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 118.279 1.04 . . . . 4.3700000000000001 108.541 -178.57 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.55 ' HB1' ' HB2' ' A' ' 35' ' ' LEU . . . -123.36 125.67 45.43 Favored 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 128.038 2.535 . . . . 1.1399999999999999 107.456 -176.216 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -140.22 92.75 2.56 Favored 'General case' 0 N--CA 1.457 -0.104 0 CA-C-O 122.01 0.909 . . . . 3.21 113.063 175.419 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.7 p -79.16 153.38 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.21 0 C-N-CA 125.405 1.482 . . . . 1.5 109.219 -172.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 65.0 ttt180 -122.61 141.05 52.13 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 106.504 -1.665 . . . . 5.3799999999999999 106.504 159.098 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 32.5 p90 -152.04 159.09 43.8 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 122.918 0.487 . . . . 2.5099999999999998 110.18 -165.81 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -98.19 98.74 6.0 Favored Pre-proline 0 CA--C 1.539 0.525 0 C-N-CA 123.676 0.791 . . . . 2.9399999999999999 110.329 170.245 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -75.22 75.99 3.62 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 122.765 2.31 . . . . 1.95 111.203 -176.623 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -159.51 -43.71 0.05 Allowed 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 125.235 1.414 . . . . 1.6000000000000001 108.915 169.811 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 33.9 t -52.13 -56.53 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.737 0 C-N-CA 124.452 1.101 . . . . 1.45 109.1 169.34 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.451 HG23 ' H ' ' A' ' 53' ' ' GLN . 6.4 tt -124.69 -128.5 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.44 -0.957 0 CA-C-N 114.603 -1.181 . . . . 2.6699999999999999 108.817 -167.417 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.451 ' H ' HG23 ' A' ' 52' ' ' ILE . 4.9 tp60 -175.18 112.65 0.28 Allowed Pre-proline 0 CA--C 1.539 0.542 0 N-CA-C 108.686 -0.857 . . . . 2.3399999999999999 108.686 -159.309 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -47.59 -44.51 25.63 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 124.728 3.619 . . . . 1.5600000000000001 116.767 176.312 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -54.33 -56.83 2.19 Favored 'Trans proline' 0 N--CA 1.445 -1.373 0 CA-C-N 121.212 1.469 . . . . 1.24 109.687 167.781 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 87.1 mtp -53.56 -48.46 69.11 Favored 'General case' 0 C--N 1.342 0.247 0 CA-C-O 119.065 -0.493 . . . . 2.5800000000000001 112.317 -175.484 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 3.6 pt -60.38 -41.14 86.26 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 CA-C-N 119.155 0.889 . . . . 2.9900000000000002 111.829 -177.459 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.96 -60.16 4.23 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 119.704 1.138 . . . . 1.6299999999999999 111.038 169.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -46.12 -52.69 11.71 Favored 'General case' 0 N--CA 1.442 -0.867 0 C-N-CA 126.497 1.919 . . . . 3.4500000000000002 112.341 -174.566 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -44.14 -39.81 4.57 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.647 0.779 . . . . 3.96 112.972 -179.484 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 43.0 mt -61.32 -36.96 76.37 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 C-N-CA 122.81 0.444 . . . . 1.46 110.005 -178.038 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 60.2 mtt180 -62.52 -62.04 2.02 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 124.237 1.015 . . . . 4.3300000000000001 108.982 178.482 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -39.4 -52.24 2.08 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 124.987 1.315 . . . . 4.9500000000000002 112.57 173.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.6 pp -83.35 -18.19 39.74 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 113.969 1.1 . . . . 2.3500000000000001 113.969 -176.835 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -171.47 -66.15 0.04 OUTLIER Glycine 0 CA--C 1.533 1.199 0 CA-C-N 120.018 1.281 . . . . 1.6599999999999999 115.757 -178.844 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -130.22 146.82 51.88 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 122.058 0.932 . . . . 3.23 113.5 -147.63 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -75.42 81.8 0.94 Allowed Glycine 0 N--CA 1.449 -0.442 0 CA-C-N 115.516 -0.765 . . . . 1.47 112.276 -167.685 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -83.22 90.7 7.14 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 126.335 1.854 . . . . 1.3600000000000001 110.507 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 20.0 p -99.55 126.83 45.59 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 125.161 1.384 . . . . 2.3399999999999999 108.439 177.13 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 90.3 t -82.64 130.23 36.1 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.712 0 C-N-CA 124.523 1.129 . . . . 1.79 109.494 -173.42 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 24.5 mt -142.06 63.37 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 C-N-CA 125.503 1.521 . . . . 2.29 108.285 -175.728 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.539 0.525 0 N-CA-C 109.171 -0.677 . . . . 4.9400000000000004 109.171 168.294 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.6 p . . . . . 0 C--O 1.235 0.317 0 CA-C-O 122.551 1.167 . . . . 2.6299999999999999 108.723 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.8 p -97.31 172.4 7.81 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 127.795 2.438 . . . . 2.0800000000000001 109.733 -169.615 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.98 153.6 50.17 Favored 'General case' 0 C--N 1.339 0.129 0 C-N-CA 122.848 0.459 . . . . 3.7200000000000002 111.12 -179.771 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 41.1 t -146.8 155.75 42.6 Favored 'General case' 0 C--O 1.231 0.107 0 C-N-CA 124.95 1.3 . . . . 1.6100000000000001 109.13 -175.43 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -97.39 136.88 37.21 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 126.081 1.752 . . . . 2.7999999999999998 108.145 174.684 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.1 mm -139.94 123.53 18.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 107.078 -1.453 . . . . 2.1099999999999999 107.078 -177.346 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 5.9 mm-40 -77.93 159.37 28.89 Favored 'General case' 0 N--CA 1.455 -0.194 0 O-C-N 120.745 -1.222 . . . . 3.7000000000000002 110.228 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.4 p -137.91 139.75 42.06 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 O-C-N 123.469 0.481 . . . . 2.9399999999999999 111.925 -172.715 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.3 m -76.77 63.89 2.25 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.436 1.095 . . . . 3.7400000000000002 113.306 -176.888 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -161.03 -60.44 0.02 OUTLIER Glycine 0 C--O 1.227 -0.293 0 N-CA-C 105.98 -2.848 . . . . 3.5099999999999998 105.98 157.349 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 9.4 ttm 54.39 20.79 2.89 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.474 1.11 . . . . 4.7800000000000002 111.421 -176.811 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 61.4 m -160.99 -38.67 0.05 OUTLIER 'General case' 0 C--N 1.335 -0.062 0 C-N-CA 124.61 1.164 . . . . 5.6200000000000001 109.856 -156.867 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 28.4 p -59.04 132.85 55.26 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 108.452 -0.944 . . . . 3.3399999999999999 108.452 -179.123 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -53.53 -31.35 45.95 Favored 'General case' 0 CA--C 1.535 0.374 0 O-C-N 121.314 -0.866 . . . . 4.0099999999999998 110.491 179.492 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.4 m -53.17 -39.74 63.84 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 126.109 1.764 . . . . 3.4399999999999999 114.443 172.212 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -35.21 -57.74 0.57 Allowed 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 125.713 1.605 . . . . 4.8099999999999996 111.601 -146.479 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.477 HG23 HG11 ' A' ' 36' ' ' VAL . 0.4 OUTLIER -62.87 -50.19 80.63 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.874 0 CA-C-N 114.794 -1.094 . . . . 3.3100000000000001 112.525 -177.121 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -54.63 -44.52 73.25 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.382 1.073 . . . . 1.26 110.484 172.631 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -54.62 -59.94 4.02 Favored 'General case' 0 C--O 1.226 -0.167 0 N-CA-C 108.635 -0.876 . . . . 3.6699999999999999 108.635 175.659 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.75 HG22 HD11 ' A' ' 34' ' ' ILE . 2.3 mt -61.09 -42.27 92.53 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.14 0 O-C-N 121.406 -0.809 . . . . 2.7400000000000002 110.952 -174.447 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 69.1 mt-10 -60.85 -25.49 66.69 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 125.557 1.543 . . . . 3.6099999999999999 112.938 174.018 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 10.5 mmm180 -73.1 -42.31 63.08 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 119.344 0.975 . . . . 7.1299999999999999 111.954 158.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.528 ' OD1' HD13 ' A' ' 25' ' ' LEU . 0.1 OUTLIER -70.93 -49.71 42.62 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 124.427 1.091 . . . . 4.4299999999999997 113.692 -160.266 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.528 HD13 ' OD1' ' A' ' 24' ' ' ASN . 3.9 mp -78.11 -60.05 2.53 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 118.977 0.808 . . . . 2.96 112.872 -176.552 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 9.5 ptm180 -39.38 -19.87 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 129.933 3.293 . . . . 6.04 118.481 -158.849 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 19.9 mtm105 -67.34 -51.97 45.84 Favored 'General case' 0 N--CA 1.439 -0.98 0 C-N-CA 127.337 2.255 . . . . 8.1799999999999997 109.487 -161.064 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 168.59 152.03 0.03 OUTLIER 'General case' 0 CA--C 1.512 -0.515 0 N-CA-C 105.519 -2.03 . . . . 7.2199999999999998 105.519 -152.754 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 99.91 44.84 0.0 OUTLIER 'General case' 0 C--N 1.34 0.157 0 C-N-CA 128.132 2.573 . . . . 7.1500000000000004 112.088 -168.633 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 56.35 42.57 89.21 Favored Glycine 0 CA--C 1.528 0.894 0 CA-C-N 116.275 -0.42 . . . . 1.74 112.527 171.766 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -77.26 135.29 26.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 N-CA-C 107.104 -1.443 . . . . 2.7599999999999998 107.104 174.808 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 54.0 m-85 -141.62 37.55 1.66 Allowed 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 122.061 0.934 . . . . 3.6299999999999999 113.397 164.324 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 75.0 m -166.39 154.41 10.24 Favored 'General case' 0 C--N 1.321 -0.663 1 C-N-CA 131.989 4.116 . . . . 2.79 103.964 122.32 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.828 HD13 ' N ' ' A' ' 35' ' ' LEU . 0.1 OUTLIER -98.3 136.6 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 N-CA-C 104.931 -2.248 . . . . 3.1600000000000001 104.931 158.782 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.828 ' N ' HD13 ' A' ' 34' ' ' ILE . 0.1 OUTLIER -156.21 175.81 13.5 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 124.403 1.081 . . . . 6.8399999999999999 110.375 -179.484 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.647 HG22 HG21 ' A' ' 21' ' ' ILE . 24.0 t -158.8 117.43 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.421 -1.875 0 C-N-CA 127.22 2.208 . . . . 1.71 106.545 -177.254 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -77.98 62.59 2.8 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 108.464 -0.939 . . . . 1.4199999999999999 108.464 168.326 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.492 HD23 ' HA ' ' A' ' 38' ' ' LEU . 0.3 OUTLIER -64.59 -32.96 74.84 Favored 'General case' 0 C--N 1.342 0.266 0 O-C-N 121.687 -0.633 . . . . 2.6499999999999999 111.705 -168.069 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 51.5 ttp -55.09 -35.67 64.84 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.299 0.64 . . . . 5.6600000000000001 111.199 173.428 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -86.99 -20.85 26.66 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.608 0.763 . . . . 1.76 110.913 176.325 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 84.35 60.01 1.97 Allowed Glycine 0 C--N 1.335 0.518 0 N-CA-C 107.768 -2.133 . . . . 0.85999999999999999 107.768 169.88 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.424 ' HZ3' ' HB3' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -163.96 167.53 20.43 Favored 'General case' 0 N--CA 1.437 -1.082 0 N-CA-C 106.363 -1.717 . . . . 4.9299999999999997 106.363 173.122 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -77.83 145.29 36.41 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 105.975 -1.861 . . . . 1.6499999999999999 105.975 167.502 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.609 ' CB ' HD13 ' A' ' 35' ' ' LEU . 19.3 mt-10 -94.56 167.48 11.45 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 105.774 -1.936 . . . . 2.9100000000000001 105.774 151.01 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.1 p -134.81 141.7 42.41 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 N-CA-C 104.606 -2.368 . . . . 1.5800000000000001 104.606 157.722 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 70.8 ttt180 -113.5 129.25 56.59 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 106.597 -1.631 . . . . 5.0300000000000002 106.597 158.089 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 7.2 p90 -157.3 172.22 19.0 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 122.968 0.507 . . . . 1.9099999999999999 111.783 -162.803 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 65.0 t-20 -109.21 88.56 5.96 Favored Pre-proline 0 CA--C 1.537 0.469 0 CA-C-N 114.677 -1.147 . . . . 2.4100000000000001 111.08 -177.637 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -67.67 79.55 0.49 Allowed 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 123.209 2.606 . . . . 2.0299999999999998 110.129 173.839 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -169.78 -47.91 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 127.712 2.405 . . . . 1.3400000000000001 106.726 172.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 57.5 t -69.87 -49.69 55.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 C-N-CA 124.261 1.025 . . . . 1.1000000000000001 109.405 173.647 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.9 tp -98.06 -68.89 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 CA-C-O 118.654 -0.689 . . . . 2.5600000000000001 111.832 -166.584 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 56.9 tp60 109.24 124.67 0.0 OUTLIER Pre-proline 0 CA--C 1.549 0.909 0 C-N-CA 128.946 2.898 . . . . 3.9300000000000002 109.894 176.547 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_exo -47.43 -59.51 1.22 Allowed 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 124.113 3.208 . . . . 1.3 117.24 -172.916 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_endo -49.06 -43.57 35.76 Favored 'Trans proline' 0 N--CA 1.45 -1.052 0 C-N-CA 121.62 1.546 . . . . 1.6899999999999999 110.645 172.675 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 58.9 mtp -68.21 -34.32 76.04 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 118.602 -0.713 . . . . 2.4500000000000002 111.302 -177.083 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 3.2 tt -62.2 -39.17 83.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-N 120.707 1.594 . . . . 2.1800000000000002 110.977 177.853 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -56.55 -46.98 80.41 Favored 'General case' 0 CA--C 1.529 0.159 0 O-C-N 122.176 -0.328 . . . . 1.1799999999999999 111.219 173.121 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -58.91 -52.41 65.86 Favored 'General case' 0 N--CA 1.435 -1.201 0 C-N-CA 123.197 0.599 . . . . 2.7400000000000002 111.99 176.355 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -58.29 -31.39 67.44 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 118.343 0.519 . . . . 4.6900000000000004 111.343 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 69.1 mt -62.95 -57.29 12.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-N 119.219 0.918 . . . . 2.02 109.95 166.167 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 87.2 mtt180 -48.64 -42.09 33.21 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.633 0.773 . . . . 4.1299999999999999 112.62 -178.066 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 91.3 mt-10 -50.9 -29.84 13.07 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 124.621 1.168 . . . . 3.7999999999999998 113.272 177.166 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 51.1 mt -82.04 -16.28 50.71 Favored 'General case' 0 N--CA 1.454 -0.26 0 O-C-N 121.711 -0.618 . . . . 1.9399999999999999 110.316 -178.162 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 134.66 -44.91 1.15 Allowed Glycine 0 C--N 1.34 0.756 0 C-N-CA 124.731 1.158 . . . . 2.4300000000000002 110.546 169.876 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 5.0 m-30 -78.37 129.04 34.51 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-O 121.278 0.561 . . . . 2.8900000000000001 109.612 -166.388 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -73.15 108.18 2.43 Favored Glycine 0 N--CA 1.442 -0.934 0 N-CA-C 110.878 -0.889 . . . . 1.3799999999999999 110.878 -171.544 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -82.91 124.33 30.25 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.073 0.949 . . . . 1.5800000000000001 109.72 179.006 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -118.34 126.35 51.94 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 108.36 -0.978 . . . . 2.75 108.36 164.113 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 65.3 t -83.36 139.11 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 C-N-CA 125.42 1.488 . . . . 1.8500000000000001 109.299 -169.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 12.1 mt -134.44 59.76 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 CA-C-O 122.439 1.114 . . . . 2.3100000000000001 109.001 -178.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 81.8 mt-10 . . . . . 0 CA--C 1.534 0.336 0 N-CA-C 107.969 -1.123 . . . . 4.6699999999999999 107.969 159.664 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.4 t . . . . . 0 C--O 1.231 0.097 0 N-CA-C 108.147 -1.057 . . . . 3.3399999999999999 108.147 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.7 m -90.57 177.44 6.36 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 107.688 -1.227 . . . . 2.1099999999999999 107.688 165.34 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.14 152.28 31.1 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 118.909 -0.567 . . . . 6.1699999999999999 110.636 165.937 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 49.1 t -137.82 154.65 49.51 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 124.63 1.172 . . . . 1.6200000000000001 108.973 171.655 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 2.5 m-30 -100.83 150.55 22.69 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 106.916 -1.513 . . . . 2.1899999999999999 106.916 176.556 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.477 HD12 HD13 ' A' ' 35' ' ' LEU . 13.5 mt -144.27 126.25 10.35 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 N-CA-C 104.773 -2.306 . . . . 1.8300000000000001 104.773 -175.451 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 3.6 tp60 -88.23 134.36 33.81 Favored 'General case' 0 N--CA 1.442 -0.866 0 N-CA-C 106.045 -1.835 . . . . 2.73 106.045 173.015 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 16.1 m -128.39 175.81 9.18 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 C-N-CA 125.343 1.457 . . . . 2.3599999999999999 109.457 -176.572 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 13.7 t -140.0 179.19 6.76 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 109.339 -0.615 . . . . 3.9199999999999999 109.339 172.598 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 84.51 -54.81 4.96 Favored Glycine 0 C--N 1.332 0.351 0 N-CA-C 105.566 -3.014 . . . . 2.8900000000000001 105.566 -163.456 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 32.4 ttm 82.48 -58.67 0.19 Allowed 'General case' 0 N--CA 1.441 -0.887 0 C-N-CA 126.964 2.106 . . . . 3.29 108.955 158.651 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.8 t -157.96 98.85 1.64 Allowed 'General case' 0 N--CA 1.442 -0.875 0 N-CA-C 106.441 -1.689 . . . . 5.9500000000000002 106.441 153.113 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.4 m -72.46 55.18 0.34 Allowed 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.184 0.994 . . . . 3.1699999999999999 109.01 175.911 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 50.93 71.04 0.46 Allowed 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.668 1.187 . . . . 2.98 111.338 -160.578 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.4 m 78.24 21.48 0.84 Allowed 'General case' 0 C--O 1.226 -0.177 0 C-N-CA 124.89 1.276 . . . . 3.6699999999999999 113.607 169.088 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -51.72 -32.42 30.18 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 124.62 1.168 . . . . 3.5499999999999998 109.558 166.068 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 19.6 m -53.85 -40.46 44.29 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 CA-C-N 115.28 -0.873 . . . . 2.5499999999999998 111.622 175.47 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.63 -46.15 70.4 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.157 0.983 . . . . 0.90000000000000002 110.15 175.174 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -58.43 -52.95 63.45 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 108.872 -0.788 . . . . 2.1099999999999999 108.872 171.832 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 58.2 mt -56.65 -56.32 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-O 118.473 -0.775 . . . . 1.99 109.102 -173.32 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -39.61 -61.21 0.85 Allowed 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 126.132 1.773 . . . . 3.1299999999999999 110.893 171.354 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.43 -39.99 61.65 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 124.068 0.947 . . . . 6.9699999999999998 111.176 178.004 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.603 ' OD1' HD13 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -71.04 -53.65 13.98 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 124.293 1.037 . . . . 3.2599999999999998 108.831 -175.492 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.603 HD13 ' OD1' ' A' ' 24' ' ' ASN . 0.0 OUTLIER -64.1 -27.34 69.03 Favored 'General case' 0 N--CA 1.462 0.17 0 O-C-N 121.07 -1.019 . . . . 2.4100000000000001 112.247 -177.103 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 58.3 mtp180 -67.95 -14.48 63.0 Favored 'General case' 0 N--CA 1.452 -0.368 0 O-C-N 121.761 -0.587 . . . . 5.8099999999999996 111.7 178.576 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -57.92 -38.79 76.51 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-N 119.158 0.89 . . . . 7.8300000000000001 112.69 161.624 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -93.05 68.3 4.35 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-O 121.977 0.894 . . . . 8.5299999999999994 109.255 -149.66 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -27.1 109.71 0.04 OUTLIER 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 127.116 2.166 . . . . 5.5800000000000001 110.057 163.462 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 135.51 -48.72 0.92 Allowed Glycine 0 CA--C 1.528 0.867 0 N-CA-C 108.246 -1.942 . . . . 1.3300000000000001 108.246 -151.691 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -78.64 133.42 30.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 C-N-CA 124.521 1.129 . . . . 2.9399999999999999 110.298 -173.085 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 24.7 t80 -141.32 35.87 1.69 Allowed 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 122.065 0.936 . . . . 6.8899999999999997 110.632 172.852 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 43.2 t -167.5 147.14 5.12 Favored 'General case' 0 N--CA 1.449 -0.478 1 C-N-CA 132.854 4.461 . . . . 2.3300000000000001 101.54 140.836 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.8 pp -78.71 156.58 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 C-N-CA 118.561 -1.256 . . . . 2.0499999999999998 108.536 165.632 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.754 HD22 ' CG1' ' A' ' 45' ' ' VAL . 0.6 OUTLIER -96.18 72.15 2.87 Favored 'General case' 0 N--CA 1.427 -1.591 0 C-N-CA 126.767 2.027 . . . . 4.7000000000000002 109.771 -173.978 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 24.7 t -135.13 141.04 43.92 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 O-C-N 121.017 -1.052 . . . . 1.4199999999999999 108.518 163.795 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -156.9 59.91 0.53 Allowed 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 125.866 1.666 . . . . 0.87 106.632 169.824 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -46.11 -36.95 6.28 Favored 'General case' 0 CA--C 1.512 -0.515 0 C-N-CA 125.603 1.561 . . . . 3.3599999999999999 113.12 -178.637 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.83 -41.12 96.0 Favored 'General case' 0 N--CA 1.439 -0.987 0 N-CA-C 108.511 -0.922 . . . . 4.7300000000000004 108.511 -164.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -77.05 -42.49 38.21 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.494 0.717 . . . . 1.4299999999999999 109.903 167.433 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 102.37 64.93 0.74 Allowed Glycine 0 C--N 1.336 0.572 0 N-CA-C 109.072 -1.611 . . . . 1.46 109.072 179.019 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -160.07 176.14 12.16 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 106.982 -1.488 . . . . 5.7400000000000002 106.982 -179.472 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.69 ' HB1' HD12 ' A' ' 35' ' ' LEU . . . -131.94 137.39 47.93 Favored 'General case' 0 N--CA 1.435 -1.188 0 C-N-CA 126.382 1.873 . . . . 1.0700000000000001 107.907 174.69 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.404 ' H ' ' HA ' ' A' ' 35' ' ' LEU . 5.6 pt-20 -128.8 109.0 10.9 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 114.456 1.28 . . . . 2.6899999999999999 114.456 177.473 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.754 ' CG1' HD22 ' A' ' 35' ' ' LEU . 3.7 m -83.9 103.33 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 N-CA-C 108.522 -0.918 . . . . 3.2799999999999998 108.522 176.765 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 7.8 ttm105 -84.43 114.34 21.83 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 103.837 -2.653 . . . . 6.8700000000000001 103.837 160.037 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -151.77 173.02 15.24 Favored 'General case' 0 C--N 1.332 -0.16 0 O-C-N 121.53 -0.731 . . . . 2.2599999999999998 112.728 -163.057 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -126.05 105.1 25.74 Favored Pre-proline 0 N--CA 1.447 -0.598 0 C-N-CA 123.666 0.786 . . . . 3.29 110.603 172.369 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -79.74 63.53 8.75 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 122.804 2.336 . . . . 1.72 109.17 -178.203 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -130.68 -49.6 1.05 Allowed 'General case' 0 C--O 1.227 -0.119 0 C-N-CA 124.187 0.995 . . . . 2.3999999999999999 109.005 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 43.0 t -63.66 -57.98 9.42 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 N-CA-C 109.609 -0.515 . . . . 2.04 109.609 174.761 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.627 HG23 ' H ' ' A' ' 53' ' ' GLN . 19.9 tt -115.01 -118.04 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.694 0 C-N-CA 124.147 0.979 . . . . 2.8700000000000001 108.469 -167.589 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.627 ' H ' HG23 ' A' ' 52' ' ' ILE . 5.7 tp60 179.99 111.73 0.19 Allowed Pre-proline 0 CA--C 1.541 0.602 0 N-CA-C 109.296 -0.631 . . . . 2.4300000000000002 109.296 -155.763 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo -46.61 -49.72 11.61 Favored 'Trans proline' 0 CA--C 1.533 0.457 0 C-N-CA 124.42 3.413 . . . . 1.8200000000000001 116.43 176.412 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -51.25 -54.21 5.79 Favored 'Trans proline' 0 N--CA 1.444 -1.439 0 C-N-CA 121.251 1.301 . . . . 1.29 109.868 170.46 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 65.6 mtt -52.45 -48.64 65.71 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 118.339 0.518 . . . . 1.6799999999999999 111.558 -179.305 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 81.5 mt -51.74 -54.09 14.31 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.862 0 CA-C-N 117.876 0.307 . . . . 2.7599999999999998 110.654 175.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.85 -33.15 74.66 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 120.76 -1.212 . . . . 1.3200000000000001 113.761 176.556 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -70.58 -52.85 18.74 Favored 'General case' 0 N--CA 1.44 -0.935 0 O-C-N 120.36 -1.462 . . . . 3.8300000000000001 110.676 -177.156 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -46.1 -43.74 15.03 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 122.548 1.165 . . . . 4.75 111.855 -178.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.61 ' CD1' HD11 ' A' ' 35' ' ' LEU . 96.8 mt -55.61 -44.5 76.88 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 C-N-CA 124.078 0.951 . . . . 1.3500000000000001 111.531 176.801 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 70.6 mtm180 -70.84 -42.04 70.7 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 124.509 1.123 . . . . 4.3499999999999996 111.428 176.512 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -54.52 -38.92 67.11 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 123.6 0.76 . . . . 2.8999999999999999 110.328 175.428 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 83.8 mt -79.36 -37.49 37.32 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 118.843 -0.598 . . . . 2.6099999999999999 110.771 174.491 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 165.76 -34.09 0.24 Allowed Glycine 0 CA--C 1.529 0.937 0 N-CA-C 115.641 1.016 . . . . 2.2999999999999998 115.641 165.7 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -77.85 128.74 34.45 Favored 'General case' 0 C--N 1.334 -0.078 0 CA-C-N 118.504 1.152 . . . . 2.9500000000000002 111.369 -159.924 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -70.21 79.08 0.41 Allowed Glycine 0 CA--C 1.523 0.541 0 C-N-CA 124.307 0.956 . . . . 1.6899999999999999 113.019 -175.511 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -83.53 126.66 33.03 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 125.561 1.545 . . . . 0.85999999999999999 111.044 -178.069 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -131.7 136.0 47.31 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 107.002 -1.481 . . . . 2.3100000000000001 107.002 174.175 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 25.6 m -82.05 153.47 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 CA-C-N 118.753 0.706 . . . . 3.21 110.757 -171.769 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 50.3 mt -136.07 120.06 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 C-N-CA 125.952 1.701 . . . . 2.1699999999999999 106.553 173.272 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 . . . . . 0 C--N 1.332 -0.177 0 N-CA-C 107.936 -1.135 . . . . 5.8399999999999999 107.936 -176.853 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.2 p . . . . . 0 N--CA 1.45 -0.445 0 CA-C-O 120.803 0.335 . . . . 2.79 111.15 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 18.7 m -149.62 174.75 12.21 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 107.595 -1.261 . . . . 1.8500000000000001 107.595 173.696 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -142.71 142.78 32.05 Favored 'General case' 0 CA--C 1.528 0.116 0 N-CA-C 108.209 -1.034 . . . . 3.4399999999999999 108.209 177.431 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.4 ' HB3' ' CG1' ' A' ' 45' ' ' VAL . 10.2 t -140.48 155.66 46.6 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 123.15 0.58 . . . . 1.3600000000000001 110.981 -163.689 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 52.6 m-85 -110.06 83.79 1.82 Allowed 'General case' 0 C--O 1.222 -0.348 0 C-N-CA 124.997 1.319 . . . . 2.1800000000000002 108.793 -178.167 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.456 ' HB ' ' HB3' ' A' ' 43' ' ' ALA . 50.8 mt -78.6 139.06 19.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 106.51 -1.663 . . . . 1.6399999999999999 106.51 -177.813 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -104.6 135.9 45.15 Favored 'General case' 0 C--O 1.231 0.126 0 N-CA-C 107.203 -1.406 . . . . 5.4800000000000004 107.203 168.332 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 46.5 t -131.53 108.95 15.2 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 C-N-CA 124.787 1.235 . . . . 3.0 108.917 -168.657 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 17.9 p -60.35 99.15 0.07 Allowed 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 120.957 0.408 . . . . 3.1499999999999999 111.176 -179.292 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 109.85 -28.41 10.63 Favored Glycine 0 C--N 1.338 0.667 0 C-N-CA 124.975 1.274 . . . . 2.1400000000000001 111.22 178.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 4.1 mpp? 67.53 -65.55 0.23 Allowed 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 127.011 2.124 . . . . 6.0099999999999998 108.059 -166.483 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -154.93 -103.62 0.04 OUTLIER 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 105.01 -2.218 . . . . 8.8200000000000003 105.01 160.558 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.0 p -145.58 35.77 1.06 Allowed 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.032 0.533 . . . . 3.3700000000000001 111.364 176.382 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 81.1 132.87 0.06 Allowed 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 127.166 2.186 . . . . 3.79 111.687 179.173 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 13.8 m 72.99 -39.24 0.44 Allowed 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 125.623 1.569 . . . . 4.6699999999999999 114.667 173.733 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 34.4 m -50.33 -28.55 8.13 Favored 'General case' 0 CA--C 1.517 -0.309 0 C-N-CA 130.346 3.458 . . . . 5.1500000000000004 111.487 175.862 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 5.8 m -41.88 -41.18 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 112.165 0.431 . . . . 2.8700000000000001 112.165 167.615 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.66 -41.65 73.95 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 124.732 1.213 . . . . 1.95 111.976 178.041 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -61.18 -51.88 67.15 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 108.229 -1.026 . . . . 4.21 108.229 170.026 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 22.6 mt -64.37 -57.11 12.83 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.542 0 N-CA-C 107.617 -1.253 . . . . 3.3900000000000001 107.617 -166.085 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -44.72 -45.5 9.88 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 126.706 2.002 . . . . 6.1100000000000003 113.237 -179.356 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 40.3 ttp180 -59.25 -47.52 85.07 Favored 'General case' 0 N--CA 1.449 -0.482 0 O-C-N 121.338 -0.852 . . . . 4.6600000000000001 111.0 171.391 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -62.94 -22.08 66.53 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.708 1.603 . . . . 3.4199999999999999 110.355 177.385 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.766 HD13 HD21 ' A' ' 35' ' ' LEU . 12.1 mt -75.96 -60.49 2.3 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 124.478 1.111 . . . . 2.8900000000000001 112.575 170.312 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.421 ' HG3' HG22 ' A' ' 34' ' ' ILE . 33.7 mtm180 -65.39 -17.66 64.7 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-N 119.146 0.884 . . . . 7.5999999999999996 112.768 -178.405 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -39.76 -53.35 2.24 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-O 116.064 -1.922 . . . . 7.4699999999999998 112.528 158.096 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -168.5 173.17 7.68 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 118.256 2.687 . . . . 6.9100000000000001 118.256 -164.741 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 77.57 57.7 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 129.61 3.164 . . . . 5.7599999999999998 111.726 170.311 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 57.2 27.4 57.57 Favored Glycine 0 CA--C 1.527 0.809 0 CA-C-N 114.945 -1.025 . . . . 1.26 112.616 176.105 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.9 mm -88.25 136.42 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 C-N-CA 124.413 1.085 . . . . 2.4399999999999999 108.447 175.867 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -143.03 48.39 1.49 Allowed 'General case' 0 C--N 1.341 0.235 0 CA-C-O 123.22 1.486 . . . . 3.6699999999999999 112.703 169.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 43.5 t -160.31 -179.27 7.56 Favored 'General case' 0 C--N 1.316 -0.874 0 C-N-CA 129.576 3.151 . . . . 1.76 105.484 152.029 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.421 HG22 ' HG3' ' A' ' 26' ' ' ARG . 0.1 OUTLIER -100.06 172.74 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 107.181 -1.414 . . . . 2.7599999999999998 107.181 153.085 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.766 HD21 HD13 ' A' ' 25' ' ' LEU . 0.3 OUTLIER -137.62 63.07 1.56 Allowed 'General case' 0 N--CA 1.429 -1.486 0 C-N-CA 130.904 3.682 . . . . 4.1900000000000004 108.555 -168.686 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 10.1 t -130.27 129.67 65.19 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.857 0 CA-C-N 115.33 -0.85 . . . . 1.27 109.414 164.873 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -130.15 62.92 1.56 Allowed 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 105.824 -1.917 . . . . 0.87 105.824 162.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.81 -31.12 71.32 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 109.687 -0.486 . . . . 3.54 109.687 -172.799 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 27.7 ptm -46.79 -38.24 9.84 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.406 1.082 . . . . 3.7200000000000002 113.245 169.596 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -94.07 -48.27 6.3 Favored 'General case' 0 C--N 1.339 0.137 0 C-N-CA 123.618 0.767 . . . . 1.53 109.415 177.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 115.13 45.24 0.64 Allowed Glycine 0 CA--C 1.522 0.53 0 N-CA-C 108.517 -1.833 . . . . 0.94999999999999996 108.517 179.308 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 61.6 mttt -147.6 176.63 9.92 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 126.343 1.857 . . . . 4.2199999999999998 108.016 -171.205 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.456 ' HB3' ' HB ' ' A' ' 7' ' ' ILE . . . -142.12 112.48 7.09 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 124.228 1.011 . . . . 1.1899999999999999 110.26 -169.829 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -105.01 85.63 2.31 Favored 'General case' 0 C--N 1.349 0.551 0 N-CA-C 115.718 1.747 . . . . 3.3500000000000001 115.718 -171.342 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.477 ' CA ' ' HB3' ' A' ' 35' ' ' LEU . 7.9 p -81.81 150.02 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.173 0 C-N-CA 123.259 0.624 . . . . 1.52 109.592 -174.05 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 20.1 ttt85 -119.94 129.38 54.3 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 104.637 -2.357 . . . . 4.5700000000000003 104.637 157.064 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 4.6 p90 -150.32 164.28 36.18 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 124.508 1.123 . . . . 2.2200000000000002 110.862 -163.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -109.95 90.48 9.46 Favored Pre-proline 0 C--O 1.237 0.406 0 C-N-CA 124.373 1.069 . . . . 2.5499999999999998 111.471 175.432 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -69.57 79.34 0.89 Allowed 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 122.769 2.313 . . . . 1.5800000000000001 110.697 172.81 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -160.88 -48.07 0.05 OUTLIER 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 128.683 2.793 . . . . 1.0800000000000001 105.156 173.088 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 73.4 t -67.34 -68.04 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.855 0 C-N-CA 123.877 0.871 . . . . 1.71 108.893 162.137 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . 0.256 16.8 tt -88.59 -57.51 4.18 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 N-CA-C 115.903 1.816 . . . . 2.21 115.903 -153.631 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 83.72 133.48 0.04 OUTLIER Pre-proline 0 CA--C 1.543 0.675 0 C-N-CA 127.414 2.286 . . . . 2.6000000000000001 110.984 -173.446 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -37.4 -49.51 1.77 Allowed 'Trans proline' 0 CA--C 1.537 0.664 1 C-N-CA 126.603 4.869 . . . . 1.5800000000000001 117.707 171.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -44.09 -61.89 0.51 Allowed 'Trans proline' 0 N--CA 1.448 -1.158 0 C-N-CA 121.847 1.698 . . . . 1.1299999999999999 110.642 167.588 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 43.0 mtt -60.12 -41.81 93.42 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 118.759 -0.639 . . . . 1.79 112.291 -175.14 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.422 HD12 HG11 ' A' ' 45' ' ' VAL . 1.0 OUTLIER -55.87 -40.45 62.12 Favored 'Isoleucine or valine' 0 C--N 1.348 0.519 0 CA-C-N 119.304 0.957 . . . . 3.6699999999999999 111.604 -178.106 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.35 -55.42 9.17 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 121.655 0.74 . . . . 1.3 110.681 171.814 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -64.37 -35.51 81.14 Favored 'General case' 0 N--CA 1.437 -1.083 0 N-CA-C 114.128 1.158 . . . . 3.1600000000000001 114.128 -162.047 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 39.0 m-85 -53.28 -36.85 61.62 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 119.596 1.089 . . . . 3.2799999999999998 110.946 170.78 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 17.3 mt -68.81 -34.02 62.39 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 O-C-N 121.154 -0.966 . . . . 1.49 109.638 -179.661 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 68.8 mtt180 -61.34 -50.77 71.58 Favored 'General case' 0 C--N 1.341 0.203 0 N-CA-C 109.282 -0.636 . . . . 4.0499999999999998 109.282 171.458 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -56.61 -35.7 68.57 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 123.717 0.807 . . . . 2.9900000000000002 111.905 177.451 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 77.1 mt -77.35 -17.88 57.89 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 118.891 -0.576 . . . . 2.21 111.277 175.798 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 151.56 -24.41 0.95 Allowed Glycine 0 CA--C 1.527 0.782 0 CA-C-N 118.973 0.806 . . . . 1.9199999999999999 114.261 163.563 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -121.36 129.76 53.24 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 118.633 1.217 . . . . 3.4500000000000002 111.806 -152.754 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -69.56 91.93 0.33 Allowed Glycine 0 N--CA 1.447 -0.624 0 N-CA-C 111.057 -0.817 . . . . 1.8100000000000001 111.057 -169.543 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -92.55 137.18 32.59 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 126.325 1.85 . . . . 0.93999999999999995 111.84 -178.334 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 3.3 t -134.17 144.3 48.42 Favored 'General case' 0 N--CA 1.439 -0.989 0 N-CA-C 108.161 -1.052 . . . . 3.2799999999999998 108.161 166.71 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 8.8 p -94.14 129.55 44.3 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 C-N-CA 126.17 1.788 . . . . 2.3799999999999999 109.657 -167.592 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 19.4 mm -137.59 126.85 35.09 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 C-N-CA 124.082 0.953 . . . . 3.7799999999999998 108.627 -178.875 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 . . . . . 0 CA--C 1.533 0.296 0 CA-C-O 121.946 0.879 . . . . 4.3700000000000001 109.556 165.978 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.0 p . . . . . 0 N--CA 1.452 -0.375 0 N-CA-C 110.464 -0.199 . . . . 2.8199999999999998 110.464 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.4 t -113.76 175.51 5.43 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 124.675 1.19 . . . . 3.3199999999999998 109.136 174.63 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 59.9 tttt -106.7 151.18 25.45 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 124.753 1.221 . . . . 4.4500000000000002 110.638 -174.271 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 42.1 t -147.61 150.48 34.51 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 108.343 -0.984 . . . . 1.4099999999999999 108.343 167.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -96.01 133.94 39.63 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 107.171 -1.418 . . . . 2.21 107.171 178.75 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.602 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 19.3 mt -135.88 90.78 0.9 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.364 0 N-CA-C 105.748 -1.945 . . . . 2.1499999999999999 105.748 -170.606 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . 0.291 0.8 OUTLIER -81.43 123.9 28.97 Favored 'General case' 0 N--CA 1.435 -1.185 0 C-N-CA 125.977 1.711 . . . . 3.1200000000000001 108.619 -162.347 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 30.6 m -117.47 175.07 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 C-N-CA 124.201 1.0 . . . . 2.1499999999999999 110.315 -171.884 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.9 t -148.3 37.22 0.84 Allowed 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 112.435 0.531 . . . . 3.6499999999999999 112.435 175.275 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -139.31 130.02 4.63 Favored Glycine 0 N--CA 1.446 -0.693 1 N-CA-C 102.148 -4.381 . . . . 3.6099999999999999 102.148 138.315 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -164.04 -33.82 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 124.357 1.063 . . . . 3.2400000000000002 111.016 -169.536 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 6.7 t -111.88 23.72 13.49 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 108.379 -0.971 . . . . 4.4699999999999998 108.379 162.572 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 24.4 p -80.97 38.0 0.45 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.889 1.276 . . . . 3.0699999999999998 110.95 -175.159 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 72.48 177.54 0.25 Allowed 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.654 1.582 . . . . 2.9100000000000001 110.637 -152.69 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -77.26 32.09 0.15 Allowed 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 114.674 1.361 . . . . 2.8100000000000001 114.674 -162.683 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 85.7 m -48.79 -39.15 24.19 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 126.065 1.746 . . . . 3.54 110.576 175.401 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 29.1 m -46.16 -48.08 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 C-N-CA 124.795 1.238 . . . . 3.0299999999999998 111.303 174.113 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.94 -43.77 70.09 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 124.351 1.06 . . . . 0.92000000000000004 110.469 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -65.76 -51.81 56.06 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 108.566 -0.902 . . . . 2.8399999999999999 108.566 174.374 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 31.1 mt -60.35 -53.36 49.87 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 N-CA-C 108.384 -0.969 . . . . 2.5699999999999998 108.384 -168.837 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -40.68 -58.68 1.57 Allowed 'General case' 0 C--O 1.234 0.242 0 C-N-CA 126.316 1.847 . . . . 4.0899999999999999 111.588 171.009 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 20.0 mmm180 -56.59 -41.2 76.56 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.062 -0.517 . . . . 5.6500000000000004 110.907 177.422 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -71.7 -29.76 64.91 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 124.388 1.075 . . . . 3.3999999999999999 110.38 -176.912 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -70.51 -58.1 4.06 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 124.499 1.119 . . . . 2.4399999999999999 110.0 176.96 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . 0.258 62.1 mtt180 -65.06 -14.52 60.67 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 115.062 1.504 . . . . 9.3699999999999992 115.062 -171.205 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 16.9 mtm180 -54.24 -38.23 65.53 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 119.426 1.012 . . . . 7.1299999999999999 111.484 166.038 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 38.7 mm-40 -92.14 81.82 5.04 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 107.985 -1.117 . . . . 6.7999999999999998 107.985 -153.413 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 46.2 tt0 -41.68 125.06 2.68 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.97 0.908 . . . . 8.6799999999999997 108.943 174.597 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 127.65 -52.36 0.83 Allowed Glycine 0 CA--C 1.522 0.501 0 N-CA-C 107.733 -2.147 . . . . 1.4299999999999999 107.733 -155.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 1.3 mt -83.46 143.3 12.18 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.147 0 C-N-CA 124.718 1.207 . . . . 2.1000000000000001 108.274 171.841 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -144.93 42.11 1.31 Allowed 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 119.032 -1.067 . . . . 3.4199999999999999 113.579 150.804 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 68.2 m -163.19 143.85 9.28 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 127.632 2.373 . . . . 1.8400000000000001 109.767 156.073 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.54 ' H ' ' CD1' ' A' ' 34' ' ' ILE . 0.0 OUTLIER -81.44 134.25 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.836 0 C-N-CA 125.948 1.699 . . . . 2.7400000000000002 111.144 -178.973 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.562 ' HA ' ' H ' ' A' ' 44' ' ' GLU . 0.6 OUTLIER -80.02 71.73 6.75 Favored 'General case' 0 N--CA 1.432 -1.361 0 O-C-N 121.072 -1.018 . . . . 4.7199999999999998 110.061 174.051 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 22.3 t -135.63 131.06 50.55 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 CA-C-O 121.631 0.729 . . . . 1.26 111.847 169.529 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -149.15 67.15 1.03 Allowed 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 127.685 2.394 . . . . 0.92000000000000004 106.796 167.406 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -53.3 -31.97 46.57 Favored 'General case' 0 CA--C 1.512 -0.502 0 N-CA-C 113.228 0.825 . . . . 3.52 113.228 -177.117 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 63.8 mtt -66.74 -42.95 85.4 Favored 'General case' 0 N--CA 1.44 -0.929 0 C-N-CA 119.385 -0.926 . . . . 4.4299999999999997 109.099 -165.749 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -73.31 -36.27 66.22 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.426 0.69 . . . . 1.5700000000000001 109.69 166.773 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 97.8 55.35 1.15 Allowed Glycine 0 CA--C 1.507 -0.449 0 N-CA-C 106.548 -2.621 . . . . 0.97999999999999998 106.548 178.387 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 24.0 mmtm -150.15 176.06 11.18 Favored 'General case' 0 N--CA 1.44 -0.928 0 N-CA-C 106.18 -1.785 . . . . 6.3600000000000003 106.18 -165.663 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.602 ' HB3' ' O ' ' A' ' 7' ' ' ILE . . . -162.07 127.05 3.37 Favored 'General case' 0 N--CA 1.432 -1.341 0 N-CA-C 107.142 -1.429 . . . . 1.1899999999999999 107.142 -162.48 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.562 ' H ' ' HA ' ' A' ' 35' ' ' LEU . 0.6 OUTLIER -151.84 107.73 3.38 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 113.371 0.878 . . . . 3.9900000000000002 113.371 -174.206 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.7 p -81.79 155.06 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.022 0 C-N-CA 124.001 0.92 . . . . 1.5900000000000001 109.62 -169.558 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 46.0 ttt180 -118.78 128.81 54.83 Favored 'General case' 0 CA--C 1.521 -0.162 0 N-CA-C 106.769 -1.567 . . . . 5.3600000000000003 106.769 158.019 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -158.63 175.23 13.91 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 123.824 0.85 . . . . 2.21 110.35 -167.715 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -110.79 140.08 22.3 Favored Pre-proline 0 N--CA 1.448 -0.53 0 N-CA-C 106.979 -1.489 . . . . 3.0800000000000001 106.979 156.624 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -85.41 3.72 7.08 Favored 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 122.385 2.056 . . . . 2.98 113.29 -175.027 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -91.3 -50.18 5.96 Favored 'General case' 0 CA--C 1.519 -0.248 0 N-CA-C 107.943 -1.132 . . . . 1.24 107.943 -168.889 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 45.0 t -61.78 -59.07 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.97 0 C-N-CA 124.557 1.143 . . . . 1.03 110.379 178.87 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 10.7 tt -95.38 -37.06 7.22 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.261 0 CA-C-O 118.615 -0.707 . . . . 2.0800000000000001 112.743 -162.061 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 13.4 mm-40 88.78 125.74 0.03 OUTLIER Pre-proline 0 CA--C 1.54 0.56 0 C-N-CA 128.926 2.89 . . . . 2.8100000000000001 113.466 176.788 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.4 ' HA ' HG22 ' A' ' 57' ' ' ILE . 79.6 Cg_exo -49.89 -48.76 18.18 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 124.593 3.529 . . . . 1.46 116.944 179.325 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -53.11 -50.74 12.98 Favored 'Trans proline' 0 N--CA 1.444 -1.407 0 CA-C-N 120.758 1.307 . . . . 1.54 108.843 172.383 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 66.4 mtt -65.18 -43.77 90.61 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 120.62 -0.432 . . . . 1.8600000000000001 110.486 -171.728 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.428 HG21 HD13 ' A' ' 57' ' ' ILE . 7.5 tt -63.54 -35.4 72.47 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 C-N-CA 120.386 -0.526 . . . . 2.1800000000000002 110.407 -177.63 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -65.86 -50.14 65.61 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 121.916 0.865 . . . . 1.21 110.384 171.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -70.87 -35.93 72.6 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-O 117.483 -1.246 . . . . 2.7599999999999998 113.964 -166.807 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 9.2 m-30 -45.88 -41.75 11.74 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 119.642 1.11 . . . . 3.2599999999999998 110.206 172.46 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 7.9 mt -69.54 -35.54 66.89 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 O-C-N 121.825 -0.547 . . . . 1.4399999999999999 111.164 -178.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 68.9 mtt180 -66.27 -52.72 44.69 Favored 'General case' 0 C--O 1.226 -0.169 0 N-CA-C 109.013 -0.736 . . . . 4.4100000000000001 109.013 176.337 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -55.31 -53.54 54.83 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 125.633 1.573 . . . . 2.9399999999999999 110.792 -178.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 74.6 mt -84.52 -32.51 23.87 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 119.17 -0.443 . . . . 2.3100000000000001 111.916 -172.714 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -115.59 -87.64 1.42 Allowed Glycine 0 CA--C 1.525 0.705 0 N-CA-C 111.7 -0.56 . . . . 2.2000000000000002 111.7 -174.692 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -140.64 -69.1 0.4 Allowed 'General case' 0 CA--C 1.512 -0.514 0 CA-C-O 122.219 1.009 . . . . 3.3599999999999999 112.767 -152.354 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 168.14 137.95 2.35 Favored Glycine 0 N--CA 1.437 -1.293 0 N-CA-C 105.648 -2.981 . . . . 1.8700000000000001 105.648 -149.56 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -155.93 110.99 2.93 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 108.481 -0.933 . . . . 1.3 108.481 -170.424 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.4 p -116.36 113.59 23.12 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 125.15 1.38 . . . . 2.27 107.947 -174.256 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 12.1 m -81.39 138.51 19.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 N-CA-C 109.365 -0.605 . . . . 2.8199999999999998 109.365 -170.791 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 19.5 pt -144.68 152.26 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 N-CA-C 107.74 -1.207 . . . . 2.96 107.74 175.043 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 . . . . . 0 N--CA 1.455 -0.18 0 N-CA-C 107.085 -1.45 . . . . 6.1100000000000003 107.085 167.129 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.4 m . . . . . 0 CA--C 1.54 0.588 0 N-CA-C 109.47 -0.567 . . . . 3.1400000000000001 109.47 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.5 m -94.83 135.02 36.83 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 125.303 1.441 . . . . 1.8899999999999999 109.273 -175.511 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 52.5 tttt -85.86 118.25 25.23 Favored 'General case' 0 CA--C 1.528 0.097 0 C-N-CA 124.281 1.033 . . . . 4.0899999999999999 109.222 175.686 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 96.5 m -127.16 131.2 50.79 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 108.872 -0.788 . . . . 3.9900000000000002 108.872 -178.163 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -89.52 135.87 33.35 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 124.491 1.117 . . . . 2.4700000000000002 108.533 -171.359 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 9.0 mt -132.16 157.24 43.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 106.529 -1.656 . . . . 1.7 106.529 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 29.9 tp60 -129.98 127.1 39.33 Favored 'General case' 0 N--CA 1.434 -1.261 0 N-CA-C 104.743 -2.317 . . . . 2.77 104.743 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 27.0 m -106.91 176.95 1.09 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 C-N-CA 125.177 1.391 . . . . 2.1800000000000002 110.085 -172.389 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 12.1 t -141.49 145.02 34.69 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 109.107 -0.701 . . . . 2.73 109.107 167.856 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 67.9 115.79 0.02 OUTLIER Glycine 0 C--N 1.335 0.508 0 N-CA-C 105.443 -3.063 . . . . 2.8599999999999999 105.443 -138.692 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 65.6 mtp -89.59 -101.44 0.09 Allowed 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 113.481 -1.359 . . . . 4.0499999999999998 108.88 -176.524 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 10.9 p -75.17 -42.28 56.27 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.153 0.981 . . . . 5.3600000000000003 109.726 177.696 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 56.7 m 55.34 21.92 4.52 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 126.697 1.999 . . . . 2.6800000000000002 112.099 178.364 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 50.87 36.62 15.16 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.297 1.039 . . . . 3.1299999999999999 113.495 -168.904 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 76.2 p 145.61 16.79 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 128.275 2.63 . . . . 2.9900000000000002 115.739 160.737 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.7 m -60.02 -35.98 76.26 Favored 'General case' 0 C--O 1.234 0.265 0 O-C-N 120.71 -1.244 . . . . 2.9399999999999999 109.872 175.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.444 HG12 HD23 ' A' ' 38' ' ' LEU . 15.2 m -65.95 -52.94 43.19 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 CA-C-N 116.089 -0.505 . . . . 2.3100000000000001 110.963 -179.333 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -47.94 -46.01 31.65 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.152 0.581 . . . . 0.88 110.616 171.569 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -55.43 -52.05 64.87 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 120.995 0.426 . . . . 1.77 110.144 174.059 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -61.9 -48.1 90.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 C-N-CA 123.768 0.827 . . . . 1.73 110.686 -175.243 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -52.25 -53.8 39.27 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 125.113 1.365 . . . . 3.1299999999999999 109.178 173.269 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 29.9 mmt180 -55.3 -41.53 72.46 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 118.414 -0.803 . . . . 5.2300000000000004 111.573 176.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 56.9 m-20 -74.34 -67.97 0.57 Allowed 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 118.829 0.74 . . . . 3.9100000000000001 112.406 -177.183 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.564 ' CD2' HD21 ' A' ' 35' ' ' LEU . 0.1 OUTLIER -75.8 -14.79 60.31 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 126.594 1.958 . . . . 2.5600000000000001 113.558 -164.637 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -21.1 -74.49 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 128.433 2.693 . . . . 8.8800000000000008 113.51 -168.165 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . 0.266 11.3 ptp180 -95.74 -62.13 1.34 Allowed 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 117.589 2.44 . . . . 12.43 117.589 170.696 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 30.54 -150.95 0.0 OUTLIER 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 129.711 3.205 . . . . 6.0800000000000001 111.965 -154.687 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -95.68 92.53 6.63 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 106.058 -1.83 . . . . 7.4000000000000004 106.058 167.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 115.07 13.94 8.8 Favored Glycine 0 CA--C 1.529 0.916 0 CA-C-O 117.137 -1.924 . . . . 1.0900000000000001 115.654 164.492 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 1.6 mt -104.04 129.52 56.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-N 120.531 2.166 . . . . 2.02 108.53 172.61 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -136.83 43.41 2.41 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 121.828 0.823 . . . . 3.1600000000000001 111.19 159.138 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 67.7 m -170.74 143.52 2.14 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 129.295 3.038 . . . . 1.51 106.35 135.699 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -83.9 160.89 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 CA-C-O 122.012 0.91 . . . . 2.4300000000000002 110.783 175.099 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.663 ' HB2' ' HB1' ' A' ' 43' ' ' ALA . 0.3 OUTLIER -72.44 69.72 0.85 Allowed 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 129.437 3.095 . . . . 5.2699999999999996 109.091 -179.035 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 23.9 t -130.6 130.83 65.04 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 CA-C-O 121.844 0.83 . . . . 1.8500000000000001 113.09 170.443 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -158.04 56.86 0.47 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 127.635 2.374 . . . . 0.71999999999999997 107.201 156.388 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.444 HD23 HG12 ' A' ' 18' ' ' VAL . 4.0 mm? -74.3 -11.08 60.17 Favored 'General case' 0 N--CA 1.463 0.191 0 O-C-N 121.058 -1.026 . . . . 5.2800000000000002 112.542 -171.716 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 27.6 ttt -53.81 -40.13 66.11 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 109.848 -0.427 . . . . 3.75 109.848 163.242 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -89.39 -34.41 16.51 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.423 0.689 . . . . 1.3100000000000001 110.487 172.908 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 106.02 44.62 1.37 Allowed Glycine 0 CA--C 1.524 0.649 0 N-CA-C 109.379 -1.488 . . . . 0.75 109.379 -179.131 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 45.8 mttt -155.02 -177.52 6.59 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 125.869 1.668 . . . . 4.4699999999999998 107.364 -153.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.663 ' HB1' ' HB2' ' A' ' 35' ' ' LEU . . . -153.87 146.98 24.6 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 125.483 1.513 . . . . 1.4199999999999999 110.432 -168.857 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -129.22 106.52 8.88 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-O 121.265 0.555 . . . . 4.3200000000000003 110.021 161.49 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -83.74 116.84 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 N-CA-C 106.165 -1.791 . . . . 2.0899999999999999 106.165 173.239 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 29.8 ttm180 -109.2 116.3 31.64 Favored 'General case' 0 CA--C 1.515 -0.381 0 N-CA-C 106.192 -1.781 . . . . 5.6500000000000004 106.192 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -148.97 173.66 13.1 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 114.65 1.352 . . . . 2.1699999999999999 114.65 -158.025 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -102.7 94.64 5.35 Favored Pre-proline 0 N--CA 1.452 -0.347 0 N-CA-C 106.795 -1.558 . . . . 3.3199999999999998 106.795 166.643 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -67.75 -4.27 11.92 Favored 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 122.408 2.072 . . . . 2.6099999999999999 113.292 -172.748 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -82.47 -28.56 31.14 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 124.175 0.99 . . . . 1.1699999999999999 108.554 177.71 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 87.0 t -84.85 -67.33 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.137 0 C-N-CA 124.629 1.172 . . . . 1.1899999999999999 107.939 -174.638 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 15.2 tt -87.45 -36.58 9.9 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 N-CA-C 113.016 0.747 . . . . 1.8300000000000001 113.016 -163.73 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 15.7 mm-40 86.88 119.18 0.03 OUTLIER Pre-proline 0 CA--C 1.541 0.625 0 C-N-CA 129.27 3.028 . . . . 2.96 112.834 -179.204 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -50.18 -47.94 21.92 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 125.117 3.878 . . . . 1.03 117.907 -178.107 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -59.08 -44.56 33.75 Favored 'Trans proline' 0 N--CA 1.442 -1.505 0 N-CA-C 108.785 -1.275 . . . . 1.02 108.785 172.026 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 87.6 mtp -69.46 -40.93 76.83 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-O 119.373 -0.346 . . . . 1.8799999999999999 110.11 -167.023 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 16.4 tt -61.87 -54.37 35.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 119.628 -0.829 . . . . 2.4199999999999999 110.765 175.72 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -46.88 -51.65 16.23 Favored 'General case' 0 C--N 1.342 0.262 0 C-N-CA 123.73 0.812 . . . . 0.96999999999999997 112.138 174.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -54.79 -51.35 66.05 Favored 'General case' 0 N--CA 1.442 -0.855 0 C-N-CA 125.292 1.437 . . . . 3.4300000000000002 111.237 175.898 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -48.68 -40.43 28.06 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 123.55 0.74 . . . . 3.6000000000000001 111.525 178.013 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.4 mm -58.14 -40.87 79.11 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-O 121.606 0.717 . . . . 2.2000000000000002 110.069 179.126 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 27.0 mtt85 -67.24 -50.54 60.28 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 123.623 0.769 . . . . 4.25 109.114 177.554 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -53.88 -48.98 69.52 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 124.034 0.933 . . . . 2.75 111.405 -178.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.7 pp -83.26 -30.98 27.21 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 119.271 -0.395 . . . . 2.8300000000000001 111.831 -175.555 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -123.3 -87.82 0.83 Allowed Glycine 0 CA--C 1.524 0.63 0 N-CA-C 111.455 -0.658 . . . . 1.6799999999999999 111.455 -175.666 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 26.5 m-85 -139.62 -74.85 0.36 Allowed 'General case' 0 CA--C 1.513 -0.452 0 CA-C-O 121.837 0.827 . . . . 3.8599999999999999 112.888 -151.718 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 171.34 128.9 1.07 Allowed Glycine 0 N--CA 1.438 -1.175 0 N-CA-C 107.825 -2.11 . . . . 1.54 107.825 -155.253 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -155.2 127.51 7.78 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 123.843 0.857 . . . . 0.90000000000000002 109.243 -172.14 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -118.23 131.03 56.39 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 126.166 1.787 . . . . 2.4100000000000001 106.724 179.312 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 79.6 t -87.05 127.68 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.737 0 C-N-CA 125.164 1.385 . . . . 1.6100000000000001 107.94 -175.856 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 13.5 mt -134.38 62.04 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 CA-C-O 122.387 1.089 . . . . 1.79 108.515 -173.187 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 . . . . . 0 C--N 1.327 -0.405 0 C-N-CA 124.231 1.012 . . . . 4.7599999999999998 109.449 171.744 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 56.4 p . . . . . 0 CA--C 1.536 0.406 0 N-CA-C 114.703 1.372 . . . . 4.3399999999999999 114.703 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.0 m -139.71 169.93 16.83 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 124.53 1.132 . . . . 1.77 109.564 -176.328 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.32 143.08 35.63 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 110.329 -0.249 . . . . 4.3499999999999996 110.329 168.637 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 51.4 t -141.28 149.62 41.52 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 125.072 1.349 . . . . 1.51 108.532 -171.949 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -106.26 142.9 35.17 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.185 1.394 . . . . 3.0699999999999998 108.422 179.661 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -141.43 109.09 2.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 107.255 -1.387 . . . . 2.6299999999999999 107.255 -163.003 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 17.5 tt0 -79.21 147.09 32.73 Favored 'General case' 0 N--CA 1.422 -1.851 0 N-CA-C 107.094 -1.447 . . . . 2.9700000000000002 107.094 -178.456 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.1 p -150.83 134.41 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 N-CA-C 108.825 -0.806 . . . . 2.8599999999999999 108.825 -168.686 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 6.1 m -83.19 73.5 10.09 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 121.959 0.885 . . . . 2.27 110.66 -167.232 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 121.57 94.25 1.3 Allowed Glycine 0 N--CA 1.443 -0.862 0 CA-C-O 124.664 2.258 . . . . 2.8500000000000001 107.765 175.943 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.443 ' HE3' HG22 ' A' ' 18' ' ' VAL . 11.9 tpt -95.56 -70.21 0.72 Allowed 'General case' 0 N--CA 1.422 -1.829 0 CA-C-N 109.456 -3.372 . . . . 7.3899999999999997 107.521 -172.857 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 5.7 m -108.08 52.89 0.7 Allowed 'General case' 0 N--CA 1.456 -0.175 0 N-CA-C 108.585 -0.895 . . . . 5.7199999999999998 108.585 -177.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 21.3 m -64.82 -61.02 2.43 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 107.507 -1.294 . . . . 3.7799999999999998 107.507 176.076 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -174.37 70.18 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 127.556 2.343 . . . . 2.7000000000000002 106.979 174.046 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . 0.26 16.6 p 77.63 23.0 0.85 Allowed 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 126.959 2.104 . . . . 2.48 114.676 176.22 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 80.1 m -52.12 -39.43 59.87 Favored 'General case' 0 CA--C 1.536 0.416 0 O-C-N 121.108 -0.995 . . . . 3.27 109.413 157.141 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.443 HG22 ' HE3' ' A' ' 12' ' ' MET . 1.0 OUTLIER -42.49 -47.87 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.034 0 C-N-CA 126.248 1.819 . . . . 2.8300000000000001 114.12 161.989 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.73 -36.07 82.54 Favored 'General case' 0 C--O 1.234 0.247 0 O-C-N 121.511 -0.743 . . . . 1.2 110.396 176.778 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -58.56 -51.79 68.4 Favored 'General case' 0 C--O 1.219 -0.522 0 N-CA-C 108.341 -0.985 . . . . 1.9199999999999999 108.341 169.708 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 86.6 mt -53.88 -52.55 34.51 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-N 119.108 0.867 . . . . 2.8799999999999999 109.863 -176.938 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.932 ' HA ' HD13 ' A' ' 34' ' ' ILE . 18.4 mt-10 -48.33 -48.7 36.09 Favored 'General case' 0 N--CA 1.444 -0.774 0 O-C-N 121.006 -1.059 . . . . 3.6099999999999999 112.722 172.22 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 5.6 ttm-85 -66.42 -27.35 67.76 Favored 'General case' 0 N--CA 1.444 -0.744 0 O-C-N 121.736 -0.603 . . . . 6.7199999999999998 112.426 173.933 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -72.78 -56.91 4.55 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 119.309 0.959 . . . . 4.46 110.571 -169.882 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.4 mt -69.52 -33.11 72.34 Favored 'General case' 0 C--O 1.223 -0.309 0 C-N-CA 119.429 -0.908 . . . . 3.23 113.003 -161.335 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.59 -17.78 0.36 Allowed 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 114.498 1.295 . . . . 7.7800000000000002 114.498 168.944 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -35.67 -56.44 0.68 Allowed 'General case' 0 C--N 1.343 0.308 0 O-C-N 121.014 -1.054 . . . . 9.8599999999999994 111.559 162.601 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.502 ' HB3' HD11 ' A' ' 52' ' ' ILE . 9.6 mt-10 -96.36 119.58 35.11 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 118.972 -1.091 . . . . 9.4900000000000002 111.492 -140.797 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 47.8 mp0 -58.51 106.4 0.39 Allowed 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.303 1.441 . . . . 4.8799999999999999 109.197 179.704 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 122.02 -1.1 10.81 Favored Glycine 0 CA--C 1.529 0.941 0 CA-C-O 118.992 -0.893 . . . . 1.26 111.915 -171.2 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -78.52 138.19 20.64 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-N 118.432 1.116 . . . . 1.9199999999999999 110.672 177.225 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -147.91 48.34 1.07 Allowed 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 122.038 0.923 . . . . 3.27 112.993 164.129 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.7 m -169.2 173.24 6.85 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 129.354 3.062 . . . . 2.4500000000000002 106.487 129.186 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.932 HD13 ' HA ' ' A' ' 22' ' ' GLU . 1.8 pp -120.1 139.41 47.48 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 N-CA-C 102.841 -3.022 . . . . 2.6499999999999999 102.841 161.045 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.467 ' HB2' ' HB3' ' A' ' 44' ' ' GLU . 1.7 mp -148.14 157.17 43.35 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 119.269 0.941 . . . . 6.8799999999999999 109.523 -167.136 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.514 ' O ' HG12 ' A' ' 36' ' ' VAL . 2.1 t -155.05 73.0 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 CA-C-O 124.857 2.265 . . . . 2.29 107.649 -159.805 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -80.29 59.51 3.42 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 113.714 -1.584 . . . . 1.1899999999999999 109.089 169.416 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.401 ' CD2' HG21 ' A' ' 18' ' ' VAL . 0.4 OUTLIER -59.64 -29.91 68.35 Favored 'General case' 0 CA--C 1.505 -0.78 0 O-C-N 121.462 -0.774 . . . . 3.9300000000000002 111.608 173.905 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 2.7 mpt? -62.35 -34.46 76.7 Favored 'General case' 0 N--CA 1.438 -1.045 0 C-N-CA 118.861 -1.136 . . . . 3.7400000000000002 109.167 -169.578 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -76.99 -53.87 7.28 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.523 0.729 . . . . 1.96 109.336 164.082 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 131.39 50.37 0.1 Allowed Glycine 0 C--N 1.338 0.676 0 N-CA-C 109.943 -1.263 . . . . 1.4399999999999999 109.943 173.389 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 75.1 mttt -149.86 150.82 32.5 Favored 'General case' 0 N--CA 1.442 -0.87 0 N-CA-C 108.656 -0.868 . . . . 4.3300000000000001 108.656 -169.176 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -76.11 163.53 27.02 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 105.577 -2.008 . . . . 1.73 105.577 155.056 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.467 ' HB3' ' HB2' ' A' ' 35' ' ' LEU . 52.5 tt0 -128.24 157.68 40.22 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 106.108 -1.812 . . . . 3.5800000000000001 106.108 163.743 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 6.8 p -132.46 134.06 59.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 N-CA-C 106.176 -1.787 . . . . 1.77 106.176 173.34 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 33.2 ttm105 -105.34 130.23 53.5 Favored 'General case' 0 N--CA 1.456 -0.165 0 N-CA-C 105.632 -1.988 . . . . 4.5800000000000001 105.632 157.759 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 5.1 p90 -155.63 172.8 17.68 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 123.082 0.553 . . . . 2.02 110.262 -164.246 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -117.78 80.59 14.24 Favored Pre-proline 0 C--O 1.238 0.45 0 CA-C-N 115.969 -0.559 . . . . 2.7599999999999998 112.211 -174.143 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -66.47 87.17 0.27 Allowed 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 123.46 2.773 . . . . 2.5299999999999998 108.531 174.201 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -178.45 -47.35 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 130.25 3.42 . . . . 2.5600000000000001 105.937 -176.213 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 73.9 t -81.42 -57.62 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.712 0 N-CA-C 108.588 -0.893 . . . . 2.0299999999999998 108.588 168.291 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.502 HD11 ' HB3' ' A' ' 28' ' ' GLU . 12.1 tt -90.09 -44.97 15.07 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.21 0 N-CA-C 115.44 1.644 . . . . 2.4900000000000002 115.44 -146.451 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 21.9 tp60 91.86 110.94 0.02 OUTLIER Pre-proline 0 CA--C 1.55 0.979 0 C-N-CA 127.244 2.218 . . . . 3.1000000000000001 111.087 176.005 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -43.04 -48.35 7.8 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 124.773 3.649 . . . . 1.3700000000000001 118.127 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -54.84 -43.35 60.1 Favored 'Trans proline' 0 N--CA 1.448 -1.162 0 CA-C-N 121.329 1.51 . . . . 1.23 110.507 172.753 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 63.9 mtt -62.37 -44.82 95.56 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 118.397 -0.811 . . . . 2.1299999999999999 110.044 178.16 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.458 HD11 HG21 ' A' ' 52' ' ' ILE . 5.7 mm -48.4 -57.06 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 CA-C-N 119.08 0.855 . . . . 2.9199999999999999 109.903 172.305 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -55.22 -46.71 75.94 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.052 0.541 . . . . 1.3 112.073 -177.081 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -70.23 -44.91 67.6 Favored 'General case' 0 N--CA 1.44 -0.948 0 C-N-CA 124.62 1.168 . . . . 3.0899999999999999 112.74 -176.622 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -48.59 -36.81 16.47 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 123.968 0.907 . . . . 3.9399999999999999 111.571 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 22.1 mt -69.98 -40.58 78.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 N-CA-C 109.658 -0.497 . . . . 1.3999999999999999 109.658 178.484 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 80.1 mtm-85 -70.96 -31.36 67.91 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 118.24 -0.886 . . . . 4.0599999999999996 112.692 -178.283 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 87.1 mt-10 -41.19 -44.33 2.55 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.926 1.291 . . . . 4.7000000000000002 113.764 179.238 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.42 -12.89 58.78 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.105 0.962 . . . . 2.8900000000000001 111.704 -173.696 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 111.32 -2.03 28.09 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 124.742 1.163 . . . . 2.3799999999999999 111.499 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -76.57 86.2 3.26 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 107.993 -1.114 . . . . 3.0099999999999998 107.993 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -61.4 104.41 0.69 Allowed Glycine 0 N--CA 1.442 -0.932 0 C-N-CA 125.672 1.606 . . . . 1.6899999999999999 109.177 -178.008 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -137.99 151.84 48.31 Favored 'General case' 0 N--CA 1.45 -0.457 0 O-C-N 124.981 1.048 . . . . 1.3899999999999999 112.494 -163.369 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 29.8 m -135.34 138.63 43.59 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 125.769 1.627 . . . . 2.6600000000000001 107.976 -170.499 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 12.7 t -82.77 111.36 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 C-N-CA 124.972 1.309 . . . . 1.8300000000000001 107.73 -177.034 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 16.2 mt -134.27 66.03 0.29 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.331 0 C-N-CA 124.499 1.119 . . . . 2.6499999999999999 109.231 -172.048 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 . . . . . 0 CA--C 1.531 0.239 0 C-N-CA 129.794 3.238 . . . . 8.0999999999999996 106.121 150.16 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 12.1 m . . . . . 0 CA--C 1.529 0.156 0 CA-C-O 123.105 1.431 . . . . 2.52 107.682 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -84.69 127.36 34.06 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 128.586 2.755 . . . . 2.1899999999999999 109.955 -168.426 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 37.2 tttt -81.83 144.13 31.25 Favored 'General case' 0 C--N 1.34 0.178 0 CA-C-N 118.761 0.71 . . . . 4.1600000000000001 109.272 174.603 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 45.5 t -143.18 156.01 44.67 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.402 0.681 . . . . 1.3200000000000001 109.324 170.628 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -102.52 139.67 37.82 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 124.555 1.142 . . . . 2.6600000000000001 108.528 175.685 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.7 mp -133.24 130.01 57.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 N-CA-C 104.91 -2.255 . . . . 2.0899999999999999 104.91 174.869 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 36.4 tp60 -91.7 126.04 36.64 Favored 'General case' 0 N--CA 1.433 -1.289 0 N-CA-C 104.042 -2.577 . . . . 3.25 104.042 169.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.4 m -109.4 136.35 45.56 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 N-CA-C 108.386 -0.968 . . . . 2.2599999999999998 108.386 179.525 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 6.1 m -87.22 55.35 3.51 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 108.925 -0.768 . . . . 2.23 108.925 171.487 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -143.95 123.08 1.95 Allowed Glycine 0 N--CA 1.445 -0.732 0 N-CA-C 103.464 -3.854 . . . . 3.1600000000000001 103.464 148.4 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 70.6 mtm -136.6 -71.92 0.45 Allowed 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 106.515 -1.661 . . . . 4.25 106.515 -176.202 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 4.9 t -74.93 51.04 0.48 Allowed 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 109.307 -0.627 . . . . 5.7599999999999998 109.307 163.121 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 14.5 t -114.42 121.65 44.21 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 105.12 -2.178 . . . . 3.0499999999999998 105.12 175.926 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -71.53 82.19 0.81 Allowed 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 123.57 0.748 . . . . 2.7799999999999998 111.999 -157.746 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 87.63 38.12 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 127.684 2.394 . . . . 2.5299999999999998 109.857 -177.916 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.8 t -47.59 -41.0 20.7 Favored 'General case' 0 CA--C 1.521 -0.136 0 C-N-CA 125.082 1.353 . . . . 3.7799999999999998 108.83 168.68 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 15.1 m -66.32 -53.34 37.43 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.06 0 CA-C-N 113.49 -1.687 . . . . 2.2200000000000002 110.321 -175.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -50.44 -45.15 55.78 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.39 0.676 . . . . 0.81999999999999995 110.309 172.485 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -56.84 -56.39 22.17 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 109.597 -0.52 . . . . 2.0299999999999998 109.597 175.66 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 27.5 mt -52.58 -54.46 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 C-N-CA 124.268 1.027 . . . . 2.3199999999999998 110.199 -179.262 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -50.32 -59.01 4.4 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 124.985 1.314 . . . . 2.9300000000000002 110.088 176.903 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 21.5 tpt180 -55.48 -41.83 73.55 Favored 'General case' 0 N--CA 1.443 -0.801 0 C-N-CA 124.666 1.186 . . . . 5.1200000000000001 111.515 -176.56 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 15.3 m-20 -72.31 -64.46 0.94 Allowed 'General case' 0 C--O 1.222 -0.362 0 N-CA-C 109.609 -0.515 . . . . 3.52 109.609 179.163 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.873 HD12 HD21 ' A' ' 35' ' ' LEU 0.319 6.9 mt -80.54 -11.09 59.71 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 128.69 2.796 . . . . 3.6600000000000001 116.808 -159.484 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -19.57 -71.5 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 126.777 2.031 . . . . 9.3300000000000001 114.345 175.458 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 30.4 mmt180 -92.35 -60.7 1.77 Allowed 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 118.828 2.899 . . . . 12.91 118.828 -179.419 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.408 ' H ' ' CD ' ' A' ' 28' ' ' GLU 0.262 2.5 mm-40 8.27 62.84 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.685 1 C-N-CA 132.665 4.386 . . . . 5.8300000000000001 112.314 -152.328 . . . . . . . . 4 3 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 18.06 58.13 0.01 OUTLIER 'General case' 0 C--N 1.343 0.299 0 C-N-CA 129.685 3.194 . . . . 6.9400000000000004 113.257 -169.342 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 166.63 -28.7 0.18 Allowed Glycine 0 CA--C 1.522 0.503 0 C-N-CA 120.134 -1.031 . . . . 1.5 113.488 -171.189 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.7 mt -81.6 111.96 18.87 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 N-CA-C 106.212 -1.773 . . . . 1.96 106.212 174.883 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 47.9 m-85 -122.6 44.16 2.71 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 122.832 1.301 . . . . 3.29 110.547 166.371 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 33.7 t -166.78 137.54 3.24 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 126.799 2.04 . . . . 1.73 105.952 142.838 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.2 pp -78.59 151.44 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.651 0 N-CA-C 107.5 -1.296 . . . . 1.9099999999999999 107.5 171.374 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.873 HD21 HD12 ' A' ' 25' ' ' LEU . 0.3 OUTLIER -94.69 77.43 3.73 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 129.466 3.106 . . . . 4.3300000000000001 110.243 -169.273 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 43.3 t -131.59 139.71 49.97 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.801 0 N-CA-C 108.997 -0.742 . . . . 1.5 108.997 168.24 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -155.99 55.99 0.59 Allowed 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 106.618 -1.623 . . . . 0.67000000000000004 106.618 168.714 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -71.61 -20.32 62.0 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 114.74 -1.118 . . . . 3.0600000000000001 111.017 -172.412 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 53.0 ttm -45.23 -38.29 5.34 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.621 0.768 . . . . 3.3999999999999999 110.935 164.157 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -95.51 -48.67 5.74 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.234 0.614 . . . . 1.79 110.235 170.674 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 119.67 54.82 0.26 Allowed Glycine 0 C--N 1.338 0.64 0 N-CA-C 109.813 -1.315 . . . . 0.91000000000000003 109.813 -177.578 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 10.2 pttt -159.15 177.98 10.5 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 107.991 -1.114 . . . . 4.1100000000000003 107.991 -173.007 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.514 ' HB1' ' HB2' ' A' ' 35' ' ' LEU . . . -132.31 124.36 28.67 Favored 'General case' 0 N--CA 1.441 -0.904 0 C-N-CA 127.081 2.153 . . . . 0.90000000000000002 108.705 -169.102 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -125.03 89.06 2.99 Favored 'General case' 0 C--N 1.343 0.296 0 N-CA-C 113.776 1.028 . . . . 3.29 113.776 -175.454 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.431 HG11 ' CD2' ' A' ' 47' ' ' TYR . 9.6 p -78.65 152.1 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.088 0 N-CA-C 108.707 -0.849 . . . . 1.6399999999999999 108.707 -174.213 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 63.9 ttm-85 -114.85 112.58 22.99 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 106.705 -1.591 . . . . 4.46 106.705 156.489 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.512 ' CZ ' ' HG3' ' A' ' 54' ' ' PRO . 0.0 OUTLIER -123.15 165.42 16.89 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 124.304 1.041 . . . . 2.3199999999999998 113.19 -169.629 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 32.6 t30 -126.94 90.99 48.12 Favored Pre-proline 0 N--CA 1.451 -0.386 0 C-N-CA 125.99 1.716 . . . . 2.3799999999999999 109.015 -178.533 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -71.64 71.26 2.6 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 122.895 2.397 . . . . 1.8500000000000001 112.081 179.122 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -123.92 -49.11 1.86 Allowed 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 126.201 1.8 . . . . 1.96 106.853 157.054 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 41.0 t -83.52 -61.44 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.923 0 C-N-CA 124.741 1.216 . . . . 1.75 110.567 175.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.473 HG23 ' H ' ' A' ' 53' ' ' GLN . 6.1 tp -78.58 -71.67 0.29 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.414 0 N-CA-C 113.008 0.744 . . . . 1.6499999999999999 113.008 -161.277 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.473 ' H ' HG23 ' A' ' 52' ' ' ILE . 4.0 mp0 82.81 128.78 0.03 OUTLIER Pre-proline 0 CA--C 1.548 0.887 0 C-N-CA 128.293 2.637 . . . . 3.8700000000000001 113.248 -176.401 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.512 ' HG3' ' CZ ' ' A' ' 47' ' ' TYR . 21.5 Cg_exo -42.88 -52.48 4.62 Favored 'Trans proline' 0 C--N 1.349 0.562 1 C-N-CA 126.744 4.963 . . . . 1.29 117.687 177.594 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -54.06 -49.25 17.73 Favored 'Trans proline' 0 N--CA 1.442 -1.553 0 CA-C-N 120.11 1.075 . . . . 0.84999999999999998 109.678 173.305 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 61.3 mtt -64.93 -45.26 86.57 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.193 -0.669 . . . . 2.1800000000000002 109.193 -170.066 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.427 HG22 ' HA ' ' A' ' 54' ' ' PRO . 16.2 tt -59.7 -49.75 82.58 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 C-N-CA 119.087 -1.045 . . . . 2.6299999999999999 111.527 177.287 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -51.8 -53.78 36.2 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 118.319 0.508 . . . . 1.0900000000000001 111.758 176.668 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -56.53 -54.49 45.25 Favored 'General case' 0 N--CA 1.432 -1.367 0 C-N-CA 124.511 1.125 . . . . 3.1200000000000001 110.676 -179.731 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 18.7 m-30 -50.25 -43.1 52.99 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 119.103 0.865 . . . . 4.1200000000000001 110.833 178.154 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 85.6 mt -65.43 -40.83 89.53 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 O-C-N 121.712 -0.617 . . . . 1.21 110.083 -179.307 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 51.8 mtp180 -59.12 -51.83 68.33 Favored 'General case' 0 CA--C 1.533 0.322 0 O-C-N 121.905 -0.497 . . . . 5.4199999999999999 111.211 171.177 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -56.5 -32.95 65.53 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 125.507 1.523 . . . . 3.0899999999999999 111.673 179.572 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 59.5 mt -77.2 -17.43 58.52 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 119.184 -0.436 . . . . 1.98 110.629 176.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 135.42 -9.67 4.36 Favored Glycine 0 CA--C 1.526 0.72 0 C-N-CA 124.069 0.842 . . . . 2.2799999999999998 112.964 167.519 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -110.28 115.03 28.96 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 118.481 1.14 . . . . 3.25 110.02 -160.606 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -63.71 86.96 0.06 OUTLIER Glycine 0 N--CA 1.447 -0.625 0 CA-C-N 115.868 -0.606 . . . . 1.3899999999999999 112.065 -176.264 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -84.06 127.74 34.09 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 126.074 1.75 . . . . 0.94999999999999996 109.829 178.284 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 9.6 t -122.18 130.38 53.15 Favored 'General case' 0 N--CA 1.436 -1.132 0 N-CA-C 105.785 -1.932 . . . . 2.2200000000000002 105.785 165.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 77.0 t -83.74 135.89 23.91 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.89 0 N-CA-C 107.398 -1.334 . . . . 1.79 107.398 -177.531 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 17.9 mt -126.91 73.81 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 N-CA-C 107.034 -1.469 . . . . 1.9099999999999999 107.034 -178.697 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 115.097 -0.956 . . . . 3.6400000000000001 110.958 167.02 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.1 p . . . . . 0 CA--C 1.538 0.519 0 N-CA-C 114.57 1.322 . . . . 2.4700000000000002 114.57 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.6 p -91.49 172.38 8.55 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 128.096 2.559 . . . . 2.21 111.075 -177.213 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 6.1 tttt -108.53 156.47 19.46 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 124.755 1.222 . . . . 4.5999999999999996 108.563 166.738 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -145.26 175.35 10.35 Favored 'General case' 0 C--O 1.235 0.324 0 O-C-N 124.142 0.901 . . . . 2.0600000000000001 109.97 162.32 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 45.0 m-85 -115.93 139.79 49.89 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 126.31 1.844 . . . . 2.8500000000000001 108.321 -171.982 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.7 pt -136.28 122.9 31.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 C-N-CA 123.914 0.885 . . . . 3.1499999999999999 110.602 178.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -80.33 132.48 35.81 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 106.677 -1.601 . . . . 3.7599999999999998 106.677 171.942 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.7 m -107.85 121.1 60.32 Favored 'Isoleucine or valine' 0 C--O 1.232 0.147 0 O-C-N 124.038 0.836 . . . . 2.1099999999999999 109.658 -176.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.3 m -66.17 73.48 0.08 Allowed 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.138 0.975 . . . . 2.46 111.596 177.229 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -173.47 -59.14 0.05 OUTLIER Glycine 0 CA--C 1.522 0.478 0 N-CA-C 106.788 -2.525 . . . . 3.3700000000000001 106.788 172.76 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 25.2 ttm 69.03 -33.21 0.24 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 126.686 1.994 . . . . 4.1699999999999999 114.664 170.56 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.7 t -155.22 52.87 0.62 Allowed 'General case' 0 N--CA 1.446 -0.625 0 C-N-CA 124.668 1.187 . . . . 4.7300000000000004 108.163 177.068 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 12.5 p -58.01 -43.05 86.47 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 108.413 -0.958 . . . . 2.7000000000000002 108.413 164.692 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 156.92 -59.88 0.0 OUTLIER 'General case' 0 CA--C 1.521 -0.16 0 C-N-CA 129.514 3.126 . . . . 3.8900000000000001 107.177 166.961 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.0 p -99.11 42.63 1.09 Allowed 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.367 1.067 . . . . 3.0699999999999998 110.916 -174.715 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 37.7 m -52.79 -51.73 59.59 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 108.49 -0.93 . . . . 4.7000000000000002 108.49 178.834 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.2 p -63.77 -55.31 23.21 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.67 0 CA-C-O 121.936 0.874 . . . . 3.6200000000000001 111.232 -178.542 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.32 -30.88 67.03 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.513 -1.221 . . . . 1.0800000000000001 112.598 -175.301 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -68.19 -57.22 6.37 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 119.68 1.127 . . . . 3.0600000000000001 108.276 169.401 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.694 HG22 HD11 ' A' ' 34' ' ' ILE 0.255 1.5 mt -62.83 -35.69 72.13 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.894 0 O-C-N 121.868 -0.52 . . . . 1.97 110.362 -166.991 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.525 ' HG2' HD12 ' A' ' 34' ' ' ILE . 16.0 mt-10 -43.59 -56.7 3.54 Favored 'General case' 0 N--CA 1.453 -0.302 0 O-C-N 121.483 -0.761 . . . . 3.3799999999999999 110.385 171.043 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.41 ' H ' ' HD2' ' A' ' 23' ' ' ARG . 0.2 OUTLIER -63.5 -44.57 93.93 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 115.414 -0.812 . . . . 5.96 110.438 175.783 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.649 ' OD1' HD13 ' A' ' 25' ' ' LEU . 0.2 OUTLIER -60.31 -42.46 95.61 Favored 'General case' 0 C--O 1.223 -0.299 0 C-N-CA 122.922 0.489 . . . . 3.9399999999999999 111.717 -168.741 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.649 HD13 ' OD1' ' A' ' 24' ' ' ASN 0.337 5.2 mp -80.33 -43.93 20.37 Favored 'General case' 0 N--CA 1.435 -1.21 0 C-N-CA 126.081 1.752 . . . . 2.7999999999999998 113.101 175.486 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 83.7 mtt180 -66.2 -20.47 66.14 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 119.364 -2.085 . . . . 7.5099999999999998 112.721 -174.503 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 4.8 mmt180 -29.98 -62.86 0.14 Allowed 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 125.717 1.607 . . . . 8.3300000000000001 112.992 162.055 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 150.98 176.92 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.178 0 C-N-CA 128.049 2.54 . . . . 7.5 106.345 -158.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 101.88 32.09 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 129.477 3.111 . . . . 8.5399999999999991 111.379 -167.464 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 55.9 42.88 87.26 Favored Glycine 0 CA--C 1.526 0.736 0 O-C-N 121.752 -0.592 . . . . 1.73 111.682 177.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 1.4 mp -74.04 142.57 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 CA-C-N 117.066 0.433 . . . . 2.2000000000000002 110.102 176.633 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -145.81 41.86 1.22 Allowed 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 122.449 1.118 . . . . 3.6899999999999999 113.657 158.939 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 58.8 m -167.93 157.8 10.15 Favored 'General case' 0 C--N 1.319 -0.743 1 C-N-CA 132.698 4.399 . . . . 2.2999999999999998 104.12 133.14 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.694 HD11 HG22 ' A' ' 21' ' ' ILE . 0.0 OUTLIER -109.65 144.95 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 N-CA-C 104.712 -2.329 . . . . 2.5600000000000001 104.712 155.636 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.659 ' N ' HD13 ' A' ' 34' ' ' ILE . 0.3 OUTLIER -147.65 148.43 31.05 Favored 'General case' 0 N--CA 1.434 -1.247 0 C-N-CA 125.965 1.706 . . . . 6.5599999999999996 106.504 -167.543 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.498 HG23 HG21 ' A' ' 21' ' ' ILE . 1.3 t -156.7 96.18 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 N-CA-C 105.207 -2.145 . . . . 2.1099999999999999 105.207 174.396 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -77.22 66.35 2.99 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 115.295 -0.866 . . . . 0.69999999999999996 109.419 176.348 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.492 HD23 ' HA ' ' A' ' 38' ' ' LEU . 9.5 mt -53.18 -36.58 61.08 Favored 'General case' 0 C--N 1.342 0.245 0 C-N-CA 123.35 0.66 . . . . 2.6400000000000001 110.832 173.752 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 16.3 tpt -51.42 -39.66 57.77 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.715 0.806 . . . . 5.0899999999999999 111.809 173.658 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -88.68 -23.94 22.88 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.621 0.769 . . . . 1.6100000000000001 111.436 178.594 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 89.09 41.83 5.77 Favored Glycine 0 C--N 1.335 0.488 0 N-CA-C 110.188 -1.165 . . . . 0.88 110.188 179.048 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 58.4 pttt -156.1 158.16 37.25 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 107.879 -1.156 . . . . 3.6699999999999999 107.879 177.541 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.423 ' HA ' ' HA ' ' A' ' 36' ' ' VAL . . . -83.88 163.98 19.73 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 108.798 -0.816 . . . . 1.4199999999999999 108.798 170.422 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.445 ' CB ' ' HB2' ' A' ' 35' ' ' LEU . 55.3 mt-10 -131.2 157.72 42.44 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.214 -0.661 . . . . 2.6600000000000001 109.214 174.751 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.593 HG12 HD21 ' A' ' 25' ' ' LEU . 13.4 m -134.7 142.43 40.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 N-CA-C 109.432 -0.581 . . . . 2.6600000000000001 109.432 173.1 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 49.1 ttt180 -127.02 125.72 41.9 Favored 'General case' 0 CA--C 1.516 -0.353 0 N-CA-C 106.487 -1.671 . . . . 5.5199999999999996 106.487 158.888 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 22.1 p90 -157.37 171.94 19.49 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 109.187 -0.672 . . . . 2.1200000000000001 109.187 -163.763 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 50.7 t-20 -103.69 93.52 5.22 Favored Pre-proline 0 CA--C 1.534 0.329 0 C-N-CA 123.207 0.603 . . . . 2.6299999999999999 110.544 176.12 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -65.24 80.86 0.21 Allowed 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 123.015 2.477 . . . . 1.6799999999999999 110.26 169.37 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -168.85 -56.61 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 128.916 2.886 . . . . 1.0800000000000001 104.894 172.748 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 68.1 t -57.24 -55.42 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 C-N-CA 124.509 1.124 . . . . 0.94999999999999996 109.689 171.58 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.505 HG23 ' H ' ' A' ' 53' ' ' GLN 0.251 9.7 tp -95.73 -75.82 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.369 0 CA-C-O 118.514 -0.755 . . . . 2.5099999999999998 111.54 -172.079 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.505 ' H ' HG23 ' A' ' 52' ' ' ILE . 0.3 OUTLIER 114.2 137.06 0.0 OUTLIER Pre-proline 0 N--CA 1.47 0.545 0 C-N-CA 130.815 3.646 . . . . 2.4300000000000002 107.012 -173.163 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_exo -50.98 -50.89 12.46 Favored 'Trans proline' 0 CA--C 1.534 0.476 0 C-N-CA 123.432 2.755 . . . . 1.0900000000000001 114.57 176.646 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -52.1 -48.8 19.84 Favored 'Trans proline' 0 N--CA 1.444 -1.406 0 CA-C-N 120.525 1.223 . . . . 1.03 110.383 168.084 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 62.7 mtt -66.14 -35.05 79.45 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 118.447 -1.301 . . . . 2.96 110.879 -171.749 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 4.4 tt -70.13 -44.98 77.64 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 CA-C-N 119.502 1.047 . . . . 2.2599999999999998 109.933 176.274 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -53.67 -41.06 66.47 Favored 'General case' 0 C--N 1.341 0.228 0 N-CA-C 112.266 0.469 . . . . 1.1000000000000001 112.266 175.642 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 30.8 mm-40 -66.66 -59.94 3.15 Favored 'General case' 0 N--CA 1.437 -1.093 0 C-N-CA 124.94 1.296 . . . . 2.6200000000000001 110.564 174.964 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -54.41 -42.75 70.84 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 117.897 0.317 . . . . 4.4800000000000004 110.231 -170.846 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.8 mt -56.26 -37.15 48.85 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 O-C-N 121.487 -0.758 . . . . 1.6699999999999999 111.637 176.517 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 42.6 mtm105 -70.18 -44.33 68.94 Favored 'General case' 0 N--CA 1.456 -0.142 0 O-C-N 121.605 -0.684 . . . . 3.8799999999999999 111.22 173.27 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -56.55 -33.89 66.55 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 119.189 0.904 . . . . 3.2400000000000002 111.604 175.266 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 83.6 mt -78.74 -16.58 57.04 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.845 0.858 . . . . 3.0800000000000001 111.362 175.253 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 136.65 -12.49 3.98 Favored Glycine 0 CA--C 1.528 0.852 0 CA-C-O 119.335 -0.703 . . . . 2.0299999999999998 113.988 164.76 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -107.94 119.43 39.44 Favored 'General case' 0 CA--C 1.522 -0.125 0 CA-C-N 118.738 1.269 . . . . 4.0300000000000002 110.523 -159.885 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -68.44 69.4 0.37 Allowed Glycine 0 C--N 1.336 0.574 0 C-N-CA 125.917 1.722 . . . . 1.6399999999999999 113.969 -172.222 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -83.6 121.13 26.83 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 126.482 1.913 . . . . 1.4199999999999999 110.738 -173.329 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 25.7 p -124.04 119.39 29.37 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 125.486 1.514 . . . . 2.7200000000000002 108.504 -179.29 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 74.9 t -81.03 128.46 38.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 C-N-CA 124.917 1.287 . . . . 1.74 109.54 -165.486 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 5.0 pt -139.13 59.49 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-O 122.197 0.999 . . . . 2.9199999999999999 112.174 -173.335 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 . . . . . 0 N--CA 1.448 -0.537 0 N-CA-C 108.596 -0.89 . . . . 5.0800000000000001 108.596 171.092 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 27.9 t . . . . . 0 C--O 1.236 0.349 0 N-CA-C 110.094 -0.336 . . . . 3.5499999999999998 110.094 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 10.6 p -85.8 141.31 29.75 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 126.245 1.818 . . . . 3.2999999999999998 108.259 164.921 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.35 147.87 28.71 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 105.384 -2.08 . . . . 7.3799999999999999 105.384 169.644 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 32.6 t -150.74 159.74 44.32 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 106.497 -1.668 . . . . 1.8999999999999999 106.497 176.167 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -135.3 148.39 49.49 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 106.143 -1.799 . . . . 3.1400000000000001 106.143 -178.954 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.1 pt -141.3 121.61 12.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 108.178 -1.045 . . . . 3.0800000000000001 108.178 -168.28 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 -80.81 125.2 29.79 Favored 'General case' 0 N--CA 1.438 -1.033 0 N-CA-C 103.685 -2.709 . . . . 3.0800000000000001 103.685 174.219 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.1 p -136.15 136.98 49.02 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.175 0 C-N-CA 123.803 0.841 . . . . 2.5600000000000001 110.169 -168.893 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.7 m -83.3 67.54 9.3 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 115.86 -0.609 . . . . 2.2400000000000002 111.843 -164.375 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 143.78 90.64 0.12 Allowed Glycine 0 CA--C 1.505 -0.548 0 N-CA-C 108.394 -1.882 . . . . 2.79 108.394 164.137 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 6.0 mmt -102.14 -56.16 2.33 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 110.704 -2.748 . . . . 6.96 109.713 171.877 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.8 m -72.35 57.06 0.37 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.594 1.158 . . . . 5.4100000000000001 109.056 172.604 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 4.3 t -112.13 173.55 6.31 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 126.946 2.099 . . . . 3.6000000000000001 105.954 179.041 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -81.68 123.09 28.42 Favored 'General case' 0 CA--C 1.52 -0.208 0 N-CA-C 107.204 -1.406 . . . . 2.4700000000000002 107.204 166.783 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 27.5 t 57.33 -84.65 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 118.607 -0.711 . . . . 3.7999999999999998 109.227 -152.651 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 5.3 m -19.36 -21.35 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 118.142 2.645 . . . . 3.0499999999999998 118.142 -99.731 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.823 ' CG2' HG11 ' A' ' 36' ' ' VAL . 0.3 OUTLIER -41.18 -38.08 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 N-CA-C 115.502 1.667 . . . . 2.77 115.502 172.326 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.26 -44.39 83.88 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.137 0.494 . . . . 1.1699999999999999 110.83 177.182 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -61.47 -51.04 70.31 Favored 'General case' 0 C--O 1.222 -0.365 0 N-CA-C 108.408 -0.96 . . . . 1.8400000000000001 108.408 174.047 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.565 HG21 HG21 ' A' ' 36' ' ' VAL 0.251 11.1 mm -47.78 -60.84 0.56 Allowed 'Isoleucine or valine' 0 C--O 1.209 -1.052 0 C-N-CA 124.59 1.156 . . . . 2.25 109.479 175.0 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.406 ' HA ' HD12 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -43.44 -45.77 6.45 Favored 'General case' 0 C--N 1.318 -0.771 0 O-C-N 116.911 -3.618 . . . . 4.9100000000000001 114.274 172.355 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 27.1 mmt85 -64.07 -31.56 72.79 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 120.857 -1.152 . . . . 4.7400000000000002 113.568 168.873 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.656 ' CG ' HD13 ' A' ' 25' ' ' LEU . 1.2 p-10 -60.6 -67.27 0.41 Allowed 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 127.423 2.289 . . . . 5.1500000000000004 111.666 -171.522 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.656 HD13 ' CG ' ' A' ' 24' ' ' ASN 0.354 5.2 mp -75.05 -26.98 59.81 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 119.508 -0.877 . . . . 3.3799999999999999 111.086 -163.163 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 92.8 mtt180 -61.74 -17.59 56.46 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 113.8 1.037 . . . . 6.71 113.8 168.854 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 23.6 mmt180 -57.11 -40.06 76.32 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 120.205 1.366 . . . . 8.5199999999999996 111.254 166.253 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -100.48 79.71 2.14 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-O 121.662 0.744 . . . . 9.2200000000000006 109.523 -146.6 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -37.02 114.91 0.35 Allowed 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 125.412 1.485 . . . . 5.6299999999999999 111.229 176.235 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 122.71 -21.73 7.47 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 111.048 -0.821 . . . . 1.1200000000000001 111.048 -167.23 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.554 HG23 ' H ' ' A' ' 33' ' ' SER . 1.2 mm -78.17 146.3 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 C-N-CA 125.079 1.352 . . . . 3.0499999999999998 108.282 164.845 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -137.96 37.37 2.37 Favored 'General case' 0 C--N 1.342 0.261 0 CA-C-O 123.065 1.412 . . . . 3.3599999999999999 113.002 153.496 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.554 ' H ' HG23 ' A' ' 31' ' ' ILE . 0.5 OUTLIER -167.88 124.65 1.11 Allowed 'General case' 0 C--N 1.318 -0.8 0 C-N-CA 125.19 1.396 . . . . 2.4500000000000002 109.026 172.134 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.732 ' C ' HD12 ' A' ' 35' ' ' LEU . 0.0 OUTLIER -106.83 105.5 18.88 Favored 'Isoleucine or valine' 0 C--N 1.346 0.418 0 CA-C-N 119.872 1.214 . . . . 2.6200000000000001 108.929 168.237 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.732 HD12 ' C ' ' A' ' 34' ' ' ILE . 6.7 mp -118.22 151.77 36.99 Favored 'General case' 0 CA--C 1.502 -0.878 0 N-CA-C 106.612 -1.625 . . . . 7.7400000000000002 106.612 -168.639 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.823 HG11 ' CG2' ' A' ' 18' ' ' VAL 0.286 1.0 OUTLIER -159.68 95.2 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.427 -1.624 0 CA-C-O 122.647 1.213 . . . . 2.2200000000000002 111.12 -172.842 . . . . . . . . 4 4 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -80.11 73.37 6.94 Favored 'General case' 0 CA--C 1.532 0.277 0 O-C-N 119.966 -1.709 . . . . 1.02 109.109 178.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.568 HD21 HG23 ' A' ' 18' ' ' VAL . 80.6 mt -44.22 -52.35 7.5 Favored 'General case' 0 C--N 1.342 0.243 0 C-N-CA 124.414 1.086 . . . . 2.7799999999999998 111.227 -176.786 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 75.1 mtm -56.11 -32.62 64.35 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.912 1.285 . . . . 3.2400000000000002 112.272 -178.016 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -84.05 -2.11 56.09 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 122.932 0.493 . . . . 2.3300000000000001 111.77 179.235 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 82.36 18.86 65.64 Favored Glycine 0 C--N 1.337 0.623 0 N-CA-C 111.12 -0.792 . . . . 1.3999999999999999 111.12 175.112 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 26.7 pttt -146.78 146.85 30.41 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 118.223 1.011 . . . . 4.4500000000000002 111.741 -170.698 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.426 ' HA ' ' HA ' ' A' ' 36' ' ' VAL . . . -83.99 162.92 20.25 Favored 'General case' 0 N--CA 1.442 -0.835 0 C-N-CA 124.904 1.282 . . . . 1.3999999999999999 109.618 165.613 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -135.32 135.84 41.09 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 126.217 1.807 . . . . 2.79 112.808 -170.055 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.0 t -131.47 138.07 53.91 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 O-C-N 120.832 -1.168 . . . . 2.96 109.457 -162.29 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.512 ' HB3' ' HB2' ' A' ' 33' ' ' SER . 47.8 ttp180 -150.18 107.59 3.63 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.92 0.888 . . . . 5.5800000000000001 109.512 179.538 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 11.5 p90 -155.58 179.21 9.4 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 124.608 1.163 . . . . 2.2200000000000002 110.168 -155.22 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -118.62 123.01 29.47 Favored Pre-proline 0 CA--C 1.535 0.395 0 C-N-CA 124.167 0.987 . . . . 3.0899999999999999 111.219 176.896 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -84.44 62.42 6.54 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 121.566 1.511 . . . . 1.5800000000000001 110.236 -173.565 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -131.33 -70.66 0.58 Allowed 'General case' 0 CA--C 1.519 -0.237 0 N-CA-C 107.0 -1.481 . . . . 1.1699999999999999 107.0 177.813 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 89.6 t -56.55 -44.31 80.43 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.779 0 C-N-CA 124.517 1.127 . . . . 1.23 111.035 177.358 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.3 tt -113.16 -24.01 4.07 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.415 0 N-CA-C 114.053 1.131 . . . . 2.3500000000000001 114.053 -149.814 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 70.92 120.47 0.03 OUTLIER Pre-proline 0 N--CA 1.471 0.602 0 C-N-CA 125.724 1.609 . . . . 2.9300000000000002 113.228 175.073 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -46.87 -43.51 23.91 Favored 'Trans proline' 0 CA--C 1.532 0.42 0 C-N-CA 124.228 3.286 . . . . 1.4299999999999999 115.77 169.014 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -58.92 -54.35 2.86 Favored 'Trans proline' 0 N--CA 1.442 -1.537 0 CA-C-N 120.835 1.334 . . . . 1.24 109.762 167.525 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 52.0 mtp -69.02 -28.58 66.7 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 118.396 -1.322 . . . . 2.0499999999999998 111.622 -166.0 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 12.4 tt -64.43 -37.04 78.98 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 CA-C-N 119.713 1.142 . . . . 2.1499999999999999 110.844 174.63 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.8 -47.64 84.89 Favored 'General case' 0 N--CA 1.455 -0.176 0 O-C-N 121.416 -0.803 . . . . 1.04 111.159 171.155 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -60.84 -57.47 12.54 Favored 'General case' 0 N--CA 1.432 -1.367 0 C-N-CA 123.718 0.807 . . . . 2.9399999999999999 112.355 -178.237 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -49.4 -38.51 29.16 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 123.488 0.715 . . . . 3.9199999999999999 111.386 -173.512 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.4 HD11 HD11 ' A' ' 25' ' ' LEU . 90.2 mt -60.99 -47.36 93.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 O-C-N 121.644 -0.66 . . . . 1.25 110.894 175.899 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 22.2 mtm105 -66.28 -32.1 73.3 Favored 'General case' 0 CA--C 1.522 -0.113 0 O-C-N 121.588 -0.695 . . . . 3.9199999999999999 112.113 177.76 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 78.3 mt-10 -58.44 -23.55 57.78 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 118.699 0.681 . . . . 3.27 112.264 172.782 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 66.0 mt -80.81 -15.98 54.95 Favored 'General case' 0 CA--C 1.535 0.37 0 O-C-N 121.515 -0.741 . . . . 1.74 111.568 173.518 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 112.08 -11.39 26.88 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 125.265 1.412 . . . . 2.1400000000000001 111.717 -177.129 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -79.8 101.63 8.6 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 117.812 0.806 . . . . 3.21 110.167 -173.915 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -63.94 86.45 0.06 OUTLIER Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 125.26 1.41 . . . . 1.3300000000000001 110.89 -179.26 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -111.51 130.11 55.83 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 128.211 2.604 . . . . 1.0700000000000001 111.526 -173.849 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 5.3 t -121.65 138.42 54.34 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 125.309 1.444 . . . . 2.1899999999999999 107.301 175.194 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.7 t -83.54 136.36 22.97 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 C-N-CA 125.869 1.667 . . . . 1.8400000000000001 110.173 -171.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 36.5 mt -145.87 83.94 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 125.301 1.44 . . . . 1.8899999999999999 109.258 -176.803 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 31.8 mp0 . . . . . 0 C--N 1.326 -0.444 0 C-N-CA 123.932 0.893 . . . . 4.7199999999999998 110.471 160.845 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' SER . . . . . 0.62 ' N ' HD21 ' A' ' 48' ' ' ASN . 12.9 m . . . . . 0 CA--C 1.538 0.49 0 CA-C-O 122.148 0.975 . . . . 2.9300000000000002 112.969 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.2 m -157.35 170.48 22.37 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 128.13 2.572 . . . . 2.1400000000000001 105.873 172.788 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 75.8 tttt -130.51 152.76 49.54 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 108.548 -0.908 . . . . 3.46 108.548 177.052 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 47.1 t -148.56 156.3 42.26 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 107.505 -1.294 . . . . 1.46 107.505 170.257 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 -106.15 138.05 43.0 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 107.123 -1.436 . . . . 2.3199999999999998 107.123 169.821 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 15.9 mt -138.09 139.53 42.07 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 N-CA-C 104.357 -2.46 . . . . 1.76 104.357 -172.693 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 11.5 mt-30 -122.6 119.34 30.51 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 120.127 1.33 . . . . 4.3899999999999997 108.327 -177.201 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 99.1 t -112.32 138.83 39.85 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 O-C-N 124.184 0.928 . . . . 2.8999999999999999 110.766 -158.649 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.4 m -66.86 -42.88 84.92 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 113.492 0.923 . . . . 2.6000000000000001 113.492 -168.063 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -138.77 48.59 0.86 Allowed Glycine 0 C--N 1.341 0.831 0 CA-C-O 124.252 2.029 . . . . 3.7000000000000002 111.226 172.19 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . 0.257 42.7 ttp -14.31 -52.2 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 109.408 -3.396 . . . . 3.5800000000000001 111.206 136.903 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 12.8 t -122.07 126.38 48.3 Favored 'General case' 0 N--CA 1.44 -0.963 0 C-N-CA 126.531 1.933 . . . . 4.3099999999999996 106.591 168.126 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.3 p -110.92 64.98 0.61 Allowed 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 107.134 -1.432 . . . . 2.98 107.134 119.705 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 64.87 -64.57 0.16 Allowed 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 128.507 2.723 . . . . 3.2999999999999998 111.737 -172.199 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.1 m -47.24 -49.25 23.69 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 127.001 2.12 . . . . 3.7200000000000002 112.133 -179.481 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 74.8 m -69.04 -20.16 64.11 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 114.59 1.329 . . . . 3.1299999999999999 114.59 -142.089 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 1.2 t -52.89 -37.96 27.25 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.281 0 CA-C-N 119.09 0.859 . . . . 2.4500000000000002 110.398 169.921 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.3 -52.22 65.33 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 123.139 0.576 . . . . 1.24 110.515 171.621 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -58.66 -53.75 54.87 Favored 'General case' 0 C--O 1.227 -0.102 0 C-N-CA 124.189 0.996 . . . . 1.8999999999999999 109.157 -176.329 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.532 ' O ' HD22 ' A' ' 25' ' ' LEU . 2.4 mt -49.04 -60.87 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.997 0 C-N-CA 125.557 1.543 . . . . 1.78 109.789 174.737 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -48.09 -59.74 3.16 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 119.916 1.235 . . . . 4.0099999999999998 113.049 176.018 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.49 -39.12 67.23 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.161 0.584 . . . . 6.5300000000000002 110.764 -177.06 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 -64.88 -60.87 2.58 Favored 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 108.417 -0.957 . . . . 3.1299999999999999 108.417 178.525 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.653 HD23 HD21 ' A' ' 35' ' ' LEU . 0.3 OUTLIER -74.13 -42.61 59.73 Favored 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 111.911 0.337 . . . . 2.4300000000000002 111.911 -161.075 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 4.5 ttm180 -67.4 -19.17 65.36 Favored 'General case' 0 N--CA 1.433 -1.285 0 CA-C-N 119.022 0.828 . . . . 7.4199999999999999 112.526 -160.242 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 31.3 mtm105 -45.82 -61.56 1.67 Allowed 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.039 0.936 . . . . 6.9400000000000004 111.941 -177.808 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -175.32 12.78 0.01 OUTLIER 'General case' 0 N--CA 1.461 0.119 0 N-CA-C 114.311 1.226 . . . . 7.0999999999999996 114.311 -158.867 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -101.24 53.49 0.83 Allowed 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 122.587 1.184 . . . . 5.6900000000000004 108.877 -144.135 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 57.56 12.29 9.14 Favored Glycine 0 CA--C 1.531 1.091 0 CA-C-N 114.053 -1.431 . . . . 1.6899999999999999 113.377 -172.151 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 1.1 pp -84.83 161.89 3.05 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 CA-C-N 119.238 1.519 . . . . 4.5700000000000003 110.645 -177.828 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -146.61 46.0 1.2 Allowed 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 122.596 1.189 . . . . 3.0 111.666 146.101 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 70.0 m -164.16 175.91 9.74 Favored 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 131.094 3.757 . . . . 2.04 105.22 154.567 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.2 pp -105.06 138.48 29.75 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.133 0 CA-C-O 122.421 1.105 . . . . 2.1000000000000001 109.859 160.547 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.653 HD21 HD23 ' A' ' 25' ' ' LEU . 0.1 OUTLIER -77.4 66.47 3.16 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 129.684 3.194 . . . . 4.5 111.021 -178.157 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 19.2 t -134.51 140.53 45.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 O-C-N 121.139 -0.976 . . . . 1.4099999999999999 110.078 169.284 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -150.18 64.47 0.96 Allowed 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 103.31 -2.848 . . . . 0.76000000000000001 103.31 162.679 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -59.04 -43.26 91.64 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 108.517 -0.92 . . . . 3.1699999999999999 108.517 -173.643 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 66.9 mtt -44.25 -37.48 3.26 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.556 0.742 . . . . 4.54 112.795 169.209 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -97.52 -10.25 25.61 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.564 1.146 . . . . 1.9199999999999999 112.923 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 87.44 36.87 8.45 Favored Glycine 0 C--N 1.341 0.825 0 CA-C-N 120.114 1.325 . . . . 1.03 110.956 173.138 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 2.3 ptmt -162.47 178.52 8.54 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 119.03 1.415 . . . . 3.4100000000000001 110.25 -174.278 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.413 ' HB1' ' HG ' ' A' ' 35' ' ' LEU . . . -118.56 133.02 56.18 Favored 'General case' 0 N--CA 1.441 -0.907 0 C-N-CA 128.051 2.54 . . . . 1.0 108.899 175.066 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -126.06 82.58 2.08 Favored 'General case' 0 C--N 1.339 0.127 0 C-N-CA 123.995 0.918 . . . . 2.8599999999999999 112.012 -172.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 9.9 p -83.19 134.53 26.72 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 C-N-CA 123.237 0.615 . . . . 1.5700000000000001 110.39 -169.561 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 35.6 ttm105 -113.14 127.64 56.25 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 103.955 -2.609 . . . . 4.2599999999999998 103.955 158.923 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 4.2 p90 -157.73 175.36 14.0 Favored 'General case' 0 CA--C 1.515 -0.373 0 C-N-CA 123.407 0.683 . . . . 2.0299999999999998 109.279 -170.172 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.62 HD21 ' N ' ' A' ' 2' ' ' SER . 23.3 t-20 -122.68 94.63 47.39 Favored Pre-proline 0 CA--C 1.533 0.325 0 CA-C-O 119.021 -0.514 . . . . 2.7599999999999998 110.245 178.663 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -71.36 73.73 2.12 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 123.78 2.987 . . . . 1.46 112.234 -176.105 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -146.93 -51.61 0.21 Allowed 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 125.883 1.673 . . . . 1.29 106.533 165.431 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 95.9 t -53.95 -57.61 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.768 0 C-N-CA 124.517 1.127 . . . . 1.1200000000000001 109.535 170.708 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.403 ' O ' ' HB2' ' A' ' 53' ' ' GLN 0.252 11.5 tt -94.81 -71.08 0.58 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.371 0 CA-C-O 118.341 -0.838 . . . . 1.8799999999999999 113.169 -169.454 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.403 ' HB2' ' O ' ' A' ' 52' ' ' ILE . 0.0 OUTLIER 109.54 139.45 0.0 OUTLIER Pre-proline 0 N--CA 1.469 0.523 0 C-N-CA 129.993 3.317 . . . . 2.96 108.498 -173.54 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_exo -51.27 -50.86 12.58 Favored 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 124.215 3.277 . . . . 1.0800000000000001 114.595 172.612 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -47.03 -55.55 3.79 Favored 'Trans proline' 0 N--CA 1.446 -1.308 0 C-N-CA 121.533 1.489 . . . . 1.0 110.308 166.147 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 25.1 mtm -62.66 -35.87 81.04 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 118.067 -1.453 . . . . 1.8500000000000001 112.242 -172.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . 0.261 2.7 tt -68.35 -39.56 81.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-N 119.023 0.829 . . . . 2.1099999999999999 111.035 179.391 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.22 -55.6 32.87 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 118.933 0.788 . . . . 0.94999999999999996 112.162 169.763 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -50.25 -47.04 55.33 Favored 'General case' 0 N--CA 1.442 -0.864 0 C-N-CA 126.169 1.788 . . . . 4.0499999999999998 110.835 -178.538 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -46.1 -42.76 14.08 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.246 0.618 . . . . 4.5199999999999996 112.325 174.433 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 40.7 mt -74.63 -44.6 46.61 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 N-CA-C 108.405 -0.961 . . . . 1.53 108.405 -177.718 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.1 -62.13 1.97 Allowed 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 124.969 1.308 . . . . 7.8399999999999999 112.894 -178.409 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -57.64 -58.71 7.12 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 124.117 0.967 . . . . 3.1299999999999999 111.447 -163.042 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.33 -34.39 23.69 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 122.766 0.427 . . . . 2.1099999999999999 111.649 -179.033 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -93.66 -91.69 1.58 Allowed Glycine 0 CA--C 1.525 0.709 0 N-CA-C 111.089 -0.805 . . . . 1.8700000000000001 111.089 -174.809 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -138.1 -79.17 0.36 Allowed 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 122.422 1.106 . . . . 3.0099999999999998 112.837 -157.474 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 156.19 122.38 0.75 Allowed Glycine 0 N--CA 1.445 -0.707 0 N-CA-C 105.406 -3.078 . . . . 1.3899999999999999 105.406 -143.503 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -145.86 116.67 7.71 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 107.929 -1.137 . . . . 1.22 107.929 -167.318 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 41.1 p -93.7 118.52 31.5 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 107.093 -1.447 . . . . 2.96 107.093 176.318 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.2 t -83.56 121.29 36.08 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 N-CA-C 107.176 -1.416 . . . . 1.6499999999999999 107.176 177.78 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 47.0 mt -145.24 77.12 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.307 0 N-CA-C 108.213 -1.032 . . . . 1.9299999999999999 108.213 -169.882 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.468 ' H ' ' CD ' ' A' ' 72' ' ' GLU . 2.3 pm0 . . . . . 0 CA--C 1.541 0.601 0 C-N-CA 123.893 0.877 . . . . 5.1299999999999999 111.011 166.803 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.7 p . . . . . 0 CA--C 1.529 0.169 0 CA-C-O 122.779 1.276 . . . . 2.9700000000000002 110.181 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.8 m -106.73 142.37 36.47 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 125.929 1.692 . . . . 2.3100000000000001 108.471 -165.63 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 18.7 ttpt -93.58 154.05 18.07 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 118.96 -0.543 . . . . 3.6899999999999999 110.219 177.381 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 9.3 t -153.59 160.63 42.5 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 108.377 -0.972 . . . . 1.72 108.377 167.234 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -105.41 157.62 17.22 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.376 1.071 . . . . 2.3799999999999999 109.249 -173.679 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.467 ' HB ' ' HB3' ' A' ' 43' ' ' ALA . 3.3 mt -145.22 147.05 19.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 N-CA-C 107.315 -1.365 . . . . 1.77 107.315 179.504 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 -108.59 141.26 40.78 Favored 'General case' 0 C--O 1.232 0.16 0 N-CA-C 107.88 -1.156 . . . . 4.1600000000000001 107.88 170.552 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 57.0 t -108.08 126.27 64.67 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 O-C-N 124.086 0.866 . . . . 2.77 109.807 179.163 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 11.1 m -75.33 75.3 2.43 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.61 0.764 . . . . 2.8500000000000001 110.968 -179.42 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 164.05 -62.47 0.25 Allowed Glycine 0 C--O 1.227 -0.323 0 N-CA-C 105.544 -3.022 . . . . 4.0300000000000002 105.544 173.382 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . 0.333 0.0 OUTLIER 59.28 138.38 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 129.347 3.059 . . . . 3.8900000000000001 114.512 178.352 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.609 ' H ' HD12 ' A' ' 38' ' ' LEU . 7.0 m 73.31 -59.11 0.58 Allowed 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 126.161 1.784 . . . . 5.2000000000000002 109.767 -177.395 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 38.5 m 51.38 -124.27 2.22 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.893 1.277 . . . . 3.1299999999999999 108.729 170.436 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -155.86 142.95 19.11 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 106.099 -1.815 . . . . 2.6899999999999999 106.099 152.397 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 56.9 p 64.54 -25.1 0.08 Allowed 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 116.536 2.05 . . . . 3.7400000000000002 116.536 -179.266 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 99.2 m -38.57 -38.69 0.41 Allowed 'General case' 0 C--O 1.225 -0.236 0 C-N-CA 125.141 1.376 . . . . 2.8500000000000001 112.186 171.687 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.6 t -65.38 -45.97 91.64 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.359 0 C-N-CA 124.544 1.137 . . . . 2.4900000000000002 109.796 -178.798 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.97 -47.01 78.43 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 123.603 0.761 . . . . 1.3 109.292 173.997 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -58.18 -58.52 8.12 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 109.005 -0.739 . . . . 1.96 109.005 179.81 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.519 HG23 HD21 ' A' ' 35' ' ' LEU . 40.5 mt -46.62 -60.05 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 C-N-CA 126.308 1.843 . . . . 1.8799999999999999 110.343 179.815 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 73.1 mt-10 -47.38 -61.77 1.75 Allowed 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.494 0.718 . . . . 3.0499999999999998 111.783 174.174 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 7.1 mpt_? -62.06 -32.59 73.13 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.978 -0.555 . . . . 6.4000000000000004 111.308 -168.796 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 18.9 m-20 -71.85 -64.58 0.9 Allowed 'General case' 0 CA--C 1.528 0.134 0 CA-C-O 121.515 0.674 . . . . 3.5800000000000001 110.67 175.381 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.485 HD12 ' CD1' ' A' ' 35' ' ' LEU . 4.3 mt -78.73 -9.87 59.57 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 125.556 1.542 . . . . 3.71 111.545 -162.652 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -21.36 -77.34 0.01 OUTLIER 'General case' 0 N--CA 1.444 -0.76 0 C-N-CA 130.223 3.409 . . . . 8.6999999999999993 112.917 -166.411 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 11.1 ptp180 -92.76 -37.93 12.07 Favored 'General case' 0 N--CA 1.435 -1.185 0 C-N-CA 129.284 3.034 . . . . 12.470000000000001 116.501 154.552 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 11.22 56.15 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.289 1.436 . . . . 8.0199999999999996 113.455 -144.784 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 14.3 mp0 32.07 54.53 0.31 Allowed 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 128.125 2.57 . . . . 7.6299999999999999 112.711 -174.899 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 179.3 -37.49 0.07 OUTLIER Glycine 0 CA--C 1.54 1.612 0 C-N-CA 123.979 0.8 . . . . 1.55 113.978 -172.961 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ILE . . . . . 0.415 HD12 ' HB3' ' A' ' 25' ' ' LEU . 6.0 mt -81.98 145.85 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 C-N-CA 127.705 2.402 . . . . 2.0499999999999998 107.199 167.876 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 79.7 m-85 -147.45 47.8 1.12 Allowed 'General case' 0 N--CA 1.456 -0.15 0 CA-C-O 122.315 1.055 . . . . 4.1500000000000004 111.119 157.824 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.8 t -168.15 135.64 2.17 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 126.15 1.78 . . . . 1.6599999999999999 106.972 145.794 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.7 pp -82.98 152.06 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 CA-C-O 123.582 1.658 . . . . 1.9399999999999999 112.223 -171.197 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.873 ' H ' HD23 ' A' ' 35' ' ' LEU . 1.9 pt? -76.48 58.48 1.34 Allowed 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 131.517 3.927 . . . . 4.7300000000000004 111.541 -167.988 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.452 HG22 HD23 ' A' ' 38' ' ' LEU . 76.8 t -135.46 122.99 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 O-C-N 121.129 -0.982 . . . . 1.46 113.556 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -133.56 57.23 1.81 Allowed 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 106.43 -1.692 . . . . 0.69999999999999996 106.43 150.351 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.609 HD12 ' H ' ' A' ' 13' ' ' THR . 0.5 OUTLIER -75.45 -6.39 49.87 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 123.615 0.766 . . . . 5.3200000000000003 111.838 -175.122 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 66.8 mtt -59.49 -41.02 88.87 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 109.791 -0.448 . . . . 4.8200000000000003 109.791 161.746 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -86.99 -41.25 14.04 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.133 0.573 . . . . 1.73 110.072 177.305 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 117.95 48.0 0.42 Allowed Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.094 -1.202 . . . . 0.89000000000000001 110.094 176.691 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -162.48 177.53 9.41 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 106.561 -1.644 . . . . 4.0499999999999998 106.561 -170.166 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.467 ' HB3' ' HB ' ' A' ' 7' ' ' ILE . . . -140.89 140.59 34.56 Favored 'General case' 0 N--CA 1.441 -0.906 0 C-N-CA 125.132 1.373 . . . . 1.02 108.887 -167.509 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -141.86 104.72 4.56 Favored 'General case' 0 C--N 1.344 0.363 0 CA-C-N 118.968 0.804 . . . . 3.2599999999999998 110.538 179.421 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.7 p -90.99 142.09 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.101 0 C-N-CA 124.33 1.052 . . . . 1.74 108.474 -172.358 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 16.6 tpp180 -107.43 122.63 47.0 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 106.07 -1.826 . . . . 4.8499999999999996 106.07 163.84 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -160.45 179.13 8.88 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 118.832 0.742 . . . . 2.23 112.19 -168.725 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 35.7 m-20 -109.24 109.82 60.46 Favored Pre-proline 0 CA--C 1.53 0.198 0 N-CA-C 108.123 -1.066 . . . . 3.1200000000000001 108.123 163.206 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -76.4 58.77 5.88 Favored 'Trans proline' 0 CA--C 1.536 0.603 0 C-N-CA 123.508 2.805 . . . . 2.3199999999999998 110.598 -178.935 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -157.44 -51.08 0.07 Allowed 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 125.873 1.669 . . . . 1.9299999999999999 107.224 -172.217 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 74.1 t -61.24 -43.56 96.71 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.866 0 C-N-CA 124.34 1.056 . . . . 1.46 109.867 173.719 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.54 HG12 HG22 ' A' ' 57' ' ' ILE . 2.2 tp -109.52 -54.62 5.42 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.255 0 C-N-CA 122.891 0.476 . . . . 1.9399999999999999 110.743 -175.06 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.412 ' HA ' ' HD3' ' A' ' 54' ' ' PRO . 2.2 mm-40 95.5 128.35 0.02 OUTLIER Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 129.21 3.004 . . . . 3.7799999999999998 110.813 171.547 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 53' ' ' GLN . 71.2 Cg_exo -55.88 -43.26 58.79 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 123.506 2.804 . . . . 1.1499999999999999 116.521 -172.444 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -58.35 -43.1 49.32 Favored 'Trans proline' 0 N--CA 1.445 -1.347 0 CA-C-N 121.533 1.583 . . . . 1.1299999999999999 109.079 175.377 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 63.5 mtt -61.77 -44.51 96.75 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 118.403 -0.808 . . . . 1.8899999999999999 109.928 179.233 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.54 HG22 HG12 ' A' ' 52' ' ' ILE . 0.6 OUTLIER -62.27 -48.54 87.89 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 CA-C-N 120.084 1.311 . . . . 2.4900000000000002 110.903 177.359 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -54.23 -38.45 65.75 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 124.332 1.053 . . . . 1.52 112.165 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -70.01 -60.7 2.14 Favored 'General case' 0 N--CA 1.442 -0.828 0 C-N-CA 125.405 1.482 . . . . 3.3100000000000001 110.644 172.185 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -44.91 -43.78 9.18 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 124.191 0.996 . . . . 3.77 112.464 -177.797 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 67.8 mt -63.23 -43.54 98.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 O-C-N 121.912 -0.493 . . . . 1.1100000000000001 110.017 -178.655 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . 0.301 7.6 ptp180 -70.83 -42.16 70.56 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-O 119.359 -0.353 . . . . 3.8500000000000001 111.604 179.152 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -55.39 -45.05 76.65 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.154 0.981 . . . . 3.0499999999999998 110.836 174.479 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 63.7 mt -81.2 -38.72 26.56 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-O 119.507 -0.283 . . . . 2.0800000000000001 110.628 -174.152 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -104.93 -90.77 2.19 Favored Glycine 0 CA--C 1.527 0.808 0 N-CA-C 111.33 -0.708 . . . . 2.0099999999999998 111.33 179.172 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 18.1 m-85 -142.29 -56.97 0.45 Allowed 'General case' 0 CA--C 1.509 -0.615 0 CA-C-O 122.464 1.126 . . . . 3.9700000000000002 111.699 -157.013 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 162.27 126.3 0.81 Allowed Glycine 0 N--CA 1.432 -1.599 0 N-CA-C 105.784 -2.927 . . . . 1.5700000000000001 105.784 -149.907 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -157.05 153.77 28.45 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 117.234 0.517 . . . . 1.04 110.102 177.713 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 2.4 t -128.16 144.69 51.13 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 106.747 -1.575 . . . . 2.7599999999999998 106.747 174.434 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 12.6 p -81.23 150.74 4.52 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 N-CA-C 107.173 -1.418 . . . . 2.2999999999999998 107.173 170.178 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 4.8 pt -154.95 175.91 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 C-N-CA 126.368 1.867 . . . . 3.0 106.833 177.869 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 . . . . . 0 N--CA 1.454 -0.259 0 N-CA-C 108.286 -1.005 . . . . 4.8899999999999997 108.286 167.316 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.5 m . . . . . 0 N--CA 1.455 -0.187 0 N-CA-C 109.169 -0.678 . . . . 2.8300000000000001 109.169 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 22.7 m -89.26 161.36 16.45 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 107.916 -1.142 . . . . 1.8 107.916 160.646 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 51.6 mtmt -113.41 160.48 18.37 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 123.777 0.831 . . . . 4.1900000000000004 108.847 162.686 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 49.7 t -155.52 154.2 31.41 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 106.931 -1.507 . . . . 1.47 106.931 170.781 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -100.93 154.91 18.28 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 122.173 0.987 . . . . 2.73 108.663 175.386 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.7 mp -134.04 138.22 50.69 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 N-CA-C 104.792 -2.299 . . . . 1.8700000000000001 104.792 169.848 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 47.9 tp60 -95.56 122.96 38.86 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 103.332 -2.84 . . . . 2.6099999999999999 103.332 165.717 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 26.0 m -118.38 147.71 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 C-N-CA 124.671 1.189 . . . . 2.5899999999999999 108.008 -178.446 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 6.9 m -105.05 70.03 0.88 Allowed 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.02 0.528 . . . . 2.5 109.694 -175.557 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 156.55 -36.49 0.59 Allowed Glycine 0 C--N 1.341 0.814 0 C-N-CA 121.029 -0.605 . . . . 2.3599999999999999 114.274 170.577 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 2.6 mpp? 46.91 42.16 11.81 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.48 1.112 . . . . 4.1200000000000001 110.589 -168.565 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.2 p 56.78 1.79 0.09 Allowed 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 115.919 1.822 . . . . 10.82 115.919 -173.53 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . 0.372 0.1 OUTLIER 77.39 174.28 0.2 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 127.334 2.254 . . . . 4.0300000000000002 112.442 -166.695 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.03 132.74 54.37 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.034 0.934 . . . . 4.04 111.221 -169.428 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 10.4 m 74.15 -37.68 0.37 Allowed 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.124 1.369 . . . . 5.0300000000000002 113.63 174.61 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 75.6 m -54.94 -28.41 50.96 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 127.159 2.184 . . . . 5.6699999999999999 111.08 176.011 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 8.1 m -38.31 -40.98 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 N-CA-C 113.378 0.881 . . . . 2.4399999999999999 113.378 164.032 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -45.56 -49.12 14.21 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 124.153 0.981 . . . . 1.6499999999999999 110.876 174.203 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -54.7 -57.43 11.51 Favored 'General case' 0 CA--C 1.519 -0.237 0 N-CA-C 109.346 -0.613 . . . . 3.2000000000000002 109.346 173.403 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 3.6 tp -67.72 -39.29 81.81 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.382 0 CA-C-N 118.401 0.546 . . . . 4.5099999999999998 109.816 -163.799 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.451 ' HG2' ' CG1' ' A' ' 34' ' ' ILE . 59.0 mt-10 -56.18 -56.6 18.94 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.993 1.317 . . . . 3.6699999999999999 110.61 171.233 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.7 tmt_? -52.99 -39.36 63.0 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 109.616 -0.513 . . . . 6.1900000000000004 109.616 176.654 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -72.41 -42.28 65.31 Favored 'General case' 0 N--CA 1.431 -1.383 0 CA-C-O 118.037 -0.983 . . . . 3.3799999999999999 109.148 -178.187 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -56.72 -37.89 71.59 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 121.335 1.88 . . . . 2.5499999999999998 109.253 176.71 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 56.7 mtp180 -65.46 -12.34 51.56 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 115.262 1.578 . . . . 6.29 115.262 175.9 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.412 ' HG2' ' CG ' ' A' ' 28' ' ' GLU . 1.0 OUTLIER -66.02 -17.87 64.97 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 121.028 1.74 . . . . 8.2400000000000002 111.294 167.247 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.412 ' CG ' ' HG2' ' A' ' 27' ' ' ARG . 6.5 mt-10 -104.06 90.85 3.72 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 108.931 -0.766 . . . . 7.7400000000000002 108.931 -166.357 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -43.64 133.15 4.69 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 107.724 -1.213 . . . . 8.4399999999999995 107.724 166.502 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 110.82 -36.27 4.33 Favored Glycine 0 CA--C 1.527 0.787 0 CA-C-O 118.639 -1.09 . . . . 1.4199999999999999 111.786 -166.149 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.7 mt -83.03 126.44 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 CA-C-N 119.316 1.558 . . . . 2.1499999999999999 108.772 174.71 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -134.89 42.07 2.82 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 122.363 1.078 . . . . 3.5699999999999998 112.4 160.455 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 9.1 t -167.76 137.78 2.73 Favored 'General case' 0 C--N 1.316 -0.866 0 C-N-CA 128.008 2.523 . . . . 2.0800000000000001 106.911 144.455 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.589 ' H ' ' CD1' ' A' ' 34' ' ' ILE . 0.0 OUTLIER -78.86 134.54 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.369 0 CA-C-O 122.814 1.293 . . . . 2.3799999999999999 109.535 -179.598 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.417 ' HA ' ' H ' ' A' ' 44' ' ' GLU . 0.7 OUTLIER -81.31 68.21 7.54 Favored 'General case' 0 N--CA 1.431 -1.382 0 CA-C-N 115.317 -0.856 . . . . 4.8300000000000001 110.481 -176.527 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 4.9 t -130.42 139.46 51.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 121.917 0.865 . . . . 1.6000000000000001 111.487 167.917 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -151.95 72.8 1.03 Allowed 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 127.602 2.361 . . . . 1.23 107.621 169.781 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.916 HD23 ' H ' ' A' ' 38' ' ' LEU . 0.2 OUTLIER -46.96 -43.69 19.38 Favored 'General case' 0 CA--C 1.509 -0.621 0 C-N-CA 124.08 0.952 . . . . 3.3599999999999999 110.572 169.006 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 24.3 ptt? -79.81 42.31 0.53 Allowed 'General case' 0 CA--C 1.545 0.786 0 CA-C-O 121.65 0.738 . . . . 4.7800000000000002 111.649 -167.446 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -178.23 -40.81 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 129.751 3.22 . . . . 1.3400000000000001 106.878 -171.423 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 98.44 49.9 1.63 Allowed Glycine 0 C--N 1.339 0.735 0 N-CA-C 108.072 -2.011 . . . . 0.88 108.072 172.628 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 46.5 mttm -152.7 179.87 8.24 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 126.217 1.807 . . . . 4.8399999999999999 108.727 -158.91 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -151.18 131.71 13.86 Favored 'General case' 0 N--CA 1.442 -0.831 0 C-N-CA 125.29 1.436 . . . . 1.1699999999999999 108.109 -171.174 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.417 ' H ' ' HA ' ' A' ' 35' ' ' LEU . 0.6 OUTLIER -136.59 102.96 5.08 Favored 'General case' 0 C--N 1.342 0.242 0 CA-C-N 118.967 0.803 . . . . 2.77 112.22 -175.627 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.4 p -82.65 146.94 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.215 0 N-CA-C 108.989 -0.745 . . . . 1.6499999999999999 108.989 -176.536 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 60.6 ttp180 -122.69 123.25 40.69 Favored 'General case' 0 C--N 1.339 0.126 0 N-CA-C 105.823 -1.917 . . . . 5.6699999999999999 105.823 159.633 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 1.5 p90 -160.27 175.23 13.1 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 118.298 0.499 . . . . 2.1200000000000001 110.994 -164.419 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -110.44 117.94 50.07 Favored Pre-proline 0 CA--C 1.539 0.546 0 C-N-CA 123.472 0.709 . . . . 3.1899999999999999 109.224 166.964 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -74.78 23.84 0.38 Allowed 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 122.933 2.422 . . . . 1.98 113.91 -170.664 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -109.55 -49.33 3.12 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.752 1.221 . . . . 1.1699999999999999 108.403 -178.716 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 98.4 t -65.52 -50.3 72.96 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.89 0 C-N-CA 124.271 1.028 . . . . 1.3200000000000001 109.917 -179.654 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.413 ' O ' ' HB2' ' A' ' 53' ' ' GLN . 3.3 tp -102.64 -62.62 2.0 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.391 0 CA-C-O 118.652 -0.69 . . . . 1.75 112.401 -163.904 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.413 ' HB2' ' O ' ' A' ' 52' ' ' ILE . 11.4 mm-40 96.14 127.12 0.02 OUTLIER Pre-proline 0 CA--C 1.548 0.873 0 C-N-CA 129.85 3.26 . . . . 3.9399999999999999 112.318 176.376 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.458 ' HA ' HG12 ' A' ' 57' ' ' ILE . 47.0 Cg_exo -44.15 -51.83 6.29 Favored 'Trans proline' 0 C--N 1.351 0.708 1 C-N-CA 125.349 4.033 . . . . 1.1899999999999999 116.4 174.33 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -52.51 -46.41 33.39 Favored 'Trans proline' 0 N--CA 1.446 -1.291 0 CA-C-N 120.706 1.288 . . . . 0.82999999999999996 110.17 173.284 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 60.1 mtp -64.46 -46.26 83.85 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 118.723 -0.656 . . . . 2.6299999999999999 111.053 -176.541 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.458 HG12 ' HA ' ' A' ' 54' ' ' PRO . 20.6 pt -60.19 -49.91 82.29 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-N 119.897 1.226 . . . . 2.4300000000000002 110.944 175.938 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -48.04 -49.63 30.66 Favored 'General case' 0 C--N 1.341 0.199 0 C-N-CA 123.442 0.697 . . . . 1.1499999999999999 110.998 176.994 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -61.92 -57.1 13.01 Favored 'General case' 0 N--CA 1.434 -1.234 0 C-N-CA 124.234 1.014 . . . . 3.0899999999999999 112.369 178.069 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 9.0 m-30 -47.66 -50.05 25.82 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 118.796 0.726 . . . . 3.4500000000000002 109.773 -174.598 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 20.0 mt -51.92 -43.23 35.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 123.319 0.648 . . . . 1.3899999999999999 112.009 175.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 91.2 mtt180 -65.37 -59.4 4.07 Favored 'General case' 0 N--CA 1.457 -0.076 0 N-CA-C 109.477 -0.564 . . . . 4.3700000000000001 109.477 175.662 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -44.62 -54.54 6.04 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 125.758 1.623 . . . . 2.9399999999999999 111.941 -173.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . 0.253 0.3 OUTLIER -84.37 -13.39 52.43 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 114.071 1.137 . . . . 2.6000000000000001 114.071 179.44 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -152.74 -88.52 0.07 OUTLIER Glycine 0 CA--C 1.531 1.036 0 CA-C-N 119.84 1.2 . . . . 1.7 115.994 -165.105 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -136.43 147.25 47.15 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-O 121.732 0.777 . . . . 3.5800000000000001 112.665 -147.016 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -58.68 108.3 1.49 Allowed Glycine 0 N--CA 1.441 -0.978 0 N-CA-C 109.097 -1.601 . . . . 1.5600000000000001 109.097 177.371 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -116.54 130.07 56.54 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 126.41 1.884 . . . . 1.22 109.088 -173.212 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 41.6 m -128.24 129.29 46.17 Favored 'General case' 0 CA--C 1.528 0.097 0 C-N-CA 124.964 1.306 . . . . 2.96 107.921 175.137 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 13.3 p -82.42 140.35 16.53 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 C-N-CA 123.741 0.817 . . . . 2.2400000000000002 109.698 -175.723 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 46.7 mt -143.26 143.18 25.02 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 125.315 1.446 . . . . 2.04 108.493 -175.818 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 . . . . . 0 N--CA 1.451 -0.387 0 N-CA-C 107.056 -1.461 . . . . 4.1200000000000001 107.056 166.145 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.5 p . . . . . 0 N--CA 1.45 -0.461 0 CA-C-O 121.002 0.429 . . . . 2.5499999999999998 110.833 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 47.5 m -154.93 165.77 35.65 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.419 1.088 . . . . 1.8500000000000001 108.939 179.161 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.53 130.74 56.61 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 125.006 1.322 . . . . 4.7000000000000002 107.988 174.784 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 51.2 t -123.01 146.42 47.66 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 118.973 0.806 . . . . 1.3300000000000001 109.427 173.196 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -92.24 133.1 36.13 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.47 1.108 . . . . 2.5299999999999998 108.952 172.704 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.0 mm -124.3 151.9 29.75 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 N-CA-C 103.822 -2.658 . . . . 2.3100000000000001 103.822 178.762 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 45.1 tp60 -117.37 125.01 50.29 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 103.551 -2.759 . . . . 3.27 103.551 168.863 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.8 m -87.91 141.36 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 N-CA-C 108.695 -0.854 . . . . 2.4100000000000001 108.695 178.762 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 52.6 p -104.4 84.99 2.27 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 105.255 -2.128 . . . . 2.98 105.255 165.802 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 177.74 -67.82 0.08 OUTLIER Glycine 0 CA--C 1.522 0.493 0 N-CA-C 105.392 -3.083 . . . . 2.3599999999999999 105.392 -178.774 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 14.1 ttp 70.99 -61.64 0.48 Allowed 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 126.774 2.029 . . . . 3.8500000000000001 112.441 165.871 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.8 m -142.65 49.43 1.5 Allowed 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 125.946 1.698 . . . . 4.7999999999999998 106.878 173.93 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.9 p -53.99 -51.77 62.85 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 109.119 -0.697 . . . . 3.4700000000000002 109.119 177.14 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 176.73 120.19 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 127.221 2.209 . . . . 3.54 107.352 157.172 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 4.2 p 48.92 38.61 12.65 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.426 0.69 . . . . 3.0699999999999998 111.044 -171.005 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 29.5 t -55.14 -44.77 75.41 Favored 'General case' 0 N--CA 1.461 0.094 0 C-N-CA 126.591 1.956 . . . . 4.0099999999999998 108.141 -178.603 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.2 m -70.79 -49.58 49.87 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.089 0 CA-C-N 113.955 -1.475 . . . . 2.23 110.989 -171.52 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.64 -41.7 73.96 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.955 0.902 . . . . 0.85999999999999999 110.824 171.074 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -55.05 -50.99 67.71 Favored 'General case' 0 C--N 1.341 0.205 0 N-CA-C 108.566 -0.901 . . . . 2.1899999999999999 108.566 172.346 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.787 HG21 HG23 ' A' ' 36' ' ' VAL . 4.6 mt -56.09 -51.21 64.62 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 CA-C-O 118.494 -0.765 . . . . 2.46 110.024 178.196 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -49.98 -57.03 8.39 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 119.332 0.969 . . . . 3.4199999999999999 110.065 177.253 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 32.6 mmt180 -51.72 -46.63 64.02 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 122.743 0.417 . . . . 4.54 111.814 177.789 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 67.4 m-20 -67.13 -63.93 0.96 Allowed 'General case' 0 C--O 1.224 -0.242 0 CA-C-O 121.825 0.821 . . . . 3.1000000000000001 109.612 -176.038 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.707 HD23 HG23 ' A' ' 21' ' ' ILE . 0.0 OUTLIER -71.1 -28.52 64.38 Favored 'General case' 0 N--CA 1.439 -1.022 0 C-N-CA 124.339 1.056 . . . . 2.3399999999999999 110.316 -165.773 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . 0.487 28.1 mtp-105 -70.11 0.51 6.03 Favored 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 116.192 1.923 . . . . 5.7699999999999996 116.192 167.996 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 9.5 mmt180 -38.07 -36.03 0.19 Allowed 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 117.777 -1.569 . . . . 7.9199999999999999 112.393 143.922 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 70.04 43.61 0.88 Allowed 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 126.075 1.75 . . . . 8.6899999999999995 108.359 -178.061 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -73.77 58.46 0.63 Allowed 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 126.832 2.053 . . . . 5.2000000000000002 108.795 179.008 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 66.0 34.28 87.98 Favored Glycine 0 CA--C 1.532 1.128 0 O-C-N 121.316 -0.865 . . . . 1.1000000000000001 112.375 -172.13 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -113.96 135.8 52.49 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 C-N-CA 126.167 1.787 . . . . 1.9299999999999999 106.993 -179.096 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -140.83 47.21 1.75 Allowed 'General case' 0 CA--C 1.53 0.184 0 CA-C-O 122.923 1.344 . . . . 3.1800000000000002 111.6 159.503 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.7 t -168.64 133.63 1.65 Allowed 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 127.791 2.437 . . . . 2.0299999999999998 105.546 144.759 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -81.0 150.99 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 CA-C-O 121.805 0.812 . . . . 2.0800000000000001 109.37 177.981 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.418 ' HB2' ' HB1' ' A' ' 43' ' ' ALA . 0.6 OUTLIER -81.13 65.5 6.29 Favored 'General case' 0 N--CA 1.435 -1.177 0 C-N-CA 124.151 0.98 . . . . 4.7199999999999998 111.04 -177.469 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.787 HG23 HG21 ' A' ' 21' ' ' ILE . 11.4 t -117.2 140.62 39.2 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 CA-C-O 121.956 0.884 . . . . 1.6599999999999999 111.321 162.018 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -155.79 59.78 0.6 Allowed 'General case' 0 C--O 1.236 0.389 0 C-N-CA 127.323 2.249 . . . . 0.80000000000000004 106.893 166.007 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.18 60.11 3.57 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 124.445 1.098 . . . . 3.3399999999999999 109.293 179.464 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 51.6 ttm -131.97 -52.2 0.97 Allowed 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 105.112 -2.181 . . . . 3.3100000000000001 105.112 163.82 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -69.13 -30.49 68.76 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.574 -0.739 . . . . 1.3100000000000001 111.169 165.005 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 96.32 45.46 2.78 Favored Glycine 0 C--N 1.341 0.835 0 N-CA-C 109.552 -1.419 . . . . 1.03 109.552 -178.514 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 50.1 mttt -147.73 -179.14 6.67 Favored 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 124.725 1.21 . . . . 4.21 108.295 -156.898 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.418 ' HB1' ' HB2' ' A' ' 35' ' ' LEU . . . -157.39 118.74 3.65 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 108.077 -1.082 . . . . 1.3300000000000001 108.077 -159.973 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -133.01 105.95 7.38 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 119.413 1.006 . . . . 2.6000000000000001 112.83 178.929 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.573 HG11 HD12 ' A' ' 57' ' ' ILE . 11.1 p -82.38 133.17 29.72 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.317 0 C-N-CA 124.421 1.088 . . . . 1.5 108.405 -177.97 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 71.4 ttt180 -110.17 127.07 54.72 Favored 'General case' 0 CA--C 1.52 -0.173 0 N-CA-C 105.764 -1.939 . . . . 4.5700000000000003 105.764 166.44 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 4.9 p90 -157.23 169.21 25.28 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 117.995 0.361 . . . . 2.0099999999999998 111.145 -161.024 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -114.43 98.19 48.3 Favored Pre-proline 0 CA--C 1.539 0.523 0 C-N-CA 124.548 1.139 . . . . 3.75 111.338 174.914 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.44 79.55 0.84 Allowed 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 122.802 2.335 . . . . 1.6299999999999999 111.46 176.858 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -143.63 -56.79 0.39 Allowed 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 105.867 -1.901 . . . . 1.3999999999999999 105.867 159.816 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 91.4 t -56.76 -62.37 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 C-N-CA 124.646 1.178 . . . . 1.3300000000000001 109.492 171.903 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.543 HG23 ' H ' ' A' ' 53' ' ' GLN 0.28 9.6 tp -89.3 -77.48 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 CA-C-O 118.669 -0.681 . . . . 1.6200000000000001 112.338 -160.341 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.543 ' H ' HG23 ' A' ' 52' ' ' ILE . 3.3 mp0 99.37 142.79 0.03 OUTLIER Pre-proline 0 CA--C 1.54 0.592 0 C-N-CA 129.808 3.243 . . . . 3.4199999999999999 111.414 -179.606 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.443 ' HA ' HG12 ' A' ' 57' ' ' ILE . 30.3 Cg_exo -47.95 -47.82 17.96 Favored 'Trans proline' 0 CA--C 1.536 0.614 1 C-N-CA 126.525 4.817 . . . . 1.1399999999999999 116.917 174.213 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -49.1 -62.11 0.48 Allowed 'Trans proline' 0 N--CA 1.446 -1.29 0 CA-C-N 120.874 1.348 . . . . 0.93000000000000005 109.777 163.445 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 1.1 ttt -53.94 -45.9 71.39 Favored 'General case' 0 N--CA 1.428 -1.541 0 N-CA-C 114.397 1.258 . . . . 3.8100000000000001 114.397 -173.18 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.573 HD12 HG11 ' A' ' 45' ' ' VAL . 5.0 pt -54.61 -50.08 62.11 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-N 120.15 1.341 . . . . 3.1800000000000002 111.101 175.063 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -55.33 -52.07 64.69 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 118.365 0.529 . . . . 1.0800000000000001 111.34 177.87 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -60.94 -58.53 8.03 Favored 'General case' 0 N--CA 1.432 -1.359 0 C-N-CA 123.769 0.828 . . . . 2.7400000000000002 111.235 -178.274 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -50.14 -35.23 25.06 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.163 0.985 . . . . 3.6000000000000001 111.909 -178.934 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.547 HG23 ' CE2' ' A' ' 66' ' ' PHE . 54.3 mt -64.44 -62.8 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 O-C-N 121.933 -0.479 . . . . 1.22 109.901 169.542 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 38.7 mtp180 -50.94 -43.56 60.24 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.451 0.701 . . . . 5.3399999999999999 112.799 -174.304 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -46.09 -33.11 3.27 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 126.058 1.743 . . . . 3.0 112.439 177.528 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 68.5 mt -82.36 -17.2 46.47 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 123.193 0.597 . . . . 1.8 112.029 -176.792 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 124.6 -35.52 3.15 Favored Glycine 0 C--N 1.339 0.708 0 CA-C-N 118.576 0.625 . . . . 2.2400000000000002 112.682 169.366 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.547 ' CE2' HG23 ' A' ' 61' ' ' ILE . 28.6 p90 -84.29 131.71 34.7 Favored 'General case' 0 N--CA 1.457 -0.106 0 N-CA-C 106.784 -1.562 . . . . 5.0099999999999998 106.784 177.24 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -88.4 162.05 31.71 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.787 -0.925 . . . . 2.1800000000000002 110.787 -163.593 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.509 ' HB2' HG21 ' A' ' 61' ' ' ILE . . . -137.53 144.12 41.98 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.487 1.115 . . . . 1.0800000000000001 109.025 -179.441 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 12.3 p -129.53 127.01 39.89 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 106.257 -1.756 . . . . 2.7400000000000002 106.257 172.917 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 28.1 t -84.66 118.04 31.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 N-CA-C 107.962 -1.125 . . . . 1.74 107.962 -176.853 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 28.4 mt -141.98 68.78 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 N-CA-C 107.511 -1.292 . . . . 2.21 107.511 -172.92 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.539 0.532 0 CA-C-N 115.673 -0.694 . . . . 4.9400000000000004 110.337 178.603 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.6 m . . . . . 0 N--CA 1.451 -0.39 0 N-CA-C 111.916 0.339 . . . . 2.6600000000000001 111.916 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.3 t -91.89 163.32 14.07 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 124.31 1.044 . . . . 2.5800000000000001 110.679 -169.653 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 3.6 ttpm? -88.96 159.5 17.61 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 125.845 1.658 . . . . 4.5899999999999999 109.968 -175.098 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.424 ' HB3' ' CG2' ' A' ' 45' ' ' VAL . 52.9 t -155.37 159.15 39.69 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 107.822 -1.177 . . . . 1.3999999999999999 107.822 153.73 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -107.49 144.48 34.38 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 125.529 1.532 . . . . 2.7799999999999998 107.151 168.708 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.7 mt -138.01 138.83 43.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 107.867 -1.16 . . . . 1.6799999999999999 107.867 -179.482 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 66.0 mt-30 -77.1 145.62 37.71 Favored 'General case' 0 CA--C 1.522 -0.12 0 N-CA-C 106.179 -1.785 . . . . 4.6500000000000004 106.179 173.412 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 17.2 m -136.93 127.42 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 N-CA-C 108.502 -0.925 . . . . 2.1600000000000001 108.502 172.727 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 72.8 p -79.81 64.52 4.69 Favored 'General case' 0 CA--C 1.534 0.344 0 O-C-N 121.863 -0.523 . . . . 3.6600000000000001 110.227 -174.81 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 152.8 55.94 0.01 OUTLIER Glycine 0 C--N 1.339 0.695 0 CA-C-O 124.904 2.391 . . . . 3.2799999999999998 113.432 169.492 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 16.7 tmm? -43.06 -50.65 6.02 Favored 'General case' 0 N--CA 1.432 -1.329 0 CA-C-N 109.816 -3.192 . . . . 4.2599999999999998 109.39 137.542 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.27 -33.95 76.38 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 125.821 1.648 . . . . 5.3700000000000001 112.848 -168.215 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 21.4 m -61.79 143.35 56.43 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 109.345 -0.613 . . . . 2.8199999999999998 109.345 -173.046 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -61.6 146.53 48.63 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 108.304 -0.998 . . . . 2.5499999999999998 108.304 163.43 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 79.92 -62.76 0.25 Allowed 'General case' 0 C--O 1.22 -0.474 0 C-N-CA 124.965 1.306 . . . . 3.1899999999999999 112.251 179.839 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 51.8 m -36.26 -48.9 0.66 Allowed 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 125.995 1.718 . . . . 3.0699999999999998 114.54 -154.854 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.418 HG13 HG11 ' A' ' 36' ' ' VAL . 0.9 OUTLIER -43.95 -43.48 1.9 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.915 0 C-N-CA 125.905 1.682 . . . . 2.6699999999999999 113.553 175.467 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.02 -44.55 94.53 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 125.828 1.651 . . . . 0.84999999999999998 111.528 170.933 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -59.4 -51.01 71.73 Favored 'General case' 0 C--O 1.218 -0.593 0 CA-C-O 118.016 -0.993 . . . . 1.8200000000000001 108.823 173.376 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.435 HG22 HD11 ' A' ' 34' ' ' ILE . 2.5 mt -45.7 -58.76 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 C-N-CA 124.898 1.279 . . . . 2.2599999999999998 109.895 173.702 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -34.94 -59.58 0.48 Allowed 'General case' 0 C--N 1.328 -0.338 0 O-C-N 119.924 -1.735 . . . . 4.2699999999999996 113.382 166.062 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 92.7 mtt180 -59.81 -35.3 74.41 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 114.517 1.303 . . . . 4.9900000000000002 114.517 173.423 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.696 ' ND2' HD13 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -64.91 -58.74 5.36 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 125.836 1.654 . . . . 4.3700000000000001 109.567 -163.984 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.78 ' HB2' HD13 ' A' ' 34' ' ' ILE 0.256 7.3 mp -73.62 -19.83 60.75 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 121.22 0.533 . . . . 3.1400000000000001 109.896 179.105 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . 0.495 84.0 mtp180 -67.17 2.91 1.34 Allowed 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 116.465 2.024 . . . . 5.5099999999999998 116.465 164.98 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.413 ' CZ ' ' HA ' ' A' ' 27' ' ' ARG . 0.2 OUTLIER -38.86 -32.71 0.09 Allowed 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 116.49 -2.084 . . . . 6.7199999999999998 113.879 145.654 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . 0.267 2.0 mt-10 64.11 45.49 4.08 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 126.366 1.867 . . . . 7.9100000000000001 111.294 174.395 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 70.1 mt-10 -105.4 79.77 1.5 Allowed 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 126.467 1.907 . . . . 6.0 108.921 -174.698 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 64.39 26.55 70.76 Favored Glycine 0 CA--C 1.532 1.119 0 CA-C-O 121.669 0.594 . . . . 1.1399999999999999 111.733 -175.653 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.1 mm -93.72 158.06 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 C-N-CA 126.19 1.796 . . . . 2.0499999999999998 108.408 176.65 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 12.6 t80 -154.37 41.76 0.49 Allowed 'General case' 0 C--N 1.339 0.12 0 C-N-CA 119.857 -0.737 . . . . 6.0300000000000002 111.482 170.995 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.43 ' HB3' HD11 ' A' ' 35' ' ' LEU . 48.4 t -171.39 -179.42 2.61 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 128.773 2.829 . . . . 1.8300000000000001 105.319 141.372 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.895 HD12 ' H ' ' A' ' 35' ' ' LEU . 2.1 tp -134.65 141.17 44.05 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.353 0 N-CA-C 106.909 -1.515 . . . . 3.6600000000000001 106.909 149.294 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.895 ' H ' HD12 ' A' ' 34' ' ' ILE . 0.3 OUTLIER -149.02 144.03 26.47 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 114.473 -1.24 . . . . 6.9000000000000004 109.619 -158.103 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.474 ' CG1' HD23 ' A' ' 38' ' ' LEU 0.258 0.9 OUTLIER -154.64 80.77 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.437 -1.095 0 CA-C-O 124.196 1.951 . . . . 2.2999999999999998 108.786 -164.012 . . . . . . . . 4 4 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -77.2 61.39 2.09 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 113.543 -1.662 . . . . 0.87 109.527 169.21 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.474 HD23 ' CG1' ' A' ' 36' ' ' VAL . 0.2 OUTLIER -46.71 -44.85 19.08 Favored 'General case' 0 CA--C 1.512 -0.487 0 C-N-CA 123.828 0.851 . . . . 3.6699999999999999 110.046 169.007 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 27.8 ttt -63.81 -36.37 83.69 Favored 'General case' 0 N--CA 1.441 -0.892 0 C-N-CA 120.208 -0.597 . . . . 5.3200000000000003 110.145 -169.199 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -74.86 -36.07 62.33 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.294 0.638 . . . . 1.8400000000000001 110.29 172.625 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 109.8 39.57 1.56 Allowed Glycine 0 C--N 1.334 0.471 0 C-N-CA 124.945 1.259 . . . . 1.2 111.009 173.43 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 29.5 pttt -158.75 157.04 30.94 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 108.436 -0.95 . . . . 3.7599999999999998 108.436 -176.464 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -82.59 147.95 28.3 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 107.279 -1.378 . . . . 1.1299999999999999 107.279 167.624 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.557 ' CB ' ' HB2' ' A' ' 35' ' ' LEU . 36.1 mt-10 -103.61 153.28 20.78 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 105.962 -1.866 . . . . 2.9700000000000002 105.962 171.008 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.577 ' HA ' HD13 ' A' ' 35' ' ' LEU . 34.1 m -137.95 148.4 25.31 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-N 119.195 0.907 . . . . 2.73 109.528 171.775 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 58.3 ttm-85 -133.47 130.77 39.05 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 106.234 -1.765 . . . . 4.8399999999999999 106.234 164.852 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 26.7 p90 -156.45 167.69 29.68 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 110.099 -0.334 . . . . 2.2999999999999998 110.099 -167.638 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -105.97 104.3 48.67 Favored Pre-proline 0 CA--C 1.542 0.661 0 C-N-CA 123.311 0.644 . . . . 3.2799999999999998 111.056 178.364 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -75.82 73.02 4.93 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 122.627 2.218 . . . . 1.98 111.661 -175.808 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -142.71 -63.72 0.42 Allowed 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 105.979 -1.86 . . . . 1.22 105.979 161.493 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 72.7 t -56.07 -52.32 51.63 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.749 0 C-N-CA 124.905 1.282 . . . . 1.3100000000000001 110.263 175.343 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 20.1 tt -84.16 -52.19 13.05 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.403 0 N-CA-C 114.125 1.158 . . . . 3.3399999999999999 114.125 -151.415 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER 71.3 109.5 0.03 OUTLIER Pre-proline 0 CA--C 1.538 0.517 0 C-N-CA 127.968 2.507 . . . . 2.7200000000000002 111.266 -165.702 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_exo -46.72 -41.29 24.67 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 123.358 2.705 . . . . 1.3600000000000001 115.102 162.186 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_endo -55.09 -50.41 13.21 Favored 'Trans proline' 0 N--CA 1.447 -1.261 0 CA-C-N 121.707 1.645 . . . . 1.1599999999999999 109.754 168.683 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 77.0 mtp -59.97 -42.51 94.3 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 118.595 -1.242 . . . . 2.5299999999999998 111.934 -179.501 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.1 pt -58.24 -47.07 88.44 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-N 121.61 2.005 . . . . 2.3900000000000001 111.829 173.984 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -51.9 -46.44 64.59 Favored 'General case' 0 C--N 1.341 0.201 0 C-N-CA 122.761 0.424 . . . . 1.4199999999999999 111.096 179.31 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -64.19 -60.8 2.77 Favored 'General case' 0 N--CA 1.434 -1.242 0 C-N-CA 123.853 0.861 . . . . 2.9399999999999999 111.84 175.467 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 8.2 m-30 -45.76 -47.39 15.51 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 125.418 1.487 . . . . 3.6299999999999999 110.071 -175.927 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 74.6 mt -57.75 -39.83 72.56 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 CA-C-N 116.62 -0.264 . . . . 1.1399999999999999 111.311 -178.61 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 21.3 mtm105 -69.82 -46.61 65.27 Favored 'General case' 0 N--CA 1.455 -0.185 0 O-C-N 121.683 -0.636 . . . . 3.6200000000000001 111.362 173.633 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -54.06 -47.21 71.91 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 122.834 0.453 . . . . 3.2400000000000002 111.24 -179.763 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.4 pp -90.0 -34.71 15.88 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 112.989 0.737 . . . . 2.8100000000000001 112.989 -176.07 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -123.67 -79.29 0.43 Allowed Glycine 0 C--N 1.34 0.763 0 N-CA-C 114.392 0.517 . . . . 2.29 114.392 -157.839 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -165.74 165.61 18.42 Favored 'General case' 0 N--CA 1.465 0.291 0 O-C-N 122.12 -0.635 . . . . 4.6299999999999999 110.994 -154.798 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -78.64 66.11 3.35 Favored Glycine 0 C--N 1.337 0.631 0 C-N-CA 124.649 1.118 . . . . 1.95 113.496 -157.408 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -90.02 148.44 23.07 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 124.696 1.198 . . . . 1.0900000000000001 113.151 -164.97 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.6 t -141.59 145.09 34.63 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 107.552 -1.277 . . . . 2.6699999999999999 107.552 174.807 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 1.8 t -81.84 130.12 36.35 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 C-N-CA 125.116 1.367 . . . . 1.8799999999999999 107.998 -178.301 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 4.9 pt -148.03 59.83 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.339 0.141 0 C-N-CA 124.564 1.146 . . . . 3.1299999999999999 110.91 -172.34 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 . . . . . 0 C--O 1.235 0.318 0 CA-C-N 116.27 -0.423 . . . . 5.6900000000000004 110.066 176.393 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.7 p . . . . . 0 CA--C 1.535 0.382 0 N-CA-C 112.069 0.396 . . . . 2.8599999999999999 112.069 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 45.5 m -149.61 157.8 43.58 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 126.565 1.946 . . . . 1.73 107.934 -177.693 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 33.4 mtmt -103.86 147.43 27.32 Favored 'General case' 0 C--O 1.231 0.081 0 N-CA-C 107.202 -1.407 . . . . 5.3300000000000001 107.202 168.349 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 38.3 t -153.25 150.47 29.0 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 108.922 -0.77 . . . . 1.7 108.922 172.591 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -112.34 146.3 38.53 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 125.927 1.691 . . . . 2.23 106.546 -179.064 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.463 HD13 HD11 ' A' ' 61' ' ' ILE . 0.0 OUTLIER -139.24 107.74 3.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 107.509 -1.293 . . . . 2.7599999999999998 107.509 -168.698 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 48.4 tp60 -82.78 123.05 28.96 Favored 'General case' 0 N--CA 1.428 -1.535 0 N-CA-C 106.036 -1.839 . . . . 2.9500000000000002 106.036 -172.547 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 9.9 p -89.38 157.26 3.02 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 C-N-CA 125.322 1.449 . . . . 3.4900000000000002 108.86 -177.232 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.8 t -111.18 21.68 16.07 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 123.115 0.566 . . . . 2.8399999999999999 112.453 176.71 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -143.35 117.36 1.09 Allowed Glycine 0 N--CA 1.444 -0.798 0 N-CA-C 106.304 -2.719 . . . . 2.3399999999999999 106.304 154.272 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 1.5 ttp -90.16 -61.78 1.61 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 113.445 -1.378 . . . . 4.6500000000000004 108.314 174.03 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 14.1 t -82.38 47.91 1.22 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.544 0.738 . . . . 6.3300000000000001 110.529 -175.866 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 15.6 p -79.38 -44.0 22.34 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 109.169 -0.678 . . . . 2.8199999999999998 109.169 170.706 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 143.14 -121.66 0.0 OUTLIER 'General case' 0 C--N 1.34 0.16 0 C-N-CA 130.663 3.585 . . . . 4.0099999999999998 106.244 177.914 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.2 m -79.41 60.58 3.22 Favored 'General case' 0 N--CA 1.451 -0.394 0 O-C-N 121.493 -0.754 . . . . 3.0 111.261 -175.389 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 4.2 t -48.59 -44.87 37.32 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 125.827 1.651 . . . . 4.6500000000000004 109.116 177.399 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.469 HG13 ' H ' ' A' ' 19' ' ' ALA . 2.5 p -55.3 -61.61 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.816 0 CA-C-N 113.988 -1.46 . . . . 3.3500000000000001 110.627 177.754 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.469 ' H ' HG13 ' A' ' 18' ' ' VAL . . . -54.28 -35.56 62.71 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.406 -1.27 . . . . 1.21 110.644 -178.811 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -63.69 -58.64 6.28 Favored 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 109.734 -0.469 . . . . 2.4700000000000002 109.734 170.701 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.554 HG21 HG23 ' A' ' 36' ' ' VAL . 1.2 mp -54.4 -48.36 68.83 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 CA-C-N 119.605 1.093 . . . . 2.27 111.18 -175.994 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -45.94 -43.08 13.67 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 120.89 -1.131 . . . . 2.9100000000000001 111.168 177.07 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.61 -46.82 58.06 Favored 'General case' 0 CA--C 1.536 0.429 0 O-C-N 121.434 -0.791 . . . . 6.0899999999999999 111.012 168.712 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -55.3 -47.23 75.87 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.808 1.243 . . . . 4.2400000000000002 113.392 -165.745 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . 0.382 0.8 OUTLIER -79.04 -23.61 44.18 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 122.11 0.957 . . . . 3.1699999999999999 112.465 -172.413 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . 0.585 53.7 mtp85 -54.14 2.12 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 120.769 3.618 . . . . 5.71 120.769 176.458 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.436 HH11 ' CG ' ' A' ' 27' ' ' ARG . 0.1 OUTLIER -45.85 -32.27 2.53 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 117.308 -1.757 . . . . 9.7699999999999996 111.03 154.046 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 64.34 -155.13 0.3 Allowed 'General case' 0 C--N 1.342 0.27 0 C-N-CA 123.845 0.858 . . . . 7.3600000000000003 108.947 -175.835 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 58.93 54.25 5.19 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 122.37 1.081 . . . . 6.5 109.062 -179.079 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 152.26 -46.3 0.59 Allowed Glycine 0 C--N 1.335 0.521 0 N-CA-C 110.528 -1.029 . . . . 1.6000000000000001 110.528 -171.765 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.9 mp -81.66 153.73 4.12 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 C-N-CA 124.323 1.049 . . . . 2.5800000000000001 108.781 -171.927 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -151.58 36.04 0.57 Allowed 'General case' 0 CA--C 1.546 0.824 0 CA-C-O 121.99 0.9 . . . . 3.54 112.616 167.579 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 57.9 m -167.55 161.59 13.82 Favored 'General case' 0 C--N 1.326 -0.444 1 C-N-CA 131.871 4.068 . . . . 2.25 103.069 145.017 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.416 HD12 ' HA ' ' A' ' 34' ' ' ILE . 10.8 tp -139.97 133.64 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 CA-C-N 122.77 2.532 . . . . 4.4500000000000002 110.863 155.379 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.491 ' O ' HG23 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -167.92 -179.08 4.03 Favored 'General case' 0 N--CA 1.44 -0.925 0 CA-C-N 111.73 -2.486 . . . . 6.1200000000000001 108.864 -153.739 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.554 HG23 HG21 ' A' ' 21' ' ' ILE . 2.4 t -159.57 128.44 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.253 0 C-N-CA 125.695 1.598 . . . . 1.6799999999999999 107.213 -175.088 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -84.23 63.64 7.83 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 107.905 -1.146 . . . . 0.89000000000000001 107.905 175.007 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -60.31 -31.75 70.56 Favored 'General case' 0 CA--C 1.532 0.25 0 O-C-N 122.043 -0.411 . . . . 2.7000000000000002 111.552 -169.507 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 67.2 mtt -53.6 -36.89 62.44 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.526 0.73 . . . . 3.2599999999999998 111.707 172.833 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -92.22 7.25 43.48 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.589 1.156 . . . . 2.2999999999999998 111.947 176.844 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.27 38.6 96.11 Favored Glycine 0 CA--C 1.522 0.483 0 C-N-CA 125.473 1.511 . . . . 1.1899999999999999 112.029 174.491 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -162.02 152.43 17.18 Favored 'General case' 0 N--CA 1.442 -0.857 0 N-CA-C 108.075 -1.083 . . . . 4.1799999999999997 108.075 -162.177 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -81.77 157.98 24.3 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 108.928 -0.768 . . . . 1.3200000000000001 108.928 176.975 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.479 ' HB3' ' CD2' ' A' ' 35' ' ' LEU 0.335 2.2 tm-20 -129.37 157.36 42.13 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 108.612 -0.885 . . . . 4.6299999999999999 108.612 165.581 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.0 p -151.97 138.12 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 N-CA-C 106.476 -1.676 . . . . 1.6200000000000001 106.476 -176.298 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 4.0 mtm180 -104.35 133.01 49.97 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 105.545 -2.02 . . . . 7.1600000000000001 105.545 158.023 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -157.32 167.64 29.69 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 123.716 0.807 . . . . 1.97 108.844 -171.407 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 54.6 t30 -116.79 97.48 50.52 Favored Pre-proline 0 CA--C 1.533 0.312 0 C-N-CA 123.83 0.852 . . . . 3.2999999999999998 110.378 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.3 72.25 2.89 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 123.309 2.672 . . . . 1.8700000000000001 111.538 -178.951 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -147.56 -56.8 0.24 Allowed 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 106.062 -1.829 . . . . 1.53 106.062 169.293 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 45.6 t -57.52 -54.78 26.58 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 C-N-CA 124.116 0.966 . . . . 1.4199999999999999 109.694 173.191 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.494 HG23 ' H ' ' A' ' 53' ' ' GLN 0.25 10.5 tp -94.2 -75.06 0.42 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.352 0 N-CA-C 112.692 0.627 . . . . 2.0800000000000001 112.692 -164.463 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.494 ' H ' HG23 ' A' ' 52' ' ' ILE . 0.0 OUTLIER 108.45 135.48 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.452 0 C-N-CA 129.845 3.258 . . . . 2.3599999999999999 108.208 -176.58 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -44.22 -51.15 7.05 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 124.63 3.553 . . . . 1.3100000000000001 114.796 171.021 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -47.19 -56.05 3.39 Favored 'Trans proline' 0 N--CA 1.448 -1.195 0 CA-C-N 121.307 1.502 . . . . 1.1000000000000001 110.929 167.008 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 51.0 mtt -59.51 -36.34 75.89 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 118.029 -1.468 . . . . 1.9099999999999999 113.134 -178.92 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.425 HD13 HG21 ' A' ' 57' ' ' ILE . 0.5 OUTLIER -62.13 -46.81 95.63 Favored 'Isoleucine or valine' 0 C--N 1.344 0.351 0 CA-C-N 120.675 1.58 . . . . 2.9399999999999999 110.619 173.841 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -53.38 -52.36 59.56 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 121.189 0.519 . . . . 1.3799999999999999 109.978 178.755 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -56.77 -49.1 76.29 Favored 'General case' 0 N--CA 1.426 -1.652 0 C-N-CA 123.474 0.709 . . . . 3.2599999999999998 111.337 176.55 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 3.9 m-30 -53.81 -33.98 57.75 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 119.31 0.959 . . . . 4.1799999999999997 111.39 178.423 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.463 HD11 HD13 ' A' ' 7' ' ' ILE . 42.0 mt -70.84 -51.35 36.82 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 O-C-N 121.477 -0.764 . . . . 1.3999999999999999 109.292 173.548 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 35.6 mtp-105 -63.85 -27.88 69.47 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 113.54 0.941 . . . . 5.7800000000000002 113.54 -174.396 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -45.93 -55.11 7.18 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 125.058 1.343 . . . . 4.9699999999999998 111.072 177.808 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -130.27 -19.65 3.11 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 124.453 1.101 . . . . 2.77 113.525 -166.8 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -96.52 -102.67 2.05 Favored Glycine 0 N--CA 1.446 -0.642 0 N-CA-C 109.086 -1.606 . . . . 2.9199999999999999 109.086 -179.03 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 27.9 m-85 -149.53 166.17 30.0 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 122.172 0.987 . . . . 2.8599999999999999 110.936 -154.837 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -78.94 69.06 2.96 Favored Glycine 0 N--CA 1.443 -0.859 0 CA-C-N 114.53 -1.213 . . . . 1.76 110.551 -178.703 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -82.64 141.78 32.23 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 113.867 -1.167 . . . . 1.3400000000000001 109.852 -176.713 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 9.3 t -115.25 139.65 49.77 Favored 'General case' 0 N--CA 1.439 -1.013 0 N-CA-C 106.77 -1.567 . . . . 2.1699999999999999 106.77 178.448 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.0 t -83.59 125.9 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.612 0 C-N-CA 125.132 1.373 . . . . 2.0 108.952 -172.385 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 13.7 mm -130.62 59.54 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 C-N-CA 125.254 1.422 . . . . 2.1099999999999999 108.472 -177.703 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 . . . . . 0 CA--C 1.532 0.26 0 N-CA-C 108.195 -1.039 . . . . 4.8099999999999996 108.195 162.015 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 . . . . . 0 N--CA 1.479 0.992 0 N-CA-C 108.295 -1.002 . . . . 7.3499999999999996 108.295 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.2 m -47.92 132.45 15.03 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 125.544 1.538 . . . . 2.6299999999999999 112.323 -176.323 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 22.9 t -113.19 178.08 4.4 Favored 'General case' 0 N--CA 1.463 0.18 0 C-N-CA 125.423 1.489 . . . . 3.1800000000000002 108.149 177.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.39 159.28 37.5 Favored 'General case' 0 N--CA 1.46 0.052 0 CA-C-N 118.273 0.488 . . . . 4.3799999999999999 112.005 -176.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 53.6 t -138.77 154.12 48.49 Favored 'General case' 0 C--N 1.333 -0.144 0 N-CA-C 106.635 -1.617 . . . . 1.45 106.635 176.078 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 81.3 m-85 -98.75 154.37 18.04 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 107.405 -1.331 . . . . 2.8700000000000001 107.405 178.369 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 18.2 mt -148.66 132.16 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 N-CA-C 105.379 -2.082 . . . . 1.6100000000000001 105.379 -176.043 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 48.5 tp60 -100.86 126.13 47.44 Favored 'General case' 0 N--CA 1.432 -1.364 0 N-CA-C 105.553 -2.017 . . . . 3.1200000000000001 105.553 176.669 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 30.1 m -98.85 137.09 27.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 C-N-CA 124.087 0.955 . . . . 2.2599999999999998 109.209 179.591 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 25.3 m -78.81 74.85 5.33 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 109.501 -0.555 . . . . 2.3399999999999999 109.501 179.271 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 117.81 77.32 0.59 Allowed Glycine 0 C--N 1.335 0.487 0 CA-C-O 124.513 2.174 . . . . 2.2400000000000002 110.485 173.637 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.9 -65.91 0.62 Allowed 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 110.024 -3.088 . . . . 4.1100000000000003 108.398 176.691 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.6 t -79.09 41.97 0.46 Allowed 'General case' 0 CA--C 1.54 0.586 0 O-C-N 121.3 -0.875 . . . . 4.8700000000000001 111.173 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 45.3 t -68.69 -43.9 75.12 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 107.115 -1.439 . . . . 2.4300000000000002 107.115 156.334 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 76.76 161.0 0.22 Allowed 'General case' 0 C--N 1.344 0.341 0 C-N-CA 126.688 1.995 . . . . 3.04 110.104 -174.197 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 10.8 m 72.05 -53.38 0.69 Allowed 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 125.183 1.393 . . . . 2.7400000000000002 112.039 -176.186 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 31.5 m -29.56 -54.65 0.15 Allowed 'General case' 0 C--O 1.223 -0.294 0 C-N-CA 127.278 2.231 . . . . 3.04 110.96 167.131 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.618 HG22 ' CG2' ' A' ' 36' ' ' VAL . 1.2 t -69.58 -36.37 70.62 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.048 0 N-CA-C 112.488 0.551 . . . . 3.2799999999999998 112.488 -174.239 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.27 -45.42 93.38 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 109.232 -0.655 . . . . 0.81000000000000005 109.232 173.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -57.54 -47.39 82.14 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 109.094 -0.706 . . . . 2.71 109.094 173.244 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.707 HG21 HD11 ' A' ' 35' ' ' LEU 0.251 53.9 mt -64.16 -44.84 97.61 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 O-C-N 121.571 -0.706 . . . . 1.95 111.296 -172.971 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -47.76 -51.79 20.98 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 119.383 0.992 . . . . 3.25 111.755 165.666 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 8.4 mmt85 -57.75 -38.22 74.99 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 118.011 -0.995 . . . . 4.5199999999999996 112.714 176.055 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -63.2 -55.74 22.49 Favored 'General case' 0 C--O 1.222 -0.35 0 CA-C-N 120.237 1.38 . . . . 3.1499999999999999 108.03 177.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 17.5 mt -77.14 -51.34 11.16 Favored 'General case' 0 N--CA 1.434 -1.229 0 C-N-CA 124.621 1.168 . . . . 2.9199999999999999 112.308 -159.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 3.1 ttm105 -65.44 -13.44 58.76 Favored 'General case' 0 N--CA 1.421 -1.915 0 O-C-N 121.499 -0.751 . . . . 8.1199999999999992 112.682 -173.544 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.1 mtp180 -42.15 -64.57 0.57 Allowed 'General case' 0 N--CA 1.448 -0.529 0 CA-C-O 118.369 -0.824 . . . . 7.9500000000000002 111.068 160.218 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 169.76 -176.66 0.03 OUTLIER 'General case' 0 C--N 1.344 0.366 0 CA-C-N 119.012 0.824 . . . . 7.3499999999999996 110.794 -156.706 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 84.82 53.46 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 127.314 2.246 . . . . 5.3600000000000003 109.747 178.356 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 72.44 14.58 77.27 Favored Glycine 0 CA--C 1.527 0.826 0 CA-C-O 118.466 -1.186 . . . . 0.94999999999999996 114.668 168.078 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 1.1 mt -84.75 130.07 36.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 N-CA-C 107.091 -1.448 . . . . 1.8500000000000001 107.091 -178.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -137.57 43.03 2.31 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-O 122.734 1.254 . . . . 3.1099999999999999 111.223 160.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.5 t -170.21 147.63 3.16 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 128.858 2.863 . . . . 1.6000000000000001 105.187 134.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.424 ' H ' HG13 ' A' ' 34' ' ' ILE . 2.6 pp -77.72 159.62 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 N-CA-C 108.141 -1.059 . . . . 2.0299999999999998 108.141 176.109 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.707 HD11 HG21 ' A' ' 21' ' ' ILE . 2.5 pp -73.96 137.16 43.39 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 104.488 -2.412 . . . . 4.7400000000000002 104.488 158.272 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.618 ' CG2' HG22 ' A' ' 18' ' ' VAL . 2.1 t -160.46 150.85 5.52 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.104 0 N-CA-C 106.112 -1.81 . . . . 1.3999999999999999 106.112 123.047 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -158.73 53.54 0.42 Allowed 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 104.325 -2.472 . . . . 0.68000000000000005 104.325 165.019 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.588 HD23 ' C ' ' A' ' 38' ' ' LEU . 1.1 tt -66.11 -31.1 71.76 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 107.294 -1.373 . . . . 3.4399999999999999 107.294 -178.689 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 27.7 ttt -45.0 -41.95 7.86 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.108 1.363 . . . . 3.29 111.875 170.037 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -85.76 -55.58 3.9 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 108.524 -0.917 . . . . 1.78 108.524 171.09 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 143.17 43.98 0.05 OUTLIER Glycine 0 CA--C 1.523 0.553 0 C-N-CA 125.089 1.328 . . . . 0.81999999999999995 111.885 167.184 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 14.1 pttp -159.92 -179.3 7.69 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 118.078 0.939 . . . . 4.0899999999999999 108.9 -164.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.574 ' CB ' HD13 ' A' ' 35' ' ' LEU . . . -130.72 143.45 50.75 Favored 'General case' 0 N--CA 1.441 -0.877 0 C-N-CA 127.475 2.31 . . . . 0.87 108.953 -177.799 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -144.01 89.13 2.01 Favored 'General case' 0 C--N 1.341 0.238 0 C-N-CA 124.104 0.961 . . . . 3.8700000000000001 111.215 173.065 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 14.0 p -80.71 137.32 21.61 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.22 0 N-CA-C 108.901 -0.777 . . . . 2.04 108.901 -176.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 70.8 ttt180 -106.58 126.75 52.67 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 107.655 -1.239 . . . . 5.2000000000000002 107.655 171.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 7.9 p90 -157.48 175.88 13.38 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 123.384 0.674 . . . . 2.1699999999999999 109.844 -167.041 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 3.3 p30 -103.89 135.18 19.39 Favored Pre-proline 0 N--CA 1.451 -0.396 0 N-CA-C 107.752 -1.203 . . . . 3.0099999999999998 107.752 164.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -81.32 1.79 9.03 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 122.29 1.993 . . . . 2.5299999999999998 113.314 -174.01 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -91.87 -49.08 6.43 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-N 119.41 1.005 . . . . 1.0800000000000001 108.535 -167.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 24.4 t -58.78 -60.39 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.755 0 C-N-CA 124.354 1.062 . . . . 0.97999999999999998 109.855 175.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 19.2 tt -93.56 -53.42 8.5 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.233 0 CA-C-O 118.855 -0.593 . . . . 1.8200000000000001 112.258 -163.517 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 9.1 mm-40 101.16 129.72 0.02 OUTLIER Pre-proline 0 CA--C 1.541 0.598 0 C-N-CA 129.574 3.15 . . . . 2.9199999999999999 112.304 -175.707 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_exo -50.89 -48.95 18.53 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 124.787 3.658 . . . . 1.1200000000000001 116.71 177.112 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -54.45 -50.55 13.06 Favored 'Trans proline' 0 N--CA 1.442 -1.514 0 CA-C-N 120.66 1.271 . . . . 1.2 108.873 169.428 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 64.1 mtt -63.03 -44.07 96.93 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 120.528 -0.469 . . . . 2.4900000000000002 110.708 -167.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 16.2 tt -61.76 -35.19 66.15 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.25 0 C-N-CA 119.61 -0.836 . . . . 2.2799999999999998 111.686 -175.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -69.93 -58.03 4.33 Favored 'General case' 0 N--CA 1.452 -0.325 0 O-C-N 122.33 -0.231 . . . . 1.4099999999999999 110.875 171.4 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -47.98 -49.29 31.15 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 125.613 1.565 . . . . 3.1699999999999999 111.861 -174.643 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 16.2 m-30 -44.18 -40.42 5.03 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.748 0.819 . . . . 3.73 112.453 177.348 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 65.9 mt -65.16 -26.76 40.54 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 O-C-N 121.513 -0.742 . . . . 1.1499999999999999 110.66 -174.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 36.0 mtm180 -58.27 -61.21 2.74 Favored 'General case' 0 C--N 1.341 0.238 0 CA-C-N 118.939 0.791 . . . . 5.5199999999999996 109.642 174.62 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -60.59 -39.18 87.12 Favored 'General case' 0 N--CA 1.44 -0.974 0 C-N-CA 123.63 0.772 . . . . 4.5199999999999996 112.77 -166.081 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -98.36 -27.53 14.06 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 113.187 0.81 . . . . 2.2400000000000002 113.187 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -112.96 -82.14 1.14 Allowed Glycine 0 CA--C 1.526 0.743 0 CA-C-N 119.215 0.916 . . . . 2.25 111.968 -172.441 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -177.05 164.94 2.32 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.562 1.145 . . . . 4.3799999999999999 109.605 -162.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -59.83 115.17 7.16 Favored Glycine 0 N--CA 1.439 -1.148 0 N-CA-C 109.601 -1.4 . . . . 1.1699999999999999 109.601 -171.379 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -115.25 91.76 3.71 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 125.435 1.494 . . . . 1.0700000000000001 109.068 -169.49 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -84.39 119.14 24.76 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 108.263 -1.014 . . . . 2.5899999999999999 108.263 -178.584 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 8.3 p -81.23 141.9 14.53 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 C-N-CA 123.265 0.626 . . . . 2.2400000000000002 109.584 -174.326 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 15.0 mt -139.79 99.06 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 C-N-CA 124.817 1.247 . . . . 1.8200000000000001 107.675 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -81.8 50.09 1.47 Allowed 'General case' 0 CA--C 1.535 0.369 0 O-C-N 121.462 -0.774 . . . . 6.3600000000000003 109.755 174.252 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -169.13 169.2 9.53 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 108.169 -1.048 . . . . 4.7000000000000002 108.169 -175.621 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 6.0 tp -160.4 124.64 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 N-CA-C 107.189 -1.411 . . . . 9.5999999999999996 107.189 174.285 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -160.02 156.34 26.86 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 106.088 -1.819 . . . . 10.0 106.088 177.12 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 158.47 -178.39 34.72 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 108.972 -1.651 . . . . 12.66 108.972 -178.577 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.211 0 N-CA-C 104.506 -2.405 . . . . 21.719999999999999 104.506 174.222 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 . . . . . 0 N--CA 1.479 1.022 0 CA-C-O 118.858 -0.592 . . . . 6.8899999999999997 110.347 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.4 m -43.64 120.49 2.0 Allowed 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.732 1.613 . . . . 3.3100000000000001 112.549 -177.586 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 26.1 m -149.04 176.23 10.63 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 126.106 1.762 . . . . 1.75 107.558 -176.277 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 39.2 pttt -125.18 158.16 34.66 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-N 119.173 0.897 . . . . 3.7999999999999998 109.108 154.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 36.6 t -142.3 152.44 42.98 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 107.275 -1.38 . . . . 1.6200000000000001 107.275 175.258 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 54.3 m-85 -84.44 148.69 26.43 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 107.421 -1.325 . . . . 2.1499999999999999 107.421 176.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.431 ' HB ' ' HB3' ' A' ' 43' ' ' ALA . 5.6 mm -130.5 141.19 46.89 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.817 0 N-CA-C 104.61 -2.367 . . . . 2.0600000000000001 104.61 173.264 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -98.24 128.27 44.6 Favored 'General case' 0 N--CA 1.435 -1.189 0 N-CA-C 103.882 -2.636 . . . . 3.5899999999999999 103.882 166.172 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.4 p -126.41 122.53 61.4 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 C-N-CA 124.674 1.19 . . . . 2.3999999999999999 108.41 179.163 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.8 t -72.76 136.9 45.56 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 109.434 -0.58 . . . . 2.6800000000000002 109.434 -176.661 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 113.8 -52.19 0.66 Allowed Glycine 0 C--N 1.335 0.518 0 N-CA-C 108.146 -1.981 . . . . 2.8500000000000001 108.146 177.244 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 59.9 mtt 75.94 -69.96 0.15 Allowed 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 126.197 1.799 . . . . 4.25 110.314 158.609 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 11.8 t -112.13 11.74 20.4 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 125.907 1.683 . . . . 4.8399999999999999 109.957 174.374 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.442 ' SG ' ' HB2' ' A' ' 17' ' ' CYS 0.267 17.2 p -63.14 144.64 56.74 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 119.017 0.826 . . . . 3.25 109.436 -176.212 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -52.61 109.9 0.45 Allowed 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 116.212 -0.449 . . . . 3.3300000000000001 111.98 -158.179 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.7 m 69.23 6.72 5.83 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 125.355 1.462 . . . . 3.02 113.873 175.713 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.442 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 48.8 t -43.99 -49.06 8.75 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 123.765 1.745 . . . . 3.79 108.607 163.626 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -72.67 -46.64 53.55 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.521 0 CA-C-N 112.199 -2.273 . . . . 2.6000000000000001 109.856 -172.182 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.67 -42.06 87.58 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 110.212 -0.292 . . . . 1.1299999999999999 110.212 175.575 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -60.03 -60.44 3.83 Favored 'General case' 0 CA--C 1.521 -0.163 0 C-N-CA 124.571 1.148 . . . . 2.0499999999999998 108.455 178.513 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.437 HG23 ' CD2' ' A' ' 35' ' ' LEU . 1.7 mt -43.69 -54.72 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 C-N-CA 123.801 0.84 . . . . 1.8400000000000001 111.314 173.868 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -54.65 -50.05 69.11 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 119.702 1.137 . . . . 3.9199999999999999 111.517 176.102 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.94 -48.93 51.65 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.592 0.757 . . . . 4.8399999999999999 112.095 176.458 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -76.28 -60.39 2.36 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 118.139 0.427 . . . . 3.5699999999999998 111.766 -177.753 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.57 -36.77 73.8 Favored 'General case' 0 C--O 1.22 -0.47 0 C-N-CA 125.756 1.623 . . . . 3.04 112.595 -152.679 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -21.5 -74.61 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 128.616 2.766 . . . . 7.7000000000000002 114.722 -158.871 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . 0.287 7.9 ptp180 -91.9 -29.9 16.43 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 127.339 2.255 . . . . 12.69 116.286 166.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 41.8 mm-40 -81.05 128.4 33.67 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 114.855 -1.066 . . . . 6.7999999999999998 108.868 -134.299 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 60.0 55.84 3.63 Favored 'General case' 0 N--CA 1.442 -0.825 0 CA-C-O 122.856 1.312 . . . . 5.0899999999999999 111.189 -171.752 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 76.16 30.87 56.52 Favored Glycine 0 CA--C 1.523 0.566 0 CA-C-N 114.006 -1.452 . . . . 1.26 112.742 162.681 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.6 mt -96.03 147.44 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 N-CA-C 108.322 -0.992 . . . . 2.0800000000000001 108.322 171.303 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -147.88 47.03 1.09 Allowed 'General case' 0 C--O 1.233 0.22 0 CA-C-O 122.309 1.052 . . . . 3.4199999999999999 111.815 158.298 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 10.3 t -165.83 148.0 7.28 Favored 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 126.995 2.118 . . . . 1.75 107.252 148.654 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.5 pp -82.4 134.35 27.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 CA-C-O 122.666 1.222 . . . . 2.4399999999999999 110.375 175.476 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.509 ' H ' ' CD2' ' A' ' 35' ' ' LEU . 0.4 OUTLIER -79.79 64.05 4.53 Favored 'General case' 0 N--CA 1.433 -1.295 0 C-N-CA 127.687 2.395 . . . . 4.71 111.624 -173.315 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.456 ' CG1' HD23 ' A' ' 38' ' ' LEU . 52.8 t -133.52 131.43 57.31 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 O-C-N 120.721 -1.237 . . . . 1.23 113.131 174.142 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -138.8 76.23 1.56 Allowed 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 105.217 -2.142 . . . . 0.87 105.217 152.375 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.456 HD23 ' CG1' ' A' ' 36' ' ' VAL . 0.3 OUTLIER -54.54 -39.78 68.01 Favored 'General case' 0 CA--C 1.511 -0.526 0 N-CA-C 109.595 -0.52 . . . . 3.3700000000000001 109.595 175.138 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 24.0 ttt -85.06 44.22 1.06 Allowed 'General case' 0 N--CA 1.442 -0.836 0 CA-C-O 121.767 0.794 . . . . 4.7999999999999998 109.1 -164.469 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -179.33 -36.71 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 129.013 2.925 . . . . 1.4199999999999999 107.076 -167.288 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 106.11 46.72 1.14 Allowed Glycine 0 C--N 1.336 0.569 0 C-N-CA 126.062 1.791 . . . . 0.87 108.983 157.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 24.8 mttm -155.27 175.14 14.24 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 108.392 -0.966 . . . . 4.6100000000000003 108.392 -157.668 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.431 ' HB3' ' HB ' ' A' ' 7' ' ' ILE . . . -144.2 142.6 30.61 Favored 'General case' 0 N--CA 1.44 -0.967 0 C-N-CA 125.315 1.446 . . . . 1.0800000000000001 107.978 -178.701 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -132.99 97.37 4.0 Favored 'General case' 0 C--N 1.338 0.103 0 N-CA-C 113.379 0.881 . . . . 3.27 113.379 171.408 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.3 p -81.11 114.96 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.518 0 N-CA-C 107.423 -1.325 . . . . 1.8200000000000001 107.423 -178.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 54.5 ttp180 -87.36 124.78 33.75 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 105.71 -1.959 . . . . 5.4299999999999997 105.71 163.114 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -158.22 170.72 21.62 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 122.96 0.504 . . . . 2.1499999999999999 110.6 -164.12 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 47.5 t-20 -108.53 88.26 4.97 Favored Pre-proline 0 N--CA 1.451 -0.421 0 C-N-CA 124.038 0.935 . . . . 2.6499999999999999 109.346 173.451 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -61.79 88.23 0.1 Allowed 'Trans proline' 0 N--CA 1.448 -1.163 0 C-N-CA 122.328 2.019 . . . . 1.6000000000000001 108.973 165.371 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -169.97 -57.56 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 130.423 3.489 . . . . 1.1799999999999999 105.101 169.332 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 65.7 t -58.45 -54.37 33.95 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 C-N-CA 124.879 1.272 . . . . 1.03 110.207 175.349 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.527 HG23 ' H ' ' A' ' 53' ' ' GLN . 8.4 tp -93.61 -73.02 0.48 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.364 0 CA-C-O 118.725 -0.655 . . . . 2.1400000000000001 111.93 -167.815 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.527 ' H ' HG23 ' A' ' 52' ' ' ILE . 0.0 OUTLIER 117.17 134.99 0.0 OUTLIER Pre-proline 0 N--CA 1.472 0.626 0 C-N-CA 130.753 3.621 . . . . 2.8900000000000001 108.185 -176.365 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -50.24 -50.86 12.24 Favored 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 123.595 2.863 . . . . 1.03 114.449 172.4 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -50.07 -54.31 5.66 Favored 'Trans proline' 0 N--CA 1.444 -1.39 0 CA-C-N 120.451 1.197 . . . . 0.80000000000000004 110.069 167.109 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 62.0 mtt -62.45 -37.61 86.57 Favored 'General case' 0 C--N 1.342 0.261 0 C-N-CA 118.336 -1.346 . . . . 2.0600000000000001 111.469 -170.487 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.451 HD12 HG21 ' A' ' 52' ' ' ILE . 3.5 tt -70.37 -45.23 75.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-N 118.808 0.731 . . . . 2.23 110.312 178.708 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -58.8 -32.85 69.72 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.102 0.561 . . . . 1.3200000000000001 112.254 176.017 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -71.78 -60.13 2.39 Favored 'General case' 0 N--CA 1.441 -0.895 0 C-N-CA 126.388 1.875 . . . . 3.5600000000000001 111.585 176.272 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -41.63 -45.32 3.35 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.79 0.836 . . . . 3.6400000000000001 111.791 -173.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 49.7 mt -57.39 -52.48 56.31 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 C-N-CA 123.88 0.872 . . . . 1.1299999999999999 110.923 -177.822 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 1.3 ptt85 -71.5 -49.68 38.73 Favored 'General case' 0 CA--C 1.521 -0.139 0 N-CA-C 109.596 -0.52 . . . . 3.9199999999999999 109.596 -177.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -59.61 -34.51 72.84 Favored 'General case' 0 N--CA 1.441 -0.896 0 C-N-CA 123.387 0.675 . . . . 6.3899999999999997 111.627 -173.855 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 86.1 mt -83.0 -47.89 11.23 Favored 'General case' 0 C--N 1.34 0.194 0 CA-C-N 118.754 0.706 . . . . 2.77 111.446 170.549 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -95.98 -92.27 1.78 Allowed Glycine 0 CA--C 1.526 0.773 0 N-CA-C 111.692 -0.563 . . . . 1.8400000000000001 111.692 -174.486 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -135.53 -72.13 0.47 Allowed 'General case' 0 CA--C 1.513 -0.469 0 CA-C-O 121.679 0.752 . . . . 3.4900000000000002 112.962 -153.304 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 173.73 119.23 0.53 Allowed Glycine 0 N--CA 1.441 -1.028 0 N-CA-C 107.935 -2.066 . . . . 1.49 107.935 -156.78 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -156.5 161.41 40.02 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 122.904 0.482 . . . . 1.1599999999999999 110.996 -173.717 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 26.2 m -153.94 148.57 26.34 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 124.031 0.932 . . . . 2.9199999999999999 108.599 178.514 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 14.3 p -82.3 143.75 11.52 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 123.624 0.77 . . . . 2.3900000000000001 109.74 -177.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 22.5 mm -133.13 140.16 47.76 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 C-N-CA 125.774 1.629 . . . . 2.0 107.528 -178.268 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -156.65 160.41 39.35 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 123.741 0.817 . . . . 4.9400000000000004 109.108 179.045 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 7.5 m-20 -91.97 92.54 8.36 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 108.24 -1.022 . . . . 5.7000000000000002 108.24 -179.367 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 10.2 tp -54.93 145.75 4.7 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 C-N-CA 122.62 0.368 . . . . 10.220000000000001 110.427 174.083 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -146.47 160.52 41.99 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 106.254 -1.758 . . . . 11.210000000000001 106.254 177.617 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -148.41 -121.49 1.18 Allowed Glycine 0 CA--C 1.527 0.8 0 N-CA-C 110.662 -0.975 . . . . 13.779999999999999 110.662 -178.792 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.248 1.009 0 N-CA-C 104.289 -2.485 . . . . 20.890000000000001 104.289 169.617 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 . . . . . 0 N--CA 1.476 0.839 0 N-CA-C 107.172 -1.418 . . . . 6.5 107.172 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.4 m -146.4 162.14 38.86 Favored 'General case' 0 N--CA 1.454 -0.236 0 O-C-N 124.359 1.037 . . . . 3.02 108.605 -176.023 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 23.0 t -141.93 169.56 17.37 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 108.956 -0.757 . . . . 2.5499999999999998 108.956 171.083 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 71.9 tttt -104.72 158.33 16.58 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.309 1.443 . . . . 3.7400000000000002 107.211 163.285 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 36.3 t -155.55 155.09 32.75 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 109.046 -0.724 . . . . 1.3600000000000001 109.046 167.753 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 5.1 m-30 -106.45 135.01 48.7 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 125.848 1.659 . . . . 2.3100000000000001 108.771 -178.263 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.3 mm -129.06 139.75 51.05 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 N-CA-C 105.463 -2.051 . . . . 2.1099999999999999 105.463 -173.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 51.3 tp60 -112.2 122.93 49.12 Favored 'General case' 0 N--CA 1.424 -1.728 0 N-CA-C 104.693 -2.336 . . . . 2.8900000000000001 104.693 -179.641 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 15.7 m -105.3 173.08 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 C-N-CA 124.378 1.071 . . . . 2.5600000000000001 108.687 178.73 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -134.42 88.73 2.48 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.562 0.745 . . . . 3.04 111.045 -173.762 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 154.9 -62.81 0.35 Allowed Glycine 0 CA--C 1.524 0.619 0 N-CA-C 107.667 -2.173 . . . . 3.7999999999999998 107.667 174.437 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 1.9 mtt 66.38 -71.71 0.09 Allowed 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 126.691 1.997 . . . . 3.73 111.213 170.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 33.1 p -79.47 52.85 1.44 Allowed 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 124.42 1.088 . . . . 5.0499999999999998 108.496 176.338 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 55.8 m -92.42 176.29 6.52 Favored 'General case' 0 N--CA 1.445 -0.725 0 C-N-CA 124.794 1.238 . . . . 2.7599999999999998 107.895 175.639 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -75.64 73.42 2.63 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 121.454 0.645 . . . . 3.3500000000000001 110.097 166.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.5 m 74.94 26.99 1.22 Allowed 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 115.24 -0.891 . . . . 2.46 113.129 159.683 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 69.9 m -44.27 -43.25 7.21 Favored 'General case' 0 CA--C 1.523 -0.075 0 C-N-CA 124.357 1.063 . . . . 3.0800000000000001 108.912 157.24 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 24.5 m -63.53 -50.97 76.14 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.001 0 CA-C-N 114.138 -1.392 . . . . 2.8399999999999999 109.993 -177.68 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -52.73 -43.82 65.97 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 122.994 0.518 . . . . 1.29 110.972 172.425 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -56.53 -50.77 70.88 Favored 'General case' 0 C--O 1.227 -0.123 0 N-CA-C 109.303 -0.628 . . . . 2.23 109.303 174.508 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.457 HG23 ' CD2' ' A' ' 25' ' ' LEU . 7.1 mt -58.44 -60.73 1.91 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 C-N-CA 123.541 0.736 . . . . 2.1000000000000001 109.039 -179.381 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -39.61 -54.92 1.95 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.942 1.297 . . . . 3.6299999999999999 112.259 172.02 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -59.83 -44.63 93.95 Favored 'General case' 0 CA--C 1.528 0.133 0 O-C-N 121.666 -0.646 . . . . 5.6299999999999999 112.422 178.319 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -56.83 -55.87 28.83 Favored 'General case' 0 C--O 1.226 -0.153 0 N-CA-C 108.4 -0.963 . . . . 2.8599999999999999 108.4 179.033 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.457 ' CD2' HG23 ' A' ' 21' ' ' ILE . 0.0 OUTLIER -74.84 -23.95 58.52 Favored 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 114.369 1.248 . . . . 2.2999999999999998 114.369 -172.325 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.55 -15.33 62.6 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 120.583 1.538 . . . . 6.5 114.802 -170.122 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 73.7 mtt180 -65.79 -19.55 65.93 Favored 'General case' 0 N--CA 1.462 0.142 0 N-CA-C 113.333 0.864 . . . . 7.2599999999999998 113.333 -157.532 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 71.25 23.25 4.09 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 125.08 1.352 . . . . 10.470000000000001 112.446 -172.065 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -76.46 59.3 1.44 Allowed 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 127.56 2.344 . . . . 5.6399999999999997 108.766 171.788 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 75.51 32.91 53.9 Favored Glycine 0 CA--C 1.535 1.311 0 C-N-CA 124.261 0.934 . . . . 1.4199999999999999 113.641 -178.644 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.45 HD12 ' HA ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -142.27 135.66 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 C-N-CA 127.212 2.205 . . . . 3.0699999999999998 105.665 -170.858 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 41.2 m-85 -145.29 48.13 1.28 Allowed 'General case' 0 C--O 1.233 0.195 0 CA-C-O 123.155 1.455 . . . . 3.2999999999999998 111.702 171.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 14.0 t -164.84 -178.64 5.35 Favored 'General case' 0 C--N 1.317 -0.841 0 C-N-CA 129.875 3.27 . . . . 2.0 106.135 151.304 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.494 HD13 ' H ' ' A' ' 34' ' ' ILE . 0.1 OUTLIER -125.2 127.49 72.16 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 C-N-CA 124.474 1.11 . . . . 2.5800000000000001 109.42 174.243 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.421 ' O ' ' HB1' ' A' ' 43' ' ' ALA . 0.9 OUTLIER -78.35 71.0 4.79 Favored 'General case' 0 N--CA 1.439 -0.993 0 O-C-N 121.099 -1.001 . . . . 4.7699999999999996 110.85 -176.834 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 18.7 t -123.9 139.83 49.19 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.885 0 CA-C-O 122.183 0.992 . . . . 1.3799999999999999 109.414 159.262 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -155.62 58.95 0.62 Allowed 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 126.418 1.887 . . . . 0.80000000000000004 107.139 168.623 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.2 pp -56.86 -32.14 65.51 Favored 'General case' 0 CA--C 1.51 -0.566 0 C-N-CA 123.45 0.7 . . . . 3.3599999999999999 112.474 -175.729 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 65.1 mtt -65.53 -40.44 92.94 Favored 'General case' 0 N--CA 1.441 -0.898 0 C-N-CA 119.761 -0.775 . . . . 4.6500000000000004 108.913 -165.438 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -76.84 -42.22 41.09 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.721 0.808 . . . . 1.48 109.842 167.242 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 111.88 57.16 0.46 Allowed Glycine 0 C--N 1.338 0.652 0 N-CA-C 109.426 -1.469 . . . . 1.02 109.426 176.061 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -160.24 -178.37 6.91 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 107.002 -1.481 . . . . 4.6100000000000003 107.002 -169.149 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.421 ' HB1' ' O ' ' A' ' 35' ' ' LEU . . . -146.35 130.1 17.09 Favored 'General case' 0 N--CA 1.434 -1.259 0 C-N-CA 126.334 1.854 . . . . 0.97999999999999998 106.001 -172.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -135.94 114.36 11.69 Favored 'General case' 0 C--N 1.342 0.261 0 CA-C-N 120.926 1.693 . . . . 2.5099999999999998 113.277 177.79 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.2 p -90.12 150.18 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.273 0 C-N-CA 125.02 1.328 . . . . 1.49 110.17 -171.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 35.4 ttm180 -125.75 131.02 52.6 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 104.863 -2.273 . . . . 4.1399999999999997 104.863 159.603 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 3.8 p90 -160.18 169.73 22.66 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-N 118.219 0.463 . . . . 2.2400000000000002 111.569 -165.305 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . 0.271 49.1 p30 -104.3 97.18 11.24 Favored Pre-proline 0 CA--C 1.542 0.671 0 N-CA-C 113.234 0.827 . . . . 3.9900000000000002 113.234 170.678 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -72.51 73.19 2.86 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 122.526 2.15 . . . . 1.46 111.331 177.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -150.27 -57.39 0.18 Allowed 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 126.548 1.939 . . . . 1.3400000000000001 106.041 171.58 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 78.6 t -58.62 -54.6 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.787 0 C-N-CA 123.778 0.831 . . . . 1.3200000000000001 109.299 171.695 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.429 HG23 ' H ' ' A' ' 53' ' ' GLN 0.265 2.5 tp -90.54 -72.97 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-O 118.306 -0.854 . . . . 1.75 112.103 -165.613 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.429 ' H ' HG23 ' A' ' 52' ' ' ILE . 0.8 OUTLIER 112.98 136.66 0.0 OUTLIER Pre-proline 0 N--CA 1.476 0.87 0 C-N-CA 131.122 3.769 . . . . 3.0299999999999998 108.653 -177.48 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -51.03 -51.13 11.85 Favored 'Trans proline' 0 CA--C 1.534 0.503 0 C-N-CA 124.054 3.17 . . . . 1.1100000000000001 115.345 174.777 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -53.8 -48.83 19.64 Favored 'Trans proline' 0 N--CA 1.444 -1.409 0 CA-C-N 120.448 1.196 . . . . 0.77000000000000002 110.282 167.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 74.5 mtp -69.13 -33.16 73.01 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 118.301 -1.359 . . . . 2.0600000000000001 110.65 -168.283 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 6.9 tt -66.42 -50.95 63.26 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 CA-C-N 119.935 1.243 . . . . 2.3700000000000001 110.324 179.451 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -51.65 -53.97 33.07 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.09 0.956 . . . . 1.0900000000000001 110.814 176.012 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 54.4 mm-40 -65.31 -38.08 89.09 Favored 'General case' 0 N--CA 1.429 -1.509 0 CA-C-O 118.866 -0.588 . . . . 3.5299999999999998 111.999 -177.741 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -54.54 -34.25 61.47 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 120.192 1.36 . . . . 4.3399999999999999 111.207 173.79 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.6 mm -60.47 -53.28 51.0 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 N-CA-C 107.746 -1.205 . . . . 2.1400000000000001 107.746 172.704 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 15.7 mtp-105 -55.58 -47.73 75.97 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 125.161 1.384 . . . . 6.3600000000000003 114.301 -177.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -45.92 -35.38 4.57 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 127.023 2.129 . . . . 3.1400000000000001 112.933 -175.414 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 58.8 mt -79.11 -16.39 56.78 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 122.93 0.492 . . . . 2.0299999999999998 111.196 -174.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 130.93 50.06 0.11 Allowed Glycine 0 CA--C 1.527 0.805 0 C-N-CA 125.182 1.372 . . . . 2.5699999999999998 111.168 170.418 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -136.39 169.62 17.38 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-O 123.519 1.628 . . . . 3.48 113.673 -168.652 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -115.18 126.89 7.39 Favored Glycine 0 N--CA 1.442 -0.957 0 N-CA-C 105.949 -2.861 . . . . 1.76 105.949 168.213 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -153.24 81.52 1.19 Allowed 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 124.533 1.133 . . . . 1.6299999999999999 108.3 -172.223 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -84.8 138.04 32.83 Favored 'General case' 0 C--O 1.225 -0.227 0 C-N-CA 123.704 0.802 . . . . 2.4399999999999999 108.882 -175.827 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 97.0 t -84.89 109.19 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 N-CA-C 108.552 -0.907 . . . . 1.6899999999999999 108.552 -177.145 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 18.9 mm -130.8 60.15 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 C-N-CA 125.156 1.383 . . . . 2.9500000000000002 109.002 -171.491 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -79.6 175.58 10.48 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.397 -0.819 . . . . 3.75 109.478 155.086 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 42.3 m-80 49.86 47.14 23.52 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.135 0.974 . . . . 5.7599999999999998 111.111 175.537 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 13.2 tt -73.85 165.65 3.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 C-N-CA 124.417 1.087 . . . . 10.08 109.936 178.428 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 58.16 48.4 12.93 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.681 1.192 . . . . 11.81 111.983 176.267 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -65.1 157.95 45.91 Favored Glycine 0 CA--C 1.53 1.02 0 N-CA-C 109.918 -1.273 . . . . 10.33 109.918 165.314 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.252 1.215 0 N-CA-C 103.459 -2.793 . . . . 16.52 103.459 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 . . . . . 0 N--CA 1.48 1.059 0 N-CA-C 110.63 -0.137 . . . . 6.6100000000000003 110.63 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 88.4 p -170.97 155.98 4.73 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 125.604 1.562 . . . . 2.4500000000000002 106.999 171.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 18.6 m -155.34 153.98 31.34 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 124.902 1.281 . . . . 2.0699999999999998 108.022 177.121 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 9.3 mtmp? -91.82 161.01 15.03 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 123.33 0.652 . . . . 3.3599999999999999 111.937 176.482 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 49.3 t -155.25 157.71 37.71 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 105.974 -1.861 . . . . 1.3300000000000001 105.974 166.12 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -98.34 146.4 25.72 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 119.804 1.184 . . . . 3.4100000000000001 108.007 171.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.509 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 12.0 mm -128.16 113.42 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 N-CA-C 105.138 -2.171 . . . . 2.1200000000000001 105.138 174.01 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 16.6 tp60 -82.38 124.49 30.06 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 104.825 -2.287 . . . . 2.8900000000000001 104.825 172.785 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.5 p -117.72 99.02 7.3 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-O 122.175 0.988 . . . . 2.3599999999999999 110.597 -169.058 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 7.0 m -67.03 94.3 0.33 Allowed 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 109.155 -0.683 . . . . 2.7799999999999998 109.155 -179.561 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 135.24 3.94 2.67 Favored Glycine 0 C--O 1.221 -0.705 0 C-N-CA 125.124 1.345 . . . . 2.54 113.047 -175.479 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -43.98 -46.89 8.49 Favored 'General case' 0 C--N 1.321 -0.647 0 O-C-N 121.561 -0.964 . . . . 3.27 110.612 162.277 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 15.3 t -74.43 12.13 0.84 Allowed 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.192 0.997 . . . . 5.9699999999999998 112.887 176.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 16.9 t -57.4 -41.77 80.95 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 107.011 -1.477 . . . . 2.5600000000000001 107.011 160.145 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 84.27 145.3 0.07 Allowed 'General case' 0 C--N 1.348 0.52 0 C-N-CA 127.934 2.494 . . . . 3.3199999999999998 110.138 -175.73 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.6 m 71.49 -30.91 0.22 Allowed 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 115.083 1.512 . . . . 3.0499999999999998 115.083 174.159 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 11.0 m -62.83 -18.21 62.49 Favored 'General case' 0 CA--C 1.517 -0.294 0 C-N-CA 128.825 2.85 . . . . 3.5299999999999998 111.821 -175.383 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 14.0 m -41.12 -43.78 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 N-CA-C 112.162 0.431 . . . . 2.25 112.162 159.207 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -52.77 -46.36 67.52 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.088 0.955 . . . . 1.1399999999999999 111.547 173.226 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -59.19 -51.98 67.65 Favored 'General case' 0 C--O 1.224 -0.249 0 N-CA-C 108.671 -0.863 . . . . 2.0099999999999998 108.671 175.353 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 38.4 mm -53.54 -59.39 1.91 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 C-N-CA 123.601 0.76 . . . . 2.04 109.123 -179.187 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -42.54 -61.07 1.31 Allowed 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.057 1.343 . . . . 3.3999999999999999 110.977 175.365 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.93 -48.93 78.21 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 119.369 -0.348 . . . . 7.8600000000000003 110.933 -175.231 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -49.86 -60.32 3.02 Favored 'General case' 0 CA--C 1.519 -0.228 0 C-N-CA 123.989 0.916 . . . . 3.1200000000000001 108.839 -179.06 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.611 ' CD2' HD21 ' A' ' 35' ' ' LEU . 0.0 OUTLIER -70.57 -32.14 69.44 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 115.623 -0.717 . . . . 2.1499999999999999 109.499 -170.397 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . 0.578 68.6 mtp180 -63.0 3.17 0.25 Allowed 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 117.827 2.529 . . . . 6.1600000000000001 117.827 163.217 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 3.5 mmt85 -43.58 -34.09 1.32 Allowed 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 116.914 -1.914 . . . . 7.8300000000000001 112.233 146.696 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . 0.25 4.2 mt-10 78.86 33.15 0.26 Allowed 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 127.191 2.196 . . . . 8.8100000000000005 112.135 176.436 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 80.1 mt-10 -73.55 69.62 1.25 Allowed 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 127.101 2.161 . . . . 5.9299999999999997 110.436 179.222 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 67.15 28.43 73.74 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 123.453 0.549 . . . . 1.0600000000000001 111.932 -179.16 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.0 mm -98.3 140.12 18.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 C-N-CA 128.416 2.686 . . . . 2.2799999999999998 109.208 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -148.47 42.51 0.99 Allowed 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 122.404 1.097 . . . . 3.9900000000000002 113.12 163.146 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 33.6 t -166.87 149.41 6.4 Favored 'General case' 0 C--N 1.317 -0.805 0 C-N-CA 131.01 3.724 . . . . 2.02 104.828 144.207 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.7 pp -83.45 151.73 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 N-CA-C 108.157 -1.053 . . . . 1.9199999999999999 108.157 163.548 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.611 HD21 ' CD2' ' A' ' 25' ' ' LEU . 0.4 OUTLIER -87.22 78.55 8.8 Favored 'General case' 0 N--CA 1.436 -1.138 0 C-N-CA 127.185 2.194 . . . . 4.4400000000000004 110.939 178.005 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 24.5 t -134.99 137.51 50.5 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 CA-C-O 121.368 0.604 . . . . 1.3300000000000001 110.145 165.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -155.92 58.47 0.6 Allowed 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 113.912 -1.494 . . . . 0.95999999999999996 107.397 164.675 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -63.61 -28.6 70.03 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.058 0.943 . . . . 3.3100000000000001 110.39 -173.819 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 63.3 mtt -46.37 -41.34 13.4 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.311 0.644 . . . . 4.5999999999999996 111.666 170.027 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -88.68 -41.52 12.55 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 122.769 0.428 . . . . 1.71 109.95 172.401 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 113.18 53.2 0.47 Allowed Glycine 0 C--N 1.335 0.488 0 N-CA-C 108.607 -1.797 . . . . 1.01 108.607 179.446 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 37.6 mtmt -151.71 175.41 12.42 Favored 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 108.293 -1.003 . . . . 3.7799999999999998 108.293 -164.202 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.525 ' HB1' HD12 ' A' ' 35' ' ' LEU . . . -148.0 119.25 7.8 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 105.646 -1.983 . . . . 0.93999999999999995 105.646 -174.089 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -128.24 96.94 4.59 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 123.553 0.741 . . . . 3.2599999999999998 111.433 -171.34 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 10.7 p -81.62 147.93 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.285 0 C-N-CA 123.226 0.61 . . . . 1.4399999999999999 109.362 -170.574 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 21.5 ttt-85 -123.13 127.76 49.14 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 105.774 -1.936 . . . . 5.8799999999999999 105.774 156.395 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 3.8 p90 -157.88 175.04 14.37 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 108.426 -0.953 . . . . 2.0600000000000001 108.426 -169.346 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -109.12 104.3 54.67 Favored Pre-proline 0 CA--C 1.537 0.467 0 CA-C-O 118.579 -0.724 . . . . 2.98 111.647 176.209 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -70.78 76.61 1.52 Allowed 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 123.257 2.638 . . . . 1.5700000000000001 111.571 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -165.53 -46.97 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 126.524 1.929 . . . . 1.3899999999999999 107.224 167.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 99.2 t -62.71 -45.54 98.57 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.885 0 C-N-CA 125.148 1.379 . . . . 1.1899999999999999 110.056 177.715 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.528 HG23 ' H ' ' A' ' 53' ' ' GLN 0.273 6.0 tp -113.17 -73.32 0.63 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.303 0 CA-C-O 118.16 -0.924 . . . . 1.99 112.187 -167.865 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.528 ' H ' HG23 ' A' ' 52' ' ' ILE . 27.8 mm100 110.86 131.93 0.0 OUTLIER Pre-proline 0 CA--C 1.54 0.588 0 C-N-CA 129.424 3.09 . . . . 3.4700000000000002 111.757 174.902 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -44.86 -53.68 4.93 Favored 'Trans proline' 0 CA--C 1.534 0.516 0 C-N-CA 125.23 3.954 . . . . 1.3100000000000001 116.427 176.014 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_endo -53.04 -47.29 28.34 Favored 'Trans proline' 0 N--CA 1.447 -1.222 0 CA-C-N 120.825 1.33 . . . . 1.0 110.022 172.737 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 64.7 mtt -62.4 -46.41 88.71 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 118.181 -0.914 . . . . 2.1299999999999999 111.41 -177.079 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 18.0 pt -61.93 -45.08 99.49 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-N 120.616 1.553 . . . . 2.3100000000000001 111.318 176.094 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -53.93 -52.65 59.91 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 121.195 0.521 . . . . 1.02 110.443 179.315 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 62.1 mm-40 -61.43 -48.49 80.95 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-O 118.359 -0.829 . . . . 3.5899999999999999 111.853 177.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -47.25 -42.44 20.57 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 119.659 1.118 . . . . 3.79 111.385 176.281 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 54.8 mt -67.05 -40.2 84.96 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 O-C-N 122.037 -0.414 . . . . 1.0 110.186 178.747 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 54.6 mtt180 -64.74 -50.62 66.15 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.647 0.779 . . . . 4.4500000000000002 111.934 177.258 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -43.66 -55.13 4.55 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 126.462 1.905 . . . . 2.9399999999999999 111.674 -175.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.38 -31.04 12.58 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 113.043 0.757 . . . . 1.8200000000000001 113.043 -179.523 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -114.9 -85.67 1.31 Allowed Glycine 0 CA--C 1.528 0.891 0 CA-C-N 119.148 0.885 . . . . 2.04 113.911 -165.631 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -147.81 156.03 42.29 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 113.558 0.948 . . . . 2.9399999999999999 113.558 -146.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -70.03 82.3 0.33 Allowed Glycine 0 N--CA 1.444 -0.786 0 CA-C-N 114.629 -1.169 . . . . 1.5 111.112 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -82.72 144.42 30.22 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 125.229 1.412 . . . . 1.1200000000000001 109.655 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.6 t -142.92 139.97 30.96 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 106.007 -1.849 . . . . 2.46 106.007 165.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.6 m -83.67 145.63 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 N-CA-C 109.586 -0.524 . . . . 2.54 109.586 -176.557 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 14.9 mm -141.27 147.73 22.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 C-N-CA 126.064 1.746 . . . . 2.21 107.309 -177.171 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -173.52 -176.43 1.29 Allowed 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 126.351 1.86 . . . . 3.7999999999999998 106.355 168.152 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -156.43 157.24 35.2 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 107.845 -1.168 . . . . 5.7400000000000002 107.845 176.667 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 15.8 tt -75.26 162.88 4.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 123.43 0.692 . . . . 10.470000000000001 109.243 173.2 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -139.16 153.03 47.88 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 105.405 -2.072 . . . . 12.949999999999999 105.405 174.284 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 160.5 -170.07 36.4 Favored Glycine 0 CA--C 1.527 0.84 0 CA-C-N 118.92 0.782 . . . . 12.76 111.327 -176.431 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.016 0 N-CA-C 104.158 -2.534 . . . . 19.960000000000001 104.158 178.483 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 41.6 t30 . . . . . 0 N--CA 1.477 0.906 0 N-CA-C 107.858 -1.164 . . . . 6.1900000000000004 107.858 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.0 m -152.68 101.43 2.63 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 108.142 -1.058 . . . . 2.52 108.142 170.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.1 m -109.18 144.02 37.82 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 126.247 1.819 . . . . 2.0099999999999998 108.116 -176.713 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 35.5 tttt -95.54 164.02 12.97 Favored 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 123.37 0.668 . . . . 4.71 110.611 -178.162 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 7.8 p -153.99 174.31 14.83 Favored 'General case' 0 C--O 1.232 0.16 0 N-CA-C 109.141 -0.689 . . . . 2.02 109.141 156.674 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -122.54 142.11 50.95 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 125.348 1.459 . . . . 2.6699999999999999 108.296 -175.508 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.406 ' HB ' ' HB3' ' A' ' 43' ' ' ALA . 10.9 mt -146.0 132.61 14.25 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 N-CA-C 106.812 -1.551 . . . . 1.5600000000000001 106.812 -167.328 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 12.5 tp60 -84.2 125.35 32.11 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 105.508 -2.034 . . . . 3.5899999999999999 105.508 165.712 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 6.7 p -110.37 101.98 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 C-N-CA 124.341 1.057 . . . . 2.3100000000000001 108.336 177.405 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 21.0 m -71.69 80.79 0.85 Allowed 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 108.974 -0.751 . . . . 2.5299999999999998 108.974 176.814 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -171.19 -52.59 0.04 OUTLIER Glycine 0 CA--C 1.53 1.012 0 C-N-CA 129.02 3.2 . . . . 2.29 106.977 172.573 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 63.8 mtt 62.92 -66.38 0.09 Allowed 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 127.489 2.315 . . . . 3.9399999999999999 112.319 175.703 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 14.6 t -151.72 53.38 0.83 Allowed 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.036 1.334 . . . . 4.96 107.751 173.595 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.0 p -43.7 -50.29 7.6 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.586 1.154 . . . . 3.1000000000000001 109.784 173.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -172.52 93.99 0.13 Allowed 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 126.748 2.019 . . . . 3.1800000000000002 106.87 156.034 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.7 m 59.11 42.48 18.83 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 121.562 0.696 . . . . 2.6299999999999999 110.548 -173.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 6.9 t -43.34 -41.99 4.33 Favored 'General case' 0 N--CA 1.461 0.109 0 C-N-CA 126.766 2.026 . . . . 4.0300000000000002 108.192 166.12 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 4.9 m -66.99 -53.32 35.1 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.972 0 C-N-CA 125.532 1.533 . . . . 2.1899999999999999 110.935 -173.612 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -50.78 -47.85 59.55 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.136 0.975 . . . . 0.90000000000000002 109.493 171.849 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -55.43 -53.29 58.05 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 108.927 -0.768 . . . . 2.1099999999999999 108.927 177.504 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.454 HG21 HG23 ' A' ' 36' ' ' VAL . 1.1 mp -53.69 -54.94 15.98 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 C-N-CA 124.469 1.108 . . . . 2.0499999999999998 110.386 178.396 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -48.91 -60.3 2.87 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 119.429 1.013 . . . . 2.96 109.541 -178.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 8.8 mpt_? -60.6 -38.65 85.4 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 115.131 -0.94 . . . . 6.4699999999999998 110.71 -176.059 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -62.24 -60.13 4.03 Favored 'General case' 0 C--O 1.227 -0.088 0 C-N-CA 122.686 0.394 . . . . 3.2200000000000002 110.208 177.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.412 ' CD2' HD21 ' A' ' 35' ' ' LEU . 0.0 OUTLIER -75.87 -64.6 1.05 Allowed 'General case' 0 N--CA 1.437 -1.11 0 CA-C-N 116.732 -0.213 . . . . 2.21 110.552 -159.793 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.53 -15.25 0.63 Allowed 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 115.665 1.728 . . . . 6.3300000000000001 115.665 -162.435 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -31.25 -59.02 0.24 Allowed 'General case' 0 N--CA 1.439 -0.99 0 C-N-CA 126.361 1.864 . . . . 6.9800000000000004 109.805 -175.077 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . 0.313 0.0 OUTLIER -167.15 -108.52 0.01 OUTLIER 'General case' 0 N--CA 1.447 -0.616 0 O-C-N 125.043 1.464 . . . . 7.3399999999999999 108.027 -171.113 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 44.48 31.16 0.57 Allowed 'General case' 0 C--N 1.314 -0.966 0 C-N-CA 127.256 2.222 . . . . 4.8600000000000003 114.628 156.848 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 60.21 31.09 72.27 Favored Glycine 0 CA--C 1.53 1.008 0 CA-C-O 118.483 -1.176 . . . . 0.95999999999999996 113.537 -178.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 1.4 mp -78.43 139.31 18.69 Favored 'Isoleucine or valine' 0 C--N 1.34 0.167 0 CA-C-N 119.196 1.498 . . . . 2.5299999999999998 107.529 169.456 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -148.22 36.45 0.83 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 120.382 -0.527 . . . . 6.5899999999999999 112.275 158.527 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 34.0 t -169.36 143.64 2.91 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 130.117 3.367 . . . . 1.99 104.32 139.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.7 pp -82.09 147.16 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 CA-C-N 119.683 1.129 . . . . 1.95 109.06 172.388 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.55 ' HB2' ' HB1' ' A' ' 43' ' ' ALA . 0.4 OUTLIER -79.41 80.39 5.78 Favored 'General case' 0 N--CA 1.44 -0.948 0 C-N-CA 125.77 1.628 . . . . 4.6200000000000001 111.384 -179.765 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.454 HG23 HG21 ' A' ' 21' ' ' ILE . 85.6 t -130.64 138.9 52.57 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.121 0 CA-C-O 121.499 0.666 . . . . 1.5900000000000001 109.252 162.523 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -153.73 57.02 0.74 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 113.666 -1.607 . . . . 0.83999999999999997 107.364 165.152 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -73.01 -15.58 61.52 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 114.913 -1.04 . . . . 3.0899999999999999 111.623 -172.645 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 93.7 mtp -49.43 -35.94 20.79 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 121.485 -0.76 . . . . 3.5899999999999999 110.885 162.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -95.39 -46.82 6.55 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.391 0.676 . . . . 1.9399999999999999 110.483 170.47 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 111.25 63.56 0.49 Allowed Glycine 0 C--N 1.339 0.722 0 N-CA-C 107.809 -2.117 . . . . 0.97999999999999998 107.809 -171.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 4.4 pttt -160.82 175.4 12.61 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 118.279 1.04 . . . . 4.3700000000000001 108.541 -178.57 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.55 ' HB1' ' HB2' ' A' ' 35' ' ' LEU . . . -123.36 125.67 45.43 Favored 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 128.038 2.535 . . . . 1.1399999999999999 107.456 -176.216 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -140.22 92.75 2.56 Favored 'General case' 0 N--CA 1.457 -0.104 0 CA-C-O 122.01 0.909 . . . . 3.21 113.063 175.419 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.7 p -79.16 153.38 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.21 0 C-N-CA 125.405 1.482 . . . . 1.5 109.219 -172.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 65.0 ttt180 -122.61 141.05 52.13 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 106.504 -1.665 . . . . 5.3799999999999999 106.504 159.098 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 32.5 p90 -152.04 159.09 43.8 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 122.918 0.487 . . . . 2.5099999999999998 110.18 -165.81 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -98.19 98.74 6.0 Favored Pre-proline 0 CA--C 1.539 0.525 0 C-N-CA 123.676 0.791 . . . . 2.9399999999999999 110.329 170.245 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -75.22 75.99 3.62 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 122.765 2.31 . . . . 1.95 111.203 -176.623 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -159.51 -43.71 0.05 Allowed 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 125.235 1.414 . . . . 1.6000000000000001 108.915 169.811 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 33.9 t -52.13 -56.53 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.737 0 C-N-CA 124.452 1.101 . . . . 1.45 109.1 169.34 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.451 HG23 ' H ' ' A' ' 53' ' ' GLN . 6.4 tt -124.69 -128.5 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.44 -0.957 0 CA-C-N 114.603 -1.181 . . . . 2.6699999999999999 108.817 -167.417 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.451 ' H ' HG23 ' A' ' 52' ' ' ILE . 4.9 tp60 -175.18 112.65 0.28 Allowed Pre-proline 0 CA--C 1.539 0.542 0 N-CA-C 108.686 -0.857 . . . . 2.3399999999999999 108.686 -159.309 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -47.59 -44.51 25.63 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 124.728 3.619 . . . . 1.5600000000000001 116.767 176.312 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -54.33 -56.83 2.19 Favored 'Trans proline' 0 N--CA 1.445 -1.373 0 CA-C-N 121.212 1.469 . . . . 1.24 109.687 167.781 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 87.1 mtp -53.56 -48.46 69.11 Favored 'General case' 0 C--N 1.342 0.247 0 CA-C-O 119.065 -0.493 . . . . 2.5800000000000001 112.317 -175.484 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 3.6 pt -60.38 -41.14 86.26 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 CA-C-N 119.155 0.889 . . . . 2.9900000000000002 111.829 -177.459 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.96 -60.16 4.23 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 119.704 1.138 . . . . 1.6299999999999999 111.038 169.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -46.12 -52.69 11.71 Favored 'General case' 0 N--CA 1.442 -0.867 0 C-N-CA 126.497 1.919 . . . . 3.4500000000000002 112.341 -174.566 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -44.14 -39.81 4.57 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.647 0.779 . . . . 3.96 112.972 -179.484 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 43.0 mt -61.32 -36.96 76.37 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 C-N-CA 122.81 0.444 . . . . 1.46 110.005 -178.038 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 60.2 mtt180 -62.52 -62.04 2.02 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 124.237 1.015 . . . . 4.3300000000000001 108.982 178.482 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -39.4 -52.24 2.08 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 124.987 1.315 . . . . 4.9500000000000002 112.57 173.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.6 pp -83.35 -18.19 39.74 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 113.969 1.1 . . . . 2.3500000000000001 113.969 -176.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -171.47 -66.15 0.04 OUTLIER Glycine 0 CA--C 1.533 1.199 0 CA-C-N 120.018 1.281 . . . . 1.6599999999999999 115.757 -178.844 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -130.22 146.82 51.88 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 122.058 0.932 . . . . 3.23 113.5 -147.63 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -75.42 81.8 0.94 Allowed Glycine 0 N--CA 1.449 -0.442 0 CA-C-N 115.516 -0.765 . . . . 1.47 112.276 -167.685 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -83.22 90.7 7.14 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 126.335 1.854 . . . . 1.3600000000000001 110.507 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 20.0 p -99.55 126.83 45.59 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 125.161 1.384 . . . . 2.3399999999999999 108.439 177.13 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 90.3 t -82.64 130.23 36.1 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.712 0 C-N-CA 124.523 1.129 . . . . 1.79 109.494 -173.42 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 24.5 mt -142.06 63.37 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 C-N-CA 125.503 1.521 . . . . 2.29 108.285 -175.728 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -65.2 154.63 37.51 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 109.171 -0.677 . . . . 4.9400000000000004 109.171 168.294 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 4.1 p30 165.46 126.23 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 128.35 2.66 . . . . 5.0999999999999996 109.249 168.741 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -163.21 138.97 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 N-CA-C 104.46 -2.422 . . . . 8.4399999999999995 104.46 175.005 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 26.67 64.7 0.08 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 126.671 1.988 . . . . 11.42 114.879 -175.375 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -151.77 47.92 0.56 Allowed Glycine 0 CA--C 1.522 0.528 0 N-CA-C 108.071 -2.012 . . . . 9.5500000000000007 108.071 177.095 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 38.4 ttt85 . . . . . 0 C--O 1.255 1.37 0 CA-C-O 116.733 -1.603 . . . . 14.51 107.562 -142.101 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 . . . . . 0 N--CA 1.476 0.834 0 N-CA-C 109.136 -0.69 . . . . 7.46 109.136 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.6 p -165.08 59.42 0.12 Allowed 'General case' 0 C--O 1.235 0.317 0 CA-C-O 122.551 1.167 . . . . 2.6299999999999999 108.723 -179.597 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.8 p -97.31 172.4 7.81 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 127.795 2.438 . . . . 2.0800000000000001 109.733 -169.615 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.98 153.6 50.17 Favored 'General case' 0 C--N 1.339 0.129 0 C-N-CA 122.848 0.459 . . . . 3.7200000000000002 111.12 -179.771 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 41.1 t -146.8 155.75 42.6 Favored 'General case' 0 C--O 1.231 0.107 0 C-N-CA 124.95 1.3 . . . . 1.6100000000000001 109.13 -175.43 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -97.39 136.88 37.21 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 126.081 1.752 . . . . 2.7999999999999998 108.145 174.684 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.1 mm -139.94 123.53 18.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 107.078 -1.453 . . . . 2.1099999999999999 107.078 -177.346 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 5.9 mm-40 -77.93 159.37 28.89 Favored 'General case' 0 N--CA 1.455 -0.194 0 O-C-N 120.745 -1.222 . . . . 3.7000000000000002 110.228 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.4 p -137.91 139.75 42.06 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 O-C-N 123.469 0.481 . . . . 2.9399999999999999 111.925 -172.715 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.3 m -76.77 63.89 2.25 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.436 1.095 . . . . 3.7400000000000002 113.306 -176.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -161.03 -60.44 0.02 OUTLIER Glycine 0 C--O 1.227 -0.293 0 N-CA-C 105.98 -2.848 . . . . 3.5099999999999998 105.98 157.349 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 9.4 ttm 54.39 20.79 2.89 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.474 1.11 . . . . 4.7800000000000002 111.421 -176.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 61.4 m -160.99 -38.67 0.05 OUTLIER 'General case' 0 C--N 1.335 -0.062 0 C-N-CA 124.61 1.164 . . . . 5.6200000000000001 109.856 -156.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 28.4 p -59.04 132.85 55.26 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 108.452 -0.944 . . . . 3.3399999999999999 108.452 -179.123 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -53.53 -31.35 45.95 Favored 'General case' 0 CA--C 1.535 0.374 0 O-C-N 121.314 -0.866 . . . . 4.0099999999999998 110.491 179.492 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.4 m -53.17 -39.74 63.84 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 126.109 1.764 . . . . 3.4399999999999999 114.443 172.212 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -35.21 -57.74 0.57 Allowed 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 125.713 1.605 . . . . 4.8099999999999996 111.601 -146.479 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.477 HG23 HG11 ' A' ' 36' ' ' VAL . 0.4 OUTLIER -62.87 -50.19 80.63 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.874 0 CA-C-N 114.794 -1.094 . . . . 3.3100000000000001 112.525 -177.121 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -54.63 -44.52 73.25 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.382 1.073 . . . . 1.26 110.484 172.631 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -54.62 -59.94 4.02 Favored 'General case' 0 C--O 1.226 -0.167 0 N-CA-C 108.635 -0.876 . . . . 3.6699999999999999 108.635 175.659 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.75 HG22 HD11 ' A' ' 34' ' ' ILE . 2.3 mt -61.09 -42.27 92.53 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.14 0 O-C-N 121.406 -0.809 . . . . 2.7400000000000002 110.952 -174.447 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 69.1 mt-10 -60.85 -25.49 66.69 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 125.557 1.543 . . . . 3.6099999999999999 112.938 174.018 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 10.5 mmm180 -73.1 -42.31 63.08 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 119.344 0.975 . . . . 7.1299999999999999 111.954 158.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.528 ' OD1' HD13 ' A' ' 25' ' ' LEU . 0.1 OUTLIER -70.93 -49.71 42.62 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 124.427 1.091 . . . . 4.4299999999999997 113.692 -160.266 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.528 HD13 ' OD1' ' A' ' 24' ' ' ASN . 3.9 mp -78.11 -60.05 2.53 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 118.977 0.808 . . . . 2.96 112.872 -176.552 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 9.5 ptm180 -39.38 -19.87 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 129.933 3.293 . . . . 6.04 118.481 -158.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 19.9 mtm105 -67.34 -51.97 45.84 Favored 'General case' 0 N--CA 1.439 -0.98 0 C-N-CA 127.337 2.255 . . . . 8.1799999999999997 109.487 -161.064 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 168.59 152.03 0.03 OUTLIER 'General case' 0 CA--C 1.512 -0.515 0 N-CA-C 105.519 -2.03 . . . . 7.2199999999999998 105.519 -152.754 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 99.91 44.84 0.0 OUTLIER 'General case' 0 C--N 1.34 0.157 0 C-N-CA 128.132 2.573 . . . . 7.1500000000000004 112.088 -168.633 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 56.35 42.57 89.21 Favored Glycine 0 CA--C 1.528 0.894 0 CA-C-N 116.275 -0.42 . . . . 1.74 112.527 171.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -77.26 135.29 26.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 N-CA-C 107.104 -1.443 . . . . 2.7599999999999998 107.104 174.808 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 54.0 m-85 -141.62 37.55 1.66 Allowed 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 122.061 0.934 . . . . 3.6299999999999999 113.397 164.324 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 75.0 m -166.39 154.41 10.24 Favored 'General case' 0 C--N 1.321 -0.663 1 C-N-CA 131.989 4.116 . . . . 2.79 103.964 122.32 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.828 HD13 ' N ' ' A' ' 35' ' ' LEU . 0.1 OUTLIER -98.3 136.6 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 N-CA-C 104.931 -2.248 . . . . 3.1600000000000001 104.931 158.782 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.828 ' N ' HD13 ' A' ' 34' ' ' ILE . 0.1 OUTLIER -156.21 175.81 13.5 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 124.403 1.081 . . . . 6.8399999999999999 110.375 -179.484 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.647 HG22 HG21 ' A' ' 21' ' ' ILE . 24.0 t -158.8 117.43 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.421 -1.875 0 C-N-CA 127.22 2.208 . . . . 1.71 106.545 -177.254 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -77.98 62.59 2.8 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 108.464 -0.939 . . . . 1.4199999999999999 108.464 168.326 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.492 HD23 ' HA ' ' A' ' 38' ' ' LEU . 0.3 OUTLIER -64.59 -32.96 74.84 Favored 'General case' 0 C--N 1.342 0.266 0 O-C-N 121.687 -0.633 . . . . 2.6499999999999999 111.705 -168.069 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 51.5 ttp -55.09 -35.67 64.84 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.299 0.64 . . . . 5.6600000000000001 111.199 173.428 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -86.99 -20.85 26.66 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.608 0.763 . . . . 1.76 110.913 176.325 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 84.35 60.01 1.97 Allowed Glycine 0 C--N 1.335 0.518 0 N-CA-C 107.768 -2.133 . . . . 0.85999999999999999 107.768 169.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.424 ' HZ3' ' HB3' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -163.96 167.53 20.43 Favored 'General case' 0 N--CA 1.437 -1.082 0 N-CA-C 106.363 -1.717 . . . . 4.9299999999999997 106.363 173.122 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -77.83 145.29 36.41 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 105.975 -1.861 . . . . 1.6499999999999999 105.975 167.502 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.609 ' CB ' HD13 ' A' ' 35' ' ' LEU . 19.3 mt-10 -94.56 167.48 11.45 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 105.774 -1.936 . . . . 2.9100000000000001 105.774 151.01 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.1 p -134.81 141.7 42.41 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 N-CA-C 104.606 -2.368 . . . . 1.5800000000000001 104.606 157.722 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 70.8 ttt180 -113.5 129.25 56.59 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 106.597 -1.631 . . . . 5.0300000000000002 106.597 158.089 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 7.2 p90 -157.3 172.22 19.0 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 122.968 0.507 . . . . 1.9099999999999999 111.783 -162.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 65.0 t-20 -109.21 88.56 5.96 Favored Pre-proline 0 CA--C 1.537 0.469 0 CA-C-N 114.677 -1.147 . . . . 2.4100000000000001 111.08 -177.637 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -67.67 79.55 0.49 Allowed 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 123.209 2.606 . . . . 2.0299999999999998 110.129 173.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -169.78 -47.91 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 127.712 2.405 . . . . 1.3400000000000001 106.726 172.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 57.5 t -69.87 -49.69 55.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 C-N-CA 124.261 1.025 . . . . 1.1000000000000001 109.405 173.647 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.9 tp -98.06 -68.89 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 CA-C-O 118.654 -0.689 . . . . 2.5600000000000001 111.832 -166.584 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 56.9 tp60 109.24 124.67 0.0 OUTLIER Pre-proline 0 CA--C 1.549 0.909 0 C-N-CA 128.946 2.898 . . . . 3.9300000000000002 109.894 176.547 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_exo -47.43 -59.51 1.22 Allowed 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 124.113 3.208 . . . . 1.3 117.24 -172.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_endo -49.06 -43.57 35.76 Favored 'Trans proline' 0 N--CA 1.45 -1.052 0 C-N-CA 121.62 1.546 . . . . 1.6899999999999999 110.645 172.675 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 58.9 mtp -68.21 -34.32 76.04 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 118.602 -0.713 . . . . 2.4500000000000002 111.302 -177.083 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 3.2 tt -62.2 -39.17 83.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-N 120.707 1.594 . . . . 2.1800000000000002 110.977 177.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -56.55 -46.98 80.41 Favored 'General case' 0 CA--C 1.529 0.159 0 O-C-N 122.176 -0.328 . . . . 1.1799999999999999 111.219 173.121 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -58.91 -52.41 65.86 Favored 'General case' 0 N--CA 1.435 -1.201 0 C-N-CA 123.197 0.599 . . . . 2.7400000000000002 111.99 176.355 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -58.29 -31.39 67.44 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 118.343 0.519 . . . . 4.6900000000000004 111.343 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 69.1 mt -62.95 -57.29 12.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-N 119.219 0.918 . . . . 2.02 109.95 166.167 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 87.2 mtt180 -48.64 -42.09 33.21 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.633 0.773 . . . . 4.1299999999999999 112.62 -178.066 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 91.3 mt-10 -50.9 -29.84 13.07 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 124.621 1.168 . . . . 3.7999999999999998 113.272 177.166 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 51.1 mt -82.04 -16.28 50.71 Favored 'General case' 0 N--CA 1.454 -0.26 0 O-C-N 121.711 -0.618 . . . . 1.9399999999999999 110.316 -178.162 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 134.66 -44.91 1.15 Allowed Glycine 0 C--N 1.34 0.756 0 C-N-CA 124.731 1.158 . . . . 2.4300000000000002 110.546 169.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 5.0 m-30 -78.37 129.04 34.51 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-O 121.278 0.561 . . . . 2.8900000000000001 109.612 -166.388 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -73.15 108.18 2.43 Favored Glycine 0 N--CA 1.442 -0.934 0 N-CA-C 110.878 -0.889 . . . . 1.3799999999999999 110.878 -171.544 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -82.91 124.33 30.25 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.073 0.949 . . . . 1.5800000000000001 109.72 179.006 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -118.34 126.35 51.94 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 108.36 -0.978 . . . . 2.75 108.36 164.113 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 65.3 t -83.36 139.11 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 C-N-CA 125.42 1.488 . . . . 1.8500000000000001 109.299 -169.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 12.1 mt -134.44 59.76 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 CA-C-O 122.439 1.114 . . . . 2.3100000000000001 109.001 -178.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 81.8 mt-10 -59.93 148.06 36.48 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 107.969 -1.123 . . . . 4.6699999999999999 107.969 159.664 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -154.14 -69.43 0.14 Allowed 'General case' 0 CA--C 1.531 0.236 0 O-C-N 122.173 -0.329 . . . . 5.7000000000000002 111.675 -167.596 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 19.6 tt -59.8 116.18 1.53 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-N 118.861 0.755 . . . . 8.8900000000000006 110.186 178.511 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -61.47 -52.52 64.18 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.946 0.899 . . . . 11.27 110.366 -178.241 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 68.57 -125.62 20.53 Favored Glycine 0 CA--C 1.528 0.893 0 N-CA-C 109.764 -1.334 . . . . 14.01 109.764 -175.058 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 56.1 ttt85 . . . . . 0 C--O 1.251 1.149 0 N-CA-C 105.178 -2.156 . . . . 22.550000000000001 105.178 175.439 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 . . . . . 0 N--CA 1.477 0.923 0 N-CA-C 107.383 -1.34 . . . . 7.3399999999999999 107.383 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.4 t -67.92 141.16 56.44 Favored 'General case' 0 C--O 1.231 0.097 0 N-CA-C 108.147 -1.057 . . . . 3.3399999999999999 108.147 169.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.7 m -90.57 177.44 6.36 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 107.688 -1.227 . . . . 2.1099999999999999 107.688 165.34 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.14 152.28 31.1 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 118.909 -0.567 . . . . 6.1699999999999999 110.636 165.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 49.1 t -137.82 154.65 49.51 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 124.63 1.172 . . . . 1.6200000000000001 108.973 171.655 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 2.5 m-30 -100.83 150.55 22.69 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 106.916 -1.513 . . . . 2.1899999999999999 106.916 176.556 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.477 HD12 HD13 ' A' ' 35' ' ' LEU . 13.5 mt -144.27 126.25 10.35 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 N-CA-C 104.773 -2.306 . . . . 1.8300000000000001 104.773 -175.451 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 3.6 tp60 -88.23 134.36 33.81 Favored 'General case' 0 N--CA 1.442 -0.866 0 N-CA-C 106.045 -1.835 . . . . 2.73 106.045 173.015 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 16.1 m -128.39 175.81 9.18 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 C-N-CA 125.343 1.457 . . . . 2.3599999999999999 109.457 -176.572 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 13.7 t -140.0 179.19 6.76 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 109.339 -0.615 . . . . 3.9199999999999999 109.339 172.598 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 84.51 -54.81 4.96 Favored Glycine 0 C--N 1.332 0.351 0 N-CA-C 105.566 -3.014 . . . . 2.8900000000000001 105.566 -163.456 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 32.4 ttm 82.48 -58.67 0.19 Allowed 'General case' 0 N--CA 1.441 -0.887 0 C-N-CA 126.964 2.106 . . . . 3.29 108.955 158.651 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.8 t -157.96 98.85 1.64 Allowed 'General case' 0 N--CA 1.442 -0.875 0 N-CA-C 106.441 -1.689 . . . . 5.9500000000000002 106.441 153.113 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.4 m -72.46 55.18 0.34 Allowed 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.184 0.994 . . . . 3.1699999999999999 109.01 175.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 50.93 71.04 0.46 Allowed 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.668 1.187 . . . . 2.98 111.338 -160.578 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.4 m 78.24 21.48 0.84 Allowed 'General case' 0 C--O 1.226 -0.177 0 C-N-CA 124.89 1.276 . . . . 3.6699999999999999 113.607 169.088 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -51.72 -32.42 30.18 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 124.62 1.168 . . . . 3.5499999999999998 109.558 166.068 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 19.6 m -53.85 -40.46 44.29 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 CA-C-N 115.28 -0.873 . . . . 2.5499999999999998 111.622 175.47 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.63 -46.15 70.4 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.157 0.983 . . . . 0.90000000000000002 110.15 175.174 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -58.43 -52.95 63.45 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 108.872 -0.788 . . . . 2.1099999999999999 108.872 171.832 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 58.2 mt -56.65 -56.32 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-O 118.473 -0.775 . . . . 1.99 109.102 -173.32 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -39.61 -61.21 0.85 Allowed 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 126.132 1.773 . . . . 3.1299999999999999 110.893 171.354 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.43 -39.99 61.65 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 124.068 0.947 . . . . 6.9699999999999998 111.176 178.004 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.603 ' OD1' HD13 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -71.04 -53.65 13.98 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 124.293 1.037 . . . . 3.2599999999999998 108.831 -175.492 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.603 HD13 ' OD1' ' A' ' 24' ' ' ASN . 0.0 OUTLIER -64.1 -27.34 69.03 Favored 'General case' 0 N--CA 1.462 0.17 0 O-C-N 121.07 -1.019 . . . . 2.4100000000000001 112.247 -177.103 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 58.3 mtp180 -67.95 -14.48 63.0 Favored 'General case' 0 N--CA 1.452 -0.368 0 O-C-N 121.761 -0.587 . . . . 5.8099999999999996 111.7 178.576 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -57.92 -38.79 76.51 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-N 119.158 0.89 . . . . 7.8300000000000001 112.69 161.624 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -93.05 68.3 4.35 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-O 121.977 0.894 . . . . 8.5299999999999994 109.255 -149.66 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -27.1 109.71 0.04 OUTLIER 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 127.116 2.166 . . . . 5.5800000000000001 110.057 163.462 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 135.51 -48.72 0.92 Allowed Glycine 0 CA--C 1.528 0.867 0 N-CA-C 108.246 -1.942 . . . . 1.3300000000000001 108.246 -151.691 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -78.64 133.42 30.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 C-N-CA 124.521 1.129 . . . . 2.9399999999999999 110.298 -173.085 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 24.7 t80 -141.32 35.87 1.69 Allowed 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 122.065 0.936 . . . . 6.8899999999999997 110.632 172.852 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 43.2 t -167.5 147.14 5.12 Favored 'General case' 0 N--CA 1.449 -0.478 1 C-N-CA 132.854 4.461 . . . . 2.3300000000000001 101.54 140.836 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.8 pp -78.71 156.58 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 C-N-CA 118.561 -1.256 . . . . 2.0499999999999998 108.536 165.632 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.754 HD22 ' CG1' ' A' ' 45' ' ' VAL . 0.6 OUTLIER -96.18 72.15 2.87 Favored 'General case' 0 N--CA 1.427 -1.591 0 C-N-CA 126.767 2.027 . . . . 4.7000000000000002 109.771 -173.978 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 24.7 t -135.13 141.04 43.92 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 O-C-N 121.017 -1.052 . . . . 1.4199999999999999 108.518 163.795 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -156.9 59.91 0.53 Allowed 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 125.866 1.666 . . . . 0.87 106.632 169.824 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -46.11 -36.95 6.28 Favored 'General case' 0 CA--C 1.512 -0.515 0 C-N-CA 125.603 1.561 . . . . 3.3599999999999999 113.12 -178.637 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.83 -41.12 96.0 Favored 'General case' 0 N--CA 1.439 -0.987 0 N-CA-C 108.511 -0.922 . . . . 4.7300000000000004 108.511 -164.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -77.05 -42.49 38.21 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.494 0.717 . . . . 1.4299999999999999 109.903 167.433 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 102.37 64.93 0.74 Allowed Glycine 0 C--N 1.336 0.572 0 N-CA-C 109.072 -1.611 . . . . 1.46 109.072 179.019 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -160.07 176.14 12.16 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 106.982 -1.488 . . . . 5.7400000000000002 106.982 -179.472 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.69 ' HB1' HD12 ' A' ' 35' ' ' LEU . . . -131.94 137.39 47.93 Favored 'General case' 0 N--CA 1.435 -1.188 0 C-N-CA 126.382 1.873 . . . . 1.0700000000000001 107.907 174.69 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.404 ' H ' ' HA ' ' A' ' 35' ' ' LEU . 5.6 pt-20 -128.8 109.0 10.9 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 114.456 1.28 . . . . 2.6899999999999999 114.456 177.473 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.754 ' CG1' HD22 ' A' ' 35' ' ' LEU . 3.7 m -83.9 103.33 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 N-CA-C 108.522 -0.918 . . . . 3.2799999999999998 108.522 176.765 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 7.8 ttm105 -84.43 114.34 21.83 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 103.837 -2.653 . . . . 6.8700000000000001 103.837 160.037 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -151.77 173.02 15.24 Favored 'General case' 0 C--N 1.332 -0.16 0 O-C-N 121.53 -0.731 . . . . 2.2599999999999998 112.728 -163.057 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -126.05 105.1 25.74 Favored Pre-proline 0 N--CA 1.447 -0.598 0 C-N-CA 123.666 0.786 . . . . 3.29 110.603 172.369 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -79.74 63.53 8.75 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 122.804 2.336 . . . . 1.72 109.17 -178.203 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -130.68 -49.6 1.05 Allowed 'General case' 0 C--O 1.227 -0.119 0 C-N-CA 124.187 0.995 . . . . 2.3999999999999999 109.005 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 43.0 t -63.66 -57.98 9.42 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 N-CA-C 109.609 -0.515 . . . . 2.04 109.609 174.761 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.627 HG23 ' H ' ' A' ' 53' ' ' GLN . 19.9 tt -115.01 -118.04 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.694 0 C-N-CA 124.147 0.979 . . . . 2.8700000000000001 108.469 -167.589 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.627 ' H ' HG23 ' A' ' 52' ' ' ILE . 5.7 tp60 179.99 111.73 0.19 Allowed Pre-proline 0 CA--C 1.541 0.602 0 N-CA-C 109.296 -0.631 . . . . 2.4300000000000002 109.296 -155.763 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo -46.61 -49.72 11.61 Favored 'Trans proline' 0 CA--C 1.533 0.457 0 C-N-CA 124.42 3.413 . . . . 1.8200000000000001 116.43 176.412 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -51.25 -54.21 5.79 Favored 'Trans proline' 0 N--CA 1.444 -1.439 0 C-N-CA 121.251 1.301 . . . . 1.29 109.868 170.46 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 65.6 mtt -52.45 -48.64 65.71 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 118.339 0.518 . . . . 1.6799999999999999 111.558 -179.305 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 81.5 mt -51.74 -54.09 14.31 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.862 0 CA-C-N 117.876 0.307 . . . . 2.7599999999999998 110.654 175.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.85 -33.15 74.66 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 120.76 -1.212 . . . . 1.3200000000000001 113.761 176.556 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -70.58 -52.85 18.74 Favored 'General case' 0 N--CA 1.44 -0.935 0 O-C-N 120.36 -1.462 . . . . 3.8300000000000001 110.676 -177.156 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -46.1 -43.74 15.03 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 122.548 1.165 . . . . 4.75 111.855 -178.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.61 ' CD1' HD11 ' A' ' 35' ' ' LEU . 96.8 mt -55.61 -44.5 76.88 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 C-N-CA 124.078 0.951 . . . . 1.3500000000000001 111.531 176.801 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 70.6 mtm180 -70.84 -42.04 70.7 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 124.509 1.123 . . . . 4.3499999999999996 111.428 176.512 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -54.52 -38.92 67.11 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 123.6 0.76 . . . . 2.8999999999999999 110.328 175.428 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 83.8 mt -79.36 -37.49 37.32 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 118.843 -0.598 . . . . 2.6099999999999999 110.771 174.491 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 165.76 -34.09 0.24 Allowed Glycine 0 CA--C 1.529 0.937 0 N-CA-C 115.641 1.016 . . . . 2.2999999999999998 115.641 165.7 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -77.85 128.74 34.45 Favored 'General case' 0 C--N 1.334 -0.078 0 CA-C-N 118.504 1.152 . . . . 2.9500000000000002 111.369 -159.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -70.21 79.08 0.41 Allowed Glycine 0 CA--C 1.523 0.541 0 C-N-CA 124.307 0.956 . . . . 1.6899999999999999 113.019 -175.511 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -83.53 126.66 33.03 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 125.561 1.545 . . . . 0.85999999999999999 111.044 -178.069 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -131.7 136.0 47.31 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 107.002 -1.481 . . . . 2.3100000000000001 107.002 174.175 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 25.6 m -82.05 153.47 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 CA-C-N 118.753 0.706 . . . . 3.21 110.757 -171.769 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 50.3 mt -136.07 120.06 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 C-N-CA 125.952 1.701 . . . . 2.1699999999999999 106.553 173.272 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -150.33 43.81 0.86 Allowed 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 107.936 -1.135 . . . . 5.8399999999999999 107.936 -176.853 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 13.2 p-10 -177.59 165.87 2.15 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 107.002 -1.481 . . . . 6.8600000000000003 107.002 -161.708 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 36.0 pt -142.47 163.38 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 N-CA-C 106.431 -1.692 . . . . 7.4299999999999997 106.431 170.736 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -162.75 -179.14 6.62 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 106.781 -1.562 . . . . 12.26 106.781 178.003 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -158.75 158.97 29.86 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 108.193 -1.963 . . . . 12.74 108.193 175.304 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.254 1.326 0 N-CA-C 105.1 -2.185 . . . . 17.600000000000001 105.1 179.157 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 . . . . . 0 N--CA 1.479 0.988 0 N-CA-C 107.897 -1.149 . . . . 5.1799999999999997 107.897 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.2 p -63.0 160.48 14.9 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 118.453 0.57 . . . . 2.79 111.15 176.187 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 18.7 m -149.62 174.75 12.21 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 107.595 -1.261 . . . . 1.8500000000000001 107.595 173.696 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -142.71 142.78 32.05 Favored 'General case' 0 CA--C 1.528 0.116 0 N-CA-C 108.209 -1.034 . . . . 3.4399999999999999 108.209 177.431 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.4 ' HB3' ' CG1' ' A' ' 45' ' ' VAL . 10.2 t -140.48 155.66 46.6 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 123.15 0.58 . . . . 1.3600000000000001 110.981 -163.689 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 52.6 m-85 -110.06 83.79 1.82 Allowed 'General case' 0 C--O 1.222 -0.348 0 C-N-CA 124.997 1.319 . . . . 2.1800000000000002 108.793 -178.167 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.456 ' HB ' ' HB3' ' A' ' 43' ' ' ALA . 50.8 mt -78.6 139.06 19.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 106.51 -1.663 . . . . 1.6399999999999999 106.51 -177.813 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -104.6 135.9 45.15 Favored 'General case' 0 C--O 1.231 0.126 0 N-CA-C 107.203 -1.406 . . . . 5.4800000000000004 107.203 168.332 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 46.5 t -131.53 108.95 15.2 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 C-N-CA 124.787 1.235 . . . . 3.0 108.917 -168.657 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 17.9 p -60.35 99.15 0.07 Allowed 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 120.957 0.408 . . . . 3.1499999999999999 111.176 -179.292 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 109.85 -28.41 10.63 Favored Glycine 0 C--N 1.338 0.667 0 C-N-CA 124.975 1.274 . . . . 2.1400000000000001 111.22 178.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 4.1 mpp? 67.53 -65.55 0.23 Allowed 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 127.011 2.124 . . . . 6.0099999999999998 108.059 -166.483 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -154.93 -103.62 0.04 OUTLIER 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 105.01 -2.218 . . . . 8.8200000000000003 105.01 160.558 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.0 p -145.58 35.77 1.06 Allowed 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.032 0.533 . . . . 3.3700000000000001 111.364 176.382 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 81.1 132.87 0.06 Allowed 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 127.166 2.186 . . . . 3.79 111.687 179.173 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 13.8 m 72.99 -39.24 0.44 Allowed 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 125.623 1.569 . . . . 4.6699999999999999 114.667 173.733 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 34.4 m -50.33 -28.55 8.13 Favored 'General case' 0 CA--C 1.517 -0.309 0 C-N-CA 130.346 3.458 . . . . 5.1500000000000004 111.487 175.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 5.8 m -41.88 -41.18 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 112.165 0.431 . . . . 2.8700000000000001 112.165 167.615 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.66 -41.65 73.95 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 124.732 1.213 . . . . 1.95 111.976 178.041 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -61.18 -51.88 67.15 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 108.229 -1.026 . . . . 4.21 108.229 170.026 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 22.6 mt -64.37 -57.11 12.83 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.542 0 N-CA-C 107.617 -1.253 . . . . 3.3900000000000001 107.617 -166.085 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -44.72 -45.5 9.88 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 126.706 2.002 . . . . 6.1100000000000003 113.237 -179.356 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 40.3 ttp180 -59.25 -47.52 85.07 Favored 'General case' 0 N--CA 1.449 -0.482 0 O-C-N 121.338 -0.852 . . . . 4.6600000000000001 111.0 171.391 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -62.94 -22.08 66.53 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.708 1.603 . . . . 3.4199999999999999 110.355 177.385 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.766 HD13 HD21 ' A' ' 35' ' ' LEU . 12.1 mt -75.96 -60.49 2.3 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 124.478 1.111 . . . . 2.8900000000000001 112.575 170.312 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.421 ' HG3' HG22 ' A' ' 34' ' ' ILE . 33.7 mtm180 -65.39 -17.66 64.7 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-N 119.146 0.884 . . . . 7.5999999999999996 112.768 -178.405 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -39.76 -53.35 2.24 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-O 116.064 -1.922 . . . . 7.4699999999999998 112.528 158.096 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -168.5 173.17 7.68 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 118.256 2.687 . . . . 6.9100000000000001 118.256 -164.741 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 77.57 57.7 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 129.61 3.164 . . . . 5.7599999999999998 111.726 170.311 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 57.2 27.4 57.57 Favored Glycine 0 CA--C 1.527 0.809 0 CA-C-N 114.945 -1.025 . . . . 1.26 112.616 176.105 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.9 mm -88.25 136.42 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 C-N-CA 124.413 1.085 . . . . 2.4399999999999999 108.447 175.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -143.03 48.39 1.49 Allowed 'General case' 0 C--N 1.341 0.235 0 CA-C-O 123.22 1.486 . . . . 3.6699999999999999 112.703 169.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 43.5 t -160.31 -179.27 7.56 Favored 'General case' 0 C--N 1.316 -0.874 0 C-N-CA 129.576 3.151 . . . . 1.76 105.484 152.029 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.421 HG22 ' HG3' ' A' ' 26' ' ' ARG . 0.1 OUTLIER -100.06 172.74 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 107.181 -1.414 . . . . 2.7599999999999998 107.181 153.085 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.766 HD21 HD13 ' A' ' 25' ' ' LEU . 0.3 OUTLIER -137.62 63.07 1.56 Allowed 'General case' 0 N--CA 1.429 -1.486 0 C-N-CA 130.904 3.682 . . . . 4.1900000000000004 108.555 -168.686 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 10.1 t -130.27 129.67 65.19 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.857 0 CA-C-N 115.33 -0.85 . . . . 1.27 109.414 164.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -130.15 62.92 1.56 Allowed 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 105.824 -1.917 . . . . 0.87 105.824 162.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.81 -31.12 71.32 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 109.687 -0.486 . . . . 3.54 109.687 -172.799 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 27.7 ptm -46.79 -38.24 9.84 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.406 1.082 . . . . 3.7200000000000002 113.245 169.596 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -94.07 -48.27 6.3 Favored 'General case' 0 C--N 1.339 0.137 0 C-N-CA 123.618 0.767 . . . . 1.53 109.415 177.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 115.13 45.24 0.64 Allowed Glycine 0 CA--C 1.522 0.53 0 N-CA-C 108.517 -1.833 . . . . 0.94999999999999996 108.517 179.308 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 61.6 mttt -147.6 176.63 9.92 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 126.343 1.857 . . . . 4.2199999999999998 108.016 -171.205 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.456 ' HB3' ' HB ' ' A' ' 7' ' ' ILE . . . -142.12 112.48 7.09 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 124.228 1.011 . . . . 1.1899999999999999 110.26 -169.829 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -105.01 85.63 2.31 Favored 'General case' 0 C--N 1.349 0.551 0 N-CA-C 115.718 1.747 . . . . 3.3500000000000001 115.718 -171.342 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.477 ' CA ' ' HB3' ' A' ' 35' ' ' LEU . 7.9 p -81.81 150.02 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.173 0 C-N-CA 123.259 0.624 . . . . 1.52 109.592 -174.05 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 20.1 ttt85 -119.94 129.38 54.3 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 104.637 -2.357 . . . . 4.5700000000000003 104.637 157.064 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 4.6 p90 -150.32 164.28 36.18 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 124.508 1.123 . . . . 2.2200000000000002 110.862 -163.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -109.95 90.48 9.46 Favored Pre-proline 0 C--O 1.237 0.406 0 C-N-CA 124.373 1.069 . . . . 2.5499999999999998 111.471 175.432 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -69.57 79.34 0.89 Allowed 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 122.769 2.313 . . . . 1.5800000000000001 110.697 172.81 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -160.88 -48.07 0.05 OUTLIER 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 128.683 2.793 . . . . 1.0800000000000001 105.156 173.088 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 73.4 t -67.34 -68.04 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.855 0 C-N-CA 123.877 0.871 . . . . 1.71 108.893 162.137 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . 0.256 16.8 tt -88.59 -57.51 4.18 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 N-CA-C 115.903 1.816 . . . . 2.21 115.903 -153.631 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 83.72 133.48 0.04 OUTLIER Pre-proline 0 CA--C 1.543 0.675 0 C-N-CA 127.414 2.286 . . . . 2.6000000000000001 110.984 -173.446 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -37.4 -49.51 1.77 Allowed 'Trans proline' 0 CA--C 1.537 0.664 1 C-N-CA 126.603 4.869 . . . . 1.5800000000000001 117.707 171.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -44.09 -61.89 0.51 Allowed 'Trans proline' 0 N--CA 1.448 -1.158 0 C-N-CA 121.847 1.698 . . . . 1.1299999999999999 110.642 167.588 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 43.0 mtt -60.12 -41.81 93.42 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 118.759 -0.639 . . . . 1.79 112.291 -175.14 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.422 HD12 HG11 ' A' ' 45' ' ' VAL . 1.0 OUTLIER -55.87 -40.45 62.12 Favored 'Isoleucine or valine' 0 C--N 1.348 0.519 0 CA-C-N 119.304 0.957 . . . . 3.6699999999999999 111.604 -178.106 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.35 -55.42 9.17 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 121.655 0.74 . . . . 1.3 110.681 171.814 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -64.37 -35.51 81.14 Favored 'General case' 0 N--CA 1.437 -1.083 0 N-CA-C 114.128 1.158 . . . . 3.1600000000000001 114.128 -162.047 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 39.0 m-85 -53.28 -36.85 61.62 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 119.596 1.089 . . . . 3.2799999999999998 110.946 170.78 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 17.3 mt -68.81 -34.02 62.39 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 O-C-N 121.154 -0.966 . . . . 1.49 109.638 -179.661 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 68.8 mtt180 -61.34 -50.77 71.58 Favored 'General case' 0 C--N 1.341 0.203 0 N-CA-C 109.282 -0.636 . . . . 4.0499999999999998 109.282 171.458 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -56.61 -35.7 68.57 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 123.717 0.807 . . . . 2.9900000000000002 111.905 177.451 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 77.1 mt -77.35 -17.88 57.89 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 118.891 -0.576 . . . . 2.21 111.277 175.798 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 151.56 -24.41 0.95 Allowed Glycine 0 CA--C 1.527 0.782 0 CA-C-N 118.973 0.806 . . . . 1.9199999999999999 114.261 163.563 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -121.36 129.76 53.24 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 118.633 1.217 . . . . 3.4500000000000002 111.806 -152.754 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -69.56 91.93 0.33 Allowed Glycine 0 N--CA 1.447 -0.624 0 N-CA-C 111.057 -0.817 . . . . 1.8100000000000001 111.057 -169.543 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -92.55 137.18 32.59 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 126.325 1.85 . . . . 0.93999999999999995 111.84 -178.334 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 3.3 t -134.17 144.3 48.42 Favored 'General case' 0 N--CA 1.439 -0.989 0 N-CA-C 108.161 -1.052 . . . . 3.2799999999999998 108.161 166.71 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 8.8 p -94.14 129.55 44.3 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 C-N-CA 126.17 1.788 . . . . 2.3799999999999999 109.657 -167.592 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 19.4 mm -137.59 126.85 35.09 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 C-N-CA 124.082 0.953 . . . . 3.7799999999999998 108.627 -178.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -139.25 49.68 1.83 Allowed 'General case' 0 CA--C 1.533 0.296 0 CA-C-O 121.946 0.879 . . . . 4.3700000000000001 109.556 165.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 47.9 t30 -160.85 164.39 31.36 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 106.458 -1.682 . . . . 6.2199999999999998 106.458 173.54 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 1.9 pp -84.31 175.54 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 N-CA-C 109.46 -0.57 . . . . 7.8600000000000003 109.46 168.221 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 57.0 tt0 -157.54 159.7 37.43 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 106.361 -1.718 . . . . 12.65 106.361 172.052 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -171.74 103.48 0.19 Allowed Glycine 0 CA--C 1.526 0.735 0 N-CA-C 108.919 -1.673 . . . . 12.43 108.919 179.194 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 2.8 ppt_? . . . . . 0 C--O 1.255 1.365 0 C-N-CA 126.741 2.016 . . . . 19.489999999999998 105.816 -179.229 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 . . . . . 0 N--CA 1.477 0.917 0 N-CA-C 107.842 -1.17 . . . . 7.2400000000000002 107.842 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.0 p -79.7 145.33 33.01 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 123.425 0.69 . . . . 2.8199999999999998 110.464 -176.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.4 t -113.76 175.51 5.43 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 124.675 1.19 . . . . 3.3199999999999998 109.136 174.63 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 59.9 tttt -106.7 151.18 25.45 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 124.753 1.221 . . . . 4.4500000000000002 110.638 -174.271 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 42.1 t -147.61 150.48 34.51 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 108.343 -0.984 . . . . 1.4099999999999999 108.343 167.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -96.01 133.94 39.63 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 107.171 -1.418 . . . . 2.21 107.171 178.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.602 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 19.3 mt -135.88 90.78 0.9 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.364 0 N-CA-C 105.748 -1.945 . . . . 2.1499999999999999 105.748 -170.606 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . 0.291 0.8 OUTLIER -81.43 123.9 28.97 Favored 'General case' 0 N--CA 1.435 -1.185 0 C-N-CA 125.977 1.711 . . . . 3.1200000000000001 108.619 -162.347 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 30.6 m -117.47 175.07 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 C-N-CA 124.201 1.0 . . . . 2.1499999999999999 110.315 -171.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.9 t -148.3 37.22 0.84 Allowed 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 112.435 0.531 . . . . 3.6499999999999999 112.435 175.275 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -139.31 130.02 4.63 Favored Glycine 0 N--CA 1.446 -0.693 1 N-CA-C 102.148 -4.381 . . . . 3.6099999999999999 102.148 138.315 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -164.04 -33.82 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 124.357 1.063 . . . . 3.2400000000000002 111.016 -169.536 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 6.7 t -111.88 23.72 13.49 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 108.379 -0.971 . . . . 4.4699999999999998 108.379 162.572 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 24.4 p -80.97 38.0 0.45 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.889 1.276 . . . . 3.0699999999999998 110.95 -175.159 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 72.48 177.54 0.25 Allowed 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.654 1.582 . . . . 2.9100000000000001 110.637 -152.69 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -77.26 32.09 0.15 Allowed 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 114.674 1.361 . . . . 2.8100000000000001 114.674 -162.683 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 85.7 m -48.79 -39.15 24.19 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 126.065 1.746 . . . . 3.54 110.576 175.401 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 29.1 m -46.16 -48.08 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 C-N-CA 124.795 1.238 . . . . 3.0299999999999998 111.303 174.113 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.94 -43.77 70.09 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 124.351 1.06 . . . . 0.92000000000000004 110.469 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -65.76 -51.81 56.06 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 108.566 -0.902 . . . . 2.8399999999999999 108.566 174.374 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 31.1 mt -60.35 -53.36 49.87 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 N-CA-C 108.384 -0.969 . . . . 2.5699999999999998 108.384 -168.837 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -40.68 -58.68 1.57 Allowed 'General case' 0 C--O 1.234 0.242 0 C-N-CA 126.316 1.847 . . . . 4.0899999999999999 111.588 171.009 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 20.0 mmm180 -56.59 -41.2 76.56 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.062 -0.517 . . . . 5.6500000000000004 110.907 177.422 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -71.7 -29.76 64.91 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 124.388 1.075 . . . . 3.3999999999999999 110.38 -176.912 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -70.51 -58.1 4.06 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 124.499 1.119 . . . . 2.4399999999999999 110.0 176.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . 0.258 62.1 mtt180 -65.06 -14.52 60.67 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 115.062 1.504 . . . . 9.3699999999999992 115.062 -171.205 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 16.9 mtm180 -54.24 -38.23 65.53 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 119.426 1.012 . . . . 7.1299999999999999 111.484 166.038 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 38.7 mm-40 -92.14 81.82 5.04 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 107.985 -1.117 . . . . 6.7999999999999998 107.985 -153.413 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 46.2 tt0 -41.68 125.06 2.68 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.97 0.908 . . . . 8.6799999999999997 108.943 174.597 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 127.65 -52.36 0.83 Allowed Glycine 0 CA--C 1.522 0.501 0 N-CA-C 107.733 -2.147 . . . . 1.4299999999999999 107.733 -155.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 1.3 mt -83.46 143.3 12.18 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.147 0 C-N-CA 124.718 1.207 . . . . 2.1000000000000001 108.274 171.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -144.93 42.11 1.31 Allowed 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 119.032 -1.067 . . . . 3.4199999999999999 113.579 150.804 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 68.2 m -163.19 143.85 9.28 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 127.632 2.373 . . . . 1.8400000000000001 109.767 156.073 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.54 ' H ' ' CD1' ' A' ' 34' ' ' ILE . 0.0 OUTLIER -81.44 134.25 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.836 0 C-N-CA 125.948 1.699 . . . . 2.7400000000000002 111.144 -178.973 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.562 ' HA ' ' H ' ' A' ' 44' ' ' GLU . 0.6 OUTLIER -80.02 71.73 6.75 Favored 'General case' 0 N--CA 1.432 -1.361 0 O-C-N 121.072 -1.018 . . . . 4.7199999999999998 110.061 174.051 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 22.3 t -135.63 131.06 50.55 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 CA-C-O 121.631 0.729 . . . . 1.26 111.847 169.529 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -149.15 67.15 1.03 Allowed 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 127.685 2.394 . . . . 0.92000000000000004 106.796 167.406 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -53.3 -31.97 46.57 Favored 'General case' 0 CA--C 1.512 -0.502 0 N-CA-C 113.228 0.825 . . . . 3.52 113.228 -177.117 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 63.8 mtt -66.74 -42.95 85.4 Favored 'General case' 0 N--CA 1.44 -0.929 0 C-N-CA 119.385 -0.926 . . . . 4.4299999999999997 109.099 -165.749 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -73.31 -36.27 66.22 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.426 0.69 . . . . 1.5700000000000001 109.69 166.773 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 97.8 55.35 1.15 Allowed Glycine 0 CA--C 1.507 -0.449 0 N-CA-C 106.548 -2.621 . . . . 0.97999999999999998 106.548 178.387 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 24.0 mmtm -150.15 176.06 11.18 Favored 'General case' 0 N--CA 1.44 -0.928 0 N-CA-C 106.18 -1.785 . . . . 6.3600000000000003 106.18 -165.663 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.602 ' HB3' ' O ' ' A' ' 7' ' ' ILE . . . -162.07 127.05 3.37 Favored 'General case' 0 N--CA 1.432 -1.341 0 N-CA-C 107.142 -1.429 . . . . 1.1899999999999999 107.142 -162.48 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.562 ' H ' ' HA ' ' A' ' 35' ' ' LEU . 0.6 OUTLIER -151.84 107.73 3.38 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 113.371 0.878 . . . . 3.9900000000000002 113.371 -174.206 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.7 p -81.79 155.06 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.022 0 C-N-CA 124.001 0.92 . . . . 1.5900000000000001 109.62 -169.558 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 46.0 ttt180 -118.78 128.81 54.83 Favored 'General case' 0 CA--C 1.521 -0.162 0 N-CA-C 106.769 -1.567 . . . . 5.3600000000000003 106.769 158.019 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -158.63 175.23 13.91 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 123.824 0.85 . . . . 2.21 110.35 -167.715 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -110.79 140.08 22.3 Favored Pre-proline 0 N--CA 1.448 -0.53 0 N-CA-C 106.979 -1.489 . . . . 3.0800000000000001 106.979 156.624 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -85.41 3.72 7.08 Favored 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 122.385 2.056 . . . . 2.98 113.29 -175.027 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -91.3 -50.18 5.96 Favored 'General case' 0 CA--C 1.519 -0.248 0 N-CA-C 107.943 -1.132 . . . . 1.24 107.943 -168.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 45.0 t -61.78 -59.07 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.97 0 C-N-CA 124.557 1.143 . . . . 1.03 110.379 178.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 10.7 tt -95.38 -37.06 7.22 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.261 0 CA-C-O 118.615 -0.707 . . . . 2.0800000000000001 112.743 -162.061 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 13.4 mm-40 88.78 125.74 0.03 OUTLIER Pre-proline 0 CA--C 1.54 0.56 0 C-N-CA 128.926 2.89 . . . . 2.8100000000000001 113.466 176.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.4 ' HA ' HG22 ' A' ' 57' ' ' ILE . 79.6 Cg_exo -49.89 -48.76 18.18 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 124.593 3.529 . . . . 1.46 116.944 179.325 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -53.11 -50.74 12.98 Favored 'Trans proline' 0 N--CA 1.444 -1.407 0 CA-C-N 120.758 1.307 . . . . 1.54 108.843 172.383 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 66.4 mtt -65.18 -43.77 90.61 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 120.62 -0.432 . . . . 1.8600000000000001 110.486 -171.728 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.428 HG21 HD13 ' A' ' 57' ' ' ILE . 7.5 tt -63.54 -35.4 72.47 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 C-N-CA 120.386 -0.526 . . . . 2.1800000000000002 110.407 -177.63 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -65.86 -50.14 65.61 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 121.916 0.865 . . . . 1.21 110.384 171.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -70.87 -35.93 72.6 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-O 117.483 -1.246 . . . . 2.7599999999999998 113.964 -166.807 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 9.2 m-30 -45.88 -41.75 11.74 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 119.642 1.11 . . . . 3.2599999999999998 110.206 172.46 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 7.9 mt -69.54 -35.54 66.89 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 O-C-N 121.825 -0.547 . . . . 1.4399999999999999 111.164 -178.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 68.9 mtt180 -66.27 -52.72 44.69 Favored 'General case' 0 C--O 1.226 -0.169 0 N-CA-C 109.013 -0.736 . . . . 4.4100000000000001 109.013 176.337 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -55.31 -53.54 54.83 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 125.633 1.573 . . . . 2.9399999999999999 110.792 -178.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 74.6 mt -84.52 -32.51 23.87 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 119.17 -0.443 . . . . 2.3100000000000001 111.916 -172.714 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -115.59 -87.64 1.42 Allowed Glycine 0 CA--C 1.525 0.705 0 N-CA-C 111.7 -0.56 . . . . 2.2000000000000002 111.7 -174.692 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -140.64 -69.1 0.4 Allowed 'General case' 0 CA--C 1.512 -0.514 0 CA-C-O 122.219 1.009 . . . . 3.3599999999999999 112.767 -152.354 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 168.14 137.95 2.35 Favored Glycine 0 N--CA 1.437 -1.293 0 N-CA-C 105.648 -2.981 . . . . 1.8700000000000001 105.648 -149.56 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -155.93 110.99 2.93 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 108.481 -0.933 . . . . 1.3 108.481 -170.424 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.4 p -116.36 113.59 23.12 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 125.15 1.38 . . . . 2.27 107.947 -174.256 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 12.1 m -81.39 138.51 19.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 N-CA-C 109.365 -0.605 . . . . 2.8199999999999998 109.365 -170.791 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 19.5 pt -144.68 152.26 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 N-CA-C 107.74 -1.207 . . . . 2.96 107.74 175.043 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -108.66 -68.72 0.9 Allowed 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 107.085 -1.45 . . . . 6.1100000000000003 107.085 167.129 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 29.1 m120 -64.21 128.25 34.97 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 108.818 -0.808 . . . . 5.3399999999999999 108.818 171.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 29.6 mm -76.99 77.68 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 N-CA-C 107.624 -1.25 . . . . 8.8399999999999999 107.624 174.283 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -52.89 142.0 20.36 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.517 0.727 . . . . 11.48 111.14 179.43 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 173.07 -161.32 32.39 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 108.059 -2.017 . . . . 11.880000000000001 108.059 -176.097 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 35.9 ptt180 . . . . . 0 C--O 1.254 1.3 0 N-CA-C 105.502 -2.036 . . . . 20.440000000000001 105.502 172.766 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 . . . . . 0 N--CA 1.477 0.921 0 N-CA-C 105.305 -2.109 . . . . 8.8800000000000008 105.305 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.4 m -42.03 145.02 0.38 Allowed 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 109.47 -0.567 . . . . 3.1400000000000001 109.47 133.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.5 m -94.83 135.02 36.83 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 125.303 1.441 . . . . 1.8899999999999999 109.273 -175.511 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 52.5 tttt -85.86 118.25 25.23 Favored 'General case' 0 CA--C 1.528 0.097 0 C-N-CA 124.281 1.033 . . . . 4.0899999999999999 109.222 175.686 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 96.5 m -127.16 131.2 50.79 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 108.872 -0.788 . . . . 3.9900000000000002 108.872 -178.163 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -89.52 135.87 33.35 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 124.491 1.117 . . . . 2.4700000000000002 108.533 -171.359 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 9.0 mt -132.16 157.24 43.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 106.529 -1.656 . . . . 1.7 106.529 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 29.9 tp60 -129.98 127.1 39.33 Favored 'General case' 0 N--CA 1.434 -1.261 0 N-CA-C 104.743 -2.317 . . . . 2.77 104.743 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 27.0 m -106.91 176.95 1.09 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 C-N-CA 125.177 1.391 . . . . 2.1800000000000002 110.085 -172.389 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 12.1 t -141.49 145.02 34.69 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 109.107 -0.701 . . . . 2.73 109.107 167.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 67.9 115.79 0.02 OUTLIER Glycine 0 C--N 1.335 0.508 0 N-CA-C 105.443 -3.063 . . . . 2.8599999999999999 105.443 -138.692 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 65.6 mtp -89.59 -101.44 0.09 Allowed 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 113.481 -1.359 . . . . 4.0499999999999998 108.88 -176.524 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 10.9 p -75.17 -42.28 56.27 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.153 0.981 . . . . 5.3600000000000003 109.726 177.696 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 56.7 m 55.34 21.92 4.52 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 126.697 1.999 . . . . 2.6800000000000002 112.099 178.364 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 50.87 36.62 15.16 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.297 1.039 . . . . 3.1299999999999999 113.495 -168.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 76.2 p 145.61 16.79 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 128.275 2.63 . . . . 2.9900000000000002 115.739 160.737 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.7 m -60.02 -35.98 76.26 Favored 'General case' 0 C--O 1.234 0.265 0 O-C-N 120.71 -1.244 . . . . 2.9399999999999999 109.872 175.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.444 HG12 HD23 ' A' ' 38' ' ' LEU . 15.2 m -65.95 -52.94 43.19 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 CA-C-N 116.089 -0.505 . . . . 2.3100000000000001 110.963 -179.333 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -47.94 -46.01 31.65 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.152 0.581 . . . . 0.88 110.616 171.569 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -55.43 -52.05 64.87 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 120.995 0.426 . . . . 1.77 110.144 174.059 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -61.9 -48.1 90.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 C-N-CA 123.768 0.827 . . . . 1.73 110.686 -175.243 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -52.25 -53.8 39.27 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 125.113 1.365 . . . . 3.1299999999999999 109.178 173.269 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 29.9 mmt180 -55.3 -41.53 72.46 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 118.414 -0.803 . . . . 5.2300000000000004 111.573 176.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 56.9 m-20 -74.34 -67.97 0.57 Allowed 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 118.829 0.74 . . . . 3.9100000000000001 112.406 -177.183 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.564 ' CD2' HD21 ' A' ' 35' ' ' LEU . 0.1 OUTLIER -75.8 -14.79 60.31 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 126.594 1.958 . . . . 2.5600000000000001 113.558 -164.637 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -21.1 -74.49 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 128.433 2.693 . . . . 8.8800000000000008 113.51 -168.165 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . 0.266 11.3 ptp180 -95.74 -62.13 1.34 Allowed 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 117.589 2.44 . . . . 12.43 117.589 170.696 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 30.54 -150.95 0.0 OUTLIER 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 129.711 3.205 . . . . 6.0800000000000001 111.965 -154.687 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -95.68 92.53 6.63 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 106.058 -1.83 . . . . 7.4000000000000004 106.058 167.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 115.07 13.94 8.8 Favored Glycine 0 CA--C 1.529 0.916 0 CA-C-O 117.137 -1.924 . . . . 1.0900000000000001 115.654 164.492 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 1.6 mt -104.04 129.52 56.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-N 120.531 2.166 . . . . 2.02 108.53 172.61 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -136.83 43.41 2.41 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 121.828 0.823 . . . . 3.1600000000000001 111.19 159.138 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 67.7 m -170.74 143.52 2.14 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 129.295 3.038 . . . . 1.51 106.35 135.699 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -83.9 160.89 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 CA-C-O 122.012 0.91 . . . . 2.4300000000000002 110.783 175.099 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.663 ' HB2' ' HB1' ' A' ' 43' ' ' ALA . 0.3 OUTLIER -72.44 69.72 0.85 Allowed 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 129.437 3.095 . . . . 5.2699999999999996 109.091 -179.035 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 23.9 t -130.6 130.83 65.04 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 CA-C-O 121.844 0.83 . . . . 1.8500000000000001 113.09 170.443 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -158.04 56.86 0.47 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 127.635 2.374 . . . . 0.71999999999999997 107.201 156.388 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.444 HD23 HG12 ' A' ' 18' ' ' VAL . 4.0 mm? -74.3 -11.08 60.17 Favored 'General case' 0 N--CA 1.463 0.191 0 O-C-N 121.058 -1.026 . . . . 5.2800000000000002 112.542 -171.716 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 27.6 ttt -53.81 -40.13 66.11 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 109.848 -0.427 . . . . 3.75 109.848 163.242 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -89.39 -34.41 16.51 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.423 0.689 . . . . 1.3100000000000001 110.487 172.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 106.02 44.62 1.37 Allowed Glycine 0 CA--C 1.524 0.649 0 N-CA-C 109.379 -1.488 . . . . 0.75 109.379 -179.131 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 45.8 mttt -155.02 -177.52 6.59 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 125.869 1.668 . . . . 4.4699999999999998 107.364 -153.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.663 ' HB1' ' HB2' ' A' ' 35' ' ' LEU . . . -153.87 146.98 24.6 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 125.483 1.513 . . . . 1.4199999999999999 110.432 -168.857 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -129.22 106.52 8.88 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-O 121.265 0.555 . . . . 4.3200000000000003 110.021 161.49 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -83.74 116.84 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 N-CA-C 106.165 -1.791 . . . . 2.0899999999999999 106.165 173.239 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 29.8 ttm180 -109.2 116.3 31.64 Favored 'General case' 0 CA--C 1.515 -0.381 0 N-CA-C 106.192 -1.781 . . . . 5.6500000000000004 106.192 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -148.97 173.66 13.1 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 114.65 1.352 . . . . 2.1699999999999999 114.65 -158.025 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -102.7 94.64 5.35 Favored Pre-proline 0 N--CA 1.452 -0.347 0 N-CA-C 106.795 -1.558 . . . . 3.3199999999999998 106.795 166.643 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -67.75 -4.27 11.92 Favored 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 122.408 2.072 . . . . 2.6099999999999999 113.292 -172.748 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -82.47 -28.56 31.14 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 124.175 0.99 . . . . 1.1699999999999999 108.554 177.71 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 87.0 t -84.85 -67.33 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.137 0 C-N-CA 124.629 1.172 . . . . 1.1899999999999999 107.939 -174.638 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 15.2 tt -87.45 -36.58 9.9 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 N-CA-C 113.016 0.747 . . . . 1.8300000000000001 113.016 -163.73 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 15.7 mm-40 86.88 119.18 0.03 OUTLIER Pre-proline 0 CA--C 1.541 0.625 0 C-N-CA 129.27 3.028 . . . . 2.96 112.834 -179.204 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -50.18 -47.94 21.92 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 125.117 3.878 . . . . 1.03 117.907 -178.107 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -59.08 -44.56 33.75 Favored 'Trans proline' 0 N--CA 1.442 -1.505 0 N-CA-C 108.785 -1.275 . . . . 1.02 108.785 172.026 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 87.6 mtp -69.46 -40.93 76.83 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-O 119.373 -0.346 . . . . 1.8799999999999999 110.11 -167.023 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 16.4 tt -61.87 -54.37 35.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 119.628 -0.829 . . . . 2.4199999999999999 110.765 175.72 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -46.88 -51.65 16.23 Favored 'General case' 0 C--N 1.342 0.262 0 C-N-CA 123.73 0.812 . . . . 0.96999999999999997 112.138 174.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -54.79 -51.35 66.05 Favored 'General case' 0 N--CA 1.442 -0.855 0 C-N-CA 125.292 1.437 . . . . 3.4300000000000002 111.237 175.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -48.68 -40.43 28.06 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 123.55 0.74 . . . . 3.6000000000000001 111.525 178.013 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.4 mm -58.14 -40.87 79.11 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-O 121.606 0.717 . . . . 2.2000000000000002 110.069 179.126 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 27.0 mtt85 -67.24 -50.54 60.28 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 123.623 0.769 . . . . 4.25 109.114 177.554 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -53.88 -48.98 69.52 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 124.034 0.933 . . . . 2.75 111.405 -178.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.7 pp -83.26 -30.98 27.21 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 119.271 -0.395 . . . . 2.8300000000000001 111.831 -175.555 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -123.3 -87.82 0.83 Allowed Glycine 0 CA--C 1.524 0.63 0 N-CA-C 111.455 -0.658 . . . . 1.6799999999999999 111.455 -175.666 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 26.5 m-85 -139.62 -74.85 0.36 Allowed 'General case' 0 CA--C 1.513 -0.452 0 CA-C-O 121.837 0.827 . . . . 3.8599999999999999 112.888 -151.718 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 171.34 128.9 1.07 Allowed Glycine 0 N--CA 1.438 -1.175 0 N-CA-C 107.825 -2.11 . . . . 1.54 107.825 -155.253 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -155.2 127.51 7.78 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 123.843 0.857 . . . . 0.90000000000000002 109.243 -172.14 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -118.23 131.03 56.39 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 126.166 1.787 . . . . 2.4100000000000001 106.724 179.312 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 79.6 t -87.05 127.68 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.737 0 C-N-CA 125.164 1.385 . . . . 1.6100000000000001 107.94 -175.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 13.5 mt -134.38 62.04 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 CA-C-O 122.387 1.089 . . . . 1.79 108.515 -173.187 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -73.1 67.2 0.88 Allowed 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 124.231 1.012 . . . . 4.7599999999999998 109.449 171.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 62.8 m-80 -134.36 170.49 15.66 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 124.554 1.142 . . . . 5.7000000000000002 109.168 -178.622 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 20.1 tt -142.94 147.19 20.89 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 N-CA-C 106.177 -1.786 . . . . 8.1500000000000004 106.177 172.48 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -140.18 169.02 18.46 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 125.098 1.359 . . . . 10.960000000000001 107.992 -174.281 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -147.99 -82.38 0.04 OUTLIER Glycine 0 CA--C 1.524 0.627 0 N-CA-C 109.106 -1.598 . . . . 12.16 109.106 174.431 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 4.2 tpp85 . . . . . 0 C--O 1.253 1.264 0 N-CA-C 105.455 -2.054 . . . . 18.02 105.455 173.193 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 1.3 m120 . . . . . 0 N--CA 1.475 0.807 0 CA-C-O 116.675 -1.631 . . . . 6.4000000000000004 107.35 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 56.4 p 38.46 89.65 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.205 1.802 . . . . 4.3399999999999999 114.703 166.159 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.0 m -139.71 169.93 16.83 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 124.53 1.132 . . . . 1.77 109.564 -176.328 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.32 143.08 35.63 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 110.329 -0.249 . . . . 4.3499999999999996 110.329 168.637 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 51.4 t -141.28 149.62 41.52 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 125.072 1.349 . . . . 1.51 108.532 -171.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -106.26 142.9 35.17 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.185 1.394 . . . . 3.0699999999999998 108.422 179.661 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -141.43 109.09 2.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 107.255 -1.387 . . . . 2.6299999999999999 107.255 -163.003 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 17.5 tt0 -79.21 147.09 32.73 Favored 'General case' 0 N--CA 1.422 -1.851 0 N-CA-C 107.094 -1.447 . . . . 2.9700000000000002 107.094 -178.456 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.1 p -150.83 134.41 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 N-CA-C 108.825 -0.806 . . . . 2.8599999999999999 108.825 -168.686 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 6.1 m -83.19 73.5 10.09 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 121.959 0.885 . . . . 2.27 110.66 -167.232 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 121.57 94.25 1.3 Allowed Glycine 0 N--CA 1.443 -0.862 0 CA-C-O 124.664 2.258 . . . . 2.8500000000000001 107.765 175.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.443 ' HE3' HG22 ' A' ' 18' ' ' VAL . 11.9 tpt -95.56 -70.21 0.72 Allowed 'General case' 0 N--CA 1.422 -1.829 0 CA-C-N 109.456 -3.372 . . . . 7.3899999999999997 107.521 -172.857 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 5.7 m -108.08 52.89 0.7 Allowed 'General case' 0 N--CA 1.456 -0.175 0 N-CA-C 108.585 -0.895 . . . . 5.7199999999999998 108.585 -177.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 21.3 m -64.82 -61.02 2.43 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 107.507 -1.294 . . . . 3.7799999999999998 107.507 176.076 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -174.37 70.18 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 127.556 2.343 . . . . 2.7000000000000002 106.979 174.046 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . 0.26 16.6 p 77.63 23.0 0.85 Allowed 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 126.959 2.104 . . . . 2.48 114.676 176.22 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 80.1 m -52.12 -39.43 59.87 Favored 'General case' 0 CA--C 1.536 0.416 0 O-C-N 121.108 -0.995 . . . . 3.27 109.413 157.141 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.443 HG22 ' HE3' ' A' ' 12' ' ' MET . 1.0 OUTLIER -42.49 -47.87 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.034 0 C-N-CA 126.248 1.819 . . . . 2.8300000000000001 114.12 161.989 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.73 -36.07 82.54 Favored 'General case' 0 C--O 1.234 0.247 0 O-C-N 121.511 -0.743 . . . . 1.2 110.396 176.778 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -58.56 -51.79 68.4 Favored 'General case' 0 C--O 1.219 -0.522 0 N-CA-C 108.341 -0.985 . . . . 1.9199999999999999 108.341 169.708 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 86.6 mt -53.88 -52.55 34.51 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-N 119.108 0.867 . . . . 2.8799999999999999 109.863 -176.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.932 ' HA ' HD13 ' A' ' 34' ' ' ILE . 18.4 mt-10 -48.33 -48.7 36.09 Favored 'General case' 0 N--CA 1.444 -0.774 0 O-C-N 121.006 -1.059 . . . . 3.6099999999999999 112.722 172.22 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 5.6 ttm-85 -66.42 -27.35 67.76 Favored 'General case' 0 N--CA 1.444 -0.744 0 O-C-N 121.736 -0.603 . . . . 6.7199999999999998 112.426 173.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -72.78 -56.91 4.55 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 119.309 0.959 . . . . 4.46 110.571 -169.882 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.4 mt -69.52 -33.11 72.34 Favored 'General case' 0 C--O 1.223 -0.309 0 C-N-CA 119.429 -0.908 . . . . 3.23 113.003 -161.335 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.59 -17.78 0.36 Allowed 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 114.498 1.295 . . . . 7.7800000000000002 114.498 168.944 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -35.67 -56.44 0.68 Allowed 'General case' 0 C--N 1.343 0.308 0 O-C-N 121.014 -1.054 . . . . 9.8599999999999994 111.559 162.601 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.502 ' HB3' HD11 ' A' ' 52' ' ' ILE . 9.6 mt-10 -96.36 119.58 35.11 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 118.972 -1.091 . . . . 9.4900000000000002 111.492 -140.797 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 47.8 mp0 -58.51 106.4 0.39 Allowed 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.303 1.441 . . . . 4.8799999999999999 109.197 179.704 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 122.02 -1.1 10.81 Favored Glycine 0 CA--C 1.529 0.941 0 CA-C-O 118.992 -0.893 . . . . 1.26 111.915 -171.2 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -78.52 138.19 20.64 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-N 118.432 1.116 . . . . 1.9199999999999999 110.672 177.225 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -147.91 48.34 1.07 Allowed 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 122.038 0.923 . . . . 3.27 112.993 164.129 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.7 m -169.2 173.24 6.85 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 129.354 3.062 . . . . 2.4500000000000002 106.487 129.186 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.932 HD13 ' HA ' ' A' ' 22' ' ' GLU . 1.8 pp -120.1 139.41 47.48 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 N-CA-C 102.841 -3.022 . . . . 2.6499999999999999 102.841 161.045 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.467 ' HB2' ' HB3' ' A' ' 44' ' ' GLU . 1.7 mp -148.14 157.17 43.35 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 119.269 0.941 . . . . 6.8799999999999999 109.523 -167.136 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.514 ' O ' HG12 ' A' ' 36' ' ' VAL . 2.1 t -155.05 73.0 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 CA-C-O 124.857 2.265 . . . . 2.29 107.649 -159.805 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -80.29 59.51 3.42 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 113.714 -1.584 . . . . 1.1899999999999999 109.089 169.416 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.401 ' CD2' HG21 ' A' ' 18' ' ' VAL . 0.4 OUTLIER -59.64 -29.91 68.35 Favored 'General case' 0 CA--C 1.505 -0.78 0 O-C-N 121.462 -0.774 . . . . 3.9300000000000002 111.608 173.905 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 2.7 mpt? -62.35 -34.46 76.7 Favored 'General case' 0 N--CA 1.438 -1.045 0 C-N-CA 118.861 -1.136 . . . . 3.7400000000000002 109.167 -169.578 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -76.99 -53.87 7.28 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.523 0.729 . . . . 1.96 109.336 164.082 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 131.39 50.37 0.1 Allowed Glycine 0 C--N 1.338 0.676 0 N-CA-C 109.943 -1.263 . . . . 1.4399999999999999 109.943 173.389 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 75.1 mttt -149.86 150.82 32.5 Favored 'General case' 0 N--CA 1.442 -0.87 0 N-CA-C 108.656 -0.868 . . . . 4.3300000000000001 108.656 -169.176 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -76.11 163.53 27.02 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 105.577 -2.008 . . . . 1.73 105.577 155.056 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.467 ' HB3' ' HB2' ' A' ' 35' ' ' LEU . 52.5 tt0 -128.24 157.68 40.22 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 106.108 -1.812 . . . . 3.5800000000000001 106.108 163.743 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 6.8 p -132.46 134.06 59.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 N-CA-C 106.176 -1.787 . . . . 1.77 106.176 173.34 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 33.2 ttm105 -105.34 130.23 53.5 Favored 'General case' 0 N--CA 1.456 -0.165 0 N-CA-C 105.632 -1.988 . . . . 4.5800000000000001 105.632 157.759 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 5.1 p90 -155.63 172.8 17.68 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 123.082 0.553 . . . . 2.02 110.262 -164.246 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -117.78 80.59 14.24 Favored Pre-proline 0 C--O 1.238 0.45 0 CA-C-N 115.969 -0.559 . . . . 2.7599999999999998 112.211 -174.143 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -66.47 87.17 0.27 Allowed 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 123.46 2.773 . . . . 2.5299999999999998 108.531 174.201 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -178.45 -47.35 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 130.25 3.42 . . . . 2.5600000000000001 105.937 -176.213 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 73.9 t -81.42 -57.62 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.712 0 N-CA-C 108.588 -0.893 . . . . 2.0299999999999998 108.588 168.291 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.502 HD11 ' HB3' ' A' ' 28' ' ' GLU . 12.1 tt -90.09 -44.97 15.07 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.21 0 N-CA-C 115.44 1.644 . . . . 2.4900000000000002 115.44 -146.451 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 21.9 tp60 91.86 110.94 0.02 OUTLIER Pre-proline 0 CA--C 1.55 0.979 0 C-N-CA 127.244 2.218 . . . . 3.1000000000000001 111.087 176.005 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -43.04 -48.35 7.8 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 124.773 3.649 . . . . 1.3700000000000001 118.127 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -54.84 -43.35 60.1 Favored 'Trans proline' 0 N--CA 1.448 -1.162 0 CA-C-N 121.329 1.51 . . . . 1.23 110.507 172.753 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 63.9 mtt -62.37 -44.82 95.56 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 118.397 -0.811 . . . . 2.1299999999999999 110.044 178.16 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.458 HD11 HG21 ' A' ' 52' ' ' ILE . 5.7 mm -48.4 -57.06 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 CA-C-N 119.08 0.855 . . . . 2.9199999999999999 109.903 172.305 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -55.22 -46.71 75.94 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.052 0.541 . . . . 1.3 112.073 -177.081 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -70.23 -44.91 67.6 Favored 'General case' 0 N--CA 1.44 -0.948 0 C-N-CA 124.62 1.168 . . . . 3.0899999999999999 112.74 -176.622 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -48.59 -36.81 16.47 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 123.968 0.907 . . . . 3.9399999999999999 111.571 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 22.1 mt -69.98 -40.58 78.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 N-CA-C 109.658 -0.497 . . . . 1.3999999999999999 109.658 178.484 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 80.1 mtm-85 -70.96 -31.36 67.91 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 118.24 -0.886 . . . . 4.0599999999999996 112.692 -178.283 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 87.1 mt-10 -41.19 -44.33 2.55 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.926 1.291 . . . . 4.7000000000000002 113.764 179.238 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.42 -12.89 58.78 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.105 0.962 . . . . 2.8900000000000001 111.704 -173.696 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 111.32 -2.03 28.09 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 124.742 1.163 . . . . 2.3799999999999999 111.499 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -76.57 86.2 3.26 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 107.993 -1.114 . . . . 3.0099999999999998 107.993 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -61.4 104.41 0.69 Allowed Glycine 0 N--CA 1.442 -0.932 0 C-N-CA 125.672 1.606 . . . . 1.6899999999999999 109.177 -178.008 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -137.99 151.84 48.31 Favored 'General case' 0 N--CA 1.45 -0.457 0 O-C-N 124.981 1.048 . . . . 1.3899999999999999 112.494 -163.369 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 29.8 m -135.34 138.63 43.59 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 125.769 1.627 . . . . 2.6600000000000001 107.976 -170.499 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 12.7 t -82.77 111.36 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 C-N-CA 124.972 1.309 . . . . 1.8300000000000001 107.73 -177.034 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 16.2 mt -134.27 66.03 0.29 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.331 0 C-N-CA 124.499 1.119 . . . . 2.6499999999999999 109.231 -172.048 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 178.67 158.38 0.52 Allowed 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 129.794 3.238 . . . . 8.0999999999999996 106.121 150.16 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 38.6 t-20 54.06 40.2 31.38 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.021 0.928 . . . . 9.3100000000000005 111.819 167.644 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -65.04 -47.35 88.3 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 N-CA-C 108.875 -0.787 . . . . 12.640000000000001 108.875 -179.449 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -113.2 148.45 35.43 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 105.529 -2.026 . . . . 13.69 105.529 161.622 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 143.18 -126.37 2.8 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 107.892 -2.083 . . . . 16.719999999999999 107.892 -174.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.94 0 N-CA-C 107.363 -1.347 . . . . 23.25 107.363 -177.585 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 . . . . . 0 N--CA 1.476 0.83 0 N-CA-C 109.405 -0.591 . . . . 6.8499999999999996 109.405 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 12.1 m -158.08 57.28 0.47 Allowed 'General case' 0 CA--C 1.529 0.156 0 CA-C-O 123.105 1.431 . . . . 2.52 107.682 179.437 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -84.69 127.36 34.06 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 128.586 2.755 . . . . 2.1899999999999999 109.955 -168.426 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 37.2 tttt -81.83 144.13 31.25 Favored 'General case' 0 C--N 1.34 0.178 0 CA-C-N 118.761 0.71 . . . . 4.1600000000000001 109.272 174.603 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 45.5 t -143.18 156.01 44.67 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.402 0.681 . . . . 1.3200000000000001 109.324 170.628 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -102.52 139.67 37.82 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 124.555 1.142 . . . . 2.6600000000000001 108.528 175.685 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.7 mp -133.24 130.01 57.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 N-CA-C 104.91 -2.255 . . . . 2.0899999999999999 104.91 174.869 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 36.4 tp60 -91.7 126.04 36.64 Favored 'General case' 0 N--CA 1.433 -1.289 0 N-CA-C 104.042 -2.577 . . . . 3.25 104.042 169.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.4 m -109.4 136.35 45.56 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 N-CA-C 108.386 -0.968 . . . . 2.2599999999999998 108.386 179.525 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 6.1 m -87.22 55.35 3.51 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 108.925 -0.768 . . . . 2.23 108.925 171.487 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -143.95 123.08 1.95 Allowed Glycine 0 N--CA 1.445 -0.732 0 N-CA-C 103.464 -3.854 . . . . 3.1600000000000001 103.464 148.4 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 70.6 mtm -136.6 -71.92 0.45 Allowed 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 106.515 -1.661 . . . . 4.25 106.515 -176.202 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 4.9 t -74.93 51.04 0.48 Allowed 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 109.307 -0.627 . . . . 5.7599999999999998 109.307 163.121 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 14.5 t -114.42 121.65 44.21 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 105.12 -2.178 . . . . 3.0499999999999998 105.12 175.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -71.53 82.19 0.81 Allowed 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 123.57 0.748 . . . . 2.7799999999999998 111.999 -157.746 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 87.63 38.12 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 127.684 2.394 . . . . 2.5299999999999998 109.857 -177.916 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.8 t -47.59 -41.0 20.7 Favored 'General case' 0 CA--C 1.521 -0.136 0 C-N-CA 125.082 1.353 . . . . 3.7799999999999998 108.83 168.68 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 15.1 m -66.32 -53.34 37.43 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.06 0 CA-C-N 113.49 -1.687 . . . . 2.2200000000000002 110.321 -175.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -50.44 -45.15 55.78 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.39 0.676 . . . . 0.81999999999999995 110.309 172.485 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -56.84 -56.39 22.17 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 109.597 -0.52 . . . . 2.0299999999999998 109.597 175.66 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 27.5 mt -52.58 -54.46 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 C-N-CA 124.268 1.027 . . . . 2.3199999999999998 110.199 -179.262 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -50.32 -59.01 4.4 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 124.985 1.314 . . . . 2.9300000000000002 110.088 176.903 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 21.5 tpt180 -55.48 -41.83 73.55 Favored 'General case' 0 N--CA 1.443 -0.801 0 C-N-CA 124.666 1.186 . . . . 5.1200000000000001 111.515 -176.56 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 15.3 m-20 -72.31 -64.46 0.94 Allowed 'General case' 0 C--O 1.222 -0.362 0 N-CA-C 109.609 -0.515 . . . . 3.52 109.609 179.163 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.873 HD12 HD21 ' A' ' 35' ' ' LEU 0.319 6.9 mt -80.54 -11.09 59.71 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 128.69 2.796 . . . . 3.6600000000000001 116.808 -159.484 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -19.57 -71.5 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 126.777 2.031 . . . . 9.3300000000000001 114.345 175.458 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 30.4 mmt180 -92.35 -60.7 1.77 Allowed 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 118.828 2.899 . . . . 12.91 118.828 -179.419 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.408 ' H ' ' CD ' ' A' ' 28' ' ' GLU 0.262 2.5 mm-40 8.27 62.84 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.685 1 C-N-CA 132.665 4.386 . . . . 5.8300000000000001 112.314 -152.328 . . . . . . . . 4 3 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 18.06 58.13 0.01 OUTLIER 'General case' 0 C--N 1.343 0.299 0 C-N-CA 129.685 3.194 . . . . 6.9400000000000004 113.257 -169.342 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 166.63 -28.7 0.18 Allowed Glycine 0 CA--C 1.522 0.503 0 C-N-CA 120.134 -1.031 . . . . 1.5 113.488 -171.189 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.7 mt -81.6 111.96 18.87 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 N-CA-C 106.212 -1.773 . . . . 1.96 106.212 174.883 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 47.9 m-85 -122.6 44.16 2.71 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 122.832 1.301 . . . . 3.29 110.547 166.371 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 33.7 t -166.78 137.54 3.24 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 126.799 2.04 . . . . 1.73 105.952 142.838 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.2 pp -78.59 151.44 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.651 0 N-CA-C 107.5 -1.296 . . . . 1.9099999999999999 107.5 171.374 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.873 HD21 HD12 ' A' ' 25' ' ' LEU . 0.3 OUTLIER -94.69 77.43 3.73 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 129.466 3.106 . . . . 4.3300000000000001 110.243 -169.273 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 43.3 t -131.59 139.71 49.97 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.801 0 N-CA-C 108.997 -0.742 . . . . 1.5 108.997 168.24 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -155.99 55.99 0.59 Allowed 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 106.618 -1.623 . . . . 0.67000000000000004 106.618 168.714 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -71.61 -20.32 62.0 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 114.74 -1.118 . . . . 3.0600000000000001 111.017 -172.412 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 53.0 ttm -45.23 -38.29 5.34 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.621 0.768 . . . . 3.3999999999999999 110.935 164.157 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -95.51 -48.67 5.74 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.234 0.614 . . . . 1.79 110.235 170.674 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 119.67 54.82 0.26 Allowed Glycine 0 C--N 1.338 0.64 0 N-CA-C 109.813 -1.315 . . . . 0.91000000000000003 109.813 -177.578 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 10.2 pttt -159.15 177.98 10.5 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 107.991 -1.114 . . . . 4.1100000000000003 107.991 -173.007 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.514 ' HB1' ' HB2' ' A' ' 35' ' ' LEU . . . -132.31 124.36 28.67 Favored 'General case' 0 N--CA 1.441 -0.904 0 C-N-CA 127.081 2.153 . . . . 0.90000000000000002 108.705 -169.102 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -125.03 89.06 2.99 Favored 'General case' 0 C--N 1.343 0.296 0 N-CA-C 113.776 1.028 . . . . 3.29 113.776 -175.454 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.431 HG11 ' CD2' ' A' ' 47' ' ' TYR . 9.6 p -78.65 152.1 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.088 0 N-CA-C 108.707 -0.849 . . . . 1.6399999999999999 108.707 -174.213 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 63.9 ttm-85 -114.85 112.58 22.99 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 106.705 -1.591 . . . . 4.46 106.705 156.489 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.512 ' CZ ' ' HG3' ' A' ' 54' ' ' PRO . 0.0 OUTLIER -123.15 165.42 16.89 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 124.304 1.041 . . . . 2.3199999999999998 113.19 -169.629 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 32.6 t30 -126.94 90.99 48.12 Favored Pre-proline 0 N--CA 1.451 -0.386 0 C-N-CA 125.99 1.716 . . . . 2.3799999999999999 109.015 -178.533 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -71.64 71.26 2.6 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 122.895 2.397 . . . . 1.8500000000000001 112.081 179.122 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -123.92 -49.11 1.86 Allowed 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 126.201 1.8 . . . . 1.96 106.853 157.054 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 41.0 t -83.52 -61.44 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.923 0 C-N-CA 124.741 1.216 . . . . 1.75 110.567 175.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.473 HG23 ' H ' ' A' ' 53' ' ' GLN . 6.1 tp -78.58 -71.67 0.29 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.414 0 N-CA-C 113.008 0.744 . . . . 1.6499999999999999 113.008 -161.277 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.473 ' H ' HG23 ' A' ' 52' ' ' ILE . 4.0 mp0 82.81 128.78 0.03 OUTLIER Pre-proline 0 CA--C 1.548 0.887 0 C-N-CA 128.293 2.637 . . . . 3.8700000000000001 113.248 -176.401 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.512 ' HG3' ' CZ ' ' A' ' 47' ' ' TYR . 21.5 Cg_exo -42.88 -52.48 4.62 Favored 'Trans proline' 0 C--N 1.349 0.562 1 C-N-CA 126.744 4.963 . . . . 1.29 117.687 177.594 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -54.06 -49.25 17.73 Favored 'Trans proline' 0 N--CA 1.442 -1.553 0 CA-C-N 120.11 1.075 . . . . 0.84999999999999998 109.678 173.305 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 61.3 mtt -64.93 -45.26 86.57 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.193 -0.669 . . . . 2.1800000000000002 109.193 -170.066 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.427 HG22 ' HA ' ' A' ' 54' ' ' PRO . 16.2 tt -59.7 -49.75 82.58 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 C-N-CA 119.087 -1.045 . . . . 2.6299999999999999 111.527 177.287 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -51.8 -53.78 36.2 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 118.319 0.508 . . . . 1.0900000000000001 111.758 176.668 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -56.53 -54.49 45.25 Favored 'General case' 0 N--CA 1.432 -1.367 0 C-N-CA 124.511 1.125 . . . . 3.1200000000000001 110.676 -179.731 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 18.7 m-30 -50.25 -43.1 52.99 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 119.103 0.865 . . . . 4.1200000000000001 110.833 178.154 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 85.6 mt -65.43 -40.83 89.53 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 O-C-N 121.712 -0.617 . . . . 1.21 110.083 -179.307 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 51.8 mtp180 -59.12 -51.83 68.33 Favored 'General case' 0 CA--C 1.533 0.322 0 O-C-N 121.905 -0.497 . . . . 5.4199999999999999 111.211 171.177 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -56.5 -32.95 65.53 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 125.507 1.523 . . . . 3.0899999999999999 111.673 179.572 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 59.5 mt -77.2 -17.43 58.52 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 119.184 -0.436 . . . . 1.98 110.629 176.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 135.42 -9.67 4.36 Favored Glycine 0 CA--C 1.526 0.72 0 C-N-CA 124.069 0.842 . . . . 2.2799999999999998 112.964 167.519 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -110.28 115.03 28.96 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 118.481 1.14 . . . . 3.25 110.02 -160.606 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -63.71 86.96 0.06 OUTLIER Glycine 0 N--CA 1.447 -0.625 0 CA-C-N 115.868 -0.606 . . . . 1.3899999999999999 112.065 -176.264 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -84.06 127.74 34.09 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 126.074 1.75 . . . . 0.94999999999999996 109.829 178.284 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 9.6 t -122.18 130.38 53.15 Favored 'General case' 0 N--CA 1.436 -1.132 0 N-CA-C 105.785 -1.932 . . . . 2.2200000000000002 105.785 165.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 77.0 t -83.74 135.89 23.91 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.89 0 N-CA-C 107.398 -1.334 . . . . 1.79 107.398 -177.531 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 17.9 mt -126.91 73.81 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 N-CA-C 107.034 -1.469 . . . . 1.9099999999999999 107.034 -178.697 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -58.99 162.43 4.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.097 -0.956 . . . . 3.6400000000000001 110.958 167.02 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 51.8 t30 -70.52 154.11 42.22 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 115.973 -0.558 . . . . 6.1500000000000004 111.019 -172.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 6.3 mt 54.03 63.68 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 C-N-CA 125.489 1.515 . . . . 7.96 110.851 179.472 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -52.86 -47.3 67.91 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.022 0.929 . . . . 11.699999999999999 111.286 176.631 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 167.22 -158.93 32.11 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 108.007 -2.037 . . . . 10.24 108.007 -175.839 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.257 1.461 0 N-CA-C 105.893 -1.892 . . . . 16.32 105.893 172.805 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 2.3 m120 . . . . . 0 N--CA 1.479 1.022 0 N-CA-C 114.419 1.266 . . . . 8.1600000000000001 114.419 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.1 p -71.29 75.69 0.73 Allowed 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 120.163 1.347 . . . . 2.4700000000000002 114.57 -162.623 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.6 p -91.49 172.38 8.55 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 128.096 2.559 . . . . 2.21 111.075 -177.213 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 6.1 tttt -108.53 156.47 19.46 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 124.755 1.222 . . . . 4.5999999999999996 108.563 166.738 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -145.26 175.35 10.35 Favored 'General case' 0 C--O 1.235 0.324 0 O-C-N 124.142 0.901 . . . . 2.0600000000000001 109.97 162.32 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 45.0 m-85 -115.93 139.79 49.89 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 126.31 1.844 . . . . 2.8500000000000001 108.321 -171.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.7 pt -136.28 122.9 31.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 C-N-CA 123.914 0.885 . . . . 3.1499999999999999 110.602 178.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -80.33 132.48 35.81 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 106.677 -1.601 . . . . 3.7599999999999998 106.677 171.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.7 m -107.85 121.1 60.32 Favored 'Isoleucine or valine' 0 C--O 1.232 0.147 0 O-C-N 124.038 0.836 . . . . 2.1099999999999999 109.658 -176.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.3 m -66.17 73.48 0.08 Allowed 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.138 0.975 . . . . 2.46 111.596 177.229 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -173.47 -59.14 0.05 OUTLIER Glycine 0 CA--C 1.522 0.478 0 N-CA-C 106.788 -2.525 . . . . 3.3700000000000001 106.788 172.76 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 25.2 ttm 69.03 -33.21 0.24 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 126.686 1.994 . . . . 4.1699999999999999 114.664 170.56 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.7 t -155.22 52.87 0.62 Allowed 'General case' 0 N--CA 1.446 -0.625 0 C-N-CA 124.668 1.187 . . . . 4.7300000000000004 108.163 177.068 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 12.5 p -58.01 -43.05 86.47 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 108.413 -0.958 . . . . 2.7000000000000002 108.413 164.692 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 156.92 -59.88 0.0 OUTLIER 'General case' 0 CA--C 1.521 -0.16 0 C-N-CA 129.514 3.126 . . . . 3.8900000000000001 107.177 166.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.0 p -99.11 42.63 1.09 Allowed 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.367 1.067 . . . . 3.0699999999999998 110.916 -174.715 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 37.7 m -52.79 -51.73 59.59 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 108.49 -0.93 . . . . 4.7000000000000002 108.49 178.834 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.2 p -63.77 -55.31 23.21 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.67 0 CA-C-O 121.936 0.874 . . . . 3.6200000000000001 111.232 -178.542 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.32 -30.88 67.03 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.513 -1.221 . . . . 1.0800000000000001 112.598 -175.301 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -68.19 -57.22 6.37 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 119.68 1.127 . . . . 3.0600000000000001 108.276 169.401 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.694 HG22 HD11 ' A' ' 34' ' ' ILE 0.255 1.5 mt -62.83 -35.69 72.13 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.894 0 O-C-N 121.868 -0.52 . . . . 1.97 110.362 -166.991 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.525 ' HG2' HD12 ' A' ' 34' ' ' ILE . 16.0 mt-10 -43.59 -56.7 3.54 Favored 'General case' 0 N--CA 1.453 -0.302 0 O-C-N 121.483 -0.761 . . . . 3.3799999999999999 110.385 171.043 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.41 ' H ' ' HD2' ' A' ' 23' ' ' ARG . 0.2 OUTLIER -63.5 -44.57 93.93 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 115.414 -0.812 . . . . 5.96 110.438 175.783 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.649 ' OD1' HD13 ' A' ' 25' ' ' LEU . 0.2 OUTLIER -60.31 -42.46 95.61 Favored 'General case' 0 C--O 1.223 -0.299 0 C-N-CA 122.922 0.489 . . . . 3.9399999999999999 111.717 -168.741 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.649 HD13 ' OD1' ' A' ' 24' ' ' ASN 0.337 5.2 mp -80.33 -43.93 20.37 Favored 'General case' 0 N--CA 1.435 -1.21 0 C-N-CA 126.081 1.752 . . . . 2.7999999999999998 113.101 175.486 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 83.7 mtt180 -66.2 -20.47 66.14 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 119.364 -2.085 . . . . 7.5099999999999998 112.721 -174.503 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 4.8 mmt180 -29.98 -62.86 0.14 Allowed 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 125.717 1.607 . . . . 8.3300000000000001 112.992 162.055 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 150.98 176.92 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.178 0 C-N-CA 128.049 2.54 . . . . 7.5 106.345 -158.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 101.88 32.09 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 129.477 3.111 . . . . 8.5399999999999991 111.379 -167.464 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 55.9 42.88 87.26 Favored Glycine 0 CA--C 1.526 0.736 0 O-C-N 121.752 -0.592 . . . . 1.73 111.682 177.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 1.4 mp -74.04 142.57 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 CA-C-N 117.066 0.433 . . . . 2.2000000000000002 110.102 176.633 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -145.81 41.86 1.22 Allowed 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 122.449 1.118 . . . . 3.6899999999999999 113.657 158.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 58.8 m -167.93 157.8 10.15 Favored 'General case' 0 C--N 1.319 -0.743 1 C-N-CA 132.698 4.399 . . . . 2.2999999999999998 104.12 133.14 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.694 HD11 HG22 ' A' ' 21' ' ' ILE . 0.0 OUTLIER -109.65 144.95 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 N-CA-C 104.712 -2.329 . . . . 2.5600000000000001 104.712 155.636 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.659 ' N ' HD13 ' A' ' 34' ' ' ILE . 0.3 OUTLIER -147.65 148.43 31.05 Favored 'General case' 0 N--CA 1.434 -1.247 0 C-N-CA 125.965 1.706 . . . . 6.5599999999999996 106.504 -167.543 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.498 HG23 HG21 ' A' ' 21' ' ' ILE . 1.3 t -156.7 96.18 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 N-CA-C 105.207 -2.145 . . . . 2.1099999999999999 105.207 174.396 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -77.22 66.35 2.99 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 115.295 -0.866 . . . . 0.69999999999999996 109.419 176.348 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.492 HD23 ' HA ' ' A' ' 38' ' ' LEU . 9.5 mt -53.18 -36.58 61.08 Favored 'General case' 0 C--N 1.342 0.245 0 C-N-CA 123.35 0.66 . . . . 2.6400000000000001 110.832 173.752 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 16.3 tpt -51.42 -39.66 57.77 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.715 0.806 . . . . 5.0899999999999999 111.809 173.658 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -88.68 -23.94 22.88 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.621 0.769 . . . . 1.6100000000000001 111.436 178.594 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 89.09 41.83 5.77 Favored Glycine 0 C--N 1.335 0.488 0 N-CA-C 110.188 -1.165 . . . . 0.88 110.188 179.048 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 58.4 pttt -156.1 158.16 37.25 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 107.879 -1.156 . . . . 3.6699999999999999 107.879 177.541 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.423 ' HA ' ' HA ' ' A' ' 36' ' ' VAL . . . -83.88 163.98 19.73 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 108.798 -0.816 . . . . 1.4199999999999999 108.798 170.422 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.445 ' CB ' ' HB2' ' A' ' 35' ' ' LEU . 55.3 mt-10 -131.2 157.72 42.44 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.214 -0.661 . . . . 2.6600000000000001 109.214 174.751 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.593 HG12 HD21 ' A' ' 25' ' ' LEU . 13.4 m -134.7 142.43 40.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 N-CA-C 109.432 -0.581 . . . . 2.6600000000000001 109.432 173.1 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 49.1 ttt180 -127.02 125.72 41.9 Favored 'General case' 0 CA--C 1.516 -0.353 0 N-CA-C 106.487 -1.671 . . . . 5.5199999999999996 106.487 158.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 22.1 p90 -157.37 171.94 19.49 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 109.187 -0.672 . . . . 2.1200000000000001 109.187 -163.763 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 50.7 t-20 -103.69 93.52 5.22 Favored Pre-proline 0 CA--C 1.534 0.329 0 C-N-CA 123.207 0.603 . . . . 2.6299999999999999 110.544 176.12 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -65.24 80.86 0.21 Allowed 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 123.015 2.477 . . . . 1.6799999999999999 110.26 169.37 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -168.85 -56.61 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 128.916 2.886 . . . . 1.0800000000000001 104.894 172.748 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 68.1 t -57.24 -55.42 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 C-N-CA 124.509 1.124 . . . . 0.94999999999999996 109.689 171.58 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.505 HG23 ' H ' ' A' ' 53' ' ' GLN 0.251 9.7 tp -95.73 -75.82 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.369 0 CA-C-O 118.514 -0.755 . . . . 2.5099999999999998 111.54 -172.079 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.505 ' H ' HG23 ' A' ' 52' ' ' ILE . 0.3 OUTLIER 114.2 137.06 0.0 OUTLIER Pre-proline 0 N--CA 1.47 0.545 0 C-N-CA 130.815 3.646 . . . . 2.4300000000000002 107.012 -173.163 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_exo -50.98 -50.89 12.46 Favored 'Trans proline' 0 CA--C 1.534 0.476 0 C-N-CA 123.432 2.755 . . . . 1.0900000000000001 114.57 176.646 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -52.1 -48.8 19.84 Favored 'Trans proline' 0 N--CA 1.444 -1.406 0 CA-C-N 120.525 1.223 . . . . 1.03 110.383 168.084 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 62.7 mtt -66.14 -35.05 79.45 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 118.447 -1.301 . . . . 2.96 110.879 -171.749 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 4.4 tt -70.13 -44.98 77.64 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 CA-C-N 119.502 1.047 . . . . 2.2599999999999998 109.933 176.274 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -53.67 -41.06 66.47 Favored 'General case' 0 C--N 1.341 0.228 0 N-CA-C 112.266 0.469 . . . . 1.1000000000000001 112.266 175.642 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 30.8 mm-40 -66.66 -59.94 3.15 Favored 'General case' 0 N--CA 1.437 -1.093 0 C-N-CA 124.94 1.296 . . . . 2.6200000000000001 110.564 174.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -54.41 -42.75 70.84 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 117.897 0.317 . . . . 4.4800000000000004 110.231 -170.846 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.8 mt -56.26 -37.15 48.85 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 O-C-N 121.487 -0.758 . . . . 1.6699999999999999 111.637 176.517 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 42.6 mtm105 -70.18 -44.33 68.94 Favored 'General case' 0 N--CA 1.456 -0.142 0 O-C-N 121.605 -0.684 . . . . 3.8799999999999999 111.22 173.27 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -56.55 -33.89 66.55 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 119.189 0.904 . . . . 3.2400000000000002 111.604 175.266 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 83.6 mt -78.74 -16.58 57.04 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.845 0.858 . . . . 3.0800000000000001 111.362 175.253 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 136.65 -12.49 3.98 Favored Glycine 0 CA--C 1.528 0.852 0 CA-C-O 119.335 -0.703 . . . . 2.0299999999999998 113.988 164.76 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -107.94 119.43 39.44 Favored 'General case' 0 CA--C 1.522 -0.125 0 CA-C-N 118.738 1.269 . . . . 4.0300000000000002 110.523 -159.885 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -68.44 69.4 0.37 Allowed Glycine 0 C--N 1.336 0.574 0 C-N-CA 125.917 1.722 . . . . 1.6399999999999999 113.969 -172.222 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -83.6 121.13 26.83 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 126.482 1.913 . . . . 1.4199999999999999 110.738 -173.329 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 25.7 p -124.04 119.39 29.37 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 125.486 1.514 . . . . 2.7200000000000002 108.504 -179.29 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 74.9 t -81.03 128.46 38.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 C-N-CA 124.917 1.287 . . . . 1.74 109.54 -165.486 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 5.0 pt -139.13 59.49 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-O 122.197 0.999 . . . . 2.9199999999999999 112.174 -173.335 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -83.15 69.33 9.87 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 108.596 -0.89 . . . . 5.0800000000000001 108.596 171.092 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -161.21 150.05 16.24 Favored 'General case' 0 CA--C 1.528 0.104 0 N-CA-C 109.224 -0.658 . . . . 5.9100000000000001 109.224 179.392 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 44.6 pt -141.63 22.98 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 C-N-CA 124.136 0.974 . . . . 7.3099999999999996 111.399 179.868 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -81.03 161.56 24.17 Favored 'General case' 0 CA--C 1.531 0.237 0 O-C-N 121.836 -0.54 . . . . 9.6400000000000006 110.256 -178.63 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 164.76 79.0 0.04 OUTLIER Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.383 -1.087 . . . . 11.720000000000001 110.383 -178.387 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.136 0 N-CA-C 105.031 -2.211 . . . . 17.52 105.031 173.303 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 . . . . . 0 N--CA 1.478 0.955 0 N-CA-C 107.622 -1.251 . . . . 5.0999999999999996 107.622 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 27.9 t -162.12 138.05 7.61 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 119.224 0.92 . . . . 3.5499999999999998 110.094 176.588 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 10.6 p -85.8 141.31 29.75 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 126.245 1.818 . . . . 3.2999999999999998 108.259 164.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.35 147.87 28.71 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 105.384 -2.08 . . . . 7.3799999999999999 105.384 169.644 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 32.6 t -150.74 159.74 44.32 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 106.497 -1.668 . . . . 1.8999999999999999 106.497 176.167 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -135.3 148.39 49.49 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 106.143 -1.799 . . . . 3.1400000000000001 106.143 -178.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.1 pt -141.3 121.61 12.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 108.178 -1.045 . . . . 3.0800000000000001 108.178 -168.28 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 -80.81 125.2 29.79 Favored 'General case' 0 N--CA 1.438 -1.033 0 N-CA-C 103.685 -2.709 . . . . 3.0800000000000001 103.685 174.219 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.1 p -136.15 136.98 49.02 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.175 0 C-N-CA 123.803 0.841 . . . . 2.5600000000000001 110.169 -168.893 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.7 m -83.3 67.54 9.3 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 115.86 -0.609 . . . . 2.2400000000000002 111.843 -164.375 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 143.78 90.64 0.12 Allowed Glycine 0 CA--C 1.505 -0.548 0 N-CA-C 108.394 -1.882 . . . . 2.79 108.394 164.137 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 6.0 mmt -102.14 -56.16 2.33 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 110.704 -2.748 . . . . 6.96 109.713 171.877 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.8 m -72.35 57.06 0.37 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.594 1.158 . . . . 5.4100000000000001 109.056 172.604 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 4.3 t -112.13 173.55 6.31 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 126.946 2.099 . . . . 3.6000000000000001 105.954 179.041 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -81.68 123.09 28.42 Favored 'General case' 0 CA--C 1.52 -0.208 0 N-CA-C 107.204 -1.406 . . . . 2.4700000000000002 107.204 166.783 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 27.5 t 57.33 -84.65 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 118.607 -0.711 . . . . 3.7999999999999998 109.227 -152.651 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 5.3 m -19.36 -21.35 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 118.142 2.645 . . . . 3.0499999999999998 118.142 -99.731 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.823 ' CG2' HG11 ' A' ' 36' ' ' VAL . 0.3 OUTLIER -41.18 -38.08 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 N-CA-C 115.502 1.667 . . . . 2.77 115.502 172.326 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.26 -44.39 83.88 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.137 0.494 . . . . 1.1699999999999999 110.83 177.182 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -61.47 -51.04 70.31 Favored 'General case' 0 C--O 1.222 -0.365 0 N-CA-C 108.408 -0.96 . . . . 1.8400000000000001 108.408 174.047 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.565 HG21 HG21 ' A' ' 36' ' ' VAL 0.251 11.1 mm -47.78 -60.84 0.56 Allowed 'Isoleucine or valine' 0 C--O 1.209 -1.052 0 C-N-CA 124.59 1.156 . . . . 2.25 109.479 175.0 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.406 ' HA ' HD12 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -43.44 -45.77 6.45 Favored 'General case' 0 C--N 1.318 -0.771 0 O-C-N 116.911 -3.618 . . . . 4.9100000000000001 114.274 172.355 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 27.1 mmt85 -64.07 -31.56 72.79 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 120.857 -1.152 . . . . 4.7400000000000002 113.568 168.873 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.656 ' CG ' HD13 ' A' ' 25' ' ' LEU . 1.2 p-10 -60.6 -67.27 0.41 Allowed 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 127.423 2.289 . . . . 5.1500000000000004 111.666 -171.522 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.656 HD13 ' CG ' ' A' ' 24' ' ' ASN 0.354 5.2 mp -75.05 -26.98 59.81 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 119.508 -0.877 . . . . 3.3799999999999999 111.086 -163.163 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 92.8 mtt180 -61.74 -17.59 56.46 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 113.8 1.037 . . . . 6.71 113.8 168.854 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 23.6 mmt180 -57.11 -40.06 76.32 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 120.205 1.366 . . . . 8.5199999999999996 111.254 166.253 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -100.48 79.71 2.14 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-O 121.662 0.744 . . . . 9.2200000000000006 109.523 -146.6 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -37.02 114.91 0.35 Allowed 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 125.412 1.485 . . . . 5.6299999999999999 111.229 176.235 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 122.71 -21.73 7.47 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 111.048 -0.821 . . . . 1.1200000000000001 111.048 -167.23 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.554 HG23 ' H ' ' A' ' 33' ' ' SER . 1.2 mm -78.17 146.3 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 C-N-CA 125.079 1.352 . . . . 3.0499999999999998 108.282 164.845 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -137.96 37.37 2.37 Favored 'General case' 0 C--N 1.342 0.261 0 CA-C-O 123.065 1.412 . . . . 3.3599999999999999 113.002 153.496 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.554 ' H ' HG23 ' A' ' 31' ' ' ILE . 0.5 OUTLIER -167.88 124.65 1.11 Allowed 'General case' 0 C--N 1.318 -0.8 0 C-N-CA 125.19 1.396 . . . . 2.4500000000000002 109.026 172.134 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.732 ' C ' HD12 ' A' ' 35' ' ' LEU . 0.0 OUTLIER -106.83 105.5 18.88 Favored 'Isoleucine or valine' 0 C--N 1.346 0.418 0 CA-C-N 119.872 1.214 . . . . 2.6200000000000001 108.929 168.237 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.732 HD12 ' C ' ' A' ' 34' ' ' ILE . 6.7 mp -118.22 151.77 36.99 Favored 'General case' 0 CA--C 1.502 -0.878 0 N-CA-C 106.612 -1.625 . . . . 7.7400000000000002 106.612 -168.639 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.823 HG11 ' CG2' ' A' ' 18' ' ' VAL 0.286 1.0 OUTLIER -159.68 95.2 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.427 -1.624 0 CA-C-O 122.647 1.213 . . . . 2.2200000000000002 111.12 -172.842 . . . . . . . . 4 4 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -80.11 73.37 6.94 Favored 'General case' 0 CA--C 1.532 0.277 0 O-C-N 119.966 -1.709 . . . . 1.02 109.109 178.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.568 HD21 HG23 ' A' ' 18' ' ' VAL . 80.6 mt -44.22 -52.35 7.5 Favored 'General case' 0 C--N 1.342 0.243 0 C-N-CA 124.414 1.086 . . . . 2.7799999999999998 111.227 -176.786 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 75.1 mtm -56.11 -32.62 64.35 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.912 1.285 . . . . 3.2400000000000002 112.272 -178.016 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -84.05 -2.11 56.09 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 122.932 0.493 . . . . 2.3300000000000001 111.77 179.235 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 82.36 18.86 65.64 Favored Glycine 0 C--N 1.337 0.623 0 N-CA-C 111.12 -0.792 . . . . 1.3999999999999999 111.12 175.112 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 26.7 pttt -146.78 146.85 30.41 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 118.223 1.011 . . . . 4.4500000000000002 111.741 -170.698 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.426 ' HA ' ' HA ' ' A' ' 36' ' ' VAL . . . -83.99 162.92 20.25 Favored 'General case' 0 N--CA 1.442 -0.835 0 C-N-CA 124.904 1.282 . . . . 1.3999999999999999 109.618 165.613 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -135.32 135.84 41.09 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 126.217 1.807 . . . . 2.79 112.808 -170.055 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.0 t -131.47 138.07 53.91 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 O-C-N 120.832 -1.168 . . . . 2.96 109.457 -162.29 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.512 ' HB3' ' HB2' ' A' ' 33' ' ' SER . 47.8 ttp180 -150.18 107.59 3.63 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.92 0.888 . . . . 5.5800000000000001 109.512 179.538 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 11.5 p90 -155.58 179.21 9.4 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 124.608 1.163 . . . . 2.2200000000000002 110.168 -155.22 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -118.62 123.01 29.47 Favored Pre-proline 0 CA--C 1.535 0.395 0 C-N-CA 124.167 0.987 . . . . 3.0899999999999999 111.219 176.896 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -84.44 62.42 6.54 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 121.566 1.511 . . . . 1.5800000000000001 110.236 -173.565 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -131.33 -70.66 0.58 Allowed 'General case' 0 CA--C 1.519 -0.237 0 N-CA-C 107.0 -1.481 . . . . 1.1699999999999999 107.0 177.813 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 89.6 t -56.55 -44.31 80.43 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.779 0 C-N-CA 124.517 1.127 . . . . 1.23 111.035 177.358 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.3 tt -113.16 -24.01 4.07 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.415 0 N-CA-C 114.053 1.131 . . . . 2.3500000000000001 114.053 -149.814 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 70.92 120.47 0.03 OUTLIER Pre-proline 0 N--CA 1.471 0.602 0 C-N-CA 125.724 1.609 . . . . 2.9300000000000002 113.228 175.073 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -46.87 -43.51 23.91 Favored 'Trans proline' 0 CA--C 1.532 0.42 0 C-N-CA 124.228 3.286 . . . . 1.4299999999999999 115.77 169.014 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -58.92 -54.35 2.86 Favored 'Trans proline' 0 N--CA 1.442 -1.537 0 CA-C-N 120.835 1.334 . . . . 1.24 109.762 167.525 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 52.0 mtp -69.02 -28.58 66.7 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 118.396 -1.322 . . . . 2.0499999999999998 111.622 -166.0 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 12.4 tt -64.43 -37.04 78.98 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 CA-C-N 119.713 1.142 . . . . 2.1499999999999999 110.844 174.63 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.8 -47.64 84.89 Favored 'General case' 0 N--CA 1.455 -0.176 0 O-C-N 121.416 -0.803 . . . . 1.04 111.159 171.155 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -60.84 -57.47 12.54 Favored 'General case' 0 N--CA 1.432 -1.367 0 C-N-CA 123.718 0.807 . . . . 2.9399999999999999 112.355 -178.237 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -49.4 -38.51 29.16 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 123.488 0.715 . . . . 3.9199999999999999 111.386 -173.512 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.4 HD11 HD11 ' A' ' 25' ' ' LEU . 90.2 mt -60.99 -47.36 93.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 O-C-N 121.644 -0.66 . . . . 1.25 110.894 175.899 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 22.2 mtm105 -66.28 -32.1 73.3 Favored 'General case' 0 CA--C 1.522 -0.113 0 O-C-N 121.588 -0.695 . . . . 3.9199999999999999 112.113 177.76 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 78.3 mt-10 -58.44 -23.55 57.78 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 118.699 0.681 . . . . 3.27 112.264 172.782 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 66.0 mt -80.81 -15.98 54.95 Favored 'General case' 0 CA--C 1.535 0.37 0 O-C-N 121.515 -0.741 . . . . 1.74 111.568 173.518 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 112.08 -11.39 26.88 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 125.265 1.412 . . . . 2.1400000000000001 111.717 -177.129 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -79.8 101.63 8.6 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 117.812 0.806 . . . . 3.21 110.167 -173.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -63.94 86.45 0.06 OUTLIER Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 125.26 1.41 . . . . 1.3300000000000001 110.89 -179.26 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -111.51 130.11 55.83 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 128.211 2.604 . . . . 1.0700000000000001 111.526 -173.849 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 5.3 t -121.65 138.42 54.34 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 125.309 1.444 . . . . 2.1899999999999999 107.301 175.194 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.7 t -83.54 136.36 22.97 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 C-N-CA 125.869 1.667 . . . . 1.8400000000000001 110.173 -171.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 36.5 mt -145.87 83.94 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 125.301 1.44 . . . . 1.8899999999999999 109.258 -176.803 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 31.8 mp0 -57.6 165.11 1.72 Allowed 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 123.932 0.893 . . . . 4.7199999999999998 110.471 160.845 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 35.2 p30 -119.5 169.47 10.01 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 125.442 1.497 . . . . 6.8099999999999996 108.542 170.454 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 46.6 pt -143.69 165.0 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.116 0 C-N-CA 125.051 1.34 . . . . 7.6699999999999999 107.537 178.683 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -70.29 -55.35 9.43 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 109.049 -0.723 . . . . 12.390000000000001 109.049 172.482 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 140.75 -134.71 6.56 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 106.748 -2.541 . . . . 10.26 106.748 -170.273 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 78.5 mtt180 . . . . . 0 C--O 1.251 1.148 0 C-N-CA 125.77 1.628 . . . . 17.91 109.968 -173.324 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 . . . . . 0 N--CA 1.479 0.977 0 N-CA-C 110.244 -0.28 . . . . 5.5 110.244 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 12.9 m 66.37 154.67 0.09 Allowed 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.182 1.393 . . . . 2.9300000000000002 112.969 -174.78 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.2 m -157.35 170.48 22.37 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 128.13 2.572 . . . . 2.1400000000000001 105.873 172.788 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 75.8 tttt -130.51 152.76 49.54 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 108.548 -0.908 . . . . 3.46 108.548 177.052 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 47.1 t -148.56 156.3 42.26 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 107.505 -1.294 . . . . 1.46 107.505 170.257 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 -106.15 138.05 43.0 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 107.123 -1.436 . . . . 2.3199999999999998 107.123 169.821 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 15.9 mt -138.09 139.53 42.07 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 N-CA-C 104.357 -2.46 . . . . 1.76 104.357 -172.693 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 11.5 mt-30 -122.6 119.34 30.51 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 120.127 1.33 . . . . 4.3899999999999997 108.327 -177.201 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 99.1 t -112.32 138.83 39.85 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 O-C-N 124.184 0.928 . . . . 2.8999999999999999 110.766 -158.649 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.4 m -66.86 -42.88 84.92 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 113.492 0.923 . . . . 2.6000000000000001 113.492 -168.063 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -138.77 48.59 0.86 Allowed Glycine 0 C--N 1.341 0.831 0 CA-C-O 124.252 2.029 . . . . 3.7000000000000002 111.226 172.19 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . 0.257 42.7 ttp -14.31 -52.2 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 109.408 -3.396 . . . . 3.5800000000000001 111.206 136.903 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 12.8 t -122.07 126.38 48.3 Favored 'General case' 0 N--CA 1.44 -0.963 0 C-N-CA 126.531 1.933 . . . . 4.3099999999999996 106.591 168.126 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.3 p -110.92 64.98 0.61 Allowed 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 107.134 -1.432 . . . . 2.98 107.134 119.705 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 64.87 -64.57 0.16 Allowed 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 128.507 2.723 . . . . 3.2999999999999998 111.737 -172.199 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.1 m -47.24 -49.25 23.69 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 127.001 2.12 . . . . 3.7200000000000002 112.133 -179.481 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 74.8 m -69.04 -20.16 64.11 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 114.59 1.329 . . . . 3.1299999999999999 114.59 -142.089 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 1.2 t -52.89 -37.96 27.25 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.281 0 CA-C-N 119.09 0.859 . . . . 2.4500000000000002 110.398 169.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.3 -52.22 65.33 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 123.139 0.576 . . . . 1.24 110.515 171.621 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -58.66 -53.75 54.87 Favored 'General case' 0 C--O 1.227 -0.102 0 C-N-CA 124.189 0.996 . . . . 1.8999999999999999 109.157 -176.329 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.532 ' O ' HD22 ' A' ' 25' ' ' LEU . 2.4 mt -49.04 -60.87 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.997 0 C-N-CA 125.557 1.543 . . . . 1.78 109.789 174.737 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -48.09 -59.74 3.16 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 119.916 1.235 . . . . 4.0099999999999998 113.049 176.018 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.49 -39.12 67.23 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.161 0.584 . . . . 6.5300000000000002 110.764 -177.06 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 -64.88 -60.87 2.58 Favored 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 108.417 -0.957 . . . . 3.1299999999999999 108.417 178.525 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.653 HD23 HD21 ' A' ' 35' ' ' LEU . 0.3 OUTLIER -74.13 -42.61 59.73 Favored 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 111.911 0.337 . . . . 2.4300000000000002 111.911 -161.075 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 4.5 ttm180 -67.4 -19.17 65.36 Favored 'General case' 0 N--CA 1.433 -1.285 0 CA-C-N 119.022 0.828 . . . . 7.4199999999999999 112.526 -160.242 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 31.3 mtm105 -45.82 -61.56 1.67 Allowed 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.039 0.936 . . . . 6.9400000000000004 111.941 -177.808 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -175.32 12.78 0.01 OUTLIER 'General case' 0 N--CA 1.461 0.119 0 N-CA-C 114.311 1.226 . . . . 7.0999999999999996 114.311 -158.867 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -101.24 53.49 0.83 Allowed 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 122.587 1.184 . . . . 5.6900000000000004 108.877 -144.135 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 57.56 12.29 9.14 Favored Glycine 0 CA--C 1.531 1.091 0 CA-C-N 114.053 -1.431 . . . . 1.6899999999999999 113.377 -172.151 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 1.1 pp -84.83 161.89 3.05 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 CA-C-N 119.238 1.519 . . . . 4.5700000000000003 110.645 -177.828 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -146.61 46.0 1.2 Allowed 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 122.596 1.189 . . . . 3.0 111.666 146.101 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 70.0 m -164.16 175.91 9.74 Favored 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 131.094 3.757 . . . . 2.04 105.22 154.567 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.2 pp -105.06 138.48 29.75 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.133 0 CA-C-O 122.421 1.105 . . . . 2.1000000000000001 109.859 160.547 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.653 HD21 HD23 ' A' ' 25' ' ' LEU . 0.1 OUTLIER -77.4 66.47 3.16 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 129.684 3.194 . . . . 4.5 111.021 -178.157 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 19.2 t -134.51 140.53 45.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 O-C-N 121.139 -0.976 . . . . 1.4099999999999999 110.078 169.284 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -150.18 64.47 0.96 Allowed 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 103.31 -2.848 . . . . 0.76000000000000001 103.31 162.679 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -59.04 -43.26 91.64 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 108.517 -0.92 . . . . 3.1699999999999999 108.517 -173.643 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 66.9 mtt -44.25 -37.48 3.26 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.556 0.742 . . . . 4.54 112.795 169.209 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -97.52 -10.25 25.61 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.564 1.146 . . . . 1.9199999999999999 112.923 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 87.44 36.87 8.45 Favored Glycine 0 C--N 1.341 0.825 0 CA-C-N 120.114 1.325 . . . . 1.03 110.956 173.138 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 2.3 ptmt -162.47 178.52 8.54 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 119.03 1.415 . . . . 3.4100000000000001 110.25 -174.278 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.413 ' HB1' ' HG ' ' A' ' 35' ' ' LEU . . . -118.56 133.02 56.18 Favored 'General case' 0 N--CA 1.441 -0.907 0 C-N-CA 128.051 2.54 . . . . 1.0 108.899 175.066 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -126.06 82.58 2.08 Favored 'General case' 0 C--N 1.339 0.127 0 C-N-CA 123.995 0.918 . . . . 2.8599999999999999 112.012 -172.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 9.9 p -83.19 134.53 26.72 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 C-N-CA 123.237 0.615 . . . . 1.5700000000000001 110.39 -169.561 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 35.6 ttm105 -113.14 127.64 56.25 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 103.955 -2.609 . . . . 4.2599999999999998 103.955 158.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 4.2 p90 -157.73 175.36 14.0 Favored 'General case' 0 CA--C 1.515 -0.373 0 C-N-CA 123.407 0.683 . . . . 2.0299999999999998 109.279 -170.172 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -122.68 94.63 47.39 Favored Pre-proline 0 CA--C 1.533 0.325 0 CA-C-O 119.021 -0.514 . . . . 2.7599999999999998 110.245 178.663 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -71.36 73.73 2.12 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 123.78 2.987 . . . . 1.46 112.234 -176.105 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -146.93 -51.61 0.21 Allowed 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 125.883 1.673 . . . . 1.29 106.533 165.431 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 95.9 t -53.95 -57.61 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.768 0 C-N-CA 124.517 1.127 . . . . 1.1200000000000001 109.535 170.708 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.403 ' O ' ' HB2' ' A' ' 53' ' ' GLN 0.252 11.5 tt -94.81 -71.08 0.58 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.371 0 CA-C-O 118.341 -0.838 . . . . 1.8799999999999999 113.169 -169.454 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.403 ' HB2' ' O ' ' A' ' 52' ' ' ILE . 0.0 OUTLIER 109.54 139.45 0.0 OUTLIER Pre-proline 0 N--CA 1.469 0.523 0 C-N-CA 129.993 3.317 . . . . 2.96 108.498 -173.54 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_exo -51.27 -50.86 12.58 Favored 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 124.215 3.277 . . . . 1.0800000000000001 114.595 172.612 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -47.03 -55.55 3.79 Favored 'Trans proline' 0 N--CA 1.446 -1.308 0 C-N-CA 121.533 1.489 . . . . 1.0 110.308 166.147 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 25.1 mtm -62.66 -35.87 81.04 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 118.067 -1.453 . . . . 1.8500000000000001 112.242 -172.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . 0.261 2.7 tt -68.35 -39.56 81.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-N 119.023 0.829 . . . . 2.1099999999999999 111.035 179.391 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.22 -55.6 32.87 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 118.933 0.788 . . . . 0.94999999999999996 112.162 169.763 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -50.25 -47.04 55.33 Favored 'General case' 0 N--CA 1.442 -0.864 0 C-N-CA 126.169 1.788 . . . . 4.0499999999999998 110.835 -178.538 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -46.1 -42.76 14.08 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.246 0.618 . . . . 4.5199999999999996 112.325 174.433 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 40.7 mt -74.63 -44.6 46.61 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 N-CA-C 108.405 -0.961 . . . . 1.53 108.405 -177.718 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.1 -62.13 1.97 Allowed 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 124.969 1.308 . . . . 7.8399999999999999 112.894 -178.409 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -57.64 -58.71 7.12 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 124.117 0.967 . . . . 3.1299999999999999 111.447 -163.042 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.33 -34.39 23.69 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 122.766 0.427 . . . . 2.1099999999999999 111.649 -179.033 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -93.66 -91.69 1.58 Allowed Glycine 0 CA--C 1.525 0.709 0 N-CA-C 111.089 -0.805 . . . . 1.8700000000000001 111.089 -174.809 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -138.1 -79.17 0.36 Allowed 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 122.422 1.106 . . . . 3.0099999999999998 112.837 -157.474 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 156.19 122.38 0.75 Allowed Glycine 0 N--CA 1.445 -0.707 0 N-CA-C 105.406 -3.078 . . . . 1.3899999999999999 105.406 -143.503 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -145.86 116.67 7.71 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 107.929 -1.137 . . . . 1.22 107.929 -167.318 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 41.1 p -93.7 118.52 31.5 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 107.093 -1.447 . . . . 2.96 107.093 176.318 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.2 t -83.56 121.29 36.08 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 N-CA-C 107.176 -1.416 . . . . 1.6499999999999999 107.176 177.78 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 47.0 mt -145.24 77.12 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.307 0 N-CA-C 108.213 -1.032 . . . . 1.9299999999999999 108.213 -169.882 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.468 ' H ' ' CD ' ' A' ' 72' ' ' GLU . 2.3 pm0 -67.27 69.6 0.09 Allowed 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.893 0.877 . . . . 5.1299999999999999 111.011 166.803 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 38.27 75.84 0.07 Allowed 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 128.492 2.717 . . . . 5.6399999999999997 114.631 171.277 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 42.4 mm -59.32 -41.32 83.82 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 C-N-CA 124.023 0.929 . . . . 9.1300000000000008 112.73 -177.735 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -143.26 157.52 44.42 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 107.154 -1.425 . . . . 9.9900000000000002 107.154 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -168.28 68.68 0.17 Allowed Glycine 0 CA--C 1.523 0.59 0 N-CA-C 108.933 -1.667 . . . . 9.8699999999999992 108.933 -177.063 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.255 1.346 0 C-N-CA 126.974 2.11 . . . . 14.279999999999999 105.658 -175.405 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 1.3 t30 . . . . . 0 N--CA 1.476 0.858 0 N-CA-C 108.626 -0.879 . . . . 5.0599999999999996 108.626 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.7 p 42.76 59.46 2.8 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 122.779 1.276 . . . . 2.9700000000000002 110.181 -166.59 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.8 m -106.73 142.37 36.47 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 125.929 1.692 . . . . 2.3100000000000001 108.471 -165.63 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 18.7 ttpt -93.58 154.05 18.07 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 118.96 -0.543 . . . . 3.6899999999999999 110.219 177.381 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 9.3 t -153.59 160.63 42.5 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 108.377 -0.972 . . . . 1.72 108.377 167.234 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -105.41 157.62 17.22 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.376 1.071 . . . . 2.3799999999999999 109.249 -173.679 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.467 ' HB ' ' HB3' ' A' ' 43' ' ' ALA . 3.3 mt -145.22 147.05 19.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 N-CA-C 107.315 -1.365 . . . . 1.77 107.315 179.504 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 -108.59 141.26 40.78 Favored 'General case' 0 C--O 1.232 0.16 0 N-CA-C 107.88 -1.156 . . . . 4.1600000000000001 107.88 170.552 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 57.0 t -108.08 126.27 64.67 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 O-C-N 124.086 0.866 . . . . 2.77 109.807 179.163 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 11.1 m -75.33 75.3 2.43 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.61 0.764 . . . . 2.8500000000000001 110.968 -179.42 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 164.05 -62.47 0.25 Allowed Glycine 0 C--O 1.227 -0.323 0 N-CA-C 105.544 -3.022 . . . . 4.0300000000000002 105.544 173.382 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . 0.333 0.0 OUTLIER 59.28 138.38 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 129.347 3.059 . . . . 3.8900000000000001 114.512 178.352 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.609 ' H ' HD12 ' A' ' 38' ' ' LEU . 7.0 m 73.31 -59.11 0.58 Allowed 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 126.161 1.784 . . . . 5.2000000000000002 109.767 -177.395 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 38.5 m 51.38 -124.27 2.22 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.893 1.277 . . . . 3.1299999999999999 108.729 170.436 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -155.86 142.95 19.11 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 106.099 -1.815 . . . . 2.6899999999999999 106.099 152.397 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 56.9 p 64.54 -25.1 0.08 Allowed 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 116.536 2.05 . . . . 3.7400000000000002 116.536 -179.266 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 99.2 m -38.57 -38.69 0.41 Allowed 'General case' 0 C--O 1.225 -0.236 0 C-N-CA 125.141 1.376 . . . . 2.8500000000000001 112.186 171.687 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.6 t -65.38 -45.97 91.64 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.359 0 C-N-CA 124.544 1.137 . . . . 2.4900000000000002 109.796 -178.798 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.97 -47.01 78.43 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 123.603 0.761 . . . . 1.3 109.292 173.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -58.18 -58.52 8.12 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 109.005 -0.739 . . . . 1.96 109.005 179.81 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.519 HG23 HD21 ' A' ' 35' ' ' LEU . 40.5 mt -46.62 -60.05 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 C-N-CA 126.308 1.843 . . . . 1.8799999999999999 110.343 179.815 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 73.1 mt-10 -47.38 -61.77 1.75 Allowed 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.494 0.718 . . . . 3.0499999999999998 111.783 174.174 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 7.1 mpt_? -62.06 -32.59 73.13 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.978 -0.555 . . . . 6.4000000000000004 111.308 -168.796 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 18.9 m-20 -71.85 -64.58 0.9 Allowed 'General case' 0 CA--C 1.528 0.134 0 CA-C-O 121.515 0.674 . . . . 3.5800000000000001 110.67 175.381 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.485 HD12 ' CD1' ' A' ' 35' ' ' LEU . 4.3 mt -78.73 -9.87 59.57 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 125.556 1.542 . . . . 3.71 111.545 -162.652 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -21.36 -77.34 0.01 OUTLIER 'General case' 0 N--CA 1.444 -0.76 0 C-N-CA 130.223 3.409 . . . . 8.6999999999999993 112.917 -166.411 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 11.1 ptp180 -92.76 -37.93 12.07 Favored 'General case' 0 N--CA 1.435 -1.185 0 C-N-CA 129.284 3.034 . . . . 12.470000000000001 116.501 154.552 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 11.22 56.15 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.289 1.436 . . . . 8.0199999999999996 113.455 -144.784 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 14.3 mp0 32.07 54.53 0.31 Allowed 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 128.125 2.57 . . . . 7.6299999999999999 112.711 -174.899 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 179.3 -37.49 0.07 OUTLIER Glycine 0 CA--C 1.54 1.612 0 C-N-CA 123.979 0.8 . . . . 1.55 113.978 -172.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.415 HD12 ' HB3' ' A' ' 25' ' ' LEU . 6.0 mt -81.98 145.85 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 C-N-CA 127.705 2.402 . . . . 2.0499999999999998 107.199 167.876 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 79.7 m-85 -147.45 47.8 1.12 Allowed 'General case' 0 N--CA 1.456 -0.15 0 CA-C-O 122.315 1.055 . . . . 4.1500000000000004 111.119 157.824 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.8 t -168.15 135.64 2.17 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 126.15 1.78 . . . . 1.6599999999999999 106.972 145.794 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.7 pp -82.98 152.06 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 CA-C-O 123.582 1.658 . . . . 1.9399999999999999 112.223 -171.197 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.873 ' H ' HD23 ' A' ' 35' ' ' LEU . 1.9 pt? -76.48 58.48 1.34 Allowed 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 131.517 3.927 . . . . 4.7300000000000004 111.541 -167.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.452 HG22 HD23 ' A' ' 38' ' ' LEU . 76.8 t -135.46 122.99 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 O-C-N 121.129 -0.982 . . . . 1.46 113.556 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -133.56 57.23 1.81 Allowed 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 106.43 -1.692 . . . . 0.69999999999999996 106.43 150.351 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.609 HD12 ' H ' ' A' ' 13' ' ' THR . 0.5 OUTLIER -75.45 -6.39 49.87 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 123.615 0.766 . . . . 5.3200000000000003 111.838 -175.122 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 66.8 mtt -59.49 -41.02 88.87 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 109.791 -0.448 . . . . 4.8200000000000003 109.791 161.746 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -86.99 -41.25 14.04 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.133 0.573 . . . . 1.73 110.072 177.305 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 117.95 48.0 0.42 Allowed Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.094 -1.202 . . . . 0.89000000000000001 110.094 176.691 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -162.48 177.53 9.41 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 106.561 -1.644 . . . . 4.0499999999999998 106.561 -170.166 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.467 ' HB3' ' HB ' ' A' ' 7' ' ' ILE . . . -140.89 140.59 34.56 Favored 'General case' 0 N--CA 1.441 -0.906 0 C-N-CA 125.132 1.373 . . . . 1.02 108.887 -167.509 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -141.86 104.72 4.56 Favored 'General case' 0 C--N 1.344 0.363 0 CA-C-N 118.968 0.804 . . . . 3.2599999999999998 110.538 179.421 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.7 p -90.99 142.09 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.101 0 C-N-CA 124.33 1.052 . . . . 1.74 108.474 -172.358 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 16.6 tpp180 -107.43 122.63 47.0 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 106.07 -1.826 . . . . 4.8499999999999996 106.07 163.84 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -160.45 179.13 8.88 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 118.832 0.742 . . . . 2.23 112.19 -168.725 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 35.7 m-20 -109.24 109.82 60.46 Favored Pre-proline 0 CA--C 1.53 0.198 0 N-CA-C 108.123 -1.066 . . . . 3.1200000000000001 108.123 163.206 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -76.4 58.77 5.88 Favored 'Trans proline' 0 CA--C 1.536 0.603 0 C-N-CA 123.508 2.805 . . . . 2.3199999999999998 110.598 -178.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -157.44 -51.08 0.07 Allowed 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 125.873 1.669 . . . . 1.9299999999999999 107.224 -172.217 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 74.1 t -61.24 -43.56 96.71 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.866 0 C-N-CA 124.34 1.056 . . . . 1.46 109.867 173.719 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.54 HG12 HG22 ' A' ' 57' ' ' ILE . 2.2 tp -109.52 -54.62 5.42 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.255 0 C-N-CA 122.891 0.476 . . . . 1.9399999999999999 110.743 -175.06 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.412 ' HA ' ' HD3' ' A' ' 54' ' ' PRO . 2.2 mm-40 95.5 128.35 0.02 OUTLIER Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 129.21 3.004 . . . . 3.7799999999999998 110.813 171.547 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 53' ' ' GLN . 71.2 Cg_exo -55.88 -43.26 58.79 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 123.506 2.804 . . . . 1.1499999999999999 116.521 -172.444 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -58.35 -43.1 49.32 Favored 'Trans proline' 0 N--CA 1.445 -1.347 0 CA-C-N 121.533 1.583 . . . . 1.1299999999999999 109.079 175.377 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 63.5 mtt -61.77 -44.51 96.75 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 118.403 -0.808 . . . . 1.8899999999999999 109.928 179.233 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.54 HG22 HG12 ' A' ' 52' ' ' ILE . 0.6 OUTLIER -62.27 -48.54 87.89 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 CA-C-N 120.084 1.311 . . . . 2.4900000000000002 110.903 177.359 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -54.23 -38.45 65.75 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 124.332 1.053 . . . . 1.52 112.165 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -70.01 -60.7 2.14 Favored 'General case' 0 N--CA 1.442 -0.828 0 C-N-CA 125.405 1.482 . . . . 3.3100000000000001 110.644 172.185 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -44.91 -43.78 9.18 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 124.191 0.996 . . . . 3.77 112.464 -177.797 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 67.8 mt -63.23 -43.54 98.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 O-C-N 121.912 -0.493 . . . . 1.1100000000000001 110.017 -178.655 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . 0.301 7.6 ptp180 -70.83 -42.16 70.56 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-O 119.359 -0.353 . . . . 3.8500000000000001 111.604 179.152 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -55.39 -45.05 76.65 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.154 0.981 . . . . 3.0499999999999998 110.836 174.479 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 63.7 mt -81.2 -38.72 26.56 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-O 119.507 -0.283 . . . . 2.0800000000000001 110.628 -174.152 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -104.93 -90.77 2.19 Favored Glycine 0 CA--C 1.527 0.808 0 N-CA-C 111.33 -0.708 . . . . 2.0099999999999998 111.33 179.172 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 18.1 m-85 -142.29 -56.97 0.45 Allowed 'General case' 0 CA--C 1.509 -0.615 0 CA-C-O 122.464 1.126 . . . . 3.9700000000000002 111.699 -157.013 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 162.27 126.3 0.81 Allowed Glycine 0 N--CA 1.432 -1.599 0 N-CA-C 105.784 -2.927 . . . . 1.5700000000000001 105.784 -149.907 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -157.05 153.77 28.45 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 117.234 0.517 . . . . 1.04 110.102 177.713 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 2.4 t -128.16 144.69 51.13 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 106.747 -1.575 . . . . 2.7599999999999998 106.747 174.434 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 12.6 p -81.23 150.74 4.52 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 N-CA-C 107.173 -1.418 . . . . 2.2999999999999998 107.173 170.178 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 4.8 pt -154.95 175.91 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 C-N-CA 126.368 1.867 . . . . 3.0 106.833 177.869 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -145.0 157.79 44.02 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 108.286 -1.005 . . . . 4.8899999999999997 108.286 167.316 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -134.15 98.39 4.11 Favored 'General case' 0 C--N 1.333 -0.115 0 N-CA-C 108.094 -1.076 . . . . 7.71 108.094 -173.584 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -57.95 115.6 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 N-CA-C 107.937 -1.134 . . . . 8.2799999999999994 107.937 168.233 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 62.96 -66.53 0.09 Allowed 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 126.443 1.897 . . . . 13.52 112.714 -171.577 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 63.4 43.06 98.84 Favored Glycine 0 CA--C 1.529 0.941 0 N-CA-C 110.066 -1.214 . . . . 14.43 110.066 -168.081 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.011 0 N-CA-C 107.703 -1.221 . . . . 18.73 107.703 176.476 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 . . . . . 0 N--CA 1.478 0.944 0 N-CA-C 107.229 -1.397 . . . . 7.1299999999999999 107.229 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.5 m -163.2 154.69 17.31 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 118.919 0.781 . . . . 2.8300000000000001 109.169 -174.076 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 22.7 m -89.26 161.36 16.45 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 107.916 -1.142 . . . . 1.8 107.916 160.646 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 51.6 mtmt -113.41 160.48 18.37 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 123.777 0.831 . . . . 4.1900000000000004 108.847 162.686 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 49.7 t -155.52 154.2 31.41 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 106.931 -1.507 . . . . 1.47 106.931 170.781 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -100.93 154.91 18.28 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 122.173 0.987 . . . . 2.73 108.663 175.386 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.7 mp -134.04 138.22 50.69 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 N-CA-C 104.792 -2.299 . . . . 1.8700000000000001 104.792 169.848 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 47.9 tp60 -95.56 122.96 38.86 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 103.332 -2.84 . . . . 2.6099999999999999 103.332 165.717 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 26.0 m -118.38 147.71 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 C-N-CA 124.671 1.189 . . . . 2.5899999999999999 108.008 -178.446 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 6.9 m -105.05 70.03 0.88 Allowed 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.02 0.528 . . . . 2.5 109.694 -175.557 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 156.55 -36.49 0.59 Allowed Glycine 0 C--N 1.341 0.814 0 C-N-CA 121.029 -0.605 . . . . 2.3599999999999999 114.274 170.577 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 2.6 mpp? 46.91 42.16 11.81 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.48 1.112 . . . . 4.1200000000000001 110.589 -168.565 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.2 p 56.78 1.79 0.09 Allowed 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 115.919 1.822 . . . . 10.82 115.919 -173.53 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . 0.372 0.1 OUTLIER 77.39 174.28 0.2 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 127.334 2.254 . . . . 4.0300000000000002 112.442 -166.695 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.03 132.74 54.37 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.034 0.934 . . . . 4.04 111.221 -169.428 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 10.4 m 74.15 -37.68 0.37 Allowed 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.124 1.369 . . . . 5.0300000000000002 113.63 174.61 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 75.6 m -54.94 -28.41 50.96 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 127.159 2.184 . . . . 5.6699999999999999 111.08 176.011 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 8.1 m -38.31 -40.98 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 N-CA-C 113.378 0.881 . . . . 2.4399999999999999 113.378 164.032 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -45.56 -49.12 14.21 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 124.153 0.981 . . . . 1.6499999999999999 110.876 174.203 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -54.7 -57.43 11.51 Favored 'General case' 0 CA--C 1.519 -0.237 0 N-CA-C 109.346 -0.613 . . . . 3.2000000000000002 109.346 173.403 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 3.6 tp -67.72 -39.29 81.81 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.382 0 CA-C-N 118.401 0.546 . . . . 4.5099999999999998 109.816 -163.799 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.451 ' HG2' ' CG1' ' A' ' 34' ' ' ILE . 59.0 mt-10 -56.18 -56.6 18.94 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.993 1.317 . . . . 3.6699999999999999 110.61 171.233 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.7 tmt_? -52.99 -39.36 63.0 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 109.616 -0.513 . . . . 6.1900000000000004 109.616 176.654 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -72.41 -42.28 65.31 Favored 'General case' 0 N--CA 1.431 -1.383 0 CA-C-O 118.037 -0.983 . . . . 3.3799999999999999 109.148 -178.187 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -56.72 -37.89 71.59 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 121.335 1.88 . . . . 2.5499999999999998 109.253 176.71 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 56.7 mtp180 -65.46 -12.34 51.56 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 115.262 1.578 . . . . 6.29 115.262 175.9 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.412 ' HG2' ' CG ' ' A' ' 28' ' ' GLU . 1.0 OUTLIER -66.02 -17.87 64.97 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 121.028 1.74 . . . . 8.2400000000000002 111.294 167.247 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.412 ' CG ' ' HG2' ' A' ' 27' ' ' ARG . 6.5 mt-10 -104.06 90.85 3.72 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 108.931 -0.766 . . . . 7.7400000000000002 108.931 -166.357 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -43.64 133.15 4.69 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 107.724 -1.213 . . . . 8.4399999999999995 107.724 166.502 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 110.82 -36.27 4.33 Favored Glycine 0 CA--C 1.527 0.787 0 CA-C-O 118.639 -1.09 . . . . 1.4199999999999999 111.786 -166.149 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.7 mt -83.03 126.44 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 CA-C-N 119.316 1.558 . . . . 2.1499999999999999 108.772 174.71 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -134.89 42.07 2.82 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 122.363 1.078 . . . . 3.5699999999999998 112.4 160.455 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 9.1 t -167.76 137.78 2.73 Favored 'General case' 0 C--N 1.316 -0.866 0 C-N-CA 128.008 2.523 . . . . 2.0800000000000001 106.911 144.455 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.589 ' H ' ' CD1' ' A' ' 34' ' ' ILE . 0.0 OUTLIER -78.86 134.54 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.369 0 CA-C-O 122.814 1.293 . . . . 2.3799999999999999 109.535 -179.598 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.417 ' HA ' ' H ' ' A' ' 44' ' ' GLU . 0.7 OUTLIER -81.31 68.21 7.54 Favored 'General case' 0 N--CA 1.431 -1.382 0 CA-C-N 115.317 -0.856 . . . . 4.8300000000000001 110.481 -176.527 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 4.9 t -130.42 139.46 51.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 121.917 0.865 . . . . 1.6000000000000001 111.487 167.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -151.95 72.8 1.03 Allowed 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 127.602 2.361 . . . . 1.23 107.621 169.781 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.916 HD23 ' H ' ' A' ' 38' ' ' LEU . 0.2 OUTLIER -46.96 -43.69 19.38 Favored 'General case' 0 CA--C 1.509 -0.621 0 C-N-CA 124.08 0.952 . . . . 3.3599999999999999 110.572 169.006 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 24.3 ptt? -79.81 42.31 0.53 Allowed 'General case' 0 CA--C 1.545 0.786 0 CA-C-O 121.65 0.738 . . . . 4.7800000000000002 111.649 -167.446 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -178.23 -40.81 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 129.751 3.22 . . . . 1.3400000000000001 106.878 -171.423 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 98.44 49.9 1.63 Allowed Glycine 0 C--N 1.339 0.735 0 N-CA-C 108.072 -2.011 . . . . 0.88 108.072 172.628 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 46.5 mttm -152.7 179.87 8.24 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 126.217 1.807 . . . . 4.8399999999999999 108.727 -158.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -151.18 131.71 13.86 Favored 'General case' 0 N--CA 1.442 -0.831 0 C-N-CA 125.29 1.436 . . . . 1.1699999999999999 108.109 -171.174 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.417 ' H ' ' HA ' ' A' ' 35' ' ' LEU . 0.6 OUTLIER -136.59 102.96 5.08 Favored 'General case' 0 C--N 1.342 0.242 0 CA-C-N 118.967 0.803 . . . . 2.77 112.22 -175.627 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.4 p -82.65 146.94 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.215 0 N-CA-C 108.989 -0.745 . . . . 1.6499999999999999 108.989 -176.536 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 60.6 ttp180 -122.69 123.25 40.69 Favored 'General case' 0 C--N 1.339 0.126 0 N-CA-C 105.823 -1.917 . . . . 5.6699999999999999 105.823 159.633 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 1.5 p90 -160.27 175.23 13.1 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 118.298 0.499 . . . . 2.1200000000000001 110.994 -164.419 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -110.44 117.94 50.07 Favored Pre-proline 0 CA--C 1.539 0.546 0 C-N-CA 123.472 0.709 . . . . 3.1899999999999999 109.224 166.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -74.78 23.84 0.38 Allowed 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 122.933 2.422 . . . . 1.98 113.91 -170.664 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -109.55 -49.33 3.12 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.752 1.221 . . . . 1.1699999999999999 108.403 -178.716 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 98.4 t -65.52 -50.3 72.96 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.89 0 C-N-CA 124.271 1.028 . . . . 1.3200000000000001 109.917 -179.654 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.413 ' O ' ' HB2' ' A' ' 53' ' ' GLN . 3.3 tp -102.64 -62.62 2.0 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.391 0 CA-C-O 118.652 -0.69 . . . . 1.75 112.401 -163.904 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.413 ' HB2' ' O ' ' A' ' 52' ' ' ILE . 11.4 mm-40 96.14 127.12 0.02 OUTLIER Pre-proline 0 CA--C 1.548 0.873 0 C-N-CA 129.85 3.26 . . . . 3.9399999999999999 112.318 176.376 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.458 ' HA ' HG12 ' A' ' 57' ' ' ILE . 47.0 Cg_exo -44.15 -51.83 6.29 Favored 'Trans proline' 0 C--N 1.351 0.708 1 C-N-CA 125.349 4.033 . . . . 1.1899999999999999 116.4 174.33 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -52.51 -46.41 33.39 Favored 'Trans proline' 0 N--CA 1.446 -1.291 0 CA-C-N 120.706 1.288 . . . . 0.82999999999999996 110.17 173.284 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 60.1 mtp -64.46 -46.26 83.85 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 118.723 -0.656 . . . . 2.6299999999999999 111.053 -176.541 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.458 HG12 ' HA ' ' A' ' 54' ' ' PRO . 20.6 pt -60.19 -49.91 82.29 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-N 119.897 1.226 . . . . 2.4300000000000002 110.944 175.938 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -48.04 -49.63 30.66 Favored 'General case' 0 C--N 1.341 0.199 0 C-N-CA 123.442 0.697 . . . . 1.1499999999999999 110.998 176.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -61.92 -57.1 13.01 Favored 'General case' 0 N--CA 1.434 -1.234 0 C-N-CA 124.234 1.014 . . . . 3.0899999999999999 112.369 178.069 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 9.0 m-30 -47.66 -50.05 25.82 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 118.796 0.726 . . . . 3.4500000000000002 109.773 -174.598 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 20.0 mt -51.92 -43.23 35.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 123.319 0.648 . . . . 1.3899999999999999 112.009 175.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 91.2 mtt180 -65.37 -59.4 4.07 Favored 'General case' 0 N--CA 1.457 -0.076 0 N-CA-C 109.477 -0.564 . . . . 4.3700000000000001 109.477 175.662 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -44.62 -54.54 6.04 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 125.758 1.623 . . . . 2.9399999999999999 111.941 -173.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . 0.253 0.3 OUTLIER -84.37 -13.39 52.43 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 114.071 1.137 . . . . 2.6000000000000001 114.071 179.44 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -152.74 -88.52 0.07 OUTLIER Glycine 0 CA--C 1.531 1.036 0 CA-C-N 119.84 1.2 . . . . 1.7 115.994 -165.105 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -136.43 147.25 47.15 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-O 121.732 0.777 . . . . 3.5800000000000001 112.665 -147.016 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -58.68 108.3 1.49 Allowed Glycine 0 N--CA 1.441 -0.978 0 N-CA-C 109.097 -1.601 . . . . 1.5600000000000001 109.097 177.371 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -116.54 130.07 56.54 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 126.41 1.884 . . . . 1.22 109.088 -173.212 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 41.6 m -128.24 129.29 46.17 Favored 'General case' 0 CA--C 1.528 0.097 0 C-N-CA 124.964 1.306 . . . . 2.96 107.921 175.137 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 13.3 p -82.42 140.35 16.53 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 C-N-CA 123.741 0.817 . . . . 2.2400000000000002 109.698 -175.723 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 46.7 mt -143.26 143.18 25.02 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 125.315 1.446 . . . . 2.04 108.493 -175.818 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -156.72 159.09 38.02 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 107.056 -1.461 . . . . 4.1200000000000001 107.056 166.145 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 48.5 m-80 -150.22 151.15 32.58 Favored 'General case' 0 N--CA 1.457 -0.122 0 N-CA-C 106.619 -1.623 . . . . 4.9299999999999997 106.619 -176.861 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 32.8 mm -138.06 140.52 40.35 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 N-CA-C 105.131 -2.174 . . . . 8.8900000000000006 105.131 175.265 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 3.64 77.52 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 129.671 3.188 . . . . 12.31 114.881 176.792 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -170.91 152.85 19.53 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 107.876 -2.089 . . . . 8.7799999999999994 107.876 175.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 39.5 ttt85 . . . . . 0 C--O 1.253 1.278 0 N-CA-C 105.032 -2.21 . . . . 16.02 105.032 -179.751 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 . . . . . 0 N--CA 1.477 0.901 0 N-CA-C 107.666 -1.235 . . . . 5.0899999999999999 107.666 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.5 p -67.32 162.32 23.1 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 119.528 1.058 . . . . 2.5499999999999998 110.833 175.149 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 47.5 m -154.93 165.77 35.65 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.419 1.088 . . . . 1.8500000000000001 108.939 179.161 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.53 130.74 56.61 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 125.006 1.322 . . . . 4.7000000000000002 107.988 174.784 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 51.2 t -123.01 146.42 47.66 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 118.973 0.806 . . . . 1.3300000000000001 109.427 173.196 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -92.24 133.1 36.13 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.47 1.108 . . . . 2.5299999999999998 108.952 172.704 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.0 mm -124.3 151.9 29.75 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 N-CA-C 103.822 -2.658 . . . . 2.3100000000000001 103.822 178.762 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 45.1 tp60 -117.37 125.01 50.29 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 103.551 -2.759 . . . . 3.27 103.551 168.863 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.8 m -87.91 141.36 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 N-CA-C 108.695 -0.854 . . . . 2.4100000000000001 108.695 178.762 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 52.6 p -104.4 84.99 2.27 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 105.255 -2.128 . . . . 2.98 105.255 165.802 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 177.74 -67.82 0.08 OUTLIER Glycine 0 CA--C 1.522 0.493 0 N-CA-C 105.392 -3.083 . . . . 2.3599999999999999 105.392 -178.774 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 14.1 ttp 70.99 -61.64 0.48 Allowed 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 126.774 2.029 . . . . 3.8500000000000001 112.441 165.871 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.8 m -142.65 49.43 1.5 Allowed 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 125.946 1.698 . . . . 4.7999999999999998 106.878 173.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.9 p -53.99 -51.77 62.85 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 109.119 -0.697 . . . . 3.4700000000000002 109.119 177.14 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 176.73 120.19 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 127.221 2.209 . . . . 3.54 107.352 157.172 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 4.2 p 48.92 38.61 12.65 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.426 0.69 . . . . 3.0699999999999998 111.044 -171.005 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 29.5 t -55.14 -44.77 75.41 Favored 'General case' 0 N--CA 1.461 0.094 0 C-N-CA 126.591 1.956 . . . . 4.0099999999999998 108.141 -178.603 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.2 m -70.79 -49.58 49.87 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.089 0 CA-C-N 113.955 -1.475 . . . . 2.23 110.989 -171.52 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.64 -41.7 73.96 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.955 0.902 . . . . 0.85999999999999999 110.824 171.074 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -55.05 -50.99 67.71 Favored 'General case' 0 C--N 1.341 0.205 0 N-CA-C 108.566 -0.901 . . . . 2.1899999999999999 108.566 172.346 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.787 HG21 HG23 ' A' ' 36' ' ' VAL . 4.6 mt -56.09 -51.21 64.62 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 CA-C-O 118.494 -0.765 . . . . 2.46 110.024 178.196 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -49.98 -57.03 8.39 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 119.332 0.969 . . . . 3.4199999999999999 110.065 177.253 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 32.6 mmt180 -51.72 -46.63 64.02 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 122.743 0.417 . . . . 4.54 111.814 177.789 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 67.4 m-20 -67.13 -63.93 0.96 Allowed 'General case' 0 C--O 1.224 -0.242 0 CA-C-O 121.825 0.821 . . . . 3.1000000000000001 109.612 -176.038 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.707 HD23 HG23 ' A' ' 21' ' ' ILE . 0.0 OUTLIER -71.1 -28.52 64.38 Favored 'General case' 0 N--CA 1.439 -1.022 0 C-N-CA 124.339 1.056 . . . . 2.3399999999999999 110.316 -165.773 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . 0.487 28.1 mtp-105 -70.11 0.51 6.03 Favored 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 116.192 1.923 . . . . 5.7699999999999996 116.192 167.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 9.5 mmt180 -38.07 -36.03 0.19 Allowed 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 117.777 -1.569 . . . . 7.9199999999999999 112.393 143.922 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 70.04 43.61 0.88 Allowed 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 126.075 1.75 . . . . 8.6899999999999995 108.359 -178.061 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -73.77 58.46 0.63 Allowed 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 126.832 2.053 . . . . 5.2000000000000002 108.795 179.008 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 66.0 34.28 87.98 Favored Glycine 0 CA--C 1.532 1.128 0 O-C-N 121.316 -0.865 . . . . 1.1000000000000001 112.375 -172.13 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -113.96 135.8 52.49 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 C-N-CA 126.167 1.787 . . . . 1.9299999999999999 106.993 -179.096 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -140.83 47.21 1.75 Allowed 'General case' 0 CA--C 1.53 0.184 0 CA-C-O 122.923 1.344 . . . . 3.1800000000000002 111.6 159.503 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.7 t -168.64 133.63 1.65 Allowed 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 127.791 2.437 . . . . 2.0299999999999998 105.546 144.759 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -81.0 150.99 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 CA-C-O 121.805 0.812 . . . . 2.0800000000000001 109.37 177.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.418 ' HB2' ' HB1' ' A' ' 43' ' ' ALA . 0.6 OUTLIER -81.13 65.5 6.29 Favored 'General case' 0 N--CA 1.435 -1.177 0 C-N-CA 124.151 0.98 . . . . 4.7199999999999998 111.04 -177.469 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.787 HG23 HG21 ' A' ' 21' ' ' ILE . 11.4 t -117.2 140.62 39.2 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 CA-C-O 121.956 0.884 . . . . 1.6599999999999999 111.321 162.018 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -155.79 59.78 0.6 Allowed 'General case' 0 C--O 1.236 0.389 0 C-N-CA 127.323 2.249 . . . . 0.80000000000000004 106.893 166.007 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.18 60.11 3.57 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 124.445 1.098 . . . . 3.3399999999999999 109.293 179.464 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 51.6 ttm -131.97 -52.2 0.97 Allowed 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 105.112 -2.181 . . . . 3.3100000000000001 105.112 163.82 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -69.13 -30.49 68.76 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.574 -0.739 . . . . 1.3100000000000001 111.169 165.005 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 96.32 45.46 2.78 Favored Glycine 0 C--N 1.341 0.835 0 N-CA-C 109.552 -1.419 . . . . 1.03 109.552 -178.514 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 50.1 mttt -147.73 -179.14 6.67 Favored 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 124.725 1.21 . . . . 4.21 108.295 -156.898 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.418 ' HB1' ' HB2' ' A' ' 35' ' ' LEU . . . -157.39 118.74 3.65 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 108.077 -1.082 . . . . 1.3300000000000001 108.077 -159.973 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -133.01 105.95 7.38 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 119.413 1.006 . . . . 2.6000000000000001 112.83 178.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.573 HG11 HD12 ' A' ' 57' ' ' ILE . 11.1 p -82.38 133.17 29.72 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.317 0 C-N-CA 124.421 1.088 . . . . 1.5 108.405 -177.97 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 71.4 ttt180 -110.17 127.07 54.72 Favored 'General case' 0 CA--C 1.52 -0.173 0 N-CA-C 105.764 -1.939 . . . . 4.5700000000000003 105.764 166.44 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 4.9 p90 -157.23 169.21 25.28 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 117.995 0.361 . . . . 2.0099999999999998 111.145 -161.024 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -114.43 98.19 48.3 Favored Pre-proline 0 CA--C 1.539 0.523 0 C-N-CA 124.548 1.139 . . . . 3.75 111.338 174.914 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.44 79.55 0.84 Allowed 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 122.802 2.335 . . . . 1.6299999999999999 111.46 176.858 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -143.63 -56.79 0.39 Allowed 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 105.867 -1.901 . . . . 1.3999999999999999 105.867 159.816 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 91.4 t -56.76 -62.37 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 C-N-CA 124.646 1.178 . . . . 1.3300000000000001 109.492 171.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.543 HG23 ' H ' ' A' ' 53' ' ' GLN 0.28 9.6 tp -89.3 -77.48 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 CA-C-O 118.669 -0.681 . . . . 1.6200000000000001 112.338 -160.341 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.543 ' H ' HG23 ' A' ' 52' ' ' ILE . 3.3 mp0 99.37 142.79 0.03 OUTLIER Pre-proline 0 CA--C 1.54 0.592 0 C-N-CA 129.808 3.243 . . . . 3.4199999999999999 111.414 -179.606 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.443 ' HA ' HG12 ' A' ' 57' ' ' ILE . 30.3 Cg_exo -47.95 -47.82 17.96 Favored 'Trans proline' 0 CA--C 1.536 0.614 1 C-N-CA 126.525 4.817 . . . . 1.1399999999999999 116.917 174.213 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -49.1 -62.11 0.48 Allowed 'Trans proline' 0 N--CA 1.446 -1.29 0 CA-C-N 120.874 1.348 . . . . 0.93000000000000005 109.777 163.445 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 1.1 ttt -53.94 -45.9 71.39 Favored 'General case' 0 N--CA 1.428 -1.541 0 N-CA-C 114.397 1.258 . . . . 3.8100000000000001 114.397 -173.18 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.573 HD12 HG11 ' A' ' 45' ' ' VAL . 5.0 pt -54.61 -50.08 62.11 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-N 120.15 1.341 . . . . 3.1800000000000002 111.101 175.063 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -55.33 -52.07 64.69 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 118.365 0.529 . . . . 1.0800000000000001 111.34 177.87 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -60.94 -58.53 8.03 Favored 'General case' 0 N--CA 1.432 -1.359 0 C-N-CA 123.769 0.828 . . . . 2.7400000000000002 111.235 -178.274 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -50.14 -35.23 25.06 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.163 0.985 . . . . 3.6000000000000001 111.909 -178.934 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.547 HG23 ' CE2' ' A' ' 66' ' ' PHE . 54.3 mt -64.44 -62.8 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 O-C-N 121.933 -0.479 . . . . 1.22 109.901 169.542 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 38.7 mtp180 -50.94 -43.56 60.24 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.451 0.701 . . . . 5.3399999999999999 112.799 -174.304 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -46.09 -33.11 3.27 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 126.058 1.743 . . . . 3.0 112.439 177.528 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 68.5 mt -82.36 -17.2 46.47 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 123.193 0.597 . . . . 1.8 112.029 -176.792 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 124.6 -35.52 3.15 Favored Glycine 0 C--N 1.339 0.708 0 CA-C-N 118.576 0.625 . . . . 2.2400000000000002 112.682 169.366 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.547 ' CE2' HG23 ' A' ' 61' ' ' ILE . 28.6 p90 -84.29 131.71 34.7 Favored 'General case' 0 N--CA 1.457 -0.106 0 N-CA-C 106.784 -1.562 . . . . 5.0099999999999998 106.784 177.24 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -88.4 162.05 31.71 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.787 -0.925 . . . . 2.1800000000000002 110.787 -163.593 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.509 ' HB2' HG21 ' A' ' 61' ' ' ILE . . . -137.53 144.12 41.98 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.487 1.115 . . . . 1.0800000000000001 109.025 -179.441 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 12.3 p -129.53 127.01 39.89 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 106.257 -1.756 . . . . 2.7400000000000002 106.257 172.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 28.1 t -84.66 118.04 31.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 N-CA-C 107.962 -1.125 . . . . 1.74 107.962 -176.853 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 28.4 mt -141.98 68.78 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 N-CA-C 107.511 -1.292 . . . . 2.21 107.511 -172.92 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -51.11 -57.55 8.41 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 115.673 -0.694 . . . . 4.9400000000000004 110.337 178.603 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -131.94 163.73 27.7 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 124.832 1.253 . . . . 4.9699999999999998 108.563 -175.659 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 4.7 mp -130.8 134.59 61.64 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 124.636 1.174 . . . . 8.7699999999999996 108.102 -173.335 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -80.75 154.55 27.17 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.995 0.918 . . . . 12.0 109.831 178.137 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -110.99 151.2 17.76 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 109.999 -1.24 . . . . 11.369999999999999 109.999 178.199 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.252 1.236 0 N-CA-C 104.801 -2.296 . . . . 18.829999999999998 104.801 178.391 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 . . . . . 0 N--CA 1.477 0.925 0 N-CA-C 107.809 -1.182 . . . . 7.29 107.809 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.6 m -55.88 118.55 4.7 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 124.179 0.992 . . . . 2.6600000000000001 111.916 -174.307 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.3 t -91.89 163.32 14.07 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 124.31 1.044 . . . . 2.5800000000000001 110.679 -169.653 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 3.6 ttpm? -88.96 159.5 17.61 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 125.845 1.658 . . . . 4.5899999999999999 109.968 -175.098 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.424 ' HB3' ' CG2' ' A' ' 45' ' ' VAL . 52.9 t -155.37 159.15 39.69 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 107.822 -1.177 . . . . 1.3999999999999999 107.822 153.73 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -107.49 144.48 34.38 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 125.529 1.532 . . . . 2.7799999999999998 107.151 168.708 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.7 mt -138.01 138.83 43.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 107.867 -1.16 . . . . 1.6799999999999999 107.867 -179.482 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 66.0 mt-30 -77.1 145.62 37.71 Favored 'General case' 0 CA--C 1.522 -0.12 0 N-CA-C 106.179 -1.785 . . . . 4.6500000000000004 106.179 173.412 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 17.2 m -136.93 127.42 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 N-CA-C 108.502 -0.925 . . . . 2.1600000000000001 108.502 172.727 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 72.8 p -79.81 64.52 4.69 Favored 'General case' 0 CA--C 1.534 0.344 0 O-C-N 121.863 -0.523 . . . . 3.6600000000000001 110.227 -174.81 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 152.8 55.94 0.01 OUTLIER Glycine 0 C--N 1.339 0.695 0 CA-C-O 124.904 2.391 . . . . 3.2799999999999998 113.432 169.492 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 16.7 tmm? -43.06 -50.65 6.02 Favored 'General case' 0 N--CA 1.432 -1.329 0 CA-C-N 109.816 -3.192 . . . . 4.2599999999999998 109.39 137.542 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.27 -33.95 76.38 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 125.821 1.648 . . . . 5.3700000000000001 112.848 -168.215 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 21.4 m -61.79 143.35 56.43 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 109.345 -0.613 . . . . 2.8199999999999998 109.345 -173.046 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -61.6 146.53 48.63 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 108.304 -0.998 . . . . 2.5499999999999998 108.304 163.43 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 79.92 -62.76 0.25 Allowed 'General case' 0 C--O 1.22 -0.474 0 C-N-CA 124.965 1.306 . . . . 3.1899999999999999 112.251 179.839 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 51.8 m -36.26 -48.9 0.66 Allowed 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 125.995 1.718 . . . . 3.0699999999999998 114.54 -154.854 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.418 HG13 HG11 ' A' ' 36' ' ' VAL . 0.9 OUTLIER -43.95 -43.48 1.9 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.915 0 C-N-CA 125.905 1.682 . . . . 2.6699999999999999 113.553 175.467 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.02 -44.55 94.53 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 125.828 1.651 . . . . 0.84999999999999998 111.528 170.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -59.4 -51.01 71.73 Favored 'General case' 0 C--O 1.218 -0.593 0 CA-C-O 118.016 -0.993 . . . . 1.8200000000000001 108.823 173.376 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.435 HG22 HD11 ' A' ' 34' ' ' ILE . 2.5 mt -45.7 -58.76 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 C-N-CA 124.898 1.279 . . . . 2.2599999999999998 109.895 173.702 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -34.94 -59.58 0.48 Allowed 'General case' 0 C--N 1.328 -0.338 0 O-C-N 119.924 -1.735 . . . . 4.2699999999999996 113.382 166.062 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 92.7 mtt180 -59.81 -35.3 74.41 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 114.517 1.303 . . . . 4.9900000000000002 114.517 173.423 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.696 ' ND2' HD13 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -64.91 -58.74 5.36 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 125.836 1.654 . . . . 4.3700000000000001 109.567 -163.984 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.78 ' HB2' HD13 ' A' ' 34' ' ' ILE 0.256 7.3 mp -73.62 -19.83 60.75 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 121.22 0.533 . . . . 3.1400000000000001 109.896 179.105 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . 0.495 84.0 mtp180 -67.17 2.91 1.34 Allowed 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 116.465 2.024 . . . . 5.5099999999999998 116.465 164.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.413 ' CZ ' ' HA ' ' A' ' 27' ' ' ARG . 0.2 OUTLIER -38.86 -32.71 0.09 Allowed 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 116.49 -2.084 . . . . 6.7199999999999998 113.879 145.654 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . 0.267 2.0 mt-10 64.11 45.49 4.08 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 126.366 1.867 . . . . 7.9100000000000001 111.294 174.395 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 70.1 mt-10 -105.4 79.77 1.5 Allowed 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 126.467 1.907 . . . . 6.0 108.921 -174.698 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 64.39 26.55 70.76 Favored Glycine 0 CA--C 1.532 1.119 0 CA-C-O 121.669 0.594 . . . . 1.1399999999999999 111.733 -175.653 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.1 mm -93.72 158.06 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 C-N-CA 126.19 1.796 . . . . 2.0499999999999998 108.408 176.65 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 12.6 t80 -154.37 41.76 0.49 Allowed 'General case' 0 C--N 1.339 0.12 0 C-N-CA 119.857 -0.737 . . . . 6.0300000000000002 111.482 170.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.43 ' HB3' HD11 ' A' ' 35' ' ' LEU . 48.4 t -171.39 -179.42 2.61 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 128.773 2.829 . . . . 1.8300000000000001 105.319 141.372 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.895 HD12 ' H ' ' A' ' 35' ' ' LEU . 2.1 tp -134.65 141.17 44.05 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.353 0 N-CA-C 106.909 -1.515 . . . . 3.6600000000000001 106.909 149.294 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.895 ' H ' HD12 ' A' ' 34' ' ' ILE . 0.3 OUTLIER -149.02 144.03 26.47 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 114.473 -1.24 . . . . 6.9000000000000004 109.619 -158.103 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.474 ' CG1' HD23 ' A' ' 38' ' ' LEU 0.258 0.9 OUTLIER -154.64 80.77 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.437 -1.095 0 CA-C-O 124.196 1.951 . . . . 2.2999999999999998 108.786 -164.012 . . . . . . . . 4 4 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -77.2 61.39 2.09 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 113.543 -1.662 . . . . 0.87 109.527 169.21 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.474 HD23 ' CG1' ' A' ' 36' ' ' VAL . 0.2 OUTLIER -46.71 -44.85 19.08 Favored 'General case' 0 CA--C 1.512 -0.487 0 C-N-CA 123.828 0.851 . . . . 3.6699999999999999 110.046 169.007 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 27.8 ttt -63.81 -36.37 83.69 Favored 'General case' 0 N--CA 1.441 -0.892 0 C-N-CA 120.208 -0.597 . . . . 5.3200000000000003 110.145 -169.199 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -74.86 -36.07 62.33 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.294 0.638 . . . . 1.8400000000000001 110.29 172.625 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 109.8 39.57 1.56 Allowed Glycine 0 C--N 1.334 0.471 0 C-N-CA 124.945 1.259 . . . . 1.2 111.009 173.43 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 29.5 pttt -158.75 157.04 30.94 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 108.436 -0.95 . . . . 3.7599999999999998 108.436 -176.464 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -82.59 147.95 28.3 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 107.279 -1.378 . . . . 1.1299999999999999 107.279 167.624 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.557 ' CB ' ' HB2' ' A' ' 35' ' ' LEU . 36.1 mt-10 -103.61 153.28 20.78 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 105.962 -1.866 . . . . 2.9700000000000002 105.962 171.008 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.577 ' HA ' HD13 ' A' ' 35' ' ' LEU . 34.1 m -137.95 148.4 25.31 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-N 119.195 0.907 . . . . 2.73 109.528 171.775 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 58.3 ttm-85 -133.47 130.77 39.05 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 106.234 -1.765 . . . . 4.8399999999999999 106.234 164.852 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 26.7 p90 -156.45 167.69 29.68 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 110.099 -0.334 . . . . 2.2999999999999998 110.099 -167.638 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -105.97 104.3 48.67 Favored Pre-proline 0 CA--C 1.542 0.661 0 C-N-CA 123.311 0.644 . . . . 3.2799999999999998 111.056 178.364 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -75.82 73.02 4.93 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 122.627 2.218 . . . . 1.98 111.661 -175.808 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -142.71 -63.72 0.42 Allowed 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 105.979 -1.86 . . . . 1.22 105.979 161.493 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 72.7 t -56.07 -52.32 51.63 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.749 0 C-N-CA 124.905 1.282 . . . . 1.3100000000000001 110.263 175.343 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 20.1 tt -84.16 -52.19 13.05 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.403 0 N-CA-C 114.125 1.158 . . . . 3.3399999999999999 114.125 -151.415 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER 71.3 109.5 0.03 OUTLIER Pre-proline 0 CA--C 1.538 0.517 0 C-N-CA 127.968 2.507 . . . . 2.7200000000000002 111.266 -165.702 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_exo -46.72 -41.29 24.67 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 123.358 2.705 . . . . 1.3600000000000001 115.102 162.186 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_endo -55.09 -50.41 13.21 Favored 'Trans proline' 0 N--CA 1.447 -1.261 0 CA-C-N 121.707 1.645 . . . . 1.1599999999999999 109.754 168.683 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 77.0 mtp -59.97 -42.51 94.3 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 118.595 -1.242 . . . . 2.5299999999999998 111.934 -179.501 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.1 pt -58.24 -47.07 88.44 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-N 121.61 2.005 . . . . 2.3900000000000001 111.829 173.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -51.9 -46.44 64.59 Favored 'General case' 0 C--N 1.341 0.201 0 C-N-CA 122.761 0.424 . . . . 1.4199999999999999 111.096 179.31 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -64.19 -60.8 2.77 Favored 'General case' 0 N--CA 1.434 -1.242 0 C-N-CA 123.853 0.861 . . . . 2.9399999999999999 111.84 175.467 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 8.2 m-30 -45.76 -47.39 15.51 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 125.418 1.487 . . . . 3.6299999999999999 110.071 -175.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 74.6 mt -57.75 -39.83 72.56 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 CA-C-N 116.62 -0.264 . . . . 1.1399999999999999 111.311 -178.61 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 21.3 mtm105 -69.82 -46.61 65.27 Favored 'General case' 0 N--CA 1.455 -0.185 0 O-C-N 121.683 -0.636 . . . . 3.6200000000000001 111.362 173.633 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -54.06 -47.21 71.91 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 122.834 0.453 . . . . 3.2400000000000002 111.24 -179.763 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.4 pp -90.0 -34.71 15.88 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 112.989 0.737 . . . . 2.8100000000000001 112.989 -176.07 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -123.67 -79.29 0.43 Allowed Glycine 0 C--N 1.34 0.763 0 N-CA-C 114.392 0.517 . . . . 2.29 114.392 -157.839 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -165.74 165.61 18.42 Favored 'General case' 0 N--CA 1.465 0.291 0 O-C-N 122.12 -0.635 . . . . 4.6299999999999999 110.994 -154.798 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -78.64 66.11 3.35 Favored Glycine 0 C--N 1.337 0.631 0 C-N-CA 124.649 1.118 . . . . 1.95 113.496 -157.408 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -90.02 148.44 23.07 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 124.696 1.198 . . . . 1.0900000000000001 113.151 -164.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.6 t -141.59 145.09 34.63 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 107.552 -1.277 . . . . 2.6699999999999999 107.552 174.807 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 1.8 t -81.84 130.12 36.35 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 C-N-CA 125.116 1.367 . . . . 1.8799999999999999 107.998 -178.301 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 4.9 pt -148.03 59.83 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.339 0.141 0 C-N-CA 124.564 1.146 . . . . 3.1299999999999999 110.91 -172.34 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -57.65 135.95 56.78 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 116.27 -0.423 . . . . 5.6900000000000004 110.066 176.393 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 178.86 145.06 0.14 Allowed 'General case' 0 N--CA 1.457 -0.093 0 C-N-CA 123.355 0.662 . . . . 5.71 111.979 -174.17 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 38.5 mt 64.31 78.86 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 C-N-CA 125.498 1.519 . . . . 9.3300000000000001 111.288 169.064 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -68.28 -47.95 66.32 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.22 0.608 . . . . 12.970000000000001 110.019 170.706 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 156.4 -163.31 31.97 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 107.015 -2.434 . . . . 13.26 107.015 -172.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.132 0 N-CA-C 104.573 -2.381 . . . . 19.399999999999999 104.573 171.728 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 8.1 p30 . . . . . 0 N--CA 1.477 0.892 0 N-CA-C 107.156 -1.424 . . . . 5.0499999999999998 107.156 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.7 p 69.91 142.05 0.05 OUTLIER 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 126.304 1.841 . . . . 2.8599999999999999 112.069 -173.301 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 45.5 m -149.61 157.8 43.58 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 126.565 1.946 . . . . 1.73 107.934 -177.693 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 33.4 mtmt -103.86 147.43 27.32 Favored 'General case' 0 C--O 1.231 0.081 0 N-CA-C 107.202 -1.407 . . . . 5.3300000000000001 107.202 168.349 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 38.3 t -153.25 150.47 29.0 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 108.922 -0.77 . . . . 1.7 108.922 172.591 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -112.34 146.3 38.53 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 125.927 1.691 . . . . 2.23 106.546 -179.064 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.463 HD13 HD11 ' A' ' 61' ' ' ILE . 0.0 OUTLIER -139.24 107.74 3.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 107.509 -1.293 . . . . 2.7599999999999998 107.509 -168.698 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 48.4 tp60 -82.78 123.05 28.96 Favored 'General case' 0 N--CA 1.428 -1.535 0 N-CA-C 106.036 -1.839 . . . . 2.9500000000000002 106.036 -172.547 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 9.9 p -89.38 157.26 3.02 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 C-N-CA 125.322 1.449 . . . . 3.4900000000000002 108.86 -177.232 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.8 t -111.18 21.68 16.07 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 123.115 0.566 . . . . 2.8399999999999999 112.453 176.71 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -143.35 117.36 1.09 Allowed Glycine 0 N--CA 1.444 -0.798 0 N-CA-C 106.304 -2.719 . . . . 2.3399999999999999 106.304 154.272 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 1.5 ttp -90.16 -61.78 1.61 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 113.445 -1.378 . . . . 4.6500000000000004 108.314 174.03 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 14.1 t -82.38 47.91 1.22 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.544 0.738 . . . . 6.3300000000000001 110.529 -175.866 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 15.6 p -79.38 -44.0 22.34 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 109.169 -0.678 . . . . 2.8199999999999998 109.169 170.706 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 143.14 -121.66 0.0 OUTLIER 'General case' 0 C--N 1.34 0.16 0 C-N-CA 130.663 3.585 . . . . 4.0099999999999998 106.244 177.914 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.2 m -79.41 60.58 3.22 Favored 'General case' 0 N--CA 1.451 -0.394 0 O-C-N 121.493 -0.754 . . . . 3.0 111.261 -175.389 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 4.2 t -48.59 -44.87 37.32 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 125.827 1.651 . . . . 4.6500000000000004 109.116 177.399 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.469 HG13 ' H ' ' A' ' 19' ' ' ALA . 2.5 p -55.3 -61.61 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.816 0 CA-C-N 113.988 -1.46 . . . . 3.3500000000000001 110.627 177.754 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.469 ' H ' HG13 ' A' ' 18' ' ' VAL . . . -54.28 -35.56 62.71 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.406 -1.27 . . . . 1.21 110.644 -178.811 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -63.69 -58.64 6.28 Favored 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 109.734 -0.469 . . . . 2.4700000000000002 109.734 170.701 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.554 HG21 HG23 ' A' ' 36' ' ' VAL . 1.2 mp -54.4 -48.36 68.83 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 CA-C-N 119.605 1.093 . . . . 2.27 111.18 -175.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -45.94 -43.08 13.67 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 120.89 -1.131 . . . . 2.9100000000000001 111.168 177.07 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.61 -46.82 58.06 Favored 'General case' 0 CA--C 1.536 0.429 0 O-C-N 121.434 -0.791 . . . . 6.0899999999999999 111.012 168.712 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -55.3 -47.23 75.87 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.808 1.243 . . . . 4.2400000000000002 113.392 -165.745 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . 0.382 0.8 OUTLIER -79.04 -23.61 44.18 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 122.11 0.957 . . . . 3.1699999999999999 112.465 -172.413 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . 0.585 53.7 mtp85 -54.14 2.12 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 120.769 3.618 . . . . 5.71 120.769 176.458 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.436 HH11 ' CG ' ' A' ' 27' ' ' ARG . 0.1 OUTLIER -45.85 -32.27 2.53 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 117.308 -1.757 . . . . 9.7699999999999996 111.03 154.046 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 64.34 -155.13 0.3 Allowed 'General case' 0 C--N 1.342 0.27 0 C-N-CA 123.845 0.858 . . . . 7.3600000000000003 108.947 -175.835 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 58.93 54.25 5.19 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 122.37 1.081 . . . . 6.5 109.062 -179.079 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 152.26 -46.3 0.59 Allowed Glycine 0 C--N 1.335 0.521 0 N-CA-C 110.528 -1.029 . . . . 1.6000000000000001 110.528 -171.765 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.9 mp -81.66 153.73 4.12 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 C-N-CA 124.323 1.049 . . . . 2.5800000000000001 108.781 -171.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -151.58 36.04 0.57 Allowed 'General case' 0 CA--C 1.546 0.824 0 CA-C-O 121.99 0.9 . . . . 3.54 112.616 167.579 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 57.9 m -167.55 161.59 13.82 Favored 'General case' 0 C--N 1.326 -0.444 1 C-N-CA 131.871 4.068 . . . . 2.25 103.069 145.017 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.416 HD12 ' HA ' ' A' ' 34' ' ' ILE . 10.8 tp -139.97 133.64 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 CA-C-N 122.77 2.532 . . . . 4.4500000000000002 110.863 155.379 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.491 ' O ' HG23 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -167.92 -179.08 4.03 Favored 'General case' 0 N--CA 1.44 -0.925 0 CA-C-N 111.73 -2.486 . . . . 6.1200000000000001 108.864 -153.739 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.554 HG23 HG21 ' A' ' 21' ' ' ILE . 2.4 t -159.57 128.44 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.253 0 C-N-CA 125.695 1.598 . . . . 1.6799999999999999 107.213 -175.088 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -84.23 63.64 7.83 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 107.905 -1.146 . . . . 0.89000000000000001 107.905 175.007 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -60.31 -31.75 70.56 Favored 'General case' 0 CA--C 1.532 0.25 0 O-C-N 122.043 -0.411 . . . . 2.7000000000000002 111.552 -169.507 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 67.2 mtt -53.6 -36.89 62.44 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.526 0.73 . . . . 3.2599999999999998 111.707 172.833 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -92.22 7.25 43.48 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.589 1.156 . . . . 2.2999999999999998 111.947 176.844 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.27 38.6 96.11 Favored Glycine 0 CA--C 1.522 0.483 0 C-N-CA 125.473 1.511 . . . . 1.1899999999999999 112.029 174.491 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -162.02 152.43 17.18 Favored 'General case' 0 N--CA 1.442 -0.857 0 N-CA-C 108.075 -1.083 . . . . 4.1799999999999997 108.075 -162.177 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -81.77 157.98 24.3 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 108.928 -0.768 . . . . 1.3200000000000001 108.928 176.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.479 ' HB3' ' CD2' ' A' ' 35' ' ' LEU 0.335 2.2 tm-20 -129.37 157.36 42.13 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 108.612 -0.885 . . . . 4.6299999999999999 108.612 165.581 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.0 p -151.97 138.12 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 N-CA-C 106.476 -1.676 . . . . 1.6200000000000001 106.476 -176.298 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 4.0 mtm180 -104.35 133.01 49.97 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 105.545 -2.02 . . . . 7.1600000000000001 105.545 158.023 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -157.32 167.64 29.69 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 123.716 0.807 . . . . 1.97 108.844 -171.407 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 54.6 t30 -116.79 97.48 50.52 Favored Pre-proline 0 CA--C 1.533 0.312 0 C-N-CA 123.83 0.852 . . . . 3.2999999999999998 110.378 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.3 72.25 2.89 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 123.309 2.672 . . . . 1.8700000000000001 111.538 -178.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -147.56 -56.8 0.24 Allowed 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 106.062 -1.829 . . . . 1.53 106.062 169.293 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 45.6 t -57.52 -54.78 26.58 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 C-N-CA 124.116 0.966 . . . . 1.4199999999999999 109.694 173.191 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.494 HG23 ' H ' ' A' ' 53' ' ' GLN 0.25 10.5 tp -94.2 -75.06 0.42 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.352 0 N-CA-C 112.692 0.627 . . . . 2.0800000000000001 112.692 -164.463 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.494 ' H ' HG23 ' A' ' 52' ' ' ILE . 0.0 OUTLIER 108.45 135.48 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.452 0 C-N-CA 129.845 3.258 . . . . 2.3599999999999999 108.208 -176.58 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -44.22 -51.15 7.05 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 124.63 3.553 . . . . 1.3100000000000001 114.796 171.021 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -47.19 -56.05 3.39 Favored 'Trans proline' 0 N--CA 1.448 -1.195 0 CA-C-N 121.307 1.502 . . . . 1.1000000000000001 110.929 167.008 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 51.0 mtt -59.51 -36.34 75.89 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 118.029 -1.468 . . . . 1.9099999999999999 113.134 -178.92 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.425 HD13 HG21 ' A' ' 57' ' ' ILE . 0.5 OUTLIER -62.13 -46.81 95.63 Favored 'Isoleucine or valine' 0 C--N 1.344 0.351 0 CA-C-N 120.675 1.58 . . . . 2.9399999999999999 110.619 173.841 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -53.38 -52.36 59.56 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 121.189 0.519 . . . . 1.3799999999999999 109.978 178.755 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -56.77 -49.1 76.29 Favored 'General case' 0 N--CA 1.426 -1.652 0 C-N-CA 123.474 0.709 . . . . 3.2599999999999998 111.337 176.55 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 3.9 m-30 -53.81 -33.98 57.75 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 119.31 0.959 . . . . 4.1799999999999997 111.39 178.423 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.463 HD11 HD13 ' A' ' 7' ' ' ILE . 42.0 mt -70.84 -51.35 36.82 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 O-C-N 121.477 -0.764 . . . . 1.3999999999999999 109.292 173.548 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 35.6 mtp-105 -63.85 -27.88 69.47 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 113.54 0.941 . . . . 5.7800000000000002 113.54 -174.396 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -45.93 -55.11 7.18 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 125.058 1.343 . . . . 4.9699999999999998 111.072 177.808 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -130.27 -19.65 3.11 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 124.453 1.101 . . . . 2.77 113.525 -166.8 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -96.52 -102.67 2.05 Favored Glycine 0 N--CA 1.446 -0.642 0 N-CA-C 109.086 -1.606 . . . . 2.9199999999999999 109.086 -179.03 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 27.9 m-85 -149.53 166.17 30.0 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 122.172 0.987 . . . . 2.8599999999999999 110.936 -154.837 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -78.94 69.06 2.96 Favored Glycine 0 N--CA 1.443 -0.859 0 CA-C-N 114.53 -1.213 . . . . 1.76 110.551 -178.703 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -82.64 141.78 32.23 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 113.867 -1.167 . . . . 1.3400000000000001 109.852 -176.713 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 9.3 t -115.25 139.65 49.77 Favored 'General case' 0 N--CA 1.439 -1.013 0 N-CA-C 106.77 -1.567 . . . . 2.1699999999999999 106.77 178.448 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.0 t -83.59 125.9 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.612 0 C-N-CA 125.132 1.373 . . . . 2.0 108.952 -172.385 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 13.7 mm -130.62 59.54 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 C-N-CA 125.254 1.422 . . . . 2.1099999999999999 108.472 -177.703 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -73.5 -45.38 54.25 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 108.195 -1.039 . . . . 4.8099999999999996 108.195 162.015 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 52.2 t30 47.91 73.0 0.22 Allowed 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.163 1.385 . . . . 5.5 113.611 157.071 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 8.8 tp -151.83 155.71 6.66 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 N-CA-C 107.246 -1.39 . . . . 7.9199999999999999 107.246 175.621 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -149.38 166.76 28.09 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 106.177 -1.786 . . . . 12.42 106.177 177.634 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 94.32 -166.77 27.1 Favored Glycine 0 CA--C 1.528 0.846 0 N-CA-C 110.402 -1.079 . . . . 14.029999999999999 110.402 -174.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 80.5 ttt180 . . . . . 0 C--O 1.249 1.061 0 N-CA-C 104.706 -2.331 . . . . 24.91 104.706 -179.895 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.2 m . . . . . 0 C--O 1.236 0.393 0 N-CA-C 112.323 0.49 . . . . 2.6299999999999999 112.323 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 22.9 t -113.19 178.08 4.4 Favored 'General case' 0 N--CA 1.463 0.18 0 C-N-CA 125.423 1.489 . . . . 3.1800000000000002 108.149 177.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.39 159.28 37.5 Favored 'General case' 0 N--CA 1.46 0.052 0 CA-C-N 118.273 0.488 . . . . 4.3799999999999999 112.005 -176.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 53.6 t -138.77 154.12 48.49 Favored 'General case' 0 C--N 1.333 -0.144 0 N-CA-C 106.635 -1.617 . . . . 1.45 106.635 176.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 81.3 m-85 -98.75 154.37 18.04 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 107.405 -1.331 . . . . 2.8700000000000001 107.405 178.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 18.2 mt -148.66 132.16 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 N-CA-C 105.379 -2.082 . . . . 1.6100000000000001 105.379 -176.043 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 48.5 tp60 -100.86 126.13 47.44 Favored 'General case' 0 N--CA 1.432 -1.364 0 N-CA-C 105.553 -2.017 . . . . 3.1200000000000001 105.553 176.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 30.1 m -98.85 137.09 27.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 C-N-CA 124.087 0.955 . . . . 2.2599999999999998 109.209 179.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 25.3 m -78.81 74.85 5.33 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 109.501 -0.555 . . . . 2.3399999999999999 109.501 179.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 117.81 77.32 0.59 Allowed Glycine 0 C--N 1.335 0.487 0 CA-C-O 124.513 2.174 . . . . 2.2400000000000002 110.485 173.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.9 -65.91 0.62 Allowed 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 110.024 -3.088 . . . . 4.1100000000000003 108.398 176.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.6 t -79.09 41.97 0.46 Allowed 'General case' 0 CA--C 1.54 0.586 0 O-C-N 121.3 -0.875 . . . . 4.8700000000000001 111.173 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 45.3 t -68.69 -43.9 75.12 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 107.115 -1.439 . . . . 2.4300000000000002 107.115 156.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 76.76 161.0 0.22 Allowed 'General case' 0 C--N 1.344 0.341 0 C-N-CA 126.688 1.995 . . . . 3.04 110.104 -174.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 10.8 m 72.05 -53.38 0.69 Allowed 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 125.183 1.393 . . . . 2.7400000000000002 112.039 -176.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 31.5 m -29.56 -54.65 0.15 Allowed 'General case' 0 C--O 1.223 -0.294 0 C-N-CA 127.278 2.231 . . . . 3.04 110.96 167.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.618 HG22 ' CG2' ' A' ' 36' ' ' VAL . 1.2 t -69.58 -36.37 70.62 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.048 0 N-CA-C 112.488 0.551 . . . . 3.2799999999999998 112.488 -174.239 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.27 -45.42 93.38 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 109.232 -0.655 . . . . 0.81000000000000005 109.232 173.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -57.54 -47.39 82.14 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 109.094 -0.706 . . . . 2.71 109.094 173.244 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.707 HG21 HD11 ' A' ' 35' ' ' LEU 0.251 53.9 mt -64.16 -44.84 97.61 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 O-C-N 121.571 -0.706 . . . . 1.95 111.296 -172.971 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -47.76 -51.79 20.98 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 119.383 0.992 . . . . 3.25 111.755 165.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 8.4 mmt85 -57.75 -38.22 74.99 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 118.011 -0.995 . . . . 4.5199999999999996 112.714 176.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 71.2 m-20 -63.2 -55.74 22.49 Favored 'General case' 0 C--O 1.222 -0.35 0 CA-C-N 120.237 1.38 . . . . 3.1499999999999999 108.03 177.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 17.5 mt -77.14 -51.34 11.16 Favored 'General case' 0 N--CA 1.434 -1.229 0 C-N-CA 124.621 1.168 . . . . 2.9199999999999999 112.308 -159.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 3.1 ttm105 -65.44 -13.44 58.76 Favored 'General case' 0 N--CA 1.421 -1.915 0 O-C-N 121.499 -0.751 . . . . 8.1199999999999992 112.682 -173.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.1 mtp180 -42.15 -64.57 0.57 Allowed 'General case' 0 N--CA 1.448 -0.529 0 CA-C-O 118.369 -0.824 . . . . 7.9500000000000002 111.068 160.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 169.76 -176.66 0.03 OUTLIER 'General case' 0 C--N 1.344 0.366 0 CA-C-N 119.012 0.824 . . . . 7.3499999999999996 110.794 -156.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 84.82 53.46 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 127.314 2.246 . . . . 5.3600000000000003 109.747 178.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 72.44 14.58 77.27 Favored Glycine 0 CA--C 1.527 0.826 0 CA-C-O 118.466 -1.186 . . . . 0.94999999999999996 114.668 168.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 1.1 mt -84.75 130.07 36.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 N-CA-C 107.091 -1.448 . . . . 1.8500000000000001 107.091 -178.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -137.57 43.03 2.31 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-O 122.734 1.254 . . . . 3.1099999999999999 111.223 160.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.5 t -170.21 147.63 3.16 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 128.858 2.863 . . . . 1.6000000000000001 105.187 134.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.424 ' H ' HG13 ' A' ' 34' ' ' ILE . 2.6 pp -77.72 159.62 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 N-CA-C 108.141 -1.059 . . . . 2.0299999999999998 108.141 176.109 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.707 HD11 HG21 ' A' ' 21' ' ' ILE . 2.5 pp -73.96 137.16 43.39 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 104.488 -2.412 . . . . 4.7400000000000002 104.488 158.272 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.618 ' CG2' HG22 ' A' ' 18' ' ' VAL . 2.1 t -160.46 150.85 5.52 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.104 0 N-CA-C 106.112 -1.81 . . . . 1.3999999999999999 106.112 123.047 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -158.73 53.54 0.42 Allowed 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 104.325 -2.472 . . . . 0.68000000000000005 104.325 165.019 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.588 HD23 ' C ' ' A' ' 38' ' ' LEU . 1.1 tt -66.11 -31.1 71.76 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 107.294 -1.373 . . . . 3.4399999999999999 107.294 -178.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 27.7 ttt -45.0 -41.95 7.86 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.108 1.363 . . . . 3.29 111.875 170.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -85.76 -55.58 3.9 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 108.524 -0.917 . . . . 1.78 108.524 171.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 143.17 43.98 0.05 OUTLIER Glycine 0 CA--C 1.523 0.553 0 C-N-CA 125.089 1.328 . . . . 0.81999999999999995 111.885 167.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 14.1 pttp -159.92 -179.3 7.69 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 118.078 0.939 . . . . 4.0899999999999999 108.9 -164.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.574 ' CB ' HD13 ' A' ' 35' ' ' LEU . . . -130.72 143.45 50.75 Favored 'General case' 0 N--CA 1.441 -0.877 0 C-N-CA 127.475 2.31 . . . . 0.87 108.953 -177.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -144.01 89.13 2.01 Favored 'General case' 0 C--N 1.341 0.238 0 C-N-CA 124.104 0.961 . . . . 3.8700000000000001 111.215 173.065 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 14.0 p -80.71 137.32 21.61 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.22 0 N-CA-C 108.901 -0.777 . . . . 2.04 108.901 -176.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 70.8 ttt180 -106.58 126.75 52.67 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 107.655 -1.239 . . . . 5.2000000000000002 107.655 171.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 7.9 p90 -157.48 175.88 13.38 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 123.384 0.674 . . . . 2.1699999999999999 109.844 -167.041 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 3.3 p30 -103.89 135.18 19.39 Favored Pre-proline 0 N--CA 1.451 -0.396 0 N-CA-C 107.752 -1.203 . . . . 3.0099999999999998 107.752 164.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -81.32 1.79 9.03 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 122.29 1.993 . . . . 2.5299999999999998 113.314 -174.01 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -91.87 -49.08 6.43 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-N 119.41 1.005 . . . . 1.0800000000000001 108.535 -167.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 24.4 t -58.78 -60.39 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.755 0 C-N-CA 124.354 1.062 . . . . 0.97999999999999998 109.855 175.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 19.2 tt -93.56 -53.42 8.5 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.233 0 CA-C-O 118.855 -0.593 . . . . 1.8200000000000001 112.258 -163.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 9.1 mm-40 101.16 129.72 0.02 OUTLIER Pre-proline 0 CA--C 1.541 0.598 0 C-N-CA 129.574 3.15 . . . . 2.9199999999999999 112.304 -175.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_exo -50.89 -48.95 18.53 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 124.787 3.658 . . . . 1.1200000000000001 116.71 177.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -54.45 -50.55 13.06 Favored 'Trans proline' 0 N--CA 1.442 -1.514 0 CA-C-N 120.66 1.271 . . . . 1.2 108.873 169.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 64.1 mtt -63.03 -44.07 96.93 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 120.528 -0.469 . . . . 2.4900000000000002 110.708 -167.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 16.2 tt -61.76 -35.19 66.15 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.25 0 C-N-CA 119.61 -0.836 . . . . 2.2799999999999998 111.686 -175.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -69.93 -58.03 4.33 Favored 'General case' 0 N--CA 1.452 -0.325 0 O-C-N 122.33 -0.231 . . . . 1.4099999999999999 110.875 171.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -47.98 -49.29 31.15 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 125.613 1.565 . . . . 3.1699999999999999 111.861 -174.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 16.2 m-30 -44.18 -40.42 5.03 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.748 0.819 . . . . 3.73 112.453 177.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 65.9 mt -65.16 -26.76 40.54 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 O-C-N 121.513 -0.742 . . . . 1.1499999999999999 110.66 -174.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 36.0 mtm180 -58.27 -61.21 2.74 Favored 'General case' 0 C--N 1.341 0.238 0 CA-C-N 118.939 0.791 . . . . 5.5199999999999996 109.642 174.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -60.59 -39.18 87.12 Favored 'General case' 0 N--CA 1.44 -0.974 0 C-N-CA 123.63 0.772 . . . . 4.5199999999999996 112.77 -166.081 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -98.36 -27.53 14.06 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 113.187 0.81 . . . . 2.2400000000000002 113.187 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -112.96 -82.14 1.14 Allowed Glycine 0 CA--C 1.526 0.743 0 CA-C-N 119.215 0.916 . . . . 2.25 111.968 -172.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -177.05 164.94 2.32 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.562 1.145 . . . . 4.3799999999999999 109.605 -162.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -59.83 115.17 7.16 Favored Glycine 0 N--CA 1.439 -1.148 0 N-CA-C 109.601 -1.4 . . . . 1.1699999999999999 109.601 -171.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -115.25 91.76 3.71 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 125.435 1.494 . . . . 1.0700000000000001 109.068 -169.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -84.39 119.14 24.76 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 108.263 -1.014 . . . . 2.5899999999999999 108.263 -178.584 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 8.3 p -81.23 141.9 14.53 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 C-N-CA 123.265 0.626 . . . . 2.2400000000000002 109.584 -174.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 15.0 mt -139.79 99.06 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 C-N-CA 124.817 1.247 . . . . 1.8200000000000001 107.675 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 . . . . . 0 CA--C 1.535 0.369 0 O-C-N 121.462 -0.774 . . . . 6.3600000000000003 109.755 174.252 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.4 m . . . . . 0 CA--C 1.533 0.303 0 N-CA-C 112.549 0.574 . . . . 3.3100000000000001 112.549 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 26.1 m -149.04 176.23 10.63 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 126.106 1.762 . . . . 1.75 107.558 -176.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 39.2 pttt -125.18 158.16 34.66 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-N 119.173 0.897 . . . . 3.7999999999999998 109.108 154.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 36.6 t -142.3 152.44 42.98 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 107.275 -1.38 . . . . 1.6200000000000001 107.275 175.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 54.3 m-85 -84.44 148.69 26.43 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 107.421 -1.325 . . . . 2.1499999999999999 107.421 176.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.431 ' HB ' ' HB3' ' A' ' 43' ' ' ALA . 5.6 mm -130.5 141.19 46.89 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.817 0 N-CA-C 104.61 -2.367 . . . . 2.0600000000000001 104.61 173.264 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -98.24 128.27 44.6 Favored 'General case' 0 N--CA 1.435 -1.189 0 N-CA-C 103.882 -2.636 . . . . 3.5899999999999999 103.882 166.172 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.4 p -126.41 122.53 61.4 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 C-N-CA 124.674 1.19 . . . . 2.3999999999999999 108.41 179.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.8 t -72.76 136.9 45.56 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 109.434 -0.58 . . . . 2.6800000000000002 109.434 -176.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 113.8 -52.19 0.66 Allowed Glycine 0 C--N 1.335 0.518 0 N-CA-C 108.146 -1.981 . . . . 2.8500000000000001 108.146 177.244 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 59.9 mtt 75.94 -69.96 0.15 Allowed 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 126.197 1.799 . . . . 4.25 110.314 158.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 11.8 t -112.13 11.74 20.4 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 125.907 1.683 . . . . 4.8399999999999999 109.957 174.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.442 ' SG ' ' HB2' ' A' ' 17' ' ' CYS 0.267 17.2 p -63.14 144.64 56.74 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 119.017 0.826 . . . . 3.25 109.436 -176.212 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -52.61 109.9 0.45 Allowed 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 116.212 -0.449 . . . . 3.3300000000000001 111.98 -158.179 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.7 m 69.23 6.72 5.83 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 125.355 1.462 . . . . 3.02 113.873 175.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.442 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 48.8 t -43.99 -49.06 8.75 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 123.765 1.745 . . . . 3.79 108.607 163.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -72.67 -46.64 53.55 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.521 0 CA-C-N 112.199 -2.273 . . . . 2.6000000000000001 109.856 -172.182 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.67 -42.06 87.58 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 110.212 -0.292 . . . . 1.1299999999999999 110.212 175.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -60.03 -60.44 3.83 Favored 'General case' 0 CA--C 1.521 -0.163 0 C-N-CA 124.571 1.148 . . . . 2.0499999999999998 108.455 178.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.437 HG23 ' CD2' ' A' ' 35' ' ' LEU . 1.7 mt -43.69 -54.72 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 C-N-CA 123.801 0.84 . . . . 1.8400000000000001 111.314 173.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -54.65 -50.05 69.11 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 119.702 1.137 . . . . 3.9199999999999999 111.517 176.102 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.94 -48.93 51.65 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.592 0.757 . . . . 4.8399999999999999 112.095 176.458 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.468 HD22 ' CD2' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -76.28 -60.39 2.36 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 118.139 0.427 . . . . 3.5699999999999998 111.766 -177.753 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.468 ' CD2' HD22 ' A' ' 24' ' ' ASN . 0.1 OUTLIER -70.57 -36.77 73.8 Favored 'General case' 0 C--O 1.22 -0.47 0 C-N-CA 125.756 1.623 . . . . 3.04 112.595 -152.679 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -21.5 -74.61 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 128.616 2.766 . . . . 7.7000000000000002 114.722 -158.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . 0.287 7.9 ptp180 -91.9 -29.9 16.43 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 127.339 2.255 . . . . 12.69 116.286 166.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 41.8 mm-40 -81.05 128.4 33.67 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 114.855 -1.066 . . . . 6.7999999999999998 108.868 -134.299 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 60.0 55.84 3.63 Favored 'General case' 0 N--CA 1.442 -0.825 0 CA-C-O 122.856 1.312 . . . . 5.0899999999999999 111.189 -171.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 76.16 30.87 56.52 Favored Glycine 0 CA--C 1.523 0.566 0 CA-C-N 114.006 -1.452 . . . . 1.26 112.742 162.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.6 mt -96.03 147.44 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 N-CA-C 108.322 -0.992 . . . . 2.0800000000000001 108.322 171.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -147.88 47.03 1.09 Allowed 'General case' 0 C--O 1.233 0.22 0 CA-C-O 122.309 1.052 . . . . 3.4199999999999999 111.815 158.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 10.3 t -165.83 148.0 7.28 Favored 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 126.995 2.118 . . . . 1.75 107.252 148.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.5 pp -82.4 134.35 27.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 CA-C-O 122.666 1.222 . . . . 2.4399999999999999 110.375 175.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.509 ' H ' ' CD2' ' A' ' 35' ' ' LEU . 0.4 OUTLIER -79.79 64.05 4.53 Favored 'General case' 0 N--CA 1.433 -1.295 0 C-N-CA 127.687 2.395 . . . . 4.71 111.624 -173.315 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.456 ' CG1' HD23 ' A' ' 38' ' ' LEU . 52.8 t -133.52 131.43 57.31 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 O-C-N 120.721 -1.237 . . . . 1.23 113.131 174.142 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -138.8 76.23 1.56 Allowed 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 105.217 -2.142 . . . . 0.87 105.217 152.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.456 HD23 ' CG1' ' A' ' 36' ' ' VAL . 0.3 OUTLIER -54.54 -39.78 68.01 Favored 'General case' 0 CA--C 1.511 -0.526 0 N-CA-C 109.595 -0.52 . . . . 3.3700000000000001 109.595 175.138 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 24.0 ttt -85.06 44.22 1.06 Allowed 'General case' 0 N--CA 1.442 -0.836 0 CA-C-O 121.767 0.794 . . . . 4.7999999999999998 109.1 -164.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -179.33 -36.71 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 129.013 2.925 . . . . 1.4199999999999999 107.076 -167.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 106.11 46.72 1.14 Allowed Glycine 0 C--N 1.336 0.569 0 C-N-CA 126.062 1.791 . . . . 0.87 108.983 157.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 24.8 mttm -155.27 175.14 14.24 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 108.392 -0.966 . . . . 4.6100000000000003 108.392 -157.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.431 ' HB3' ' HB ' ' A' ' 7' ' ' ILE . . . -144.2 142.6 30.61 Favored 'General case' 0 N--CA 1.44 -0.967 0 C-N-CA 125.315 1.446 . . . . 1.0800000000000001 107.978 -178.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -132.99 97.37 4.0 Favored 'General case' 0 C--N 1.338 0.103 0 N-CA-C 113.379 0.881 . . . . 3.27 113.379 171.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.3 p -81.11 114.96 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.518 0 N-CA-C 107.423 -1.325 . . . . 1.8200000000000001 107.423 -178.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 54.5 ttp180 -87.36 124.78 33.75 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 105.71 -1.959 . . . . 5.4299999999999997 105.71 163.114 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -158.22 170.72 21.62 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 122.96 0.504 . . . . 2.1499999999999999 110.6 -164.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 47.5 t-20 -108.53 88.26 4.97 Favored Pre-proline 0 N--CA 1.451 -0.421 0 C-N-CA 124.038 0.935 . . . . 2.6499999999999999 109.346 173.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -61.79 88.23 0.1 Allowed 'Trans proline' 0 N--CA 1.448 -1.163 0 C-N-CA 122.328 2.019 . . . . 1.6000000000000001 108.973 165.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -169.97 -57.56 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 130.423 3.489 . . . . 1.1799999999999999 105.101 169.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 65.7 t -58.45 -54.37 33.95 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 C-N-CA 124.879 1.272 . . . . 1.03 110.207 175.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.527 HG23 ' H ' ' A' ' 53' ' ' GLN . 8.4 tp -93.61 -73.02 0.48 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.364 0 CA-C-O 118.725 -0.655 . . . . 2.1400000000000001 111.93 -167.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.527 ' H ' HG23 ' A' ' 52' ' ' ILE . 0.0 OUTLIER 117.17 134.99 0.0 OUTLIER Pre-proline 0 N--CA 1.472 0.626 0 C-N-CA 130.753 3.621 . . . . 2.8900000000000001 108.185 -176.365 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -50.24 -50.86 12.24 Favored 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 123.595 2.863 . . . . 1.03 114.449 172.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -50.07 -54.31 5.66 Favored 'Trans proline' 0 N--CA 1.444 -1.39 0 CA-C-N 120.451 1.197 . . . . 0.80000000000000004 110.069 167.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 62.0 mtt -62.45 -37.61 86.57 Favored 'General case' 0 C--N 1.342 0.261 0 C-N-CA 118.336 -1.346 . . . . 2.0600000000000001 111.469 -170.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.451 HD12 HG21 ' A' ' 52' ' ' ILE . 3.5 tt -70.37 -45.23 75.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-N 118.808 0.731 . . . . 2.23 110.312 178.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -58.8 -32.85 69.72 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.102 0.561 . . . . 1.3200000000000001 112.254 176.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -71.78 -60.13 2.39 Favored 'General case' 0 N--CA 1.441 -0.895 0 C-N-CA 126.388 1.875 . . . . 3.5600000000000001 111.585 176.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -41.63 -45.32 3.35 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.79 0.836 . . . . 3.6400000000000001 111.791 -173.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 49.7 mt -57.39 -52.48 56.31 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 C-N-CA 123.88 0.872 . . . . 1.1299999999999999 110.923 -177.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 1.3 ptt85 -71.5 -49.68 38.73 Favored 'General case' 0 CA--C 1.521 -0.139 0 N-CA-C 109.596 -0.52 . . . . 3.9199999999999999 109.596 -177.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -59.61 -34.51 72.84 Favored 'General case' 0 N--CA 1.441 -0.896 0 C-N-CA 123.387 0.675 . . . . 6.3899999999999997 111.627 -173.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 86.1 mt -83.0 -47.89 11.23 Favored 'General case' 0 C--N 1.34 0.194 0 CA-C-N 118.754 0.706 . . . . 2.77 111.446 170.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -95.98 -92.27 1.78 Allowed Glycine 0 CA--C 1.526 0.773 0 N-CA-C 111.692 -0.563 . . . . 1.8400000000000001 111.692 -174.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -135.53 -72.13 0.47 Allowed 'General case' 0 CA--C 1.513 -0.469 0 CA-C-O 121.679 0.752 . . . . 3.4900000000000002 112.962 -153.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 173.73 119.23 0.53 Allowed Glycine 0 N--CA 1.441 -1.028 0 N-CA-C 107.935 -2.066 . . . . 1.49 107.935 -156.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -156.5 161.41 40.02 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 122.904 0.482 . . . . 1.1599999999999999 110.996 -173.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 26.2 m -153.94 148.57 26.34 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 124.031 0.932 . . . . 2.9199999999999999 108.599 178.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 14.3 p -82.3 143.75 11.52 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 123.624 0.77 . . . . 2.3900000000000001 109.74 -177.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 22.5 mm -133.13 140.16 47.76 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 C-N-CA 125.774 1.629 . . . . 2.0 107.528 -178.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 . . . . . 0 N--CA 1.453 -0.322 0 C-N-CA 123.741 0.817 . . . . 4.9400000000000004 109.108 179.045 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.4 m . . . . . 0 N--CA 1.454 -0.236 0 N-CA-C 108.605 -0.887 . . . . 3.02 108.605 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 23.0 t -141.93 169.56 17.37 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 108.956 -0.757 . . . . 2.5499999999999998 108.956 171.083 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 71.9 tttt -104.72 158.33 16.58 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.309 1.443 . . . . 3.7400000000000002 107.211 163.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 36.3 t -155.55 155.09 32.75 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 109.046 -0.724 . . . . 1.3600000000000001 109.046 167.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 5.1 m-30 -106.45 135.01 48.7 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 125.848 1.659 . . . . 2.3100000000000001 108.771 -178.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.3 mm -129.06 139.75 51.05 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 N-CA-C 105.463 -2.051 . . . . 2.1099999999999999 105.463 -173.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 51.3 tp60 -112.2 122.93 49.12 Favored 'General case' 0 N--CA 1.424 -1.728 0 N-CA-C 104.693 -2.336 . . . . 2.8900000000000001 104.693 -179.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 15.7 m -105.3 173.08 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 C-N-CA 124.378 1.071 . . . . 2.5600000000000001 108.687 178.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -134.42 88.73 2.48 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.562 0.745 . . . . 3.04 111.045 -173.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 154.9 -62.81 0.35 Allowed Glycine 0 CA--C 1.524 0.619 0 N-CA-C 107.667 -2.173 . . . . 3.7999999999999998 107.667 174.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 1.9 mtt 66.38 -71.71 0.09 Allowed 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 126.691 1.997 . . . . 3.73 111.213 170.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 33.1 p -79.47 52.85 1.44 Allowed 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 124.42 1.088 . . . . 5.0499999999999998 108.496 176.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 55.8 m -92.42 176.29 6.52 Favored 'General case' 0 N--CA 1.445 -0.725 0 C-N-CA 124.794 1.238 . . . . 2.7599999999999998 107.895 175.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -75.64 73.42 2.63 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 121.454 0.645 . . . . 3.3500000000000001 110.097 166.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.5 m 74.94 26.99 1.22 Allowed 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 115.24 -0.891 . . . . 2.46 113.129 159.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 69.9 m -44.27 -43.25 7.21 Favored 'General case' 0 CA--C 1.523 -0.075 0 C-N-CA 124.357 1.063 . . . . 3.0800000000000001 108.912 157.24 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 24.5 m -63.53 -50.97 76.14 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.001 0 CA-C-N 114.138 -1.392 . . . . 2.8399999999999999 109.993 -177.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -52.73 -43.82 65.97 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 122.994 0.518 . . . . 1.29 110.972 172.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -56.53 -50.77 70.88 Favored 'General case' 0 C--O 1.227 -0.123 0 N-CA-C 109.303 -0.628 . . . . 2.23 109.303 174.508 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.457 HG23 ' CD2' ' A' ' 25' ' ' LEU . 7.1 mt -58.44 -60.73 1.91 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 C-N-CA 123.541 0.736 . . . . 2.1000000000000001 109.039 -179.381 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -39.61 -54.92 1.95 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.942 1.297 . . . . 3.6299999999999999 112.259 172.02 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -59.83 -44.63 93.95 Favored 'General case' 0 CA--C 1.528 0.133 0 O-C-N 121.666 -0.646 . . . . 5.6299999999999999 112.422 178.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -56.83 -55.87 28.83 Favored 'General case' 0 C--O 1.226 -0.153 0 N-CA-C 108.4 -0.963 . . . . 2.8599999999999999 108.4 179.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.457 ' CD2' HG23 ' A' ' 21' ' ' ILE . 0.0 OUTLIER -74.84 -23.95 58.52 Favored 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 114.369 1.248 . . . . 2.2999999999999998 114.369 -172.325 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.55 -15.33 62.6 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 120.583 1.538 . . . . 6.5 114.802 -170.122 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 73.7 mtt180 -65.79 -19.55 65.93 Favored 'General case' 0 N--CA 1.462 0.142 0 N-CA-C 113.333 0.864 . . . . 7.2599999999999998 113.333 -157.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 71.25 23.25 4.09 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 125.08 1.352 . . . . 10.470000000000001 112.446 -172.065 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -76.46 59.3 1.44 Allowed 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 127.56 2.344 . . . . 5.6399999999999997 108.766 171.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 75.51 32.91 53.9 Favored Glycine 0 CA--C 1.535 1.311 0 C-N-CA 124.261 0.934 . . . . 1.4199999999999999 113.641 -178.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.45 HD12 ' HA ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -142.27 135.66 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 C-N-CA 127.212 2.205 . . . . 3.0699999999999998 105.665 -170.858 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 41.2 m-85 -145.29 48.13 1.28 Allowed 'General case' 0 C--O 1.233 0.195 0 CA-C-O 123.155 1.455 . . . . 3.2999999999999998 111.702 171.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 14.0 t -164.84 -178.64 5.35 Favored 'General case' 0 C--N 1.317 -0.841 0 C-N-CA 129.875 3.27 . . . . 2.0 106.135 151.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.494 HD13 ' H ' ' A' ' 34' ' ' ILE . 0.1 OUTLIER -125.2 127.49 72.16 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 C-N-CA 124.474 1.11 . . . . 2.5800000000000001 109.42 174.243 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.421 ' O ' ' HB1' ' A' ' 43' ' ' ALA . 0.9 OUTLIER -78.35 71.0 4.79 Favored 'General case' 0 N--CA 1.439 -0.993 0 O-C-N 121.099 -1.001 . . . . 4.7699999999999996 110.85 -176.834 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 18.7 t -123.9 139.83 49.19 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.885 0 CA-C-O 122.183 0.992 . . . . 1.3799999999999999 109.414 159.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -155.62 58.95 0.62 Allowed 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 126.418 1.887 . . . . 0.80000000000000004 107.139 168.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.2 pp -56.86 -32.14 65.51 Favored 'General case' 0 CA--C 1.51 -0.566 0 C-N-CA 123.45 0.7 . . . . 3.3599999999999999 112.474 -175.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 65.1 mtt -65.53 -40.44 92.94 Favored 'General case' 0 N--CA 1.441 -0.898 0 C-N-CA 119.761 -0.775 . . . . 4.6500000000000004 108.913 -165.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -76.84 -42.22 41.09 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.721 0.808 . . . . 1.48 109.842 167.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 111.88 57.16 0.46 Allowed Glycine 0 C--N 1.338 0.652 0 N-CA-C 109.426 -1.469 . . . . 1.02 109.426 176.061 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -160.24 -178.37 6.91 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 107.002 -1.481 . . . . 4.6100000000000003 107.002 -169.149 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.421 ' HB1' ' O ' ' A' ' 35' ' ' LEU . . . -146.35 130.1 17.09 Favored 'General case' 0 N--CA 1.434 -1.259 0 C-N-CA 126.334 1.854 . . . . 0.97999999999999998 106.001 -172.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -135.94 114.36 11.69 Favored 'General case' 0 C--N 1.342 0.261 0 CA-C-N 120.926 1.693 . . . . 2.5099999999999998 113.277 177.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.2 p -90.12 150.18 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.273 0 C-N-CA 125.02 1.328 . . . . 1.49 110.17 -171.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 35.4 ttm180 -125.75 131.02 52.6 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 104.863 -2.273 . . . . 4.1399999999999997 104.863 159.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 3.8 p90 -160.18 169.73 22.66 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-N 118.219 0.463 . . . . 2.2400000000000002 111.569 -165.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . 0.271 49.1 p30 -104.3 97.18 11.24 Favored Pre-proline 0 CA--C 1.542 0.671 0 N-CA-C 113.234 0.827 . . . . 3.9900000000000002 113.234 170.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -72.51 73.19 2.86 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 122.526 2.15 . . . . 1.46 111.331 177.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -150.27 -57.39 0.18 Allowed 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 126.548 1.939 . . . . 1.3400000000000001 106.041 171.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 78.6 t -58.62 -54.6 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.787 0 C-N-CA 123.778 0.831 . . . . 1.3200000000000001 109.299 171.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.429 HG23 ' H ' ' A' ' 53' ' ' GLN 0.265 2.5 tp -90.54 -72.97 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-O 118.306 -0.854 . . . . 1.75 112.103 -165.613 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.429 ' H ' HG23 ' A' ' 52' ' ' ILE . 0.0 OUTLIER 112.98 136.66 0.0 OUTLIER Pre-proline 0 N--CA 1.476 0.87 0 C-N-CA 131.122 3.769 . . . . 3.0299999999999998 108.653 -177.48 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -51.03 -51.13 11.85 Favored 'Trans proline' 0 CA--C 1.534 0.503 0 C-N-CA 124.054 3.17 . . . . 1.1100000000000001 115.345 174.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -53.8 -48.83 19.64 Favored 'Trans proline' 0 N--CA 1.444 -1.409 0 CA-C-N 120.448 1.196 . . . . 0.77000000000000002 110.282 167.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 74.5 mtp -69.13 -33.16 73.01 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 118.301 -1.359 . . . . 2.0600000000000001 110.65 -168.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 6.9 tt -66.42 -50.95 63.26 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 CA-C-N 119.935 1.243 . . . . 2.3700000000000001 110.324 179.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -51.65 -53.97 33.07 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.09 0.956 . . . . 1.0900000000000001 110.814 176.012 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 54.4 mm-40 -65.31 -38.08 89.09 Favored 'General case' 0 N--CA 1.429 -1.509 0 CA-C-O 118.866 -0.588 . . . . 3.5299999999999998 111.999 -177.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -54.54 -34.25 61.47 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 120.192 1.36 . . . . 4.3399999999999999 111.207 173.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.6 mm -60.47 -53.28 51.0 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 N-CA-C 107.746 -1.205 . . . . 2.1400000000000001 107.746 172.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 15.7 mtp-105 -55.58 -47.73 75.97 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 125.161 1.384 . . . . 6.3600000000000003 114.301 -177.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -45.92 -35.38 4.57 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 127.023 2.129 . . . . 3.1400000000000001 112.933 -175.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 58.8 mt -79.11 -16.39 56.78 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 122.93 0.492 . . . . 2.0299999999999998 111.196 -174.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 130.93 50.06 0.11 Allowed Glycine 0 CA--C 1.527 0.805 0 C-N-CA 125.182 1.372 . . . . 2.5699999999999998 111.168 170.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -136.39 169.62 17.38 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-O 123.519 1.628 . . . . 3.48 113.673 -168.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -115.18 126.89 7.39 Favored Glycine 0 N--CA 1.442 -0.957 0 N-CA-C 105.949 -2.861 . . . . 1.76 105.949 168.213 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -153.24 81.52 1.19 Allowed 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 124.533 1.133 . . . . 1.6299999999999999 108.3 -172.223 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -84.8 138.04 32.83 Favored 'General case' 0 C--O 1.225 -0.227 0 C-N-CA 123.704 0.802 . . . . 2.4399999999999999 108.882 -175.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 97.0 t -84.89 109.19 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 N-CA-C 108.552 -0.907 . . . . 1.6899999999999999 108.552 -177.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 18.9 mm -130.8 60.15 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 C-N-CA 125.156 1.383 . . . . 2.9500000000000002 109.002 -171.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 . . . . . 0 C--N 1.328 -0.356 0 CA-C-N 115.397 -0.819 . . . . 3.75 109.478 155.086 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 88.4 p . . . . . 0 CA--C 1.531 0.236 0 N-CA-C 106.999 -1.482 . . . . 2.4500000000000002 106.999 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 18.6 m -155.34 153.98 31.34 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 124.902 1.281 . . . . 2.0699999999999998 108.022 177.121 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 9.3 mtmp? -91.82 161.01 15.03 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 123.33 0.652 . . . . 3.3599999999999999 111.937 176.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 49.3 t -155.25 157.71 37.71 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 105.974 -1.861 . . . . 1.3300000000000001 105.974 166.12 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -98.34 146.4 25.72 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 119.804 1.184 . . . . 3.4100000000000001 108.007 171.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.509 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 12.0 mm -128.16 113.42 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 N-CA-C 105.138 -2.171 . . . . 2.1200000000000001 105.138 174.01 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 16.6 tp60 -82.38 124.49 30.06 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 104.825 -2.287 . . . . 2.8900000000000001 104.825 172.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.5 p -117.72 99.02 7.3 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-O 122.175 0.988 . . . . 2.3599999999999999 110.597 -169.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 7.0 m -67.03 94.3 0.33 Allowed 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 109.155 -0.683 . . . . 2.7799999999999998 109.155 -179.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 135.24 3.94 2.67 Favored Glycine 0 C--O 1.221 -0.705 0 C-N-CA 125.124 1.345 . . . . 2.54 113.047 -175.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -43.98 -46.89 8.49 Favored 'General case' 0 C--N 1.321 -0.647 0 O-C-N 121.561 -0.964 . . . . 3.27 110.612 162.277 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 15.3 t -74.43 12.13 0.84 Allowed 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.192 0.997 . . . . 5.9699999999999998 112.887 176.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 16.9 t -57.4 -41.77 80.95 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 107.011 -1.477 . . . . 2.5600000000000001 107.011 160.145 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 84.27 145.3 0.07 Allowed 'General case' 0 C--N 1.348 0.52 0 C-N-CA 127.934 2.494 . . . . 3.3199999999999998 110.138 -175.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.6 m 71.49 -30.91 0.22 Allowed 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 115.083 1.512 . . . . 3.0499999999999998 115.083 174.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 11.0 m -62.83 -18.21 62.49 Favored 'General case' 0 CA--C 1.517 -0.294 0 C-N-CA 128.825 2.85 . . . . 3.5299999999999998 111.821 -175.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 14.0 m -41.12 -43.78 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 N-CA-C 112.162 0.431 . . . . 2.25 112.162 159.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -52.77 -46.36 67.52 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.088 0.955 . . . . 1.1399999999999999 111.547 173.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -59.19 -51.98 67.65 Favored 'General case' 0 C--O 1.224 -0.249 0 N-CA-C 108.671 -0.863 . . . . 2.0099999999999998 108.671 175.353 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 38.4 mm -53.54 -59.39 1.91 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 C-N-CA 123.601 0.76 . . . . 2.04 109.123 -179.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -42.54 -61.07 1.31 Allowed 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.057 1.343 . . . . 3.3999999999999999 110.977 175.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.93 -48.93 78.21 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 119.369 -0.348 . . . . 7.8600000000000003 110.933 -175.231 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -49.86 -60.32 3.02 Favored 'General case' 0 CA--C 1.519 -0.228 0 C-N-CA 123.989 0.916 . . . . 3.1200000000000001 108.839 -179.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.611 ' CD2' HD21 ' A' ' 35' ' ' LEU . 0.0 OUTLIER -70.57 -32.14 69.44 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 115.623 -0.717 . . . . 2.1499999999999999 109.499 -170.397 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . 0.578 68.6 mtp180 -63.0 3.17 0.25 Allowed 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 117.827 2.529 . . . . 6.1600000000000001 117.827 163.217 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 3.5 mmt85 -43.58 -34.09 1.32 Allowed 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 116.914 -1.914 . . . . 7.8300000000000001 112.233 146.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . 0.25 4.2 mt-10 78.86 33.15 0.26 Allowed 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 127.191 2.196 . . . . 8.8100000000000005 112.135 176.436 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 80.1 mt-10 -73.55 69.62 1.25 Allowed 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 127.101 2.161 . . . . 5.9299999999999997 110.436 179.222 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 67.15 28.43 73.74 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 123.453 0.549 . . . . 1.0600000000000001 111.932 -179.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.0 mm -98.3 140.12 18.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 C-N-CA 128.416 2.686 . . . . 2.2799999999999998 109.208 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -148.47 42.51 0.99 Allowed 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 122.404 1.097 . . . . 3.9900000000000002 113.12 163.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 33.6 t -166.87 149.41 6.4 Favored 'General case' 0 C--N 1.317 -0.805 0 C-N-CA 131.01 3.724 . . . . 2.02 104.828 144.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.7 pp -83.45 151.73 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 N-CA-C 108.157 -1.053 . . . . 1.9199999999999999 108.157 163.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.611 HD21 ' CD2' ' A' ' 25' ' ' LEU . 0.4 OUTLIER -87.22 78.55 8.8 Favored 'General case' 0 N--CA 1.436 -1.138 0 C-N-CA 127.185 2.194 . . . . 4.4400000000000004 110.939 178.005 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 24.5 t -134.99 137.51 50.5 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 CA-C-O 121.368 0.604 . . . . 1.3300000000000001 110.145 165.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -155.92 58.47 0.6 Allowed 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 113.912 -1.494 . . . . 0.95999999999999996 107.397 164.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -63.61 -28.6 70.03 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.058 0.943 . . . . 3.3100000000000001 110.39 -173.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 63.3 mtt -46.37 -41.34 13.4 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.311 0.644 . . . . 4.5999999999999996 111.666 170.027 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -88.68 -41.52 12.55 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 122.769 0.428 . . . . 1.71 109.95 172.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 113.18 53.2 0.47 Allowed Glycine 0 C--N 1.335 0.488 0 N-CA-C 108.607 -1.797 . . . . 1.01 108.607 179.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 37.6 mtmt -151.71 175.41 12.42 Favored 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 108.293 -1.003 . . . . 3.7799999999999998 108.293 -164.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.525 ' HB1' HD12 ' A' ' 35' ' ' LEU . . . -148.0 119.25 7.8 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 105.646 -1.983 . . . . 0.93999999999999995 105.646 -174.089 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -128.24 96.94 4.59 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 123.553 0.741 . . . . 3.2599999999999998 111.433 -171.34 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 10.7 p -81.62 147.93 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.285 0 C-N-CA 123.226 0.61 . . . . 1.4399999999999999 109.362 -170.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 21.5 ttt-85 -123.13 127.76 49.14 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 105.774 -1.936 . . . . 5.8799999999999999 105.774 156.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 3.8 p90 -157.88 175.04 14.37 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 108.426 -0.953 . . . . 2.0600000000000001 108.426 -169.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -109.12 104.3 54.67 Favored Pre-proline 0 CA--C 1.537 0.467 0 CA-C-O 118.579 -0.724 . . . . 2.98 111.647 176.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -70.78 76.61 1.52 Allowed 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 123.257 2.638 . . . . 1.5700000000000001 111.571 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -165.53 -46.97 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 126.524 1.929 . . . . 1.3899999999999999 107.224 167.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 99.2 t -62.71 -45.54 98.57 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.885 0 C-N-CA 125.148 1.379 . . . . 1.1899999999999999 110.056 177.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.528 HG23 ' H ' ' A' ' 53' ' ' GLN 0.273 6.0 tp -113.17 -73.32 0.63 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.303 0 CA-C-O 118.16 -0.924 . . . . 1.99 112.187 -167.865 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.528 ' H ' HG23 ' A' ' 52' ' ' ILE . 27.8 mm100 110.86 131.93 0.0 OUTLIER Pre-proline 0 CA--C 1.54 0.588 0 C-N-CA 129.424 3.09 . . . . 3.4700000000000002 111.757 174.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -44.86 -53.68 4.93 Favored 'Trans proline' 0 CA--C 1.534 0.516 0 C-N-CA 125.23 3.954 . . . . 1.3100000000000001 116.427 176.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_endo -53.04 -47.29 28.34 Favored 'Trans proline' 0 N--CA 1.447 -1.222 0 CA-C-N 120.825 1.33 . . . . 1.0 110.022 172.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 64.7 mtt -62.4 -46.41 88.71 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 118.181 -0.914 . . . . 2.1299999999999999 111.41 -177.079 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 18.0 pt -61.93 -45.08 99.49 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-N 120.616 1.553 . . . . 2.3100000000000001 111.318 176.094 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -53.93 -52.65 59.91 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 121.195 0.521 . . . . 1.02 110.443 179.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 62.1 mm-40 -61.43 -48.49 80.95 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-O 118.359 -0.829 . . . . 3.5899999999999999 111.853 177.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -47.25 -42.44 20.57 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 119.659 1.118 . . . . 3.79 111.385 176.281 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 54.8 mt -67.05 -40.2 84.96 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 O-C-N 122.037 -0.414 . . . . 1.0 110.186 178.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 54.6 mtt180 -64.74 -50.62 66.15 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.647 0.779 . . . . 4.4500000000000002 111.934 177.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -43.66 -55.13 4.55 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 126.462 1.905 . . . . 2.9399999999999999 111.674 -175.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.38 -31.04 12.58 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 113.043 0.757 . . . . 1.8200000000000001 113.043 -179.523 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -114.9 -85.67 1.31 Allowed Glycine 0 CA--C 1.528 0.891 0 CA-C-N 119.148 0.885 . . . . 2.04 113.911 -165.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -147.81 156.03 42.29 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 113.558 0.948 . . . . 2.9399999999999999 113.558 -146.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -70.03 82.3 0.33 Allowed Glycine 0 N--CA 1.444 -0.786 0 CA-C-N 114.629 -1.169 . . . . 1.5 111.112 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -82.72 144.42 30.22 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 125.229 1.412 . . . . 1.1200000000000001 109.655 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.6 t -142.92 139.97 30.96 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 106.007 -1.849 . . . . 2.46 106.007 165.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.6 m -83.67 145.63 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 N-CA-C 109.586 -0.524 . . . . 2.54 109.586 -176.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 14.9 mm -141.27 147.73 22.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 C-N-CA 126.064 1.746 . . . . 2.21 107.309 -177.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 . . . . . 0 CA--C 1.531 0.244 0 C-N-CA 126.351 1.86 . . . . 3.7999999999999998 106.355 168.152 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.0 m . . . . . 0 N--CA 1.451 -0.393 0 N-CA-C 108.142 -1.058 . . . . 2.52 108.142 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.1 m -109.18 144.02 37.82 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 126.247 1.819 . . . . 2.0099999999999998 108.116 -176.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 35.5 tttt -95.54 164.02 12.97 Favored 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 123.37 0.668 . . . . 4.71 110.611 -178.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 7.8 p -153.99 174.31 14.83 Favored 'General case' 0 C--O 1.232 0.16 0 N-CA-C 109.141 -0.689 . . . . 2.02 109.141 156.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -122.54 142.11 50.95 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 125.348 1.459 . . . . 2.6699999999999999 108.296 -175.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.406 ' HB ' ' HB3' ' A' ' 43' ' ' ALA . 10.9 mt -146.0 132.61 14.25 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 N-CA-C 106.812 -1.551 . . . . 1.5600000000000001 106.812 -167.328 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 12.5 tp60 -84.2 125.35 32.11 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 105.508 -2.034 . . . . 3.5899999999999999 105.508 165.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 6.7 p -110.37 101.98 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 C-N-CA 124.341 1.057 . . . . 2.3100000000000001 108.336 177.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 21.0 m -71.69 80.79 0.85 Allowed 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 108.974 -0.751 . . . . 2.5299999999999998 108.974 176.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -171.19 -52.59 0.04 OUTLIER Glycine 0 CA--C 1.53 1.012 0 C-N-CA 129.02 3.2 . . . . 2.29 106.977 172.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 63.8 mtt 62.92 -66.38 0.09 Allowed 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 127.489 2.315 . . . . 3.9399999999999999 112.319 175.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 14.6 t -151.72 53.38 0.83 Allowed 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.036 1.334 . . . . 4.96 107.751 173.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.0 p -43.7 -50.29 7.6 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.586 1.154 . . . . 3.1000000000000001 109.784 173.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -172.52 93.99 0.13 Allowed 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 126.748 2.019 . . . . 3.1800000000000002 106.87 156.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.7 m 59.11 42.48 18.83 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 121.562 0.696 . . . . 2.6299999999999999 110.548 -173.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 6.9 t -43.34 -41.99 4.33 Favored 'General case' 0 N--CA 1.461 0.109 0 C-N-CA 126.766 2.026 . . . . 4.0300000000000002 108.192 166.12 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 4.9 m -66.99 -53.32 35.1 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.972 0 C-N-CA 125.532 1.533 . . . . 2.1899999999999999 110.935 -173.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -50.78 -47.85 59.55 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.136 0.975 . . . . 0.90000000000000002 109.493 171.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -55.43 -53.29 58.05 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 108.927 -0.768 . . . . 2.1099999999999999 108.927 177.504 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.454 HG21 HG23 ' A' ' 36' ' ' VAL . 1.1 mp -53.69 -54.94 15.98 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 C-N-CA 124.469 1.108 . . . . 2.0499999999999998 110.386 178.396 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -48.91 -60.3 2.87 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 119.429 1.013 . . . . 2.96 109.541 -178.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 8.8 mpt_? -60.6 -38.65 85.4 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 115.131 -0.94 . . . . 6.4699999999999998 110.71 -176.059 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -62.24 -60.13 4.03 Favored 'General case' 0 C--O 1.227 -0.088 0 C-N-CA 122.686 0.394 . . . . 3.2200000000000002 110.208 177.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.412 ' CD2' HD21 ' A' ' 35' ' ' LEU . 0.0 OUTLIER -75.87 -64.6 1.05 Allowed 'General case' 0 N--CA 1.437 -1.11 0 CA-C-N 116.732 -0.213 . . . . 2.21 110.552 -159.793 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.53 -15.25 0.63 Allowed 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 115.665 1.728 . . . . 6.3300000000000001 115.665 -162.435 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -31.25 -59.02 0.24 Allowed 'General case' 0 N--CA 1.439 -0.99 0 C-N-CA 126.361 1.864 . . . . 6.9800000000000004 109.805 -175.077 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . 0.313 0.0 OUTLIER -167.15 -108.52 0.01 OUTLIER 'General case' 0 N--CA 1.447 -0.616 0 O-C-N 125.043 1.464 . . . . 7.3399999999999999 108.027 -171.113 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 44.48 31.16 0.57 Allowed 'General case' 0 C--N 1.314 -0.966 0 C-N-CA 127.256 2.222 . . . . 4.8600000000000003 114.628 156.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 60.21 31.09 72.27 Favored Glycine 0 CA--C 1.53 1.008 0 CA-C-O 118.483 -1.176 . . . . 0.95999999999999996 113.537 -178.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 1.4 mp -78.43 139.31 18.69 Favored 'Isoleucine or valine' 0 C--N 1.34 0.167 0 CA-C-N 119.196 1.498 . . . . 2.5299999999999998 107.529 169.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -148.22 36.45 0.83 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 120.382 -0.527 . . . . 6.5899999999999999 112.275 158.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 34.0 t -169.36 143.64 2.91 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 130.117 3.367 . . . . 1.99 104.32 139.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.7 pp -82.09 147.16 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 CA-C-N 119.683 1.129 . . . . 1.95 109.06 172.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.55 ' HB2' ' HB1' ' A' ' 43' ' ' ALA . 0.4 OUTLIER -79.41 80.39 5.78 Favored 'General case' 0 N--CA 1.44 -0.948 0 C-N-CA 125.77 1.628 . . . . 4.6200000000000001 111.384 -179.765 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.454 HG23 HG21 ' A' ' 21' ' ' ILE . 85.6 t -130.64 138.9 52.57 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.121 0 CA-C-O 121.499 0.666 . . . . 1.5900000000000001 109.252 162.523 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -153.73 57.02 0.74 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 113.666 -1.607 . . . . 0.83999999999999997 107.364 165.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -73.01 -15.58 61.52 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 114.913 -1.04 . . . . 3.0899999999999999 111.623 -172.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 93.7 mtp -49.43 -35.94 20.79 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 121.485 -0.76 . . . . 3.5899999999999999 110.885 162.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -95.39 -46.82 6.55 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.391 0.676 . . . . 1.9399999999999999 110.483 170.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 111.25 63.56 0.49 Allowed Glycine 0 C--N 1.339 0.722 0 N-CA-C 107.809 -2.117 . . . . 0.97999999999999998 107.809 -171.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 4.4 pttt -160.82 175.4 12.61 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 118.279 1.04 . . . . 4.3700000000000001 108.541 -178.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.55 ' HB1' ' HB2' ' A' ' 35' ' ' LEU . . . -123.36 125.67 45.43 Favored 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 128.038 2.535 . . . . 1.1399999999999999 107.456 -176.216 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -140.22 92.75 2.56 Favored 'General case' 0 N--CA 1.457 -0.104 0 CA-C-O 122.01 0.909 . . . . 3.21 113.063 175.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.7 p -79.16 153.38 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.21 0 C-N-CA 125.405 1.482 . . . . 1.5 109.219 -172.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 65.0 ttt180 -122.61 141.05 52.13 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 106.504 -1.665 . . . . 5.3799999999999999 106.504 159.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 32.5 p90 -152.04 159.09 43.8 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 122.918 0.487 . . . . 2.5099999999999998 110.18 -165.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -98.19 98.74 6.0 Favored Pre-proline 0 CA--C 1.539 0.525 0 C-N-CA 123.676 0.791 . . . . 2.9399999999999999 110.329 170.245 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -75.22 75.99 3.62 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 122.765 2.31 . . . . 1.95 111.203 -176.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -159.51 -43.71 0.05 Allowed 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 125.235 1.414 . . . . 1.6000000000000001 108.915 169.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 33.9 t -52.13 -56.53 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.737 0 C-N-CA 124.452 1.101 . . . . 1.45 109.1 169.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.451 HG23 ' H ' ' A' ' 53' ' ' GLN . 6.4 tt -124.69 -128.5 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.44 -0.957 0 CA-C-N 114.603 -1.181 . . . . 2.6699999999999999 108.817 -167.417 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.451 ' H ' HG23 ' A' ' 52' ' ' ILE . 4.9 tp60 -175.18 112.65 0.28 Allowed Pre-proline 0 CA--C 1.539 0.542 0 N-CA-C 108.686 -0.857 . . . . 2.3399999999999999 108.686 -159.309 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -47.59 -44.51 25.63 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 124.728 3.619 . . . . 1.5600000000000001 116.767 176.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -54.33 -56.83 2.19 Favored 'Trans proline' 0 N--CA 1.445 -1.373 0 CA-C-N 121.212 1.469 . . . . 1.24 109.687 167.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 87.1 mtp -53.56 -48.46 69.11 Favored 'General case' 0 C--N 1.342 0.247 0 CA-C-O 119.065 -0.493 . . . . 2.5800000000000001 112.317 -175.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 3.6 pt -60.38 -41.14 86.26 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 CA-C-N 119.155 0.889 . . . . 2.9900000000000002 111.829 -177.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.96 -60.16 4.23 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 119.704 1.138 . . . . 1.6299999999999999 111.038 169.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -46.12 -52.69 11.71 Favored 'General case' 0 N--CA 1.442 -0.867 0 C-N-CA 126.497 1.919 . . . . 3.4500000000000002 112.341 -174.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -44.14 -39.81 4.57 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.647 0.779 . . . . 3.96 112.972 -179.484 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 43.0 mt -61.32 -36.96 76.37 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 C-N-CA 122.81 0.444 . . . . 1.46 110.005 -178.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 60.2 mtt180 -62.52 -62.04 2.02 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 124.237 1.015 . . . . 4.3300000000000001 108.982 178.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -39.4 -52.24 2.08 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 124.987 1.315 . . . . 4.9500000000000002 112.57 173.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.6 pp -83.35 -18.19 39.74 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 113.969 1.1 . . . . 2.3500000000000001 113.969 -176.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -171.47 -66.15 0.04 OUTLIER Glycine 0 CA--C 1.533 1.199 0 CA-C-N 120.018 1.281 . . . . 1.6599999999999999 115.757 -178.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -130.22 146.82 51.88 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 122.058 0.932 . . . . 3.23 113.5 -147.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -75.42 81.8 0.94 Allowed Glycine 0 N--CA 1.449 -0.442 0 CA-C-N 115.516 -0.765 . . . . 1.47 112.276 -167.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -83.22 90.7 7.14 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 126.335 1.854 . . . . 1.3600000000000001 110.507 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 20.0 p -99.55 126.83 45.59 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 125.161 1.384 . . . . 2.3399999999999999 108.439 177.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 90.3 t -82.64 130.23 36.1 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.712 0 C-N-CA 124.523 1.129 . . . . 1.79 109.494 -173.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 24.5 mt -142.06 63.37 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 C-N-CA 125.503 1.521 . . . . 2.29 108.285 -175.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.539 0.525 0 N-CA-C 109.171 -0.677 . . . . 4.9400000000000004 109.171 168.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.6 p . . . . . 0 C--O 1.235 0.317 0 CA-C-O 122.551 1.167 . . . . 2.6299999999999999 108.723 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.8 p -97.31 172.4 7.81 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 127.795 2.438 . . . . 2.0800000000000001 109.733 -169.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.98 153.6 50.17 Favored 'General case' 0 C--N 1.339 0.129 0 C-N-CA 122.848 0.459 . . . . 3.7200000000000002 111.12 -179.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 41.1 t -146.8 155.75 42.6 Favored 'General case' 0 C--O 1.231 0.107 0 C-N-CA 124.95 1.3 . . . . 1.6100000000000001 109.13 -175.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -97.39 136.88 37.21 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 126.081 1.752 . . . . 2.7999999999999998 108.145 174.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.1 mm -139.94 123.53 18.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 107.078 -1.453 . . . . 2.1099999999999999 107.078 -177.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 5.9 mm-40 -77.93 159.37 28.89 Favored 'General case' 0 N--CA 1.455 -0.194 0 O-C-N 120.745 -1.222 . . . . 3.7000000000000002 110.228 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.4 p -137.91 139.75 42.06 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 O-C-N 123.469 0.481 . . . . 2.9399999999999999 111.925 -172.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.3 m -76.77 63.89 2.25 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.436 1.095 . . . . 3.7400000000000002 113.306 -176.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -161.03 -60.44 0.02 OUTLIER Glycine 0 C--O 1.227 -0.293 0 N-CA-C 105.98 -2.848 . . . . 3.5099999999999998 105.98 157.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 9.4 ttm 54.39 20.79 2.89 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.474 1.11 . . . . 4.7800000000000002 111.421 -176.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 61.4 m -160.99 -38.67 0.05 OUTLIER 'General case' 0 C--N 1.335 -0.062 0 C-N-CA 124.61 1.164 . . . . 5.6200000000000001 109.856 -156.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 28.4 p -59.04 132.85 55.26 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 108.452 -0.944 . . . . 3.3399999999999999 108.452 -179.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -53.53 -31.35 45.95 Favored 'General case' 0 CA--C 1.535 0.374 0 O-C-N 121.314 -0.866 . . . . 4.0099999999999998 110.491 179.492 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.4 m -53.17 -39.74 63.84 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 126.109 1.764 . . . . 3.4399999999999999 114.443 172.212 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -35.21 -57.74 0.57 Allowed 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 125.713 1.605 . . . . 4.8099999999999996 111.601 -146.479 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.477 HG23 HG11 ' A' ' 36' ' ' VAL . 0.4 OUTLIER -62.87 -50.19 80.63 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.874 0 CA-C-N 114.794 -1.094 . . . . 3.3100000000000001 112.525 -177.121 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -54.63 -44.52 73.25 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.382 1.073 . . . . 1.26 110.484 172.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -54.62 -59.94 4.02 Favored 'General case' 0 C--O 1.226 -0.167 0 N-CA-C 108.635 -0.876 . . . . 3.6699999999999999 108.635 175.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.75 HG22 HD11 ' A' ' 34' ' ' ILE . 2.3 mt -61.09 -42.27 92.53 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.14 0 O-C-N 121.406 -0.809 . . . . 2.7400000000000002 110.952 -174.447 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 69.1 mt-10 -60.85 -25.49 66.69 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 125.557 1.543 . . . . 3.6099999999999999 112.938 174.018 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 10.5 mmm180 -73.1 -42.31 63.08 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 119.344 0.975 . . . . 7.1299999999999999 111.954 158.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.678 ' ND2' HD13 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -70.93 -49.71 42.62 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 124.427 1.091 . . . . 4.4299999999999997 113.692 -160.266 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.678 HD13 ' ND2' ' A' ' 24' ' ' ASN . 3.9 mp -78.11 -60.05 2.53 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 118.977 0.808 . . . . 2.96 112.872 -176.552 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 9.5 ptm180 -39.38 -19.87 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 129.933 3.293 . . . . 6.04 118.481 -158.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 19.9 mtm105 -67.34 -51.97 45.84 Favored 'General case' 0 N--CA 1.439 -0.98 0 C-N-CA 127.337 2.255 . . . . 8.1799999999999997 109.487 -161.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 168.59 152.03 0.03 OUTLIER 'General case' 0 CA--C 1.512 -0.515 0 N-CA-C 105.519 -2.03 . . . . 7.2199999999999998 105.519 -152.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 99.91 44.84 0.0 OUTLIER 'General case' 0 C--N 1.34 0.157 0 C-N-CA 128.132 2.573 . . . . 7.1500000000000004 112.088 -168.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 56.35 42.57 89.21 Favored Glycine 0 CA--C 1.528 0.894 0 CA-C-N 116.275 -0.42 . . . . 1.74 112.527 171.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -77.26 135.29 26.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 N-CA-C 107.104 -1.443 . . . . 2.7599999999999998 107.104 174.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 54.0 m-85 -141.62 37.55 1.66 Allowed 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 122.061 0.934 . . . . 3.6299999999999999 113.397 164.324 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 75.0 m -166.39 154.41 10.24 Favored 'General case' 0 C--N 1.321 -0.663 1 C-N-CA 131.989 4.116 . . . . 2.79 103.964 122.32 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.828 HD13 ' N ' ' A' ' 35' ' ' LEU . 0.1 OUTLIER -98.3 136.6 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 N-CA-C 104.931 -2.248 . . . . 3.1600000000000001 104.931 158.782 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.828 ' N ' HD13 ' A' ' 34' ' ' ILE . 0.1 OUTLIER -156.21 175.81 13.5 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 124.403 1.081 . . . . 6.8399999999999999 110.375 -179.484 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.647 HG22 HG21 ' A' ' 21' ' ' ILE . 24.0 t -158.8 117.43 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.421 -1.875 0 C-N-CA 127.22 2.208 . . . . 1.71 106.545 -177.254 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -77.98 62.59 2.8 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 108.464 -0.939 . . . . 1.4199999999999999 108.464 168.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.492 HD23 ' HA ' ' A' ' 38' ' ' LEU . 0.3 OUTLIER -64.59 -32.96 74.84 Favored 'General case' 0 C--N 1.342 0.266 0 O-C-N 121.687 -0.633 . . . . 2.6499999999999999 111.705 -168.069 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 51.5 ttp -55.09 -35.67 64.84 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.299 0.64 . . . . 5.6600000000000001 111.199 173.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -86.99 -20.85 26.66 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.608 0.763 . . . . 1.76 110.913 176.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 84.35 60.01 1.97 Allowed Glycine 0 C--N 1.335 0.518 0 N-CA-C 107.768 -2.133 . . . . 0.85999999999999999 107.768 169.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.424 ' HZ3' ' HB3' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -163.96 167.53 20.43 Favored 'General case' 0 N--CA 1.437 -1.082 0 N-CA-C 106.363 -1.717 . . . . 4.9299999999999997 106.363 173.122 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -77.83 145.29 36.41 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 105.975 -1.861 . . . . 1.6499999999999999 105.975 167.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.609 ' CB ' HD13 ' A' ' 35' ' ' LEU . 19.3 mt-10 -94.56 167.48 11.45 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 105.774 -1.936 . . . . 2.9100000000000001 105.774 151.01 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.1 p -134.81 141.7 42.41 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 N-CA-C 104.606 -2.368 . . . . 1.5800000000000001 104.606 157.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 70.8 ttt180 -113.5 129.25 56.59 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 106.597 -1.631 . . . . 5.0300000000000002 106.597 158.089 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 7.2 p90 -157.3 172.22 19.0 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 122.968 0.507 . . . . 1.9099999999999999 111.783 -162.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 65.0 t-20 -109.21 88.56 5.96 Favored Pre-proline 0 CA--C 1.537 0.469 0 CA-C-N 114.677 -1.147 . . . . 2.4100000000000001 111.08 -177.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -67.67 79.55 0.49 Allowed 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 123.209 2.606 . . . . 2.0299999999999998 110.129 173.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -169.78 -47.91 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 127.712 2.405 . . . . 1.3400000000000001 106.726 172.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 57.5 t -69.87 -49.69 55.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 C-N-CA 124.261 1.025 . . . . 1.1000000000000001 109.405 173.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.9 tp -98.06 -68.89 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 CA-C-O 118.654 -0.689 . . . . 2.5600000000000001 111.832 -166.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 56.9 tp60 109.24 124.67 0.0 OUTLIER Pre-proline 0 CA--C 1.549 0.909 0 C-N-CA 128.946 2.898 . . . . 3.9300000000000002 109.894 176.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_exo -47.43 -59.51 1.22 Allowed 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 124.113 3.208 . . . . 1.3 117.24 -172.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_endo -49.06 -43.57 35.76 Favored 'Trans proline' 0 N--CA 1.45 -1.052 0 C-N-CA 121.62 1.546 . . . . 1.6899999999999999 110.645 172.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 58.9 mtp -68.21 -34.32 76.04 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 118.602 -0.713 . . . . 2.4500000000000002 111.302 -177.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 3.2 tt -62.2 -39.17 83.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-N 120.707 1.594 . . . . 2.1800000000000002 110.977 177.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -56.55 -46.98 80.41 Favored 'General case' 0 CA--C 1.529 0.159 0 O-C-N 122.176 -0.328 . . . . 1.1799999999999999 111.219 173.121 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -58.91 -52.41 65.86 Favored 'General case' 0 N--CA 1.435 -1.201 0 C-N-CA 123.197 0.599 . . . . 2.7400000000000002 111.99 176.355 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -58.29 -31.39 67.44 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 118.343 0.519 . . . . 4.6900000000000004 111.343 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 69.1 mt -62.95 -57.29 12.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-N 119.219 0.918 . . . . 2.02 109.95 166.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 87.2 mtt180 -48.64 -42.09 33.21 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.633 0.773 . . . . 4.1299999999999999 112.62 -178.066 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 91.3 mt-10 -50.9 -29.84 13.07 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 124.621 1.168 . . . . 3.7999999999999998 113.272 177.166 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 51.1 mt -82.04 -16.28 50.71 Favored 'General case' 0 N--CA 1.454 -0.26 0 O-C-N 121.711 -0.618 . . . . 1.9399999999999999 110.316 -178.162 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 134.66 -44.91 1.15 Allowed Glycine 0 C--N 1.34 0.756 0 C-N-CA 124.731 1.158 . . . . 2.4300000000000002 110.546 169.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 5.0 m-30 -78.37 129.04 34.51 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-O 121.278 0.561 . . . . 2.8900000000000001 109.612 -166.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -73.15 108.18 2.43 Favored Glycine 0 N--CA 1.442 -0.934 0 N-CA-C 110.878 -0.889 . . . . 1.3799999999999999 110.878 -171.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -82.91 124.33 30.25 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.073 0.949 . . . . 1.5800000000000001 109.72 179.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -118.34 126.35 51.94 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 108.36 -0.978 . . . . 2.75 108.36 164.113 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 65.3 t -83.36 139.11 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 C-N-CA 125.42 1.488 . . . . 1.8500000000000001 109.299 -169.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 12.1 mt -134.44 59.76 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 CA-C-O 122.439 1.114 . . . . 2.3100000000000001 109.001 -178.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 81.8 mt-10 . . . . . 0 CA--C 1.534 0.336 0 N-CA-C 107.969 -1.123 . . . . 4.6699999999999999 107.969 159.664 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.4 t . . . . . 0 C--O 1.231 0.097 0 N-CA-C 108.147 -1.057 . . . . 3.3399999999999999 108.147 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.7 m -90.57 177.44 6.36 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 107.688 -1.227 . . . . 2.1099999999999999 107.688 165.34 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.14 152.28 31.1 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 118.909 -0.567 . . . . 6.1699999999999999 110.636 165.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 49.1 t -137.82 154.65 49.51 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 124.63 1.172 . . . . 1.6200000000000001 108.973 171.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 2.5 m-30 -100.83 150.55 22.69 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 106.916 -1.513 . . . . 2.1899999999999999 106.916 176.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.477 HD12 HD13 ' A' ' 35' ' ' LEU . 13.5 mt -144.27 126.25 10.35 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 N-CA-C 104.773 -2.306 . . . . 1.8300000000000001 104.773 -175.451 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 3.6 tp60 -88.23 134.36 33.81 Favored 'General case' 0 N--CA 1.442 -0.866 0 N-CA-C 106.045 -1.835 . . . . 2.73 106.045 173.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 16.1 m -128.39 175.81 9.18 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 C-N-CA 125.343 1.457 . . . . 2.3599999999999999 109.457 -176.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 13.7 t -140.0 179.19 6.76 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 109.339 -0.615 . . . . 3.9199999999999999 109.339 172.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 84.51 -54.81 4.96 Favored Glycine 0 C--N 1.332 0.351 0 N-CA-C 105.566 -3.014 . . . . 2.8900000000000001 105.566 -163.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 32.4 ttm 82.48 -58.67 0.19 Allowed 'General case' 0 N--CA 1.441 -0.887 0 C-N-CA 126.964 2.106 . . . . 3.29 108.955 158.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.8 t -157.96 98.85 1.64 Allowed 'General case' 0 N--CA 1.442 -0.875 0 N-CA-C 106.441 -1.689 . . . . 5.9500000000000002 106.441 153.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.4 m -72.46 55.18 0.34 Allowed 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.184 0.994 . . . . 3.1699999999999999 109.01 175.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 50.93 71.04 0.46 Allowed 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.668 1.187 . . . . 2.98 111.338 -160.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.4 m 78.24 21.48 0.84 Allowed 'General case' 0 C--O 1.226 -0.177 0 C-N-CA 124.89 1.276 . . . . 3.6699999999999999 113.607 169.088 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -51.72 -32.42 30.18 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 124.62 1.168 . . . . 3.5499999999999998 109.558 166.068 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 19.6 m -53.85 -40.46 44.29 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 CA-C-N 115.28 -0.873 . . . . 2.5499999999999998 111.622 175.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.63 -46.15 70.4 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.157 0.983 . . . . 0.90000000000000002 110.15 175.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -58.43 -52.95 63.45 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 108.872 -0.788 . . . . 2.1099999999999999 108.872 171.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.477 ' HA ' HD22 ' A' ' 24' ' ' ASN . 58.2 mt -56.65 -56.32 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-O 118.473 -0.775 . . . . 1.99 109.102 -173.32 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -39.61 -61.21 0.85 Allowed 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 126.132 1.773 . . . . 3.1299999999999999 110.893 171.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.43 -39.99 61.65 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 124.068 0.947 . . . . 6.9699999999999998 111.176 178.004 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.748 ' ND2' HD13 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -71.04 -53.65 13.98 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 124.293 1.037 . . . . 3.2599999999999998 108.831 -175.492 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.748 HD13 ' ND2' ' A' ' 24' ' ' ASN . 0.0 OUTLIER -64.1 -27.34 69.03 Favored 'General case' 0 N--CA 1.462 0.17 0 O-C-N 121.07 -1.019 . . . . 2.4100000000000001 112.247 -177.103 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 58.3 mtp180 -67.95 -14.48 63.0 Favored 'General case' 0 N--CA 1.452 -0.368 0 O-C-N 121.761 -0.587 . . . . 5.8099999999999996 111.7 178.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -57.92 -38.79 76.51 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-N 119.158 0.89 . . . . 7.8300000000000001 112.69 161.624 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -93.05 68.3 4.35 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-O 121.977 0.894 . . . . 8.5299999999999994 109.255 -149.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -27.1 109.71 0.04 OUTLIER 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 127.116 2.166 . . . . 5.5800000000000001 110.057 163.462 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 135.51 -48.72 0.92 Allowed Glycine 0 CA--C 1.528 0.867 0 N-CA-C 108.246 -1.942 . . . . 1.3300000000000001 108.246 -151.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -78.64 133.42 30.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 C-N-CA 124.521 1.129 . . . . 2.9399999999999999 110.298 -173.085 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 24.7 t80 -141.32 35.87 1.69 Allowed 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 122.065 0.936 . . . . 6.8899999999999997 110.632 172.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 43.2 t -167.5 147.14 5.12 Favored 'General case' 0 N--CA 1.449 -0.478 1 C-N-CA 132.854 4.461 . . . . 2.3300000000000001 101.54 140.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.8 pp -78.71 156.58 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 C-N-CA 118.561 -1.256 . . . . 2.0499999999999998 108.536 165.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.754 HD22 ' CG1' ' A' ' 45' ' ' VAL . 0.6 OUTLIER -96.18 72.15 2.87 Favored 'General case' 0 N--CA 1.427 -1.591 0 C-N-CA 126.767 2.027 . . . . 4.7000000000000002 109.771 -173.978 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 24.7 t -135.13 141.04 43.92 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 O-C-N 121.017 -1.052 . . . . 1.4199999999999999 108.518 163.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -156.9 59.91 0.53 Allowed 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 125.866 1.666 . . . . 0.87 106.632 169.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -46.11 -36.95 6.28 Favored 'General case' 0 CA--C 1.512 -0.515 0 C-N-CA 125.603 1.561 . . . . 3.3599999999999999 113.12 -178.637 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.83 -41.12 96.0 Favored 'General case' 0 N--CA 1.439 -0.987 0 N-CA-C 108.511 -0.922 . . . . 4.7300000000000004 108.511 -164.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -77.05 -42.49 38.21 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.494 0.717 . . . . 1.4299999999999999 109.903 167.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 102.37 64.93 0.74 Allowed Glycine 0 C--N 1.336 0.572 0 N-CA-C 109.072 -1.611 . . . . 1.46 109.072 179.019 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -160.07 176.14 12.16 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 106.982 -1.488 . . . . 5.7400000000000002 106.982 -179.472 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.69 ' HB1' HD12 ' A' ' 35' ' ' LEU . . . -131.94 137.39 47.93 Favored 'General case' 0 N--CA 1.435 -1.188 0 C-N-CA 126.382 1.873 . . . . 1.0700000000000001 107.907 174.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.404 ' H ' ' HA ' ' A' ' 35' ' ' LEU . 5.6 pt-20 -128.8 109.0 10.9 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 114.456 1.28 . . . . 2.6899999999999999 114.456 177.473 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.754 ' CG1' HD22 ' A' ' 35' ' ' LEU . 3.7 m -83.9 103.33 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 N-CA-C 108.522 -0.918 . . . . 3.2799999999999998 108.522 176.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 7.8 ttm105 -84.43 114.34 21.83 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 103.837 -2.653 . . . . 6.8700000000000001 103.837 160.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -151.77 173.02 15.24 Favored 'General case' 0 C--N 1.332 -0.16 0 O-C-N 121.53 -0.731 . . . . 2.2599999999999998 112.728 -163.057 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -126.05 105.1 25.74 Favored Pre-proline 0 N--CA 1.447 -0.598 0 C-N-CA 123.666 0.786 . . . . 3.29 110.603 172.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -79.74 63.53 8.75 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 122.804 2.336 . . . . 1.72 109.17 -178.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -130.68 -49.6 1.05 Allowed 'General case' 0 C--O 1.227 -0.119 0 C-N-CA 124.187 0.995 . . . . 2.3999999999999999 109.005 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 43.0 t -63.66 -57.98 9.42 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 N-CA-C 109.609 -0.515 . . . . 2.04 109.609 174.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.627 HG23 ' H ' ' A' ' 53' ' ' GLN . 19.9 tt -115.01 -118.04 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.694 0 C-N-CA 124.147 0.979 . . . . 2.8700000000000001 108.469 -167.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.627 ' H ' HG23 ' A' ' 52' ' ' ILE . 5.7 tp60 179.99 111.73 0.19 Allowed Pre-proline 0 CA--C 1.541 0.602 0 N-CA-C 109.296 -0.631 . . . . 2.4300000000000002 109.296 -155.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo -46.61 -49.72 11.61 Favored 'Trans proline' 0 CA--C 1.533 0.457 0 C-N-CA 124.42 3.413 . . . . 1.8200000000000001 116.43 176.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -51.25 -54.21 5.79 Favored 'Trans proline' 0 N--CA 1.444 -1.439 0 C-N-CA 121.251 1.301 . . . . 1.29 109.868 170.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 65.6 mtt -52.45 -48.64 65.71 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 118.339 0.518 . . . . 1.6799999999999999 111.558 -179.305 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 81.5 mt -51.74 -54.09 14.31 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.862 0 CA-C-N 117.876 0.307 . . . . 2.7599999999999998 110.654 175.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.85 -33.15 74.66 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 120.76 -1.212 . . . . 1.3200000000000001 113.761 176.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -70.58 -52.85 18.74 Favored 'General case' 0 N--CA 1.44 -0.935 0 O-C-N 120.36 -1.462 . . . . 3.8300000000000001 110.676 -177.156 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -46.1 -43.74 15.03 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 122.548 1.165 . . . . 4.75 111.855 -178.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.61 ' CD1' HD11 ' A' ' 35' ' ' LEU . 96.8 mt -55.61 -44.5 76.88 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 C-N-CA 124.078 0.951 . . . . 1.3500000000000001 111.531 176.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 70.6 mtm180 -70.84 -42.04 70.7 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 124.509 1.123 . . . . 4.3499999999999996 111.428 176.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -54.52 -38.92 67.11 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 123.6 0.76 . . . . 2.8999999999999999 110.328 175.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 83.8 mt -79.36 -37.49 37.32 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 118.843 -0.598 . . . . 2.6099999999999999 110.771 174.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 165.76 -34.09 0.24 Allowed Glycine 0 CA--C 1.529 0.937 0 N-CA-C 115.641 1.016 . . . . 2.2999999999999998 115.641 165.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -77.85 128.74 34.45 Favored 'General case' 0 C--N 1.334 -0.078 0 CA-C-N 118.504 1.152 . . . . 2.9500000000000002 111.369 -159.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -70.21 79.08 0.41 Allowed Glycine 0 CA--C 1.523 0.541 0 C-N-CA 124.307 0.956 . . . . 1.6899999999999999 113.019 -175.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -83.53 126.66 33.03 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 125.561 1.545 . . . . 0.85999999999999999 111.044 -178.069 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -131.7 136.0 47.31 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 107.002 -1.481 . . . . 2.3100000000000001 107.002 174.175 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 25.6 m -82.05 153.47 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 CA-C-N 118.753 0.706 . . . . 3.21 110.757 -171.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 50.3 mt -136.07 120.06 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 C-N-CA 125.952 1.701 . . . . 2.1699999999999999 106.553 173.272 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 . . . . . 0 C--N 1.332 -0.177 0 N-CA-C 107.936 -1.135 . . . . 5.8399999999999999 107.936 -176.853 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.2 p . . . . . 0 N--CA 1.45 -0.445 0 CA-C-O 120.803 0.335 . . . . 2.79 111.15 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 18.7 m -149.62 174.75 12.21 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 107.595 -1.261 . . . . 1.8500000000000001 107.595 173.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -142.71 142.78 32.05 Favored 'General case' 0 CA--C 1.528 0.116 0 N-CA-C 108.209 -1.034 . . . . 3.4399999999999999 108.209 177.431 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.4 ' HB3' ' CG1' ' A' ' 45' ' ' VAL . 10.2 t -140.48 155.66 46.6 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 123.15 0.58 . . . . 1.3600000000000001 110.981 -163.689 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 52.6 m-85 -110.06 83.79 1.82 Allowed 'General case' 0 C--O 1.222 -0.348 0 C-N-CA 124.997 1.319 . . . . 2.1800000000000002 108.793 -178.167 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.456 ' HB ' ' HB3' ' A' ' 43' ' ' ALA . 50.8 mt -78.6 139.06 19.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 106.51 -1.663 . . . . 1.6399999999999999 106.51 -177.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -104.6 135.9 45.15 Favored 'General case' 0 C--O 1.231 0.126 0 N-CA-C 107.203 -1.406 . . . . 5.4800000000000004 107.203 168.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 46.5 t -131.53 108.95 15.2 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 C-N-CA 124.787 1.235 . . . . 3.0 108.917 -168.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 17.9 p -60.35 99.15 0.07 Allowed 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 120.957 0.408 . . . . 3.1499999999999999 111.176 -179.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 109.85 -28.41 10.63 Favored Glycine 0 C--N 1.338 0.667 0 C-N-CA 124.975 1.274 . . . . 2.1400000000000001 111.22 178.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 4.1 mpp? 67.53 -65.55 0.23 Allowed 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 127.011 2.124 . . . . 6.0099999999999998 108.059 -166.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -154.93 -103.62 0.04 OUTLIER 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 105.01 -2.218 . . . . 8.8200000000000003 105.01 160.558 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.0 p -145.58 35.77 1.06 Allowed 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.032 0.533 . . . . 3.3700000000000001 111.364 176.382 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 81.1 132.87 0.06 Allowed 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 127.166 2.186 . . . . 3.79 111.687 179.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 13.8 m 72.99 -39.24 0.44 Allowed 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 125.623 1.569 . . . . 4.6699999999999999 114.667 173.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 34.4 m -50.33 -28.55 8.13 Favored 'General case' 0 CA--C 1.517 -0.309 0 C-N-CA 130.346 3.458 . . . . 5.1500000000000004 111.487 175.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 5.8 m -41.88 -41.18 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 112.165 0.431 . . . . 2.8700000000000001 112.165 167.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.66 -41.65 73.95 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 124.732 1.213 . . . . 1.95 111.976 178.041 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -61.18 -51.88 67.15 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 108.229 -1.026 . . . . 4.21 108.229 170.026 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 22.6 mt -64.37 -57.11 12.83 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.542 0 N-CA-C 107.617 -1.253 . . . . 3.3900000000000001 107.617 -166.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -44.72 -45.5 9.88 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 126.706 2.002 . . . . 6.1100000000000003 113.237 -179.356 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 40.3 ttp180 -59.25 -47.52 85.07 Favored 'General case' 0 N--CA 1.449 -0.482 0 O-C-N 121.338 -0.852 . . . . 4.6600000000000001 111.0 171.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -62.94 -22.08 66.53 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.708 1.603 . . . . 3.4199999999999999 110.355 177.385 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.766 HD13 HD21 ' A' ' 35' ' ' LEU . 12.1 mt -75.96 -60.49 2.3 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 124.478 1.111 . . . . 2.8900000000000001 112.575 170.312 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.421 ' HG3' HG22 ' A' ' 34' ' ' ILE . 33.7 mtm180 -65.39 -17.66 64.7 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-N 119.146 0.884 . . . . 7.5999999999999996 112.768 -178.405 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -39.76 -53.35 2.24 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-O 116.064 -1.922 . . . . 7.4699999999999998 112.528 158.096 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -168.5 173.17 7.68 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 118.256 2.687 . . . . 6.9100000000000001 118.256 -164.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 77.57 57.7 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 129.61 3.164 . . . . 5.7599999999999998 111.726 170.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 57.2 27.4 57.57 Favored Glycine 0 CA--C 1.527 0.809 0 CA-C-N 114.945 -1.025 . . . . 1.26 112.616 176.105 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.9 mm -88.25 136.42 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 C-N-CA 124.413 1.085 . . . . 2.4399999999999999 108.447 175.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -143.03 48.39 1.49 Allowed 'General case' 0 C--N 1.341 0.235 0 CA-C-O 123.22 1.486 . . . . 3.6699999999999999 112.703 169.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 43.5 t -160.31 -179.27 7.56 Favored 'General case' 0 C--N 1.316 -0.874 0 C-N-CA 129.576 3.151 . . . . 1.76 105.484 152.029 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.421 HG22 ' HG3' ' A' ' 26' ' ' ARG . 0.1 OUTLIER -100.06 172.74 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 107.181 -1.414 . . . . 2.7599999999999998 107.181 153.085 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.766 HD21 HD13 ' A' ' 25' ' ' LEU . 0.3 OUTLIER -137.62 63.07 1.56 Allowed 'General case' 0 N--CA 1.429 -1.486 0 C-N-CA 130.904 3.682 . . . . 4.1900000000000004 108.555 -168.686 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 10.1 t -130.27 129.67 65.19 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.857 0 CA-C-N 115.33 -0.85 . . . . 1.27 109.414 164.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -130.15 62.92 1.56 Allowed 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 105.824 -1.917 . . . . 0.87 105.824 162.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.81 -31.12 71.32 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 109.687 -0.486 . . . . 3.54 109.687 -172.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 27.7 ptm -46.79 -38.24 9.84 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.406 1.082 . . . . 3.7200000000000002 113.245 169.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -94.07 -48.27 6.3 Favored 'General case' 0 C--N 1.339 0.137 0 C-N-CA 123.618 0.767 . . . . 1.53 109.415 177.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 115.13 45.24 0.64 Allowed Glycine 0 CA--C 1.522 0.53 0 N-CA-C 108.517 -1.833 . . . . 0.94999999999999996 108.517 179.308 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 61.6 mttt -147.6 176.63 9.92 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 126.343 1.857 . . . . 4.2199999999999998 108.016 -171.205 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.456 ' HB3' ' HB ' ' A' ' 7' ' ' ILE . . . -142.12 112.48 7.09 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 124.228 1.011 . . . . 1.1899999999999999 110.26 -169.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -105.01 85.63 2.31 Favored 'General case' 0 C--N 1.349 0.551 0 N-CA-C 115.718 1.747 . . . . 3.3500000000000001 115.718 -171.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.477 ' CA ' ' HB3' ' A' ' 35' ' ' LEU . 7.9 p -81.81 150.02 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.173 0 C-N-CA 123.259 0.624 . . . . 1.52 109.592 -174.05 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 20.1 ttt85 -119.94 129.38 54.3 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 104.637 -2.357 . . . . 4.5700000000000003 104.637 157.064 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 4.6 p90 -150.32 164.28 36.18 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 124.508 1.123 . . . . 2.2200000000000002 110.862 -163.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -109.95 90.48 9.46 Favored Pre-proline 0 C--O 1.237 0.406 0 C-N-CA 124.373 1.069 . . . . 2.5499999999999998 111.471 175.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -69.57 79.34 0.89 Allowed 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 122.769 2.313 . . . . 1.5800000000000001 110.697 172.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -160.88 -48.07 0.05 OUTLIER 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 128.683 2.793 . . . . 1.0800000000000001 105.156 173.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 73.4 t -67.34 -68.04 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.855 0 C-N-CA 123.877 0.871 . . . . 1.71 108.893 162.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . 0.256 16.8 tt -88.59 -57.51 4.18 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 N-CA-C 115.903 1.816 . . . . 2.21 115.903 -153.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER 83.72 133.48 0.04 OUTLIER Pre-proline 0 CA--C 1.543 0.675 0 C-N-CA 127.414 2.286 . . . . 2.6000000000000001 110.984 -173.446 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -37.4 -49.51 1.77 Allowed 'Trans proline' 0 CA--C 1.537 0.664 1 C-N-CA 126.603 4.869 . . . . 1.5800000000000001 117.707 171.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -44.09 -61.89 0.51 Allowed 'Trans proline' 0 N--CA 1.448 -1.158 0 C-N-CA 121.847 1.698 . . . . 1.1299999999999999 110.642 167.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 43.0 mtt -60.12 -41.81 93.42 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 118.759 -0.639 . . . . 1.79 112.291 -175.14 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.422 HD12 HG11 ' A' ' 45' ' ' VAL . 1.0 OUTLIER -55.87 -40.45 62.12 Favored 'Isoleucine or valine' 0 C--N 1.348 0.519 0 CA-C-N 119.304 0.957 . . . . 3.6699999999999999 111.604 -178.106 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.35 -55.42 9.17 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 121.655 0.74 . . . . 1.3 110.681 171.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -64.37 -35.51 81.14 Favored 'General case' 0 N--CA 1.437 -1.083 0 N-CA-C 114.128 1.158 . . . . 3.1600000000000001 114.128 -162.047 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 39.0 m-85 -53.28 -36.85 61.62 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 119.596 1.089 . . . . 3.2799999999999998 110.946 170.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 17.3 mt -68.81 -34.02 62.39 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 O-C-N 121.154 -0.966 . . . . 1.49 109.638 -179.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 68.8 mtt180 -61.34 -50.77 71.58 Favored 'General case' 0 C--N 1.341 0.203 0 N-CA-C 109.282 -0.636 . . . . 4.0499999999999998 109.282 171.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -56.61 -35.7 68.57 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 123.717 0.807 . . . . 2.9900000000000002 111.905 177.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 77.1 mt -77.35 -17.88 57.89 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 118.891 -0.576 . . . . 2.21 111.277 175.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 151.56 -24.41 0.95 Allowed Glycine 0 CA--C 1.527 0.782 0 CA-C-N 118.973 0.806 . . . . 1.9199999999999999 114.261 163.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -121.36 129.76 53.24 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 118.633 1.217 . . . . 3.4500000000000002 111.806 -152.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -69.56 91.93 0.33 Allowed Glycine 0 N--CA 1.447 -0.624 0 N-CA-C 111.057 -0.817 . . . . 1.8100000000000001 111.057 -169.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -92.55 137.18 32.59 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 126.325 1.85 . . . . 0.93999999999999995 111.84 -178.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 3.3 t -134.17 144.3 48.42 Favored 'General case' 0 N--CA 1.439 -0.989 0 N-CA-C 108.161 -1.052 . . . . 3.2799999999999998 108.161 166.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 8.8 p -94.14 129.55 44.3 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 C-N-CA 126.17 1.788 . . . . 2.3799999999999999 109.657 -167.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 19.4 mm -137.59 126.85 35.09 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 C-N-CA 124.082 0.953 . . . . 3.7799999999999998 108.627 -178.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 . . . . . 0 CA--C 1.533 0.296 0 CA-C-O 121.946 0.879 . . . . 4.3700000000000001 109.556 165.978 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.0 p . . . . . 0 N--CA 1.452 -0.375 0 N-CA-C 110.464 -0.199 . . . . 2.8199999999999998 110.464 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.4 t -113.76 175.51 5.43 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 124.675 1.19 . . . . 3.3199999999999998 109.136 174.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 59.9 tttt -106.7 151.18 25.45 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 124.753 1.221 . . . . 4.4500000000000002 110.638 -174.271 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 42.1 t -147.61 150.48 34.51 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 108.343 -0.984 . . . . 1.4099999999999999 108.343 167.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -96.01 133.94 39.63 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 107.171 -1.418 . . . . 2.21 107.171 178.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.602 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 19.3 mt -135.88 90.78 0.9 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.364 0 N-CA-C 105.748 -1.945 . . . . 2.1499999999999999 105.748 -170.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . 0.291 0.8 OUTLIER -81.43 123.9 28.97 Favored 'General case' 0 N--CA 1.435 -1.185 0 C-N-CA 125.977 1.711 . . . . 3.1200000000000001 108.619 -162.347 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 30.6 m -117.47 175.07 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 C-N-CA 124.201 1.0 . . . . 2.1499999999999999 110.315 -171.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.9 t -148.3 37.22 0.84 Allowed 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 112.435 0.531 . . . . 3.6499999999999999 112.435 175.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -139.31 130.02 4.63 Favored Glycine 0 N--CA 1.446 -0.693 1 N-CA-C 102.148 -4.381 . . . . 3.6099999999999999 102.148 138.315 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -164.04 -33.82 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 124.357 1.063 . . . . 3.2400000000000002 111.016 -169.536 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 6.7 t -111.88 23.72 13.49 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 108.379 -0.971 . . . . 4.4699999999999998 108.379 162.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 24.4 p -80.97 38.0 0.45 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.889 1.276 . . . . 3.0699999999999998 110.95 -175.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 72.48 177.54 0.25 Allowed 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.654 1.582 . . . . 2.9100000000000001 110.637 -152.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -77.26 32.09 0.15 Allowed 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 114.674 1.361 . . . . 2.8100000000000001 114.674 -162.683 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 85.7 m -48.79 -39.15 24.19 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 126.065 1.746 . . . . 3.54 110.576 175.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 29.1 m -46.16 -48.08 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 C-N-CA 124.795 1.238 . . . . 3.0299999999999998 111.303 174.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.94 -43.77 70.09 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 124.351 1.06 . . . . 0.92000000000000004 110.469 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -65.76 -51.81 56.06 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 108.566 -0.902 . . . . 2.8399999999999999 108.566 174.374 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 31.1 mt -60.35 -53.36 49.87 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 N-CA-C 108.384 -0.969 . . . . 2.5699999999999998 108.384 -168.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -40.68 -58.68 1.57 Allowed 'General case' 0 C--O 1.234 0.242 0 C-N-CA 126.316 1.847 . . . . 4.0899999999999999 111.588 171.009 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 20.0 mmm180 -56.59 -41.2 76.56 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.062 -0.517 . . . . 5.6500000000000004 110.907 177.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -71.7 -29.76 64.91 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 124.388 1.075 . . . . 3.3999999999999999 110.38 -176.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -70.51 -58.1 4.06 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 124.499 1.119 . . . . 2.4399999999999999 110.0 176.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . 0.258 62.1 mtt180 -65.06 -14.52 60.67 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 115.062 1.504 . . . . 9.3699999999999992 115.062 -171.205 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 16.9 mtm180 -54.24 -38.23 65.53 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 119.426 1.012 . . . . 7.1299999999999999 111.484 166.038 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 38.7 mm-40 -92.14 81.82 5.04 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 107.985 -1.117 . . . . 6.7999999999999998 107.985 -153.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 46.2 tt0 -41.68 125.06 2.68 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.97 0.908 . . . . 8.6799999999999997 108.943 174.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 127.65 -52.36 0.83 Allowed Glycine 0 CA--C 1.522 0.501 0 N-CA-C 107.733 -2.147 . . . . 1.4299999999999999 107.733 -155.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 1.3 mt -83.46 143.3 12.18 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.147 0 C-N-CA 124.718 1.207 . . . . 2.1000000000000001 108.274 171.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -144.93 42.11 1.31 Allowed 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 119.032 -1.067 . . . . 3.4199999999999999 113.579 150.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 68.2 m -163.19 143.85 9.28 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 127.632 2.373 . . . . 1.8400000000000001 109.767 156.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.54 ' H ' ' CD1' ' A' ' 34' ' ' ILE . 0.0 OUTLIER -81.44 134.25 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.836 0 C-N-CA 125.948 1.699 . . . . 2.7400000000000002 111.144 -178.973 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.562 ' HA ' ' H ' ' A' ' 44' ' ' GLU . 0.6 OUTLIER -80.02 71.73 6.75 Favored 'General case' 0 N--CA 1.432 -1.361 0 O-C-N 121.072 -1.018 . . . . 4.7199999999999998 110.061 174.051 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 22.3 t -135.63 131.06 50.55 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 CA-C-O 121.631 0.729 . . . . 1.26 111.847 169.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -149.15 67.15 1.03 Allowed 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 127.685 2.394 . . . . 0.92000000000000004 106.796 167.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -53.3 -31.97 46.57 Favored 'General case' 0 CA--C 1.512 -0.502 0 N-CA-C 113.228 0.825 . . . . 3.52 113.228 -177.117 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 63.8 mtt -66.74 -42.95 85.4 Favored 'General case' 0 N--CA 1.44 -0.929 0 C-N-CA 119.385 -0.926 . . . . 4.4299999999999997 109.099 -165.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -73.31 -36.27 66.22 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.426 0.69 . . . . 1.5700000000000001 109.69 166.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 97.8 55.35 1.15 Allowed Glycine 0 CA--C 1.507 -0.449 0 N-CA-C 106.548 -2.621 . . . . 0.97999999999999998 106.548 178.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 24.0 mmtm -150.15 176.06 11.18 Favored 'General case' 0 N--CA 1.44 -0.928 0 N-CA-C 106.18 -1.785 . . . . 6.3600000000000003 106.18 -165.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.602 ' HB3' ' O ' ' A' ' 7' ' ' ILE . . . -162.07 127.05 3.37 Favored 'General case' 0 N--CA 1.432 -1.341 0 N-CA-C 107.142 -1.429 . . . . 1.1899999999999999 107.142 -162.48 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.562 ' H ' ' HA ' ' A' ' 35' ' ' LEU . 0.6 OUTLIER -151.84 107.73 3.38 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 113.371 0.878 . . . . 3.9900000000000002 113.371 -174.206 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.7 p -81.79 155.06 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.022 0 C-N-CA 124.001 0.92 . . . . 1.5900000000000001 109.62 -169.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 46.0 ttt180 -118.78 128.81 54.83 Favored 'General case' 0 CA--C 1.521 -0.162 0 N-CA-C 106.769 -1.567 . . . . 5.3600000000000003 106.769 158.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -158.63 175.23 13.91 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 123.824 0.85 . . . . 2.21 110.35 -167.715 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -110.79 140.08 22.3 Favored Pre-proline 0 N--CA 1.448 -0.53 0 N-CA-C 106.979 -1.489 . . . . 3.0800000000000001 106.979 156.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -85.41 3.72 7.08 Favored 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 122.385 2.056 . . . . 2.98 113.29 -175.027 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -91.3 -50.18 5.96 Favored 'General case' 0 CA--C 1.519 -0.248 0 N-CA-C 107.943 -1.132 . . . . 1.24 107.943 -168.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 45.0 t -61.78 -59.07 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.97 0 C-N-CA 124.557 1.143 . . . . 1.03 110.379 178.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 10.7 tt -95.38 -37.06 7.22 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.261 0 CA-C-O 118.615 -0.707 . . . . 2.0800000000000001 112.743 -162.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 13.4 mm-40 88.78 125.74 0.03 OUTLIER Pre-proline 0 CA--C 1.54 0.56 0 C-N-CA 128.926 2.89 . . . . 2.8100000000000001 113.466 176.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.4 ' HA ' HG22 ' A' ' 57' ' ' ILE . 79.6 Cg_exo -49.89 -48.76 18.18 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 124.593 3.529 . . . . 1.46 116.944 179.325 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -53.11 -50.74 12.98 Favored 'Trans proline' 0 N--CA 1.444 -1.407 0 CA-C-N 120.758 1.307 . . . . 1.54 108.843 172.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 66.4 mtt -65.18 -43.77 90.61 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 120.62 -0.432 . . . . 1.8600000000000001 110.486 -171.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.428 HG21 HD13 ' A' ' 57' ' ' ILE . 7.5 tt -63.54 -35.4 72.47 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 C-N-CA 120.386 -0.526 . . . . 2.1800000000000002 110.407 -177.63 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -65.86 -50.14 65.61 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 121.916 0.865 . . . . 1.21 110.384 171.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -70.87 -35.93 72.6 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-O 117.483 -1.246 . . . . 2.7599999999999998 113.964 -166.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 9.2 m-30 -45.88 -41.75 11.74 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 119.642 1.11 . . . . 3.2599999999999998 110.206 172.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 7.9 mt -69.54 -35.54 66.89 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 O-C-N 121.825 -0.547 . . . . 1.4399999999999999 111.164 -178.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 68.9 mtt180 -66.27 -52.72 44.69 Favored 'General case' 0 C--O 1.226 -0.169 0 N-CA-C 109.013 -0.736 . . . . 4.4100000000000001 109.013 176.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -55.31 -53.54 54.83 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 125.633 1.573 . . . . 2.9399999999999999 110.792 -178.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 74.6 mt -84.52 -32.51 23.87 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 119.17 -0.443 . . . . 2.3100000000000001 111.916 -172.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -115.59 -87.64 1.42 Allowed Glycine 0 CA--C 1.525 0.705 0 N-CA-C 111.7 -0.56 . . . . 2.2000000000000002 111.7 -174.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -140.64 -69.1 0.4 Allowed 'General case' 0 CA--C 1.512 -0.514 0 CA-C-O 122.219 1.009 . . . . 3.3599999999999999 112.767 -152.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 168.14 137.95 2.35 Favored Glycine 0 N--CA 1.437 -1.293 0 N-CA-C 105.648 -2.981 . . . . 1.8700000000000001 105.648 -149.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -155.93 110.99 2.93 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 108.481 -0.933 . . . . 1.3 108.481 -170.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.4 p -116.36 113.59 23.12 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 125.15 1.38 . . . . 2.27 107.947 -174.256 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 12.1 m -81.39 138.51 19.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 N-CA-C 109.365 -0.605 . . . . 2.8199999999999998 109.365 -170.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 19.5 pt -144.68 152.26 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 N-CA-C 107.74 -1.207 . . . . 2.96 107.74 175.043 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 . . . . . 0 N--CA 1.455 -0.18 0 N-CA-C 107.085 -1.45 . . . . 6.1100000000000003 107.085 167.129 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.4 m . . . . . 0 CA--C 1.54 0.588 0 N-CA-C 109.47 -0.567 . . . . 3.1400000000000001 109.47 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.5 m -94.83 135.02 36.83 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 125.303 1.441 . . . . 1.8899999999999999 109.273 -175.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 52.5 tttt -85.86 118.25 25.23 Favored 'General case' 0 CA--C 1.528 0.097 0 C-N-CA 124.281 1.033 . . . . 4.0899999999999999 109.222 175.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 96.5 m -127.16 131.2 50.79 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 108.872 -0.788 . . . . 3.9900000000000002 108.872 -178.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -89.52 135.87 33.35 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 124.491 1.117 . . . . 2.4700000000000002 108.533 -171.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 9.0 mt -132.16 157.24 43.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 106.529 -1.656 . . . . 1.7 106.529 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 29.9 tp60 -129.98 127.1 39.33 Favored 'General case' 0 N--CA 1.434 -1.261 0 N-CA-C 104.743 -2.317 . . . . 2.77 104.743 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 27.0 m -106.91 176.95 1.09 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 C-N-CA 125.177 1.391 . . . . 2.1800000000000002 110.085 -172.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 12.1 t -141.49 145.02 34.69 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 109.107 -0.701 . . . . 2.73 109.107 167.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 67.9 115.79 0.02 OUTLIER Glycine 0 C--N 1.335 0.508 0 N-CA-C 105.443 -3.063 . . . . 2.8599999999999999 105.443 -138.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 65.6 mtp -89.59 -101.44 0.09 Allowed 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 113.481 -1.359 . . . . 4.0499999999999998 108.88 -176.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 10.9 p -75.17 -42.28 56.27 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.153 0.981 . . . . 5.3600000000000003 109.726 177.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 56.7 m 55.34 21.92 4.52 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 126.697 1.999 . . . . 2.6800000000000002 112.099 178.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 50.87 36.62 15.16 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.297 1.039 . . . . 3.1299999999999999 113.495 -168.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 76.2 p 145.61 16.79 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 128.275 2.63 . . . . 2.9900000000000002 115.739 160.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.7 m -60.02 -35.98 76.26 Favored 'General case' 0 C--O 1.234 0.265 0 O-C-N 120.71 -1.244 . . . . 2.9399999999999999 109.872 175.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.444 HG12 HD23 ' A' ' 38' ' ' LEU . 15.2 m -65.95 -52.94 43.19 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 CA-C-N 116.089 -0.505 . . . . 2.3100000000000001 110.963 -179.333 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -47.94 -46.01 31.65 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.152 0.581 . . . . 0.88 110.616 171.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -55.43 -52.05 64.87 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 120.995 0.426 . . . . 1.77 110.144 174.059 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -61.9 -48.1 90.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 C-N-CA 123.768 0.827 . . . . 1.73 110.686 -175.243 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -52.25 -53.8 39.27 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 125.113 1.365 . . . . 3.1299999999999999 109.178 173.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 29.9 mmt180 -55.3 -41.53 72.46 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 118.414 -0.803 . . . . 5.2300000000000004 111.573 176.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 56.9 m-20 -74.34 -67.97 0.57 Allowed 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 118.829 0.74 . . . . 3.9100000000000001 112.406 -177.183 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.564 ' CD2' HD21 ' A' ' 35' ' ' LEU . 0.1 OUTLIER -75.8 -14.79 60.31 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 126.594 1.958 . . . . 2.5600000000000001 113.558 -164.637 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -21.1 -74.49 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 128.433 2.693 . . . . 8.8800000000000008 113.51 -168.165 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . 0.266 11.3 ptp180 -95.74 -62.13 1.34 Allowed 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 117.589 2.44 . . . . 12.43 117.589 170.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 30.54 -150.95 0.0 OUTLIER 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 129.711 3.205 . . . . 6.0800000000000001 111.965 -154.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -95.68 92.53 6.63 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 106.058 -1.83 . . . . 7.4000000000000004 106.058 167.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 115.07 13.94 8.8 Favored Glycine 0 CA--C 1.529 0.916 0 CA-C-O 117.137 -1.924 . . . . 1.0900000000000001 115.654 164.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 1.6 mt -104.04 129.52 56.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-N 120.531 2.166 . . . . 2.02 108.53 172.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -136.83 43.41 2.41 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 121.828 0.823 . . . . 3.1600000000000001 111.19 159.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 67.7 m -170.74 143.52 2.14 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 129.295 3.038 . . . . 1.51 106.35 135.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -83.9 160.89 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 CA-C-O 122.012 0.91 . . . . 2.4300000000000002 110.783 175.099 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.663 ' HB2' ' HB1' ' A' ' 43' ' ' ALA . 0.3 OUTLIER -72.44 69.72 0.85 Allowed 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 129.437 3.095 . . . . 5.2699999999999996 109.091 -179.035 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 23.9 t -130.6 130.83 65.04 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 CA-C-O 121.844 0.83 . . . . 1.8500000000000001 113.09 170.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -158.04 56.86 0.47 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 127.635 2.374 . . . . 0.71999999999999997 107.201 156.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.444 HD23 HG12 ' A' ' 18' ' ' VAL . 4.0 mm? -74.3 -11.08 60.17 Favored 'General case' 0 N--CA 1.463 0.191 0 O-C-N 121.058 -1.026 . . . . 5.2800000000000002 112.542 -171.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 27.6 ttt -53.81 -40.13 66.11 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 109.848 -0.427 . . . . 3.75 109.848 163.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -89.39 -34.41 16.51 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.423 0.689 . . . . 1.3100000000000001 110.487 172.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 106.02 44.62 1.37 Allowed Glycine 0 CA--C 1.524 0.649 0 N-CA-C 109.379 -1.488 . . . . 0.75 109.379 -179.131 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 45.8 mttt -155.02 -177.52 6.59 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 125.869 1.668 . . . . 4.4699999999999998 107.364 -153.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.663 ' HB1' ' HB2' ' A' ' 35' ' ' LEU . . . -153.87 146.98 24.6 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 125.483 1.513 . . . . 1.4199999999999999 110.432 -168.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -129.22 106.52 8.88 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-O 121.265 0.555 . . . . 4.3200000000000003 110.021 161.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -83.74 116.84 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 N-CA-C 106.165 -1.791 . . . . 2.0899999999999999 106.165 173.239 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 29.8 ttm180 -109.2 116.3 31.64 Favored 'General case' 0 CA--C 1.515 -0.381 0 N-CA-C 106.192 -1.781 . . . . 5.6500000000000004 106.192 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -148.97 173.66 13.1 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 114.65 1.352 . . . . 2.1699999999999999 114.65 -158.025 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -102.7 94.64 5.35 Favored Pre-proline 0 N--CA 1.452 -0.347 0 N-CA-C 106.795 -1.558 . . . . 3.3199999999999998 106.795 166.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -67.75 -4.27 11.92 Favored 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 122.408 2.072 . . . . 2.6099999999999999 113.292 -172.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -82.47 -28.56 31.14 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 124.175 0.99 . . . . 1.1699999999999999 108.554 177.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 87.0 t -84.85 -67.33 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.137 0 C-N-CA 124.629 1.172 . . . . 1.1899999999999999 107.939 -174.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 15.2 tt -87.45 -36.58 9.9 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 N-CA-C 113.016 0.747 . . . . 1.8300000000000001 113.016 -163.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 15.7 mm-40 86.88 119.18 0.03 OUTLIER Pre-proline 0 CA--C 1.541 0.625 0 C-N-CA 129.27 3.028 . . . . 2.96 112.834 -179.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -50.18 -47.94 21.92 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 125.117 3.878 . . . . 1.03 117.907 -178.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -59.08 -44.56 33.75 Favored 'Trans proline' 0 N--CA 1.442 -1.505 0 N-CA-C 108.785 -1.275 . . . . 1.02 108.785 172.026 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 87.6 mtp -69.46 -40.93 76.83 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-O 119.373 -0.346 . . . . 1.8799999999999999 110.11 -167.023 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 16.4 tt -61.87 -54.37 35.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 119.628 -0.829 . . . . 2.4199999999999999 110.765 175.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -46.88 -51.65 16.23 Favored 'General case' 0 C--N 1.342 0.262 0 C-N-CA 123.73 0.812 . . . . 0.96999999999999997 112.138 174.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -54.79 -51.35 66.05 Favored 'General case' 0 N--CA 1.442 -0.855 0 C-N-CA 125.292 1.437 . . . . 3.4300000000000002 111.237 175.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -48.68 -40.43 28.06 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 123.55 0.74 . . . . 3.6000000000000001 111.525 178.013 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.4 mm -58.14 -40.87 79.11 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-O 121.606 0.717 . . . . 2.2000000000000002 110.069 179.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 27.0 mtt85 -67.24 -50.54 60.28 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 123.623 0.769 . . . . 4.25 109.114 177.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -53.88 -48.98 69.52 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 124.034 0.933 . . . . 2.75 111.405 -178.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.7 pp -83.26 -30.98 27.21 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 119.271 -0.395 . . . . 2.8300000000000001 111.831 -175.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -123.3 -87.82 0.83 Allowed Glycine 0 CA--C 1.524 0.63 0 N-CA-C 111.455 -0.658 . . . . 1.6799999999999999 111.455 -175.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 26.5 m-85 -139.62 -74.85 0.36 Allowed 'General case' 0 CA--C 1.513 -0.452 0 CA-C-O 121.837 0.827 . . . . 3.8599999999999999 112.888 -151.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 171.34 128.9 1.07 Allowed Glycine 0 N--CA 1.438 -1.175 0 N-CA-C 107.825 -2.11 . . . . 1.54 107.825 -155.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -155.2 127.51 7.78 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 123.843 0.857 . . . . 0.90000000000000002 109.243 -172.14 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -118.23 131.03 56.39 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 126.166 1.787 . . . . 2.4100000000000001 106.724 179.312 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 79.6 t -87.05 127.68 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.737 0 C-N-CA 125.164 1.385 . . . . 1.6100000000000001 107.94 -175.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 13.5 mt -134.38 62.04 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 CA-C-O 122.387 1.089 . . . . 1.79 108.515 -173.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 . . . . . 0 C--N 1.327 -0.405 0 C-N-CA 124.231 1.012 . . . . 4.7599999999999998 109.449 171.744 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 56.4 p . . . . . 0 CA--C 1.536 0.406 0 N-CA-C 114.703 1.372 . . . . 4.3399999999999999 114.703 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.0 m -139.71 169.93 16.83 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 124.53 1.132 . . . . 1.77 109.564 -176.328 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.32 143.08 35.63 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 110.329 -0.249 . . . . 4.3499999999999996 110.329 168.637 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 51.4 t -141.28 149.62 41.52 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 125.072 1.349 . . . . 1.51 108.532 -171.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -106.26 142.9 35.17 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.185 1.394 . . . . 3.0699999999999998 108.422 179.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -141.43 109.09 2.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 107.255 -1.387 . . . . 2.6299999999999999 107.255 -163.003 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 17.5 tt0 -79.21 147.09 32.73 Favored 'General case' 0 N--CA 1.422 -1.851 0 N-CA-C 107.094 -1.447 . . . . 2.9700000000000002 107.094 -178.456 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.1 p -150.83 134.41 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 N-CA-C 108.825 -0.806 . . . . 2.8599999999999999 108.825 -168.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 6.1 m -83.19 73.5 10.09 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 121.959 0.885 . . . . 2.27 110.66 -167.232 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 121.57 94.25 1.3 Allowed Glycine 0 N--CA 1.443 -0.862 0 CA-C-O 124.664 2.258 . . . . 2.8500000000000001 107.765 175.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.443 ' HE3' HG22 ' A' ' 18' ' ' VAL . 11.9 tpt -95.56 -70.21 0.72 Allowed 'General case' 0 N--CA 1.422 -1.829 0 CA-C-N 109.456 -3.372 . . . . 7.3899999999999997 107.521 -172.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 5.7 m -108.08 52.89 0.7 Allowed 'General case' 0 N--CA 1.456 -0.175 0 N-CA-C 108.585 -0.895 . . . . 5.7199999999999998 108.585 -177.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 21.3 m -64.82 -61.02 2.43 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 107.507 -1.294 . . . . 3.7799999999999998 107.507 176.076 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -174.37 70.18 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 127.556 2.343 . . . . 2.7000000000000002 106.979 174.046 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . 0.26 16.6 p 77.63 23.0 0.85 Allowed 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 126.959 2.104 . . . . 2.48 114.676 176.22 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 80.1 m -52.12 -39.43 59.87 Favored 'General case' 0 CA--C 1.536 0.416 0 O-C-N 121.108 -0.995 . . . . 3.27 109.413 157.141 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.443 HG22 ' HE3' ' A' ' 12' ' ' MET . 1.0 OUTLIER -42.49 -47.87 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.034 0 C-N-CA 126.248 1.819 . . . . 2.8300000000000001 114.12 161.989 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.73 -36.07 82.54 Favored 'General case' 0 C--O 1.234 0.247 0 O-C-N 121.511 -0.743 . . . . 1.2 110.396 176.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -58.56 -51.79 68.4 Favored 'General case' 0 C--O 1.219 -0.522 0 N-CA-C 108.341 -0.985 . . . . 1.9199999999999999 108.341 169.708 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 86.6 mt -53.88 -52.55 34.51 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-N 119.108 0.867 . . . . 2.8799999999999999 109.863 -176.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.932 ' HA ' HD13 ' A' ' 34' ' ' ILE . 18.4 mt-10 -48.33 -48.7 36.09 Favored 'General case' 0 N--CA 1.444 -0.774 0 O-C-N 121.006 -1.059 . . . . 3.6099999999999999 112.722 172.22 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 5.6 ttm-85 -66.42 -27.35 67.76 Favored 'General case' 0 N--CA 1.444 -0.744 0 O-C-N 121.736 -0.603 . . . . 6.7199999999999998 112.426 173.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.409 ' ND2' ' HG ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -72.78 -56.91 4.55 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 119.309 0.959 . . . . 4.46 110.571 -169.882 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.409 ' HG ' ' ND2' ' A' ' 24' ' ' ASN . 3.4 mt -69.52 -33.11 72.34 Favored 'General case' 0 C--O 1.223 -0.309 0 C-N-CA 119.429 -0.908 . . . . 3.23 113.003 -161.335 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.59 -17.78 0.36 Allowed 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 114.498 1.295 . . . . 7.7800000000000002 114.498 168.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -35.67 -56.44 0.68 Allowed 'General case' 0 C--N 1.343 0.308 0 O-C-N 121.014 -1.054 . . . . 9.8599999999999994 111.559 162.601 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.502 ' HB3' HD11 ' A' ' 52' ' ' ILE . 9.6 mt-10 -96.36 119.58 35.11 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 118.972 -1.091 . . . . 9.4900000000000002 111.492 -140.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 47.8 mp0 -58.51 106.4 0.39 Allowed 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.303 1.441 . . . . 4.8799999999999999 109.197 179.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 122.02 -1.1 10.81 Favored Glycine 0 CA--C 1.529 0.941 0 CA-C-O 118.992 -0.893 . . . . 1.26 111.915 -171.2 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -78.52 138.19 20.64 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-N 118.432 1.116 . . . . 1.9199999999999999 110.672 177.225 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -147.91 48.34 1.07 Allowed 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 122.038 0.923 . . . . 3.27 112.993 164.129 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.7 m -169.2 173.24 6.85 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 129.354 3.062 . . . . 2.4500000000000002 106.487 129.186 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.932 HD13 ' HA ' ' A' ' 22' ' ' GLU . 1.8 pp -120.1 139.41 47.48 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 N-CA-C 102.841 -3.022 . . . . 2.6499999999999999 102.841 161.045 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.467 ' HB2' ' HB3' ' A' ' 44' ' ' GLU . 1.7 mp -148.14 157.17 43.35 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 119.269 0.941 . . . . 6.8799999999999999 109.523 -167.136 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.514 ' O ' HG12 ' A' ' 36' ' ' VAL . 2.1 t -155.05 73.0 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 CA-C-O 124.857 2.265 . . . . 2.29 107.649 -159.805 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -80.29 59.51 3.42 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 113.714 -1.584 . . . . 1.1899999999999999 109.089 169.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.401 ' CD2' HG21 ' A' ' 18' ' ' VAL . 0.4 OUTLIER -59.64 -29.91 68.35 Favored 'General case' 0 CA--C 1.505 -0.78 0 O-C-N 121.462 -0.774 . . . . 3.9300000000000002 111.608 173.905 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 2.7 mpt? -62.35 -34.46 76.7 Favored 'General case' 0 N--CA 1.438 -1.045 0 C-N-CA 118.861 -1.136 . . . . 3.7400000000000002 109.167 -169.578 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -76.99 -53.87 7.28 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.523 0.729 . . . . 1.96 109.336 164.082 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 131.39 50.37 0.1 Allowed Glycine 0 C--N 1.338 0.676 0 N-CA-C 109.943 -1.263 . . . . 1.4399999999999999 109.943 173.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 75.1 mttt -149.86 150.82 32.5 Favored 'General case' 0 N--CA 1.442 -0.87 0 N-CA-C 108.656 -0.868 . . . . 4.3300000000000001 108.656 -169.176 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -76.11 163.53 27.02 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 105.577 -2.008 . . . . 1.73 105.577 155.056 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.467 ' HB3' ' HB2' ' A' ' 35' ' ' LEU . 52.5 tt0 -128.24 157.68 40.22 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 106.108 -1.812 . . . . 3.5800000000000001 106.108 163.743 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 6.8 p -132.46 134.06 59.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 N-CA-C 106.176 -1.787 . . . . 1.77 106.176 173.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 33.2 ttm105 -105.34 130.23 53.5 Favored 'General case' 0 N--CA 1.456 -0.165 0 N-CA-C 105.632 -1.988 . . . . 4.5800000000000001 105.632 157.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 5.1 p90 -155.63 172.8 17.68 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 123.082 0.553 . . . . 2.02 110.262 -164.246 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -117.78 80.59 14.24 Favored Pre-proline 0 C--O 1.238 0.45 0 CA-C-N 115.969 -0.559 . . . . 2.7599999999999998 112.211 -174.143 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -66.47 87.17 0.27 Allowed 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 123.46 2.773 . . . . 2.5299999999999998 108.531 174.201 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -178.45 -47.35 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 130.25 3.42 . . . . 2.5600000000000001 105.937 -176.213 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 73.9 t -81.42 -57.62 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.712 0 N-CA-C 108.588 -0.893 . . . . 2.0299999999999998 108.588 168.291 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.502 HD11 ' HB3' ' A' ' 28' ' ' GLU . 12.1 tt -90.09 -44.97 15.07 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.21 0 N-CA-C 115.44 1.644 . . . . 2.4900000000000002 115.44 -146.451 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 21.9 tp60 91.86 110.94 0.02 OUTLIER Pre-proline 0 CA--C 1.55 0.979 0 C-N-CA 127.244 2.218 . . . . 3.1000000000000001 111.087 176.005 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -43.04 -48.35 7.8 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 124.773 3.649 . . . . 1.3700000000000001 118.127 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -54.84 -43.35 60.1 Favored 'Trans proline' 0 N--CA 1.448 -1.162 0 CA-C-N 121.329 1.51 . . . . 1.23 110.507 172.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 63.9 mtt -62.37 -44.82 95.56 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 118.397 -0.811 . . . . 2.1299999999999999 110.044 178.16 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.458 HD11 HG21 ' A' ' 52' ' ' ILE . 5.7 mm -48.4 -57.06 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 CA-C-N 119.08 0.855 . . . . 2.9199999999999999 109.903 172.305 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -55.22 -46.71 75.94 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.052 0.541 . . . . 1.3 112.073 -177.081 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -70.23 -44.91 67.6 Favored 'General case' 0 N--CA 1.44 -0.948 0 C-N-CA 124.62 1.168 . . . . 3.0899999999999999 112.74 -176.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -48.59 -36.81 16.47 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 123.968 0.907 . . . . 3.9399999999999999 111.571 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 22.1 mt -69.98 -40.58 78.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 N-CA-C 109.658 -0.497 . . . . 1.3999999999999999 109.658 178.484 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 80.1 mtm-85 -70.96 -31.36 67.91 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 118.24 -0.886 . . . . 4.0599999999999996 112.692 -178.283 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 87.1 mt-10 -41.19 -44.33 2.55 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.926 1.291 . . . . 4.7000000000000002 113.764 179.238 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.42 -12.89 58.78 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.105 0.962 . . . . 2.8900000000000001 111.704 -173.696 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 111.32 -2.03 28.09 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 124.742 1.163 . . . . 2.3799999999999999 111.499 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -76.57 86.2 3.26 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 107.993 -1.114 . . . . 3.0099999999999998 107.993 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -61.4 104.41 0.69 Allowed Glycine 0 N--CA 1.442 -0.932 0 C-N-CA 125.672 1.606 . . . . 1.6899999999999999 109.177 -178.008 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -137.99 151.84 48.31 Favored 'General case' 0 N--CA 1.45 -0.457 0 O-C-N 124.981 1.048 . . . . 1.3899999999999999 112.494 -163.369 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 29.8 m -135.34 138.63 43.59 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 125.769 1.627 . . . . 2.6600000000000001 107.976 -170.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 12.7 t -82.77 111.36 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 C-N-CA 124.972 1.309 . . . . 1.8300000000000001 107.73 -177.034 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 16.2 mt -134.27 66.03 0.29 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.331 0 C-N-CA 124.499 1.119 . . . . 2.6499999999999999 109.231 -172.048 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 . . . . . 0 CA--C 1.531 0.239 0 C-N-CA 129.794 3.238 . . . . 8.0999999999999996 106.121 150.16 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 12.1 m . . . . . 0 CA--C 1.529 0.156 0 CA-C-O 123.105 1.431 . . . . 2.52 107.682 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -84.69 127.36 34.06 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 128.586 2.755 . . . . 2.1899999999999999 109.955 -168.426 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 37.2 tttt -81.83 144.13 31.25 Favored 'General case' 0 C--N 1.34 0.178 0 CA-C-N 118.761 0.71 . . . . 4.1600000000000001 109.272 174.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 45.5 t -143.18 156.01 44.67 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.402 0.681 . . . . 1.3200000000000001 109.324 170.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -102.52 139.67 37.82 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 124.555 1.142 . . . . 2.6600000000000001 108.528 175.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.7 mp -133.24 130.01 57.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 N-CA-C 104.91 -2.255 . . . . 2.0899999999999999 104.91 174.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 36.4 tp60 -91.7 126.04 36.64 Favored 'General case' 0 N--CA 1.433 -1.289 0 N-CA-C 104.042 -2.577 . . . . 3.25 104.042 169.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.4 m -109.4 136.35 45.56 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 N-CA-C 108.386 -0.968 . . . . 2.2599999999999998 108.386 179.525 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 6.1 m -87.22 55.35 3.51 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 108.925 -0.768 . . . . 2.23 108.925 171.487 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -143.95 123.08 1.95 Allowed Glycine 0 N--CA 1.445 -0.732 0 N-CA-C 103.464 -3.854 . . . . 3.1600000000000001 103.464 148.4 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 70.6 mtm -136.6 -71.92 0.45 Allowed 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 106.515 -1.661 . . . . 4.25 106.515 -176.202 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 4.9 t -74.93 51.04 0.48 Allowed 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 109.307 -0.627 . . . . 5.7599999999999998 109.307 163.121 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 14.5 t -114.42 121.65 44.21 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 105.12 -2.178 . . . . 3.0499999999999998 105.12 175.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -71.53 82.19 0.81 Allowed 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 123.57 0.748 . . . . 2.7799999999999998 111.999 -157.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 87.63 38.12 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 127.684 2.394 . . . . 2.5299999999999998 109.857 -177.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.8 t -47.59 -41.0 20.7 Favored 'General case' 0 CA--C 1.521 -0.136 0 C-N-CA 125.082 1.353 . . . . 3.7799999999999998 108.83 168.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 15.1 m -66.32 -53.34 37.43 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.06 0 CA-C-N 113.49 -1.687 . . . . 2.2200000000000002 110.321 -175.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -50.44 -45.15 55.78 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.39 0.676 . . . . 0.81999999999999995 110.309 172.485 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -56.84 -56.39 22.17 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 109.597 -0.52 . . . . 2.0299999999999998 109.597 175.66 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 27.5 mt -52.58 -54.46 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 C-N-CA 124.268 1.027 . . . . 2.3199999999999998 110.199 -179.262 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -50.32 -59.01 4.4 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 124.985 1.314 . . . . 2.9300000000000002 110.088 176.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 21.5 tpt180 -55.48 -41.83 73.55 Favored 'General case' 0 N--CA 1.443 -0.801 0 C-N-CA 124.666 1.186 . . . . 5.1200000000000001 111.515 -176.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 15.3 m-20 -72.31 -64.46 0.94 Allowed 'General case' 0 C--O 1.222 -0.362 0 N-CA-C 109.609 -0.515 . . . . 3.52 109.609 179.163 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.873 HD12 HD21 ' A' ' 35' ' ' LEU 0.319 6.9 mt -80.54 -11.09 59.71 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 128.69 2.796 . . . . 3.6600000000000001 116.808 -159.484 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -19.57 -71.5 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 126.777 2.031 . . . . 9.3300000000000001 114.345 175.458 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 30.4 mmt180 -92.35 -60.7 1.77 Allowed 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 118.828 2.899 . . . . 12.91 118.828 -179.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.408 ' H ' ' CD ' ' A' ' 28' ' ' GLU 0.262 2.5 mm-40 8.27 62.84 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.685 1 C-N-CA 132.665 4.386 . . . . 5.8300000000000001 112.314 -152.328 . . . . . . . . 4 3 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 18.06 58.13 0.01 OUTLIER 'General case' 0 C--N 1.343 0.299 0 C-N-CA 129.685 3.194 . . . . 6.9400000000000004 113.257 -169.342 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 166.63 -28.7 0.18 Allowed Glycine 0 CA--C 1.522 0.503 0 C-N-CA 120.134 -1.031 . . . . 1.5 113.488 -171.189 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.7 mt -81.6 111.96 18.87 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 N-CA-C 106.212 -1.773 . . . . 1.96 106.212 174.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 47.9 m-85 -122.6 44.16 2.71 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 122.832 1.301 . . . . 3.29 110.547 166.371 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 33.7 t -166.78 137.54 3.24 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 126.799 2.04 . . . . 1.73 105.952 142.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.2 pp -78.59 151.44 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.651 0 N-CA-C 107.5 -1.296 . . . . 1.9099999999999999 107.5 171.374 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.873 HD21 HD12 ' A' ' 25' ' ' LEU . 0.3 OUTLIER -94.69 77.43 3.73 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 129.466 3.106 . . . . 4.3300000000000001 110.243 -169.273 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 43.3 t -131.59 139.71 49.97 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.801 0 N-CA-C 108.997 -0.742 . . . . 1.5 108.997 168.24 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -155.99 55.99 0.59 Allowed 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 106.618 -1.623 . . . . 0.67000000000000004 106.618 168.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -71.61 -20.32 62.0 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 114.74 -1.118 . . . . 3.0600000000000001 111.017 -172.412 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 53.0 ttm -45.23 -38.29 5.34 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.621 0.768 . . . . 3.3999999999999999 110.935 164.157 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -95.51 -48.67 5.74 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.234 0.614 . . . . 1.79 110.235 170.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 119.67 54.82 0.26 Allowed Glycine 0 C--N 1.338 0.64 0 N-CA-C 109.813 -1.315 . . . . 0.91000000000000003 109.813 -177.578 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 10.2 pttt -159.15 177.98 10.5 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 107.991 -1.114 . . . . 4.1100000000000003 107.991 -173.007 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.514 ' HB1' ' HB2' ' A' ' 35' ' ' LEU . . . -132.31 124.36 28.67 Favored 'General case' 0 N--CA 1.441 -0.904 0 C-N-CA 127.081 2.153 . . . . 0.90000000000000002 108.705 -169.102 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -125.03 89.06 2.99 Favored 'General case' 0 C--N 1.343 0.296 0 N-CA-C 113.776 1.028 . . . . 3.29 113.776 -175.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.431 HG11 ' CD2' ' A' ' 47' ' ' TYR . 9.6 p -78.65 152.1 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.088 0 N-CA-C 108.707 -0.849 . . . . 1.6399999999999999 108.707 -174.213 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 63.9 ttm-85 -114.85 112.58 22.99 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 106.705 -1.591 . . . . 4.46 106.705 156.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.512 ' CZ ' ' HG3' ' A' ' 54' ' ' PRO . 0.0 OUTLIER -123.15 165.42 16.89 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 124.304 1.041 . . . . 2.3199999999999998 113.19 -169.629 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 32.6 t30 -126.94 90.99 48.12 Favored Pre-proline 0 N--CA 1.451 -0.386 0 C-N-CA 125.99 1.716 . . . . 2.3799999999999999 109.015 -178.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -71.64 71.26 2.6 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 122.895 2.397 . . . . 1.8500000000000001 112.081 179.122 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -123.92 -49.11 1.86 Allowed 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 126.201 1.8 . . . . 1.96 106.853 157.054 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 41.0 t -83.52 -61.44 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.923 0 C-N-CA 124.741 1.216 . . . . 1.75 110.567 175.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.473 HG23 ' H ' ' A' ' 53' ' ' GLN . 6.1 tp -78.58 -71.67 0.29 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.414 0 N-CA-C 113.008 0.744 . . . . 1.6499999999999999 113.008 -161.277 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.473 ' H ' HG23 ' A' ' 52' ' ' ILE . 4.0 mp0 82.81 128.78 0.03 OUTLIER Pre-proline 0 CA--C 1.548 0.887 0 C-N-CA 128.293 2.637 . . . . 3.8700000000000001 113.248 -176.401 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.512 ' HG3' ' CZ ' ' A' ' 47' ' ' TYR . 21.5 Cg_exo -42.88 -52.48 4.62 Favored 'Trans proline' 0 C--N 1.349 0.562 1 C-N-CA 126.744 4.963 . . . . 1.29 117.687 177.594 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -54.06 -49.25 17.73 Favored 'Trans proline' 0 N--CA 1.442 -1.553 0 CA-C-N 120.11 1.075 . . . . 0.84999999999999998 109.678 173.305 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 61.3 mtt -64.93 -45.26 86.57 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.193 -0.669 . . . . 2.1800000000000002 109.193 -170.066 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.427 HG22 ' HA ' ' A' ' 54' ' ' PRO . 16.2 tt -59.7 -49.75 82.58 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 C-N-CA 119.087 -1.045 . . . . 2.6299999999999999 111.527 177.287 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -51.8 -53.78 36.2 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 118.319 0.508 . . . . 1.0900000000000001 111.758 176.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -56.53 -54.49 45.25 Favored 'General case' 0 N--CA 1.432 -1.367 0 C-N-CA 124.511 1.125 . . . . 3.1200000000000001 110.676 -179.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 18.7 m-30 -50.25 -43.1 52.99 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 119.103 0.865 . . . . 4.1200000000000001 110.833 178.154 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 85.6 mt -65.43 -40.83 89.53 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 O-C-N 121.712 -0.617 . . . . 1.21 110.083 -179.307 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 51.8 mtp180 -59.12 -51.83 68.33 Favored 'General case' 0 CA--C 1.533 0.322 0 O-C-N 121.905 -0.497 . . . . 5.4199999999999999 111.211 171.177 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -56.5 -32.95 65.53 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 125.507 1.523 . . . . 3.0899999999999999 111.673 179.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 59.5 mt -77.2 -17.43 58.52 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 119.184 -0.436 . . . . 1.98 110.629 176.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 135.42 -9.67 4.36 Favored Glycine 0 CA--C 1.526 0.72 0 C-N-CA 124.069 0.842 . . . . 2.2799999999999998 112.964 167.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -110.28 115.03 28.96 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 118.481 1.14 . . . . 3.25 110.02 -160.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -63.71 86.96 0.06 OUTLIER Glycine 0 N--CA 1.447 -0.625 0 CA-C-N 115.868 -0.606 . . . . 1.3899999999999999 112.065 -176.264 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -84.06 127.74 34.09 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 126.074 1.75 . . . . 0.94999999999999996 109.829 178.284 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 9.6 t -122.18 130.38 53.15 Favored 'General case' 0 N--CA 1.436 -1.132 0 N-CA-C 105.785 -1.932 . . . . 2.2200000000000002 105.785 165.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 77.0 t -83.74 135.89 23.91 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.89 0 N-CA-C 107.398 -1.334 . . . . 1.79 107.398 -177.531 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 17.9 mt -126.91 73.81 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 N-CA-C 107.034 -1.469 . . . . 1.9099999999999999 107.034 -178.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 115.097 -0.956 . . . . 3.6400000000000001 110.958 167.02 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.1 p . . . . . 0 CA--C 1.538 0.519 0 N-CA-C 114.57 1.322 . . . . 2.4700000000000002 114.57 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.6 p -91.49 172.38 8.55 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 128.096 2.559 . . . . 2.21 111.075 -177.213 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 6.1 tttt -108.53 156.47 19.46 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 124.755 1.222 . . . . 4.5999999999999996 108.563 166.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -145.26 175.35 10.35 Favored 'General case' 0 C--O 1.235 0.324 0 O-C-N 124.142 0.901 . . . . 2.0600000000000001 109.97 162.32 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 45.0 m-85 -115.93 139.79 49.89 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 126.31 1.844 . . . . 2.8500000000000001 108.321 -171.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.7 pt -136.28 122.9 31.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 C-N-CA 123.914 0.885 . . . . 3.1499999999999999 110.602 178.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -80.33 132.48 35.81 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 106.677 -1.601 . . . . 3.7599999999999998 106.677 171.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.7 m -107.85 121.1 60.32 Favored 'Isoleucine or valine' 0 C--O 1.232 0.147 0 O-C-N 124.038 0.836 . . . . 2.1099999999999999 109.658 -176.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.3 m -66.17 73.48 0.08 Allowed 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.138 0.975 . . . . 2.46 111.596 177.229 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -173.47 -59.14 0.05 OUTLIER Glycine 0 CA--C 1.522 0.478 0 N-CA-C 106.788 -2.525 . . . . 3.3700000000000001 106.788 172.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 25.2 ttm 69.03 -33.21 0.24 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 126.686 1.994 . . . . 4.1699999999999999 114.664 170.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.7 t -155.22 52.87 0.62 Allowed 'General case' 0 N--CA 1.446 -0.625 0 C-N-CA 124.668 1.187 . . . . 4.7300000000000004 108.163 177.068 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 12.5 p -58.01 -43.05 86.47 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 108.413 -0.958 . . . . 2.7000000000000002 108.413 164.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 156.92 -59.88 0.0 OUTLIER 'General case' 0 CA--C 1.521 -0.16 0 C-N-CA 129.514 3.126 . . . . 3.8900000000000001 107.177 166.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.0 p -99.11 42.63 1.09 Allowed 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.367 1.067 . . . . 3.0699999999999998 110.916 -174.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 37.7 m -52.79 -51.73 59.59 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 108.49 -0.93 . . . . 4.7000000000000002 108.49 178.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.2 p -63.77 -55.31 23.21 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.67 0 CA-C-O 121.936 0.874 . . . . 3.6200000000000001 111.232 -178.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.32 -30.88 67.03 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.513 -1.221 . . . . 1.0800000000000001 112.598 -175.301 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -68.19 -57.22 6.37 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 119.68 1.127 . . . . 3.0600000000000001 108.276 169.401 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.694 HG22 HD11 ' A' ' 34' ' ' ILE 0.255 1.5 mt -62.83 -35.69 72.13 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.894 0 O-C-N 121.868 -0.52 . . . . 1.97 110.362 -166.991 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.525 ' HG2' HD12 ' A' ' 34' ' ' ILE . 16.0 mt-10 -43.59 -56.7 3.54 Favored 'General case' 0 N--CA 1.453 -0.302 0 O-C-N 121.483 -0.761 . . . . 3.3799999999999999 110.385 171.043 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.41 ' HD2' ' H ' ' A' ' 23' ' ' ARG . 0.2 OUTLIER -63.5 -44.57 93.93 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 115.414 -0.812 . . . . 5.96 110.438 175.783 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.795 ' ND2' HD13 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -60.31 -42.46 95.61 Favored 'General case' 0 C--O 1.223 -0.299 0 C-N-CA 122.922 0.489 . . . . 3.9399999999999999 111.717 -168.741 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.795 HD13 ' ND2' ' A' ' 24' ' ' ASN 0.337 5.2 mp -80.33 -43.93 20.37 Favored 'General case' 0 N--CA 1.435 -1.21 0 C-N-CA 126.081 1.752 . . . . 2.7999999999999998 113.101 175.486 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 83.7 mtt180 -66.2 -20.47 66.14 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 119.364 -2.085 . . . . 7.5099999999999998 112.721 -174.503 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 4.8 mmt180 -29.98 -62.86 0.14 Allowed 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 125.717 1.607 . . . . 8.3300000000000001 112.992 162.055 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 150.98 176.92 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.178 0 C-N-CA 128.049 2.54 . . . . 7.5 106.345 -158.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 101.88 32.09 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 129.477 3.111 . . . . 8.5399999999999991 111.379 -167.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 55.9 42.88 87.26 Favored Glycine 0 CA--C 1.526 0.736 0 O-C-N 121.752 -0.592 . . . . 1.73 111.682 177.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 1.4 mp -74.04 142.57 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 CA-C-N 117.066 0.433 . . . . 2.2000000000000002 110.102 176.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -145.81 41.86 1.22 Allowed 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 122.449 1.118 . . . . 3.6899999999999999 113.657 158.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 58.8 m -167.93 157.8 10.15 Favored 'General case' 0 C--N 1.319 -0.743 1 C-N-CA 132.698 4.399 . . . . 2.2999999999999998 104.12 133.14 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.694 HD11 HG22 ' A' ' 21' ' ' ILE . 0.0 OUTLIER -109.65 144.95 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 N-CA-C 104.712 -2.329 . . . . 2.5600000000000001 104.712 155.636 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.659 ' N ' HD13 ' A' ' 34' ' ' ILE . 0.3 OUTLIER -147.65 148.43 31.05 Favored 'General case' 0 N--CA 1.434 -1.247 0 C-N-CA 125.965 1.706 . . . . 6.5599999999999996 106.504 -167.543 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.498 HG23 HG21 ' A' ' 21' ' ' ILE . 1.3 t -156.7 96.18 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 N-CA-C 105.207 -2.145 . . . . 2.1099999999999999 105.207 174.396 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -77.22 66.35 2.99 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 115.295 -0.866 . . . . 0.69999999999999996 109.419 176.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.492 HD23 ' HA ' ' A' ' 38' ' ' LEU . 9.5 mt -53.18 -36.58 61.08 Favored 'General case' 0 C--N 1.342 0.245 0 C-N-CA 123.35 0.66 . . . . 2.6400000000000001 110.832 173.752 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 16.3 tpt -51.42 -39.66 57.77 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.715 0.806 . . . . 5.0899999999999999 111.809 173.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -88.68 -23.94 22.88 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.621 0.769 . . . . 1.6100000000000001 111.436 178.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 89.09 41.83 5.77 Favored Glycine 0 C--N 1.335 0.488 0 N-CA-C 110.188 -1.165 . . . . 0.88 110.188 179.048 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 58.4 pttt -156.1 158.16 37.25 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 107.879 -1.156 . . . . 3.6699999999999999 107.879 177.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.423 ' HA ' ' HA ' ' A' ' 36' ' ' VAL . . . -83.88 163.98 19.73 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 108.798 -0.816 . . . . 1.4199999999999999 108.798 170.422 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.445 ' CB ' ' HB2' ' A' ' 35' ' ' LEU . 55.3 mt-10 -131.2 157.72 42.44 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.214 -0.661 . . . . 2.6600000000000001 109.214 174.751 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.593 HG12 HD21 ' A' ' 25' ' ' LEU . 13.4 m -134.7 142.43 40.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 N-CA-C 109.432 -0.581 . . . . 2.6600000000000001 109.432 173.1 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 49.1 ttt180 -127.02 125.72 41.9 Favored 'General case' 0 CA--C 1.516 -0.353 0 N-CA-C 106.487 -1.671 . . . . 5.5199999999999996 106.487 158.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 22.1 p90 -157.37 171.94 19.49 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 109.187 -0.672 . . . . 2.1200000000000001 109.187 -163.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 50.7 t-20 -103.69 93.52 5.22 Favored Pre-proline 0 CA--C 1.534 0.329 0 C-N-CA 123.207 0.603 . . . . 2.6299999999999999 110.544 176.12 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -65.24 80.86 0.21 Allowed 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 123.015 2.477 . . . . 1.6799999999999999 110.26 169.37 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -168.85 -56.61 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 128.916 2.886 . . . . 1.0800000000000001 104.894 172.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 68.1 t -57.24 -55.42 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 C-N-CA 124.509 1.124 . . . . 0.94999999999999996 109.689 171.58 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.505 HG23 ' H ' ' A' ' 53' ' ' GLN 0.251 9.7 tp -95.73 -75.82 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.369 0 CA-C-O 118.514 -0.755 . . . . 2.5099999999999998 111.54 -172.079 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.505 ' H ' HG23 ' A' ' 52' ' ' ILE . 0.0 OUTLIER 114.2 137.06 0.0 OUTLIER Pre-proline 0 N--CA 1.47 0.545 0 C-N-CA 130.815 3.646 . . . . 2.4300000000000002 107.012 -173.163 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_exo -50.98 -50.89 12.46 Favored 'Trans proline' 0 CA--C 1.534 0.476 0 C-N-CA 123.432 2.755 . . . . 1.0900000000000001 114.57 176.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -52.1 -48.8 19.84 Favored 'Trans proline' 0 N--CA 1.444 -1.406 0 CA-C-N 120.525 1.223 . . . . 1.03 110.383 168.084 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 62.7 mtt -66.14 -35.05 79.45 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 118.447 -1.301 . . . . 2.96 110.879 -171.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 4.4 tt -70.13 -44.98 77.64 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 CA-C-N 119.502 1.047 . . . . 2.2599999999999998 109.933 176.274 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -53.67 -41.06 66.47 Favored 'General case' 0 C--N 1.341 0.228 0 N-CA-C 112.266 0.469 . . . . 1.1000000000000001 112.266 175.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 30.8 mm-40 -66.66 -59.94 3.15 Favored 'General case' 0 N--CA 1.437 -1.093 0 C-N-CA 124.94 1.296 . . . . 2.6200000000000001 110.564 174.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -54.41 -42.75 70.84 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 117.897 0.317 . . . . 4.4800000000000004 110.231 -170.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.8 mt -56.26 -37.15 48.85 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 O-C-N 121.487 -0.758 . . . . 1.6699999999999999 111.637 176.517 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 42.6 mtm105 -70.18 -44.33 68.94 Favored 'General case' 0 N--CA 1.456 -0.142 0 O-C-N 121.605 -0.684 . . . . 3.8799999999999999 111.22 173.27 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -56.55 -33.89 66.55 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 119.189 0.904 . . . . 3.2400000000000002 111.604 175.266 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 83.6 mt -78.74 -16.58 57.04 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.845 0.858 . . . . 3.0800000000000001 111.362 175.253 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 136.65 -12.49 3.98 Favored Glycine 0 CA--C 1.528 0.852 0 CA-C-O 119.335 -0.703 . . . . 2.0299999999999998 113.988 164.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -107.94 119.43 39.44 Favored 'General case' 0 CA--C 1.522 -0.125 0 CA-C-N 118.738 1.269 . . . . 4.0300000000000002 110.523 -159.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -68.44 69.4 0.37 Allowed Glycine 0 C--N 1.336 0.574 0 C-N-CA 125.917 1.722 . . . . 1.6399999999999999 113.969 -172.222 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -83.6 121.13 26.83 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 126.482 1.913 . . . . 1.4199999999999999 110.738 -173.329 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 25.7 p -124.04 119.39 29.37 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 125.486 1.514 . . . . 2.7200000000000002 108.504 -179.29 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 74.9 t -81.03 128.46 38.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 C-N-CA 124.917 1.287 . . . . 1.74 109.54 -165.486 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 5.0 pt -139.13 59.49 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-O 122.197 0.999 . . . . 2.9199999999999999 112.174 -173.335 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 . . . . . 0 N--CA 1.448 -0.537 0 N-CA-C 108.596 -0.89 . . . . 5.0800000000000001 108.596 171.092 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 27.9 t . . . . . 0 C--O 1.236 0.349 0 N-CA-C 110.094 -0.336 . . . . 3.5499999999999998 110.094 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 10.6 p -85.8 141.31 29.75 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 126.245 1.818 . . . . 3.2999999999999998 108.259 164.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.35 147.87 28.71 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 105.384 -2.08 . . . . 7.3799999999999999 105.384 169.644 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 32.6 t -150.74 159.74 44.32 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 106.497 -1.668 . . . . 1.8999999999999999 106.497 176.167 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -135.3 148.39 49.49 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 106.143 -1.799 . . . . 3.1400000000000001 106.143 -178.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.1 pt -141.3 121.61 12.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 108.178 -1.045 . . . . 3.0800000000000001 108.178 -168.28 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 24.1 tp60 -80.81 125.2 29.79 Favored 'General case' 0 N--CA 1.438 -1.033 0 N-CA-C 103.685 -2.709 . . . . 3.0800000000000001 103.685 174.219 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.1 p -136.15 136.98 49.02 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.175 0 C-N-CA 123.803 0.841 . . . . 2.5600000000000001 110.169 -168.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.7 m -83.3 67.54 9.3 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 115.86 -0.609 . . . . 2.2400000000000002 111.843 -164.375 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 143.78 90.64 0.12 Allowed Glycine 0 CA--C 1.505 -0.548 0 N-CA-C 108.394 -1.882 . . . . 2.79 108.394 164.137 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 6.0 mmt -102.14 -56.16 2.33 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 110.704 -2.748 . . . . 6.96 109.713 171.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.8 m -72.35 57.06 0.37 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.594 1.158 . . . . 5.4100000000000001 109.056 172.604 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 4.3 t -112.13 173.55 6.31 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 126.946 2.099 . . . . 3.6000000000000001 105.954 179.041 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -81.68 123.09 28.42 Favored 'General case' 0 CA--C 1.52 -0.208 0 N-CA-C 107.204 -1.406 . . . . 2.4700000000000002 107.204 166.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 27.5 t 57.33 -84.65 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 118.607 -0.711 . . . . 3.7999999999999998 109.227 -152.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 5.3 m -19.36 -21.35 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 118.142 2.645 . . . . 3.0499999999999998 118.142 -99.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.823 ' CG2' HG11 ' A' ' 36' ' ' VAL . 0.3 OUTLIER -41.18 -38.08 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 N-CA-C 115.502 1.667 . . . . 2.77 115.502 172.326 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.26 -44.39 83.88 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.137 0.494 . . . . 1.1699999999999999 110.83 177.182 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -61.47 -51.04 70.31 Favored 'General case' 0 C--O 1.222 -0.365 0 N-CA-C 108.408 -0.96 . . . . 1.8400000000000001 108.408 174.047 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.565 HG21 HG21 ' A' ' 36' ' ' VAL 0.251 11.1 mm -47.78 -60.84 0.56 Allowed 'Isoleucine or valine' 0 C--O 1.209 -1.052 0 C-N-CA 124.59 1.156 . . . . 2.25 109.479 175.0 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.406 ' HA ' HD12 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -43.44 -45.77 6.45 Favored 'General case' 0 C--N 1.318 -0.771 0 O-C-N 116.911 -3.618 . . . . 4.9100000000000001 114.274 172.355 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 27.1 mmt85 -64.07 -31.56 72.79 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 120.857 -1.152 . . . . 4.7400000000000002 113.568 168.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.722 ' ND2' HD13 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -60.6 -67.27 0.41 Allowed 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 127.423 2.289 . . . . 5.1500000000000004 111.666 -171.522 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.722 HD13 ' ND2' ' A' ' 24' ' ' ASN 0.354 5.2 mp -75.05 -26.98 59.81 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 119.508 -0.877 . . . . 3.3799999999999999 111.086 -163.163 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 92.8 mtt180 -61.74 -17.59 56.46 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 113.8 1.037 . . . . 6.71 113.8 168.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 23.6 mmt180 -57.11 -40.06 76.32 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 120.205 1.366 . . . . 8.5199999999999996 111.254 166.253 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -100.48 79.71 2.14 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-O 121.662 0.744 . . . . 9.2200000000000006 109.523 -146.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -37.02 114.91 0.35 Allowed 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 125.412 1.485 . . . . 5.6299999999999999 111.229 176.235 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 122.71 -21.73 7.47 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 111.048 -0.821 . . . . 1.1200000000000001 111.048 -167.23 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.554 HG23 ' H ' ' A' ' 33' ' ' SER . 1.2 mm -78.17 146.3 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 C-N-CA 125.079 1.352 . . . . 3.0499999999999998 108.282 164.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -137.96 37.37 2.37 Favored 'General case' 0 C--N 1.342 0.261 0 CA-C-O 123.065 1.412 . . . . 3.3599999999999999 113.002 153.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.554 ' H ' HG23 ' A' ' 31' ' ' ILE . 0.5 OUTLIER -167.88 124.65 1.11 Allowed 'General case' 0 C--N 1.318 -0.8 0 C-N-CA 125.19 1.396 . . . . 2.4500000000000002 109.026 172.134 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.732 ' C ' HD12 ' A' ' 35' ' ' LEU . 0.0 OUTLIER -106.83 105.5 18.88 Favored 'Isoleucine or valine' 0 C--N 1.346 0.418 0 CA-C-N 119.872 1.214 . . . . 2.6200000000000001 108.929 168.237 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.732 HD12 ' C ' ' A' ' 34' ' ' ILE . 6.7 mp -118.22 151.77 36.99 Favored 'General case' 0 CA--C 1.502 -0.878 0 N-CA-C 106.612 -1.625 . . . . 7.7400000000000002 106.612 -168.639 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.823 HG11 ' CG2' ' A' ' 18' ' ' VAL 0.286 1.0 OUTLIER -159.68 95.2 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.427 -1.624 0 CA-C-O 122.647 1.213 . . . . 2.2200000000000002 111.12 -172.842 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -80.11 73.37 6.94 Favored 'General case' 0 CA--C 1.532 0.277 0 O-C-N 119.966 -1.709 . . . . 1.02 109.109 178.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.568 HD21 HG23 ' A' ' 18' ' ' VAL . 80.6 mt -44.22 -52.35 7.5 Favored 'General case' 0 C--N 1.342 0.243 0 C-N-CA 124.414 1.086 . . . . 2.7799999999999998 111.227 -176.786 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 75.1 mtm -56.11 -32.62 64.35 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.912 1.285 . . . . 3.2400000000000002 112.272 -178.016 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -84.05 -2.11 56.09 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 122.932 0.493 . . . . 2.3300000000000001 111.77 179.235 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 82.36 18.86 65.64 Favored Glycine 0 C--N 1.337 0.623 0 N-CA-C 111.12 -0.792 . . . . 1.3999999999999999 111.12 175.112 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 26.7 pttt -146.78 146.85 30.41 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 118.223 1.011 . . . . 4.4500000000000002 111.741 -170.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.426 ' HA ' ' HA ' ' A' ' 36' ' ' VAL . . . -83.99 162.92 20.25 Favored 'General case' 0 N--CA 1.442 -0.835 0 C-N-CA 124.904 1.282 . . . . 1.3999999999999999 109.618 165.613 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -135.32 135.84 41.09 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 126.217 1.807 . . . . 2.79 112.808 -170.055 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.0 t -131.47 138.07 53.91 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 O-C-N 120.832 -1.168 . . . . 2.96 109.457 -162.29 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.512 ' HB3' ' HB2' ' A' ' 33' ' ' SER . 47.8 ttp180 -150.18 107.59 3.63 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.92 0.888 . . . . 5.5800000000000001 109.512 179.538 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 11.5 p90 -155.58 179.21 9.4 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 124.608 1.163 . . . . 2.2200000000000002 110.168 -155.22 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -118.62 123.01 29.47 Favored Pre-proline 0 CA--C 1.535 0.395 0 C-N-CA 124.167 0.987 . . . . 3.0899999999999999 111.219 176.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -84.44 62.42 6.54 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 121.566 1.511 . . . . 1.5800000000000001 110.236 -173.565 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -131.33 -70.66 0.58 Allowed 'General case' 0 CA--C 1.519 -0.237 0 N-CA-C 107.0 -1.481 . . . . 1.1699999999999999 107.0 177.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 89.6 t -56.55 -44.31 80.43 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.779 0 C-N-CA 124.517 1.127 . . . . 1.23 111.035 177.358 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.3 tt -113.16 -24.01 4.07 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.415 0 N-CA-C 114.053 1.131 . . . . 2.3500000000000001 114.053 -149.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 70.92 120.47 0.03 OUTLIER Pre-proline 0 N--CA 1.471 0.602 0 C-N-CA 125.724 1.609 . . . . 2.9300000000000002 113.228 175.073 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -46.87 -43.51 23.91 Favored 'Trans proline' 0 CA--C 1.532 0.42 0 C-N-CA 124.228 3.286 . . . . 1.4299999999999999 115.77 169.014 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -58.92 -54.35 2.86 Favored 'Trans proline' 0 N--CA 1.442 -1.537 0 CA-C-N 120.835 1.334 . . . . 1.24 109.762 167.525 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 52.0 mtp -69.02 -28.58 66.7 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 118.396 -1.322 . . . . 2.0499999999999998 111.622 -166.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 12.4 tt -64.43 -37.04 78.98 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 CA-C-N 119.713 1.142 . . . . 2.1499999999999999 110.844 174.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.8 -47.64 84.89 Favored 'General case' 0 N--CA 1.455 -0.176 0 O-C-N 121.416 -0.803 . . . . 1.04 111.159 171.155 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -60.84 -57.47 12.54 Favored 'General case' 0 N--CA 1.432 -1.367 0 C-N-CA 123.718 0.807 . . . . 2.9399999999999999 112.355 -178.237 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -49.4 -38.51 29.16 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 123.488 0.715 . . . . 3.9199999999999999 111.386 -173.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.4 HD11 HD11 ' A' ' 25' ' ' LEU . 90.2 mt -60.99 -47.36 93.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 O-C-N 121.644 -0.66 . . . . 1.25 110.894 175.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 22.2 mtm105 -66.28 -32.1 73.3 Favored 'General case' 0 CA--C 1.522 -0.113 0 O-C-N 121.588 -0.695 . . . . 3.9199999999999999 112.113 177.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 78.3 mt-10 -58.44 -23.55 57.78 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 118.699 0.681 . . . . 3.27 112.264 172.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 66.0 mt -80.81 -15.98 54.95 Favored 'General case' 0 CA--C 1.535 0.37 0 O-C-N 121.515 -0.741 . . . . 1.74 111.568 173.518 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 112.08 -11.39 26.88 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 125.265 1.412 . . . . 2.1400000000000001 111.717 -177.129 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -79.8 101.63 8.6 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 117.812 0.806 . . . . 3.21 110.167 -173.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -63.94 86.45 0.06 OUTLIER Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 125.26 1.41 . . . . 1.3300000000000001 110.89 -179.26 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -111.51 130.11 55.83 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 128.211 2.604 . . . . 1.0700000000000001 111.526 -173.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 5.3 t -121.65 138.42 54.34 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 125.309 1.444 . . . . 2.1899999999999999 107.301 175.194 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.7 t -83.54 136.36 22.97 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 C-N-CA 125.869 1.667 . . . . 1.8400000000000001 110.173 -171.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 36.5 mt -145.87 83.94 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 125.301 1.44 . . . . 1.8899999999999999 109.258 -176.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 31.8 mp0 . . . . . 0 C--N 1.326 -0.444 0 C-N-CA 123.932 0.893 . . . . 4.7199999999999998 110.471 160.845 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 12.9 m . . . . . 0 CA--C 1.538 0.49 0 CA-C-O 122.148 0.975 . . . . 2.9300000000000002 112.969 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.2 m -157.35 170.48 22.37 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 128.13 2.572 . . . . 2.1400000000000001 105.873 172.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 75.8 tttt -130.51 152.76 49.54 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 108.548 -0.908 . . . . 3.46 108.548 177.052 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 47.1 t -148.56 156.3 42.26 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 107.505 -1.294 . . . . 1.46 107.505 170.257 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 -106.15 138.05 43.0 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 107.123 -1.436 . . . . 2.3199999999999998 107.123 169.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 15.9 mt -138.09 139.53 42.07 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 N-CA-C 104.357 -2.46 . . . . 1.76 104.357 -172.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 11.5 mt-30 -122.6 119.34 30.51 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 120.127 1.33 . . . . 4.3899999999999997 108.327 -177.201 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 99.1 t -112.32 138.83 39.85 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 O-C-N 124.184 0.928 . . . . 2.8999999999999999 110.766 -158.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.4 m -66.86 -42.88 84.92 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 113.492 0.923 . . . . 2.6000000000000001 113.492 -168.063 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -138.77 48.59 0.86 Allowed Glycine 0 C--N 1.341 0.831 0 CA-C-O 124.252 2.029 . . . . 3.7000000000000002 111.226 172.19 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . 0.257 42.7 ttp -14.31 -52.2 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 109.408 -3.396 . . . . 3.5800000000000001 111.206 136.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 12.8 t -122.07 126.38 48.3 Favored 'General case' 0 N--CA 1.44 -0.963 0 C-N-CA 126.531 1.933 . . . . 4.3099999999999996 106.591 168.126 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.3 p -110.92 64.98 0.61 Allowed 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 107.134 -1.432 . . . . 2.98 107.134 119.705 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 64.87 -64.57 0.16 Allowed 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 128.507 2.723 . . . . 3.2999999999999998 111.737 -172.199 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.1 m -47.24 -49.25 23.69 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 127.001 2.12 . . . . 3.7200000000000002 112.133 -179.481 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 74.8 m -69.04 -20.16 64.11 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 114.59 1.329 . . . . 3.1299999999999999 114.59 -142.089 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 1.2 t -52.89 -37.96 27.25 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.281 0 CA-C-N 119.09 0.859 . . . . 2.4500000000000002 110.398 169.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.3 -52.22 65.33 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 123.139 0.576 . . . . 1.24 110.515 171.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -58.66 -53.75 54.87 Favored 'General case' 0 C--O 1.227 -0.102 0 C-N-CA 124.189 0.996 . . . . 1.8999999999999999 109.157 -176.329 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.532 ' O ' HD22 ' A' ' 25' ' ' LEU . 2.4 mt -49.04 -60.87 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.997 0 C-N-CA 125.557 1.543 . . . . 1.78 109.789 174.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -48.09 -59.74 3.16 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 119.916 1.235 . . . . 4.0099999999999998 113.049 176.018 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.49 -39.12 67.23 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.161 0.584 . . . . 6.5300000000000002 110.764 -177.06 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 -64.88 -60.87 2.58 Favored 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 108.417 -0.957 . . . . 3.1299999999999999 108.417 178.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.653 HD23 HD21 ' A' ' 35' ' ' LEU . 0.3 OUTLIER -74.13 -42.61 59.73 Favored 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 111.911 0.337 . . . . 2.4300000000000002 111.911 -161.075 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 4.5 ttm180 -67.4 -19.17 65.36 Favored 'General case' 0 N--CA 1.433 -1.285 0 CA-C-N 119.022 0.828 . . . . 7.4199999999999999 112.526 -160.242 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 31.3 mtm105 -45.82 -61.56 1.67 Allowed 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.039 0.936 . . . . 6.9400000000000004 111.941 -177.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -175.32 12.78 0.01 OUTLIER 'General case' 0 N--CA 1.461 0.119 0 N-CA-C 114.311 1.226 . . . . 7.0999999999999996 114.311 -158.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -101.24 53.49 0.83 Allowed 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 122.587 1.184 . . . . 5.6900000000000004 108.877 -144.135 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 57.56 12.29 9.14 Favored Glycine 0 CA--C 1.531 1.091 0 CA-C-N 114.053 -1.431 . . . . 1.6899999999999999 113.377 -172.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 1.1 pp -84.83 161.89 3.05 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 CA-C-N 119.238 1.519 . . . . 4.5700000000000003 110.645 -177.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -146.61 46.0 1.2 Allowed 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 122.596 1.189 . . . . 3.0 111.666 146.101 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 70.0 m -164.16 175.91 9.74 Favored 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 131.094 3.757 . . . . 2.04 105.22 154.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.2 pp -105.06 138.48 29.75 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.133 0 CA-C-O 122.421 1.105 . . . . 2.1000000000000001 109.859 160.547 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.653 HD21 HD23 ' A' ' 25' ' ' LEU . 0.1 OUTLIER -77.4 66.47 3.16 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 129.684 3.194 . . . . 4.5 111.021 -178.157 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 19.2 t -134.51 140.53 45.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 O-C-N 121.139 -0.976 . . . . 1.4099999999999999 110.078 169.284 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -150.18 64.47 0.96 Allowed 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 103.31 -2.848 . . . . 0.76000000000000001 103.31 162.679 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -59.04 -43.26 91.64 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 108.517 -0.92 . . . . 3.1699999999999999 108.517 -173.643 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 66.9 mtt -44.25 -37.48 3.26 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.556 0.742 . . . . 4.54 112.795 169.209 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -97.52 -10.25 25.61 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.564 1.146 . . . . 1.9199999999999999 112.923 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 87.44 36.87 8.45 Favored Glycine 0 C--N 1.341 0.825 0 CA-C-N 120.114 1.325 . . . . 1.03 110.956 173.138 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 2.3 ptmt -162.47 178.52 8.54 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 119.03 1.415 . . . . 3.4100000000000001 110.25 -174.278 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.413 ' HB1' ' HG ' ' A' ' 35' ' ' LEU . . . -118.56 133.02 56.18 Favored 'General case' 0 N--CA 1.441 -0.907 0 C-N-CA 128.051 2.54 . . . . 1.0 108.899 175.066 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -126.06 82.58 2.08 Favored 'General case' 0 C--N 1.339 0.127 0 C-N-CA 123.995 0.918 . . . . 2.8599999999999999 112.012 -172.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 9.9 p -83.19 134.53 26.72 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 C-N-CA 123.237 0.615 . . . . 1.5700000000000001 110.39 -169.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 35.6 ttm105 -113.14 127.64 56.25 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 103.955 -2.609 . . . . 4.2599999999999998 103.955 158.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 4.2 p90 -157.73 175.36 14.0 Favored 'General case' 0 CA--C 1.515 -0.373 0 C-N-CA 123.407 0.683 . . . . 2.0299999999999998 109.279 -170.172 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -122.68 94.63 47.39 Favored Pre-proline 0 CA--C 1.533 0.325 0 CA-C-O 119.021 -0.514 . . . . 2.7599999999999998 110.245 178.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -71.36 73.73 2.12 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 123.78 2.987 . . . . 1.46 112.234 -176.105 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -146.93 -51.61 0.21 Allowed 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 125.883 1.673 . . . . 1.29 106.533 165.431 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 95.9 t -53.95 -57.61 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.768 0 C-N-CA 124.517 1.127 . . . . 1.1200000000000001 109.535 170.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.403 ' O ' ' HB2' ' A' ' 53' ' ' GLN 0.252 11.5 tt -94.81 -71.08 0.58 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.371 0 CA-C-O 118.341 -0.838 . . . . 1.8799999999999999 113.169 -169.454 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.403 ' HB2' ' O ' ' A' ' 52' ' ' ILE . 0.0 OUTLIER 109.54 139.45 0.0 OUTLIER Pre-proline 0 N--CA 1.469 0.523 0 C-N-CA 129.993 3.317 . . . . 2.96 108.498 -173.54 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_exo -51.27 -50.86 12.58 Favored 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 124.215 3.277 . . . . 1.0800000000000001 114.595 172.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -47.03 -55.55 3.79 Favored 'Trans proline' 0 N--CA 1.446 -1.308 0 C-N-CA 121.533 1.489 . . . . 1.0 110.308 166.147 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 25.1 mtm -62.66 -35.87 81.04 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 118.067 -1.453 . . . . 1.8500000000000001 112.242 -172.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . 0.261 2.7 tt -68.35 -39.56 81.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-N 119.023 0.829 . . . . 2.1099999999999999 111.035 179.391 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.22 -55.6 32.87 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 118.933 0.788 . . . . 0.94999999999999996 112.162 169.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -50.25 -47.04 55.33 Favored 'General case' 0 N--CA 1.442 -0.864 0 C-N-CA 126.169 1.788 . . . . 4.0499999999999998 110.835 -178.538 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -46.1 -42.76 14.08 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.246 0.618 . . . . 4.5199999999999996 112.325 174.433 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 40.7 mt -74.63 -44.6 46.61 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 N-CA-C 108.405 -0.961 . . . . 1.53 108.405 -177.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.1 -62.13 1.97 Allowed 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 124.969 1.308 . . . . 7.8399999999999999 112.894 -178.409 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -57.64 -58.71 7.12 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 124.117 0.967 . . . . 3.1299999999999999 111.447 -163.042 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.33 -34.39 23.69 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 122.766 0.427 . . . . 2.1099999999999999 111.649 -179.033 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -93.66 -91.69 1.58 Allowed Glycine 0 CA--C 1.525 0.709 0 N-CA-C 111.089 -0.805 . . . . 1.8700000000000001 111.089 -174.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -138.1 -79.17 0.36 Allowed 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 122.422 1.106 . . . . 3.0099999999999998 112.837 -157.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 156.19 122.38 0.75 Allowed Glycine 0 N--CA 1.445 -0.707 0 N-CA-C 105.406 -3.078 . . . . 1.3899999999999999 105.406 -143.503 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -145.86 116.67 7.71 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 107.929 -1.137 . . . . 1.22 107.929 -167.318 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 41.1 p -93.7 118.52 31.5 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 107.093 -1.447 . . . . 2.96 107.093 176.318 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.2 t -83.56 121.29 36.08 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 N-CA-C 107.176 -1.416 . . . . 1.6499999999999999 107.176 177.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 47.0 mt -145.24 77.12 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.307 0 N-CA-C 108.213 -1.032 . . . . 1.9299999999999999 108.213 -169.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.468 ' H ' ' CD ' ' A' ' 72' ' ' GLU . 2.3 pm0 . . . . . 0 CA--C 1.541 0.601 0 C-N-CA 123.893 0.877 . . . . 5.1299999999999999 111.011 166.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.7 p . . . . . 0 CA--C 1.529 0.169 0 CA-C-O 122.779 1.276 . . . . 2.9700000000000002 110.181 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.8 m -106.73 142.37 36.47 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 125.929 1.692 . . . . 2.3100000000000001 108.471 -165.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 18.7 ttpt -93.58 154.05 18.07 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 118.96 -0.543 . . . . 3.6899999999999999 110.219 177.381 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 9.3 t -153.59 160.63 42.5 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 108.377 -0.972 . . . . 1.72 108.377 167.234 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -105.41 157.62 17.22 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.376 1.071 . . . . 2.3799999999999999 109.249 -173.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.467 ' HB ' ' HB3' ' A' ' 43' ' ' ALA . 3.3 mt -145.22 147.05 19.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 N-CA-C 107.315 -1.365 . . . . 1.77 107.315 179.504 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 -108.59 141.26 40.78 Favored 'General case' 0 C--O 1.232 0.16 0 N-CA-C 107.88 -1.156 . . . . 4.1600000000000001 107.88 170.552 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 57.0 t -108.08 126.27 64.67 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 O-C-N 124.086 0.866 . . . . 2.77 109.807 179.163 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 11.1 m -75.33 75.3 2.43 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.61 0.764 . . . . 2.8500000000000001 110.968 -179.42 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 164.05 -62.47 0.25 Allowed Glycine 0 C--O 1.227 -0.323 0 N-CA-C 105.544 -3.022 . . . . 4.0300000000000002 105.544 173.382 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . 0.333 0.0 OUTLIER 59.28 138.38 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 129.347 3.059 . . . . 3.8900000000000001 114.512 178.352 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.609 ' H ' HD12 ' A' ' 38' ' ' LEU . 7.0 m 73.31 -59.11 0.58 Allowed 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 126.161 1.784 . . . . 5.2000000000000002 109.767 -177.395 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 38.5 m 51.38 -124.27 2.22 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.893 1.277 . . . . 3.1299999999999999 108.729 170.436 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -155.86 142.95 19.11 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 106.099 -1.815 . . . . 2.6899999999999999 106.099 152.397 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 56.9 p 64.54 -25.1 0.08 Allowed 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 116.536 2.05 . . . . 3.7400000000000002 116.536 -179.266 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 99.2 m -38.57 -38.69 0.41 Allowed 'General case' 0 C--O 1.225 -0.236 0 C-N-CA 125.141 1.376 . . . . 2.8500000000000001 112.186 171.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.6 t -65.38 -45.97 91.64 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.359 0 C-N-CA 124.544 1.137 . . . . 2.4900000000000002 109.796 -178.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.97 -47.01 78.43 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 123.603 0.761 . . . . 1.3 109.292 173.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -58.18 -58.52 8.12 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 109.005 -0.739 . . . . 1.96 109.005 179.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.519 HG23 HD21 ' A' ' 35' ' ' LEU . 40.5 mt -46.62 -60.05 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 C-N-CA 126.308 1.843 . . . . 1.8799999999999999 110.343 179.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 73.1 mt-10 -47.38 -61.77 1.75 Allowed 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.494 0.718 . . . . 3.0499999999999998 111.783 174.174 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 7.1 mpt_? -62.06 -32.59 73.13 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.978 -0.555 . . . . 6.4000000000000004 111.308 -168.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 18.9 m-20 -71.85 -64.58 0.9 Allowed 'General case' 0 CA--C 1.528 0.134 0 CA-C-O 121.515 0.674 . . . . 3.5800000000000001 110.67 175.381 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.485 HD12 ' CD1' ' A' ' 35' ' ' LEU . 4.3 mt -78.73 -9.87 59.57 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 125.556 1.542 . . . . 3.71 111.545 -162.652 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -21.36 -77.34 0.01 OUTLIER 'General case' 0 N--CA 1.444 -0.76 0 C-N-CA 130.223 3.409 . . . . 8.6999999999999993 112.917 -166.411 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 11.1 ptp180 -92.76 -37.93 12.07 Favored 'General case' 0 N--CA 1.435 -1.185 0 C-N-CA 129.284 3.034 . . . . 12.470000000000001 116.501 154.552 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 11.22 56.15 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.289 1.436 . . . . 8.0199999999999996 113.455 -144.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 14.3 mp0 32.07 54.53 0.31 Allowed 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 128.125 2.57 . . . . 7.6299999999999999 112.711 -174.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 179.3 -37.49 0.07 OUTLIER Glycine 0 CA--C 1.54 1.612 0 C-N-CA 123.979 0.8 . . . . 1.55 113.978 -172.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . 0.415 HD12 ' HB3' ' A' ' 25' ' ' LEU . 6.0 mt -81.98 145.85 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 C-N-CA 127.705 2.402 . . . . 2.0499999999999998 107.199 167.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 79.7 m-85 -147.45 47.8 1.12 Allowed 'General case' 0 N--CA 1.456 -0.15 0 CA-C-O 122.315 1.055 . . . . 4.1500000000000004 111.119 157.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.8 t -168.15 135.64 2.17 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 126.15 1.78 . . . . 1.6599999999999999 106.972 145.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.7 pp -82.98 152.06 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 CA-C-O 123.582 1.658 . . . . 1.9399999999999999 112.223 -171.197 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.873 ' H ' HD23 ' A' ' 35' ' ' LEU . 1.9 pt? -76.48 58.48 1.34 Allowed 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 131.517 3.927 . . . . 4.7300000000000004 111.541 -167.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.452 HG22 HD23 ' A' ' 38' ' ' LEU . 76.8 t -135.46 122.99 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 O-C-N 121.129 -0.982 . . . . 1.46 113.556 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -133.56 57.23 1.81 Allowed 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 106.43 -1.692 . . . . 0.69999999999999996 106.43 150.351 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.609 HD12 ' H ' ' A' ' 13' ' ' THR . 0.5 OUTLIER -75.45 -6.39 49.87 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 123.615 0.766 . . . . 5.3200000000000003 111.838 -175.122 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 66.8 mtt -59.49 -41.02 88.87 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 109.791 -0.448 . . . . 4.8200000000000003 109.791 161.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -86.99 -41.25 14.04 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.133 0.573 . . . . 1.73 110.072 177.305 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 117.95 48.0 0.42 Allowed Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.094 -1.202 . . . . 0.89000000000000001 110.094 176.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -162.48 177.53 9.41 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 106.561 -1.644 . . . . 4.0499999999999998 106.561 -170.166 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.467 ' HB3' ' HB ' ' A' ' 7' ' ' ILE . . . -140.89 140.59 34.56 Favored 'General case' 0 N--CA 1.441 -0.906 0 C-N-CA 125.132 1.373 . . . . 1.02 108.887 -167.509 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -141.86 104.72 4.56 Favored 'General case' 0 C--N 1.344 0.363 0 CA-C-N 118.968 0.804 . . . . 3.2599999999999998 110.538 179.421 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.7 p -90.99 142.09 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.101 0 C-N-CA 124.33 1.052 . . . . 1.74 108.474 -172.358 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 16.6 tpp180 -107.43 122.63 47.0 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 106.07 -1.826 . . . . 4.8499999999999996 106.07 163.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -160.45 179.13 8.88 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 118.832 0.742 . . . . 2.23 112.19 -168.725 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 35.7 m-20 -109.24 109.82 60.46 Favored Pre-proline 0 CA--C 1.53 0.198 0 N-CA-C 108.123 -1.066 . . . . 3.1200000000000001 108.123 163.206 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -76.4 58.77 5.88 Favored 'Trans proline' 0 CA--C 1.536 0.603 0 C-N-CA 123.508 2.805 . . . . 2.3199999999999998 110.598 -178.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -157.44 -51.08 0.07 Allowed 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 125.873 1.669 . . . . 1.9299999999999999 107.224 -172.217 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 74.1 t -61.24 -43.56 96.71 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.866 0 C-N-CA 124.34 1.056 . . . . 1.46 109.867 173.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.54 HG12 HG22 ' A' ' 57' ' ' ILE . 2.2 tp -109.52 -54.62 5.42 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.255 0 C-N-CA 122.891 0.476 . . . . 1.9399999999999999 110.743 -175.06 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.412 ' HA ' ' HD3' ' A' ' 54' ' ' PRO . 2.2 mm-40 95.5 128.35 0.02 OUTLIER Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 129.21 3.004 . . . . 3.7799999999999998 110.813 171.547 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 53' ' ' GLN . 71.2 Cg_exo -55.88 -43.26 58.79 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 123.506 2.804 . . . . 1.1499999999999999 116.521 -172.444 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -58.35 -43.1 49.32 Favored 'Trans proline' 0 N--CA 1.445 -1.347 0 CA-C-N 121.533 1.583 . . . . 1.1299999999999999 109.079 175.377 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 63.5 mtt -61.77 -44.51 96.75 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 118.403 -0.808 . . . . 1.8899999999999999 109.928 179.233 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.54 HG22 HG12 ' A' ' 52' ' ' ILE . 0.6 OUTLIER -62.27 -48.54 87.89 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 CA-C-N 120.084 1.311 . . . . 2.4900000000000002 110.903 177.359 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -54.23 -38.45 65.75 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 124.332 1.053 . . . . 1.52 112.165 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -70.01 -60.7 2.14 Favored 'General case' 0 N--CA 1.442 -0.828 0 C-N-CA 125.405 1.482 . . . . 3.3100000000000001 110.644 172.185 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -44.91 -43.78 9.18 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 124.191 0.996 . . . . 3.77 112.464 -177.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 67.8 mt -63.23 -43.54 98.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 O-C-N 121.912 -0.493 . . . . 1.1100000000000001 110.017 -178.655 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . 0.301 7.6 ptp180 -70.83 -42.16 70.56 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-O 119.359 -0.353 . . . . 3.8500000000000001 111.604 179.152 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -55.39 -45.05 76.65 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.154 0.981 . . . . 3.0499999999999998 110.836 174.479 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 63.7 mt -81.2 -38.72 26.56 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-O 119.507 -0.283 . . . . 2.0800000000000001 110.628 -174.152 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -104.93 -90.77 2.19 Favored Glycine 0 CA--C 1.527 0.808 0 N-CA-C 111.33 -0.708 . . . . 2.0099999999999998 111.33 179.172 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 18.1 m-85 -142.29 -56.97 0.45 Allowed 'General case' 0 CA--C 1.509 -0.615 0 CA-C-O 122.464 1.126 . . . . 3.9700000000000002 111.699 -157.013 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 162.27 126.3 0.81 Allowed Glycine 0 N--CA 1.432 -1.599 0 N-CA-C 105.784 -2.927 . . . . 1.5700000000000001 105.784 -149.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -157.05 153.77 28.45 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 117.234 0.517 . . . . 1.04 110.102 177.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 2.4 t -128.16 144.69 51.13 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 106.747 -1.575 . . . . 2.7599999999999998 106.747 174.434 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 12.6 p -81.23 150.74 4.52 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 N-CA-C 107.173 -1.418 . . . . 2.2999999999999998 107.173 170.178 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 4.8 pt -154.95 175.91 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 C-N-CA 126.368 1.867 . . . . 3.0 106.833 177.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 . . . . . 0 N--CA 1.454 -0.259 0 N-CA-C 108.286 -1.005 . . . . 4.8899999999999997 108.286 167.316 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.5 m . . . . . 0 N--CA 1.455 -0.187 0 N-CA-C 109.169 -0.678 . . . . 2.8300000000000001 109.169 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 22.7 m -89.26 161.36 16.45 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 107.916 -1.142 . . . . 1.8 107.916 160.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 51.6 mtmt -113.41 160.48 18.37 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 123.777 0.831 . . . . 4.1900000000000004 108.847 162.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 49.7 t -155.52 154.2 31.41 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 106.931 -1.507 . . . . 1.47 106.931 170.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -100.93 154.91 18.28 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 122.173 0.987 . . . . 2.73 108.663 175.386 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.7 mp -134.04 138.22 50.69 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 N-CA-C 104.792 -2.299 . . . . 1.8700000000000001 104.792 169.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 47.9 tp60 -95.56 122.96 38.86 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 103.332 -2.84 . . . . 2.6099999999999999 103.332 165.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 26.0 m -118.38 147.71 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 C-N-CA 124.671 1.189 . . . . 2.5899999999999999 108.008 -178.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 6.9 m -105.05 70.03 0.88 Allowed 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.02 0.528 . . . . 2.5 109.694 -175.557 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 156.55 -36.49 0.59 Allowed Glycine 0 C--N 1.341 0.814 0 C-N-CA 121.029 -0.605 . . . . 2.3599999999999999 114.274 170.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 2.6 mpp? 46.91 42.16 11.81 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.48 1.112 . . . . 4.1200000000000001 110.589 -168.565 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.2 p 56.78 1.79 0.09 Allowed 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 115.919 1.822 . . . . 10.82 115.919 -173.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . 0.372 0.1 OUTLIER 77.39 174.28 0.2 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 127.334 2.254 . . . . 4.0300000000000002 112.442 -166.695 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.03 132.74 54.37 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.034 0.934 . . . . 4.04 111.221 -169.428 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 10.4 m 74.15 -37.68 0.37 Allowed 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.124 1.369 . . . . 5.0300000000000002 113.63 174.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 75.6 m -54.94 -28.41 50.96 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 127.159 2.184 . . . . 5.6699999999999999 111.08 176.011 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 8.1 m -38.31 -40.98 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 N-CA-C 113.378 0.881 . . . . 2.4399999999999999 113.378 164.032 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -45.56 -49.12 14.21 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 124.153 0.981 . . . . 1.6499999999999999 110.876 174.203 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -54.7 -57.43 11.51 Favored 'General case' 0 CA--C 1.519 -0.237 0 N-CA-C 109.346 -0.613 . . . . 3.2000000000000002 109.346 173.403 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 3.6 tp -67.72 -39.29 81.81 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.382 0 CA-C-N 118.401 0.546 . . . . 4.5099999999999998 109.816 -163.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.451 ' HG2' ' CG1' ' A' ' 34' ' ' ILE . 59.0 mt-10 -56.18 -56.6 18.94 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.993 1.317 . . . . 3.6699999999999999 110.61 171.233 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.7 tmt_? -52.99 -39.36 63.0 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 109.616 -0.513 . . . . 6.1900000000000004 109.616 176.654 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -72.41 -42.28 65.31 Favored 'General case' 0 N--CA 1.431 -1.383 0 CA-C-O 118.037 -0.983 . . . . 3.3799999999999999 109.148 -178.187 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -56.72 -37.89 71.59 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 121.335 1.88 . . . . 2.5499999999999998 109.253 176.71 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 56.7 mtp180 -65.46 -12.34 51.56 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 115.262 1.578 . . . . 6.29 115.262 175.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.412 ' HG2' ' CG ' ' A' ' 28' ' ' GLU . 1.0 OUTLIER -66.02 -17.87 64.97 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 121.028 1.74 . . . . 8.2400000000000002 111.294 167.247 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.412 ' CG ' ' HG2' ' A' ' 27' ' ' ARG . 6.5 mt-10 -104.06 90.85 3.72 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 108.931 -0.766 . . . . 7.7400000000000002 108.931 -166.357 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -43.64 133.15 4.69 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 107.724 -1.213 . . . . 8.4399999999999995 107.724 166.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 110.82 -36.27 4.33 Favored Glycine 0 CA--C 1.527 0.787 0 CA-C-O 118.639 -1.09 . . . . 1.4199999999999999 111.786 -166.149 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.7 mt -83.03 126.44 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 CA-C-N 119.316 1.558 . . . . 2.1499999999999999 108.772 174.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -134.89 42.07 2.82 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 122.363 1.078 . . . . 3.5699999999999998 112.4 160.455 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 9.1 t -167.76 137.78 2.73 Favored 'General case' 0 C--N 1.316 -0.866 0 C-N-CA 128.008 2.523 . . . . 2.0800000000000001 106.911 144.455 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.589 ' H ' ' CD1' ' A' ' 34' ' ' ILE . 0.0 OUTLIER -78.86 134.54 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.369 0 CA-C-O 122.814 1.293 . . . . 2.3799999999999999 109.535 -179.598 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.417 ' HA ' ' H ' ' A' ' 44' ' ' GLU . 0.7 OUTLIER -81.31 68.21 7.54 Favored 'General case' 0 N--CA 1.431 -1.382 0 CA-C-N 115.317 -0.856 . . . . 4.8300000000000001 110.481 -176.527 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 4.9 t -130.42 139.46 51.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 121.917 0.865 . . . . 1.6000000000000001 111.487 167.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -151.95 72.8 1.03 Allowed 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 127.602 2.361 . . . . 1.23 107.621 169.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.916 HD23 ' H ' ' A' ' 38' ' ' LEU . 0.2 OUTLIER -46.96 -43.69 19.38 Favored 'General case' 0 CA--C 1.509 -0.621 0 C-N-CA 124.08 0.952 . . . . 3.3599999999999999 110.572 169.006 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 24.3 ptt? -79.81 42.31 0.53 Allowed 'General case' 0 CA--C 1.545 0.786 0 CA-C-O 121.65 0.738 . . . . 4.7800000000000002 111.649 -167.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -178.23 -40.81 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 129.751 3.22 . . . . 1.3400000000000001 106.878 -171.423 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 98.44 49.9 1.63 Allowed Glycine 0 C--N 1.339 0.735 0 N-CA-C 108.072 -2.011 . . . . 0.88 108.072 172.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 46.5 mttm -152.7 179.87 8.24 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 126.217 1.807 . . . . 4.8399999999999999 108.727 -158.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -151.18 131.71 13.86 Favored 'General case' 0 N--CA 1.442 -0.831 0 C-N-CA 125.29 1.436 . . . . 1.1699999999999999 108.109 -171.174 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.417 ' H ' ' HA ' ' A' ' 35' ' ' LEU . 0.6 OUTLIER -136.59 102.96 5.08 Favored 'General case' 0 C--N 1.342 0.242 0 CA-C-N 118.967 0.803 . . . . 2.77 112.22 -175.627 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.4 p -82.65 146.94 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.215 0 N-CA-C 108.989 -0.745 . . . . 1.6499999999999999 108.989 -176.536 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 60.6 ttp180 -122.69 123.25 40.69 Favored 'General case' 0 C--N 1.339 0.126 0 N-CA-C 105.823 -1.917 . . . . 5.6699999999999999 105.823 159.633 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 1.5 p90 -160.27 175.23 13.1 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 118.298 0.499 . . . . 2.1200000000000001 110.994 -164.419 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -110.44 117.94 50.07 Favored Pre-proline 0 CA--C 1.539 0.546 0 C-N-CA 123.472 0.709 . . . . 3.1899999999999999 109.224 166.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -74.78 23.84 0.38 Allowed 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 122.933 2.422 . . . . 1.98 113.91 -170.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -109.55 -49.33 3.12 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.752 1.221 . . . . 1.1699999999999999 108.403 -178.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 98.4 t -65.52 -50.3 72.96 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.89 0 C-N-CA 124.271 1.028 . . . . 1.3200000000000001 109.917 -179.654 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.413 ' O ' ' HB2' ' A' ' 53' ' ' GLN . 3.3 tp -102.64 -62.62 2.0 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.391 0 CA-C-O 118.652 -0.69 . . . . 1.75 112.401 -163.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.413 ' HB2' ' O ' ' A' ' 52' ' ' ILE . 11.4 mm-40 96.14 127.12 0.02 OUTLIER Pre-proline 0 CA--C 1.548 0.873 0 C-N-CA 129.85 3.26 . . . . 3.9399999999999999 112.318 176.376 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.458 ' HA ' HG12 ' A' ' 57' ' ' ILE . 47.0 Cg_exo -44.15 -51.83 6.29 Favored 'Trans proline' 0 C--N 1.351 0.708 1 C-N-CA 125.349 4.033 . . . . 1.1899999999999999 116.4 174.33 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -52.51 -46.41 33.39 Favored 'Trans proline' 0 N--CA 1.446 -1.291 0 CA-C-N 120.706 1.288 . . . . 0.82999999999999996 110.17 173.284 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 60.1 mtp -64.46 -46.26 83.85 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 118.723 -0.656 . . . . 2.6299999999999999 111.053 -176.541 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.458 HG12 ' HA ' ' A' ' 54' ' ' PRO . 20.6 pt -60.19 -49.91 82.29 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-N 119.897 1.226 . . . . 2.4300000000000002 110.944 175.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -48.04 -49.63 30.66 Favored 'General case' 0 C--N 1.341 0.199 0 C-N-CA 123.442 0.697 . . . . 1.1499999999999999 110.998 176.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -61.92 -57.1 13.01 Favored 'General case' 0 N--CA 1.434 -1.234 0 C-N-CA 124.234 1.014 . . . . 3.0899999999999999 112.369 178.069 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 9.0 m-30 -47.66 -50.05 25.82 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 118.796 0.726 . . . . 3.4500000000000002 109.773 -174.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 20.0 mt -51.92 -43.23 35.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 123.319 0.648 . . . . 1.3899999999999999 112.009 175.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 91.2 mtt180 -65.37 -59.4 4.07 Favored 'General case' 0 N--CA 1.457 -0.076 0 N-CA-C 109.477 -0.564 . . . . 4.3700000000000001 109.477 175.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -44.62 -54.54 6.04 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 125.758 1.623 . . . . 2.9399999999999999 111.941 -173.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . 0.253 0.3 OUTLIER -84.37 -13.39 52.43 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 114.071 1.137 . . . . 2.6000000000000001 114.071 179.44 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -152.74 -88.52 0.07 OUTLIER Glycine 0 CA--C 1.531 1.036 0 CA-C-N 119.84 1.2 . . . . 1.7 115.994 -165.105 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -136.43 147.25 47.15 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-O 121.732 0.777 . . . . 3.5800000000000001 112.665 -147.016 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -58.68 108.3 1.49 Allowed Glycine 0 N--CA 1.441 -0.978 0 N-CA-C 109.097 -1.601 . . . . 1.5600000000000001 109.097 177.371 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -116.54 130.07 56.54 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 126.41 1.884 . . . . 1.22 109.088 -173.212 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 41.6 m -128.24 129.29 46.17 Favored 'General case' 0 CA--C 1.528 0.097 0 C-N-CA 124.964 1.306 . . . . 2.96 107.921 175.137 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 13.3 p -82.42 140.35 16.53 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 C-N-CA 123.741 0.817 . . . . 2.2400000000000002 109.698 -175.723 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 46.7 mt -143.26 143.18 25.02 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 125.315 1.446 . . . . 2.04 108.493 -175.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 . . . . . 0 N--CA 1.451 -0.387 0 N-CA-C 107.056 -1.461 . . . . 4.1200000000000001 107.056 166.145 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.5 p . . . . . 0 N--CA 1.45 -0.461 0 CA-C-O 121.002 0.429 . . . . 2.5499999999999998 110.833 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 47.5 m -154.93 165.77 35.65 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.419 1.088 . . . . 1.8500000000000001 108.939 179.161 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.53 130.74 56.61 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 125.006 1.322 . . . . 4.7000000000000002 107.988 174.784 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 51.2 t -123.01 146.42 47.66 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 118.973 0.806 . . . . 1.3300000000000001 109.427 173.196 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -92.24 133.1 36.13 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.47 1.108 . . . . 2.5299999999999998 108.952 172.704 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.0 mm -124.3 151.9 29.75 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 N-CA-C 103.822 -2.658 . . . . 2.3100000000000001 103.822 178.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 45.1 tp60 -117.37 125.01 50.29 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 103.551 -2.759 . . . . 3.27 103.551 168.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.8 m -87.91 141.36 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 N-CA-C 108.695 -0.854 . . . . 2.4100000000000001 108.695 178.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 52.6 p -104.4 84.99 2.27 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 105.255 -2.128 . . . . 2.98 105.255 165.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 177.74 -67.82 0.08 OUTLIER Glycine 0 CA--C 1.522 0.493 0 N-CA-C 105.392 -3.083 . . . . 2.3599999999999999 105.392 -178.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 14.1 ttp 70.99 -61.64 0.48 Allowed 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 126.774 2.029 . . . . 3.8500000000000001 112.441 165.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.8 m -142.65 49.43 1.5 Allowed 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 125.946 1.698 . . . . 4.7999999999999998 106.878 173.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.9 p -53.99 -51.77 62.85 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 109.119 -0.697 . . . . 3.4700000000000002 109.119 177.14 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 176.73 120.19 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 127.221 2.209 . . . . 3.54 107.352 157.172 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 4.2 p 48.92 38.61 12.65 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.426 0.69 . . . . 3.0699999999999998 111.044 -171.005 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 29.5 t -55.14 -44.77 75.41 Favored 'General case' 0 N--CA 1.461 0.094 0 C-N-CA 126.591 1.956 . . . . 4.0099999999999998 108.141 -178.603 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.2 m -70.79 -49.58 49.87 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.089 0 CA-C-N 113.955 -1.475 . . . . 2.23 110.989 -171.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.64 -41.7 73.96 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.955 0.902 . . . . 0.85999999999999999 110.824 171.074 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -55.05 -50.99 67.71 Favored 'General case' 0 C--N 1.341 0.205 0 N-CA-C 108.566 -0.901 . . . . 2.1899999999999999 108.566 172.346 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.787 HG21 HG23 ' A' ' 36' ' ' VAL . 4.6 mt -56.09 -51.21 64.62 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 CA-C-O 118.494 -0.765 . . . . 2.46 110.024 178.196 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -49.98 -57.03 8.39 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 119.332 0.969 . . . . 3.4199999999999999 110.065 177.253 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 32.6 mmt180 -51.72 -46.63 64.02 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 122.743 0.417 . . . . 4.54 111.814 177.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 67.4 m-20 -67.13 -63.93 0.96 Allowed 'General case' 0 C--O 1.224 -0.242 0 CA-C-O 121.825 0.821 . . . . 3.1000000000000001 109.612 -176.038 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.707 HD23 HG23 ' A' ' 21' ' ' ILE . 0.0 OUTLIER -71.1 -28.52 64.38 Favored 'General case' 0 N--CA 1.439 -1.022 0 C-N-CA 124.339 1.056 . . . . 2.3399999999999999 110.316 -165.773 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . 0.487 28.1 mtp-105 -70.11 0.51 6.03 Favored 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 116.192 1.923 . . . . 5.7699999999999996 116.192 167.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 9.5 mmt180 -38.07 -36.03 0.19 Allowed 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 117.777 -1.569 . . . . 7.9199999999999999 112.393 143.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 70.04 43.61 0.88 Allowed 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 126.075 1.75 . . . . 8.6899999999999995 108.359 -178.061 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -73.77 58.46 0.63 Allowed 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 126.832 2.053 . . . . 5.2000000000000002 108.795 179.008 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 66.0 34.28 87.98 Favored Glycine 0 CA--C 1.532 1.128 0 O-C-N 121.316 -0.865 . . . . 1.1000000000000001 112.375 -172.13 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -113.96 135.8 52.49 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 C-N-CA 126.167 1.787 . . . . 1.9299999999999999 106.993 -179.096 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -140.83 47.21 1.75 Allowed 'General case' 0 CA--C 1.53 0.184 0 CA-C-O 122.923 1.344 . . . . 3.1800000000000002 111.6 159.503 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.7 t -168.64 133.63 1.65 Allowed 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 127.791 2.437 . . . . 2.0299999999999998 105.546 144.759 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -81.0 150.99 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 CA-C-O 121.805 0.812 . . . . 2.0800000000000001 109.37 177.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.418 ' HB2' ' HB1' ' A' ' 43' ' ' ALA . 0.6 OUTLIER -81.13 65.5 6.29 Favored 'General case' 0 N--CA 1.435 -1.177 0 C-N-CA 124.151 0.98 . . . . 4.7199999999999998 111.04 -177.469 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.787 HG23 HG21 ' A' ' 21' ' ' ILE . 11.4 t -117.2 140.62 39.2 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 CA-C-O 121.956 0.884 . . . . 1.6599999999999999 111.321 162.018 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -155.79 59.78 0.6 Allowed 'General case' 0 C--O 1.236 0.389 0 C-N-CA 127.323 2.249 . . . . 0.80000000000000004 106.893 166.007 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.18 60.11 3.57 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 124.445 1.098 . . . . 3.3399999999999999 109.293 179.464 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 51.6 ttm -131.97 -52.2 0.97 Allowed 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 105.112 -2.181 . . . . 3.3100000000000001 105.112 163.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -69.13 -30.49 68.76 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.574 -0.739 . . . . 1.3100000000000001 111.169 165.005 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 96.32 45.46 2.78 Favored Glycine 0 C--N 1.341 0.835 0 N-CA-C 109.552 -1.419 . . . . 1.03 109.552 -178.514 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 50.1 mttt -147.73 -179.14 6.67 Favored 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 124.725 1.21 . . . . 4.21 108.295 -156.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.418 ' HB1' ' HB2' ' A' ' 35' ' ' LEU . . . -157.39 118.74 3.65 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 108.077 -1.082 . . . . 1.3300000000000001 108.077 -159.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -133.01 105.95 7.38 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 119.413 1.006 . . . . 2.6000000000000001 112.83 178.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.573 HG11 HD12 ' A' ' 57' ' ' ILE . 11.1 p -82.38 133.17 29.72 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.317 0 C-N-CA 124.421 1.088 . . . . 1.5 108.405 -177.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 71.4 ttt180 -110.17 127.07 54.72 Favored 'General case' 0 CA--C 1.52 -0.173 0 N-CA-C 105.764 -1.939 . . . . 4.5700000000000003 105.764 166.44 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 4.9 p90 -157.23 169.21 25.28 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 117.995 0.361 . . . . 2.0099999999999998 111.145 -161.024 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -114.43 98.19 48.3 Favored Pre-proline 0 CA--C 1.539 0.523 0 C-N-CA 124.548 1.139 . . . . 3.75 111.338 174.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.44 79.55 0.84 Allowed 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 122.802 2.335 . . . . 1.6299999999999999 111.46 176.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -143.63 -56.79 0.39 Allowed 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 105.867 -1.901 . . . . 1.3999999999999999 105.867 159.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 91.4 t -56.76 -62.37 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 C-N-CA 124.646 1.178 . . . . 1.3300000000000001 109.492 171.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.543 HG23 ' H ' ' A' ' 53' ' ' GLN 0.28 9.6 tp -89.3 -77.48 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 CA-C-O 118.669 -0.681 . . . . 1.6200000000000001 112.338 -160.341 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.543 ' H ' HG23 ' A' ' 52' ' ' ILE . 3.3 mp0 99.37 142.79 0.03 OUTLIER Pre-proline 0 CA--C 1.54 0.592 0 C-N-CA 129.808 3.243 . . . . 3.4199999999999999 111.414 -179.606 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.443 ' HA ' HG12 ' A' ' 57' ' ' ILE . 30.3 Cg_exo -47.95 -47.82 17.96 Favored 'Trans proline' 0 CA--C 1.536 0.614 1 C-N-CA 126.525 4.817 . . . . 1.1399999999999999 116.917 174.213 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -49.1 -62.11 0.48 Allowed 'Trans proline' 0 N--CA 1.446 -1.29 0 CA-C-N 120.874 1.348 . . . . 0.93000000000000005 109.777 163.445 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 1.1 ttt -53.94 -45.9 71.39 Favored 'General case' 0 N--CA 1.428 -1.541 0 N-CA-C 114.397 1.258 . . . . 3.8100000000000001 114.397 -173.18 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.573 HD12 HG11 ' A' ' 45' ' ' VAL . 5.0 pt -54.61 -50.08 62.11 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-N 120.15 1.341 . . . . 3.1800000000000002 111.101 175.063 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -55.33 -52.07 64.69 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 118.365 0.529 . . . . 1.0800000000000001 111.34 177.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -60.94 -58.53 8.03 Favored 'General case' 0 N--CA 1.432 -1.359 0 C-N-CA 123.769 0.828 . . . . 2.7400000000000002 111.235 -178.274 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -50.14 -35.23 25.06 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.163 0.985 . . . . 3.6000000000000001 111.909 -178.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.547 HG23 ' CE2' ' A' ' 66' ' ' PHE . 54.3 mt -64.44 -62.8 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 O-C-N 121.933 -0.479 . . . . 1.22 109.901 169.542 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 38.7 mtp180 -50.94 -43.56 60.24 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.451 0.701 . . . . 5.3399999999999999 112.799 -174.304 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -46.09 -33.11 3.27 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 126.058 1.743 . . . . 3.0 112.439 177.528 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 68.5 mt -82.36 -17.2 46.47 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 123.193 0.597 . . . . 1.8 112.029 -176.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 124.6 -35.52 3.15 Favored Glycine 0 C--N 1.339 0.708 0 CA-C-N 118.576 0.625 . . . . 2.2400000000000002 112.682 169.366 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.547 ' CE2' HG23 ' A' ' 61' ' ' ILE . 28.6 p90 -84.29 131.71 34.7 Favored 'General case' 0 N--CA 1.457 -0.106 0 N-CA-C 106.784 -1.562 . . . . 5.0099999999999998 106.784 177.24 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -88.4 162.05 31.71 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.787 -0.925 . . . . 2.1800000000000002 110.787 -163.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.509 ' HB2' HG21 ' A' ' 61' ' ' ILE . . . -137.53 144.12 41.98 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.487 1.115 . . . . 1.0800000000000001 109.025 -179.441 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 12.3 p -129.53 127.01 39.89 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 106.257 -1.756 . . . . 2.7400000000000002 106.257 172.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 28.1 t -84.66 118.04 31.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 N-CA-C 107.962 -1.125 . . . . 1.74 107.962 -176.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 28.4 mt -141.98 68.78 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 N-CA-C 107.511 -1.292 . . . . 2.21 107.511 -172.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.539 0.532 0 CA-C-N 115.673 -0.694 . . . . 4.9400000000000004 110.337 178.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.6 m . . . . . 0 N--CA 1.451 -0.39 0 N-CA-C 111.916 0.339 . . . . 2.6600000000000001 111.916 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.3 t -91.89 163.32 14.07 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 124.31 1.044 . . . . 2.5800000000000001 110.679 -169.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 3.6 ttpm? -88.96 159.5 17.61 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 125.845 1.658 . . . . 4.5899999999999999 109.968 -175.098 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.424 ' HB3' ' CG2' ' A' ' 45' ' ' VAL . 52.9 t -155.37 159.15 39.69 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 107.822 -1.177 . . . . 1.3999999999999999 107.822 153.73 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -107.49 144.48 34.38 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 125.529 1.532 . . . . 2.7799999999999998 107.151 168.708 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.7 mt -138.01 138.83 43.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 107.867 -1.16 . . . . 1.6799999999999999 107.867 -179.482 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 66.0 mt-30 -77.1 145.62 37.71 Favored 'General case' 0 CA--C 1.522 -0.12 0 N-CA-C 106.179 -1.785 . . . . 4.6500000000000004 106.179 173.412 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 17.2 m -136.93 127.42 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 N-CA-C 108.502 -0.925 . . . . 2.1600000000000001 108.502 172.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 72.8 p -79.81 64.52 4.69 Favored 'General case' 0 CA--C 1.534 0.344 0 O-C-N 121.863 -0.523 . . . . 3.6600000000000001 110.227 -174.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 152.8 55.94 0.01 OUTLIER Glycine 0 C--N 1.339 0.695 0 CA-C-O 124.904 2.391 . . . . 3.2799999999999998 113.432 169.492 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 16.7 tmm? -43.06 -50.65 6.02 Favored 'General case' 0 N--CA 1.432 -1.329 0 CA-C-N 109.816 -3.192 . . . . 4.2599999999999998 109.39 137.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.27 -33.95 76.38 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 125.821 1.648 . . . . 5.3700000000000001 112.848 -168.215 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 21.4 m -61.79 143.35 56.43 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 109.345 -0.613 . . . . 2.8199999999999998 109.345 -173.046 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -61.6 146.53 48.63 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 108.304 -0.998 . . . . 2.5499999999999998 108.304 163.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 79.92 -62.76 0.25 Allowed 'General case' 0 C--O 1.22 -0.474 0 C-N-CA 124.965 1.306 . . . . 3.1899999999999999 112.251 179.839 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 51.8 m -36.26 -48.9 0.66 Allowed 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 125.995 1.718 . . . . 3.0699999999999998 114.54 -154.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.418 HG13 HG11 ' A' ' 36' ' ' VAL . 0.9 OUTLIER -43.95 -43.48 1.9 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.915 0 C-N-CA 125.905 1.682 . . . . 2.6699999999999999 113.553 175.467 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.02 -44.55 94.53 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 125.828 1.651 . . . . 0.84999999999999998 111.528 170.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -59.4 -51.01 71.73 Favored 'General case' 0 C--O 1.218 -0.593 0 CA-C-O 118.016 -0.993 . . . . 1.8200000000000001 108.823 173.376 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.435 HG22 HD11 ' A' ' 34' ' ' ILE . 2.5 mt -45.7 -58.76 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 C-N-CA 124.898 1.279 . . . . 2.2599999999999998 109.895 173.702 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -34.94 -59.58 0.48 Allowed 'General case' 0 C--N 1.328 -0.338 0 O-C-N 119.924 -1.735 . . . . 4.2699999999999996 113.382 166.062 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 92.7 mtt180 -59.81 -35.3 74.41 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 114.517 1.303 . . . . 4.9900000000000002 114.517 173.423 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.696 ' ND2' HD13 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -64.91 -58.74 5.36 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 125.836 1.654 . . . . 4.3700000000000001 109.567 -163.984 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.78 ' HB2' HD13 ' A' ' 34' ' ' ILE 0.256 7.3 mp -73.62 -19.83 60.75 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 121.22 0.533 . . . . 3.1400000000000001 109.896 179.105 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . 0.495 84.0 mtp180 -67.17 2.91 1.34 Allowed 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 116.465 2.024 . . . . 5.5099999999999998 116.465 164.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.413 ' CZ ' ' HA ' ' A' ' 27' ' ' ARG . 0.2 OUTLIER -38.86 -32.71 0.09 Allowed 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 116.49 -2.084 . . . . 6.7199999999999998 113.879 145.654 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . 0.267 2.0 mt-10 64.11 45.49 4.08 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 126.366 1.867 . . . . 7.9100000000000001 111.294 174.395 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 70.1 mt-10 -105.4 79.77 1.5 Allowed 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 126.467 1.907 . . . . 6.0 108.921 -174.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 64.39 26.55 70.76 Favored Glycine 0 CA--C 1.532 1.119 0 CA-C-O 121.669 0.594 . . . . 1.1399999999999999 111.733 -175.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.1 mm -93.72 158.06 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 C-N-CA 126.19 1.796 . . . . 2.0499999999999998 108.408 176.65 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 12.6 t80 -154.37 41.76 0.49 Allowed 'General case' 0 C--N 1.339 0.12 0 C-N-CA 119.857 -0.737 . . . . 6.0300000000000002 111.482 170.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.43 ' HB3' HD11 ' A' ' 35' ' ' LEU . 48.4 t -171.39 -179.42 2.61 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 128.773 2.829 . . . . 1.8300000000000001 105.319 141.372 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.895 HD12 ' H ' ' A' ' 35' ' ' LEU . 2.1 tp -134.65 141.17 44.05 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.353 0 N-CA-C 106.909 -1.515 . . . . 3.6600000000000001 106.909 149.294 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.895 ' H ' HD12 ' A' ' 34' ' ' ILE . 0.3 OUTLIER -149.02 144.03 26.47 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 114.473 -1.24 . . . . 6.9000000000000004 109.619 -158.103 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.474 ' CG1' HD23 ' A' ' 38' ' ' LEU 0.258 0.9 OUTLIER -154.64 80.77 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.437 -1.095 0 CA-C-O 124.196 1.951 . . . . 2.2999999999999998 108.786 -164.012 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -77.2 61.39 2.09 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 113.543 -1.662 . . . . 0.87 109.527 169.21 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.474 HD23 ' CG1' ' A' ' 36' ' ' VAL . 0.2 OUTLIER -46.71 -44.85 19.08 Favored 'General case' 0 CA--C 1.512 -0.487 0 C-N-CA 123.828 0.851 . . . . 3.6699999999999999 110.046 169.007 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 27.8 ttt -63.81 -36.37 83.69 Favored 'General case' 0 N--CA 1.441 -0.892 0 C-N-CA 120.208 -0.597 . . . . 5.3200000000000003 110.145 -169.199 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -74.86 -36.07 62.33 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.294 0.638 . . . . 1.8400000000000001 110.29 172.625 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 109.8 39.57 1.56 Allowed Glycine 0 C--N 1.334 0.471 0 C-N-CA 124.945 1.259 . . . . 1.2 111.009 173.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 29.5 pttt -158.75 157.04 30.94 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 108.436 -0.95 . . . . 3.7599999999999998 108.436 -176.464 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -82.59 147.95 28.3 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 107.279 -1.378 . . . . 1.1299999999999999 107.279 167.624 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.557 ' CB ' ' HB2' ' A' ' 35' ' ' LEU . 36.1 mt-10 -103.61 153.28 20.78 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 105.962 -1.866 . . . . 2.9700000000000002 105.962 171.008 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.577 ' HA ' HD13 ' A' ' 35' ' ' LEU . 34.1 m -137.95 148.4 25.31 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-N 119.195 0.907 . . . . 2.73 109.528 171.775 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 58.3 ttm-85 -133.47 130.77 39.05 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 106.234 -1.765 . . . . 4.8399999999999999 106.234 164.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 26.7 p90 -156.45 167.69 29.68 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 110.099 -0.334 . . . . 2.2999999999999998 110.099 -167.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -105.97 104.3 48.67 Favored Pre-proline 0 CA--C 1.542 0.661 0 C-N-CA 123.311 0.644 . . . . 3.2799999999999998 111.056 178.364 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -75.82 73.02 4.93 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 122.627 2.218 . . . . 1.98 111.661 -175.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -142.71 -63.72 0.42 Allowed 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 105.979 -1.86 . . . . 1.22 105.979 161.493 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 72.7 t -56.07 -52.32 51.63 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.749 0 C-N-CA 124.905 1.282 . . . . 1.3100000000000001 110.263 175.343 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 20.1 tt -84.16 -52.19 13.05 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.403 0 N-CA-C 114.125 1.158 . . . . 3.3399999999999999 114.125 -151.415 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER 71.3 109.5 0.03 OUTLIER Pre-proline 0 CA--C 1.538 0.517 0 C-N-CA 127.968 2.507 . . . . 2.7200000000000002 111.266 -165.702 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_exo -46.72 -41.29 24.67 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 123.358 2.705 . . . . 1.3600000000000001 115.102 162.186 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_endo -55.09 -50.41 13.21 Favored 'Trans proline' 0 N--CA 1.447 -1.261 0 CA-C-N 121.707 1.645 . . . . 1.1599999999999999 109.754 168.683 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 77.0 mtp -59.97 -42.51 94.3 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 118.595 -1.242 . . . . 2.5299999999999998 111.934 -179.501 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.1 pt -58.24 -47.07 88.44 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-N 121.61 2.005 . . . . 2.3900000000000001 111.829 173.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -51.9 -46.44 64.59 Favored 'General case' 0 C--N 1.341 0.201 0 C-N-CA 122.761 0.424 . . . . 1.4199999999999999 111.096 179.31 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -64.19 -60.8 2.77 Favored 'General case' 0 N--CA 1.434 -1.242 0 C-N-CA 123.853 0.861 . . . . 2.9399999999999999 111.84 175.467 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 8.2 m-30 -45.76 -47.39 15.51 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 125.418 1.487 . . . . 3.6299999999999999 110.071 -175.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 74.6 mt -57.75 -39.83 72.56 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 CA-C-N 116.62 -0.264 . . . . 1.1399999999999999 111.311 -178.61 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 21.3 mtm105 -69.82 -46.61 65.27 Favored 'General case' 0 N--CA 1.455 -0.185 0 O-C-N 121.683 -0.636 . . . . 3.6200000000000001 111.362 173.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -54.06 -47.21 71.91 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 122.834 0.453 . . . . 3.2400000000000002 111.24 -179.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.4 pp -90.0 -34.71 15.88 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 112.989 0.737 . . . . 2.8100000000000001 112.989 -176.07 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -123.67 -79.29 0.43 Allowed Glycine 0 C--N 1.34 0.763 0 N-CA-C 114.392 0.517 . . . . 2.29 114.392 -157.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -165.74 165.61 18.42 Favored 'General case' 0 N--CA 1.465 0.291 0 O-C-N 122.12 -0.635 . . . . 4.6299999999999999 110.994 -154.798 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -78.64 66.11 3.35 Favored Glycine 0 C--N 1.337 0.631 0 C-N-CA 124.649 1.118 . . . . 1.95 113.496 -157.408 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -90.02 148.44 23.07 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 124.696 1.198 . . . . 1.0900000000000001 113.151 -164.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.6 t -141.59 145.09 34.63 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 107.552 -1.277 . . . . 2.6699999999999999 107.552 174.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 1.8 t -81.84 130.12 36.35 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 C-N-CA 125.116 1.367 . . . . 1.8799999999999999 107.998 -178.301 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 4.9 pt -148.03 59.83 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.339 0.141 0 C-N-CA 124.564 1.146 . . . . 3.1299999999999999 110.91 -172.34 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 . . . . . 0 C--O 1.235 0.318 0 CA-C-N 116.27 -0.423 . . . . 5.6900000000000004 110.066 176.393 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.7 p . . . . . 0 CA--C 1.535 0.382 0 N-CA-C 112.069 0.396 . . . . 2.8599999999999999 112.069 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 45.5 m -149.61 157.8 43.58 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 126.565 1.946 . . . . 1.73 107.934 -177.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 33.4 mtmt -103.86 147.43 27.32 Favored 'General case' 0 C--O 1.231 0.081 0 N-CA-C 107.202 -1.407 . . . . 5.3300000000000001 107.202 168.349 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 38.3 t -153.25 150.47 29.0 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 108.922 -0.77 . . . . 1.7 108.922 172.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -112.34 146.3 38.53 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 125.927 1.691 . . . . 2.23 106.546 -179.064 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.463 HD13 HD11 ' A' ' 61' ' ' ILE . 0.0 OUTLIER -139.24 107.74 3.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 107.509 -1.293 . . . . 2.7599999999999998 107.509 -168.698 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 48.4 tp60 -82.78 123.05 28.96 Favored 'General case' 0 N--CA 1.428 -1.535 0 N-CA-C 106.036 -1.839 . . . . 2.9500000000000002 106.036 -172.547 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 9.9 p -89.38 157.26 3.02 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 C-N-CA 125.322 1.449 . . . . 3.4900000000000002 108.86 -177.232 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.8 t -111.18 21.68 16.07 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 123.115 0.566 . . . . 2.8399999999999999 112.453 176.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -143.35 117.36 1.09 Allowed Glycine 0 N--CA 1.444 -0.798 0 N-CA-C 106.304 -2.719 . . . . 2.3399999999999999 106.304 154.272 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 1.5 ttp -90.16 -61.78 1.61 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 113.445 -1.378 . . . . 4.6500000000000004 108.314 174.03 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 14.1 t -82.38 47.91 1.22 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.544 0.738 . . . . 6.3300000000000001 110.529 -175.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 15.6 p -79.38 -44.0 22.34 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 109.169 -0.678 . . . . 2.8199999999999998 109.169 170.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 143.14 -121.66 0.0 OUTLIER 'General case' 0 C--N 1.34 0.16 0 C-N-CA 130.663 3.585 . . . . 4.0099999999999998 106.244 177.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.2 m -79.41 60.58 3.22 Favored 'General case' 0 N--CA 1.451 -0.394 0 O-C-N 121.493 -0.754 . . . . 3.0 111.261 -175.389 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 4.2 t -48.59 -44.87 37.32 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 125.827 1.651 . . . . 4.6500000000000004 109.116 177.399 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.469 HG13 ' H ' ' A' ' 19' ' ' ALA . 2.5 p -55.3 -61.61 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.816 0 CA-C-N 113.988 -1.46 . . . . 3.3500000000000001 110.627 177.754 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.469 ' H ' HG13 ' A' ' 18' ' ' VAL . . . -54.28 -35.56 62.71 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.406 -1.27 . . . . 1.21 110.644 -178.811 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.458 ' ND2' HD12 ' A' ' 21' ' ' ILE . 0.8 OUTLIER -63.69 -58.64 6.28 Favored 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 109.734 -0.469 . . . . 2.4700000000000002 109.734 170.701 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.554 HG21 HG23 ' A' ' 36' ' ' VAL . 1.2 mp -54.4 -48.36 68.83 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 CA-C-N 119.605 1.093 . . . . 2.27 111.18 -175.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -45.94 -43.08 13.67 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 120.89 -1.131 . . . . 2.9100000000000001 111.168 177.07 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.61 -46.82 58.06 Favored 'General case' 0 CA--C 1.536 0.429 0 O-C-N 121.434 -0.791 . . . . 6.0899999999999999 111.012 168.712 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.565 HD21 HD13 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -55.3 -47.23 75.87 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.808 1.243 . . . . 4.2400000000000002 113.392 -165.745 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.565 HD13 HD21 ' A' ' 24' ' ' ASN 0.382 0.8 OUTLIER -79.04 -23.61 44.18 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 122.11 0.957 . . . . 3.1699999999999999 112.465 -172.413 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . 0.585 53.7 mtp85 -54.14 2.12 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 120.769 3.618 . . . . 5.71 120.769 176.458 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.436 ' CG ' HH11 ' A' ' 27' ' ' ARG . 0.1 OUTLIER -45.85 -32.27 2.53 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 117.308 -1.757 . . . . 9.7699999999999996 111.03 154.046 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 64.34 -155.13 0.3 Allowed 'General case' 0 C--N 1.342 0.27 0 C-N-CA 123.845 0.858 . . . . 7.3600000000000003 108.947 -175.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 58.93 54.25 5.19 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 122.37 1.081 . . . . 6.5 109.062 -179.079 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 152.26 -46.3 0.59 Allowed Glycine 0 C--N 1.335 0.521 0 N-CA-C 110.528 -1.029 . . . . 1.6000000000000001 110.528 -171.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.9 mp -81.66 153.73 4.12 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 C-N-CA 124.323 1.049 . . . . 2.5800000000000001 108.781 -171.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -151.58 36.04 0.57 Allowed 'General case' 0 CA--C 1.546 0.824 0 CA-C-O 121.99 0.9 . . . . 3.54 112.616 167.579 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 57.9 m -167.55 161.59 13.82 Favored 'General case' 0 C--N 1.326 -0.444 1 C-N-CA 131.871 4.068 . . . . 2.25 103.069 145.017 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.416 HD12 ' HA ' ' A' ' 34' ' ' ILE . 10.8 tp -139.97 133.64 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 CA-C-N 122.77 2.532 . . . . 4.4500000000000002 110.863 155.379 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.491 ' O ' HG23 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -167.92 -179.08 4.03 Favored 'General case' 0 N--CA 1.44 -0.925 0 CA-C-N 111.73 -2.486 . . . . 6.1200000000000001 108.864 -153.739 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.554 HG23 HG21 ' A' ' 21' ' ' ILE . 2.4 t -159.57 128.44 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.253 0 C-N-CA 125.695 1.598 . . . . 1.6799999999999999 107.213 -175.088 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -84.23 63.64 7.83 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 107.905 -1.146 . . . . 0.89000000000000001 107.905 175.007 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -60.31 -31.75 70.56 Favored 'General case' 0 CA--C 1.532 0.25 0 O-C-N 122.043 -0.411 . . . . 2.7000000000000002 111.552 -169.507 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 67.2 mtt -53.6 -36.89 62.44 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.526 0.73 . . . . 3.2599999999999998 111.707 172.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -92.22 7.25 43.48 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.589 1.156 . . . . 2.2999999999999998 111.947 176.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.27 38.6 96.11 Favored Glycine 0 CA--C 1.522 0.483 0 C-N-CA 125.473 1.511 . . . . 1.1899999999999999 112.029 174.491 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -162.02 152.43 17.18 Favored 'General case' 0 N--CA 1.442 -0.857 0 N-CA-C 108.075 -1.083 . . . . 4.1799999999999997 108.075 -162.177 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -81.77 157.98 24.3 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 108.928 -0.768 . . . . 1.3200000000000001 108.928 176.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.479 ' HB3' ' CD2' ' A' ' 35' ' ' LEU 0.335 2.2 tm-20 -129.37 157.36 42.13 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 108.612 -0.885 . . . . 4.6299999999999999 108.612 165.581 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.0 p -151.97 138.12 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 N-CA-C 106.476 -1.676 . . . . 1.6200000000000001 106.476 -176.298 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 4.0 mtm180 -104.35 133.01 49.97 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 105.545 -2.02 . . . . 7.1600000000000001 105.545 158.023 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -157.32 167.64 29.69 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 123.716 0.807 . . . . 1.97 108.844 -171.407 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 54.6 t30 -116.79 97.48 50.52 Favored Pre-proline 0 CA--C 1.533 0.312 0 C-N-CA 123.83 0.852 . . . . 3.2999999999999998 110.378 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.3 72.25 2.89 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 123.309 2.672 . . . . 1.8700000000000001 111.538 -178.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -147.56 -56.8 0.24 Allowed 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 106.062 -1.829 . . . . 1.53 106.062 169.293 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 45.6 t -57.52 -54.78 26.58 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 C-N-CA 124.116 0.966 . . . . 1.4199999999999999 109.694 173.191 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.494 HG23 ' H ' ' A' ' 53' ' ' GLN 0.25 10.5 tp -94.2 -75.06 0.42 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.352 0 N-CA-C 112.692 0.627 . . . . 2.0800000000000001 112.692 -164.463 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.494 ' H ' HG23 ' A' ' 52' ' ' ILE . 0.0 OUTLIER 108.45 135.48 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.452 0 C-N-CA 129.845 3.258 . . . . 2.3599999999999999 108.208 -176.58 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -44.22 -51.15 7.05 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 124.63 3.553 . . . . 1.3100000000000001 114.796 171.021 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -47.19 -56.05 3.39 Favored 'Trans proline' 0 N--CA 1.448 -1.195 0 CA-C-N 121.307 1.502 . . . . 1.1000000000000001 110.929 167.008 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 51.0 mtt -59.51 -36.34 75.89 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 118.029 -1.468 . . . . 1.9099999999999999 113.134 -178.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.425 HD13 HG21 ' A' ' 57' ' ' ILE . 0.5 OUTLIER -62.13 -46.81 95.63 Favored 'Isoleucine or valine' 0 C--N 1.344 0.351 0 CA-C-N 120.675 1.58 . . . . 2.9399999999999999 110.619 173.841 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -53.38 -52.36 59.56 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 121.189 0.519 . . . . 1.3799999999999999 109.978 178.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -56.77 -49.1 76.29 Favored 'General case' 0 N--CA 1.426 -1.652 0 C-N-CA 123.474 0.709 . . . . 3.2599999999999998 111.337 176.55 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 3.9 m-30 -53.81 -33.98 57.75 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 119.31 0.959 . . . . 4.1799999999999997 111.39 178.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.463 HD11 HD13 ' A' ' 7' ' ' ILE . 42.0 mt -70.84 -51.35 36.82 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 O-C-N 121.477 -0.764 . . . . 1.3999999999999999 109.292 173.548 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 35.6 mtp-105 -63.85 -27.88 69.47 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 113.54 0.941 . . . . 5.7800000000000002 113.54 -174.396 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -45.93 -55.11 7.18 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 125.058 1.343 . . . . 4.9699999999999998 111.072 177.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -130.27 -19.65 3.11 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 124.453 1.101 . . . . 2.77 113.525 -166.8 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -96.52 -102.67 2.05 Favored Glycine 0 N--CA 1.446 -0.642 0 N-CA-C 109.086 -1.606 . . . . 2.9199999999999999 109.086 -179.03 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 27.9 m-85 -149.53 166.17 30.0 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 122.172 0.987 . . . . 2.8599999999999999 110.936 -154.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -78.94 69.06 2.96 Favored Glycine 0 N--CA 1.443 -0.859 0 CA-C-N 114.53 -1.213 . . . . 1.76 110.551 -178.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -82.64 141.78 32.23 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 113.867 -1.167 . . . . 1.3400000000000001 109.852 -176.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 9.3 t -115.25 139.65 49.77 Favored 'General case' 0 N--CA 1.439 -1.013 0 N-CA-C 106.77 -1.567 . . . . 2.1699999999999999 106.77 178.448 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.0 t -83.59 125.9 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.612 0 C-N-CA 125.132 1.373 . . . . 2.0 108.952 -172.385 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 13.7 mm -130.62 59.54 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 C-N-CA 125.254 1.422 . . . . 2.1099999999999999 108.472 -177.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 . . . . . 0 CA--C 1.532 0.26 0 N-CA-C 108.195 -1.039 . . . . 4.8099999999999996 108.195 162.015 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 . . . . . 0 N--CA 1.479 0.992 0 N-CA-C 108.295 -1.002 . . . . 7.3499999999999996 108.295 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.2 m -47.92 132.45 15.03 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 125.544 1.538 . . . . 2.6299999999999999 112.323 -176.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 22.9 t -113.19 178.08 4.4 Favored 'General case' 0 N--CA 1.463 0.18 0 C-N-CA 125.423 1.489 . . . . 3.1800000000000002 108.149 177.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.39 159.28 37.5 Favored 'General case' 0 N--CA 1.46 0.052 0 CA-C-N 118.273 0.488 . . . . 4.3799999999999999 112.005 -176.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 53.6 t -138.77 154.12 48.49 Favored 'General case' 0 C--N 1.333 -0.144 0 N-CA-C 106.635 -1.617 . . . . 1.45 106.635 176.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 81.3 m-85 -98.75 154.37 18.04 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 107.405 -1.331 . . . . 2.8700000000000001 107.405 178.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 18.2 mt -148.66 132.16 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 N-CA-C 105.379 -2.082 . . . . 1.6100000000000001 105.379 -176.043 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 48.5 tp60 -100.86 126.13 47.44 Favored 'General case' 0 N--CA 1.432 -1.364 0 N-CA-C 105.553 -2.017 . . . . 3.1200000000000001 105.553 176.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 30.1 m -98.85 137.09 27.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 C-N-CA 124.087 0.955 . . . . 2.2599999999999998 109.209 179.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 25.3 m -78.81 74.85 5.33 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 109.501 -0.555 . . . . 2.3399999999999999 109.501 179.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 117.81 77.32 0.59 Allowed Glycine 0 C--N 1.335 0.487 0 CA-C-O 124.513 2.174 . . . . 2.2400000000000002 110.485 173.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.9 -65.91 0.62 Allowed 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 110.024 -3.088 . . . . 4.1100000000000003 108.398 176.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.6 t -79.09 41.97 0.46 Allowed 'General case' 0 CA--C 1.54 0.586 0 O-C-N 121.3 -0.875 . . . . 4.8700000000000001 111.173 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 45.3 t -68.69 -43.9 75.12 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 107.115 -1.439 . . . . 2.4300000000000002 107.115 156.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 76.76 161.0 0.22 Allowed 'General case' 0 C--N 1.344 0.341 0 C-N-CA 126.688 1.995 . . . . 3.04 110.104 -174.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 10.8 m 72.05 -53.38 0.69 Allowed 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 125.183 1.393 . . . . 2.7400000000000002 112.039 -176.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 31.5 m -29.56 -54.65 0.15 Allowed 'General case' 0 C--O 1.223 -0.294 0 C-N-CA 127.278 2.231 . . . . 3.04 110.96 167.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.618 HG22 ' CG2' ' A' ' 36' ' ' VAL . 1.2 t -69.58 -36.37 70.62 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.048 0 N-CA-C 112.488 0.551 . . . . 3.2799999999999998 112.488 -174.239 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.27 -45.42 93.38 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 109.232 -0.655 . . . . 0.81000000000000005 109.232 173.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -57.54 -47.39 82.14 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 109.094 -0.706 . . . . 2.71 109.094 173.244 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.707 HG21 HD11 ' A' ' 35' ' ' LEU 0.251 53.9 mt -64.16 -44.84 97.61 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 O-C-N 121.571 -0.706 . . . . 1.95 111.296 -172.971 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -47.76 -51.79 20.98 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 119.383 0.992 . . . . 3.25 111.755 165.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 8.4 mmt85 -57.75 -38.22 74.99 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 118.011 -0.995 . . . . 4.5199999999999996 112.714 176.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 71.2 m-20 -63.2 -55.74 22.49 Favored 'General case' 0 C--O 1.222 -0.35 0 CA-C-N 120.237 1.38 . . . . 3.1499999999999999 108.03 177.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 17.5 mt -77.14 -51.34 11.16 Favored 'General case' 0 N--CA 1.434 -1.229 0 C-N-CA 124.621 1.168 . . . . 2.9199999999999999 112.308 -159.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 3.1 ttm105 -65.44 -13.44 58.76 Favored 'General case' 0 N--CA 1.421 -1.915 0 O-C-N 121.499 -0.751 . . . . 8.1199999999999992 112.682 -173.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.1 mtp180 -42.15 -64.57 0.57 Allowed 'General case' 0 N--CA 1.448 -0.529 0 CA-C-O 118.369 -0.824 . . . . 7.9500000000000002 111.068 160.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 169.76 -176.66 0.03 OUTLIER 'General case' 0 C--N 1.344 0.366 0 CA-C-N 119.012 0.824 . . . . 7.3499999999999996 110.794 -156.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 84.82 53.46 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 127.314 2.246 . . . . 5.3600000000000003 109.747 178.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 72.44 14.58 77.27 Favored Glycine 0 CA--C 1.527 0.826 0 CA-C-O 118.466 -1.186 . . . . 0.94999999999999996 114.668 168.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 1.1 mt -84.75 130.07 36.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 N-CA-C 107.091 -1.448 . . . . 1.8500000000000001 107.091 -178.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -137.57 43.03 2.31 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-O 122.734 1.254 . . . . 3.1099999999999999 111.223 160.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.5 t -170.21 147.63 3.16 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 128.858 2.863 . . . . 1.6000000000000001 105.187 134.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.424 ' H ' HG13 ' A' ' 34' ' ' ILE . 2.6 pp -77.72 159.62 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 N-CA-C 108.141 -1.059 . . . . 2.0299999999999998 108.141 176.109 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.707 HD11 HG21 ' A' ' 21' ' ' ILE . 2.5 pp -73.96 137.16 43.39 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 104.488 -2.412 . . . . 4.7400000000000002 104.488 158.272 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.618 ' CG2' HG22 ' A' ' 18' ' ' VAL . 2.1 t -160.46 150.85 5.52 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.104 0 N-CA-C 106.112 -1.81 . . . . 1.3999999999999999 106.112 123.047 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -158.73 53.54 0.42 Allowed 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 104.325 -2.472 . . . . 0.68000000000000005 104.325 165.019 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.588 HD23 ' C ' ' A' ' 38' ' ' LEU . 1.1 tt -66.11 -31.1 71.76 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 107.294 -1.373 . . . . 3.4399999999999999 107.294 -178.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 27.7 ttt -45.0 -41.95 7.86 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.108 1.363 . . . . 3.29 111.875 170.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -85.76 -55.58 3.9 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 108.524 -0.917 . . . . 1.78 108.524 171.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 143.17 43.98 0.05 OUTLIER Glycine 0 CA--C 1.523 0.553 0 C-N-CA 125.089 1.328 . . . . 0.81999999999999995 111.885 167.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 14.1 pttp -159.92 -179.3 7.69 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 118.078 0.939 . . . . 4.0899999999999999 108.9 -164.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.574 ' CB ' HD13 ' A' ' 35' ' ' LEU . . . -130.72 143.45 50.75 Favored 'General case' 0 N--CA 1.441 -0.877 0 C-N-CA 127.475 2.31 . . . . 0.87 108.953 -177.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -144.01 89.13 2.01 Favored 'General case' 0 C--N 1.341 0.238 0 C-N-CA 124.104 0.961 . . . . 3.8700000000000001 111.215 173.065 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 14.0 p -80.71 137.32 21.61 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.22 0 N-CA-C 108.901 -0.777 . . . . 2.04 108.901 -176.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 70.8 ttt180 -106.58 126.75 52.67 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 107.655 -1.239 . . . . 5.2000000000000002 107.655 171.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 7.9 p90 -157.48 175.88 13.38 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 123.384 0.674 . . . . 2.1699999999999999 109.844 -167.041 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 3.3 p30 -103.89 135.18 19.39 Favored Pre-proline 0 N--CA 1.451 -0.396 0 N-CA-C 107.752 -1.203 . . . . 3.0099999999999998 107.752 164.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -81.32 1.79 9.03 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 122.29 1.993 . . . . 2.5299999999999998 113.314 -174.01 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -91.87 -49.08 6.43 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-N 119.41 1.005 . . . . 1.0800000000000001 108.535 -167.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 24.4 t -58.78 -60.39 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.755 0 C-N-CA 124.354 1.062 . . . . 0.97999999999999998 109.855 175.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 19.2 tt -93.56 -53.42 8.5 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.233 0 CA-C-O 118.855 -0.593 . . . . 1.8200000000000001 112.258 -163.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 9.1 mm-40 101.16 129.72 0.02 OUTLIER Pre-proline 0 CA--C 1.541 0.598 0 C-N-CA 129.574 3.15 . . . . 2.9199999999999999 112.304 -175.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_exo -50.89 -48.95 18.53 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 124.787 3.658 . . . . 1.1200000000000001 116.71 177.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -54.45 -50.55 13.06 Favored 'Trans proline' 0 N--CA 1.442 -1.514 0 CA-C-N 120.66 1.271 . . . . 1.2 108.873 169.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 64.1 mtt -63.03 -44.07 96.93 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 120.528 -0.469 . . . . 2.4900000000000002 110.708 -167.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 16.2 tt -61.76 -35.19 66.15 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.25 0 C-N-CA 119.61 -0.836 . . . . 2.2799999999999998 111.686 -175.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -69.93 -58.03 4.33 Favored 'General case' 0 N--CA 1.452 -0.325 0 O-C-N 122.33 -0.231 . . . . 1.4099999999999999 110.875 171.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -47.98 -49.29 31.15 Favored 'General case' 0 N--CA 1.438 -1.06 0 C-N-CA 125.613 1.565 . . . . 3.1699999999999999 111.861 -174.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 16.2 m-30 -44.18 -40.42 5.03 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.748 0.819 . . . . 3.73 112.453 177.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 65.9 mt -65.16 -26.76 40.54 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 O-C-N 121.513 -0.742 . . . . 1.1499999999999999 110.66 -174.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 36.0 mtm180 -58.27 -61.21 2.74 Favored 'General case' 0 C--N 1.341 0.238 0 CA-C-N 118.939 0.791 . . . . 5.5199999999999996 109.642 174.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -60.59 -39.18 87.12 Favored 'General case' 0 N--CA 1.44 -0.974 0 C-N-CA 123.63 0.772 . . . . 4.5199999999999996 112.77 -166.081 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -98.36 -27.53 14.06 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 113.187 0.81 . . . . 2.2400000000000002 113.187 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -112.96 -82.14 1.14 Allowed Glycine 0 CA--C 1.526 0.743 0 CA-C-N 119.215 0.916 . . . . 2.25 111.968 -172.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -177.05 164.94 2.32 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.562 1.145 . . . . 4.3799999999999999 109.605 -162.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -59.83 115.17 7.16 Favored Glycine 0 N--CA 1.439 -1.148 0 N-CA-C 109.601 -1.4 . . . . 1.1699999999999999 109.601 -171.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -115.25 91.76 3.71 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 125.435 1.494 . . . . 1.0700000000000001 109.068 -169.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -84.39 119.14 24.76 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 108.263 -1.014 . . . . 2.5899999999999999 108.263 -178.584 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 8.3 p -81.23 141.9 14.53 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 C-N-CA 123.265 0.626 . . . . 2.2400000000000002 109.584 -174.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 15.0 mt -139.79 99.06 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 C-N-CA 124.817 1.247 . . . . 1.8200000000000001 107.675 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -81.8 50.09 1.47 Allowed 'General case' 0 CA--C 1.535 0.369 0 O-C-N 121.462 -0.774 . . . . 6.3600000000000003 109.755 174.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -169.13 169.2 9.53 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 108.169 -1.048 . . . . 4.7000000000000002 108.169 -175.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 6.0 tp -160.4 124.64 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 N-CA-C 107.189 -1.411 . . . . 9.5999999999999996 107.189 174.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -160.02 156.34 26.86 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 106.088 -1.819 . . . . 10.0 106.088 177.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 158.47 -178.39 34.72 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 108.972 -1.651 . . . . 12.66 108.972 -178.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.211 0 N-CA-C 104.506 -2.405 . . . . 21.719999999999999 104.506 174.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 . . . . . 0 N--CA 1.479 1.022 0 CA-C-O 118.858 -0.592 . . . . 6.8899999999999997 110.347 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.4 m -43.64 120.49 2.0 Allowed 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.732 1.613 . . . . 3.3100000000000001 112.549 -177.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 26.1 m -149.04 176.23 10.63 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 126.106 1.762 . . . . 1.75 107.558 -176.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 39.2 pttt -125.18 158.16 34.66 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-N 119.173 0.897 . . . . 3.7999999999999998 109.108 154.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 36.6 t -142.3 152.44 42.98 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 107.275 -1.38 . . . . 1.6200000000000001 107.275 175.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 54.3 m-85 -84.44 148.69 26.43 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 107.421 -1.325 . . . . 2.1499999999999999 107.421 176.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.431 ' HB ' ' HB3' ' A' ' 43' ' ' ALA . 5.6 mm -130.5 141.19 46.89 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.817 0 N-CA-C 104.61 -2.367 . . . . 2.0600000000000001 104.61 173.264 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -98.24 128.27 44.6 Favored 'General case' 0 N--CA 1.435 -1.189 0 N-CA-C 103.882 -2.636 . . . . 3.5899999999999999 103.882 166.172 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.4 p -126.41 122.53 61.4 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.161 0 C-N-CA 124.674 1.19 . . . . 2.3999999999999999 108.41 179.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.8 t -72.76 136.9 45.56 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 109.434 -0.58 . . . . 2.6800000000000002 109.434 -176.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 113.8 -52.19 0.66 Allowed Glycine 0 C--N 1.335 0.518 0 N-CA-C 108.146 -1.981 . . . . 2.8500000000000001 108.146 177.244 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 59.9 mtt 75.94 -69.96 0.15 Allowed 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 126.197 1.799 . . . . 4.25 110.314 158.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 11.8 t -112.13 11.74 20.4 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 125.907 1.683 . . . . 4.8399999999999999 109.957 174.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.442 ' SG ' ' HB2' ' A' ' 17' ' ' CYS 0.267 17.2 p -63.14 144.64 56.74 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 119.017 0.826 . . . . 3.25 109.436 -176.212 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -52.61 109.9 0.45 Allowed 'General case' 0 N--CA 1.455 -0.185 0 CA-C-N 116.212 -0.449 . . . . 3.3300000000000001 111.98 -158.179 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.7 m 69.23 6.72 5.83 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 125.355 1.462 . . . . 3.02 113.873 175.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.442 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 48.8 t -43.99 -49.06 8.75 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 123.765 1.745 . . . . 3.79 108.607 163.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -72.67 -46.64 53.55 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.521 0 CA-C-N 112.199 -2.273 . . . . 2.6000000000000001 109.856 -172.182 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.67 -42.06 87.58 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 110.212 -0.292 . . . . 1.1299999999999999 110.212 175.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -60.03 -60.44 3.83 Favored 'General case' 0 CA--C 1.521 -0.163 0 C-N-CA 124.571 1.148 . . . . 2.0499999999999998 108.455 178.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.437 HG23 ' CD2' ' A' ' 35' ' ' LEU . 1.7 mt -43.69 -54.72 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 C-N-CA 123.801 0.84 . . . . 1.8400000000000001 111.314 173.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -54.65 -50.05 69.11 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 119.702 1.137 . . . . 3.9199999999999999 111.517 176.102 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.94 -48.93 51.65 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.592 0.757 . . . . 4.8399999999999999 112.095 176.458 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.468 HD22 ' CD2' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -76.28 -60.39 2.36 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 118.139 0.427 . . . . 3.5699999999999998 111.766 -177.753 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.468 ' CD2' HD22 ' A' ' 24' ' ' ASN . 0.1 OUTLIER -70.57 -36.77 73.8 Favored 'General case' 0 C--O 1.22 -0.47 0 C-N-CA 125.756 1.623 . . . . 3.04 112.595 -152.679 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -21.5 -74.61 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 128.616 2.766 . . . . 7.7000000000000002 114.722 -158.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . 0.287 7.9 ptp180 -91.9 -29.9 16.43 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 127.339 2.255 . . . . 12.69 116.286 166.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 41.8 mm-40 -81.05 128.4 33.67 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 114.855 -1.066 . . . . 6.7999999999999998 108.868 -134.299 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 60.0 55.84 3.63 Favored 'General case' 0 N--CA 1.442 -0.825 0 CA-C-O 122.856 1.312 . . . . 5.0899999999999999 111.189 -171.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 76.16 30.87 56.52 Favored Glycine 0 CA--C 1.523 0.566 0 CA-C-N 114.006 -1.452 . . . . 1.26 112.742 162.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.6 mt -96.03 147.44 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 N-CA-C 108.322 -0.992 . . . . 2.0800000000000001 108.322 171.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -147.88 47.03 1.09 Allowed 'General case' 0 C--O 1.233 0.22 0 CA-C-O 122.309 1.052 . . . . 3.4199999999999999 111.815 158.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 10.3 t -165.83 148.0 7.28 Favored 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 126.995 2.118 . . . . 1.75 107.252 148.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.5 pp -82.4 134.35 27.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 CA-C-O 122.666 1.222 . . . . 2.4399999999999999 110.375 175.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.509 ' H ' ' CD2' ' A' ' 35' ' ' LEU . 0.4 OUTLIER -79.79 64.05 4.53 Favored 'General case' 0 N--CA 1.433 -1.295 0 C-N-CA 127.687 2.395 . . . . 4.71 111.624 -173.315 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.456 ' CG1' HD23 ' A' ' 38' ' ' LEU . 52.8 t -133.52 131.43 57.31 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 O-C-N 120.721 -1.237 . . . . 1.23 113.131 174.142 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -138.8 76.23 1.56 Allowed 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 105.217 -2.142 . . . . 0.87 105.217 152.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.456 HD23 ' CG1' ' A' ' 36' ' ' VAL . 0.3 OUTLIER -54.54 -39.78 68.01 Favored 'General case' 0 CA--C 1.511 -0.526 0 N-CA-C 109.595 -0.52 . . . . 3.3700000000000001 109.595 175.138 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 24.0 ttt -85.06 44.22 1.06 Allowed 'General case' 0 N--CA 1.442 -0.836 0 CA-C-O 121.767 0.794 . . . . 4.7999999999999998 109.1 -164.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -179.33 -36.71 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 129.013 2.925 . . . . 1.4199999999999999 107.076 -167.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 106.11 46.72 1.14 Allowed Glycine 0 C--N 1.336 0.569 0 C-N-CA 126.062 1.791 . . . . 0.87 108.983 157.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 24.8 mttm -155.27 175.14 14.24 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 108.392 -0.966 . . . . 4.6100000000000003 108.392 -157.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.431 ' HB3' ' HB ' ' A' ' 7' ' ' ILE . . . -144.2 142.6 30.61 Favored 'General case' 0 N--CA 1.44 -0.967 0 C-N-CA 125.315 1.446 . . . . 1.0800000000000001 107.978 -178.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -132.99 97.37 4.0 Favored 'General case' 0 C--N 1.338 0.103 0 N-CA-C 113.379 0.881 . . . . 3.27 113.379 171.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.3 p -81.11 114.96 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.518 0 N-CA-C 107.423 -1.325 . . . . 1.8200000000000001 107.423 -178.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 54.5 ttp180 -87.36 124.78 33.75 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 105.71 -1.959 . . . . 5.4299999999999997 105.71 163.114 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -158.22 170.72 21.62 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 122.96 0.504 . . . . 2.1499999999999999 110.6 -164.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 47.5 t-20 -108.53 88.26 4.97 Favored Pre-proline 0 N--CA 1.451 -0.421 0 C-N-CA 124.038 0.935 . . . . 2.6499999999999999 109.346 173.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -61.79 88.23 0.1 Allowed 'Trans proline' 0 N--CA 1.448 -1.163 0 C-N-CA 122.328 2.019 . . . . 1.6000000000000001 108.973 165.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -169.97 -57.56 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 130.423 3.489 . . . . 1.1799999999999999 105.101 169.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 65.7 t -58.45 -54.37 33.95 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 C-N-CA 124.879 1.272 . . . . 1.03 110.207 175.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.527 HG23 ' H ' ' A' ' 53' ' ' GLN . 8.4 tp -93.61 -73.02 0.48 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.364 0 CA-C-O 118.725 -0.655 . . . . 2.1400000000000001 111.93 -167.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.527 ' H ' HG23 ' A' ' 52' ' ' ILE . 0.0 OUTLIER 117.17 134.99 0.0 OUTLIER Pre-proline 0 N--CA 1.472 0.626 0 C-N-CA 130.753 3.621 . . . . 2.8900000000000001 108.185 -176.365 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -50.24 -50.86 12.24 Favored 'Trans proline' 0 N--CA 1.458 -0.561 0 C-N-CA 123.595 2.863 . . . . 1.03 114.449 172.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -50.07 -54.31 5.66 Favored 'Trans proline' 0 N--CA 1.444 -1.39 0 CA-C-N 120.451 1.197 . . . . 0.80000000000000004 110.069 167.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 62.0 mtt -62.45 -37.61 86.57 Favored 'General case' 0 C--N 1.342 0.261 0 C-N-CA 118.336 -1.346 . . . . 2.0600000000000001 111.469 -170.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.451 HD12 HG21 ' A' ' 52' ' ' ILE . 3.5 tt -70.37 -45.23 75.97 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-N 118.808 0.731 . . . . 2.23 110.312 178.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -58.8 -32.85 69.72 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.102 0.561 . . . . 1.3200000000000001 112.254 176.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -71.78 -60.13 2.39 Favored 'General case' 0 N--CA 1.441 -0.895 0 C-N-CA 126.388 1.875 . . . . 3.5600000000000001 111.585 176.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -41.63 -45.32 3.35 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.79 0.836 . . . . 3.6400000000000001 111.791 -173.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 49.7 mt -57.39 -52.48 56.31 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 C-N-CA 123.88 0.872 . . . . 1.1299999999999999 110.923 -177.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 1.3 ptt85 -71.5 -49.68 38.73 Favored 'General case' 0 CA--C 1.521 -0.139 0 N-CA-C 109.596 -0.52 . . . . 3.9199999999999999 109.596 -177.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -59.61 -34.51 72.84 Favored 'General case' 0 N--CA 1.441 -0.896 0 C-N-CA 123.387 0.675 . . . . 6.3899999999999997 111.627 -173.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 86.1 mt -83.0 -47.89 11.23 Favored 'General case' 0 C--N 1.34 0.194 0 CA-C-N 118.754 0.706 . . . . 2.77 111.446 170.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -95.98 -92.27 1.78 Allowed Glycine 0 CA--C 1.526 0.773 0 N-CA-C 111.692 -0.563 . . . . 1.8400000000000001 111.692 -174.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -135.53 -72.13 0.47 Allowed 'General case' 0 CA--C 1.513 -0.469 0 CA-C-O 121.679 0.752 . . . . 3.4900000000000002 112.962 -153.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 173.73 119.23 0.53 Allowed Glycine 0 N--CA 1.441 -1.028 0 N-CA-C 107.935 -2.066 . . . . 1.49 107.935 -156.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -156.5 161.41 40.02 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 122.904 0.482 . . . . 1.1599999999999999 110.996 -173.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 26.2 m -153.94 148.57 26.34 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 124.031 0.932 . . . . 2.9199999999999999 108.599 178.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 14.3 p -82.3 143.75 11.52 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 C-N-CA 123.624 0.77 . . . . 2.3900000000000001 109.74 -177.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 22.5 mm -133.13 140.16 47.76 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 C-N-CA 125.774 1.629 . . . . 2.0 107.528 -178.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -156.65 160.41 39.35 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 123.741 0.817 . . . . 4.9400000000000004 109.108 179.045 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 7.5 m-20 -91.97 92.54 8.36 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 108.24 -1.022 . . . . 5.7000000000000002 108.24 -179.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 10.2 tp -54.93 145.75 4.7 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 C-N-CA 122.62 0.368 . . . . 10.220000000000001 110.427 174.083 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -146.47 160.52 41.99 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 106.254 -1.758 . . . . 11.210000000000001 106.254 177.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -148.41 -121.49 1.18 Allowed Glycine 0 CA--C 1.527 0.8 0 N-CA-C 110.662 -0.975 . . . . 13.779999999999999 110.662 -178.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.248 1.009 0 N-CA-C 104.289 -2.485 . . . . 20.890000000000001 104.289 169.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 . . . . . 0 N--CA 1.476 0.839 0 N-CA-C 107.172 -1.418 . . . . 6.5 107.172 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.4 m -146.4 162.14 38.86 Favored 'General case' 0 N--CA 1.454 -0.236 0 O-C-N 124.359 1.037 . . . . 3.02 108.605 -176.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 23.0 t -141.93 169.56 17.37 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 108.956 -0.757 . . . . 2.5499999999999998 108.956 171.083 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 71.9 tttt -104.72 158.33 16.58 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 125.309 1.443 . . . . 3.7400000000000002 107.211 163.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 36.3 t -155.55 155.09 32.75 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 109.046 -0.724 . . . . 1.3600000000000001 109.046 167.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 5.1 m-30 -106.45 135.01 48.7 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 125.848 1.659 . . . . 2.3100000000000001 108.771 -178.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.3 mm -129.06 139.75 51.05 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 N-CA-C 105.463 -2.051 . . . . 2.1099999999999999 105.463 -173.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 51.3 tp60 -112.2 122.93 49.12 Favored 'General case' 0 N--CA 1.424 -1.728 0 N-CA-C 104.693 -2.336 . . . . 2.8900000000000001 104.693 -179.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 15.7 m -105.3 173.08 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 C-N-CA 124.378 1.071 . . . . 2.5600000000000001 108.687 178.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -134.42 88.73 2.48 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.562 0.745 . . . . 3.04 111.045 -173.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 154.9 -62.81 0.35 Allowed Glycine 0 CA--C 1.524 0.619 0 N-CA-C 107.667 -2.173 . . . . 3.7999999999999998 107.667 174.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 1.9 mtt 66.38 -71.71 0.09 Allowed 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 126.691 1.997 . . . . 3.73 111.213 170.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 33.1 p -79.47 52.85 1.44 Allowed 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 124.42 1.088 . . . . 5.0499999999999998 108.496 176.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 55.8 m -92.42 176.29 6.52 Favored 'General case' 0 N--CA 1.445 -0.725 0 C-N-CA 124.794 1.238 . . . . 2.7599999999999998 107.895 175.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -75.64 73.42 2.63 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 121.454 0.645 . . . . 3.3500000000000001 110.097 166.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.5 m 74.94 26.99 1.22 Allowed 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 115.24 -0.891 . . . . 2.46 113.129 159.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 69.9 m -44.27 -43.25 7.21 Favored 'General case' 0 CA--C 1.523 -0.075 0 C-N-CA 124.357 1.063 . . . . 3.0800000000000001 108.912 157.24 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 24.5 m -63.53 -50.97 76.14 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.001 0 CA-C-N 114.138 -1.392 . . . . 2.8399999999999999 109.993 -177.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -52.73 -43.82 65.97 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 122.994 0.518 . . . . 1.29 110.972 172.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -56.53 -50.77 70.88 Favored 'General case' 0 C--O 1.227 -0.123 0 N-CA-C 109.303 -0.628 . . . . 2.23 109.303 174.508 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.457 HG23 ' CD2' ' A' ' 25' ' ' LEU . 7.1 mt -58.44 -60.73 1.91 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 C-N-CA 123.541 0.736 . . . . 2.1000000000000001 109.039 -179.381 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -39.61 -54.92 1.95 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.942 1.297 . . . . 3.6299999999999999 112.259 172.02 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -59.83 -44.63 93.95 Favored 'General case' 0 CA--C 1.528 0.133 0 O-C-N 121.666 -0.646 . . . . 5.6299999999999999 112.422 178.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -56.83 -55.87 28.83 Favored 'General case' 0 C--O 1.226 -0.153 0 N-CA-C 108.4 -0.963 . . . . 2.8599999999999999 108.4 179.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.457 ' CD2' HG23 ' A' ' 21' ' ' ILE . 0.0 OUTLIER -74.84 -23.95 58.52 Favored 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 114.369 1.248 . . . . 2.2999999999999998 114.369 -172.325 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.55 -15.33 62.6 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 120.583 1.538 . . . . 6.5 114.802 -170.122 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 73.7 mtt180 -65.79 -19.55 65.93 Favored 'General case' 0 N--CA 1.462 0.142 0 N-CA-C 113.333 0.864 . . . . 7.2599999999999998 113.333 -157.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 71.25 23.25 4.09 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 125.08 1.352 . . . . 10.470000000000001 112.446 -172.065 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -76.46 59.3 1.44 Allowed 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 127.56 2.344 . . . . 5.6399999999999997 108.766 171.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 75.51 32.91 53.9 Favored Glycine 0 CA--C 1.535 1.311 0 C-N-CA 124.261 0.934 . . . . 1.4199999999999999 113.641 -178.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.45 HD12 ' HA ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -142.27 135.66 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 C-N-CA 127.212 2.205 . . . . 3.0699999999999998 105.665 -170.858 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 41.2 m-85 -145.29 48.13 1.28 Allowed 'General case' 0 C--O 1.233 0.195 0 CA-C-O 123.155 1.455 . . . . 3.2999999999999998 111.702 171.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 14.0 t -164.84 -178.64 5.35 Favored 'General case' 0 C--N 1.317 -0.841 0 C-N-CA 129.875 3.27 . . . . 2.0 106.135 151.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.494 HD13 ' H ' ' A' ' 34' ' ' ILE . 0.1 OUTLIER -125.2 127.49 72.16 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 C-N-CA 124.474 1.11 . . . . 2.5800000000000001 109.42 174.243 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.421 ' O ' ' HB1' ' A' ' 43' ' ' ALA . 0.9 OUTLIER -78.35 71.0 4.79 Favored 'General case' 0 N--CA 1.439 -0.993 0 O-C-N 121.099 -1.001 . . . . 4.7699999999999996 110.85 -176.834 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 18.7 t -123.9 139.83 49.19 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.885 0 CA-C-O 122.183 0.992 . . . . 1.3799999999999999 109.414 159.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -155.62 58.95 0.62 Allowed 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 126.418 1.887 . . . . 0.80000000000000004 107.139 168.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.2 pp -56.86 -32.14 65.51 Favored 'General case' 0 CA--C 1.51 -0.566 0 C-N-CA 123.45 0.7 . . . . 3.3599999999999999 112.474 -175.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 65.1 mtt -65.53 -40.44 92.94 Favored 'General case' 0 N--CA 1.441 -0.898 0 C-N-CA 119.761 -0.775 . . . . 4.6500000000000004 108.913 -165.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -76.84 -42.22 41.09 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.721 0.808 . . . . 1.48 109.842 167.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 111.88 57.16 0.46 Allowed Glycine 0 C--N 1.338 0.652 0 N-CA-C 109.426 -1.469 . . . . 1.02 109.426 176.061 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -160.24 -178.37 6.91 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 107.002 -1.481 . . . . 4.6100000000000003 107.002 -169.149 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.421 ' HB1' ' O ' ' A' ' 35' ' ' LEU . . . -146.35 130.1 17.09 Favored 'General case' 0 N--CA 1.434 -1.259 0 C-N-CA 126.334 1.854 . . . . 0.97999999999999998 106.001 -172.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -135.94 114.36 11.69 Favored 'General case' 0 C--N 1.342 0.261 0 CA-C-N 120.926 1.693 . . . . 2.5099999999999998 113.277 177.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.2 p -90.12 150.18 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.273 0 C-N-CA 125.02 1.328 . . . . 1.49 110.17 -171.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 35.4 ttm180 -125.75 131.02 52.6 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 104.863 -2.273 . . . . 4.1399999999999997 104.863 159.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 3.8 p90 -160.18 169.73 22.66 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-N 118.219 0.463 . . . . 2.2400000000000002 111.569 -165.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . 0.271 49.1 p30 -104.3 97.18 11.24 Favored Pre-proline 0 CA--C 1.542 0.671 0 N-CA-C 113.234 0.827 . . . . 3.9900000000000002 113.234 170.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -72.51 73.19 2.86 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 122.526 2.15 . . . . 1.46 111.331 177.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -150.27 -57.39 0.18 Allowed 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 126.548 1.939 . . . . 1.3400000000000001 106.041 171.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 78.6 t -58.62 -54.6 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.787 0 C-N-CA 123.778 0.831 . . . . 1.3200000000000001 109.299 171.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.429 HG23 ' H ' ' A' ' 53' ' ' GLN 0.265 2.5 tp -90.54 -72.97 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-O 118.306 -0.854 . . . . 1.75 112.103 -165.613 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.429 ' H ' HG23 ' A' ' 52' ' ' ILE . 0.0 OUTLIER 112.98 136.66 0.0 OUTLIER Pre-proline 0 N--CA 1.476 0.87 0 C-N-CA 131.122 3.769 . . . . 3.0299999999999998 108.653 -177.48 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -51.03 -51.13 11.85 Favored 'Trans proline' 0 CA--C 1.534 0.503 0 C-N-CA 124.054 3.17 . . . . 1.1100000000000001 115.345 174.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -53.8 -48.83 19.64 Favored 'Trans proline' 0 N--CA 1.444 -1.409 0 CA-C-N 120.448 1.196 . . . . 0.77000000000000002 110.282 167.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 74.5 mtp -69.13 -33.16 73.01 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 118.301 -1.359 . . . . 2.0600000000000001 110.65 -168.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 6.9 tt -66.42 -50.95 63.26 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 CA-C-N 119.935 1.243 . . . . 2.3700000000000001 110.324 179.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -51.65 -53.97 33.07 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.09 0.956 . . . . 1.0900000000000001 110.814 176.012 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 54.4 mm-40 -65.31 -38.08 89.09 Favored 'General case' 0 N--CA 1.429 -1.509 0 CA-C-O 118.866 -0.588 . . . . 3.5299999999999998 111.999 -177.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -54.54 -34.25 61.47 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 120.192 1.36 . . . . 4.3399999999999999 111.207 173.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.6 mm -60.47 -53.28 51.0 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 N-CA-C 107.746 -1.205 . . . . 2.1400000000000001 107.746 172.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 15.7 mtp-105 -55.58 -47.73 75.97 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 125.161 1.384 . . . . 6.3600000000000003 114.301 -177.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -45.92 -35.38 4.57 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 127.023 2.129 . . . . 3.1400000000000001 112.933 -175.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 58.8 mt -79.11 -16.39 56.78 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 122.93 0.492 . . . . 2.0299999999999998 111.196 -174.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 130.93 50.06 0.11 Allowed Glycine 0 CA--C 1.527 0.805 0 C-N-CA 125.182 1.372 . . . . 2.5699999999999998 111.168 170.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -136.39 169.62 17.38 Favored 'General case' 0 C--O 1.238 0.473 0 CA-C-O 123.519 1.628 . . . . 3.48 113.673 -168.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -115.18 126.89 7.39 Favored Glycine 0 N--CA 1.442 -0.957 0 N-CA-C 105.949 -2.861 . . . . 1.76 105.949 168.213 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -153.24 81.52 1.19 Allowed 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 124.533 1.133 . . . . 1.6299999999999999 108.3 -172.223 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -84.8 138.04 32.83 Favored 'General case' 0 C--O 1.225 -0.227 0 C-N-CA 123.704 0.802 . . . . 2.4399999999999999 108.882 -175.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 97.0 t -84.89 109.19 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 N-CA-C 108.552 -0.907 . . . . 1.6899999999999999 108.552 -177.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 18.9 mm -130.8 60.15 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 C-N-CA 125.156 1.383 . . . . 2.9500000000000002 109.002 -171.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -79.6 175.58 10.48 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.397 -0.819 . . . . 3.75 109.478 155.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 42.3 m-80 49.86 47.14 23.52 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.135 0.974 . . . . 5.7599999999999998 111.111 175.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 13.2 tt -73.85 165.65 3.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 C-N-CA 124.417 1.087 . . . . 10.08 109.936 178.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 58.16 48.4 12.93 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.681 1.192 . . . . 11.81 111.983 176.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -65.1 157.95 45.91 Favored Glycine 0 CA--C 1.53 1.02 0 N-CA-C 109.918 -1.273 . . . . 10.33 109.918 165.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.252 1.215 0 N-CA-C 103.459 -2.793 . . . . 16.52 103.459 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 . . . . . 0 N--CA 1.48 1.059 0 N-CA-C 110.63 -0.137 . . . . 6.6100000000000003 110.63 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 88.4 p -170.97 155.98 4.73 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 125.604 1.562 . . . . 2.4500000000000002 106.999 171.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 18.6 m -155.34 153.98 31.34 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 124.902 1.281 . . . . 2.0699999999999998 108.022 177.121 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 9.3 mtmp? -91.82 161.01 15.03 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 123.33 0.652 . . . . 3.3599999999999999 111.937 176.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 49.3 t -155.25 157.71 37.71 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 105.974 -1.861 . . . . 1.3300000000000001 105.974 166.12 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -98.34 146.4 25.72 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 119.804 1.184 . . . . 3.4100000000000001 108.007 171.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.509 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 12.0 mm -128.16 113.42 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 N-CA-C 105.138 -2.171 . . . . 2.1200000000000001 105.138 174.01 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 16.6 tp60 -82.38 124.49 30.06 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 104.825 -2.287 . . . . 2.8900000000000001 104.825 172.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.5 p -117.72 99.02 7.3 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-O 122.175 0.988 . . . . 2.3599999999999999 110.597 -169.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 7.0 m -67.03 94.3 0.33 Allowed 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 109.155 -0.683 . . . . 2.7799999999999998 109.155 -179.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 135.24 3.94 2.67 Favored Glycine 0 C--O 1.221 -0.705 0 C-N-CA 125.124 1.345 . . . . 2.54 113.047 -175.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -43.98 -46.89 8.49 Favored 'General case' 0 C--N 1.321 -0.647 0 O-C-N 121.561 -0.964 . . . . 3.27 110.612 162.277 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 15.3 t -74.43 12.13 0.84 Allowed 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.192 0.997 . . . . 5.9699999999999998 112.887 176.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 16.9 t -57.4 -41.77 80.95 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 107.011 -1.477 . . . . 2.5600000000000001 107.011 160.145 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 84.27 145.3 0.07 Allowed 'General case' 0 C--N 1.348 0.52 0 C-N-CA 127.934 2.494 . . . . 3.3199999999999998 110.138 -175.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.6 m 71.49 -30.91 0.22 Allowed 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 115.083 1.512 . . . . 3.0499999999999998 115.083 174.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 11.0 m -62.83 -18.21 62.49 Favored 'General case' 0 CA--C 1.517 -0.294 0 C-N-CA 128.825 2.85 . . . . 3.5299999999999998 111.821 -175.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 14.0 m -41.12 -43.78 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 N-CA-C 112.162 0.431 . . . . 2.25 112.162 159.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -52.77 -46.36 67.52 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.088 0.955 . . . . 1.1399999999999999 111.547 173.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -59.19 -51.98 67.65 Favored 'General case' 0 C--O 1.224 -0.249 0 N-CA-C 108.671 -0.863 . . . . 2.0099999999999998 108.671 175.353 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 38.4 mm -53.54 -59.39 1.91 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 C-N-CA 123.601 0.76 . . . . 2.04 109.123 -179.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -42.54 -61.07 1.31 Allowed 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.057 1.343 . . . . 3.3999999999999999 110.977 175.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.93 -48.93 78.21 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 119.369 -0.348 . . . . 7.8600000000000003 110.933 -175.231 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -49.86 -60.32 3.02 Favored 'General case' 0 CA--C 1.519 -0.228 0 C-N-CA 123.989 0.916 . . . . 3.1200000000000001 108.839 -179.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.611 ' CD2' HD21 ' A' ' 35' ' ' LEU . 0.0 OUTLIER -70.57 -32.14 69.44 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 115.623 -0.717 . . . . 2.1499999999999999 109.499 -170.397 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . 0.578 68.6 mtp180 -63.0 3.17 0.25 Allowed 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 117.827 2.529 . . . . 6.1600000000000001 117.827 163.217 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 3.5 mmt85 -43.58 -34.09 1.32 Allowed 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 116.914 -1.914 . . . . 7.8300000000000001 112.233 146.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . 0.25 4.2 mt-10 78.86 33.15 0.26 Allowed 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 127.191 2.196 . . . . 8.8100000000000005 112.135 176.436 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 80.1 mt-10 -73.55 69.62 1.25 Allowed 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 127.101 2.161 . . . . 5.9299999999999997 110.436 179.222 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 67.15 28.43 73.74 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 123.453 0.549 . . . . 1.0600000000000001 111.932 -179.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.0 mm -98.3 140.12 18.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 C-N-CA 128.416 2.686 . . . . 2.2799999999999998 109.208 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -148.47 42.51 0.99 Allowed 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 122.404 1.097 . . . . 3.9900000000000002 113.12 163.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 33.6 t -166.87 149.41 6.4 Favored 'General case' 0 C--N 1.317 -0.805 0 C-N-CA 131.01 3.724 . . . . 2.02 104.828 144.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.7 pp -83.45 151.73 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 N-CA-C 108.157 -1.053 . . . . 1.9199999999999999 108.157 163.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.611 HD21 ' CD2' ' A' ' 25' ' ' LEU . 0.4 OUTLIER -87.22 78.55 8.8 Favored 'General case' 0 N--CA 1.436 -1.138 0 C-N-CA 127.185 2.194 . . . . 4.4400000000000004 110.939 178.005 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 24.5 t -134.99 137.51 50.5 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 CA-C-O 121.368 0.604 . . . . 1.3300000000000001 110.145 165.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -155.92 58.47 0.6 Allowed 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 113.912 -1.494 . . . . 0.95999999999999996 107.397 164.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -63.61 -28.6 70.03 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.058 0.943 . . . . 3.3100000000000001 110.39 -173.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 63.3 mtt -46.37 -41.34 13.4 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.311 0.644 . . . . 4.5999999999999996 111.666 170.027 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -88.68 -41.52 12.55 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 122.769 0.428 . . . . 1.71 109.95 172.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 113.18 53.2 0.47 Allowed Glycine 0 C--N 1.335 0.488 0 N-CA-C 108.607 -1.797 . . . . 1.01 108.607 179.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 37.6 mtmt -151.71 175.41 12.42 Favored 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 108.293 -1.003 . . . . 3.7799999999999998 108.293 -164.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.525 ' HB1' HD12 ' A' ' 35' ' ' LEU . . . -148.0 119.25 7.8 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 105.646 -1.983 . . . . 0.93999999999999995 105.646 -174.089 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -128.24 96.94 4.59 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 123.553 0.741 . . . . 3.2599999999999998 111.433 -171.34 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 10.7 p -81.62 147.93 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.285 0 C-N-CA 123.226 0.61 . . . . 1.4399999999999999 109.362 -170.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 21.5 ttt-85 -123.13 127.76 49.14 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 105.774 -1.936 . . . . 5.8799999999999999 105.774 156.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 3.8 p90 -157.88 175.04 14.37 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 108.426 -0.953 . . . . 2.0600000000000001 108.426 -169.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -109.12 104.3 54.67 Favored Pre-proline 0 CA--C 1.537 0.467 0 CA-C-O 118.579 -0.724 . . . . 2.98 111.647 176.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -70.78 76.61 1.52 Allowed 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 123.257 2.638 . . . . 1.5700000000000001 111.571 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -165.53 -46.97 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 126.524 1.929 . . . . 1.3899999999999999 107.224 167.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 99.2 t -62.71 -45.54 98.57 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.885 0 C-N-CA 125.148 1.379 . . . . 1.1899999999999999 110.056 177.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.528 HG23 ' H ' ' A' ' 53' ' ' GLN 0.273 6.0 tp -113.17 -73.32 0.63 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.303 0 CA-C-O 118.16 -0.924 . . . . 1.99 112.187 -167.865 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.528 ' H ' HG23 ' A' ' 52' ' ' ILE . 27.8 mm100 110.86 131.93 0.0 OUTLIER Pre-proline 0 CA--C 1.54 0.588 0 C-N-CA 129.424 3.09 . . . . 3.4700000000000002 111.757 174.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -44.86 -53.68 4.93 Favored 'Trans proline' 0 CA--C 1.534 0.516 0 C-N-CA 125.23 3.954 . . . . 1.3100000000000001 116.427 176.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_endo -53.04 -47.29 28.34 Favored 'Trans proline' 0 N--CA 1.447 -1.222 0 CA-C-N 120.825 1.33 . . . . 1.0 110.022 172.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 64.7 mtt -62.4 -46.41 88.71 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 118.181 -0.914 . . . . 2.1299999999999999 111.41 -177.079 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 18.0 pt -61.93 -45.08 99.49 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-N 120.616 1.553 . . . . 2.3100000000000001 111.318 176.094 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -53.93 -52.65 59.91 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 121.195 0.521 . . . . 1.02 110.443 179.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 62.1 mm-40 -61.43 -48.49 80.95 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-O 118.359 -0.829 . . . . 3.5899999999999999 111.853 177.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -47.25 -42.44 20.57 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 119.659 1.118 . . . . 3.79 111.385 176.281 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 54.8 mt -67.05 -40.2 84.96 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 O-C-N 122.037 -0.414 . . . . 1.0 110.186 178.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 54.6 mtt180 -64.74 -50.62 66.15 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.647 0.779 . . . . 4.4500000000000002 111.934 177.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -43.66 -55.13 4.55 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 126.462 1.905 . . . . 2.9399999999999999 111.674 -175.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.38 -31.04 12.58 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 113.043 0.757 . . . . 1.8200000000000001 113.043 -179.523 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -114.9 -85.67 1.31 Allowed Glycine 0 CA--C 1.528 0.891 0 CA-C-N 119.148 0.885 . . . . 2.04 113.911 -165.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -147.81 156.03 42.29 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 113.558 0.948 . . . . 2.9399999999999999 113.558 -146.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -70.03 82.3 0.33 Allowed Glycine 0 N--CA 1.444 -0.786 0 CA-C-N 114.629 -1.169 . . . . 1.5 111.112 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -82.72 144.42 30.22 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 125.229 1.412 . . . . 1.1200000000000001 109.655 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.6 t -142.92 139.97 30.96 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 106.007 -1.849 . . . . 2.46 106.007 165.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.6 m -83.67 145.63 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 N-CA-C 109.586 -0.524 . . . . 2.54 109.586 -176.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 14.9 mm -141.27 147.73 22.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 C-N-CA 126.064 1.746 . . . . 2.21 107.309 -177.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -173.52 -176.43 1.29 Allowed 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 126.351 1.86 . . . . 3.7999999999999998 106.355 168.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -156.43 157.24 35.2 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 107.845 -1.168 . . . . 5.7400000000000002 107.845 176.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 15.8 tt -75.26 162.88 4.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 123.43 0.692 . . . . 10.470000000000001 109.243 173.2 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -139.16 153.03 47.88 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 105.405 -2.072 . . . . 12.949999999999999 105.405 174.284 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 160.5 -170.07 36.4 Favored Glycine 0 CA--C 1.527 0.84 0 CA-C-N 118.92 0.782 . . . . 12.76 111.327 -176.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.016 0 N-CA-C 104.158 -2.534 . . . . 19.960000000000001 104.158 178.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 41.6 t30 . . . . . 0 N--CA 1.477 0.906 0 N-CA-C 107.858 -1.164 . . . . 6.1900000000000004 107.858 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.0 m -152.68 101.43 2.63 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 108.142 -1.058 . . . . 2.52 108.142 170.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.1 m -109.18 144.02 37.82 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 126.247 1.819 . . . . 2.0099999999999998 108.116 -176.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 35.5 tttt -95.54 164.02 12.97 Favored 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 123.37 0.668 . . . . 4.71 110.611 -178.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 7.8 p -153.99 174.31 14.83 Favored 'General case' 0 C--O 1.232 0.16 0 N-CA-C 109.141 -0.689 . . . . 2.02 109.141 156.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -122.54 142.11 50.95 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 125.348 1.459 . . . . 2.6699999999999999 108.296 -175.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.406 ' HB ' ' HB3' ' A' ' 43' ' ' ALA . 10.9 mt -146.0 132.61 14.25 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 N-CA-C 106.812 -1.551 . . . . 1.5600000000000001 106.812 -167.328 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 12.5 tp60 -84.2 125.35 32.11 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 105.508 -2.034 . . . . 3.5899999999999999 105.508 165.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 6.7 p -110.37 101.98 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 C-N-CA 124.341 1.057 . . . . 2.3100000000000001 108.336 177.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 21.0 m -71.69 80.79 0.85 Allowed 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 108.974 -0.751 . . . . 2.5299999999999998 108.974 176.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -171.19 -52.59 0.04 OUTLIER Glycine 0 CA--C 1.53 1.012 0 C-N-CA 129.02 3.2 . . . . 2.29 106.977 172.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 63.8 mtt 62.92 -66.38 0.09 Allowed 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 127.489 2.315 . . . . 3.9399999999999999 112.319 175.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 14.6 t -151.72 53.38 0.83 Allowed 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.036 1.334 . . . . 4.96 107.751 173.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.0 p -43.7 -50.29 7.6 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.586 1.154 . . . . 3.1000000000000001 109.784 173.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -172.52 93.99 0.13 Allowed 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 126.748 2.019 . . . . 3.1800000000000002 106.87 156.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.7 m 59.11 42.48 18.83 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 121.562 0.696 . . . . 2.6299999999999999 110.548 -173.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 6.9 t -43.34 -41.99 4.33 Favored 'General case' 0 N--CA 1.461 0.109 0 C-N-CA 126.766 2.026 . . . . 4.0300000000000002 108.192 166.12 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 4.9 m -66.99 -53.32 35.1 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.972 0 C-N-CA 125.532 1.533 . . . . 2.1899999999999999 110.935 -173.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -50.78 -47.85 59.55 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.136 0.975 . . . . 0.90000000000000002 109.493 171.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -55.43 -53.29 58.05 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 108.927 -0.768 . . . . 2.1099999999999999 108.927 177.504 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.454 HG21 HG23 ' A' ' 36' ' ' VAL . 1.1 mp -53.69 -54.94 15.98 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 C-N-CA 124.469 1.108 . . . . 2.0499999999999998 110.386 178.396 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -48.91 -60.3 2.87 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 119.429 1.013 . . . . 2.96 109.541 -178.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 8.8 mpt_? -60.6 -38.65 85.4 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 115.131 -0.94 . . . . 6.4699999999999998 110.71 -176.059 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -62.24 -60.13 4.03 Favored 'General case' 0 C--O 1.227 -0.088 0 C-N-CA 122.686 0.394 . . . . 3.2200000000000002 110.208 177.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.412 ' CD2' HD21 ' A' ' 35' ' ' LEU . 0.0 OUTLIER -75.87 -64.6 1.05 Allowed 'General case' 0 N--CA 1.437 -1.11 0 CA-C-N 116.732 -0.213 . . . . 2.21 110.552 -159.793 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.53 -15.25 0.63 Allowed 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 115.665 1.728 . . . . 6.3300000000000001 115.665 -162.435 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -31.25 -59.02 0.24 Allowed 'General case' 0 N--CA 1.439 -0.99 0 C-N-CA 126.361 1.864 . . . . 6.9800000000000004 109.805 -175.077 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . 0.313 0.0 OUTLIER -167.15 -108.52 0.01 OUTLIER 'General case' 0 N--CA 1.447 -0.616 0 O-C-N 125.043 1.464 . . . . 7.3399999999999999 108.027 -171.113 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 44.48 31.16 0.57 Allowed 'General case' 0 C--N 1.314 -0.966 0 C-N-CA 127.256 2.222 . . . . 4.8600000000000003 114.628 156.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 60.21 31.09 72.27 Favored Glycine 0 CA--C 1.53 1.008 0 CA-C-O 118.483 -1.176 . . . . 0.95999999999999996 113.537 -178.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 1.4 mp -78.43 139.31 18.69 Favored 'Isoleucine or valine' 0 C--N 1.34 0.167 0 CA-C-N 119.196 1.498 . . . . 2.5299999999999998 107.529 169.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -148.22 36.45 0.83 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 120.382 -0.527 . . . . 6.5899999999999999 112.275 158.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 34.0 t -169.36 143.64 2.91 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 130.117 3.367 . . . . 1.99 104.32 139.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.7 pp -82.09 147.16 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 CA-C-N 119.683 1.129 . . . . 1.95 109.06 172.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.55 ' HB2' ' HB1' ' A' ' 43' ' ' ALA . 0.4 OUTLIER -79.41 80.39 5.78 Favored 'General case' 0 N--CA 1.44 -0.948 0 C-N-CA 125.77 1.628 . . . . 4.6200000000000001 111.384 -179.765 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.454 HG23 HG21 ' A' ' 21' ' ' ILE . 85.6 t -130.64 138.9 52.57 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.121 0 CA-C-O 121.499 0.666 . . . . 1.5900000000000001 109.252 162.523 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -153.73 57.02 0.74 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 113.666 -1.607 . . . . 0.83999999999999997 107.364 165.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -73.01 -15.58 61.52 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 114.913 -1.04 . . . . 3.0899999999999999 111.623 -172.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 93.7 mtp -49.43 -35.94 20.79 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 121.485 -0.76 . . . . 3.5899999999999999 110.885 162.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -95.39 -46.82 6.55 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.391 0.676 . . . . 1.9399999999999999 110.483 170.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 111.25 63.56 0.49 Allowed Glycine 0 C--N 1.339 0.722 0 N-CA-C 107.809 -2.117 . . . . 0.97999999999999998 107.809 -171.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 4.4 pttt -160.82 175.4 12.61 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-N 118.279 1.04 . . . . 4.3700000000000001 108.541 -178.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.55 ' HB1' ' HB2' ' A' ' 35' ' ' LEU . . . -123.36 125.67 45.43 Favored 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 128.038 2.535 . . . . 1.1399999999999999 107.456 -176.216 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -140.22 92.75 2.56 Favored 'General case' 0 N--CA 1.457 -0.104 0 CA-C-O 122.01 0.909 . . . . 3.21 113.063 175.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.7 p -79.16 153.38 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.21 0 C-N-CA 125.405 1.482 . . . . 1.5 109.219 -172.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 65.0 ttt180 -122.61 141.05 52.13 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 106.504 -1.665 . . . . 5.3799999999999999 106.504 159.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 32.5 p90 -152.04 159.09 43.8 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 122.918 0.487 . . . . 2.5099999999999998 110.18 -165.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -98.19 98.74 6.0 Favored Pre-proline 0 CA--C 1.539 0.525 0 C-N-CA 123.676 0.791 . . . . 2.9399999999999999 110.329 170.245 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -75.22 75.99 3.62 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 122.765 2.31 . . . . 1.95 111.203 -176.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -159.51 -43.71 0.05 Allowed 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 125.235 1.414 . . . . 1.6000000000000001 108.915 169.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 33.9 t -52.13 -56.53 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.737 0 C-N-CA 124.452 1.101 . . . . 1.45 109.1 169.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.451 HG23 ' H ' ' A' ' 53' ' ' GLN . 6.4 tt -124.69 -128.5 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.44 -0.957 0 CA-C-N 114.603 -1.181 . . . . 2.6699999999999999 108.817 -167.417 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.451 ' H ' HG23 ' A' ' 52' ' ' ILE . 4.9 tp60 -175.18 112.65 0.28 Allowed Pre-proline 0 CA--C 1.539 0.542 0 N-CA-C 108.686 -0.857 . . . . 2.3399999999999999 108.686 -159.309 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -47.59 -44.51 25.63 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 124.728 3.619 . . . . 1.5600000000000001 116.767 176.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -54.33 -56.83 2.19 Favored 'Trans proline' 0 N--CA 1.445 -1.373 0 CA-C-N 121.212 1.469 . . . . 1.24 109.687 167.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 87.1 mtp -53.56 -48.46 69.11 Favored 'General case' 0 C--N 1.342 0.247 0 CA-C-O 119.065 -0.493 . . . . 2.5800000000000001 112.317 -175.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 3.6 pt -60.38 -41.14 86.26 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 CA-C-N 119.155 0.889 . . . . 2.9900000000000002 111.829 -177.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.96 -60.16 4.23 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 119.704 1.138 . . . . 1.6299999999999999 111.038 169.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -46.12 -52.69 11.71 Favored 'General case' 0 N--CA 1.442 -0.867 0 C-N-CA 126.497 1.919 . . . . 3.4500000000000002 112.341 -174.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -44.14 -39.81 4.57 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.647 0.779 . . . . 3.96 112.972 -179.484 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 43.0 mt -61.32 -36.96 76.37 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 C-N-CA 122.81 0.444 . . . . 1.46 110.005 -178.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 60.2 mtt180 -62.52 -62.04 2.02 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 124.237 1.015 . . . . 4.3300000000000001 108.982 178.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -39.4 -52.24 2.08 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 124.987 1.315 . . . . 4.9500000000000002 112.57 173.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.6 pp -83.35 -18.19 39.74 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 113.969 1.1 . . . . 2.3500000000000001 113.969 -176.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -171.47 -66.15 0.04 OUTLIER Glycine 0 CA--C 1.533 1.199 0 CA-C-N 120.018 1.281 . . . . 1.6599999999999999 115.757 -178.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -130.22 146.82 51.88 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 122.058 0.932 . . . . 3.23 113.5 -147.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -75.42 81.8 0.94 Allowed Glycine 0 N--CA 1.449 -0.442 0 CA-C-N 115.516 -0.765 . . . . 1.47 112.276 -167.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -83.22 90.7 7.14 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 126.335 1.854 . . . . 1.3600000000000001 110.507 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 20.0 p -99.55 126.83 45.59 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 125.161 1.384 . . . . 2.3399999999999999 108.439 177.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 90.3 t -82.64 130.23 36.1 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.712 0 C-N-CA 124.523 1.129 . . . . 1.79 109.494 -173.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 24.5 mt -142.06 63.37 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 C-N-CA 125.503 1.521 . . . . 2.29 108.285 -175.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -65.2 154.63 37.51 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 109.171 -0.677 . . . . 4.9400000000000004 109.171 168.294 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 4.1 p30 165.46 126.23 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 128.35 2.66 . . . . 5.0999999999999996 109.249 168.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -163.21 138.97 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 N-CA-C 104.46 -2.422 . . . . 8.4399999999999995 104.46 175.005 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 26.67 64.7 0.08 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 126.671 1.988 . . . . 11.42 114.879 -175.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -151.77 47.92 0.56 Allowed Glycine 0 CA--C 1.522 0.528 0 N-CA-C 108.071 -2.012 . . . . 9.5500000000000007 108.071 177.095 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 38.4 ttt85 . . . . . 0 C--O 1.255 1.37 0 CA-C-O 116.733 -1.603 . . . . 14.51 107.562 -142.101 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 . . . . . 0 N--CA 1.476 0.834 0 N-CA-C 109.136 -0.69 . . . . 7.46 109.136 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.6 p -165.08 59.42 0.12 Allowed 'General case' 0 C--O 1.235 0.317 0 CA-C-O 122.551 1.167 . . . . 2.6299999999999999 108.723 -179.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.8 p -97.31 172.4 7.81 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 127.795 2.438 . . . . 2.0800000000000001 109.733 -169.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.98 153.6 50.17 Favored 'General case' 0 C--N 1.339 0.129 0 C-N-CA 122.848 0.459 . . . . 3.7200000000000002 111.12 -179.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 41.1 t -146.8 155.75 42.6 Favored 'General case' 0 C--O 1.231 0.107 0 C-N-CA 124.95 1.3 . . . . 1.6100000000000001 109.13 -175.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -97.39 136.88 37.21 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 126.081 1.752 . . . . 2.7999999999999998 108.145 174.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.1 mm -139.94 123.53 18.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 107.078 -1.453 . . . . 2.1099999999999999 107.078 -177.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 5.9 mm-40 -77.93 159.37 28.89 Favored 'General case' 0 N--CA 1.455 -0.194 0 O-C-N 120.745 -1.222 . . . . 3.7000000000000002 110.228 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.4 p -137.91 139.75 42.06 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 O-C-N 123.469 0.481 . . . . 2.9399999999999999 111.925 -172.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.3 m -76.77 63.89 2.25 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.436 1.095 . . . . 3.7400000000000002 113.306 -176.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -161.03 -60.44 0.02 OUTLIER Glycine 0 C--O 1.227 -0.293 0 N-CA-C 105.98 -2.848 . . . . 3.5099999999999998 105.98 157.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 9.4 ttm 54.39 20.79 2.89 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.474 1.11 . . . . 4.7800000000000002 111.421 -176.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 61.4 m -160.99 -38.67 0.05 OUTLIER 'General case' 0 C--N 1.335 -0.062 0 C-N-CA 124.61 1.164 . . . . 5.6200000000000001 109.856 -156.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 28.4 p -59.04 132.85 55.26 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 108.452 -0.944 . . . . 3.3399999999999999 108.452 -179.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -53.53 -31.35 45.95 Favored 'General case' 0 CA--C 1.535 0.374 0 O-C-N 121.314 -0.866 . . . . 4.0099999999999998 110.491 179.492 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.4 m -53.17 -39.74 63.84 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 126.109 1.764 . . . . 3.4399999999999999 114.443 172.212 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -35.21 -57.74 0.57 Allowed 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 125.713 1.605 . . . . 4.8099999999999996 111.601 -146.479 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.477 HG23 HG11 ' A' ' 36' ' ' VAL . 0.4 OUTLIER -62.87 -50.19 80.63 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.874 0 CA-C-N 114.794 -1.094 . . . . 3.3100000000000001 112.525 -177.121 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -54.63 -44.52 73.25 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.382 1.073 . . . . 1.26 110.484 172.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -54.62 -59.94 4.02 Favored 'General case' 0 C--O 1.226 -0.167 0 N-CA-C 108.635 -0.876 . . . . 3.6699999999999999 108.635 175.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.75 HG22 HD11 ' A' ' 34' ' ' ILE . 2.3 mt -61.09 -42.27 92.53 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.14 0 O-C-N 121.406 -0.809 . . . . 2.7400000000000002 110.952 -174.447 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 69.1 mt-10 -60.85 -25.49 66.69 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 125.557 1.543 . . . . 3.6099999999999999 112.938 174.018 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 10.5 mmm180 -73.1 -42.31 63.08 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 119.344 0.975 . . . . 7.1299999999999999 111.954 158.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.678 ' ND2' HD13 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -70.93 -49.71 42.62 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 124.427 1.091 . . . . 4.4299999999999997 113.692 -160.266 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.678 HD13 ' ND2' ' A' ' 24' ' ' ASN . 3.9 mp -78.11 -60.05 2.53 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 118.977 0.808 . . . . 2.96 112.872 -176.552 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 9.5 ptm180 -39.38 -19.87 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 129.933 3.293 . . . . 6.04 118.481 -158.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 19.9 mtm105 -67.34 -51.97 45.84 Favored 'General case' 0 N--CA 1.439 -0.98 0 C-N-CA 127.337 2.255 . . . . 8.1799999999999997 109.487 -161.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 168.59 152.03 0.03 OUTLIER 'General case' 0 CA--C 1.512 -0.515 0 N-CA-C 105.519 -2.03 . . . . 7.2199999999999998 105.519 -152.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 99.91 44.84 0.0 OUTLIER 'General case' 0 C--N 1.34 0.157 0 C-N-CA 128.132 2.573 . . . . 7.1500000000000004 112.088 -168.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 56.35 42.57 89.21 Favored Glycine 0 CA--C 1.528 0.894 0 CA-C-N 116.275 -0.42 . . . . 1.74 112.527 171.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -77.26 135.29 26.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 N-CA-C 107.104 -1.443 . . . . 2.7599999999999998 107.104 174.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 54.0 m-85 -141.62 37.55 1.66 Allowed 'General case' 0 CA--C 1.54 0.564 0 CA-C-O 122.061 0.934 . . . . 3.6299999999999999 113.397 164.324 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 75.0 m -166.39 154.41 10.24 Favored 'General case' 0 C--N 1.321 -0.663 1 C-N-CA 131.989 4.116 . . . . 2.79 103.964 122.32 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.828 HD13 ' N ' ' A' ' 35' ' ' LEU . 0.1 OUTLIER -98.3 136.6 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 N-CA-C 104.931 -2.248 . . . . 3.1600000000000001 104.931 158.782 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.828 ' N ' HD13 ' A' ' 34' ' ' ILE . 0.1 OUTLIER -156.21 175.81 13.5 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 124.403 1.081 . . . . 6.8399999999999999 110.375 -179.484 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.647 HG22 HG21 ' A' ' 21' ' ' ILE . 24.0 t -158.8 117.43 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.421 -1.875 0 C-N-CA 127.22 2.208 . . . . 1.71 106.545 -177.254 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -77.98 62.59 2.8 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 108.464 -0.939 . . . . 1.4199999999999999 108.464 168.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.492 HD23 ' HA ' ' A' ' 38' ' ' LEU . 0.3 OUTLIER -64.59 -32.96 74.84 Favored 'General case' 0 C--N 1.342 0.266 0 O-C-N 121.687 -0.633 . . . . 2.6499999999999999 111.705 -168.069 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 51.5 ttp -55.09 -35.67 64.84 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.299 0.64 . . . . 5.6600000000000001 111.199 173.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -86.99 -20.85 26.66 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.608 0.763 . . . . 1.76 110.913 176.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 84.35 60.01 1.97 Allowed Glycine 0 C--N 1.335 0.518 0 N-CA-C 107.768 -2.133 . . . . 0.85999999999999999 107.768 169.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.424 ' HZ3' ' HB3' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -163.96 167.53 20.43 Favored 'General case' 0 N--CA 1.437 -1.082 0 N-CA-C 106.363 -1.717 . . . . 4.9299999999999997 106.363 173.122 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -77.83 145.29 36.41 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 105.975 -1.861 . . . . 1.6499999999999999 105.975 167.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.609 ' CB ' HD13 ' A' ' 35' ' ' LEU . 19.3 mt-10 -94.56 167.48 11.45 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 105.774 -1.936 . . . . 2.9100000000000001 105.774 151.01 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 3.1 p -134.81 141.7 42.41 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.459 0 N-CA-C 104.606 -2.368 . . . . 1.5800000000000001 104.606 157.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 70.8 ttt180 -113.5 129.25 56.59 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 106.597 -1.631 . . . . 5.0300000000000002 106.597 158.089 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 7.2 p90 -157.3 172.22 19.0 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 122.968 0.507 . . . . 1.9099999999999999 111.783 -162.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 65.0 t-20 -109.21 88.56 5.96 Favored Pre-proline 0 CA--C 1.537 0.469 0 CA-C-N 114.677 -1.147 . . . . 2.4100000000000001 111.08 -177.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -67.67 79.55 0.49 Allowed 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 123.209 2.606 . . . . 2.0299999999999998 110.129 173.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -169.78 -47.91 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 127.712 2.405 . . . . 1.3400000000000001 106.726 172.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 57.5 t -69.87 -49.69 55.04 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 C-N-CA 124.261 1.025 . . . . 1.1000000000000001 109.405 173.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.9 tp -98.06 -68.89 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 CA-C-O 118.654 -0.689 . . . . 2.5600000000000001 111.832 -166.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 56.9 tp60 109.24 124.67 0.0 OUTLIER Pre-proline 0 CA--C 1.549 0.909 0 C-N-CA 128.946 2.898 . . . . 3.9300000000000002 109.894 176.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_exo -47.43 -59.51 1.22 Allowed 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 124.113 3.208 . . . . 1.3 117.24 -172.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_endo -49.06 -43.57 35.76 Favored 'Trans proline' 0 N--CA 1.45 -1.052 0 C-N-CA 121.62 1.546 . . . . 1.6899999999999999 110.645 172.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 58.9 mtp -68.21 -34.32 76.04 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-O 118.602 -0.713 . . . . 2.4500000000000002 111.302 -177.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 3.2 tt -62.2 -39.17 83.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-N 120.707 1.594 . . . . 2.1800000000000002 110.977 177.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -56.55 -46.98 80.41 Favored 'General case' 0 CA--C 1.529 0.159 0 O-C-N 122.176 -0.328 . . . . 1.1799999999999999 111.219 173.121 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -58.91 -52.41 65.86 Favored 'General case' 0 N--CA 1.435 -1.201 0 C-N-CA 123.197 0.599 . . . . 2.7400000000000002 111.99 176.355 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -58.29 -31.39 67.44 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 118.343 0.519 . . . . 4.6900000000000004 111.343 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 69.1 mt -62.95 -57.29 12.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-N 119.219 0.918 . . . . 2.02 109.95 166.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 87.2 mtt180 -48.64 -42.09 33.21 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.633 0.773 . . . . 4.1299999999999999 112.62 -178.066 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 91.3 mt-10 -50.9 -29.84 13.07 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 124.621 1.168 . . . . 3.7999999999999998 113.272 177.166 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 51.1 mt -82.04 -16.28 50.71 Favored 'General case' 0 N--CA 1.454 -0.26 0 O-C-N 121.711 -0.618 . . . . 1.9399999999999999 110.316 -178.162 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 134.66 -44.91 1.15 Allowed Glycine 0 C--N 1.34 0.756 0 C-N-CA 124.731 1.158 . . . . 2.4300000000000002 110.546 169.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 5.0 m-30 -78.37 129.04 34.51 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-O 121.278 0.561 . . . . 2.8900000000000001 109.612 -166.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -73.15 108.18 2.43 Favored Glycine 0 N--CA 1.442 -0.934 0 N-CA-C 110.878 -0.889 . . . . 1.3799999999999999 110.878 -171.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -82.91 124.33 30.25 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.073 0.949 . . . . 1.5800000000000001 109.72 179.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -118.34 126.35 51.94 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 108.36 -0.978 . . . . 2.75 108.36 164.113 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 65.3 t -83.36 139.11 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 C-N-CA 125.42 1.488 . . . . 1.8500000000000001 109.299 -169.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 12.1 mt -134.44 59.76 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 CA-C-O 122.439 1.114 . . . . 2.3100000000000001 109.001 -178.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 81.8 mt-10 -59.93 148.06 36.48 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 107.969 -1.123 . . . . 4.6699999999999999 107.969 159.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -154.14 -69.43 0.14 Allowed 'General case' 0 CA--C 1.531 0.236 0 O-C-N 122.173 -0.329 . . . . 5.7000000000000002 111.675 -167.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 19.6 tt -59.8 116.18 1.53 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-N 118.861 0.755 . . . . 8.8900000000000006 110.186 178.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -61.47 -52.52 64.18 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.946 0.899 . . . . 11.27 110.366 -178.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 68.57 -125.62 20.53 Favored Glycine 0 CA--C 1.528 0.893 0 N-CA-C 109.764 -1.334 . . . . 14.01 109.764 -175.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 56.1 ttt85 . . . . . 0 C--O 1.251 1.149 0 N-CA-C 105.178 -2.156 . . . . 22.550000000000001 105.178 175.439 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 . . . . . 0 N--CA 1.477 0.923 0 N-CA-C 107.383 -1.34 . . . . 7.3399999999999999 107.383 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.4 t -67.92 141.16 56.44 Favored 'General case' 0 C--O 1.231 0.097 0 N-CA-C 108.147 -1.057 . . . . 3.3399999999999999 108.147 169.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.7 m -90.57 177.44 6.36 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 107.688 -1.227 . . . . 2.1099999999999999 107.688 165.34 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.14 152.28 31.1 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 118.909 -0.567 . . . . 6.1699999999999999 110.636 165.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 49.1 t -137.82 154.65 49.51 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 124.63 1.172 . . . . 1.6200000000000001 108.973 171.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 2.5 m-30 -100.83 150.55 22.69 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 106.916 -1.513 . . . . 2.1899999999999999 106.916 176.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.477 HD12 HD13 ' A' ' 35' ' ' LEU . 13.5 mt -144.27 126.25 10.35 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 N-CA-C 104.773 -2.306 . . . . 1.8300000000000001 104.773 -175.451 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 3.6 tp60 -88.23 134.36 33.81 Favored 'General case' 0 N--CA 1.442 -0.866 0 N-CA-C 106.045 -1.835 . . . . 2.73 106.045 173.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 16.1 m -128.39 175.81 9.18 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 C-N-CA 125.343 1.457 . . . . 2.3599999999999999 109.457 -176.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 13.7 t -140.0 179.19 6.76 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 109.339 -0.615 . . . . 3.9199999999999999 109.339 172.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 84.51 -54.81 4.96 Favored Glycine 0 C--N 1.332 0.351 0 N-CA-C 105.566 -3.014 . . . . 2.8900000000000001 105.566 -163.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 32.4 ttm 82.48 -58.67 0.19 Allowed 'General case' 0 N--CA 1.441 -0.887 0 C-N-CA 126.964 2.106 . . . . 3.29 108.955 158.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.8 t -157.96 98.85 1.64 Allowed 'General case' 0 N--CA 1.442 -0.875 0 N-CA-C 106.441 -1.689 . . . . 5.9500000000000002 106.441 153.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.4 m -72.46 55.18 0.34 Allowed 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.184 0.994 . . . . 3.1699999999999999 109.01 175.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 50.93 71.04 0.46 Allowed 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.668 1.187 . . . . 2.98 111.338 -160.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.4 m 78.24 21.48 0.84 Allowed 'General case' 0 C--O 1.226 -0.177 0 C-N-CA 124.89 1.276 . . . . 3.6699999999999999 113.607 169.088 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -51.72 -32.42 30.18 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 124.62 1.168 . . . . 3.5499999999999998 109.558 166.068 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 19.6 m -53.85 -40.46 44.29 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 CA-C-N 115.28 -0.873 . . . . 2.5499999999999998 111.622 175.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.63 -46.15 70.4 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.157 0.983 . . . . 0.90000000000000002 110.15 175.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -58.43 -52.95 63.45 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 108.872 -0.788 . . . . 2.1099999999999999 108.872 171.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.477 ' HA ' HD22 ' A' ' 24' ' ' ASN . 58.2 mt -56.65 -56.32 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-O 118.473 -0.775 . . . . 1.99 109.102 -173.32 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -39.61 -61.21 0.85 Allowed 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 126.132 1.773 . . . . 3.1299999999999999 110.893 171.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.43 -39.99 61.65 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 124.068 0.947 . . . . 6.9699999999999998 111.176 178.004 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.748 ' ND2' HD13 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -71.04 -53.65 13.98 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 124.293 1.037 . . . . 3.2599999999999998 108.831 -175.492 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.748 HD13 ' ND2' ' A' ' 24' ' ' ASN . 0.0 OUTLIER -64.1 -27.34 69.03 Favored 'General case' 0 N--CA 1.462 0.17 0 O-C-N 121.07 -1.019 . . . . 2.4100000000000001 112.247 -177.103 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 58.3 mtp180 -67.95 -14.48 63.0 Favored 'General case' 0 N--CA 1.452 -0.368 0 O-C-N 121.761 -0.587 . . . . 5.8099999999999996 111.7 178.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -57.92 -38.79 76.51 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-N 119.158 0.89 . . . . 7.8300000000000001 112.69 161.624 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -93.05 68.3 4.35 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-O 121.977 0.894 . . . . 8.5299999999999994 109.255 -149.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -27.1 109.71 0.04 OUTLIER 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 127.116 2.166 . . . . 5.5800000000000001 110.057 163.462 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 135.51 -48.72 0.92 Allowed Glycine 0 CA--C 1.528 0.867 0 N-CA-C 108.246 -1.942 . . . . 1.3300000000000001 108.246 -151.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -78.64 133.42 30.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 C-N-CA 124.521 1.129 . . . . 2.9399999999999999 110.298 -173.085 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 24.7 t80 -141.32 35.87 1.69 Allowed 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 122.065 0.936 . . . . 6.8899999999999997 110.632 172.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 43.2 t -167.5 147.14 5.12 Favored 'General case' 0 N--CA 1.449 -0.478 1 C-N-CA 132.854 4.461 . . . . 2.3300000000000001 101.54 140.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.8 pp -78.71 156.58 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 C-N-CA 118.561 -1.256 . . . . 2.0499999999999998 108.536 165.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.754 HD22 ' CG1' ' A' ' 45' ' ' VAL . 0.6 OUTLIER -96.18 72.15 2.87 Favored 'General case' 0 N--CA 1.427 -1.591 0 C-N-CA 126.767 2.027 . . . . 4.7000000000000002 109.771 -173.978 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 24.7 t -135.13 141.04 43.92 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 O-C-N 121.017 -1.052 . . . . 1.4199999999999999 108.518 163.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -156.9 59.91 0.53 Allowed 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 125.866 1.666 . . . . 0.87 106.632 169.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -46.11 -36.95 6.28 Favored 'General case' 0 CA--C 1.512 -0.515 0 C-N-CA 125.603 1.561 . . . . 3.3599999999999999 113.12 -178.637 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.83 -41.12 96.0 Favored 'General case' 0 N--CA 1.439 -0.987 0 N-CA-C 108.511 -0.922 . . . . 4.7300000000000004 108.511 -164.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -77.05 -42.49 38.21 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.494 0.717 . . . . 1.4299999999999999 109.903 167.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 102.37 64.93 0.74 Allowed Glycine 0 C--N 1.336 0.572 0 N-CA-C 109.072 -1.611 . . . . 1.46 109.072 179.019 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -160.07 176.14 12.16 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 106.982 -1.488 . . . . 5.7400000000000002 106.982 -179.472 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.69 ' HB1' HD12 ' A' ' 35' ' ' LEU . . . -131.94 137.39 47.93 Favored 'General case' 0 N--CA 1.435 -1.188 0 C-N-CA 126.382 1.873 . . . . 1.0700000000000001 107.907 174.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.404 ' H ' ' HA ' ' A' ' 35' ' ' LEU . 5.6 pt-20 -128.8 109.0 10.9 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 114.456 1.28 . . . . 2.6899999999999999 114.456 177.473 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.754 ' CG1' HD22 ' A' ' 35' ' ' LEU . 3.7 m -83.9 103.33 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 N-CA-C 108.522 -0.918 . . . . 3.2799999999999998 108.522 176.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 7.8 ttm105 -84.43 114.34 21.83 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 103.837 -2.653 . . . . 6.8700000000000001 103.837 160.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -151.77 173.02 15.24 Favored 'General case' 0 C--N 1.332 -0.16 0 O-C-N 121.53 -0.731 . . . . 2.2599999999999998 112.728 -163.057 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -126.05 105.1 25.74 Favored Pre-proline 0 N--CA 1.447 -0.598 0 C-N-CA 123.666 0.786 . . . . 3.29 110.603 172.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -79.74 63.53 8.75 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 122.804 2.336 . . . . 1.72 109.17 -178.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -130.68 -49.6 1.05 Allowed 'General case' 0 C--O 1.227 -0.119 0 C-N-CA 124.187 0.995 . . . . 2.3999999999999999 109.005 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 43.0 t -63.66 -57.98 9.42 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 N-CA-C 109.609 -0.515 . . . . 2.04 109.609 174.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.627 HG23 ' H ' ' A' ' 53' ' ' GLN . 19.9 tt -115.01 -118.04 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.694 0 C-N-CA 124.147 0.979 . . . . 2.8700000000000001 108.469 -167.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.627 ' H ' HG23 ' A' ' 52' ' ' ILE . 5.7 tp60 179.99 111.73 0.19 Allowed Pre-proline 0 CA--C 1.541 0.602 0 N-CA-C 109.296 -0.631 . . . . 2.4300000000000002 109.296 -155.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo -46.61 -49.72 11.61 Favored 'Trans proline' 0 CA--C 1.533 0.457 0 C-N-CA 124.42 3.413 . . . . 1.8200000000000001 116.43 176.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -51.25 -54.21 5.79 Favored 'Trans proline' 0 N--CA 1.444 -1.439 0 C-N-CA 121.251 1.301 . . . . 1.29 109.868 170.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 65.6 mtt -52.45 -48.64 65.71 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 118.339 0.518 . . . . 1.6799999999999999 111.558 -179.305 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 81.5 mt -51.74 -54.09 14.31 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.862 0 CA-C-N 117.876 0.307 . . . . 2.7599999999999998 110.654 175.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.85 -33.15 74.66 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 120.76 -1.212 . . . . 1.3200000000000001 113.761 176.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -70.58 -52.85 18.74 Favored 'General case' 0 N--CA 1.44 -0.935 0 O-C-N 120.36 -1.462 . . . . 3.8300000000000001 110.676 -177.156 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -46.1 -43.74 15.03 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 122.548 1.165 . . . . 4.75 111.855 -178.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.61 ' CD1' HD11 ' A' ' 35' ' ' LEU . 96.8 mt -55.61 -44.5 76.88 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 C-N-CA 124.078 0.951 . . . . 1.3500000000000001 111.531 176.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 70.6 mtm180 -70.84 -42.04 70.7 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 124.509 1.123 . . . . 4.3499999999999996 111.428 176.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -54.52 -38.92 67.11 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 123.6 0.76 . . . . 2.8999999999999999 110.328 175.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 83.8 mt -79.36 -37.49 37.32 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 118.843 -0.598 . . . . 2.6099999999999999 110.771 174.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 165.76 -34.09 0.24 Allowed Glycine 0 CA--C 1.529 0.937 0 N-CA-C 115.641 1.016 . . . . 2.2999999999999998 115.641 165.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -77.85 128.74 34.45 Favored 'General case' 0 C--N 1.334 -0.078 0 CA-C-N 118.504 1.152 . . . . 2.9500000000000002 111.369 -159.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -70.21 79.08 0.41 Allowed Glycine 0 CA--C 1.523 0.541 0 C-N-CA 124.307 0.956 . . . . 1.6899999999999999 113.019 -175.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -83.53 126.66 33.03 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 125.561 1.545 . . . . 0.85999999999999999 111.044 -178.069 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -131.7 136.0 47.31 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 107.002 -1.481 . . . . 2.3100000000000001 107.002 174.175 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 25.6 m -82.05 153.47 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 CA-C-N 118.753 0.706 . . . . 3.21 110.757 -171.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 50.3 mt -136.07 120.06 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 C-N-CA 125.952 1.701 . . . . 2.1699999999999999 106.553 173.272 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -150.33 43.81 0.86 Allowed 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 107.936 -1.135 . . . . 5.8399999999999999 107.936 -176.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 13.2 p-10 -177.59 165.87 2.15 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 107.002 -1.481 . . . . 6.8600000000000003 107.002 -161.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 36.0 pt -142.47 163.38 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 N-CA-C 106.431 -1.692 . . . . 7.4299999999999997 106.431 170.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -162.75 -179.14 6.62 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 106.781 -1.562 . . . . 12.26 106.781 178.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -158.75 158.97 29.86 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 108.193 -1.963 . . . . 12.74 108.193 175.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.254 1.326 0 N-CA-C 105.1 -2.185 . . . . 17.600000000000001 105.1 179.157 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 . . . . . 0 N--CA 1.479 0.988 0 N-CA-C 107.897 -1.149 . . . . 5.1799999999999997 107.897 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.2 p -63.0 160.48 14.9 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 118.453 0.57 . . . . 2.79 111.15 176.187 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 18.7 m -149.62 174.75 12.21 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 107.595 -1.261 . . . . 1.8500000000000001 107.595 173.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -142.71 142.78 32.05 Favored 'General case' 0 CA--C 1.528 0.116 0 N-CA-C 108.209 -1.034 . . . . 3.4399999999999999 108.209 177.431 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.4 ' HB3' ' CG1' ' A' ' 45' ' ' VAL . 10.2 t -140.48 155.66 46.6 Favored 'General case' 0 N--CA 1.462 0.172 0 C-N-CA 123.15 0.58 . . . . 1.3600000000000001 110.981 -163.689 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 52.6 m-85 -110.06 83.79 1.82 Allowed 'General case' 0 C--O 1.222 -0.348 0 C-N-CA 124.997 1.319 . . . . 2.1800000000000002 108.793 -178.167 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.456 ' HB ' ' HB3' ' A' ' 43' ' ' ALA . 50.8 mt -78.6 139.06 19.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 106.51 -1.663 . . . . 1.6399999999999999 106.51 -177.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -104.6 135.9 45.15 Favored 'General case' 0 C--O 1.231 0.126 0 N-CA-C 107.203 -1.406 . . . . 5.4800000000000004 107.203 168.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 46.5 t -131.53 108.95 15.2 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 C-N-CA 124.787 1.235 . . . . 3.0 108.917 -168.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 17.9 p -60.35 99.15 0.07 Allowed 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 120.957 0.408 . . . . 3.1499999999999999 111.176 -179.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 109.85 -28.41 10.63 Favored Glycine 0 C--N 1.338 0.667 0 C-N-CA 124.975 1.274 . . . . 2.1400000000000001 111.22 178.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 4.1 mpp? 67.53 -65.55 0.23 Allowed 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 127.011 2.124 . . . . 6.0099999999999998 108.059 -166.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -154.93 -103.62 0.04 OUTLIER 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 105.01 -2.218 . . . . 8.8200000000000003 105.01 160.558 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.0 p -145.58 35.77 1.06 Allowed 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.032 0.533 . . . . 3.3700000000000001 111.364 176.382 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 81.1 132.87 0.06 Allowed 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 127.166 2.186 . . . . 3.79 111.687 179.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 13.8 m 72.99 -39.24 0.44 Allowed 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 125.623 1.569 . . . . 4.6699999999999999 114.667 173.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 34.4 m -50.33 -28.55 8.13 Favored 'General case' 0 CA--C 1.517 -0.309 0 C-N-CA 130.346 3.458 . . . . 5.1500000000000004 111.487 175.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 5.8 m -41.88 -41.18 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 112.165 0.431 . . . . 2.8700000000000001 112.165 167.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.66 -41.65 73.95 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 124.732 1.213 . . . . 1.95 111.976 178.041 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -61.18 -51.88 67.15 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 108.229 -1.026 . . . . 4.21 108.229 170.026 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 22.6 mt -64.37 -57.11 12.83 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.542 0 N-CA-C 107.617 -1.253 . . . . 3.3900000000000001 107.617 -166.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -44.72 -45.5 9.88 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 126.706 2.002 . . . . 6.1100000000000003 113.237 -179.356 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 40.3 ttp180 -59.25 -47.52 85.07 Favored 'General case' 0 N--CA 1.449 -0.482 0 O-C-N 121.338 -0.852 . . . . 4.6600000000000001 111.0 171.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -62.94 -22.08 66.53 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.708 1.603 . . . . 3.4199999999999999 110.355 177.385 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.766 HD13 HD21 ' A' ' 35' ' ' LEU . 12.1 mt -75.96 -60.49 2.3 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 124.478 1.111 . . . . 2.8900000000000001 112.575 170.312 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.421 ' HG3' HG22 ' A' ' 34' ' ' ILE . 33.7 mtm180 -65.39 -17.66 64.7 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-N 119.146 0.884 . . . . 7.5999999999999996 112.768 -178.405 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -39.76 -53.35 2.24 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-O 116.064 -1.922 . . . . 7.4699999999999998 112.528 158.096 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -168.5 173.17 7.68 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 118.256 2.687 . . . . 6.9100000000000001 118.256 -164.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 77.57 57.7 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 129.61 3.164 . . . . 5.7599999999999998 111.726 170.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 57.2 27.4 57.57 Favored Glycine 0 CA--C 1.527 0.809 0 CA-C-N 114.945 -1.025 . . . . 1.26 112.616 176.105 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 5.9 mm -88.25 136.42 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 C-N-CA 124.413 1.085 . . . . 2.4399999999999999 108.447 175.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -143.03 48.39 1.49 Allowed 'General case' 0 C--N 1.341 0.235 0 CA-C-O 123.22 1.486 . . . . 3.6699999999999999 112.703 169.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 43.5 t -160.31 -179.27 7.56 Favored 'General case' 0 C--N 1.316 -0.874 0 C-N-CA 129.576 3.151 . . . . 1.76 105.484 152.029 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.421 HG22 ' HG3' ' A' ' 26' ' ' ARG . 0.1 OUTLIER -100.06 172.74 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 107.181 -1.414 . . . . 2.7599999999999998 107.181 153.085 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.766 HD21 HD13 ' A' ' 25' ' ' LEU . 0.3 OUTLIER -137.62 63.07 1.56 Allowed 'General case' 0 N--CA 1.429 -1.486 0 C-N-CA 130.904 3.682 . . . . 4.1900000000000004 108.555 -168.686 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 10.1 t -130.27 129.67 65.19 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.857 0 CA-C-N 115.33 -0.85 . . . . 1.27 109.414 164.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -130.15 62.92 1.56 Allowed 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 105.824 -1.917 . . . . 0.87 105.824 162.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.81 -31.12 71.32 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 109.687 -0.486 . . . . 3.54 109.687 -172.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 27.7 ptm -46.79 -38.24 9.84 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.406 1.082 . . . . 3.7200000000000002 113.245 169.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -94.07 -48.27 6.3 Favored 'General case' 0 C--N 1.339 0.137 0 C-N-CA 123.618 0.767 . . . . 1.53 109.415 177.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 115.13 45.24 0.64 Allowed Glycine 0 CA--C 1.522 0.53 0 N-CA-C 108.517 -1.833 . . . . 0.94999999999999996 108.517 179.308 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 61.6 mttt -147.6 176.63 9.92 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 126.343 1.857 . . . . 4.2199999999999998 108.016 -171.205 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.456 ' HB3' ' HB ' ' A' ' 7' ' ' ILE . . . -142.12 112.48 7.09 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 124.228 1.011 . . . . 1.1899999999999999 110.26 -169.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -105.01 85.63 2.31 Favored 'General case' 0 C--N 1.349 0.551 0 N-CA-C 115.718 1.747 . . . . 3.3500000000000001 115.718 -171.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.477 ' CA ' ' HB3' ' A' ' 35' ' ' LEU . 7.9 p -81.81 150.02 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.173 0 C-N-CA 123.259 0.624 . . . . 1.52 109.592 -174.05 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 20.1 ttt85 -119.94 129.38 54.3 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 104.637 -2.357 . . . . 4.5700000000000003 104.637 157.064 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 4.6 p90 -150.32 164.28 36.18 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 124.508 1.123 . . . . 2.2200000000000002 110.862 -163.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -109.95 90.48 9.46 Favored Pre-proline 0 C--O 1.237 0.406 0 C-N-CA 124.373 1.069 . . . . 2.5499999999999998 111.471 175.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -69.57 79.34 0.89 Allowed 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 122.769 2.313 . . . . 1.5800000000000001 110.697 172.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -160.88 -48.07 0.05 OUTLIER 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 128.683 2.793 . . . . 1.0800000000000001 105.156 173.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 73.4 t -67.34 -68.04 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.855 0 C-N-CA 123.877 0.871 . . . . 1.71 108.893 162.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . 0.256 16.8 tt -88.59 -57.51 4.18 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 N-CA-C 115.903 1.816 . . . . 2.21 115.903 -153.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER 83.72 133.48 0.04 OUTLIER Pre-proline 0 CA--C 1.543 0.675 0 C-N-CA 127.414 2.286 . . . . 2.6000000000000001 110.984 -173.446 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -37.4 -49.51 1.77 Allowed 'Trans proline' 0 CA--C 1.537 0.664 1 C-N-CA 126.603 4.869 . . . . 1.5800000000000001 117.707 171.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -44.09 -61.89 0.51 Allowed 'Trans proline' 0 N--CA 1.448 -1.158 0 C-N-CA 121.847 1.698 . . . . 1.1299999999999999 110.642 167.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 43.0 mtt -60.12 -41.81 93.42 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 118.759 -0.639 . . . . 1.79 112.291 -175.14 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.422 HD12 HG11 ' A' ' 45' ' ' VAL . 1.0 OUTLIER -55.87 -40.45 62.12 Favored 'Isoleucine or valine' 0 C--N 1.348 0.519 0 CA-C-N 119.304 0.957 . . . . 3.6699999999999999 111.604 -178.106 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -70.35 -55.42 9.17 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-O 121.655 0.74 . . . . 1.3 110.681 171.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -64.37 -35.51 81.14 Favored 'General case' 0 N--CA 1.437 -1.083 0 N-CA-C 114.128 1.158 . . . . 3.1600000000000001 114.128 -162.047 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 39.0 m-85 -53.28 -36.85 61.62 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 119.596 1.089 . . . . 3.2799999999999998 110.946 170.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 17.3 mt -68.81 -34.02 62.39 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 O-C-N 121.154 -0.966 . . . . 1.49 109.638 -179.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 68.8 mtt180 -61.34 -50.77 71.58 Favored 'General case' 0 C--N 1.341 0.203 0 N-CA-C 109.282 -0.636 . . . . 4.0499999999999998 109.282 171.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -56.61 -35.7 68.57 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 123.717 0.807 . . . . 2.9900000000000002 111.905 177.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 77.1 mt -77.35 -17.88 57.89 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 118.891 -0.576 . . . . 2.21 111.277 175.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 151.56 -24.41 0.95 Allowed Glycine 0 CA--C 1.527 0.782 0 CA-C-N 118.973 0.806 . . . . 1.9199999999999999 114.261 163.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -121.36 129.76 53.24 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 118.633 1.217 . . . . 3.4500000000000002 111.806 -152.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -69.56 91.93 0.33 Allowed Glycine 0 N--CA 1.447 -0.624 0 N-CA-C 111.057 -0.817 . . . . 1.8100000000000001 111.057 -169.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -92.55 137.18 32.59 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 126.325 1.85 . . . . 0.93999999999999995 111.84 -178.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 3.3 t -134.17 144.3 48.42 Favored 'General case' 0 N--CA 1.439 -0.989 0 N-CA-C 108.161 -1.052 . . . . 3.2799999999999998 108.161 166.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 8.8 p -94.14 129.55 44.3 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 C-N-CA 126.17 1.788 . . . . 2.3799999999999999 109.657 -167.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 19.4 mm -137.59 126.85 35.09 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 C-N-CA 124.082 0.953 . . . . 3.7799999999999998 108.627 -178.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -139.25 49.68 1.83 Allowed 'General case' 0 CA--C 1.533 0.296 0 CA-C-O 121.946 0.879 . . . . 4.3700000000000001 109.556 165.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 47.9 t30 -160.85 164.39 31.36 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 106.458 -1.682 . . . . 6.2199999999999998 106.458 173.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 1.9 pp -84.31 175.54 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 N-CA-C 109.46 -0.57 . . . . 7.8600000000000003 109.46 168.221 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 57.0 tt0 -157.54 159.7 37.43 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 106.361 -1.718 . . . . 12.65 106.361 172.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -171.74 103.48 0.19 Allowed Glycine 0 CA--C 1.526 0.735 0 N-CA-C 108.919 -1.673 . . . . 12.43 108.919 179.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 2.8 ppt_? . . . . . 0 C--O 1.255 1.365 0 C-N-CA 126.741 2.016 . . . . 19.489999999999998 105.816 -179.229 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 . . . . . 0 N--CA 1.477 0.917 0 N-CA-C 107.842 -1.17 . . . . 7.2400000000000002 107.842 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.0 p -79.7 145.33 33.01 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 123.425 0.69 . . . . 2.8199999999999998 110.464 -176.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.4 t -113.76 175.51 5.43 Favored 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 124.675 1.19 . . . . 3.3199999999999998 109.136 174.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 59.9 tttt -106.7 151.18 25.45 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 124.753 1.221 . . . . 4.4500000000000002 110.638 -174.271 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 42.1 t -147.61 150.48 34.51 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 108.343 -0.984 . . . . 1.4099999999999999 108.343 167.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -96.01 133.94 39.63 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 107.171 -1.418 . . . . 2.21 107.171 178.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.602 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 19.3 mt -135.88 90.78 0.9 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.364 0 N-CA-C 105.748 -1.945 . . . . 2.1499999999999999 105.748 -170.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . 0.291 0.8 OUTLIER -81.43 123.9 28.97 Favored 'General case' 0 N--CA 1.435 -1.185 0 C-N-CA 125.977 1.711 . . . . 3.1200000000000001 108.619 -162.347 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 30.6 m -117.47 175.07 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 C-N-CA 124.201 1.0 . . . . 2.1499999999999999 110.315 -171.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.9 t -148.3 37.22 0.84 Allowed 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 112.435 0.531 . . . . 3.6499999999999999 112.435 175.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -139.31 130.02 4.63 Favored Glycine 0 N--CA 1.446 -0.693 1 N-CA-C 102.148 -4.381 . . . . 3.6099999999999999 102.148 138.315 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -164.04 -33.82 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 124.357 1.063 . . . . 3.2400000000000002 111.016 -169.536 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 6.7 t -111.88 23.72 13.49 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 108.379 -0.971 . . . . 4.4699999999999998 108.379 162.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 24.4 p -80.97 38.0 0.45 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.889 1.276 . . . . 3.0699999999999998 110.95 -175.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 72.48 177.54 0.25 Allowed 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.654 1.582 . . . . 2.9100000000000001 110.637 -152.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -77.26 32.09 0.15 Allowed 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 114.674 1.361 . . . . 2.8100000000000001 114.674 -162.683 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 85.7 m -48.79 -39.15 24.19 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 126.065 1.746 . . . . 3.54 110.576 175.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 29.1 m -46.16 -48.08 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 C-N-CA 124.795 1.238 . . . . 3.0299999999999998 111.303 174.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.94 -43.77 70.09 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 124.351 1.06 . . . . 0.92000000000000004 110.469 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -65.76 -51.81 56.06 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 108.566 -0.902 . . . . 2.8399999999999999 108.566 174.374 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 31.1 mt -60.35 -53.36 49.87 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 N-CA-C 108.384 -0.969 . . . . 2.5699999999999998 108.384 -168.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -40.68 -58.68 1.57 Allowed 'General case' 0 C--O 1.234 0.242 0 C-N-CA 126.316 1.847 . . . . 4.0899999999999999 111.588 171.009 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 20.0 mmm180 -56.59 -41.2 76.56 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.062 -0.517 . . . . 5.6500000000000004 110.907 177.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -71.7 -29.76 64.91 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 124.388 1.075 . . . . 3.3999999999999999 110.38 -176.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -70.51 -58.1 4.06 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 124.499 1.119 . . . . 2.4399999999999999 110.0 176.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . 0.258 62.1 mtt180 -65.06 -14.52 60.67 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 115.062 1.504 . . . . 9.3699999999999992 115.062 -171.205 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 16.9 mtm180 -54.24 -38.23 65.53 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 119.426 1.012 . . . . 7.1299999999999999 111.484 166.038 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 38.7 mm-40 -92.14 81.82 5.04 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 107.985 -1.117 . . . . 6.7999999999999998 107.985 -153.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 46.2 tt0 -41.68 125.06 2.68 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.97 0.908 . . . . 8.6799999999999997 108.943 174.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 127.65 -52.36 0.83 Allowed Glycine 0 CA--C 1.522 0.501 0 N-CA-C 107.733 -2.147 . . . . 1.4299999999999999 107.733 -155.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 1.3 mt -83.46 143.3 12.18 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.147 0 C-N-CA 124.718 1.207 . . . . 2.1000000000000001 108.274 171.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -144.93 42.11 1.31 Allowed 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 119.032 -1.067 . . . . 3.4199999999999999 113.579 150.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 68.2 m -163.19 143.85 9.28 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 127.632 2.373 . . . . 1.8400000000000001 109.767 156.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.54 ' H ' ' CD1' ' A' ' 34' ' ' ILE . 0.0 OUTLIER -81.44 134.25 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.836 0 C-N-CA 125.948 1.699 . . . . 2.7400000000000002 111.144 -178.973 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.562 ' HA ' ' H ' ' A' ' 44' ' ' GLU . 0.6 OUTLIER -80.02 71.73 6.75 Favored 'General case' 0 N--CA 1.432 -1.361 0 O-C-N 121.072 -1.018 . . . . 4.7199999999999998 110.061 174.051 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 22.3 t -135.63 131.06 50.55 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 CA-C-O 121.631 0.729 . . . . 1.26 111.847 169.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -149.15 67.15 1.03 Allowed 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 127.685 2.394 . . . . 0.92000000000000004 106.796 167.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -53.3 -31.97 46.57 Favored 'General case' 0 CA--C 1.512 -0.502 0 N-CA-C 113.228 0.825 . . . . 3.52 113.228 -177.117 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 63.8 mtt -66.74 -42.95 85.4 Favored 'General case' 0 N--CA 1.44 -0.929 0 C-N-CA 119.385 -0.926 . . . . 4.4299999999999997 109.099 -165.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -73.31 -36.27 66.22 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.426 0.69 . . . . 1.5700000000000001 109.69 166.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 97.8 55.35 1.15 Allowed Glycine 0 CA--C 1.507 -0.449 0 N-CA-C 106.548 -2.621 . . . . 0.97999999999999998 106.548 178.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 24.0 mmtm -150.15 176.06 11.18 Favored 'General case' 0 N--CA 1.44 -0.928 0 N-CA-C 106.18 -1.785 . . . . 6.3600000000000003 106.18 -165.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.602 ' HB3' ' O ' ' A' ' 7' ' ' ILE . . . -162.07 127.05 3.37 Favored 'General case' 0 N--CA 1.432 -1.341 0 N-CA-C 107.142 -1.429 . . . . 1.1899999999999999 107.142 -162.48 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.562 ' H ' ' HA ' ' A' ' 35' ' ' LEU . 0.6 OUTLIER -151.84 107.73 3.38 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 113.371 0.878 . . . . 3.9900000000000002 113.371 -174.206 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.7 p -81.79 155.06 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.022 0 C-N-CA 124.001 0.92 . . . . 1.5900000000000001 109.62 -169.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 46.0 ttt180 -118.78 128.81 54.83 Favored 'General case' 0 CA--C 1.521 -0.162 0 N-CA-C 106.769 -1.567 . . . . 5.3600000000000003 106.769 158.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -158.63 175.23 13.91 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 123.824 0.85 . . . . 2.21 110.35 -167.715 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -110.79 140.08 22.3 Favored Pre-proline 0 N--CA 1.448 -0.53 0 N-CA-C 106.979 -1.489 . . . . 3.0800000000000001 106.979 156.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -85.41 3.72 7.08 Favored 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 122.385 2.056 . . . . 2.98 113.29 -175.027 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -91.3 -50.18 5.96 Favored 'General case' 0 CA--C 1.519 -0.248 0 N-CA-C 107.943 -1.132 . . . . 1.24 107.943 -168.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 45.0 t -61.78 -59.07 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.97 0 C-N-CA 124.557 1.143 . . . . 1.03 110.379 178.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 10.7 tt -95.38 -37.06 7.22 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.261 0 CA-C-O 118.615 -0.707 . . . . 2.0800000000000001 112.743 -162.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 13.4 mm-40 88.78 125.74 0.03 OUTLIER Pre-proline 0 CA--C 1.54 0.56 0 C-N-CA 128.926 2.89 . . . . 2.8100000000000001 113.466 176.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.4 ' HA ' HG22 ' A' ' 57' ' ' ILE . 79.6 Cg_exo -49.89 -48.76 18.18 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 124.593 3.529 . . . . 1.46 116.944 179.325 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -53.11 -50.74 12.98 Favored 'Trans proline' 0 N--CA 1.444 -1.407 0 CA-C-N 120.758 1.307 . . . . 1.54 108.843 172.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 66.4 mtt -65.18 -43.77 90.61 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 120.62 -0.432 . . . . 1.8600000000000001 110.486 -171.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.428 HG21 HD13 ' A' ' 57' ' ' ILE . 7.5 tt -63.54 -35.4 72.47 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 C-N-CA 120.386 -0.526 . . . . 2.1800000000000002 110.407 -177.63 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -65.86 -50.14 65.61 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 121.916 0.865 . . . . 1.21 110.384 171.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -70.87 -35.93 72.6 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-O 117.483 -1.246 . . . . 2.7599999999999998 113.964 -166.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 9.2 m-30 -45.88 -41.75 11.74 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 119.642 1.11 . . . . 3.2599999999999998 110.206 172.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 7.9 mt -69.54 -35.54 66.89 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 O-C-N 121.825 -0.547 . . . . 1.4399999999999999 111.164 -178.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 68.9 mtt180 -66.27 -52.72 44.69 Favored 'General case' 0 C--O 1.226 -0.169 0 N-CA-C 109.013 -0.736 . . . . 4.4100000000000001 109.013 176.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -55.31 -53.54 54.83 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 125.633 1.573 . . . . 2.9399999999999999 110.792 -178.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 74.6 mt -84.52 -32.51 23.87 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 119.17 -0.443 . . . . 2.3100000000000001 111.916 -172.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -115.59 -87.64 1.42 Allowed Glycine 0 CA--C 1.525 0.705 0 N-CA-C 111.7 -0.56 . . . . 2.2000000000000002 111.7 -174.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -140.64 -69.1 0.4 Allowed 'General case' 0 CA--C 1.512 -0.514 0 CA-C-O 122.219 1.009 . . . . 3.3599999999999999 112.767 -152.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 168.14 137.95 2.35 Favored Glycine 0 N--CA 1.437 -1.293 0 N-CA-C 105.648 -2.981 . . . . 1.8700000000000001 105.648 -149.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -155.93 110.99 2.93 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 108.481 -0.933 . . . . 1.3 108.481 -170.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.4 p -116.36 113.59 23.12 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 125.15 1.38 . . . . 2.27 107.947 -174.256 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 12.1 m -81.39 138.51 19.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 N-CA-C 109.365 -0.605 . . . . 2.8199999999999998 109.365 -170.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 19.5 pt -144.68 152.26 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 N-CA-C 107.74 -1.207 . . . . 2.96 107.74 175.043 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -108.66 -68.72 0.9 Allowed 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 107.085 -1.45 . . . . 6.1100000000000003 107.085 167.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 29.1 m120 -64.21 128.25 34.97 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 108.818 -0.808 . . . . 5.3399999999999999 108.818 171.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 29.6 mm -76.99 77.68 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 N-CA-C 107.624 -1.25 . . . . 8.8399999999999999 107.624 174.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -52.89 142.0 20.36 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.517 0.727 . . . . 11.48 111.14 179.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 173.07 -161.32 32.39 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 108.059 -2.017 . . . . 11.880000000000001 108.059 -176.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 35.9 ptt180 . . . . . 0 C--O 1.254 1.3 0 N-CA-C 105.502 -2.036 . . . . 20.440000000000001 105.502 172.766 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 . . . . . 0 N--CA 1.477 0.921 0 N-CA-C 105.305 -2.109 . . . . 8.8800000000000008 105.305 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.4 m -42.03 145.02 0.38 Allowed 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 109.47 -0.567 . . . . 3.1400000000000001 109.47 133.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.5 m -94.83 135.02 36.83 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 125.303 1.441 . . . . 1.8899999999999999 109.273 -175.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 52.5 tttt -85.86 118.25 25.23 Favored 'General case' 0 CA--C 1.528 0.097 0 C-N-CA 124.281 1.033 . . . . 4.0899999999999999 109.222 175.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 96.5 m -127.16 131.2 50.79 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 108.872 -0.788 . . . . 3.9900000000000002 108.872 -178.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -89.52 135.87 33.35 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 124.491 1.117 . . . . 2.4700000000000002 108.533 -171.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 9.0 mt -132.16 157.24 43.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 106.529 -1.656 . . . . 1.7 106.529 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 29.9 tp60 -129.98 127.1 39.33 Favored 'General case' 0 N--CA 1.434 -1.261 0 N-CA-C 104.743 -2.317 . . . . 2.77 104.743 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 27.0 m -106.91 176.95 1.09 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 C-N-CA 125.177 1.391 . . . . 2.1800000000000002 110.085 -172.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 12.1 t -141.49 145.02 34.69 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 109.107 -0.701 . . . . 2.73 109.107 167.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 67.9 115.79 0.02 OUTLIER Glycine 0 C--N 1.335 0.508 0 N-CA-C 105.443 -3.063 . . . . 2.8599999999999999 105.443 -138.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 65.6 mtp -89.59 -101.44 0.09 Allowed 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 113.481 -1.359 . . . . 4.0499999999999998 108.88 -176.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 10.9 p -75.17 -42.28 56.27 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 124.153 0.981 . . . . 5.3600000000000003 109.726 177.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 56.7 m 55.34 21.92 4.52 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 126.697 1.999 . . . . 2.6800000000000002 112.099 178.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 50.87 36.62 15.16 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.297 1.039 . . . . 3.1299999999999999 113.495 -168.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 76.2 p 145.61 16.79 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 128.275 2.63 . . . . 2.9900000000000002 115.739 160.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.7 m -60.02 -35.98 76.26 Favored 'General case' 0 C--O 1.234 0.265 0 O-C-N 120.71 -1.244 . . . . 2.9399999999999999 109.872 175.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.444 HG12 HD23 ' A' ' 38' ' ' LEU . 15.2 m -65.95 -52.94 43.19 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 CA-C-N 116.089 -0.505 . . . . 2.3100000000000001 110.963 -179.333 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -47.94 -46.01 31.65 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.152 0.581 . . . . 0.88 110.616 171.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -55.43 -52.05 64.87 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 120.995 0.426 . . . . 1.77 110.144 174.059 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -61.9 -48.1 90.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 C-N-CA 123.768 0.827 . . . . 1.73 110.686 -175.243 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -52.25 -53.8 39.27 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 125.113 1.365 . . . . 3.1299999999999999 109.178 173.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 29.9 mmt180 -55.3 -41.53 72.46 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 118.414 -0.803 . . . . 5.2300000000000004 111.573 176.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 56.9 m-20 -74.34 -67.97 0.57 Allowed 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 118.829 0.74 . . . . 3.9100000000000001 112.406 -177.183 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.564 ' CD2' HD21 ' A' ' 35' ' ' LEU . 0.1 OUTLIER -75.8 -14.79 60.31 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 126.594 1.958 . . . . 2.5600000000000001 113.558 -164.637 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -21.1 -74.49 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 128.433 2.693 . . . . 8.8800000000000008 113.51 -168.165 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . 0.266 11.3 ptp180 -95.74 -62.13 1.34 Allowed 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 117.589 2.44 . . . . 12.43 117.589 170.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 30.54 -150.95 0.0 OUTLIER 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 129.711 3.205 . . . . 6.0800000000000001 111.965 -154.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -95.68 92.53 6.63 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 106.058 -1.83 . . . . 7.4000000000000004 106.058 167.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 115.07 13.94 8.8 Favored Glycine 0 CA--C 1.529 0.916 0 CA-C-O 117.137 -1.924 . . . . 1.0900000000000001 115.654 164.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 1.6 mt -104.04 129.52 56.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 CA-C-N 120.531 2.166 . . . . 2.02 108.53 172.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -136.83 43.41 2.41 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 121.828 0.823 . . . . 3.1600000000000001 111.19 159.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 67.7 m -170.74 143.52 2.14 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 129.295 3.038 . . . . 1.51 106.35 135.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -83.9 160.89 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 CA-C-O 122.012 0.91 . . . . 2.4300000000000002 110.783 175.099 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.663 ' HB2' ' HB1' ' A' ' 43' ' ' ALA . 0.3 OUTLIER -72.44 69.72 0.85 Allowed 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 129.437 3.095 . . . . 5.2699999999999996 109.091 -179.035 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 23.9 t -130.6 130.83 65.04 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 CA-C-O 121.844 0.83 . . . . 1.8500000000000001 113.09 170.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -158.04 56.86 0.47 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 127.635 2.374 . . . . 0.71999999999999997 107.201 156.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.444 HD23 HG12 ' A' ' 18' ' ' VAL . 4.0 mm? -74.3 -11.08 60.17 Favored 'General case' 0 N--CA 1.463 0.191 0 O-C-N 121.058 -1.026 . . . . 5.2800000000000002 112.542 -171.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 27.6 ttt -53.81 -40.13 66.11 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 109.848 -0.427 . . . . 3.75 109.848 163.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -89.39 -34.41 16.51 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.423 0.689 . . . . 1.3100000000000001 110.487 172.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 106.02 44.62 1.37 Allowed Glycine 0 CA--C 1.524 0.649 0 N-CA-C 109.379 -1.488 . . . . 0.75 109.379 -179.131 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 45.8 mttt -155.02 -177.52 6.59 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 125.869 1.668 . . . . 4.4699999999999998 107.364 -153.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.663 ' HB1' ' HB2' ' A' ' 35' ' ' LEU . . . -153.87 146.98 24.6 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 125.483 1.513 . . . . 1.4199999999999999 110.432 -168.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -129.22 106.52 8.88 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-O 121.265 0.555 . . . . 4.3200000000000003 110.021 161.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -83.74 116.84 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 N-CA-C 106.165 -1.791 . . . . 2.0899999999999999 106.165 173.239 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 29.8 ttm180 -109.2 116.3 31.64 Favored 'General case' 0 CA--C 1.515 -0.381 0 N-CA-C 106.192 -1.781 . . . . 5.6500000000000004 106.192 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -148.97 173.66 13.1 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 114.65 1.352 . . . . 2.1699999999999999 114.65 -158.025 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -102.7 94.64 5.35 Favored Pre-proline 0 N--CA 1.452 -0.347 0 N-CA-C 106.795 -1.558 . . . . 3.3199999999999998 106.795 166.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -67.75 -4.27 11.92 Favored 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 122.408 2.072 . . . . 2.6099999999999999 113.292 -172.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -82.47 -28.56 31.14 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 124.175 0.99 . . . . 1.1699999999999999 108.554 177.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 87.0 t -84.85 -67.33 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.137 0 C-N-CA 124.629 1.172 . . . . 1.1899999999999999 107.939 -174.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 15.2 tt -87.45 -36.58 9.9 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 N-CA-C 113.016 0.747 . . . . 1.8300000000000001 113.016 -163.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 15.7 mm-40 86.88 119.18 0.03 OUTLIER Pre-proline 0 CA--C 1.541 0.625 0 C-N-CA 129.27 3.028 . . . . 2.96 112.834 -179.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -50.18 -47.94 21.92 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 125.117 3.878 . . . . 1.03 117.907 -178.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -59.08 -44.56 33.75 Favored 'Trans proline' 0 N--CA 1.442 -1.505 0 N-CA-C 108.785 -1.275 . . . . 1.02 108.785 172.026 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 87.6 mtp -69.46 -40.93 76.83 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-O 119.373 -0.346 . . . . 1.8799999999999999 110.11 -167.023 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 16.4 tt -61.87 -54.37 35.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 119.628 -0.829 . . . . 2.4199999999999999 110.765 175.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -46.88 -51.65 16.23 Favored 'General case' 0 C--N 1.342 0.262 0 C-N-CA 123.73 0.812 . . . . 0.96999999999999997 112.138 174.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -54.79 -51.35 66.05 Favored 'General case' 0 N--CA 1.442 -0.855 0 C-N-CA 125.292 1.437 . . . . 3.4300000000000002 111.237 175.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -48.68 -40.43 28.06 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 123.55 0.74 . . . . 3.6000000000000001 111.525 178.013 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.4 mm -58.14 -40.87 79.11 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-O 121.606 0.717 . . . . 2.2000000000000002 110.069 179.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 27.0 mtt85 -67.24 -50.54 60.28 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 123.623 0.769 . . . . 4.25 109.114 177.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -53.88 -48.98 69.52 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 124.034 0.933 . . . . 2.75 111.405 -178.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.7 pp -83.26 -30.98 27.21 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 119.271 -0.395 . . . . 2.8300000000000001 111.831 -175.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -123.3 -87.82 0.83 Allowed Glycine 0 CA--C 1.524 0.63 0 N-CA-C 111.455 -0.658 . . . . 1.6799999999999999 111.455 -175.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 26.5 m-85 -139.62 -74.85 0.36 Allowed 'General case' 0 CA--C 1.513 -0.452 0 CA-C-O 121.837 0.827 . . . . 3.8599999999999999 112.888 -151.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 171.34 128.9 1.07 Allowed Glycine 0 N--CA 1.438 -1.175 0 N-CA-C 107.825 -2.11 . . . . 1.54 107.825 -155.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -155.2 127.51 7.78 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 123.843 0.857 . . . . 0.90000000000000002 109.243 -172.14 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -118.23 131.03 56.39 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 126.166 1.787 . . . . 2.4100000000000001 106.724 179.312 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 79.6 t -87.05 127.68 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.737 0 C-N-CA 125.164 1.385 . . . . 1.6100000000000001 107.94 -175.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 13.5 mt -134.38 62.04 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 CA-C-O 122.387 1.089 . . . . 1.79 108.515 -173.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -73.1 67.2 0.88 Allowed 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 124.231 1.012 . . . . 4.7599999999999998 109.449 171.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 62.8 m-80 -134.36 170.49 15.66 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 124.554 1.142 . . . . 5.7000000000000002 109.168 -178.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 20.1 tt -142.94 147.19 20.89 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 N-CA-C 106.177 -1.786 . . . . 8.1500000000000004 106.177 172.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -140.18 169.02 18.46 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 125.098 1.359 . . . . 10.960000000000001 107.992 -174.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -147.99 -82.38 0.04 OUTLIER Glycine 0 CA--C 1.524 0.627 0 N-CA-C 109.106 -1.598 . . . . 12.16 109.106 174.431 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 4.2 tpp85 . . . . . 0 C--O 1.253 1.264 0 N-CA-C 105.455 -2.054 . . . . 18.02 105.455 173.193 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 1.3 m120 . . . . . 0 N--CA 1.475 0.807 0 CA-C-O 116.675 -1.631 . . . . 6.4000000000000004 107.35 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 56.4 p 38.46 89.65 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.205 1.802 . . . . 4.3399999999999999 114.703 166.159 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.0 m -139.71 169.93 16.83 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 124.53 1.132 . . . . 1.77 109.564 -176.328 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.32 143.08 35.63 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 110.329 -0.249 . . . . 4.3499999999999996 110.329 168.637 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 51.4 t -141.28 149.62 41.52 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 125.072 1.349 . . . . 1.51 108.532 -171.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -106.26 142.9 35.17 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.185 1.394 . . . . 3.0699999999999998 108.422 179.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -141.43 109.09 2.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 107.255 -1.387 . . . . 2.6299999999999999 107.255 -163.003 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 17.5 tt0 -79.21 147.09 32.73 Favored 'General case' 0 N--CA 1.422 -1.851 0 N-CA-C 107.094 -1.447 . . . . 2.9700000000000002 107.094 -178.456 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.1 p -150.83 134.41 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 N-CA-C 108.825 -0.806 . . . . 2.8599999999999999 108.825 -168.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 6.1 m -83.19 73.5 10.09 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 121.959 0.885 . . . . 2.27 110.66 -167.232 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 121.57 94.25 1.3 Allowed Glycine 0 N--CA 1.443 -0.862 0 CA-C-O 124.664 2.258 . . . . 2.8500000000000001 107.765 175.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.443 ' HE3' HG22 ' A' ' 18' ' ' VAL . 11.9 tpt -95.56 -70.21 0.72 Allowed 'General case' 0 N--CA 1.422 -1.829 0 CA-C-N 109.456 -3.372 . . . . 7.3899999999999997 107.521 -172.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 5.7 m -108.08 52.89 0.7 Allowed 'General case' 0 N--CA 1.456 -0.175 0 N-CA-C 108.585 -0.895 . . . . 5.7199999999999998 108.585 -177.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 21.3 m -64.82 -61.02 2.43 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 107.507 -1.294 . . . . 3.7799999999999998 107.507 176.076 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -174.37 70.18 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 127.556 2.343 . . . . 2.7000000000000002 106.979 174.046 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . 0.26 16.6 p 77.63 23.0 0.85 Allowed 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 126.959 2.104 . . . . 2.48 114.676 176.22 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 80.1 m -52.12 -39.43 59.87 Favored 'General case' 0 CA--C 1.536 0.416 0 O-C-N 121.108 -0.995 . . . . 3.27 109.413 157.141 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.443 HG22 ' HE3' ' A' ' 12' ' ' MET . 1.0 OUTLIER -42.49 -47.87 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.034 0 C-N-CA 126.248 1.819 . . . . 2.8300000000000001 114.12 161.989 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.73 -36.07 82.54 Favored 'General case' 0 C--O 1.234 0.247 0 O-C-N 121.511 -0.743 . . . . 1.2 110.396 176.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -58.56 -51.79 68.4 Favored 'General case' 0 C--O 1.219 -0.522 0 N-CA-C 108.341 -0.985 . . . . 1.9199999999999999 108.341 169.708 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 86.6 mt -53.88 -52.55 34.51 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-N 119.108 0.867 . . . . 2.8799999999999999 109.863 -176.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.932 ' HA ' HD13 ' A' ' 34' ' ' ILE . 18.4 mt-10 -48.33 -48.7 36.09 Favored 'General case' 0 N--CA 1.444 -0.774 0 O-C-N 121.006 -1.059 . . . . 3.6099999999999999 112.722 172.22 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 5.6 ttm-85 -66.42 -27.35 67.76 Favored 'General case' 0 N--CA 1.444 -0.744 0 O-C-N 121.736 -0.603 . . . . 6.7199999999999998 112.426 173.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.409 ' ND2' ' HG ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -72.78 -56.91 4.55 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 119.309 0.959 . . . . 4.46 110.571 -169.882 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.409 ' HG ' ' ND2' ' A' ' 24' ' ' ASN . 3.4 mt -69.52 -33.11 72.34 Favored 'General case' 0 C--O 1.223 -0.309 0 C-N-CA 119.429 -0.908 . . . . 3.23 113.003 -161.335 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.59 -17.78 0.36 Allowed 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 114.498 1.295 . . . . 7.7800000000000002 114.498 168.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -35.67 -56.44 0.68 Allowed 'General case' 0 C--N 1.343 0.308 0 O-C-N 121.014 -1.054 . . . . 9.8599999999999994 111.559 162.601 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.502 ' HB3' HD11 ' A' ' 52' ' ' ILE . 9.6 mt-10 -96.36 119.58 35.11 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 118.972 -1.091 . . . . 9.4900000000000002 111.492 -140.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 47.8 mp0 -58.51 106.4 0.39 Allowed 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.303 1.441 . . . . 4.8799999999999999 109.197 179.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 122.02 -1.1 10.81 Favored Glycine 0 CA--C 1.529 0.941 0 CA-C-O 118.992 -0.893 . . . . 1.26 111.915 -171.2 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -78.52 138.19 20.64 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-N 118.432 1.116 . . . . 1.9199999999999999 110.672 177.225 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -147.91 48.34 1.07 Allowed 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 122.038 0.923 . . . . 3.27 112.993 164.129 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.7 m -169.2 173.24 6.85 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 129.354 3.062 . . . . 2.4500000000000002 106.487 129.186 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.932 HD13 ' HA ' ' A' ' 22' ' ' GLU . 1.8 pp -120.1 139.41 47.48 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 N-CA-C 102.841 -3.022 . . . . 2.6499999999999999 102.841 161.045 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.467 ' HB2' ' HB3' ' A' ' 44' ' ' GLU . 1.7 mp -148.14 157.17 43.35 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 119.269 0.941 . . . . 6.8799999999999999 109.523 -167.136 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.514 ' O ' HG12 ' A' ' 36' ' ' VAL . 2.1 t -155.05 73.0 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 CA-C-O 124.857 2.265 . . . . 2.29 107.649 -159.805 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -80.29 59.51 3.42 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 113.714 -1.584 . . . . 1.1899999999999999 109.089 169.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.401 ' CD2' HG21 ' A' ' 18' ' ' VAL . 0.4 OUTLIER -59.64 -29.91 68.35 Favored 'General case' 0 CA--C 1.505 -0.78 0 O-C-N 121.462 -0.774 . . . . 3.9300000000000002 111.608 173.905 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 2.7 mpt? -62.35 -34.46 76.7 Favored 'General case' 0 N--CA 1.438 -1.045 0 C-N-CA 118.861 -1.136 . . . . 3.7400000000000002 109.167 -169.578 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -76.99 -53.87 7.28 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.523 0.729 . . . . 1.96 109.336 164.082 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 131.39 50.37 0.1 Allowed Glycine 0 C--N 1.338 0.676 0 N-CA-C 109.943 -1.263 . . . . 1.4399999999999999 109.943 173.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 75.1 mttt -149.86 150.82 32.5 Favored 'General case' 0 N--CA 1.442 -0.87 0 N-CA-C 108.656 -0.868 . . . . 4.3300000000000001 108.656 -169.176 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -76.11 163.53 27.02 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 105.577 -2.008 . . . . 1.73 105.577 155.056 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.467 ' HB3' ' HB2' ' A' ' 35' ' ' LEU . 52.5 tt0 -128.24 157.68 40.22 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 106.108 -1.812 . . . . 3.5800000000000001 106.108 163.743 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 6.8 p -132.46 134.06 59.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 N-CA-C 106.176 -1.787 . . . . 1.77 106.176 173.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 33.2 ttm105 -105.34 130.23 53.5 Favored 'General case' 0 N--CA 1.456 -0.165 0 N-CA-C 105.632 -1.988 . . . . 4.5800000000000001 105.632 157.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 5.1 p90 -155.63 172.8 17.68 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 123.082 0.553 . . . . 2.02 110.262 -164.246 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -117.78 80.59 14.24 Favored Pre-proline 0 C--O 1.238 0.45 0 CA-C-N 115.969 -0.559 . . . . 2.7599999999999998 112.211 -174.143 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -66.47 87.17 0.27 Allowed 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 123.46 2.773 . . . . 2.5299999999999998 108.531 174.201 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -178.45 -47.35 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 130.25 3.42 . . . . 2.5600000000000001 105.937 -176.213 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 73.9 t -81.42 -57.62 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.712 0 N-CA-C 108.588 -0.893 . . . . 2.0299999999999998 108.588 168.291 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.502 HD11 ' HB3' ' A' ' 28' ' ' GLU . 12.1 tt -90.09 -44.97 15.07 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.21 0 N-CA-C 115.44 1.644 . . . . 2.4900000000000002 115.44 -146.451 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 21.9 tp60 91.86 110.94 0.02 OUTLIER Pre-proline 0 CA--C 1.55 0.979 0 C-N-CA 127.244 2.218 . . . . 3.1000000000000001 111.087 176.005 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -43.04 -48.35 7.8 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 124.773 3.649 . . . . 1.3700000000000001 118.127 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -54.84 -43.35 60.1 Favored 'Trans proline' 0 N--CA 1.448 -1.162 0 CA-C-N 121.329 1.51 . . . . 1.23 110.507 172.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 63.9 mtt -62.37 -44.82 95.56 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 118.397 -0.811 . . . . 2.1299999999999999 110.044 178.16 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.458 HD11 HG21 ' A' ' 52' ' ' ILE . 5.7 mm -48.4 -57.06 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 CA-C-N 119.08 0.855 . . . . 2.9199999999999999 109.903 172.305 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -55.22 -46.71 75.94 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.052 0.541 . . . . 1.3 112.073 -177.081 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -70.23 -44.91 67.6 Favored 'General case' 0 N--CA 1.44 -0.948 0 C-N-CA 124.62 1.168 . . . . 3.0899999999999999 112.74 -176.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -48.59 -36.81 16.47 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 123.968 0.907 . . . . 3.9399999999999999 111.571 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 22.1 mt -69.98 -40.58 78.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 N-CA-C 109.658 -0.497 . . . . 1.3999999999999999 109.658 178.484 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 80.1 mtm-85 -70.96 -31.36 67.91 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 118.24 -0.886 . . . . 4.0599999999999996 112.692 -178.283 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 87.1 mt-10 -41.19 -44.33 2.55 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.926 1.291 . . . . 4.7000000000000002 113.764 179.238 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.42 -12.89 58.78 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.105 0.962 . . . . 2.8900000000000001 111.704 -173.696 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 111.32 -2.03 28.09 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 124.742 1.163 . . . . 2.3799999999999999 111.499 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -76.57 86.2 3.26 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 107.993 -1.114 . . . . 3.0099999999999998 107.993 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -61.4 104.41 0.69 Allowed Glycine 0 N--CA 1.442 -0.932 0 C-N-CA 125.672 1.606 . . . . 1.6899999999999999 109.177 -178.008 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -137.99 151.84 48.31 Favored 'General case' 0 N--CA 1.45 -0.457 0 O-C-N 124.981 1.048 . . . . 1.3899999999999999 112.494 -163.369 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 29.8 m -135.34 138.63 43.59 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 125.769 1.627 . . . . 2.6600000000000001 107.976 -170.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 12.7 t -82.77 111.36 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 C-N-CA 124.972 1.309 . . . . 1.8300000000000001 107.73 -177.034 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 16.2 mt -134.27 66.03 0.29 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.331 0 C-N-CA 124.499 1.119 . . . . 2.6499999999999999 109.231 -172.048 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 178.67 158.38 0.52 Allowed 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 129.794 3.238 . . . . 8.0999999999999996 106.121 150.16 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 38.6 t-20 54.06 40.2 31.38 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.021 0.928 . . . . 9.3100000000000005 111.819 167.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -65.04 -47.35 88.3 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 N-CA-C 108.875 -0.787 . . . . 12.640000000000001 108.875 -179.449 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -113.2 148.45 35.43 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 105.529 -2.026 . . . . 13.69 105.529 161.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 143.18 -126.37 2.8 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 107.892 -2.083 . . . . 16.719999999999999 107.892 -174.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.94 0 N-CA-C 107.363 -1.347 . . . . 23.25 107.363 -177.585 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 . . . . . 0 N--CA 1.476 0.83 0 N-CA-C 109.405 -0.591 . . . . 6.8499999999999996 109.405 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 12.1 m -158.08 57.28 0.47 Allowed 'General case' 0 CA--C 1.529 0.156 0 CA-C-O 123.105 1.431 . . . . 2.52 107.682 179.437 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -84.69 127.36 34.06 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 128.586 2.755 . . . . 2.1899999999999999 109.955 -168.426 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 37.2 tttt -81.83 144.13 31.25 Favored 'General case' 0 C--N 1.34 0.178 0 CA-C-N 118.761 0.71 . . . . 4.1600000000000001 109.272 174.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 45.5 t -143.18 156.01 44.67 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 123.402 0.681 . . . . 1.3200000000000001 109.324 170.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -102.52 139.67 37.82 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 124.555 1.142 . . . . 2.6600000000000001 108.528 175.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.7 mp -133.24 130.01 57.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 N-CA-C 104.91 -2.255 . . . . 2.0899999999999999 104.91 174.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 36.4 tp60 -91.7 126.04 36.64 Favored 'General case' 0 N--CA 1.433 -1.289 0 N-CA-C 104.042 -2.577 . . . . 3.25 104.042 169.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.4 m -109.4 136.35 45.56 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 N-CA-C 108.386 -0.968 . . . . 2.2599999999999998 108.386 179.525 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 6.1 m -87.22 55.35 3.51 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 108.925 -0.768 . . . . 2.23 108.925 171.487 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -143.95 123.08 1.95 Allowed Glycine 0 N--CA 1.445 -0.732 0 N-CA-C 103.464 -3.854 . . . . 3.1600000000000001 103.464 148.4 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 70.6 mtm -136.6 -71.92 0.45 Allowed 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 106.515 -1.661 . . . . 4.25 106.515 -176.202 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 4.9 t -74.93 51.04 0.48 Allowed 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 109.307 -0.627 . . . . 5.7599999999999998 109.307 163.121 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 14.5 t -114.42 121.65 44.21 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 105.12 -2.178 . . . . 3.0499999999999998 105.12 175.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -71.53 82.19 0.81 Allowed 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 123.57 0.748 . . . . 2.7799999999999998 111.999 -157.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 87.63 38.12 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 127.684 2.394 . . . . 2.5299999999999998 109.857 -177.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.8 t -47.59 -41.0 20.7 Favored 'General case' 0 CA--C 1.521 -0.136 0 C-N-CA 125.082 1.353 . . . . 3.7799999999999998 108.83 168.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 15.1 m -66.32 -53.34 37.43 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.06 0 CA-C-N 113.49 -1.687 . . . . 2.2200000000000002 110.321 -175.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -50.44 -45.15 55.78 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.39 0.676 . . . . 0.81999999999999995 110.309 172.485 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -56.84 -56.39 22.17 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 109.597 -0.52 . . . . 2.0299999999999998 109.597 175.66 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 27.5 mt -52.58 -54.46 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 C-N-CA 124.268 1.027 . . . . 2.3199999999999998 110.199 -179.262 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -50.32 -59.01 4.4 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 124.985 1.314 . . . . 2.9300000000000002 110.088 176.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 21.5 tpt180 -55.48 -41.83 73.55 Favored 'General case' 0 N--CA 1.443 -0.801 0 C-N-CA 124.666 1.186 . . . . 5.1200000000000001 111.515 -176.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 15.3 m-20 -72.31 -64.46 0.94 Allowed 'General case' 0 C--O 1.222 -0.362 0 N-CA-C 109.609 -0.515 . . . . 3.52 109.609 179.163 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.873 HD12 HD21 ' A' ' 35' ' ' LEU 0.319 6.9 mt -80.54 -11.09 59.71 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 128.69 2.796 . . . . 3.6600000000000001 116.808 -159.484 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -19.57 -71.5 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 126.777 2.031 . . . . 9.3300000000000001 114.345 175.458 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 30.4 mmt180 -92.35 -60.7 1.77 Allowed 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 118.828 2.899 . . . . 12.91 118.828 -179.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.408 ' H ' ' CD ' ' A' ' 28' ' ' GLU 0.262 2.5 mm-40 8.27 62.84 0.0 OUTLIER 'General case' 0 C--N 1.32 -0.685 1 C-N-CA 132.665 4.386 . . . . 5.8300000000000001 112.314 -152.328 . . . . . . . . 4 3 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 18.06 58.13 0.01 OUTLIER 'General case' 0 C--N 1.343 0.299 0 C-N-CA 129.685 3.194 . . . . 6.9400000000000004 113.257 -169.342 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 166.63 -28.7 0.18 Allowed Glycine 0 CA--C 1.522 0.503 0 C-N-CA 120.134 -1.031 . . . . 1.5 113.488 -171.189 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.7 mt -81.6 111.96 18.87 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 N-CA-C 106.212 -1.773 . . . . 1.96 106.212 174.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 47.9 m-85 -122.6 44.16 2.71 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 122.832 1.301 . . . . 3.29 110.547 166.371 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 33.7 t -166.78 137.54 3.24 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 126.799 2.04 . . . . 1.73 105.952 142.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.2 pp -78.59 151.44 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.651 0 N-CA-C 107.5 -1.296 . . . . 1.9099999999999999 107.5 171.374 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.873 HD21 HD12 ' A' ' 25' ' ' LEU . 0.3 OUTLIER -94.69 77.43 3.73 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 129.466 3.106 . . . . 4.3300000000000001 110.243 -169.273 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 43.3 t -131.59 139.71 49.97 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.801 0 N-CA-C 108.997 -0.742 . . . . 1.5 108.997 168.24 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -155.99 55.99 0.59 Allowed 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 106.618 -1.623 . . . . 0.67000000000000004 106.618 168.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -71.61 -20.32 62.0 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 114.74 -1.118 . . . . 3.0600000000000001 111.017 -172.412 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 53.0 ttm -45.23 -38.29 5.34 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.621 0.768 . . . . 3.3999999999999999 110.935 164.157 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -95.51 -48.67 5.74 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.234 0.614 . . . . 1.79 110.235 170.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 119.67 54.82 0.26 Allowed Glycine 0 C--N 1.338 0.64 0 N-CA-C 109.813 -1.315 . . . . 0.91000000000000003 109.813 -177.578 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 10.2 pttt -159.15 177.98 10.5 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 107.991 -1.114 . . . . 4.1100000000000003 107.991 -173.007 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.514 ' HB1' ' HB2' ' A' ' 35' ' ' LEU . . . -132.31 124.36 28.67 Favored 'General case' 0 N--CA 1.441 -0.904 0 C-N-CA 127.081 2.153 . . . . 0.90000000000000002 108.705 -169.102 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -125.03 89.06 2.99 Favored 'General case' 0 C--N 1.343 0.296 0 N-CA-C 113.776 1.028 . . . . 3.29 113.776 -175.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.431 HG11 ' CD2' ' A' ' 47' ' ' TYR . 9.6 p -78.65 152.1 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.088 0 N-CA-C 108.707 -0.849 . . . . 1.6399999999999999 108.707 -174.213 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 63.9 ttm-85 -114.85 112.58 22.99 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 106.705 -1.591 . . . . 4.46 106.705 156.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.512 ' CZ ' ' HG3' ' A' ' 54' ' ' PRO . 0.0 OUTLIER -123.15 165.42 16.89 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 124.304 1.041 . . . . 2.3199999999999998 113.19 -169.629 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 32.6 t30 -126.94 90.99 48.12 Favored Pre-proline 0 N--CA 1.451 -0.386 0 C-N-CA 125.99 1.716 . . . . 2.3799999999999999 109.015 -178.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -71.64 71.26 2.6 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 122.895 2.397 . . . . 1.8500000000000001 112.081 179.122 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -123.92 -49.11 1.86 Allowed 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 126.201 1.8 . . . . 1.96 106.853 157.054 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 41.0 t -83.52 -61.44 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.923 0 C-N-CA 124.741 1.216 . . . . 1.75 110.567 175.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.473 HG23 ' H ' ' A' ' 53' ' ' GLN . 6.1 tp -78.58 -71.67 0.29 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.414 0 N-CA-C 113.008 0.744 . . . . 1.6499999999999999 113.008 -161.277 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.473 ' H ' HG23 ' A' ' 52' ' ' ILE . 4.0 mp0 82.81 128.78 0.03 OUTLIER Pre-proline 0 CA--C 1.548 0.887 0 C-N-CA 128.293 2.637 . . . . 3.8700000000000001 113.248 -176.401 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.512 ' HG3' ' CZ ' ' A' ' 47' ' ' TYR . 21.5 Cg_exo -42.88 -52.48 4.62 Favored 'Trans proline' 0 C--N 1.349 0.562 1 C-N-CA 126.744 4.963 . . . . 1.29 117.687 177.594 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -54.06 -49.25 17.73 Favored 'Trans proline' 0 N--CA 1.442 -1.553 0 CA-C-N 120.11 1.075 . . . . 0.84999999999999998 109.678 173.305 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 61.3 mtt -64.93 -45.26 86.57 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.193 -0.669 . . . . 2.1800000000000002 109.193 -170.066 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.427 HG22 ' HA ' ' A' ' 54' ' ' PRO . 16.2 tt -59.7 -49.75 82.58 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 C-N-CA 119.087 -1.045 . . . . 2.6299999999999999 111.527 177.287 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -51.8 -53.78 36.2 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 118.319 0.508 . . . . 1.0900000000000001 111.758 176.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -56.53 -54.49 45.25 Favored 'General case' 0 N--CA 1.432 -1.367 0 C-N-CA 124.511 1.125 . . . . 3.1200000000000001 110.676 -179.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 18.7 m-30 -50.25 -43.1 52.99 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 119.103 0.865 . . . . 4.1200000000000001 110.833 178.154 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 85.6 mt -65.43 -40.83 89.53 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 O-C-N 121.712 -0.617 . . . . 1.21 110.083 -179.307 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 51.8 mtp180 -59.12 -51.83 68.33 Favored 'General case' 0 CA--C 1.533 0.322 0 O-C-N 121.905 -0.497 . . . . 5.4199999999999999 111.211 171.177 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -56.5 -32.95 65.53 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 125.507 1.523 . . . . 3.0899999999999999 111.673 179.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 59.5 mt -77.2 -17.43 58.52 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-O 119.184 -0.436 . . . . 1.98 110.629 176.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 135.42 -9.67 4.36 Favored Glycine 0 CA--C 1.526 0.72 0 C-N-CA 124.069 0.842 . . . . 2.2799999999999998 112.964 167.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -110.28 115.03 28.96 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 118.481 1.14 . . . . 3.25 110.02 -160.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -63.71 86.96 0.06 OUTLIER Glycine 0 N--CA 1.447 -0.625 0 CA-C-N 115.868 -0.606 . . . . 1.3899999999999999 112.065 -176.264 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -84.06 127.74 34.09 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 126.074 1.75 . . . . 0.94999999999999996 109.829 178.284 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 9.6 t -122.18 130.38 53.15 Favored 'General case' 0 N--CA 1.436 -1.132 0 N-CA-C 105.785 -1.932 . . . . 2.2200000000000002 105.785 165.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 77.0 t -83.74 135.89 23.91 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.89 0 N-CA-C 107.398 -1.334 . . . . 1.79 107.398 -177.531 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 17.9 mt -126.91 73.81 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 N-CA-C 107.034 -1.469 . . . . 1.9099999999999999 107.034 -178.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -58.99 162.43 4.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.097 -0.956 . . . . 3.6400000000000001 110.958 167.02 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 51.8 t30 -70.52 154.11 42.22 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 115.973 -0.558 . . . . 6.1500000000000004 111.019 -172.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 6.3 mt 54.03 63.68 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 C-N-CA 125.489 1.515 . . . . 7.96 110.851 179.472 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -52.86 -47.3 67.91 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.022 0.929 . . . . 11.699999999999999 111.286 176.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 167.22 -158.93 32.11 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 108.007 -2.037 . . . . 10.24 108.007 -175.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.257 1.461 0 N-CA-C 105.893 -1.892 . . . . 16.32 105.893 172.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 2.3 m120 . . . . . 0 N--CA 1.479 1.022 0 N-CA-C 114.419 1.266 . . . . 8.1600000000000001 114.419 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.1 p -71.29 75.69 0.73 Allowed 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 120.163 1.347 . . . . 2.4700000000000002 114.57 -162.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.6 p -91.49 172.38 8.55 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 128.096 2.559 . . . . 2.21 111.075 -177.213 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 6.1 tttt -108.53 156.47 19.46 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 124.755 1.222 . . . . 4.5999999999999996 108.563 166.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -145.26 175.35 10.35 Favored 'General case' 0 C--O 1.235 0.324 0 O-C-N 124.142 0.901 . . . . 2.0600000000000001 109.97 162.32 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 45.0 m-85 -115.93 139.79 49.89 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 126.31 1.844 . . . . 2.8500000000000001 108.321 -171.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.7 pt -136.28 122.9 31.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 C-N-CA 123.914 0.885 . . . . 3.1499999999999999 110.602 178.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -80.33 132.48 35.81 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 106.677 -1.601 . . . . 3.7599999999999998 106.677 171.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.7 m -107.85 121.1 60.32 Favored 'Isoleucine or valine' 0 C--O 1.232 0.147 0 O-C-N 124.038 0.836 . . . . 2.1099999999999999 109.658 -176.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.3 m -66.17 73.48 0.08 Allowed 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.138 0.975 . . . . 2.46 111.596 177.229 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -173.47 -59.14 0.05 OUTLIER Glycine 0 CA--C 1.522 0.478 0 N-CA-C 106.788 -2.525 . . . . 3.3700000000000001 106.788 172.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 25.2 ttm 69.03 -33.21 0.24 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 126.686 1.994 . . . . 4.1699999999999999 114.664 170.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.7 t -155.22 52.87 0.62 Allowed 'General case' 0 N--CA 1.446 -0.625 0 C-N-CA 124.668 1.187 . . . . 4.7300000000000004 108.163 177.068 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 12.5 p -58.01 -43.05 86.47 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 108.413 -0.958 . . . . 2.7000000000000002 108.413 164.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 156.92 -59.88 0.0 OUTLIER 'General case' 0 CA--C 1.521 -0.16 0 C-N-CA 129.514 3.126 . . . . 3.8900000000000001 107.177 166.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.0 p -99.11 42.63 1.09 Allowed 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.367 1.067 . . . . 3.0699999999999998 110.916 -174.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 37.7 m -52.79 -51.73 59.59 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 108.49 -0.93 . . . . 4.7000000000000002 108.49 178.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.2 p -63.77 -55.31 23.21 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.67 0 CA-C-O 121.936 0.874 . . . . 3.6200000000000001 111.232 -178.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.32 -30.88 67.03 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.513 -1.221 . . . . 1.0800000000000001 112.598 -175.301 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -68.19 -57.22 6.37 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 119.68 1.127 . . . . 3.0600000000000001 108.276 169.401 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.694 HG22 HD11 ' A' ' 34' ' ' ILE 0.255 1.5 mt -62.83 -35.69 72.13 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.894 0 O-C-N 121.868 -0.52 . . . . 1.97 110.362 -166.991 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.525 ' HG2' HD12 ' A' ' 34' ' ' ILE . 16.0 mt-10 -43.59 -56.7 3.54 Favored 'General case' 0 N--CA 1.453 -0.302 0 O-C-N 121.483 -0.761 . . . . 3.3799999999999999 110.385 171.043 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.41 ' HD2' ' H ' ' A' ' 23' ' ' ARG . 0.2 OUTLIER -63.5 -44.57 93.93 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 115.414 -0.812 . . . . 5.96 110.438 175.783 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.795 ' ND2' HD13 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -60.31 -42.46 95.61 Favored 'General case' 0 C--O 1.223 -0.299 0 C-N-CA 122.922 0.489 . . . . 3.9399999999999999 111.717 -168.741 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.795 HD13 ' ND2' ' A' ' 24' ' ' ASN 0.337 5.2 mp -80.33 -43.93 20.37 Favored 'General case' 0 N--CA 1.435 -1.21 0 C-N-CA 126.081 1.752 . . . . 2.7999999999999998 113.101 175.486 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 83.7 mtt180 -66.2 -20.47 66.14 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 119.364 -2.085 . . . . 7.5099999999999998 112.721 -174.503 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 4.8 mmt180 -29.98 -62.86 0.14 Allowed 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 125.717 1.607 . . . . 8.3300000000000001 112.992 162.055 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 150.98 176.92 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.178 0 C-N-CA 128.049 2.54 . . . . 7.5 106.345 -158.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 101.88 32.09 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 129.477 3.111 . . . . 8.5399999999999991 111.379 -167.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 55.9 42.88 87.26 Favored Glycine 0 CA--C 1.526 0.736 0 O-C-N 121.752 -0.592 . . . . 1.73 111.682 177.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 1.4 mp -74.04 142.57 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.171 0 CA-C-N 117.066 0.433 . . . . 2.2000000000000002 110.102 176.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -145.81 41.86 1.22 Allowed 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 122.449 1.118 . . . . 3.6899999999999999 113.657 158.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 58.8 m -167.93 157.8 10.15 Favored 'General case' 0 C--N 1.319 -0.743 1 C-N-CA 132.698 4.399 . . . . 2.2999999999999998 104.12 133.14 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.694 HD11 HG22 ' A' ' 21' ' ' ILE . 0.0 OUTLIER -109.65 144.95 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 N-CA-C 104.712 -2.329 . . . . 2.5600000000000001 104.712 155.636 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.659 ' N ' HD13 ' A' ' 34' ' ' ILE . 0.3 OUTLIER -147.65 148.43 31.05 Favored 'General case' 0 N--CA 1.434 -1.247 0 C-N-CA 125.965 1.706 . . . . 6.5599999999999996 106.504 -167.543 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.498 HG23 HG21 ' A' ' 21' ' ' ILE . 1.3 t -156.7 96.18 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 N-CA-C 105.207 -2.145 . . . . 2.1099999999999999 105.207 174.396 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -77.22 66.35 2.99 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 115.295 -0.866 . . . . 0.69999999999999996 109.419 176.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.492 HD23 ' HA ' ' A' ' 38' ' ' LEU . 9.5 mt -53.18 -36.58 61.08 Favored 'General case' 0 C--N 1.342 0.245 0 C-N-CA 123.35 0.66 . . . . 2.6400000000000001 110.832 173.752 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 16.3 tpt -51.42 -39.66 57.77 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.715 0.806 . . . . 5.0899999999999999 111.809 173.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -88.68 -23.94 22.88 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.621 0.769 . . . . 1.6100000000000001 111.436 178.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 89.09 41.83 5.77 Favored Glycine 0 C--N 1.335 0.488 0 N-CA-C 110.188 -1.165 . . . . 0.88 110.188 179.048 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 58.4 pttt -156.1 158.16 37.25 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 107.879 -1.156 . . . . 3.6699999999999999 107.879 177.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.423 ' HA ' ' HA ' ' A' ' 36' ' ' VAL . . . -83.88 163.98 19.73 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 108.798 -0.816 . . . . 1.4199999999999999 108.798 170.422 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.445 ' CB ' ' HB2' ' A' ' 35' ' ' LEU . 55.3 mt-10 -131.2 157.72 42.44 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 109.214 -0.661 . . . . 2.6600000000000001 109.214 174.751 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.593 HG12 HD21 ' A' ' 25' ' ' LEU . 13.4 m -134.7 142.43 40.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 N-CA-C 109.432 -0.581 . . . . 2.6600000000000001 109.432 173.1 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 49.1 ttt180 -127.02 125.72 41.9 Favored 'General case' 0 CA--C 1.516 -0.353 0 N-CA-C 106.487 -1.671 . . . . 5.5199999999999996 106.487 158.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 22.1 p90 -157.37 171.94 19.49 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 109.187 -0.672 . . . . 2.1200000000000001 109.187 -163.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 50.7 t-20 -103.69 93.52 5.22 Favored Pre-proline 0 CA--C 1.534 0.329 0 C-N-CA 123.207 0.603 . . . . 2.6299999999999999 110.544 176.12 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -65.24 80.86 0.21 Allowed 'Trans proline' 0 N--CA 1.455 -0.784 0 C-N-CA 123.015 2.477 . . . . 1.6799999999999999 110.26 169.37 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -168.85 -56.61 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 128.916 2.886 . . . . 1.0800000000000001 104.894 172.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 68.1 t -57.24 -55.42 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 C-N-CA 124.509 1.124 . . . . 0.94999999999999996 109.689 171.58 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.505 HG23 ' H ' ' A' ' 53' ' ' GLN 0.251 9.7 tp -95.73 -75.82 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.369 0 CA-C-O 118.514 -0.755 . . . . 2.5099999999999998 111.54 -172.079 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.505 ' H ' HG23 ' A' ' 52' ' ' ILE . 0.0 OUTLIER 114.2 137.06 0.0 OUTLIER Pre-proline 0 N--CA 1.47 0.545 0 C-N-CA 130.815 3.646 . . . . 2.4300000000000002 107.012 -173.163 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_exo -50.98 -50.89 12.46 Favored 'Trans proline' 0 CA--C 1.534 0.476 0 C-N-CA 123.432 2.755 . . . . 1.0900000000000001 114.57 176.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -52.1 -48.8 19.84 Favored 'Trans proline' 0 N--CA 1.444 -1.406 0 CA-C-N 120.525 1.223 . . . . 1.03 110.383 168.084 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 62.7 mtt -66.14 -35.05 79.45 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 118.447 -1.301 . . . . 2.96 110.879 -171.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 4.4 tt -70.13 -44.98 77.64 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 CA-C-N 119.502 1.047 . . . . 2.2599999999999998 109.933 176.274 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -53.67 -41.06 66.47 Favored 'General case' 0 C--N 1.341 0.228 0 N-CA-C 112.266 0.469 . . . . 1.1000000000000001 112.266 175.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 30.8 mm-40 -66.66 -59.94 3.15 Favored 'General case' 0 N--CA 1.437 -1.093 0 C-N-CA 124.94 1.296 . . . . 2.6200000000000001 110.564 174.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -54.41 -42.75 70.84 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 117.897 0.317 . . . . 4.4800000000000004 110.231 -170.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.8 mt -56.26 -37.15 48.85 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 O-C-N 121.487 -0.758 . . . . 1.6699999999999999 111.637 176.517 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 42.6 mtm105 -70.18 -44.33 68.94 Favored 'General case' 0 N--CA 1.456 -0.142 0 O-C-N 121.605 -0.684 . . . . 3.8799999999999999 111.22 173.27 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -56.55 -33.89 66.55 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 119.189 0.904 . . . . 3.2400000000000002 111.604 175.266 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 83.6 mt -78.74 -16.58 57.04 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.845 0.858 . . . . 3.0800000000000001 111.362 175.253 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 136.65 -12.49 3.98 Favored Glycine 0 CA--C 1.528 0.852 0 CA-C-O 119.335 -0.703 . . . . 2.0299999999999998 113.988 164.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -107.94 119.43 39.44 Favored 'General case' 0 CA--C 1.522 -0.125 0 CA-C-N 118.738 1.269 . . . . 4.0300000000000002 110.523 -159.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -68.44 69.4 0.37 Allowed Glycine 0 C--N 1.336 0.574 0 C-N-CA 125.917 1.722 . . . . 1.6399999999999999 113.969 -172.222 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -83.6 121.13 26.83 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 126.482 1.913 . . . . 1.4199999999999999 110.738 -173.329 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 25.7 p -124.04 119.39 29.37 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 125.486 1.514 . . . . 2.7200000000000002 108.504 -179.29 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 74.9 t -81.03 128.46 38.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 C-N-CA 124.917 1.287 . . . . 1.74 109.54 -165.486 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 5.0 pt -139.13 59.49 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-O 122.197 0.999 . . . . 2.9199999999999999 112.174 -173.335 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -83.15 69.33 9.87 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 108.596 -0.89 . . . . 5.0800000000000001 108.596 171.092 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -161.21 150.05 16.24 Favored 'General case' 0 CA--C 1.528 0.104 0 N-CA-C 109.224 -0.658 . . . . 5.9100000000000001 109.224 179.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 44.6 pt -141.63 22.98 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 C-N-CA 124.136 0.974 . . . . 7.3099999999999996 111.399 179.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -81.03 161.56 24.17 Favored 'General case' 0 CA--C 1.531 0.237 0 O-C-N 121.836 -0.54 . . . . 9.6400000000000006 110.256 -178.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 164.76 79.0 0.04 OUTLIER Glycine 0 CA--C 1.525 0.714 0 N-CA-C 110.383 -1.087 . . . . 11.720000000000001 110.383 -178.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.136 0 N-CA-C 105.031 -2.211 . . . . 17.52 105.031 173.303 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 . . . . . 0 N--CA 1.478 0.955 0 N-CA-C 107.622 -1.251 . . . . 5.0999999999999996 107.622 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 27.9 t -162.12 138.05 7.61 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 119.224 0.92 . . . . 3.5499999999999998 110.094 176.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 10.6 p -85.8 141.31 29.75 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 126.245 1.818 . . . . 3.2999999999999998 108.259 164.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.35 147.87 28.71 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 105.384 -2.08 . . . . 7.3799999999999999 105.384 169.644 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 32.6 t -150.74 159.74 44.32 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 106.497 -1.668 . . . . 1.8999999999999999 106.497 176.167 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -135.3 148.39 49.49 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 106.143 -1.799 . . . . 3.1400000000000001 106.143 -178.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.1 pt -141.3 121.61 12.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 108.178 -1.045 . . . . 3.0800000000000001 108.178 -168.28 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 24.1 tp60 -80.81 125.2 29.79 Favored 'General case' 0 N--CA 1.438 -1.033 0 N-CA-C 103.685 -2.709 . . . . 3.0800000000000001 103.685 174.219 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.1 p -136.15 136.98 49.02 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.175 0 C-N-CA 123.803 0.841 . . . . 2.5600000000000001 110.169 -168.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.7 m -83.3 67.54 9.3 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 115.86 -0.609 . . . . 2.2400000000000002 111.843 -164.375 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 143.78 90.64 0.12 Allowed Glycine 0 CA--C 1.505 -0.548 0 N-CA-C 108.394 -1.882 . . . . 2.79 108.394 164.137 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 6.0 mmt -102.14 -56.16 2.33 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 110.704 -2.748 . . . . 6.96 109.713 171.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.8 m -72.35 57.06 0.37 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.594 1.158 . . . . 5.4100000000000001 109.056 172.604 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 4.3 t -112.13 173.55 6.31 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 126.946 2.099 . . . . 3.6000000000000001 105.954 179.041 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -81.68 123.09 28.42 Favored 'General case' 0 CA--C 1.52 -0.208 0 N-CA-C 107.204 -1.406 . . . . 2.4700000000000002 107.204 166.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 27.5 t 57.33 -84.65 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 118.607 -0.711 . . . . 3.7999999999999998 109.227 -152.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 5.3 m -19.36 -21.35 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 118.142 2.645 . . . . 3.0499999999999998 118.142 -99.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.823 ' CG2' HG11 ' A' ' 36' ' ' VAL . 0.3 OUTLIER -41.18 -38.08 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 N-CA-C 115.502 1.667 . . . . 2.77 115.502 172.326 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.26 -44.39 83.88 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.137 0.494 . . . . 1.1699999999999999 110.83 177.182 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -61.47 -51.04 70.31 Favored 'General case' 0 C--O 1.222 -0.365 0 N-CA-C 108.408 -0.96 . . . . 1.8400000000000001 108.408 174.047 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.565 HG21 HG21 ' A' ' 36' ' ' VAL 0.251 11.1 mm -47.78 -60.84 0.56 Allowed 'Isoleucine or valine' 0 C--O 1.209 -1.052 0 C-N-CA 124.59 1.156 . . . . 2.25 109.479 175.0 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.406 ' HA ' HD12 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -43.44 -45.77 6.45 Favored 'General case' 0 C--N 1.318 -0.771 0 O-C-N 116.911 -3.618 . . . . 4.9100000000000001 114.274 172.355 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 27.1 mmt85 -64.07 -31.56 72.79 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 120.857 -1.152 . . . . 4.7400000000000002 113.568 168.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.722 ' ND2' HD13 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -60.6 -67.27 0.41 Allowed 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 127.423 2.289 . . . . 5.1500000000000004 111.666 -171.522 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.722 HD13 ' ND2' ' A' ' 24' ' ' ASN 0.354 5.2 mp -75.05 -26.98 59.81 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 119.508 -0.877 . . . . 3.3799999999999999 111.086 -163.163 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 92.8 mtt180 -61.74 -17.59 56.46 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 113.8 1.037 . . . . 6.71 113.8 168.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 23.6 mmt180 -57.11 -40.06 76.32 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 120.205 1.366 . . . . 8.5199999999999996 111.254 166.253 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -100.48 79.71 2.14 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-O 121.662 0.744 . . . . 9.2200000000000006 109.523 -146.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -37.02 114.91 0.35 Allowed 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 125.412 1.485 . . . . 5.6299999999999999 111.229 176.235 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 122.71 -21.73 7.47 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 111.048 -0.821 . . . . 1.1200000000000001 111.048 -167.23 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.554 HG23 ' H ' ' A' ' 33' ' ' SER . 1.2 mm -78.17 146.3 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 C-N-CA 125.079 1.352 . . . . 3.0499999999999998 108.282 164.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -137.96 37.37 2.37 Favored 'General case' 0 C--N 1.342 0.261 0 CA-C-O 123.065 1.412 . . . . 3.3599999999999999 113.002 153.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.554 ' H ' HG23 ' A' ' 31' ' ' ILE . 0.5 OUTLIER -167.88 124.65 1.11 Allowed 'General case' 0 C--N 1.318 -0.8 0 C-N-CA 125.19 1.396 . . . . 2.4500000000000002 109.026 172.134 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.732 ' C ' HD12 ' A' ' 35' ' ' LEU . 0.0 OUTLIER -106.83 105.5 18.88 Favored 'Isoleucine or valine' 0 C--N 1.346 0.418 0 CA-C-N 119.872 1.214 . . . . 2.6200000000000001 108.929 168.237 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.732 HD12 ' C ' ' A' ' 34' ' ' ILE . 6.7 mp -118.22 151.77 36.99 Favored 'General case' 0 CA--C 1.502 -0.878 0 N-CA-C 106.612 -1.625 . . . . 7.7400000000000002 106.612 -168.639 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.823 HG11 ' CG2' ' A' ' 18' ' ' VAL 0.286 1.0 OUTLIER -159.68 95.2 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.427 -1.624 0 CA-C-O 122.647 1.213 . . . . 2.2200000000000002 111.12 -172.842 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -80.11 73.37 6.94 Favored 'General case' 0 CA--C 1.532 0.277 0 O-C-N 119.966 -1.709 . . . . 1.02 109.109 178.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.568 HD21 HG23 ' A' ' 18' ' ' VAL . 80.6 mt -44.22 -52.35 7.5 Favored 'General case' 0 C--N 1.342 0.243 0 C-N-CA 124.414 1.086 . . . . 2.7799999999999998 111.227 -176.786 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 75.1 mtm -56.11 -32.62 64.35 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.912 1.285 . . . . 3.2400000000000002 112.272 -178.016 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -84.05 -2.11 56.09 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 122.932 0.493 . . . . 2.3300000000000001 111.77 179.235 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 82.36 18.86 65.64 Favored Glycine 0 C--N 1.337 0.623 0 N-CA-C 111.12 -0.792 . . . . 1.3999999999999999 111.12 175.112 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 26.7 pttt -146.78 146.85 30.41 Favored 'General case' 0 N--CA 1.45 -0.475 0 CA-C-N 118.223 1.011 . . . . 4.4500000000000002 111.741 -170.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.426 ' HA ' ' HA ' ' A' ' 36' ' ' VAL . . . -83.99 162.92 20.25 Favored 'General case' 0 N--CA 1.442 -0.835 0 C-N-CA 124.904 1.282 . . . . 1.3999999999999999 109.618 165.613 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -135.32 135.84 41.09 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 126.217 1.807 . . . . 2.79 112.808 -170.055 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 11.0 t -131.47 138.07 53.91 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 O-C-N 120.832 -1.168 . . . . 2.96 109.457 -162.29 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.512 ' HB3' ' HB2' ' A' ' 33' ' ' SER . 47.8 ttp180 -150.18 107.59 3.63 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.92 0.888 . . . . 5.5800000000000001 109.512 179.538 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 11.5 p90 -155.58 179.21 9.4 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 124.608 1.163 . . . . 2.2200000000000002 110.168 -155.22 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -118.62 123.01 29.47 Favored Pre-proline 0 CA--C 1.535 0.395 0 C-N-CA 124.167 0.987 . . . . 3.0899999999999999 111.219 176.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -84.44 62.42 6.54 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 121.566 1.511 . . . . 1.5800000000000001 110.236 -173.565 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -131.33 -70.66 0.58 Allowed 'General case' 0 CA--C 1.519 -0.237 0 N-CA-C 107.0 -1.481 . . . . 1.1699999999999999 107.0 177.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 89.6 t -56.55 -44.31 80.43 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.779 0 C-N-CA 124.517 1.127 . . . . 1.23 111.035 177.358 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.3 tt -113.16 -24.01 4.07 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.415 0 N-CA-C 114.053 1.131 . . . . 2.3500000000000001 114.053 -149.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 70.92 120.47 0.03 OUTLIER Pre-proline 0 N--CA 1.471 0.602 0 C-N-CA 125.724 1.609 . . . . 2.9300000000000002 113.228 175.073 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -46.87 -43.51 23.91 Favored 'Trans proline' 0 CA--C 1.532 0.42 0 C-N-CA 124.228 3.286 . . . . 1.4299999999999999 115.77 169.014 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -58.92 -54.35 2.86 Favored 'Trans proline' 0 N--CA 1.442 -1.537 0 CA-C-N 120.835 1.334 . . . . 1.24 109.762 167.525 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 52.0 mtp -69.02 -28.58 66.7 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 118.396 -1.322 . . . . 2.0499999999999998 111.622 -166.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 12.4 tt -64.43 -37.04 78.98 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 CA-C-N 119.713 1.142 . . . . 2.1499999999999999 110.844 174.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.8 -47.64 84.89 Favored 'General case' 0 N--CA 1.455 -0.176 0 O-C-N 121.416 -0.803 . . . . 1.04 111.159 171.155 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -60.84 -57.47 12.54 Favored 'General case' 0 N--CA 1.432 -1.367 0 C-N-CA 123.718 0.807 . . . . 2.9399999999999999 112.355 -178.237 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -49.4 -38.51 29.16 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 123.488 0.715 . . . . 3.9199999999999999 111.386 -173.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.4 HD11 HD11 ' A' ' 25' ' ' LEU . 90.2 mt -60.99 -47.36 93.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 O-C-N 121.644 -0.66 . . . . 1.25 110.894 175.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 22.2 mtm105 -66.28 -32.1 73.3 Favored 'General case' 0 CA--C 1.522 -0.113 0 O-C-N 121.588 -0.695 . . . . 3.9199999999999999 112.113 177.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 78.3 mt-10 -58.44 -23.55 57.78 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 118.699 0.681 . . . . 3.27 112.264 172.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 66.0 mt -80.81 -15.98 54.95 Favored 'General case' 0 CA--C 1.535 0.37 0 O-C-N 121.515 -0.741 . . . . 1.74 111.568 173.518 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 112.08 -11.39 26.88 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 125.265 1.412 . . . . 2.1400000000000001 111.717 -177.129 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -79.8 101.63 8.6 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 117.812 0.806 . . . . 3.21 110.167 -173.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -63.94 86.45 0.06 OUTLIER Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 125.26 1.41 . . . . 1.3300000000000001 110.89 -179.26 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -111.51 130.11 55.83 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 128.211 2.604 . . . . 1.0700000000000001 111.526 -173.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 5.3 t -121.65 138.42 54.34 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 125.309 1.444 . . . . 2.1899999999999999 107.301 175.194 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.7 t -83.54 136.36 22.97 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.173 0 C-N-CA 125.869 1.667 . . . . 1.8400000000000001 110.173 -171.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 36.5 mt -145.87 83.94 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 C-N-CA 125.301 1.44 . . . . 1.8899999999999999 109.258 -176.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 31.8 mp0 -57.6 165.11 1.72 Allowed 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 123.932 0.893 . . . . 4.7199999999999998 110.471 160.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 35.2 p30 -119.5 169.47 10.01 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 125.442 1.497 . . . . 6.8099999999999996 108.542 170.454 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 46.6 pt -143.69 165.0 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.116 0 C-N-CA 125.051 1.34 . . . . 7.6699999999999999 107.537 178.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -70.29 -55.35 9.43 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 109.049 -0.723 . . . . 12.390000000000001 109.049 172.482 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 140.75 -134.71 6.56 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 106.748 -2.541 . . . . 10.26 106.748 -170.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 78.5 mtt180 . . . . . 0 C--O 1.251 1.148 0 C-N-CA 125.77 1.628 . . . . 17.91 109.968 -173.324 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 . . . . . 0 N--CA 1.479 0.977 0 N-CA-C 110.244 -0.28 . . . . 5.5 110.244 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 12.9 m 66.37 154.67 0.09 Allowed 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.182 1.393 . . . . 2.9300000000000002 112.969 -174.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.2 m -157.35 170.48 22.37 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 128.13 2.572 . . . . 2.1400000000000001 105.873 172.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 75.8 tttt -130.51 152.76 49.54 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 108.548 -0.908 . . . . 3.46 108.548 177.052 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 47.1 t -148.56 156.3 42.26 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 107.505 -1.294 . . . . 1.46 107.505 170.257 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 -106.15 138.05 43.0 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 107.123 -1.436 . . . . 2.3199999999999998 107.123 169.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 15.9 mt -138.09 139.53 42.07 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 N-CA-C 104.357 -2.46 . . . . 1.76 104.357 -172.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 11.5 mt-30 -122.6 119.34 30.51 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 120.127 1.33 . . . . 4.3899999999999997 108.327 -177.201 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 99.1 t -112.32 138.83 39.85 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 O-C-N 124.184 0.928 . . . . 2.8999999999999999 110.766 -158.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.4 m -66.86 -42.88 84.92 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 113.492 0.923 . . . . 2.6000000000000001 113.492 -168.063 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -138.77 48.59 0.86 Allowed Glycine 0 C--N 1.341 0.831 0 CA-C-O 124.252 2.029 . . . . 3.7000000000000002 111.226 172.19 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . 0.257 42.7 ttp -14.31 -52.2 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 109.408 -3.396 . . . . 3.5800000000000001 111.206 136.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 12.8 t -122.07 126.38 48.3 Favored 'General case' 0 N--CA 1.44 -0.963 0 C-N-CA 126.531 1.933 . . . . 4.3099999999999996 106.591 168.126 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.3 p -110.92 64.98 0.61 Allowed 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 107.134 -1.432 . . . . 2.98 107.134 119.705 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 64.87 -64.57 0.16 Allowed 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 128.507 2.723 . . . . 3.2999999999999998 111.737 -172.199 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.1 m -47.24 -49.25 23.69 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 127.001 2.12 . . . . 3.7200000000000002 112.133 -179.481 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 74.8 m -69.04 -20.16 64.11 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 114.59 1.329 . . . . 3.1299999999999999 114.59 -142.089 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 1.2 t -52.89 -37.96 27.25 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.281 0 CA-C-N 119.09 0.859 . . . . 2.4500000000000002 110.398 169.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.3 -52.22 65.33 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 123.139 0.576 . . . . 1.24 110.515 171.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -58.66 -53.75 54.87 Favored 'General case' 0 C--O 1.227 -0.102 0 C-N-CA 124.189 0.996 . . . . 1.8999999999999999 109.157 -176.329 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.532 ' O ' HD22 ' A' ' 25' ' ' LEU . 2.4 mt -49.04 -60.87 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -0.997 0 C-N-CA 125.557 1.543 . . . . 1.78 109.789 174.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -48.09 -59.74 3.16 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 119.916 1.235 . . . . 4.0099999999999998 113.049 176.018 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.49 -39.12 67.23 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.161 0.584 . . . . 6.5300000000000002 110.764 -177.06 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 -64.88 -60.87 2.58 Favored 'General case' 0 CA--C 1.519 -0.216 0 N-CA-C 108.417 -0.957 . . . . 3.1299999999999999 108.417 178.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.653 HD23 HD21 ' A' ' 35' ' ' LEU . 0.3 OUTLIER -74.13 -42.61 59.73 Favored 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 111.911 0.337 . . . . 2.4300000000000002 111.911 -161.075 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 4.5 ttm180 -67.4 -19.17 65.36 Favored 'General case' 0 N--CA 1.433 -1.285 0 CA-C-N 119.022 0.828 . . . . 7.4199999999999999 112.526 -160.242 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 31.3 mtm105 -45.82 -61.56 1.67 Allowed 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.039 0.936 . . . . 6.9400000000000004 111.941 -177.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -175.32 12.78 0.01 OUTLIER 'General case' 0 N--CA 1.461 0.119 0 N-CA-C 114.311 1.226 . . . . 7.0999999999999996 114.311 -158.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -101.24 53.49 0.83 Allowed 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 122.587 1.184 . . . . 5.6900000000000004 108.877 -144.135 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 57.56 12.29 9.14 Favored Glycine 0 CA--C 1.531 1.091 0 CA-C-N 114.053 -1.431 . . . . 1.6899999999999999 113.377 -172.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 1.1 pp -84.83 161.89 3.05 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 CA-C-N 119.238 1.519 . . . . 4.5700000000000003 110.645 -177.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -146.61 46.0 1.2 Allowed 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 122.596 1.189 . . . . 3.0 111.666 146.101 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 70.0 m -164.16 175.91 9.74 Favored 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 131.094 3.757 . . . . 2.04 105.22 154.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.2 pp -105.06 138.48 29.75 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.133 0 CA-C-O 122.421 1.105 . . . . 2.1000000000000001 109.859 160.547 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.653 HD21 HD23 ' A' ' 25' ' ' LEU . 0.1 OUTLIER -77.4 66.47 3.16 Favored 'General case' 0 N--CA 1.43 -1.471 0 C-N-CA 129.684 3.194 . . . . 4.5 111.021 -178.157 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 19.2 t -134.51 140.53 45.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 O-C-N 121.139 -0.976 . . . . 1.4099999999999999 110.078 169.284 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -150.18 64.47 0.96 Allowed 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 103.31 -2.848 . . . . 0.76000000000000001 103.31 162.679 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -59.04 -43.26 91.64 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 108.517 -0.92 . . . . 3.1699999999999999 108.517 -173.643 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 66.9 mtt -44.25 -37.48 3.26 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.556 0.742 . . . . 4.54 112.795 169.209 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -97.52 -10.25 25.61 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.564 1.146 . . . . 1.9199999999999999 112.923 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 87.44 36.87 8.45 Favored Glycine 0 C--N 1.341 0.825 0 CA-C-N 120.114 1.325 . . . . 1.03 110.956 173.138 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 2.3 ptmt -162.47 178.52 8.54 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 119.03 1.415 . . . . 3.4100000000000001 110.25 -174.278 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.413 ' HB1' ' HG ' ' A' ' 35' ' ' LEU . . . -118.56 133.02 56.18 Favored 'General case' 0 N--CA 1.441 -0.907 0 C-N-CA 128.051 2.54 . . . . 1.0 108.899 175.066 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -126.06 82.58 2.08 Favored 'General case' 0 C--N 1.339 0.127 0 C-N-CA 123.995 0.918 . . . . 2.8599999999999999 112.012 -172.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 9.9 p -83.19 134.53 26.72 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.462 0 C-N-CA 123.237 0.615 . . . . 1.5700000000000001 110.39 -169.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 35.6 ttm105 -113.14 127.64 56.25 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 103.955 -2.609 . . . . 4.2599999999999998 103.955 158.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 4.2 p90 -157.73 175.36 14.0 Favored 'General case' 0 CA--C 1.515 -0.373 0 C-N-CA 123.407 0.683 . . . . 2.0299999999999998 109.279 -170.172 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -122.68 94.63 47.39 Favored Pre-proline 0 CA--C 1.533 0.325 0 CA-C-O 119.021 -0.514 . . . . 2.7599999999999998 110.245 178.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -71.36 73.73 2.12 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 123.78 2.987 . . . . 1.46 112.234 -176.105 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -146.93 -51.61 0.21 Allowed 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 125.883 1.673 . . . . 1.29 106.533 165.431 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 95.9 t -53.95 -57.61 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.768 0 C-N-CA 124.517 1.127 . . . . 1.1200000000000001 109.535 170.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.403 ' O ' ' HB2' ' A' ' 53' ' ' GLN 0.252 11.5 tt -94.81 -71.08 0.58 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.371 0 CA-C-O 118.341 -0.838 . . . . 1.8799999999999999 113.169 -169.454 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.403 ' HB2' ' O ' ' A' ' 52' ' ' ILE . 0.0 OUTLIER 109.54 139.45 0.0 OUTLIER Pre-proline 0 N--CA 1.469 0.523 0 C-N-CA 129.993 3.317 . . . . 2.96 108.498 -173.54 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_exo -51.27 -50.86 12.58 Favored 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 124.215 3.277 . . . . 1.0800000000000001 114.595 172.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -47.03 -55.55 3.79 Favored 'Trans proline' 0 N--CA 1.446 -1.308 0 C-N-CA 121.533 1.489 . . . . 1.0 110.308 166.147 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 25.1 mtm -62.66 -35.87 81.04 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 118.067 -1.453 . . . . 1.8500000000000001 112.242 -172.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . 0.261 2.7 tt -68.35 -39.56 81.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-N 119.023 0.829 . . . . 2.1099999999999999 111.035 179.391 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -59.22 -55.6 32.87 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 118.933 0.788 . . . . 0.94999999999999996 112.162 169.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -50.25 -47.04 55.33 Favored 'General case' 0 N--CA 1.442 -0.864 0 C-N-CA 126.169 1.788 . . . . 4.0499999999999998 110.835 -178.538 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -46.1 -42.76 14.08 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.246 0.618 . . . . 4.5199999999999996 112.325 174.433 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 40.7 mt -74.63 -44.6 46.61 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 N-CA-C 108.405 -0.961 . . . . 1.53 108.405 -177.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.1 -62.13 1.97 Allowed 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 124.969 1.308 . . . . 7.8399999999999999 112.894 -178.409 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -57.64 -58.71 7.12 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 124.117 0.967 . . . . 3.1299999999999999 111.447 -163.042 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.33 -34.39 23.69 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 122.766 0.427 . . . . 2.1099999999999999 111.649 -179.033 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -93.66 -91.69 1.58 Allowed Glycine 0 CA--C 1.525 0.709 0 N-CA-C 111.089 -0.805 . . . . 1.8700000000000001 111.089 -174.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -138.1 -79.17 0.36 Allowed 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 122.422 1.106 . . . . 3.0099999999999998 112.837 -157.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 156.19 122.38 0.75 Allowed Glycine 0 N--CA 1.445 -0.707 0 N-CA-C 105.406 -3.078 . . . . 1.3899999999999999 105.406 -143.503 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -145.86 116.67 7.71 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 107.929 -1.137 . . . . 1.22 107.929 -167.318 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 41.1 p -93.7 118.52 31.5 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 107.093 -1.447 . . . . 2.96 107.093 176.318 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.2 t -83.56 121.29 36.08 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 N-CA-C 107.176 -1.416 . . . . 1.6499999999999999 107.176 177.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 47.0 mt -145.24 77.12 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.307 0 N-CA-C 108.213 -1.032 . . . . 1.9299999999999999 108.213 -169.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.468 ' H ' ' CD ' ' A' ' 72' ' ' GLU . 2.3 pm0 -67.27 69.6 0.09 Allowed 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.893 0.877 . . . . 5.1299999999999999 111.011 166.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 38.27 75.84 0.07 Allowed 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 128.492 2.717 . . . . 5.6399999999999997 114.631 171.277 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 42.4 mm -59.32 -41.32 83.82 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 C-N-CA 124.023 0.929 . . . . 9.1300000000000008 112.73 -177.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -143.26 157.52 44.42 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 107.154 -1.425 . . . . 9.9900000000000002 107.154 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -168.28 68.68 0.17 Allowed Glycine 0 CA--C 1.523 0.59 0 N-CA-C 108.933 -1.667 . . . . 9.8699999999999992 108.933 -177.063 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.255 1.346 0 C-N-CA 126.974 2.11 . . . . 14.279999999999999 105.658 -175.405 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 1.3 t30 . . . . . 0 N--CA 1.476 0.858 0 N-CA-C 108.626 -0.879 . . . . 5.0599999999999996 108.626 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.7 p 42.76 59.46 2.8 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 122.779 1.276 . . . . 2.9700000000000002 110.181 -166.59 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.8 m -106.73 142.37 36.47 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 125.929 1.692 . . . . 2.3100000000000001 108.471 -165.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 18.7 ttpt -93.58 154.05 18.07 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 118.96 -0.543 . . . . 3.6899999999999999 110.219 177.381 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 9.3 t -153.59 160.63 42.5 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 108.377 -0.972 . . . . 1.72 108.377 167.234 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -105.41 157.62 17.22 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.376 1.071 . . . . 2.3799999999999999 109.249 -173.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.467 ' HB ' ' HB3' ' A' ' 43' ' ' ALA . 3.3 mt -145.22 147.05 19.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 N-CA-C 107.315 -1.365 . . . . 1.77 107.315 179.504 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 -108.59 141.26 40.78 Favored 'General case' 0 C--O 1.232 0.16 0 N-CA-C 107.88 -1.156 . . . . 4.1600000000000001 107.88 170.552 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 57.0 t -108.08 126.27 64.67 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 O-C-N 124.086 0.866 . . . . 2.77 109.807 179.163 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 11.1 m -75.33 75.3 2.43 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.61 0.764 . . . . 2.8500000000000001 110.968 -179.42 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 164.05 -62.47 0.25 Allowed Glycine 0 C--O 1.227 -0.323 0 N-CA-C 105.544 -3.022 . . . . 4.0300000000000002 105.544 173.382 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . 0.333 0.0 OUTLIER 59.28 138.38 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 129.347 3.059 . . . . 3.8900000000000001 114.512 178.352 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.609 ' H ' HD12 ' A' ' 38' ' ' LEU . 7.0 m 73.31 -59.11 0.58 Allowed 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 126.161 1.784 . . . . 5.2000000000000002 109.767 -177.395 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 38.5 m 51.38 -124.27 2.22 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.893 1.277 . . . . 3.1299999999999999 108.729 170.436 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -155.86 142.95 19.11 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 106.099 -1.815 . . . . 2.6899999999999999 106.099 152.397 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 56.9 p 64.54 -25.1 0.08 Allowed 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 116.536 2.05 . . . . 3.7400000000000002 116.536 -179.266 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 99.2 m -38.57 -38.69 0.41 Allowed 'General case' 0 C--O 1.225 -0.236 0 C-N-CA 125.141 1.376 . . . . 2.8500000000000001 112.186 171.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.6 t -65.38 -45.97 91.64 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.359 0 C-N-CA 124.544 1.137 . . . . 2.4900000000000002 109.796 -178.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.97 -47.01 78.43 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 123.603 0.761 . . . . 1.3 109.292 173.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -58.18 -58.52 8.12 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 109.005 -0.739 . . . . 1.96 109.005 179.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.519 HG23 HD21 ' A' ' 35' ' ' LEU . 40.5 mt -46.62 -60.05 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 C-N-CA 126.308 1.843 . . . . 1.8799999999999999 110.343 179.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 73.1 mt-10 -47.38 -61.77 1.75 Allowed 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.494 0.718 . . . . 3.0499999999999998 111.783 174.174 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 7.1 mpt_? -62.06 -32.59 73.13 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.978 -0.555 . . . . 6.4000000000000004 111.308 -168.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 18.9 m-20 -71.85 -64.58 0.9 Allowed 'General case' 0 CA--C 1.528 0.134 0 CA-C-O 121.515 0.674 . . . . 3.5800000000000001 110.67 175.381 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.485 HD12 ' CD1' ' A' ' 35' ' ' LEU . 4.3 mt -78.73 -9.87 59.57 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 125.556 1.542 . . . . 3.71 111.545 -162.652 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -21.36 -77.34 0.01 OUTLIER 'General case' 0 N--CA 1.444 -0.76 0 C-N-CA 130.223 3.409 . . . . 8.6999999999999993 112.917 -166.411 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 11.1 ptp180 -92.76 -37.93 12.07 Favored 'General case' 0 N--CA 1.435 -1.185 0 C-N-CA 129.284 3.034 . . . . 12.470000000000001 116.501 154.552 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 23.9 pt-20 11.22 56.15 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.289 1.436 . . . . 8.0199999999999996 113.455 -144.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 14.3 mp0 32.07 54.53 0.31 Allowed 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 128.125 2.57 . . . . 7.6299999999999999 112.711 -174.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 179.3 -37.49 0.07 OUTLIER Glycine 0 CA--C 1.54 1.612 0 C-N-CA 123.979 0.8 . . . . 1.55 113.978 -172.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.415 HD12 ' HB3' ' A' ' 25' ' ' LEU . 6.0 mt -81.98 145.85 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 C-N-CA 127.705 2.402 . . . . 2.0499999999999998 107.199 167.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 79.7 m-85 -147.45 47.8 1.12 Allowed 'General case' 0 N--CA 1.456 -0.15 0 CA-C-O 122.315 1.055 . . . . 4.1500000000000004 111.119 157.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.8 t -168.15 135.64 2.17 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 126.15 1.78 . . . . 1.6599999999999999 106.972 145.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.7 pp -82.98 152.06 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 CA-C-O 123.582 1.658 . . . . 1.9399999999999999 112.223 -171.197 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.873 ' H ' HD23 ' A' ' 35' ' ' LEU . 1.9 pt? -76.48 58.48 1.34 Allowed 'General case' 0 N--CA 1.43 -1.443 0 C-N-CA 131.517 3.927 . . . . 4.7300000000000004 111.541 -167.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.452 HG22 HD23 ' A' ' 38' ' ' LEU . 76.8 t -135.46 122.99 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 O-C-N 121.129 -0.982 . . . . 1.46 113.556 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -133.56 57.23 1.81 Allowed 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 106.43 -1.692 . . . . 0.69999999999999996 106.43 150.351 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.609 HD12 ' H ' ' A' ' 13' ' ' THR . 0.5 OUTLIER -75.45 -6.39 49.87 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 123.615 0.766 . . . . 5.3200000000000003 111.838 -175.122 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 66.8 mtt -59.49 -41.02 88.87 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 109.791 -0.448 . . . . 4.8200000000000003 109.791 161.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -86.99 -41.25 14.04 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.133 0.573 . . . . 1.73 110.072 177.305 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 117.95 48.0 0.42 Allowed Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.094 -1.202 . . . . 0.89000000000000001 110.094 176.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -162.48 177.53 9.41 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 106.561 -1.644 . . . . 4.0499999999999998 106.561 -170.166 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.467 ' HB3' ' HB ' ' A' ' 7' ' ' ILE . . . -140.89 140.59 34.56 Favored 'General case' 0 N--CA 1.441 -0.906 0 C-N-CA 125.132 1.373 . . . . 1.02 108.887 -167.509 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -141.86 104.72 4.56 Favored 'General case' 0 C--N 1.344 0.363 0 CA-C-N 118.968 0.804 . . . . 3.2599999999999998 110.538 179.421 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 7.7 p -90.99 142.09 13.46 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.101 0 C-N-CA 124.33 1.052 . . . . 1.74 108.474 -172.358 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 16.6 tpp180 -107.43 122.63 47.0 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 106.07 -1.826 . . . . 4.8499999999999996 106.07 163.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -160.45 179.13 8.88 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 118.832 0.742 . . . . 2.23 112.19 -168.725 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 35.7 m-20 -109.24 109.82 60.46 Favored Pre-proline 0 CA--C 1.53 0.198 0 N-CA-C 108.123 -1.066 . . . . 3.1200000000000001 108.123 163.206 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -76.4 58.77 5.88 Favored 'Trans proline' 0 CA--C 1.536 0.603 0 C-N-CA 123.508 2.805 . . . . 2.3199999999999998 110.598 -178.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -157.44 -51.08 0.07 Allowed 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 125.873 1.669 . . . . 1.9299999999999999 107.224 -172.217 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 74.1 t -61.24 -43.56 96.71 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.866 0 C-N-CA 124.34 1.056 . . . . 1.46 109.867 173.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.54 HG12 HG22 ' A' ' 57' ' ' ILE . 2.2 tp -109.52 -54.62 5.42 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.255 0 C-N-CA 122.891 0.476 . . . . 1.9399999999999999 110.743 -175.06 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.412 ' HA ' ' HD3' ' A' ' 54' ' ' PRO . 2.2 mm-40 95.5 128.35 0.02 OUTLIER Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 129.21 3.004 . . . . 3.7799999999999998 110.813 171.547 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 53' ' ' GLN . 71.2 Cg_exo -55.88 -43.26 58.79 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 123.506 2.804 . . . . 1.1499999999999999 116.521 -172.444 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -58.35 -43.1 49.32 Favored 'Trans proline' 0 N--CA 1.445 -1.347 0 CA-C-N 121.533 1.583 . . . . 1.1299999999999999 109.079 175.377 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 63.5 mtt -61.77 -44.51 96.75 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 118.403 -0.808 . . . . 1.8899999999999999 109.928 179.233 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.54 HG22 HG12 ' A' ' 52' ' ' ILE . 0.6 OUTLIER -62.27 -48.54 87.89 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 CA-C-N 120.084 1.311 . . . . 2.4900000000000002 110.903 177.359 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -54.23 -38.45 65.75 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 124.332 1.053 . . . . 1.52 112.165 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -70.01 -60.7 2.14 Favored 'General case' 0 N--CA 1.442 -0.828 0 C-N-CA 125.405 1.482 . . . . 3.3100000000000001 110.644 172.185 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -44.91 -43.78 9.18 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 124.191 0.996 . . . . 3.77 112.464 -177.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 67.8 mt -63.23 -43.54 98.8 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 O-C-N 121.912 -0.493 . . . . 1.1100000000000001 110.017 -178.655 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . 0.301 7.6 ptp180 -70.83 -42.16 70.56 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-O 119.359 -0.353 . . . . 3.8500000000000001 111.604 179.152 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -55.39 -45.05 76.65 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 124.154 0.981 . . . . 3.0499999999999998 110.836 174.479 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 63.7 mt -81.2 -38.72 26.56 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-O 119.507 -0.283 . . . . 2.0800000000000001 110.628 -174.152 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -104.93 -90.77 2.19 Favored Glycine 0 CA--C 1.527 0.808 0 N-CA-C 111.33 -0.708 . . . . 2.0099999999999998 111.33 179.172 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 18.1 m-85 -142.29 -56.97 0.45 Allowed 'General case' 0 CA--C 1.509 -0.615 0 CA-C-O 122.464 1.126 . . . . 3.9700000000000002 111.699 -157.013 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 162.27 126.3 0.81 Allowed Glycine 0 N--CA 1.432 -1.599 0 N-CA-C 105.784 -2.927 . . . . 1.5700000000000001 105.784 -149.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -157.05 153.77 28.45 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 117.234 0.517 . . . . 1.04 110.102 177.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 2.4 t -128.16 144.69 51.13 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 106.747 -1.575 . . . . 2.7599999999999998 106.747 174.434 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 12.6 p -81.23 150.74 4.52 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 N-CA-C 107.173 -1.418 . . . . 2.2999999999999998 107.173 170.178 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 4.8 pt -154.95 175.91 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 C-N-CA 126.368 1.867 . . . . 3.0 106.833 177.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -145.0 157.79 44.02 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 108.286 -1.005 . . . . 4.8899999999999997 108.286 167.316 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -134.15 98.39 4.11 Favored 'General case' 0 C--N 1.333 -0.115 0 N-CA-C 108.094 -1.076 . . . . 7.71 108.094 -173.584 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -57.95 115.6 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 N-CA-C 107.937 -1.134 . . . . 8.2799999999999994 107.937 168.233 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 62.96 -66.53 0.09 Allowed 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 126.443 1.897 . . . . 13.52 112.714 -171.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 63.4 43.06 98.84 Favored Glycine 0 CA--C 1.529 0.941 0 N-CA-C 110.066 -1.214 . . . . 14.43 110.066 -168.081 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.011 0 N-CA-C 107.703 -1.221 . . . . 18.73 107.703 176.476 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 . . . . . 0 N--CA 1.478 0.944 0 N-CA-C 107.229 -1.397 . . . . 7.1299999999999999 107.229 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.5 m -163.2 154.69 17.31 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 118.919 0.781 . . . . 2.8300000000000001 109.169 -174.076 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 22.7 m -89.26 161.36 16.45 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 107.916 -1.142 . . . . 1.8 107.916 160.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 51.6 mtmt -113.41 160.48 18.37 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 123.777 0.831 . . . . 4.1900000000000004 108.847 162.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 49.7 t -155.52 154.2 31.41 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 106.931 -1.507 . . . . 1.47 106.931 170.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -100.93 154.91 18.28 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 122.173 0.987 . . . . 2.73 108.663 175.386 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.7 mp -134.04 138.22 50.69 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 N-CA-C 104.792 -2.299 . . . . 1.8700000000000001 104.792 169.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 47.9 tp60 -95.56 122.96 38.86 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 103.332 -2.84 . . . . 2.6099999999999999 103.332 165.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 26.0 m -118.38 147.71 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 C-N-CA 124.671 1.189 . . . . 2.5899999999999999 108.008 -178.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 6.9 m -105.05 70.03 0.88 Allowed 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.02 0.528 . . . . 2.5 109.694 -175.557 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 156.55 -36.49 0.59 Allowed Glycine 0 C--N 1.341 0.814 0 C-N-CA 121.029 -0.605 . . . . 2.3599999999999999 114.274 170.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 2.6 mpp? 46.91 42.16 11.81 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.48 1.112 . . . . 4.1200000000000001 110.589 -168.565 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.2 p 56.78 1.79 0.09 Allowed 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 115.919 1.822 . . . . 10.82 115.919 -173.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . 0.372 0.1 OUTLIER 77.39 174.28 0.2 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 127.334 2.254 . . . . 4.0300000000000002 112.442 -166.695 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.03 132.74 54.37 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.034 0.934 . . . . 4.04 111.221 -169.428 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 10.4 m 74.15 -37.68 0.37 Allowed 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.124 1.369 . . . . 5.0300000000000002 113.63 174.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 75.6 m -54.94 -28.41 50.96 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 127.159 2.184 . . . . 5.6699999999999999 111.08 176.011 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 8.1 m -38.31 -40.98 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 N-CA-C 113.378 0.881 . . . . 2.4399999999999999 113.378 164.032 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -45.56 -49.12 14.21 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 124.153 0.981 . . . . 1.6499999999999999 110.876 174.203 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -54.7 -57.43 11.51 Favored 'General case' 0 CA--C 1.519 -0.237 0 N-CA-C 109.346 -0.613 . . . . 3.2000000000000002 109.346 173.403 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 3.6 tp -67.72 -39.29 81.81 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.382 0 CA-C-N 118.401 0.546 . . . . 4.5099999999999998 109.816 -163.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.451 ' HG2' ' CG1' ' A' ' 34' ' ' ILE . 59.0 mt-10 -56.18 -56.6 18.94 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.993 1.317 . . . . 3.6699999999999999 110.61 171.233 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.7 tmt_? -52.99 -39.36 63.0 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 109.616 -0.513 . . . . 6.1900000000000004 109.616 176.654 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -72.41 -42.28 65.31 Favored 'General case' 0 N--CA 1.431 -1.383 0 CA-C-O 118.037 -0.983 . . . . 3.3799999999999999 109.148 -178.187 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -56.72 -37.89 71.59 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 121.335 1.88 . . . . 2.5499999999999998 109.253 176.71 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 56.7 mtp180 -65.46 -12.34 51.56 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 115.262 1.578 . . . . 6.29 115.262 175.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.412 ' HG2' ' CG ' ' A' ' 28' ' ' GLU . 1.0 OUTLIER -66.02 -17.87 64.97 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 121.028 1.74 . . . . 8.2400000000000002 111.294 167.247 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.412 ' CG ' ' HG2' ' A' ' 27' ' ' ARG . 6.5 mt-10 -104.06 90.85 3.72 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 108.931 -0.766 . . . . 7.7400000000000002 108.931 -166.357 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -43.64 133.15 4.69 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 107.724 -1.213 . . . . 8.4399999999999995 107.724 166.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 110.82 -36.27 4.33 Favored Glycine 0 CA--C 1.527 0.787 0 CA-C-O 118.639 -1.09 . . . . 1.4199999999999999 111.786 -166.149 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 3.7 mt -83.03 126.44 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.378 0 CA-C-N 119.316 1.558 . . . . 2.1499999999999999 108.772 174.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -134.89 42.07 2.82 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 122.363 1.078 . . . . 3.5699999999999998 112.4 160.455 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 9.1 t -167.76 137.78 2.73 Favored 'General case' 0 C--N 1.316 -0.866 0 C-N-CA 128.008 2.523 . . . . 2.0800000000000001 106.911 144.455 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.589 ' H ' ' CD1' ' A' ' 34' ' ' ILE . 0.0 OUTLIER -78.86 134.54 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.369 0 CA-C-O 122.814 1.293 . . . . 2.3799999999999999 109.535 -179.598 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.417 ' HA ' ' H ' ' A' ' 44' ' ' GLU . 0.7 OUTLIER -81.31 68.21 7.54 Favored 'General case' 0 N--CA 1.431 -1.382 0 CA-C-N 115.317 -0.856 . . . . 4.8300000000000001 110.481 -176.527 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 4.9 t -130.42 139.46 51.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 121.917 0.865 . . . . 1.6000000000000001 111.487 167.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -151.95 72.8 1.03 Allowed 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 127.602 2.361 . . . . 1.23 107.621 169.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.916 HD23 ' H ' ' A' ' 38' ' ' LEU . 0.2 OUTLIER -46.96 -43.69 19.38 Favored 'General case' 0 CA--C 1.509 -0.621 0 C-N-CA 124.08 0.952 . . . . 3.3599999999999999 110.572 169.006 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 24.3 ptt? -79.81 42.31 0.53 Allowed 'General case' 0 CA--C 1.545 0.786 0 CA-C-O 121.65 0.738 . . . . 4.7800000000000002 111.649 -167.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -178.23 -40.81 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 129.751 3.22 . . . . 1.3400000000000001 106.878 -171.423 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 98.44 49.9 1.63 Allowed Glycine 0 C--N 1.339 0.735 0 N-CA-C 108.072 -2.011 . . . . 0.88 108.072 172.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 46.5 mttm -152.7 179.87 8.24 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 126.217 1.807 . . . . 4.8399999999999999 108.727 -158.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -151.18 131.71 13.86 Favored 'General case' 0 N--CA 1.442 -0.831 0 C-N-CA 125.29 1.436 . . . . 1.1699999999999999 108.109 -171.174 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.417 ' H ' ' HA ' ' A' ' 35' ' ' LEU . 0.6 OUTLIER -136.59 102.96 5.08 Favored 'General case' 0 C--N 1.342 0.242 0 CA-C-N 118.967 0.803 . . . . 2.77 112.22 -175.627 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 12.4 p -82.65 146.94 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.215 0 N-CA-C 108.989 -0.745 . . . . 1.6499999999999999 108.989 -176.536 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 60.6 ttp180 -122.69 123.25 40.69 Favored 'General case' 0 C--N 1.339 0.126 0 N-CA-C 105.823 -1.917 . . . . 5.6699999999999999 105.823 159.633 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 1.5 p90 -160.27 175.23 13.1 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 118.298 0.499 . . . . 2.1200000000000001 110.994 -164.419 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -110.44 117.94 50.07 Favored Pre-proline 0 CA--C 1.539 0.546 0 C-N-CA 123.472 0.709 . . . . 3.1899999999999999 109.224 166.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -74.78 23.84 0.38 Allowed 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 122.933 2.422 . . . . 1.98 113.91 -170.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -109.55 -49.33 3.12 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.752 1.221 . . . . 1.1699999999999999 108.403 -178.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 98.4 t -65.52 -50.3 72.96 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.89 0 C-N-CA 124.271 1.028 . . . . 1.3200000000000001 109.917 -179.654 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.413 ' O ' ' HB2' ' A' ' 53' ' ' GLN . 3.3 tp -102.64 -62.62 2.0 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.391 0 CA-C-O 118.652 -0.69 . . . . 1.75 112.401 -163.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.413 ' HB2' ' O ' ' A' ' 52' ' ' ILE . 11.4 mm-40 96.14 127.12 0.02 OUTLIER Pre-proline 0 CA--C 1.548 0.873 0 C-N-CA 129.85 3.26 . . . . 3.9399999999999999 112.318 176.376 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.458 ' HA ' HG12 ' A' ' 57' ' ' ILE . 47.0 Cg_exo -44.15 -51.83 6.29 Favored 'Trans proline' 0 C--N 1.351 0.708 1 C-N-CA 125.349 4.033 . . . . 1.1899999999999999 116.4 174.33 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -52.51 -46.41 33.39 Favored 'Trans proline' 0 N--CA 1.446 -1.291 0 CA-C-N 120.706 1.288 . . . . 0.82999999999999996 110.17 173.284 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 60.1 mtp -64.46 -46.26 83.85 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 118.723 -0.656 . . . . 2.6299999999999999 111.053 -176.541 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.458 HG12 ' HA ' ' A' ' 54' ' ' PRO . 20.6 pt -60.19 -49.91 82.29 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 CA-C-N 119.897 1.226 . . . . 2.4300000000000002 110.944 175.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -48.04 -49.63 30.66 Favored 'General case' 0 C--N 1.341 0.199 0 C-N-CA 123.442 0.697 . . . . 1.1499999999999999 110.998 176.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -61.92 -57.1 13.01 Favored 'General case' 0 N--CA 1.434 -1.234 0 C-N-CA 124.234 1.014 . . . . 3.0899999999999999 112.369 178.069 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 9.0 m-30 -47.66 -50.05 25.82 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 118.796 0.726 . . . . 3.4500000000000002 109.773 -174.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 20.0 mt -51.92 -43.23 35.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 123.319 0.648 . . . . 1.3899999999999999 112.009 175.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 91.2 mtt180 -65.37 -59.4 4.07 Favored 'General case' 0 N--CA 1.457 -0.076 0 N-CA-C 109.477 -0.564 . . . . 4.3700000000000001 109.477 175.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -44.62 -54.54 6.04 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 125.758 1.623 . . . . 2.9399999999999999 111.941 -173.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . 0.253 0.3 OUTLIER -84.37 -13.39 52.43 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 114.071 1.137 . . . . 2.6000000000000001 114.071 179.44 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -152.74 -88.52 0.07 OUTLIER Glycine 0 CA--C 1.531 1.036 0 CA-C-N 119.84 1.2 . . . . 1.7 115.994 -165.105 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -136.43 147.25 47.15 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-O 121.732 0.777 . . . . 3.5800000000000001 112.665 -147.016 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -58.68 108.3 1.49 Allowed Glycine 0 N--CA 1.441 -0.978 0 N-CA-C 109.097 -1.601 . . . . 1.5600000000000001 109.097 177.371 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -116.54 130.07 56.54 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 126.41 1.884 . . . . 1.22 109.088 -173.212 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 41.6 m -128.24 129.29 46.17 Favored 'General case' 0 CA--C 1.528 0.097 0 C-N-CA 124.964 1.306 . . . . 2.96 107.921 175.137 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 13.3 p -82.42 140.35 16.53 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 C-N-CA 123.741 0.817 . . . . 2.2400000000000002 109.698 -175.723 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 46.7 mt -143.26 143.18 25.02 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 125.315 1.446 . . . . 2.04 108.493 -175.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -156.72 159.09 38.02 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 107.056 -1.461 . . . . 4.1200000000000001 107.056 166.145 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 48.5 m-80 -150.22 151.15 32.58 Favored 'General case' 0 N--CA 1.457 -0.122 0 N-CA-C 106.619 -1.623 . . . . 4.9299999999999997 106.619 -176.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 32.8 mm -138.06 140.52 40.35 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 N-CA-C 105.131 -2.174 . . . . 8.8900000000000006 105.131 175.265 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 3.64 77.52 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 129.671 3.188 . . . . 12.31 114.881 176.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -170.91 152.85 19.53 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 107.876 -2.089 . . . . 8.7799999999999994 107.876 175.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 39.5 ttt85 . . . . . 0 C--O 1.253 1.278 0 N-CA-C 105.032 -2.21 . . . . 16.02 105.032 -179.751 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 . . . . . 0 N--CA 1.477 0.901 0 N-CA-C 107.666 -1.235 . . . . 5.0899999999999999 107.666 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.5 p -67.32 162.32 23.1 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 119.528 1.058 . . . . 2.5499999999999998 110.833 175.149 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 47.5 m -154.93 165.77 35.65 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.419 1.088 . . . . 1.8500000000000001 108.939 179.161 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.53 130.74 56.61 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 125.006 1.322 . . . . 4.7000000000000002 107.988 174.784 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 51.2 t -123.01 146.42 47.66 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 118.973 0.806 . . . . 1.3300000000000001 109.427 173.196 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -92.24 133.1 36.13 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.47 1.108 . . . . 2.5299999999999998 108.952 172.704 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.0 mm -124.3 151.9 29.75 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 N-CA-C 103.822 -2.658 . . . . 2.3100000000000001 103.822 178.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 45.1 tp60 -117.37 125.01 50.29 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 103.551 -2.759 . . . . 3.27 103.551 168.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.8 m -87.91 141.36 14.43 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 N-CA-C 108.695 -0.854 . . . . 2.4100000000000001 108.695 178.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 52.6 p -104.4 84.99 2.27 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 105.255 -2.128 . . . . 2.98 105.255 165.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 177.74 -67.82 0.08 OUTLIER Glycine 0 CA--C 1.522 0.493 0 N-CA-C 105.392 -3.083 . . . . 2.3599999999999999 105.392 -178.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 14.1 ttp 70.99 -61.64 0.48 Allowed 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 126.774 2.029 . . . . 3.8500000000000001 112.441 165.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.8 m -142.65 49.43 1.5 Allowed 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 125.946 1.698 . . . . 4.7999999999999998 106.878 173.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.9 p -53.99 -51.77 62.85 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 109.119 -0.697 . . . . 3.4700000000000002 109.119 177.14 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 176.73 120.19 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 127.221 2.209 . . . . 3.54 107.352 157.172 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 4.2 p 48.92 38.61 12.65 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.426 0.69 . . . . 3.0699999999999998 111.044 -171.005 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 29.5 t -55.14 -44.77 75.41 Favored 'General case' 0 N--CA 1.461 0.094 0 C-N-CA 126.591 1.956 . . . . 4.0099999999999998 108.141 -178.603 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.2 m -70.79 -49.58 49.87 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.089 0 CA-C-N 113.955 -1.475 . . . . 2.23 110.989 -171.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.64 -41.7 73.96 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.955 0.902 . . . . 0.85999999999999999 110.824 171.074 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -55.05 -50.99 67.71 Favored 'General case' 0 C--N 1.341 0.205 0 N-CA-C 108.566 -0.901 . . . . 2.1899999999999999 108.566 172.346 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.787 HG21 HG23 ' A' ' 36' ' ' VAL . 4.6 mt -56.09 -51.21 64.62 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 CA-C-O 118.494 -0.765 . . . . 2.46 110.024 178.196 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -49.98 -57.03 8.39 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 119.332 0.969 . . . . 3.4199999999999999 110.065 177.253 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 32.6 mmt180 -51.72 -46.63 64.02 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 122.743 0.417 . . . . 4.54 111.814 177.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 67.4 m-20 -67.13 -63.93 0.96 Allowed 'General case' 0 C--O 1.224 -0.242 0 CA-C-O 121.825 0.821 . . . . 3.1000000000000001 109.612 -176.038 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.707 HD23 HG23 ' A' ' 21' ' ' ILE . 0.0 OUTLIER -71.1 -28.52 64.38 Favored 'General case' 0 N--CA 1.439 -1.022 0 C-N-CA 124.339 1.056 . . . . 2.3399999999999999 110.316 -165.773 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . 0.487 28.1 mtp-105 -70.11 0.51 6.03 Favored 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 116.192 1.923 . . . . 5.7699999999999996 116.192 167.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 9.5 mmt180 -38.07 -36.03 0.19 Allowed 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 117.777 -1.569 . . . . 7.9199999999999999 112.393 143.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 70.04 43.61 0.88 Allowed 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 126.075 1.75 . . . . 8.6899999999999995 108.359 -178.061 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -73.77 58.46 0.63 Allowed 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 126.832 2.053 . . . . 5.2000000000000002 108.795 179.008 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 66.0 34.28 87.98 Favored Glycine 0 CA--C 1.532 1.128 0 O-C-N 121.316 -0.865 . . . . 1.1000000000000001 112.375 -172.13 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -113.96 135.8 52.49 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 C-N-CA 126.167 1.787 . . . . 1.9299999999999999 106.993 -179.096 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -140.83 47.21 1.75 Allowed 'General case' 0 CA--C 1.53 0.184 0 CA-C-O 122.923 1.344 . . . . 3.1800000000000002 111.6 159.503 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.7 t -168.64 133.63 1.65 Allowed 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 127.791 2.437 . . . . 2.0299999999999998 105.546 144.759 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -81.0 150.99 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 CA-C-O 121.805 0.812 . . . . 2.0800000000000001 109.37 177.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.418 ' HB2' ' HB1' ' A' ' 43' ' ' ALA . 0.6 OUTLIER -81.13 65.5 6.29 Favored 'General case' 0 N--CA 1.435 -1.177 0 C-N-CA 124.151 0.98 . . . . 4.7199999999999998 111.04 -177.469 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.787 HG23 HG21 ' A' ' 21' ' ' ILE . 11.4 t -117.2 140.62 39.2 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 CA-C-O 121.956 0.884 . . . . 1.6599999999999999 111.321 162.018 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -155.79 59.78 0.6 Allowed 'General case' 0 C--O 1.236 0.389 0 C-N-CA 127.323 2.249 . . . . 0.80000000000000004 106.893 166.007 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.18 60.11 3.57 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 124.445 1.098 . . . . 3.3399999999999999 109.293 179.464 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 51.6 ttm -131.97 -52.2 0.97 Allowed 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 105.112 -2.181 . . . . 3.3100000000000001 105.112 163.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -69.13 -30.49 68.76 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 115.574 -0.739 . . . . 1.3100000000000001 111.169 165.005 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 96.32 45.46 2.78 Favored Glycine 0 C--N 1.341 0.835 0 N-CA-C 109.552 -1.419 . . . . 1.03 109.552 -178.514 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 50.1 mttt -147.73 -179.14 6.67 Favored 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 124.725 1.21 . . . . 4.21 108.295 -156.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.418 ' HB1' ' HB2' ' A' ' 35' ' ' LEU . . . -157.39 118.74 3.65 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 108.077 -1.082 . . . . 1.3300000000000001 108.077 -159.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -133.01 105.95 7.38 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 119.413 1.006 . . . . 2.6000000000000001 112.83 178.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.573 HG11 HD12 ' A' ' 57' ' ' ILE . 11.1 p -82.38 133.17 29.72 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.317 0 C-N-CA 124.421 1.088 . . . . 1.5 108.405 -177.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 71.4 ttt180 -110.17 127.07 54.72 Favored 'General case' 0 CA--C 1.52 -0.173 0 N-CA-C 105.764 -1.939 . . . . 4.5700000000000003 105.764 166.44 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 4.9 p90 -157.23 169.21 25.28 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 117.995 0.361 . . . . 2.0099999999999998 111.145 -161.024 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -114.43 98.19 48.3 Favored Pre-proline 0 CA--C 1.539 0.523 0 C-N-CA 124.548 1.139 . . . . 3.75 111.338 174.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.44 79.55 0.84 Allowed 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 122.802 2.335 . . . . 1.6299999999999999 111.46 176.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -143.63 -56.79 0.39 Allowed 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 105.867 -1.901 . . . . 1.3999999999999999 105.867 159.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 91.4 t -56.76 -62.37 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 C-N-CA 124.646 1.178 . . . . 1.3300000000000001 109.492 171.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.543 HG23 ' H ' ' A' ' 53' ' ' GLN 0.28 9.6 tp -89.3 -77.48 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 CA-C-O 118.669 -0.681 . . . . 1.6200000000000001 112.338 -160.341 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.543 ' H ' HG23 ' A' ' 52' ' ' ILE . 3.3 mp0 99.37 142.79 0.03 OUTLIER Pre-proline 0 CA--C 1.54 0.592 0 C-N-CA 129.808 3.243 . . . . 3.4199999999999999 111.414 -179.606 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.443 ' HA ' HG12 ' A' ' 57' ' ' ILE . 30.3 Cg_exo -47.95 -47.82 17.96 Favored 'Trans proline' 0 CA--C 1.536 0.614 1 C-N-CA 126.525 4.817 . . . . 1.1399999999999999 116.917 174.213 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -49.1 -62.11 0.48 Allowed 'Trans proline' 0 N--CA 1.446 -1.29 0 CA-C-N 120.874 1.348 . . . . 0.93000000000000005 109.777 163.445 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 1.1 ttt -53.94 -45.9 71.39 Favored 'General case' 0 N--CA 1.428 -1.541 0 N-CA-C 114.397 1.258 . . . . 3.8100000000000001 114.397 -173.18 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.573 HD12 HG11 ' A' ' 45' ' ' VAL . 5.0 pt -54.61 -50.08 62.11 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-N 120.15 1.341 . . . . 3.1800000000000002 111.101 175.063 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -55.33 -52.07 64.69 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 118.365 0.529 . . . . 1.0800000000000001 111.34 177.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -60.94 -58.53 8.03 Favored 'General case' 0 N--CA 1.432 -1.359 0 C-N-CA 123.769 0.828 . . . . 2.7400000000000002 111.235 -178.274 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -50.14 -35.23 25.06 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.163 0.985 . . . . 3.6000000000000001 111.909 -178.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.547 HG23 ' CE2' ' A' ' 66' ' ' PHE . 54.3 mt -64.44 -62.8 1.05 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 O-C-N 121.933 -0.479 . . . . 1.22 109.901 169.542 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 38.7 mtp180 -50.94 -43.56 60.24 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.451 0.701 . . . . 5.3399999999999999 112.799 -174.304 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -46.09 -33.11 3.27 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 126.058 1.743 . . . . 3.0 112.439 177.528 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 68.5 mt -82.36 -17.2 46.47 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 123.193 0.597 . . . . 1.8 112.029 -176.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 124.6 -35.52 3.15 Favored Glycine 0 C--N 1.339 0.708 0 CA-C-N 118.576 0.625 . . . . 2.2400000000000002 112.682 169.366 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.547 ' CE2' HG23 ' A' ' 61' ' ' ILE . 28.6 p90 -84.29 131.71 34.7 Favored 'General case' 0 N--CA 1.457 -0.106 0 N-CA-C 106.784 -1.562 . . . . 5.0099999999999998 106.784 177.24 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -88.4 162.05 31.71 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.787 -0.925 . . . . 2.1800000000000002 110.787 -163.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.509 ' HB2' HG21 ' A' ' 61' ' ' ILE . . . -137.53 144.12 41.98 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.487 1.115 . . . . 1.0800000000000001 109.025 -179.441 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 12.3 p -129.53 127.01 39.89 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 106.257 -1.756 . . . . 2.7400000000000002 106.257 172.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 28.1 t -84.66 118.04 31.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 N-CA-C 107.962 -1.125 . . . . 1.74 107.962 -176.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 28.4 mt -141.98 68.78 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 N-CA-C 107.511 -1.292 . . . . 2.21 107.511 -172.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -51.11 -57.55 8.41 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 115.673 -0.694 . . . . 4.9400000000000004 110.337 178.603 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -131.94 163.73 27.7 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 124.832 1.253 . . . . 4.9699999999999998 108.563 -175.659 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 4.7 mp -130.8 134.59 61.64 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 124.636 1.174 . . . . 8.7699999999999996 108.102 -173.335 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -80.75 154.55 27.17 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.995 0.918 . . . . 12.0 109.831 178.137 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -110.99 151.2 17.76 Favored Glycine 0 CA--C 1.526 0.772 0 N-CA-C 109.999 -1.24 . . . . 11.369999999999999 109.999 178.199 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.252 1.236 0 N-CA-C 104.801 -2.296 . . . . 18.829999999999998 104.801 178.391 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 . . . . . 0 N--CA 1.477 0.925 0 N-CA-C 107.809 -1.182 . . . . 7.29 107.809 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.6 m -55.88 118.55 4.7 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 124.179 0.992 . . . . 2.6600000000000001 111.916 -174.307 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.3 t -91.89 163.32 14.07 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 124.31 1.044 . . . . 2.5800000000000001 110.679 -169.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 3.6 ttpm? -88.96 159.5 17.61 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 125.845 1.658 . . . . 4.5899999999999999 109.968 -175.098 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.424 ' HB3' ' CG2' ' A' ' 45' ' ' VAL . 52.9 t -155.37 159.15 39.69 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 107.822 -1.177 . . . . 1.3999999999999999 107.822 153.73 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -107.49 144.48 34.38 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 125.529 1.532 . . . . 2.7799999999999998 107.151 168.708 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 7.7 mt -138.01 138.83 43.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 N-CA-C 107.867 -1.16 . . . . 1.6799999999999999 107.867 -179.482 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 66.0 mt-30 -77.1 145.62 37.71 Favored 'General case' 0 CA--C 1.522 -0.12 0 N-CA-C 106.179 -1.785 . . . . 4.6500000000000004 106.179 173.412 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 17.2 m -136.93 127.42 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 N-CA-C 108.502 -0.925 . . . . 2.1600000000000001 108.502 172.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 72.8 p -79.81 64.52 4.69 Favored 'General case' 0 CA--C 1.534 0.344 0 O-C-N 121.863 -0.523 . . . . 3.6600000000000001 110.227 -174.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 152.8 55.94 0.01 OUTLIER Glycine 0 C--N 1.339 0.695 0 CA-C-O 124.904 2.391 . . . . 3.2799999999999998 113.432 169.492 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 16.7 tmm? -43.06 -50.65 6.02 Favored 'General case' 0 N--CA 1.432 -1.329 0 CA-C-N 109.816 -3.192 . . . . 4.2599999999999998 109.39 137.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.27 -33.95 76.38 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 125.821 1.648 . . . . 5.3700000000000001 112.848 -168.215 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 21.4 m -61.79 143.35 56.43 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 109.345 -0.613 . . . . 2.8199999999999998 109.345 -173.046 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -61.6 146.53 48.63 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 108.304 -0.998 . . . . 2.5499999999999998 108.304 163.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 79.92 -62.76 0.25 Allowed 'General case' 0 C--O 1.22 -0.474 0 C-N-CA 124.965 1.306 . . . . 3.1899999999999999 112.251 179.839 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 51.8 m -36.26 -48.9 0.66 Allowed 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 125.995 1.718 . . . . 3.0699999999999998 114.54 -154.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.418 HG13 HG11 ' A' ' 36' ' ' VAL . 0.9 OUTLIER -43.95 -43.48 1.9 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.915 0 C-N-CA 125.905 1.682 . . . . 2.6699999999999999 113.553 175.467 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.02 -44.55 94.53 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 125.828 1.651 . . . . 0.84999999999999998 111.528 170.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -59.4 -51.01 71.73 Favored 'General case' 0 C--O 1.218 -0.593 0 CA-C-O 118.016 -0.993 . . . . 1.8200000000000001 108.823 173.376 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.435 HG22 HD11 ' A' ' 34' ' ' ILE . 2.5 mt -45.7 -58.76 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 C-N-CA 124.898 1.279 . . . . 2.2599999999999998 109.895 173.702 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -34.94 -59.58 0.48 Allowed 'General case' 0 C--N 1.328 -0.338 0 O-C-N 119.924 -1.735 . . . . 4.2699999999999996 113.382 166.062 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 92.7 mtt180 -59.81 -35.3 74.41 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 114.517 1.303 . . . . 4.9900000000000002 114.517 173.423 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.696 ' ND2' HD13 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -64.91 -58.74 5.36 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 125.836 1.654 . . . . 4.3700000000000001 109.567 -163.984 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.78 ' HB2' HD13 ' A' ' 34' ' ' ILE 0.256 7.3 mp -73.62 -19.83 60.75 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 121.22 0.533 . . . . 3.1400000000000001 109.896 179.105 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . 0.495 84.0 mtp180 -67.17 2.91 1.34 Allowed 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 116.465 2.024 . . . . 5.5099999999999998 116.465 164.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.413 ' CZ ' ' HA ' ' A' ' 27' ' ' ARG . 0.2 OUTLIER -38.86 -32.71 0.09 Allowed 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 116.49 -2.084 . . . . 6.7199999999999998 113.879 145.654 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . 0.267 2.0 mt-10 64.11 45.49 4.08 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 126.366 1.867 . . . . 7.9100000000000001 111.294 174.395 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 70.1 mt-10 -105.4 79.77 1.5 Allowed 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 126.467 1.907 . . . . 6.0 108.921 -174.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 64.39 26.55 70.76 Favored Glycine 0 CA--C 1.532 1.119 0 CA-C-O 121.669 0.594 . . . . 1.1399999999999999 111.733 -175.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.1 mm -93.72 158.06 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 C-N-CA 126.19 1.796 . . . . 2.0499999999999998 108.408 176.65 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 12.6 t80 -154.37 41.76 0.49 Allowed 'General case' 0 C--N 1.339 0.12 0 C-N-CA 119.857 -0.737 . . . . 6.0300000000000002 111.482 170.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.43 ' HB3' HD11 ' A' ' 35' ' ' LEU . 48.4 t -171.39 -179.42 2.61 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 128.773 2.829 . . . . 1.8300000000000001 105.319 141.372 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.895 HD12 ' H ' ' A' ' 35' ' ' LEU . 2.1 tp -134.65 141.17 44.05 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.353 0 N-CA-C 106.909 -1.515 . . . . 3.6600000000000001 106.909 149.294 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.895 ' H ' HD12 ' A' ' 34' ' ' ILE . 0.3 OUTLIER -149.02 144.03 26.47 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 114.473 -1.24 . . . . 6.9000000000000004 109.619 -158.103 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.474 ' CG1' HD23 ' A' ' 38' ' ' LEU 0.258 0.9 OUTLIER -154.64 80.77 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.437 -1.095 0 CA-C-O 124.196 1.951 . . . . 2.2999999999999998 108.786 -164.012 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -77.2 61.39 2.09 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 113.543 -1.662 . . . . 0.87 109.527 169.21 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.474 HD23 ' CG1' ' A' ' 36' ' ' VAL . 0.2 OUTLIER -46.71 -44.85 19.08 Favored 'General case' 0 CA--C 1.512 -0.487 0 C-N-CA 123.828 0.851 . . . . 3.6699999999999999 110.046 169.007 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 27.8 ttt -63.81 -36.37 83.69 Favored 'General case' 0 N--CA 1.441 -0.892 0 C-N-CA 120.208 -0.597 . . . . 5.3200000000000003 110.145 -169.199 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -74.86 -36.07 62.33 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.294 0.638 . . . . 1.8400000000000001 110.29 172.625 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 109.8 39.57 1.56 Allowed Glycine 0 C--N 1.334 0.471 0 C-N-CA 124.945 1.259 . . . . 1.2 111.009 173.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 29.5 pttt -158.75 157.04 30.94 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 108.436 -0.95 . . . . 3.7599999999999998 108.436 -176.464 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -82.59 147.95 28.3 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 107.279 -1.378 . . . . 1.1299999999999999 107.279 167.624 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.557 ' CB ' ' HB2' ' A' ' 35' ' ' LEU . 36.1 mt-10 -103.61 153.28 20.78 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 105.962 -1.866 . . . . 2.9700000000000002 105.962 171.008 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.577 ' HA ' HD13 ' A' ' 35' ' ' LEU . 34.1 m -137.95 148.4 25.31 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-N 119.195 0.907 . . . . 2.73 109.528 171.775 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 58.3 ttm-85 -133.47 130.77 39.05 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 106.234 -1.765 . . . . 4.8399999999999999 106.234 164.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 26.7 p90 -156.45 167.69 29.68 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 110.099 -0.334 . . . . 2.2999999999999998 110.099 -167.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -105.97 104.3 48.67 Favored Pre-proline 0 CA--C 1.542 0.661 0 C-N-CA 123.311 0.644 . . . . 3.2799999999999998 111.056 178.364 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -75.82 73.02 4.93 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 122.627 2.218 . . . . 1.98 111.661 -175.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -142.71 -63.72 0.42 Allowed 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 105.979 -1.86 . . . . 1.22 105.979 161.493 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 72.7 t -56.07 -52.32 51.63 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.749 0 C-N-CA 124.905 1.282 . . . . 1.3100000000000001 110.263 175.343 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 20.1 tt -84.16 -52.19 13.05 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.403 0 N-CA-C 114.125 1.158 . . . . 3.3399999999999999 114.125 -151.415 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER 71.3 109.5 0.03 OUTLIER Pre-proline 0 CA--C 1.538 0.517 0 C-N-CA 127.968 2.507 . . . . 2.7200000000000002 111.266 -165.702 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_exo -46.72 -41.29 24.67 Favored 'Trans proline' 0 CA--C 1.54 0.814 0 C-N-CA 123.358 2.705 . . . . 1.3600000000000001 115.102 162.186 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_endo -55.09 -50.41 13.21 Favored 'Trans proline' 0 N--CA 1.447 -1.261 0 CA-C-N 121.707 1.645 . . . . 1.1599999999999999 109.754 168.683 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 77.0 mtp -59.97 -42.51 94.3 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 118.595 -1.242 . . . . 2.5299999999999998 111.934 -179.501 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.1 pt -58.24 -47.07 88.44 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-N 121.61 2.005 . . . . 2.3900000000000001 111.829 173.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -51.9 -46.44 64.59 Favored 'General case' 0 C--N 1.341 0.201 0 C-N-CA 122.761 0.424 . . . . 1.4199999999999999 111.096 179.31 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -64.19 -60.8 2.77 Favored 'General case' 0 N--CA 1.434 -1.242 0 C-N-CA 123.853 0.861 . . . . 2.9399999999999999 111.84 175.467 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 8.2 m-30 -45.76 -47.39 15.51 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 125.418 1.487 . . . . 3.6299999999999999 110.071 -175.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 74.6 mt -57.75 -39.83 72.56 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 CA-C-N 116.62 -0.264 . . . . 1.1399999999999999 111.311 -178.61 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 21.3 mtm105 -69.82 -46.61 65.27 Favored 'General case' 0 N--CA 1.455 -0.185 0 O-C-N 121.683 -0.636 . . . . 3.6200000000000001 111.362 173.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -54.06 -47.21 71.91 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 122.834 0.453 . . . . 3.2400000000000002 111.24 -179.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.4 pp -90.0 -34.71 15.88 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 112.989 0.737 . . . . 2.8100000000000001 112.989 -176.07 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -123.67 -79.29 0.43 Allowed Glycine 0 C--N 1.34 0.763 0 N-CA-C 114.392 0.517 . . . . 2.29 114.392 -157.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -165.74 165.61 18.42 Favored 'General case' 0 N--CA 1.465 0.291 0 O-C-N 122.12 -0.635 . . . . 4.6299999999999999 110.994 -154.798 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -78.64 66.11 3.35 Favored Glycine 0 C--N 1.337 0.631 0 C-N-CA 124.649 1.118 . . . . 1.95 113.496 -157.408 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -90.02 148.44 23.07 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 124.696 1.198 . . . . 1.0900000000000001 113.151 -164.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.6 t -141.59 145.09 34.63 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 107.552 -1.277 . . . . 2.6699999999999999 107.552 174.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 1.8 t -81.84 130.12 36.35 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 C-N-CA 125.116 1.367 . . . . 1.8799999999999999 107.998 -178.301 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 4.9 pt -148.03 59.83 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.339 0.141 0 C-N-CA 124.564 1.146 . . . . 3.1299999999999999 110.91 -172.34 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -57.65 135.95 56.78 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 116.27 -0.423 . . . . 5.6900000000000004 110.066 176.393 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 178.86 145.06 0.14 Allowed 'General case' 0 N--CA 1.457 -0.093 0 C-N-CA 123.355 0.662 . . . . 5.71 111.979 -174.17 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 38.5 mt 64.31 78.86 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 C-N-CA 125.498 1.519 . . . . 9.3300000000000001 111.288 169.064 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -68.28 -47.95 66.32 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.22 0.608 . . . . 12.970000000000001 110.019 170.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 156.4 -163.31 31.97 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 107.015 -2.434 . . . . 13.26 107.015 -172.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.132 0 N-CA-C 104.573 -2.381 . . . . 19.399999999999999 104.573 171.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 8.1 p30 . . . . . 0 N--CA 1.477 0.892 0 N-CA-C 107.156 -1.424 . . . . 5.0499999999999998 107.156 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.7 p 69.91 142.05 0.05 OUTLIER 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 126.304 1.841 . . . . 2.8599999999999999 112.069 -173.301 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 45.5 m -149.61 157.8 43.58 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 126.565 1.946 . . . . 1.73 107.934 -177.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 33.4 mtmt -103.86 147.43 27.32 Favored 'General case' 0 C--O 1.231 0.081 0 N-CA-C 107.202 -1.407 . . . . 5.3300000000000001 107.202 168.349 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 38.3 t -153.25 150.47 29.0 Favored 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 108.922 -0.77 . . . . 1.7 108.922 172.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -112.34 146.3 38.53 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 125.927 1.691 . . . . 2.23 106.546 -179.064 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.463 HD13 HD11 ' A' ' 61' ' ' ILE . 0.0 OUTLIER -139.24 107.74 3.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 107.509 -1.293 . . . . 2.7599999999999998 107.509 -168.698 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 48.4 tp60 -82.78 123.05 28.96 Favored 'General case' 0 N--CA 1.428 -1.535 0 N-CA-C 106.036 -1.839 . . . . 2.9500000000000002 106.036 -172.547 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 9.9 p -89.38 157.26 3.02 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 C-N-CA 125.322 1.449 . . . . 3.4900000000000002 108.86 -177.232 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.8 t -111.18 21.68 16.07 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 123.115 0.566 . . . . 2.8399999999999999 112.453 176.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -143.35 117.36 1.09 Allowed Glycine 0 N--CA 1.444 -0.798 0 N-CA-C 106.304 -2.719 . . . . 2.3399999999999999 106.304 154.272 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 1.5 ttp -90.16 -61.78 1.61 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 113.445 -1.378 . . . . 4.6500000000000004 108.314 174.03 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 14.1 t -82.38 47.91 1.22 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.544 0.738 . . . . 6.3300000000000001 110.529 -175.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 15.6 p -79.38 -44.0 22.34 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 109.169 -0.678 . . . . 2.8199999999999998 109.169 170.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 143.14 -121.66 0.0 OUTLIER 'General case' 0 C--N 1.34 0.16 0 C-N-CA 130.663 3.585 . . . . 4.0099999999999998 106.244 177.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.2 m -79.41 60.58 3.22 Favored 'General case' 0 N--CA 1.451 -0.394 0 O-C-N 121.493 -0.754 . . . . 3.0 111.261 -175.389 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 4.2 t -48.59 -44.87 37.32 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 125.827 1.651 . . . . 4.6500000000000004 109.116 177.399 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.469 HG13 ' H ' ' A' ' 19' ' ' ALA . 2.5 p -55.3 -61.61 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.816 0 CA-C-N 113.988 -1.46 . . . . 3.3500000000000001 110.627 177.754 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.469 ' H ' HG13 ' A' ' 18' ' ' VAL . . . -54.28 -35.56 62.71 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.406 -1.27 . . . . 1.21 110.644 -178.811 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.458 ' ND2' HD12 ' A' ' 21' ' ' ILE . 0.8 OUTLIER -63.69 -58.64 6.28 Favored 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 109.734 -0.469 . . . . 2.4700000000000002 109.734 170.701 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.554 HG21 HG23 ' A' ' 36' ' ' VAL . 1.2 mp -54.4 -48.36 68.83 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 CA-C-N 119.605 1.093 . . . . 2.27 111.18 -175.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -45.94 -43.08 13.67 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 120.89 -1.131 . . . . 2.9100000000000001 111.168 177.07 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.61 -46.82 58.06 Favored 'General case' 0 CA--C 1.536 0.429 0 O-C-N 121.434 -0.791 . . . . 6.0899999999999999 111.012 168.712 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.565 HD21 HD13 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -55.3 -47.23 75.87 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.808 1.243 . . . . 4.2400000000000002 113.392 -165.745 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.565 HD13 HD21 ' A' ' 24' ' ' ASN 0.382 0.8 OUTLIER -79.04 -23.61 44.18 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 122.11 0.957 . . . . 3.1699999999999999 112.465 -172.413 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . 0.585 53.7 mtp85 -54.14 2.12 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 120.769 3.618 . . . . 5.71 120.769 176.458 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.436 ' CG ' HH11 ' A' ' 27' ' ' ARG . 0.1 OUTLIER -45.85 -32.27 2.53 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 117.308 -1.757 . . . . 9.7699999999999996 111.03 154.046 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 64.34 -155.13 0.3 Allowed 'General case' 0 C--N 1.342 0.27 0 C-N-CA 123.845 0.858 . . . . 7.3600000000000003 108.947 -175.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 58.93 54.25 5.19 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 122.37 1.081 . . . . 6.5 109.062 -179.079 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 152.26 -46.3 0.59 Allowed Glycine 0 C--N 1.335 0.521 0 N-CA-C 110.528 -1.029 . . . . 1.6000000000000001 110.528 -171.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 2.9 mp -81.66 153.73 4.12 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 C-N-CA 124.323 1.049 . . . . 2.5800000000000001 108.781 -171.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -151.58 36.04 0.57 Allowed 'General case' 0 CA--C 1.546 0.824 0 CA-C-O 121.99 0.9 . . . . 3.54 112.616 167.579 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 57.9 m -167.55 161.59 13.82 Favored 'General case' 0 C--N 1.326 -0.444 1 C-N-CA 131.871 4.068 . . . . 2.25 103.069 145.017 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.416 HD12 ' HA ' ' A' ' 34' ' ' ILE . 10.8 tp -139.97 133.64 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 CA-C-N 122.77 2.532 . . . . 4.4500000000000002 110.863 155.379 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.491 ' O ' HG23 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -167.92 -179.08 4.03 Favored 'General case' 0 N--CA 1.44 -0.925 0 CA-C-N 111.73 -2.486 . . . . 6.1200000000000001 108.864 -153.739 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.554 HG23 HG21 ' A' ' 21' ' ' ILE . 2.4 t -159.57 128.44 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.434 -1.253 0 C-N-CA 125.695 1.598 . . . . 1.6799999999999999 107.213 -175.088 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -84.23 63.64 7.83 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 107.905 -1.146 . . . . 0.89000000000000001 107.905 175.007 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -60.31 -31.75 70.56 Favored 'General case' 0 CA--C 1.532 0.25 0 O-C-N 122.043 -0.411 . . . . 2.7000000000000002 111.552 -169.507 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 67.2 mtt -53.6 -36.89 62.44 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.526 0.73 . . . . 3.2599999999999998 111.707 172.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -92.22 7.25 43.48 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.589 1.156 . . . . 2.2999999999999998 111.947 176.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 64.27 38.6 96.11 Favored Glycine 0 CA--C 1.522 0.483 0 C-N-CA 125.473 1.511 . . . . 1.1899999999999999 112.029 174.491 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -162.02 152.43 17.18 Favored 'General case' 0 N--CA 1.442 -0.857 0 N-CA-C 108.075 -1.083 . . . . 4.1799999999999997 108.075 -162.177 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -81.77 157.98 24.3 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 108.928 -0.768 . . . . 1.3200000000000001 108.928 176.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.479 ' HB3' ' CD2' ' A' ' 35' ' ' LEU 0.335 2.2 tm-20 -129.37 157.36 42.13 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 108.612 -0.885 . . . . 4.6299999999999999 108.612 165.581 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 2.0 p -151.97 138.12 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.42 0 N-CA-C 106.476 -1.676 . . . . 1.6200000000000001 106.476 -176.298 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 4.0 mtm180 -104.35 133.01 49.97 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 105.545 -2.02 . . . . 7.1600000000000001 105.545 158.023 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -157.32 167.64 29.69 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 123.716 0.807 . . . . 1.97 108.844 -171.407 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 54.6 t30 -116.79 97.48 50.52 Favored Pre-proline 0 CA--C 1.533 0.312 0 C-N-CA 123.83 0.852 . . . . 3.2999999999999998 110.378 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.3 72.25 2.89 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 123.309 2.672 . . . . 1.8700000000000001 111.538 -178.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -147.56 -56.8 0.24 Allowed 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 106.062 -1.829 . . . . 1.53 106.062 169.293 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 45.6 t -57.52 -54.78 26.58 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 C-N-CA 124.116 0.966 . . . . 1.4199999999999999 109.694 173.191 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.494 HG23 ' H ' ' A' ' 53' ' ' GLN 0.25 10.5 tp -94.2 -75.06 0.42 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.352 0 N-CA-C 112.692 0.627 . . . . 2.0800000000000001 112.692 -164.463 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.494 ' H ' HG23 ' A' ' 52' ' ' ILE . 0.0 OUTLIER 108.45 135.48 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.452 0 C-N-CA 129.845 3.258 . . . . 2.3599999999999999 108.208 -176.58 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -44.22 -51.15 7.05 Favored 'Trans proline' 0 CA--C 1.537 0.663 0 C-N-CA 124.63 3.553 . . . . 1.3100000000000001 114.796 171.021 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -47.19 -56.05 3.39 Favored 'Trans proline' 0 N--CA 1.448 -1.195 0 CA-C-N 121.307 1.502 . . . . 1.1000000000000001 110.929 167.008 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 51.0 mtt -59.51 -36.34 75.89 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 118.029 -1.468 . . . . 1.9099999999999999 113.134 -178.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.425 HD13 HG21 ' A' ' 57' ' ' ILE . 0.5 OUTLIER -62.13 -46.81 95.63 Favored 'Isoleucine or valine' 0 C--N 1.344 0.351 0 CA-C-N 120.675 1.58 . . . . 2.9399999999999999 110.619 173.841 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -53.38 -52.36 59.56 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 121.189 0.519 . . . . 1.3799999999999999 109.978 178.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -56.77 -49.1 76.29 Favored 'General case' 0 N--CA 1.426 -1.652 0 C-N-CA 123.474 0.709 . . . . 3.2599999999999998 111.337 176.55 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . . . . . . . . . 3.9 m-30 -53.81 -33.98 57.75 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-N 119.31 0.959 . . . . 4.1799999999999997 111.39 178.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.463 HD11 HD13 ' A' ' 7' ' ' ILE . 42.0 mt -70.84 -51.35 36.82 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 O-C-N 121.477 -0.764 . . . . 1.3999999999999999 109.292 173.548 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 35.6 mtp-105 -63.85 -27.88 69.47 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 113.54 0.941 . . . . 5.7800000000000002 113.54 -174.396 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -45.93 -55.11 7.18 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 125.058 1.343 . . . . 4.9699999999999998 111.072 177.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -130.27 -19.65 3.11 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 124.453 1.101 . . . . 2.77 113.525 -166.8 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -96.52 -102.67 2.05 Favored Glycine 0 N--CA 1.446 -0.642 0 N-CA-C 109.086 -1.606 . . . . 2.9199999999999999 109.086 -179.03 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 27.9 m-85 -149.53 166.17 30.0 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 122.172 0.987 . . . . 2.8599999999999999 110.936 -154.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -78.94 69.06 2.96 Favored Glycine 0 N--CA 1.443 -0.859 0 CA-C-N 114.53 -1.213 . . . . 1.76 110.551 -178.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -82.64 141.78 32.23 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 113.867 -1.167 . . . . 1.3400000000000001 109.852 -176.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 9.3 t -115.25 139.65 49.77 Favored 'General case' 0 N--CA 1.439 -1.013 0 N-CA-C 106.77 -1.567 . . . . 2.1699999999999999 106.77 178.448 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 21.0 t -83.59 125.9 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.612 0 C-N-CA 125.132 1.373 . . . . 2.0 108.952 -172.385 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 13.7 mm -130.62 59.54 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 C-N-CA 125.254 1.422 . . . . 2.1099999999999999 108.472 -177.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -73.5 -45.38 54.25 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 108.195 -1.039 . . . . 4.8099999999999996 108.195 162.015 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 52.2 t30 47.91 73.0 0.22 Allowed 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.163 1.385 . . . . 5.5 113.611 157.071 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 8.8 tp -151.83 155.71 6.66 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 N-CA-C 107.246 -1.39 . . . . 7.9199999999999999 107.246 175.621 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -149.38 166.76 28.09 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 106.177 -1.786 . . . . 12.42 106.177 177.634 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 94.32 -166.77 27.1 Favored Glycine 0 CA--C 1.528 0.846 0 N-CA-C 110.402 -1.079 . . . . 14.029999999999999 110.402 -174.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 80.5 ttt180 . . . . . 0 C--O 1.249 1.061 0 N-CA-C 104.706 -2.331 . . . . 24.91 104.706 -179.895 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_